FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Assareh, A
   Haybar, H
   Yoosefi, H
   Bozorgmanesh, M
AF Assareh, Ahmadreza
   Haybar, Habib
   Yoosefi, Hojjat
   Bozorgmanesh, Mohammadreza
TI Bedside-Friendly Prediction for Presence of Post-Myocardial lnfarction
   Systolic Dysfunction Using Multimarker Panel: Integrating Salivary
   Diagnostics into Clinical Practice
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Interleukins; Transforming growth factor-beta; Tumor necrosis
   factor-alpha; Saliva; Left ventricular dysfunction
ID CHRONIC HEART-FAILURE; NECROSIS-FACTOR-ALPHA; CORONARY-ARTERY-DISEASE;
   ACUTE MYOCARDIAL-INFARCTION; PRIMARY-CARE; INFLAMMATION; RISK;
   ATHEROSCLEROSIS; MORTALITY; RULE
AB Background and Objectives: We investigated if a combination of plasma or salivary interleukin-2 (IL-2), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), transforming growth factor-beta (TGF-beta), and troponin can improve estimation of the pretest probability of the left ventricular systolic dysfunction (LVSD).
   Subjects and Methods: Eighty patients with newly-diagnosed myocardial infarction (MI) were echocardiographically examined for LVSD (ejection fraction <= 40%). Measurements included traditional MI risk factors, plasma and salivary concentrations of troponin, IL-2, IL-6, TNF-alpha, and TGF-beta. With the LVSD as the outcome variable, we developed logistic regression models, starting with a basic model incorporating traditional risk factors and consecutively adding salivary and plasma biomarkers. Models were compared using several criteria, including (but not limited to) C statistic (discrimination) and net reclassification improvement index (NRI).
   Results: Apart from troponin, plasma, and salivary values of the biomarkers were correlated: spearman's rho was 0.19 (p=0.088) for troponin, 0.36 (p=0.001) for IL-2, 0.74 (p<0.001) for IL-6, 0.61 (p<0.001) for TNF-alpha, and 0.65 (p<0.001) for TGF-beta. The predictive performances of the basic model for estimating the pretest probability of the presence of LVSD considerably improved when cytokines were added (salivary added: C-statistic from 0.77 to 0.82 and NRI 77%; plasma added: C-statistic to 0.80 and NRI 134%).
   Conclusion: Multiple biomarkers added diagnostic value to the standard risk factors for predicting the presence of post-MI LVSD.
C1 [Assareh, Ahmadreza; Haybar, Habib] Ahvaz Jundishapur Univ Med Sci, Cardiovasc Res Ctr, Ahwaz, Iran.
   [Yoosefi, Hojjat] Ahvaz Jundishapur Univ Med Sci, Dept Periodontal, Ahwaz, Iran.
   [Bozorgmanesh, Mohammadreza] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran.
RP Haybar, H (corresponding author), Ahvaz Jundishapur Univ Med Sci, Cardiovasc Res Ctr, Golestan Hosp, Ahwaz, Iran.
EM takamoolsk@yahoo.com
RI Yousefimanesh, Hojatollah/AAB-9400-2020; Heybar, Habib/U-3984-2017;
   assareh, ahmad reza/S-1122-2017
OI Yousefimanesh, Hojatollah/0000-0003-0844-2295; Heybar,
   Habib/0000-0002-9204-8698; assareh, ahmad reza/0000-0003-1982-6438
CR Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4
   [Anonymous], AM J CARDIOL
   Aukrust P, 2005, ANN MED, V37, P74, DOI 10.1080/07853890510007232
   Aukrust P, 2004, AUTOIMMUN REV, V3, P221, DOI 10.1016/S1568-9972(03)00103-4
   Daniels LB, 2010, EUR HEART J, V31, P2980, DOI 10.1093/eurheartj/ehq336
   Fahey T, 2007, FAM PRACT, V24, P628, DOI 10.1093/fampra/cmm055
   Gheorghiade M, 1998, CIRCULATION, V97, P282, DOI 10.1161/01.CIR.97.3.282
   Gheorghiade M, 2006, CIRCULATION, V114, P1202, DOI 10.1161/CIRCULATIONAHA.106.623199
   Halawa B, 1999, Pol Arch Med Wewn, V101, P197
   Hobbs FDR, 2002, HEART, V88, P9
   Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586
   Kim HC, 2010, J AM COLL CARDIOL, V55, P2080, DOI 10.1016/j.jacc.2009.12.047
   Lecour S, 2009, J MOL CELL CARDIOL, V47, P32, DOI 10.1016/j.yjmcc.2009.03.019
   Libby P, 2001, CIRCULATION, V104, P365
   Libby P, 1996, CURR OPIN LIPIDOL, V7, P330, DOI 10.1097/00041433-199610000-00012
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706
   ORAL H, 1995, CLIN CARDIOL, V18, P20
   PASYK S, 1971, AM J PHYSIOL, V220, P646
   PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001
   Rakhit RD, 2005, CORONARY ARTERY DIS, V16, P147, DOI 10.1097/00019501-200505000-00003
   Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149
   Seta Y, 1996, J Card Fail, V2, P243, DOI 10.1016/S1071-9164(96)80047-9
   Slavkin HC, 1998, J AM DENT ASSOC, V129, P1138, DOI 10.14219/jada.archive.1998.0390
   Smith JG, 2010, J AM COLL CARDIOL, V56, P1713, DOI 10.1016/j.jacc.2010.05.049
   Streckfus CF, 2002, ORAL DIS, V8, P69, DOI 10.1034/j.1601-0825.2002.1o834.x
   Sutton MS, 2002, EUR HEART J, V23, P509, DOI 10.1053/euhj.2001.3026
   Timmers L, 2012, CARDIOVASC RES, V94, P276, DOI 10.1093/cvr/cvs018
   Valgimigli M, 2005, CIRCULATION, V111, P863, DOI 10.1161/01.CIR.0000155614.35441.69
   Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064
NR 30
TC 5
Z9 5
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2013
VL 43
IS 4
BP 246
EP 254
DI 10.4070/kcj.2013.43.4.246
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FV
UT WOS:000342385300006
PM 23682284
OA Green Published
DA 2021-04-22
ER

PT J
AU Nah, DY
   Lee, CG
   Bae, JH
   Chung, JW
   Rhee, MY
   Kim, JH
   Kim, YS
   Kim, YK
   Lee, MM
AF Nah, Deuk-Young
   Lee, Chang Geun
   Bae, Jun-Ho
   Chung, Jin-Wook
   Rhee, Moo-Yong
   Kim, Ji-Hyun
   Kim, Yong-Seok
   Kim, Young-Kwon
   Lee, Myoung-Mook
TI Subclinical Renal Insufficiency Range of Estimated Glomerular Filtration
   Rate and Microalbuminuria Are Independently Associated with Increased
   Arterial Stiffness in Never Treated Hypertensives
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Glomerular filtration rate; Renal insufficiency; Arterial stiffness
ID URINARY ALBUMIN EXCRETION; ALL-CAUSE MORTALITY; AORTIC STIFFNESS;
   CARDIOVASCULAR MORTALITY; RISK; DISEASE; AGE; PREDICTOR; EVENTS
AB Background and Objectives: Microalbuminuria (MAU) and decreased estimated glomerular filtration rate (eGFR) are risk factors for cardiovascular disease (CVD) in patients with hypertension. However, in hypertensive patients with normal or minimally reduced eGFR (>= 60 mL/min/1.73 m(2)) and with normo-or MAU, the value of combined estimation of eGFR and urine microalbumin for the risk assessment has not been widely reported. We evaluated the association between arterial stiffness and the combined estimation of eGFR and urine microalbumin.
   Subjects and Methods: Subjects with never treated hypertension and normal or minimally reduced eGFR were evaluated (n=491, 50.1 +/- 10.4 years). eGFR was calculated by the simplified Modification of Diet in Renal Disease formula. Urinary albumin-to-creatinine ratio (UACR) was assessed with spot urine. Arterial stiffness was assessed with heart-femoral pulse wave velocity (hfPWV). All subjects were divided into four groups; group 1, eGFR >= 90 mL/min/1.73 m(2) (normal eGFR) and normo-albuminuria (NAU); group 2, eGFR 89.9-60 mL/min/1.73 m(2) (minimally reduced eGFR) and NAU; group 3, normal eGFR and MAU; group 4, minimally reduced eGFR and MAU.
   Results: Group 1 had the lowest hfPWV (964.6 +/- 145.4; group 2, 1013.5 +/- 168.9; group 3, 1058.2 +/- 238.0; group 4, 1065.8 +/- 162.9 cm/sec). Analysis adjusting age, sex, body mass index, heart rate and mean arterial pressure showed significantly lower hfPWV of group 1 compared to group 2 (p=0.032) and 3 (p=0.007). Multiple regression analysis showed a significant association of hfPWV with logUACR {beta=0.096, 95% confidence interval (CI) 8.974-60.610, p=0.008} and eGFR (beta=-0.069, 95% CI -1.194 - -0.005, p=0.048).
   Conclusion: Minimally reduced eGFR or MAU is independently associated with increased arterial stiffness, indicating greater CVD risk.
C1 [Nah, Deuk-Young; Bae, Jun-Ho; Chung, Jin-Wook] Dongguk Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Lee, Chang Geun; Rhee, Moo-Yong; Kim, Ji-Hyun; Kim, Yong-Seok; Kim, Young-Kwon; Lee, Myoung-Mook] Dongguk Univ, Ilsan Hosp, Ctr Cardiovasc, Dept Internal Med, Goyang 410773, South Korea.
RP Rhee, MY (corresponding author), Dongguk Univ, Ilsan Hosp, Ctr Cardiovasc, Dept Internal Med, 27 Dongguk Ro, Goyang 410773, South Korea.
EM mooyong_rhee@dumc.or.kr
CR Astor BC, 2008, AM J EPIDEMIOL, V167, P1226, DOI 10.1093/aje/kwn033
   AVOLIO AP, 1985, CIRCULATION, V71, P202, DOI 10.1161/01.CIR.71.2.202
   Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135
   Bian SY, 2012, J GERIATR CARDIOL, V9, P158, DOI 10.3724/SP.J.1263.2012.03051
   Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434
   Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031
   CHAUVEAU P, 1993, KIDNEY INT, V43, pS72
   Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939
   Emoto M, 1998, DIABETES CARE, V21, P1178, DOI 10.2337/diacare.21.7.1178
   Hermans MMH, 2007, J AM SOC NEPHROL, V18, P1942, DOI 10.1681/ASN.2006111217
   Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81
   Kawamoto R, 2008, INTERNAL MED, V47, P593, DOI 10.2169/internalmedicine.47.0825
   Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170
   Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48
   Koenig W, 2009, ANN MED, V41, P332, DOI 10.1080/07853890902769675
   Lajemi M, 2001, J HYPERTENS, V19, P407, DOI 10.1097/00004872-200103000-00008
   Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236
   Leoncini G, 2002, J HUM HYPERTENS, V16, P399, DOI 10.1038/sj.jhh.1001408
   Mancia G, 2007, EUR HEART J, V28, P1462, DOI 10.1093/eurheartj/ehm236
   Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5
   Pannier B, 2005, HYPERTENSION, V45, P592, DOI 10.1161/01.HYP.0000159190.71253.c3
   Raymond NT, 2007, NEPHROL DIAL TRANSPL, V22, P3214, DOI 10.1093/ndt/gfm396
   Tomiyama H, 2004, HYPERTENS RES, V27, P465, DOI 10.1291/hypres.27.465
   van der Velde M, 2010, CLIN J AM SOC NEPHRO, V5, P2053, DOI 10.2215/CJN.08851209
   Viazzi F, 2010, J HYPERTENS, V28, P848, DOI 10.1097/HJH.0b013e328336ed09
   이무용, 2008, Korean Circulation Journal, V38, P343
NR 26
TC 9
Z9 12
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2013
VL 43
IS 4
BP 255
EP 260
DI 10.4070/kcj.2013.43.4.255
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FV
UT WOS:000342385300007
PM 23682285
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, DH
   Rha, SW
   Kook, H
   Kim, W
   Lee, SK
   Oh, SK
   Choi, CU
   Oh, DJ
AF Kim, Dong Hyeok
   Rha, Seung-Woon
   Kook, Hyungdon
   Kim, Woohyeun
   Lee, Sun Ki
   Oh, Suk-Kyu
   Choi, Cheol Ung
   Oh, Dong Joo
TI Three-Dimensional Angiography-Guided Percutaneous Transluminal
   Angioplasty for Distal Aorta and Bi-Iliac Chronic Total Occlusion
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Percutaneous transluminal angioplasty; Aorta; abdominal; Occulusion;
   Angiography; Imaging; three-dimensional
ID MANAGEMENT; ARTERIES
AB Percutaneous recanalization of chronic total occlusions (CTOs) in peripheral arteries, especially TASC D classification including the distal aorta and both iliac arteries is still technically challenging. The conventional technique using standard guidewires and catheters guided by computed tomography and angiography can achieve a limited initial success, depending on lesion characteristics and operator's experience. A special imaging technique using 3-dimensional rotational angiography and spatio-temporal reconstruction with endoview for a better examination of the proximal stump, exact obstruction location, and distal stump direction in a stumpless lesion can be indispensable for successful intervention. We report a successful revascularization case of stumpless distal aorta and bi-iliac CTO guided by this specialized imaging technique.
C1 [Kim, Dong Hyeok; Rha, Seung-Woon; Kook, Hyungdon; Kim, Woohyeun; Lee, Sun Ki; Oh, Suk-Kyu; Choi, Cheol Ung; Oh, Dong Joo] Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul 152703, South Korea.
RP Rha, SW (corresponding author), Korea Univ, Guro Hosp, Ctr Cardiovasc, 148 Gurodong Ro, Seoul 152703, South Korea.
EM swrha617@yahoo.co.kr
CR Al-Ameri H, 2009, J INVASIVE CARDIOL, V21, P468
   Dvir D, 2008, CATHETER CARDIO INTE, V71, P784, DOI 10.1002/ccd.21530
   Gallagher KA, 2011, J ENDOVASC THER, V18, P624, DOI 10.1583/11-3539.1
   Kawarada O, 2010, J VASC SURG, V52, P475, DOI 10.1016/j.jvs.2010.03.025
   Kawasaki D, 2008, CATHETER CARDIO INTE, V71, P727, DOI 10.1002/ccd.21503
   Lee JB, 2012, INT J CARDIOVAS IMAG, V28, P1627, DOI 10.1007/s10554-011-9993-0
   Pannu N, 2006, JAMA-J AM MED ASSOC, V295, P2765, DOI 10.1001/jama.295.23.2765
   VANDERHEIJDEN FHWM, 1993, BRIT J SURG, V80, P959, DOI 10.1002/bjs.1800800806
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2013
VL 43
IS 4
BP 261
EP 264
DI 10.4070/kcj.2013.43.4.261
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FV
UT WOS:000342385300008
PM 23682286
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, JW
   Nah, DY
   Bae, JH
AF Chung, Jin Wook
   Nah, Deuk Young
   Bae, Jun Ho
TI Percutaneous Transluminal Angioplasty of Contralateral Iliac and
   Superficial Femoral Arteries via Graft Vessel in a Patient with
   FemoroFemoral Bypass Graft
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Peripheral artery disease; Percutaneous transluminal angioplasty;
   Femoral artery; Bypass grafting
ID OCTOGENARIANS; DISEASE
AB Peripheral arterial disease represents a significant problem, particularly among the elderly population. There has been great progress made in the treatment of peripheral arterial disease in recent years. Percutaneous transluminal angioplasty (PTA) has been employed as a method of treatment for patients with a variety of peripheral arterial disease. We report our experience with PTA of contralateral common iliac and superficial femoral arteries via graft vessel in a patient with femorofemoral bypass due to ipsilateral iliac artery occlusion.
C1 [Chung, Jin Wook; Nah, Deuk Young; Bae, Jun Ho] Dongguk Univ, Gyeongju Hosp, Dept Cardiol, Coll Med, Gyeongju 780350, South Korea.
RP Nah, DY (corresponding author), Dongguk Univ, Gyeongju Hosp, Dept Cardiol, Coll Med, 87 Dongdae Ro, Gyeongju 780350, South Korea.
EM ptca@dongguk.ac.kr
CR Brosi P, 2007, J VASC SURG, V46, P1198, DOI 10.1016/j.jvs.2007.07.047
   Chang JB, 2001, J VASC SURG, V34, P133, DOI 10.1067/mva.2001.113979
   Gallagher MJ, 2005, AM J CARDIOL, V96, P382, DOI 10.1016/j.amjcard.2005.03.081
   Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009
   Narins CR, 2009, CARDIOL J, V16, P88
   Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI [10.1016/j.ejvs.2006.09.024, 10.1016/j.jvs.2006.12.037]
   Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0
NR 7
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2013
VL 43
IS 4
BP 265
EP 268
DI 10.4070/kcj.2013.43.4.265
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FV
UT WOS:000342385300009
PM 23682287
OA Green Published
DA 2021-04-22
ER

PT J
AU Kook, H
   Rha, SW
   Kim, W
   Kim, DH
   Lee, S
   Oh, SK
   Ahn, TH
   Shim, WH
AF Kook, Hyungdon
   Rha, Seung-Woon
   Kim, Woohyeun
   Kim, Dong Hyeok
   Lee, Sunki
   Oh, Suk-Kyu
   Ahn, Tae Hoon
   Shim, Won Heum
TI A Case of Successful Bare Metal Stenting for Aortic Coarctation in an
   Adult
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic coarctation; Stents; Angioplasty
ID CONGENITAL HEART-DISEASE; THORACIC AORTA; IMPLANTATION; MANAGEMENT;
   SURGEONS
AB Aortic coarctation is a correctable hypertensive disease. For safety reasons and due to the invasiveness of surgical techniques, percutaneous interventions have become drastically more popular in recent times. In elderly patients with aortic coarctation who are at risk of an aortic wall aneurysm and rupture, covered stents are preferred but in younger patients, bare metal stenting may be sufficient for long-term safety. Herein we present a 47-year-old typical aortic coarctation patient who was successfully treated with a bare metal stent.
C1 [Kook, Hyungdon; Rha, Seung-Woon; Kim, Woohyeun; Kim, Dong Hyeok; Lee, Sunki; Oh, Suk-Kyu] Korea Univ, Guro Hosp, Dept Internal Med, Ctr Cardiovasc, Seoul 152703, South Korea.
   [Ahn, Tae Hoon] Gachon Univ, Gil Hosp, Dept Internal Med, Inchon, South Korea.
   [Shim, Won Heum] Sejong Gen Hosp, Dept Internal Med, Puchon, South Korea.
RP Rha, SW (corresponding author), Korea Univ, Guro Hosp, Dept Internal Med, Ctr Cardiovasc, 148 Gurodong Ro, Seoul 152703, South Korea.
EM swrha617@yahoo.co.kr
CR Brickner ME, 2000, NEW ENGL J MED, V342, P256, DOI 10.1056/NEJM200001273420407
   Butera G, 2007, AM HEART J, V154, P795, DOI 10.1016/j.ahj.2007.06.018
   Butera G, 2012, EXPERT REV MED DEVIC, V9, P123, DOI [10.1586/ERD.12.2, 10.1586/erd.12.2]
   Carr JA, 2006, J AM COLL CARDIOL, V47, P1101, DOI 10.1016/j.jacc.2005.10.063
   Cevik S, 2004, TEX HEART I J, V31, P429
   Forbes TJ, 2007, CATHETER CARDIO INTE, V70, P276, DOI 10.1002/ccd.21164
   Godart F, 2011, ARCH CARDIOVASC DIS, V104, P627, DOI 10.1016/j.acvd.2011.08.005
   Grech V, 1999, INT J CARDIOL, V68, P197, DOI 10.1016/S0167-5273(98)00352-0
   Keith DS, 2002, J VASC SURG, V35, P166, DOI 10.1067/mva.2002.118807
   Kenny D, 2011, CARDIOL J, V18, P487, DOI 10.5603/CJ.2011.0003
   Mullen MJ, 2003, HEART, V89, P3, DOI 10.1136/heart.89.1.3
   Orend KH, 2007, EUR J VASC ENDOVASC, V34, P666, DOI 10.1016/j.ejvs.2007.06.022
   Rehders TC, 2004, J ENDOVASC THER, V11, P659, DOI 10.1583/04-1311R.1
   Tanous D, 2009, CURR OPIN CARDIOL, V24, P509, DOI 10.1097/HCO.0b013e328330cc22
   Teixeira Ana M, 2005, Rev Port Cardiol, V24, P1559
   Tzifa A, 2006, J AM COLL CARDIOL, V47, P1457, DOI 10.1016/j.jacc.2005.11.061
   Warnes CA, 2008, CIRCULATION, V118, pE714, DOI 10.1161/CIRCULATIONAHA.108.190690
NR 17
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2013
VL 43
IS 4
BP 269
EP 272
DI 10.4070/kcj.2013.43.4.269
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FV
UT WOS:000342385300010
PM 23682288
OA Green Published
DA 2021-04-22
ER

PT J
AU Heo, YH
   Kim, SJ
   Lee, SY
   Baek, JS
AF Heo, Young Hee
   Kim, Soo-Jin
   Lee, Sang Yun
   Baek, Jae Suk
TI A Case Demonstrating a Percutaneous Closure Using the Amplatzer Duct
   Occluder for Paravalvular Leakage after Tricuspid Valve Replacement
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Tricuspid regurgitation; Cardiac valve prosthesis; Amplatzer occluder
ID MITRAL-VALVE; PERIPROSTHETIC LEAKAGE; REGURGITATION; REOPERATION
AB There has been a dramatic increase in the number and type of procedures performed in the field of cardiac intervention in the past decade. Percutaneous intervention is becoming an increasingly recognized modality for the management of prosthetic paravalvular leakages (PVLs) in severely symptomatic non-surgical candidates. Herein, we report our experience of percutaneous closure using the Amplatzer duct occluder for a PVL in a patient who underwent tricuspid valve replacement.
C1 [Heo, Young Hee] Kyung Hee Univ, Sch Med, Dept Pediat, Seoul, South Korea.
   [Kim, Soo-Jin] Konkuk Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Seoul 143729, South Korea.
   [Lee, Sang Yun; Baek, Jae Suk] Sejong Gen Hosp, Dept Pediat, Puchon, South Korea.
RP Kim, SJ (corresponding author), Konkuk Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, 120-1 Neungdong Ro, Seoul 143729, South Korea.
EM ksoojn@yahoo.co.kr
RI Kim, Soo-Jin/P-2677-2014
OI Kim, Soo-Jin/0000-0001-9671-6019
CR Bhindi R, 2008, NAT CLIN PRACT CARD, V5, P140, DOI 10.1038/ncpcardio1112
   Davila-Roman VG, 2004, J AM COLL CARDIOL, V44, P1467, DOI 10.1016/j.jacc.2003.12.060
   DHASMANA JP, 1983, ANN THORAC SURG, V35, P170, DOI 10.1016/S0003-4975(10)61456-7
   ECHEVARRIA JR, 1991, EUR J CARDIO-THORAC, V5, P523, DOI 10.1016/1010-7940(91)90105-S
   Fanning JP, 2012, HEART LUNG CIRC, V21, P174, DOI 10.1016/j.hlc.2011.09.008
   Hein Ralph, 2006, EuroIntervention, V2, P318
   HOURIHAN M, 1992, J AM COLL CARDIOL, V20, P1371, DOI 10.1016/0735-1097(92)90250-Q
   KING TD, 1976, JAMA-J AM MED ASSOC, V235, P2506, DOI 10.1001/jama.235.23.2506
   Kort HW, 2004, CATHETER CARDIO INTE, V61, P548, DOI 10.1002/ccd.10785
   Lasorda DM, 2008, J INTERV CARDIOL, V21, P190, DOI 10.1111/j.1540-8183.2007.00343.x
   Moscucci M, 2001, CIRCULATION, V104, pE85, DOI 10.1161/hc4101.096829
   ORSZULAK TA, 1983, ANN THORAC SURG, V35, P584, DOI 10.1016/S0003-4975(10)61067-3
   Pate GE, 2006, CATHETER CARDIO INTE, V67, P158, DOI 10.1002/ccd.20560
   Piechaud Jean-Francois, 2003, J Interv Cardiol, V16, P153, DOI 10.1046/j.1540-8183.2003.08028.x
   Rallidis LS, 1999, AM HEART J, V138, P351, DOI 10.1016/S0002-8703(99)70124-9
   RASHKIND WJ, 1987, CIRCULATION, V75, P583, DOI 10.1161/01.CIR.75.3.583
   Sorajja P, 2007, CATHETER CARDIO INTE, V70, P815, DOI 10.1002/ccd.21270
NR 17
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2013
VL 43
IS 4
BP 273
EP 276
DI 10.4070/kcj.2013.43.4.273
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FV
UT WOS:000342385300011
PM 23682289
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, TK
   Yang, JH
   Yoo, H
   Ahn, J
   Jeon, J
   Song, YB
   Gwon, HC
AF Park, Taek Kyu
   Yang, Jeong Hoon
   Yoo, Hongseok
   Ahn, Joonseong
   Jeon, Jaryong
   Song, Young Bin
   Gwon, Hyeon-Cheol
TI A Retrograde Approach to Coronary Ostial Stenosis after a Bentall
   Procedure in a Patient with Behcet's Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Behcet disease; Percutaneous coronary intervention; Coronary occlusion
ID CHRONIC TOTAL OCCLUSIONS; RECANALIZATION; ARTERIES
AB We describe a case of chronic total occlusion of the right coronary artery ostium 5 months after a repeated Bentall procedure in a patient with Behcet's disease. In this patient, an antegrade approach to delivering the guidewire during percutaneous coronary intervention was not successful. Coronary angiography revealed the existence of collateral blood supply from the left coronary artery. Using a retrograde approach, a guidewire was successfully advanced from the distal left circumflex artery through the collateral vessel and into the posterolateral branch of the right coronary artery. After the guidewire crossed over the occluded right coronary artery ostium and was snared into the ascending aorta, antegrade access for balloon and stent delivery succeeded.
C1 [Park, Taek Kyu; Yang, Jeong Hoon; Yoo, Hongseok; Ahn, Joonseong; Jeon, Jaryong; Song, Young Bin; Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Cardiac & Vasc Ctr, Seoul 135710, South Korea.
RP Gwon, HC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Cardiac & Vasc Ctr, 50 Irwon Dong, Seoul 135710, South Korea.
EM hcgwon@skku.edu
RI Yoo, Hongseok/AAZ-8139-2020
OI Yoo, Hongseok/0000-0002-2227-6441
CR Balbi M, 2004, CATHETER CARDIO INTE, V62, P343, DOI 10.1002/ccd.20115
   Galassi AR, 2010, INT J CARDIOL, V142, P304, DOI 10.1016/j.ijcard.2008.12.033
   Gurgun C, 2002, JPN HEART J, V43, P389, DOI 10.1536/jhj.43.389
   Huang Xiao-ming, 2010, Zhonghua Yi Xue Za Zhi, V90, P2357
   Joyal D, 2012, JACC-CARDIOVASC INTE, V5, P1, DOI 10.1016/j.jcin.2011.10.011
   Joyal D, 2010, AM HEART J, V160, P179, DOI 10.1016/j.ahj.2010.04.015
   Marino M, 2010, CARDIOVASC REVASCULA, V11, DOI 10.1016/j.carrev.2009.07.003
   Nonoyama M, 1997, Kyobu Geka, V50, P569
   Rathore S, 2010, JACC-CARDIOVASC INTE, V3, P155, DOI 10.1016/j.jcin.2009.10.030
   Rathore S, 2009, CIRC-CARDIOVASC INTE, V2, P124, DOI 10.1161/CIRCINTERVENTIONS.108.838862
   Terasawa A, 2010, J CARDIOL, V55, P147, DOI 10.1016/j.jjcc.2009.04.013
   Tsukui H, 2001, ANN THORAC SURG, V72, P1733, DOI 10.1016/S0003-4975(01)02566-8
   Worthley Matthew I, 2005, J Invasive Cardiol, V17, P680
NR 13
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2013
VL 43
IS 4
BP 277
EP 280
DI 10.4070/kcj.2013.43.4.277
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FV
UT WOS:000342385300012
PM 23682290
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahn, DS
   Chung, JH
   Kim, YN
   Oh, YS
   Lim, DS
   Choi, RK
AF Ahn, Dae Sung
   Chung, Jae Hoon
   Kim, Yu Na
   Oh, Young Soo
   Lim, Dal Soo
   Choi, Rak Kyeong
TI Right Coronary Artery to Left Ventricular Fistula Associated with
   Infective Endocarditis of the Mitral Valve
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Endocarditis; bacterial; Fistula; Coronary vessel anomalies
ID ARTERIOVENOUS-FISTULA; MANAGEMENT
AB A 27-year-old man with bacterial endocarditis of the mitral valve and embolic episodes was bound to have a large right coronary artery fistula communicating with the left ventricle, immediately inferior to the posterior mitral annulus. The perforation of the posterior leaflet and coronary arteriovenous fistula was identified using two-dimensional Doppler echocardiography. The diagnosis was confirmed by coronary angiography, and the patient underwent a successful operation.
C1 [Choi, Rak Kyeong] Sejong Gen Hosp, Dept Internal Med, Div Cardiol, Puchon 422711, South Korea.
   Sejong Gen Hosp, Sejong Med Res Inst, Puchon 422711, South Korea.
RP Choi, RK (corresponding author), Sejong Gen Hosp, Dept Internal Med, Div Cardiol, 28 Hohyeon Ro 489beon Gil, Puchon 422711, South Korea.
EM yoorimbin@sejongh.co.kr
CR EDWARDS JE, 1972, CIRCULATION, V46, P623, DOI 10.1161/01.CIR.46.3.623
   KIMBALL TR, 1989, AM HEART J, V117, P968, DOI 10.1016/0002-8703(89)90639-X
   Lee CW, 2012, KOREAN CIRC J, V42, P69, DOI 10.4070/kcj.2012.42.1.69
   LIBERTHSON RR, 1979, CIRCULATION, V59, P849, DOI 10.1161/01.CIR.59.5.849
   MIYATAKE K, 1984, BRIT HEART J, V51, P508
   RITTENHOUSE EA, 1975, ANN THORAC SURG, V20, P468, DOI 10.1016/S0003-4975(10)64245-2
NR 6
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2013
VL 43
IS 4
BP 281
EP 283
DI 10.4070/kcj.2013.43.4.281
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FV
UT WOS:000342385300013
PM 23682291
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, SJ
   Park, JK
   Oh, S
   Jeon, DW
   Yang, JY
   Choi, YS
   Youn, HJ
AF Yoon, Se-Jung
   Park, Jong-Kwan
   Oh, Seungjin
   Jeon, Dong Woon
   Yang, Joo Young
   Choi, Yoon-Suk
   Youn, Ho-Joong
TI Various Expressions of Coronary Doppler Patterns of Myocardial Bridging
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID FLOW; ANGIOGRAPHY
C1 [Yoon, Se-Jung; Park, Jong-Kwan; Oh, Seungjin; Jeon, Dong Woon; Yang, Joo Young; Choi, Yoon-Suk] Natl Hlth Insurance Corp, Ilsan Hosp, Div Cardiol, Goyang, South Korea.
   [Youn, Ho-Joong] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, Seoul 137701, South Korea.
RP Youn, HJ (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Cardiol,Dept Internal Med, 222 Banpo Daero, Seoul 137701, South Korea.
EM younhj@catholic.ac.kr
OI Park, Jong Kwan/0000-0002-5506-1412
CR Inaba S, 2011, EUR J ECHOCARDIOGR, V12, DOI 10.1093/ejechocard/jeq159
   Kneale BJ, 1996, HEART, V76, P374, DOI 10.1136/hrt.76.4.374
   Schwarz ER, 1997, EUR HEART J, V18, P434
   Tio RA, 1997, HEART, V77, P280, DOI 10.1136/hrt.77.3.280
   Youn Ho-Joong, 2003, Korean Circulation Journal, V33, P259
NR 5
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2013
VL 43
IS 4
BP 284
EP 285
DI 10.4070/kcj.2013.43.4.284
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FV
UT WOS:000342385300014
PM 23682292
OA Green Published
DA 2021-04-22
ER

PT J
AU Song, YH
AF Song, Young-Hwan
TI A Memory Molecule, Ca2+/Calmodulin-Dependent Protein Kinase II and Redox
   Stress; Key Factors for Arrhythmias in a Diseased Heart
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Calcium-calmodulin-dependent protein kinase type 2; Oxidative stress;
   Arrhythmias cardiac; Heart failure
ID LATE SODIUM CURRENT; CA2+ CURRENT; OXIDATIVE STRESS; VENTRICULAR
   MYOCYTES; CARDIAC DYSFUNCTION; ATRIAL-FIBRILLATION; HYDROGEN-PEROXIDE;
   ANGIOTENSIN-II; BETA-SUBUNIT; CAMKII
AB Arrhythmias can develop in various cardiac diseases, such as ischemic heart disease, cardiomyopathy and congenital heart disease. It can also contribute to the aggravation of heart failure and sudden cardiac death. Redox stress and Ca2+ overload are thought to be the important triggering factors in the generation of arrhythmias in failing myocardium. From recent studies, it appears evident that Ca2+/calmodulin-dependent protein kinase II (CaMKII) plays a central role in the arrhythmogenic processes in heart failure by sensing intracellular Ca2+ and redox stress, affecting individual ion channels and thereby leading to electrical instability in the heart. CaMKII, a multifunctional serine/threonine kinase, is an abundant molecule in the neuron and the heart. It has a specific property as "a memory molecule" such that the binding of calcified calmodulin (Ca2+/CaM) to the regulatory domain on CaMKII initially activates this enzyme. Further, it allows autophosphorylation of T287 or oxidation of M281/282 in the regulatory domain, resulting in sustained activation of CaMKII even after the dissociation of Ca2+/CaM. This review provides the understanding of both the structural and functional properties of CaMKII, the experimental findings of the interactions between CaMKII, redox stress and individual ion channels, and the evidences proving the potential participation of CaMKII and oxidative stress in the diverse arrhythmogenic processes in a diseased heart.
C1 Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Pediat, Seoul 139707, South Korea.
RP Song, YH (corresponding author), Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Pediat, 1342 Dongil Ro, Seoul 139707, South Korea.
EM yyyyysong@paik.ac.kr
CR Ai X, 2005, CIRC RES, V97, P1314, DOI 10.1161/01.RES.0000194329.41863.89
   Aiba T, 2010, CARDIOVASC RES, V85, P454, DOI 10.1093/cvr/cvp324
   Anderson ME, 2005, PHARMACOL THERAPEUT, V106, P39, DOI 10.1016/j.pharmthera.2004.11.002
   ANDERSON ME, 1994, CIRC RES, V75, P854, DOI 10.1161/01.RES.75.5.854
   Belevych AE, 2009, CARDIOVASC RES, V84, P387, DOI 10.1093/cvr/cvp246
   BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0
   Bers DM, 2009, J CARDIOVASC PHARM, V54, P180, DOI 10.1097/FJC.0b013e3181a25078
   Boron WF, 2005, MED PHYSL CELLULAR M, P1319
   Chelu MG, 2009, J CLIN INVEST, V119, P1940, DOI 10.1172/JCI37059
   Cingolani HE, 2006, HYPERTENSION, V47, P727, DOI 10.1161/01.HYP.0000208302.62399.68
   Dudley SC, 2005, CIRCULATION, V112, P1266, DOI 10.1161/CIRCULATIONAHA.105.538108
   ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201
   El-Haou S, 2009, CIRC RES, V104, P758, DOI 10.1161/CIRCRESAHA.108.191007
   Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048
   Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010
   GOLDHABER JI, 1994, J PHYSIOL-LONDON, V477, P135, DOI 10.1113/jphysiol.1994.sp020178
   Gradman AH, 2009, AM HEART J, V157, pS1, DOI 10.1016/j.ahj.2009.04.005
   Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006
   Guo JQ, 2000, AM J PHYSIOL-HEART C, V279, pH992
   Hashambhoy YL, 2009, BIOPHYS J, V96, P1770, DOI 10.1016/j.bpj.2008.11.055
   House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810
   Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228
   Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621
   Kassmann M, 2008, PFLUG ARCH EUR J PHY, V456, P1085, DOI 10.1007/s00424-008-0477-6
   Khoo MSC, 2006, CIRCULATION, V114, P1352, DOI 10.1161/CIRCULATIONAHA.106.644583
   Kim YM, 2005, CIRC RES, V97, P629, DOI 10.1161/01.RES.0000183735.09871.61
   Koval OM, 2010, P NATL ACAD SCI USA, V107, P4996, DOI 10.1073/pnas.0913760107
   KRANIAS EG, 1988, MOL CELL BIOCHEM, V82, P37
   KRELL MJ, 1986, AM HEART J, V112, P787, DOI 10.1016/0002-8703(86)90475-8
   Li JD, 2007, CHANNELS, V1, P387, DOI 10.4161/chan.5449
   Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753
   LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055
   Lo LW, 2007, EUR J PHARMACOL, V571, P197, DOI 10.1016/j.ejphar.2007.05.066
   Maltsev VA, 2008, AM J PHYSIOL-HEART C, V294, pH1597, DOI 10.1152/ajpheart.00484.2007
   Maltsev VA, 2007, EUR J HEART FAIL, V9, P219, DOI 10.1016/j.ejheart.2006.08.007
   Mangmool S, 2010, J CELL BIOL, V189, P573, DOI 10.1083/jcb.200911047
   Mattiazzi A, 2011, HEART RHYTHM, V8, P784, DOI 10.1016/j.hrthm.2010.11.035
   Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1
   Picht E, 2007, J MOL CELL CARDIOL, V42, P196, DOI 10.1016/j.yjmcc.2006.09.007
   Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426
   Rigg L, 2003, CARDIOVASC RES, V57, P497, DOI 10.1016/S0008-6363(02)00668-5
   Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029
   SATOH N, 1995, EUR J PHARM-ENVIRON, V292, P233, DOI 10.1016/0926-6917(95)90027-6
   Smyth JW, 2010, J CLIN INVEST, V120, P266, DOI 10.1172/JCI39740
   Song Y, 2006, J PHARMACOL EXP THER, V318, P214, DOI 10.1124/jpet.106.101832
   Song YH, 2011, FREE RADICAL BIO MED, V51, P1708, DOI 10.1016/j.freeradbiomed.2011.07.022
   Song YH, 2010, J MOL CELL CARDIOL, V48, P773, DOI 10.1016/j.yjmcc.2009.10.020
   Su Z, 2007, BIOCHEM PHARMACOL, V74, P702, DOI 10.1016/j.bcp.2007.06.002
   Swaminathan PD, 2011, J CLIN INVEST, V121, P3277, DOI 10.1172/JCI57833
   Talukder MAH, 1997, N-S ARCH PHARMACOL, V355, P87
   Tang XD, 2001, J GEN PHYSIOL, V117, P253, DOI 10.1085/jgp.117.3.253
   Tessier S, 1999, CIRC RES, V85, P810, DOI 10.1161/01.RES.85.9.810
   Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857
   Tomaselli GF, 2010, NAT MED, V16, P648, DOI 10.1038/nm0610-648
   Wagner M, 2008, PFLUG ARCH EUR J PHY, V457, P339, DOI 10.1007/s00424-008-0518-1
   Wagner S, 2006, J CLIN INVEST, V116, P3127, DOI 10.1172/JCI26620
   Wagner S, 2009, CIRC-ARRHYTHMIA ELEC, V2, P285, DOI 10.1161/CIRCEP.108.842799
   Wang W, 2004, CIRC RES, V95, P798, DOI 10.1161/01.RES.0000145361.50017.aa
   Wehrens XHT, 2004, CIRC RES, V94, pE61, DOI 10.1161/01.RES.0000125626.33738.E2
   WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983
   Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7
   Wu YJ, 2009, P NATL ACAD SCI USA, V106, P5972, DOI 10.1073/pnas.0806422106
   XIAO RP, 1994, P NATL ACAD SCI USA, V91, P9659, DOI 10.1073/pnas.91.20.9659
   Xie LH, 2009, CIRC RES, V104, P79, DOI 10.1161/CIRCRESAHA.108.183475
   YUAN WL, 1994, AM J PHYSIOL, V267, pH982
   Yue LX, 1999, CIRC RES, V84, P776
   Zeng QH, 2008, J PHARMACOL EXP THER, V326, P732, DOI 10.1124/jpet.108.140301
   Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215
   Zhang T, 2010, CIRC RES, V106, P354, DOI 10.1161/CIRCRESAHA.109.207423
NR 69
TC 7
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 145
EP 151
DI 10.4070/kcj.2013.43.3.145
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100001
PM 23613689
OA Green Published
DA 2021-04-22
ER

PT J
AU Hong, YJ
AF Hong, Young Joon
TI Usefulness of Coronary Computed Tomography Angiography Evaluating the
   Clinical Importance of Coronary Artery Calcium and Noncalcified Plaque
   in Asymptomatic Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID RISK-FACTORS; DISEASE; SCORE
C1 Chonnam Natl Univ Hosp, Dept Internal Med, Div Cardiol, Kwangju 501757, South Korea.
RP Hong, YJ (corresponding author), Chonnam Natl Univ Hosp, Dept Internal Med, Div Cardiol, 42 Jaebong Ro, Kwangju 501757, South Korea.
EM hyj200@hanmail.net
CR Achenbach S, 2004, CIRCULATION, V109, P14, DOI 10.1161/01.CIR.0000111517.69230.0F
   Aggarwal NR, 2011, CATHETER CARDIO INTE, V78, P1116, DOI 10.1002/ccd.23138
   Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088
   Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458
   Cheng VY, 2007, AM J CARDIOL, V99, P1183, DOI 10.1016/j.amjcard.2006.12.026
   Cho I, 2013, KOREAN CIRC J, V43, P154, DOI 10.4070/kcj.2013.43.3.154
   Fujii K, 2003, CIRCULATION, V108, P2473, DOI 10.1161/01.CIR.0000097121.95451.39
   Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210
   Tuzcu EM, 2001, CIRCULATION, V103, P2705
   Yoo DH, 2011, INT J CARDIOVAS IMAG, V27, P27, DOI 10.1007/s10554-011-9968-1
NR 10
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 152
EP 153
DI 10.4070/kcj.2013.43.3.152
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100002
PM 23613690
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, I
   Suh, JW
   Chang, HJ
   Kim, KI
   Jeon, EJ
   Choi, SI
   Cho, YS
   Youn, TJ
   Chae, IH
   Kim, CH
   Choi, DJ
AF Cho, Iksung
   Suh, Jung-won
   Chang, Hyuk-Jae
   Kim, Kwang-Il
   Jeon, Eun Ju
   Choi, Sang Il
   Cho, Young-Seok
   Youn, Tae-Jin
   Chae, In-Ho
   Kim, Cheol-Ho
   Choi, Dong-Ju
TI Prevalence and Prognostic Implication of Non-Calcified Plaque in
   Asymptomatic Population with Coronary Artery Calcium Score of Zero
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary; Atherosclerotic plaque; Calcium; Computed tomography
ID COMPUTED TOMOGRAPHIC ANGIOGRAPHY; EXPERT CONSENSUS DOCUMENT;
   NORTH-AMERICAN-SOCIETY; ALL-CAUSE MORTALITY; CHEST-PAIN; TASK-FORCE;
   CARDIOVASCULAR-ANGIOGRAPHY; DIAGNOSTIC PERFORMANCE; NUCLEAR-CARDIOLOGY;
   HEART-ASSOCIATION
AB Background and Objectives: Non-calcified plaque (NCP) identified by coronary CT angiography (CCTA) has been reported in up to 10% of individuals with coronary artery calcium score (CACS) of zero. However, clinical risk factors and the prognostic value of NCP in asymptomatic subjects with CACS of zero are unknown.
   Subjects and Methods: The study population consisted of consecutive asymptomatic subjects (48 +/- 8 years, 57% men) who underwent CCTA from December 2005 to January 2008 as part of a general health evaluation.
   Results: Among 4491 of overall asymptomatic individuals with CACS of zero, 313 subjects (7%) had NCP: 279 patients (6%) with non-obstructive and 34 (1%) with obstructive. In multivariable analyses, age, male gender, diabetes, hypertension, and dyslipidemia were significantly associated with presence of NCP (all p<0.05). During the median follow-up duration of 22 months (interquartile percentile: 18 to 28 months) of subjects with NCP (n=313) and age, gender, and CCTA date matched individuals without NCP (n=313), there was no clinical event including all-cause death nor composite outcome of cardiac death, myocardial infarct, unstable angina requiring hospitalization, and revascularization after 90 days from index CCTA in both groups.
   Conclusion: In the largest series of asymptomatic individuals with CACS of zero undergoing CCTA, age, male gender, diabetes, hypertension, and dyslipidemia were independently associated with NCP. However, a future risk of exclusive NCP in asymptomatic subjects with CACS of zero was negligible.
C1 [Cho, Iksung; Suh, Jung-won; Kim, Kwang-Il; Cho, Young-Seok; Youn, Tae-Jin; Chae, In-Ho; Kim, Cheol-Ho; Choi, Dong-Ju] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam 463707, South Korea.
   [Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Jeon, Eun Ju; Choi, Sang Il] Seoul Natl Univ, Bundang Hosp, Div Radiol, Songnam 463707, South Korea.
RP Suh, JW (corresponding author), Seoul Natl Univ, Bundang Hosp, Ctr Cardiovasc, Dept Internal Med,Coll Med, 82 Gumi Ro 173beon Gil, Songnam 463707, South Korea.
EM suhjw1@gmail.com
RI Kim, Kwang-il/D-8024-2012
OI Kim, Kwang-il/0000-0002-6658-047X; Chang, Hyuk-Jae/0000-0002-6139-7545
FU Korean Society of Cardiology
FX This study was supported by grant from the Korean Society of Cardiology
   in 2008.
CR Achenbach S, 2010, EUR HEART J, V31, P1442, DOI 10.1093/eurheartj/ehq150
   AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T
   Akram K, 2009, ATHEROSCLEROSIS, V203, P533, DOI 10.1016/j.atherosclerosis.2008.07.008
   Bodi V, 2012, RADIOLOGY, V262, P91, DOI 10.1148/radiol.11110134
   Budoff MJ, 2008, J AM COLL CARDIOL, V52, P1724, DOI 10.1016/j.jacc.2008.07.031
   Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079
   Cheng VY, 2007, AM J CARDIOL, V99, P1183, DOI 10.1016/j.amjcard.2006.12.026
   Cho I, 2012, CIRCULATION, V126, P304, DOI 10.1161/CIRCULATIONAHA.111.081380
   Choi EK, 2008, J AM COLL CARDIOL, V52, P357, DOI 10.1016/j.jacc.2008.02.086
   Cury RC, 2005, AM J CARDIOL, V96, P784, DOI 10.1016/j.amjcard.2005.05.020
   Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100
   Ergun E, 2011, INT J CARDIOVAS IMAG, V27, P451, DOI 10.1007/s10554-010-9681-5
   Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210
   Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425
   Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Hadamitzky M, 2009, JACC-CARDIOVASC IMAG, V2, P404, DOI 10.1016/j.jcmg.2008.11.015
   Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003
   Kelle S, 2011, JACC-CARDIOVASC IMAG, V4, P161, DOI 10.1016/j.jcmg.2010.11.012
   Mark DB, 2010, CIRCULATION, V121, P2509, DOI 10.1161/CIR.0b013e3181d4b618
   Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058
   Miller JM, 2008, NEW ENGL J MED, V359, P2324, DOI 10.1056/NEJMoa0806576
   Raggi P, 2008, J AM COLL CARDIOL, V52, P17, DOI 10.1016/j.jacc.2008.04.004
   Rubinshtein R, 2007, AM J CARDIOL, V99, P472, DOI 10.1016/j.amjcard.2006.08.060
   Shmilovich H, 2011, ATHEROSCLEROSIS, V219, P588, DOI 10.1016/j.atherosclerosis.2011.07.128
   Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005
NR 26
TC 10
Z9 10
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 154
EP 160
DI 10.4070/kcj.2013.43.3.154
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100003
PM 23613691
OA Green Published
DA 2021-04-22
ER

PT J
AU Yun, KH
   Ko, JS
   Rhee, SJ
   Lee, EM
   Yoo, NJ
   Kim, NH
   Oh, SK
   Jeong, JW
AF Yun, Kyeong Ho
   Ko, Jum Suk
   Rhee, Sang Jae
   Lee, Eun Mi
   Yoo, Nam Jin
   Kim, Nam-Ho
   Oh, Seok Kyu
   Jeong, Jin-Won
TI Long-Term Predictors of Clinical Events after Off-Label Use of
   Drug-Eluting Stent beyond 1 Year
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Drug-eluting stents; Angioplasty; Coronary thrombosis; Treatment outcome
ID SIROLIMUS; OUTCOMES; TRIAL; MULTICENTER; THROMBOSIS; THERAPIES;
   EFFICACY; INSIGHTS
AB Background and Objectives: We evaluated the long-term outcomes and predictors of clinical events after off-label use of drug-eluting stents (DES) beyond 1 year after procedure.
   Subjects and Methods: A total of 518 patients who underwent DES implantation for off-label indications and did not have any major adverse cardiac events (MACE) during the first year were analyzed. The occurrence of MACE, including cardiac death, myocardial infarction (MI), stent thrombosis and target vessel revascularization, were evaluated for a median 1179 days (interquartile range 769-1541) after the first year.
   Results: Major adverse cardiac events occurred in 43 patients (8.3%) including 8 cases (1.5%) of cardiac death, 9 cases (1.7%) of MI, 24 cases (4.6%) of target vessel revascularization, and 11 cases (2.1%) of stent thrombosis. Patients with MACE had a higher serum creatinine level, higher incidence of in-stent restenosis lesion, more overlapping stents, a greater number of stents, and longer stents than did patients without MACE. Multivariate analysis revealed that serum creatinine level >1.5 mg/dL {hazard ratio (HR) 2.3, p=0.019}, stent length >33 mm (HR 2.4, p=0.035), and in-stent restenosis lesions (HR 2.4, p=0.040) were independent risk factors for MACE. Patients with DES length >33 mm had a higher incidence of MACE than those with DES length <= 33 mm (HR 2.7, log rank p=0.002).
   Conclusion: The risk of stent thrombosis and target vessel revascularization persisted in patients undergoing off-label DES implantation beyond 1-year follow-up. A total DES length >33 mm was a significant procedural predictor associated with the incidence of MACE.
C1 [Yun, Kyeong Ho; Ko, Jum Suk; Rhee, Sang Jae; Lee, Eun Mi; Yoo, Nam Jin; Kim, Nam-Ho; Oh, Seok Kyu; Jeong, Jin-Won] Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, Iksan 570711, South Korea.
RP Yun, KH (corresponding author), Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, 895 Muwang Ro, Iksan 570711, South Korea.
EM ards7210@yahoo.co.kr
CR Babapulle MN, 2004, LANCET, V364, P583, DOI 10.1016/S0140-6736(04)16850-5
   Beohar N, 2010, J INTERV CARDIOL, V23, P528, DOI 10.1111/j.1540-8183.2010.00588.x
   Brodie BR, 2008, JACC-CARDIOVASC INTE, V1, P405, DOI 10.1016/j.jcin.2008.06.005
   Caixeta A, 2009, J AM COLL CARDIOL, V54, P894, DOI 10.1016/j.jacc.2009.04.077
   Colombo A, 2001, J AM COLL CARDIOL, V38, P1427, DOI 10.1016/S0735-1097(01)01557-1
   Dangas GD, 2010, J AM COLL CARDIOL, V56, P1897, DOI 10.1016/j.jacc.2010.07.028
   Dawkins KD, 2005, CIRCULATION, V112, P3306, DOI 10.1161/CIRCULATIONAHA.105.552190
   Ellis SG, 2009, JACC-CARDIOVASC INTE, V2, P1248, DOI 10.1016/j.jcin.2009.10.003
   이철환, 2007, Korean Circulation Journal, V37, P97
   Kandzari DE, 2011, JACC-CARDIOVASC INTE, V4, P543, DOI 10.1016/j.jcin.2010.12.014
   Katritsis DG, 2011, J INTERV CARDIOL, V24, P437, DOI 10.1111/j.1540-8183.2011.00662.x
   Katritsis DG, 2009, AM J CARDIOL, V104, P786, DOI 10.1016/j.amjcard.2009.04.056
   Kim YH, 2006, CIRCULATION, V114, P2148, DOI 10.1161/CIRCULATIONAHA.106.666396
   Ko YG, 2011, INT J CARDIOL, V152, P302, DOI 10.1016/j.ijcard.2010.07.023
   Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
   Nikol S, 1996, ATHEROSCLEROSIS, V123, P17, DOI 10.1016/0021-9150(96)05807-8
   Park KW, 2010, AM HEART J, V159, P446, DOI 10.1016/j.ahj.2010.01.001
   Park K, 2012, CIRC-CARDIOVASC INTE, V5, P174, DOI 10.1161/CIRCINTERVENTIONS.111.964650
   Planer D, 2008, AM J CARDIOL, V101, P953, DOI 10.1016/j.amjcard.2007.11.043
   Serruys Patrick W, 2008, EuroIntervention, V3, P450
   Serruys PW, 2010, J AM COLL CARDIOL, V55, P1093, DOI 10.1016/j.jacc.2009.11.049
   Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441
   Suh J, 2010, JACC-CARDIOVASC INTE, V3, P383, DOI 10.1016/j.jcin.2009.10.033
   Weisz G, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.050
   Win HK, 2007, JAMA-J AM MED ASSOC, V297, P2001, DOI 10.1001/jama.297.18.2001
NR 25
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 161
EP 167
DI 10.4070/kcj.2013.43.3.161
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100004
PM 23613692
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, DH
   Youn, HJ
   Choi, YS
   Lee, JM
   Park, CS
   Jung, HO
   Jeon, HK
   Lee, MY
AF Lee, Dong-Hyeon
   Youn, Ho-Joong
   Choi, Yun-Seok
   Lee, Jong-Min
   Park, Chul-Soo
   Jung, Hae-Ok
   Jeon, Hui-Kyung
   Lee, Man-Young
TI C-Type Natriuretic Peptide as a Surrogate Marker in Variant Angina
   Pectoris
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Natriuretic peptide; C-type; Angina pectoris; variant; Endothelium;
   Acetylcholine
ID SMOOTH-MUSCLE-CELLS; CORONARY-ARTERY SPASM; CHRONIC HEART-FAILURE;
   ENDOTHELIAL FUNCTION; SYSTEM; ATHEROSCLEROSIS; VASODILATATION;
   EXPRESSION; PROGRESS; RESERVE
AB Background and Objectives: The purpose of this study was to assess the value of C-type natriuretic peptide (CNP) as a surrogate marker for detection of coronary artery spasm in variant angina pectoris (VAP).
   Subjects and Methods: Sixty-six patients (mean age: 51 +/- 11 years, M : F=40 : 26) who underwent coronary angiography on suspicion of angina and who were diagnosed with VAP by the acetylcholine-induced spasm provocation test (SPT) were enrolled and divided into a SPT (-) group (n=23) and a SPT (+) group (n=43). Concentrations of CNP and other markers were determined by immunoassay in both groups.
   Results: Plasma CNP and creatine kinase myoglobin band (CK-MB) concentrations were significantly increased in the SPT (+) group relative to the SPT (-) group (CNP, 5.268 +/- 1.800 pg/mL vs. 3.342 +/- 1.150 pg/mL, p=0.002; CK-MB, 2.54 +/- 1.03 ng/dL vs. 1.86 +/- 0.96 ng/dL, p=0.019, respectively) while plasma high sensitivity C-reactive protein (hs-CRP) and N-terminal pro-brain natriuretic peptide (NT pro-BNP) concentrations were not significantly different between the SPT (-) group and SPT (+) group (hs-CRP, 2.76 +/- 4.99 mg/L vs. 3.13 +/- 4.88 mg/L, p=0.789; NT pro-BNP, 49 +/- 47 pg/mL vs. 57 +/- 63 pg/mL, p=0.818, respectively). Plasma CNP concentration was independently associated with the VAP via SPT {odds ratio: 2.014 (95% confidence interval: 1.016-3.992), p=0.045}. A CNP cut-off value of 4.096 pg/mL was found to have a sensitivity of 68.2% and a specificity of 40.0% for predicting the probability of VAP via SPT.
   Conclusion: Increased plasma CNP concentration in patients with VAP may have an impact on the regulation of endothelial function in accordance with the progression of atherosclerosis. Further analysis is warranted to develop clinical applications of this finding.
C1 [Lee, Dong-Hyeon; Youn, Ho-Joong; Choi, Yun-Seok; Lee, Jong-Min; Park, Chul-Soo; Jung, Hae-Ok; Jeon, Hui-Kyung; Lee, Man-Young] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Cardiol,Dept Internal Med, Seoul 137701, South Korea.
RP Youn, HJ (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Cardiol,Dept Internal Med, 222 Banpo Daero, Seoul 137701, South Korea.
EM younhj@catholic.ac.kr
FU Seoul R&BD Program in the Republic of Korea [10526]
FX This study was supported by a grant from the Seoul R&BD Program in the
   Republic of Korea (10526).
CR Costa MA, 2007, BIOCHEM BIOPH RES CO, V359, P180, DOI 10.1016/j.bbrc.2007.05.095
   Baim DS, 2000, GROSSMANS CARDIAC CA, P247
   BRAUNWALD E, 1981, JAMA-J AM MED ASSOC, V246, P1957, DOI 10.1001/jama.246.17.1957
   Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889
   Chun TH, 1997, HYPERTENSION, V29, P1296, DOI 10.1161/01.HYP.29.6.1296
   Del Ry S, 2008, PEPTIDES, V29, P79, DOI 10.1016/j.peptides.2007.10.022
   EGASHIRA K, 1993, NEW ENGL J MED, V328, P1659, DOI 10.1056/NEJM199306103282302
   HILLIS LD, 1978, NEW ENGL J MED, V299, P695, DOI 10.1056/NEJM197809282991305
   Hwang HJ, 2010, ECHOCARDIOGR-J CARD, V27, P435, DOI 10.1111/j.1540-8175.2009.01038.x
   Kalra PR, 2003, CIRCULATION, V107, P571, DOI 10.1161/01.CIR.0000047280.15244.EB
   Kelsall CJ, 2006, VASC PHARMACOL, V45, P368, DOI 10.1016/j.vph.2006.06.011
   Komatsu Y, 1996, CIRC RES, V78, P606, DOI 10.1161/01.RES.78.4.606
   KOMATSU Y, 1992, LANCET, V340, P622, DOI 10.1016/0140-6736(92)92167-E
   Kuo JY, 2007, SCAND CARDIOVASC J, V41, P155, DOI 10.1080/14017430701302482
   Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146
   Lupattelli G, 2006, VASA-J VASCULAR DIS, V35, P215, DOI 10.1024/0301-1526.35.4.215
   MARX JL, 1980, SCIENCE, V208, P1127
   Mayer S, 1998, CLIN CARDIOL, V21, P243, DOI 10.1002/clc.4960210403
   Naruko T, 2005, ATHEROSCLEROSIS, V181, P241, DOI 10.1016/j.atherosclerosis.2005.01.023
   OGAWA Y, 1992, HYPERTENSION, V19, P809, DOI 10.1161/01.HYP.19.6.809
   OKUMURA K, 1988, CIRCULATION, V77, P535, DOI 10.1161/01.CIR.77.3.535
   Palmer SC, 2009, HYPERTENSION, V54, P612, DOI 10.1161/HYPERTENSIONAHA.109.135608
   Park CS, 2006, INT J CARDIOL, V113, P118, DOI 10.1016/j.ijcard.2005.08.018
   Park CS, 2004, KOREAN CIRC J, V34, P485
   PRINZMETAL M, 1959, AM J MED, V27, P375, DOI 10.1016/0002-9343(59)90003-8
   SUDOH T, 1990, BIOCHEM BIOPH RES CO, V168, P863, DOI 10.1016/0006-291X(90)92401-K
   Suzuki T, 2001, CARDIOVASC RES, V51, P489, DOI 10.1016/S0008-6363(01)00238-3
   Vlachopoulos C, 2010, ATHEROSCLEROSIS, V211, P649, DOI 10.1016/j.atherosclerosis.2010.03.020
   YANDLE TG, 1994, J INTERN MED, V235, P561, DOI 10.1111/j.1365-2796.1994.tb01263.x
NR 29
TC 1
Z9 2
U1 1
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 168
EP 173
DI 10.4070/kcj.2013.43.3.168
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100005
PM 23613693
OA Green Published
DA 2021-04-22
ER

PT J
AU Jo, SH
   Kim, LS
   Kim, SA
   Kim, HS
   Han, SJ
   Park, WJ
   Choi, YJ
AF Jo, Sang-Ho
   Kim, Lee Su
   Kim, Sung-Ai
   Kim, Hyun-Sook
   Han, Sang-Jin
   Park, Woo Jung
   Choi, Young Jin
TI Evaluation of Short-Term Use of N-Acetylcysteine as a Strategy for
   Prevention of Anthracycline-Induced Cardiomyopathy: EPOCH Trial - A
   Prospective Randomized Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Acetylcysteine; Anthracyclines; Cardiomyopathies
ID HIGH-DOSE CHEMOTHERAPY; CARDIAC TOXICITY; NATRIURETIC PEPTIDES;
   DOXORUBICIN THERAPY; NAD(P)H OXIDASE; CARDIOTOXICITY; CANCER;
   DYSFUNCTION; MANAGEMENT; HEART
AB Background and Objectives: We investigate to determine whether N-acetylcysteine (NAC) can prevent anthracycline-induced cardiotoxicity.
   Subjects and Methods: A total of 103 patients were enrolled in this prospective randomized open label controlled trial. They are patients first diagnosed with breast cancer or lymphoma, who require chemotherapy, including anthracycline like adriamycine or epirubicine. Patients were randomized to the NAC group {n=50; 1200 mg orally every 8 hours starting before and ending after the intravenous infusion of anthracycline in all chemotherapy cycles (3-6)} or the control group (n=53). Primary outcome was the decrease in left ventricular ejection fraction (LVEF) absolutely >= 10% from the baseline and concomitantly <50% at 6-month. Composite of all-cause death, heart failure and readmission were compared.
   Results: The primary outcome was not significantly different in the NAC and control groups {3/47 (6.4%) vs. 1/52 (1.9%), p=0.343}. The mean LVEF significantly decreased in both the NAC (from 64.5 to 60.8%, p=0.001) and control groups (from 64.1 to 61.3%, p<0.001) after the completion of whole chemotherapy. The mean LVEF change did not differ between the two groups (-3.64% in NAC vs. -2.78% in control group, p=0.502). Left ventricular (LV) end systolic dimension increased with higher trend in NAC by 3.08 +/- 4.56 mm as compared with 1.47 +/- 1.83 mm in the control group (p=0.064). LV end diastolic dimension did not change in each group and change does not differ in both. Peak E, A and E/A ratio change and cardiac enzymes were comparable in two groups. Cumulative 12-month event rate was 6% and 3.8% in the NAC group and the control group, respectively, with no difference (p=0.672).
   Conclusion: We cannot prove that NAC prevents anthracycline-induced cardiomyopathy.
C1 [Jo, Sang-Ho; Kim, Sung-Ai; Kim, Hyun-Sook; Han, Sang-Jin; Park, Woo Jung] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Cardiol, Anyang 431070, South Korea.
   [Kim, Lee Su] Hallym Univ, Sacred Heart Hosp, Div Breast & Endocrine Surg, Anyang 431070, South Korea.
   [Choi, Young Jin] Sejong Gen Hosp, Dept Internal Med, Div Cardiol, Puchon, South Korea.
RP Jo, SH (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Cardiol, 22 Gwanpyeong Ro 170beon Gil, Anyang 431070, South Korea.
EM sophi5@medimail.co.kr
FU Korean Society of Cardiology
FX This study was supported by grants from the Korean Society of Cardiology
   (2008).
CR BRISTOW MR, 1978, CANCER TREAT REP, V62, P873
   Cardinale D, 2004, CIRCULATION, V109, P2749, DOI 10.1161/01.CIR.0000130926.51766.CC
   Cardinale D, 2006, CIRCULATION, V114, P2474, DOI 10.1161/CIRCULATIONAHA.106.635144
   Chao HH, 2011, INT J CARDIOL, V146, P145, DOI 10.1016/j.ijcard.2009.06.010
   Deng SW, 2007, FREE RADICAL BIO MED, V42, P466, DOI 10.1016/j.freeradbiomed.2006.11.013
   DOROSHOW JH, 1981, J CLIN INVEST, V68, P1053, DOI 10.1172/JCI110328
   Fallah-Rad N, 2011, J AM COLL CARDIOL, V57, P2263, DOI 10.1016/j.jacc.2010.11.063
   Feola M, 2011, INT J CARDIOL, V148, P194, DOI 10.1016/j.ijcard.2009.09.564
   Figueredo VM, 2011, AM J MED, V124, P480, DOI 10.1016/j.amjmed.2010.11.031
   Hequet O, 2004, J CLIN ONCOL, V22, P1864, DOI 10.1200/JCO.2004.06.033
   Hong HJ, 2012, INT J CARDIOL, V157, P174, DOI 10.1016/j.ijcard.2010.12.012
   Kalay N, 2006, J AM COLL CARDIOL, V48, P2258, DOI 10.1016/j.jacc.2006.07.052
   Lee CYW, 2007, HEART FAIL REV, V12, P131, DOI 10.1007/s10741-007-9016-3
   Li K, 2006, CIRCULATION, V113, P2211, DOI 10.1161/CIRCULATIONAHA.105.560250
   Li LH, 2006, CIRCULATION, V113, P535, DOI 10.1161/CIRCULATIONAHA.105.568402
   LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602
   Neilan TG, 2006, EUR HEART J, V27, P1251, DOI 10.1093/eurheartj/ehl003
   Pai VB, 2000, DRUG SAFETY, V22, P263, DOI 10.2165/00002018-200022040-00002
   Rosenthal DS, 2001, HEART DIS TXB CARDIO, P1746
   Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009
   STEINHERZ LJ, 1991, JAMA-J AM MED ASSOC, V266, P1672, DOI 10.1001/jama.266.12.1672
   Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407
   Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002
   Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304
   Urbanova D, 2008, ONCOL RES, V17, P51
   Yeh ETH, 2004, CIRCULATION, V109, P3122, DOI 10.1161/01.CIR.0000133187.74800.B9
   Zucchi Riccardo, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P151, DOI 10.2174/1568011033353434
NR 27
TC 9
Z9 9
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 174
EP 181
DI 10.4070/kcj.2013.43.3.174
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100006
PM 23613694
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, G
   Lee, SE
   Hong, YM
   Sohn, S
AF Lee, Goni
   Lee, Seung Eun
   Hong, Young Mi
   Sohn, Sejung
TI Is High-Dose Aspirin Necessary in the Acute Phase of Kawasaki Disease?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Kawasaki disease; Aspirin; Therapeutics
ID GAMMA-GLOBULIN TREATMENT; INTRAVENOUS IMMUNOGLOBULIN; SERUM
   CONCENTRATIONS; SALICYLATES; DIAGNOSIS; THERAPY
AB Background and Objectives: We sought to determine whether high-dose aspirin is necessary for the acute therapy of Kawasaki disease (KD) in the intravenous immunoglobulin (IVIG) era.
   Subjects and Methods: Two groups of KD patients treated during the different periods were included. Study group (n=51, treated with IVIG without concomitant use of aspirin in the acute phase) was compared with control group (n=129, treated with IVIG plus high-dose aspirin) with regard to the response to IVIG, duration of fever after IVIG completion, time to C-reactive protein (CRP) <3 mg/dL, and the incidence of coronary artery lesions (CALs).
   Results: There was no difference between the groups in age, sex, and duration of fever before treatment. Pre-IVIG laboratory measures also did not differ from each other. IVIG-resistant cases were 8 (15.7%) in study group and 22 (17.1%) in control group (p=1.000). Mean duration of fever after IVIG completion in IVIG-responsive patients was 13.3 +/- 13.5 hours in study group compared to 6.2 +/- 8.3 hours in control group (p=0.000). The mean time to decrease in CRP was 4.0 +/- 1.7 days in study group and 4.1 +/- 2.2 days in control group (p=0.828). There were 2 (3.9%) patients with CALs in study group and 10 (7.8%) in control group (p=0.514).
   Conclusion: Although high-dose aspirin shortens the duration of fever, treatment without aspirin in the acute phase has no influence on the response to IVIG, resolution of inflammation, or the development of CALs. In the IVIG era, high-dose aspirin may provide little benefit to the treatment in the acute phase of KD.
C1 [Lee, Goni; Lee, Seung Eun; Hong, Young Mi; Sohn, Sejung] Ewha Womans Univ, Mokdong Hosp, Sch Med, Dept Pediat, Seoul 158710, South Korea.
RP Sohn, S (corresponding author), Ewha Womans Univ, Mokdong Hosp, Sch Med, Dept Pediat, 1071 Anyangcheon Ro, Seoul 158710, South Korea.
EM sohn@ewha.ac.kr
CR AKAGI T, 1990, Kurume Medical Journal, V37, P203
   Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009
   BURNS JC, 1984, J PEDIATR-US, V105, P206, DOI 10.1016/S0022-3476(84)80114-6
   DAJANI AS, 1993, CIRCULATION, V87, P1776, DOI 10.1161/01.CIR.87.5.1776
   de Zorzi A, 1998, J PEDIATR-US, V133, P254, DOI 10.1016/S0022-3476(98)70229-X
   DURONGPISITKUL K, 1995, PEDIATRICS, V96, P1057
   Hsieh KS, 2004, PEDIATRICS, V114, pE689, DOI 10.1542/peds.2004-1037
   Kim HK, 2011, KOREAN CIRC J, V41, P379, DOI 10.4070/kcj.2011.41.7.379
   Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865
   KOREN G, 1984, J PEDIATR-US, V105, P991, DOI 10.1016/S0022-3476(84)80097-9
   KOREN G, 1988, J PEDIATR-US, V112, P663, DOI 10.1016/S0022-3476(88)80194-X
   KOREN G, 1991, J PEDIATR-US, V118, P456, DOI 10.1016/S0022-3476(05)82168-7
   Kusakawa S, 1987, Prog Clin Biol Res, V250, P401
   Lee J H, 1992, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V33, P67
   Matsubara T, 1996, J PEDIATR-US, V128, P701, DOI 10.1016/S0022-3476(96)80140-5
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   RATNATUNGA CP, 1992, CIRCULATION, V85, P1077, DOI 10.1161/01.CIR.85.3.1077
   Research Committee on Kawasaki Disease, 1984, REP SUBC STAND DIAGN
   Saulsbury FT, 2002, CLIN PEDIATR, V41, P597, DOI 10.1177/000992280204100807
   SUNDEL RP, 1990, J PEDIATR-US, V117, P371, DOI 10.1016/S0022-3476(05)81075-3
   Terai M, 1997, J PEDIATR-US, V131, P888, DOI 10.1016/S0022-3476(97)70038-6
   Wallace CA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e78
   YOKOYAMA T, 1980, Kurume Medical Journal, V27, P57
NR 23
TC 21
Z9 22
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 182
EP 186
DI 10.4070/kcj.2013.43.3.182
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100007
PM 23613695
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, S
   Yi, J
   Park, SW
AF Chung, Seungmin
   Yi, Joohee
   Park, Seung Woo
TI Electromagnetic Interference of Wireless Local Area Network on
   Electrocardiogram Monitoring System: A Case Report
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Wireless technology; Electrocardiography
ID PHONES
AB Electromagnetic interference (EMI) (c)an affect various medical devices. Herein, we report the case of EMI from wireless local area network (WLAN) on an electrocardiogram (ECG) monitoring system. A patient who had a prior myocardial infarction participated in the cardiac rehabilitation program in the sports medicine center of our hospital under the wireless ECG monitoring system. After WLAN was installed, wireless ECG monitoring system failed to show a proper ECG signal. ECG signal was distorted when WLAN was turned on, but it was normalized after turning off the WLAN.
C1 [Chung, Seungmin; Park, Seung Woo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Cardiac & Vasc Ctr, Seoul 135710, South Korea.
   [Yi, Joohee; Park, Seung Woo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Informat Strategy, Seoul 135710, South Korea.
RP Park, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Cardiac & Vasc Ctr, 50 Irwon Dong, Seoul 135710, South Korea.
EM s.woo.park@samsung.com
CR Baranchuk A, 2009, CLIN CARDIOL, V32, P588, DOI 10.1002/clc.20459
   Fetter JG, 1998, J AM COLL CARDIOL, V31, P623, DOI 10.1016/S0735-1097(97)00546-9
   Garcia CU, 2007, TELEMED J E-HEALTH, V13, P519, DOI 10.1089/tmj.2007.0005
   Hekmat K, 2004, EUROPACE, V6, P363, DOI 10.1016/j.eupc.2004.03.010
   Kapa S, 2011, INT J MED INFORM, V80, P239, DOI 10.1016/j.ijmedinf.2011.01.001
   Klein AA, 2003, ANAESTHESIA, V58, P353, DOI 10.1046/j.1365-2044.2003.03079.x
   Lapinsky SE, 2006, J CRIT CARE, V21, P267, DOI 10.1016/j.jcrc.2006.03.010
   Shaw CI, 2004, CRIT CARE MED, V32, P928, DOI 10.1097/01.CCM.0000120061.01431.DB
   Tri JL, 2005, MAYO CLIN PROC, V80, P1286, DOI 10.4065/80.10.1286
NR 9
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 187
EP 188
DI 10.4070/kcj.2013.43.3.187
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100008
PM 23613696
OA Green Published
DA 2021-04-22
ER

PT J
AU Namgung, J
AF Namgung, June
TI Successful Ablation of Resistant Left Lateral Accessory Pathway and
   Coexisting Atypical Atrioventricular Nodal Reentrant Tachycardia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Accessory atrioventricular bundle; Tachycardia; atrioventricular nodal
   reentry; Radiofrequency catheter ablation
ID PARKINSON-WHITE-SYNDROME; RADIOFREQUENCY CATHETER ABLATION
AB A 41-year-old male was presented with drug-resistant supraventricular tachycardia. Electrophysiological study confirmed that the supraventricular tachycardia was caused by dual atrioventricular nodal pathways and a left lateral accessory pathway ( AP). The left lateral AP was resistant to traditional endocardial ablation, but was successfully eliminated by radiofrequency ablation via the intracoronary sinus approach.
C1 [Namgung, June] Inje Univ, Coll Med, Ilsan Paik Hosp, Div Cardiol,Dept Internal Med, Goyang 411706, South Korea.
RP Namgung, J (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Div Cardiol,Dept Internal Med,Vis Cardiac & Vasc, 170 Juhwa Ro, Goyang 411706, South Korea.
EM jnamgung@paik.ac.kr
CR BECKER AE, 1978, CIRCULATION, V57, P870, DOI 10.1161/01.CIR.57.5.870
   CALKINS H, 1992, CIRCULATION, V85, P1337, DOI 10.1161/01.CIR.85.4.1337
   Chen YJ, 1996, INT J CARDIOL, V56, P275, DOI 10.1016/0167-5273(96)02762-3
   HAISSAGUERRE M, 1992, CIRCULATION, V86, P1464, DOI 10.1161/01.CIR.86.5.1464
   JACKMAN WM, 1991, NEW ENGL J MED, V324, P1605, DOI 10.1056/NEJM199106063242301
   LESH MD, 1992, J AM COLL CARDIOL, V19, P1303, DOI 10.1016/0735-1097(92)90338-N
NR 6
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 189
EP 192
DI 10.4070/kcj.2013.43.3.189
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100009
PM 23613697
OA Green Published
DA 2021-04-22
ER

PT J
AU Yang, DH
   Kwon, HJ
   Kim, JC
   Jang, JH
   Shin, SH
   Kwan, J
   Woo, SI
   Park, KS
   Kim, DH
AF Yang, Dong-Hyuk
   Kwon, Hyuk-jeong
   Kim, Jin-Chul
   Jang, Ji-Hun
   Shin, Sung-Hee
   Kwan, Jun
   Woo, Sung-Il
   Park, Keum-Soo
   Kim, Dae-Hyeok
TI Transient J-Wave Appearance in the Inferior-Lateral Leads during
   Electrical Storm in a Patient with Brugada Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Brugada syndrome; Sudden cardiac death
ID SUDDEN CARDIAC DEATH
AB A 67-year-old male patient was admitted with an abrupt sudden cardiac death. He represented with an extreme electrical storm of 30 times of ventricular fibrillation (VF) episodes on one day. External shocks were performed to terminate VF. Transient J-wave in the inferior-lateral leads and Brugada electrocardiography pattern on the right precordial leads appeared during the electrical storm. And J-wave disappeared after the termination of electrical storm. We report a case of the appearance of J-wave during electrical storm in a patient with Brugada syndrome.
C1 [Yang, Dong-Hyuk; Kwon, Hyuk-jeong; Kim, Jin-Chul; Jang, Ji-Hun; Shin, Sung-Hee; Kwan, Jun; Woo, Sung-Il; Park, Keum-Soo; Kim, Dae-Hyeok] Inha Univ, Coll Med, Dept Internal Med, Div Cardiol, Inchon 400711, South Korea.
RP Kim, DH (corresponding author), Inha Univ, Coll Med, Dept Internal Med, Div Cardiol, 27 Inhang Ro, Inchon 400711, South Korea.
EM kdhmd@inha.ac.kr
OI Jang, Ji-Hun/0000-0002-4946-2199
CR BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J
   Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968
   Kamakura S, 2009, CIRC-ARRHYTHMIA ELEC, V2, P495, DOI 10.1161/CIRCEP.108.816892
   Letsas KP, 2008, HEART RHYTHM, V5, P1685, DOI 10.1016/j.hrthm.2008.09.021
   Sarkozy A, 2009, CIRC-ARRHYTHMIA ELEC, V2, P154, DOI 10.1161/CIRCEP.108.795153
   Sorgente A, 2010, J CARDIOVASC ELECTR, V21, P1413, DOI 10.1111/j.1540-8167.2010.01791.x
   Yan GX, 1996, CIRCULATION, V93, P372, DOI 10.1161/01.CIR.93.2.372
NR 7
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 193
EP 195
DI 10.4070/kcj.2013.43.3.193
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100010
PM 23613698
OA Green Published
DA 2021-04-22
ER

PT J
AU Sen, T
AF Sen, Taner
TI Coronary Slow Flow Phenomenon Leads to ST Elevation Myocardial
   Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Slow-flow phenomenon; Acute anterior wall myocardial infarction
ID ARTERIES; ANGINA
AB The exact etiology of the coronary slow flow phenomenon (CSFP) is not certain. CSFP is not a normal variant as it is an absolutely pathological entity. Furthermore, CSFP not only leads to myocardial ischemia but it can also cause classical acute ST elevation myocardial infarction, which necessitates coronary angiography for a definite diagnosis.
C1 Kutahya Evliya Celebi Educ & Res Hosp, Dept Cardiol, Atakent, Kutahya, Turkey.
RP Sen, T (corresponding author), Kutahya Evliya Celebi Educ & Res Hosp, Dept Cardiol, 75 Yil Seyfi Efendi St Gencer Apt 3-15, Atakent, Kutahya, Turkey.
EM medicineman_tr@hotmail.com
RI sen, taner/A-8531-2018; sen, taner/AAA-8384-2021
CR Demirkol MO, 2002, CORONARY ARTERY DIS, V13, P223, DOI 10.1097/00019501-200206000-00004
   Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879
   Kapoor A, 1998, INT J CARDIOL, V67, P257, DOI 10.1016/S0167-5273(98)00324-6
   Mangieri E, 1996, CATHETER CARDIO DIAG, V37, P375, DOI 10.1002/(SICI)1097-0304(199604)37:4<375::AID-CCD7>3.0.CO;2-8
   MOSSERI M, 1986, CIRCULATION, V74, P964, DOI 10.1161/01.CIR.74.5.964
   Singh Sandeep, 2004, Indian Heart J, V56, P613
   Tatli E, 2009, INT J CARDIOL, V131, pE101, DOI 10.1016/j.ijcard.2007.07.069
NR 7
TC 14
Z9 15
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 196
EP 198
DI 10.4070/kcj.2013.43.3.196
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100011
PM 23613699
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, YG
   Kim, HJ
   Choi, WS
   Im, MS
   Yoon, CH
   Suh, JW
   Choi, DJ
AF Kim, Yun Gi
   Kim, Hyun Jin
   Choi, Won-Suk
   Im, Moon-sun
   Yoon, Chang-Hwan
   Suh, Jung-Won
   Choi, Dong-Ju
TI Does a Negative Ergonovine Provocation Test Truly Predict Freedom from
   Variant Angina?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angina pectoris; variant; Ergonovine; Coronary vasospasm
ID CALCIUM-ANTAGONISTS; FREQUENCY; ATTACKS; SPASM
AB Ergonovine provocation test is known to be very sensitive for diagnosing variant angina. The patient described in this study initially presented with atypical chest pain and underwent coronary angiography and ergonovine provocation tests, which were negative. The patient was subsequently prescribed a proton pump inhibitor and prokinetics for pain relief, but then presented with acute myocardial infarction and cardiogenic shock due to coronary artery vasospasm 5 years later. This case suggests that ergonovine provocation test generates false negative results, which can lead to unwanted outcomes. Even with a negative ergonovine provocation test, prescription of calcium channel blockers or nitrates should be considered in patients with a clinical history suggestive of variant angina.
C1 [Kim, Yun Gi; Kim, Hyun Jin; Choi, Won-Suk; Im, Moon-sun] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea.
   [Kim, Yun Gi; Kim, Hyun Jin; Choi, Won-Suk; Im, Moon-sun] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.
   [Yoon, Chang-Hwan; Suh, Jung-Won; Choi, Dong-Ju] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, Songnam 463707, South Korea.
   [Yoon, Chang-Hwan; Suh, Jung-Won; Choi, Dong-Ju] Seoul Natl Univ, Bundang Hosp, Ctr Cardiovasc, Songnam 463707, South Korea.
RP Choi, DJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, 82 Gumi Ro 173Beon Gil, Songnam 463707, South Korea.
EM djchoi@snu.ac.kr
OI Yoon, Chang-Hwan/0000-0001-6305-4442
CR BERTRAND ME, 1982, CIRCULATION, V65, P1299, DOI 10.1161/01.CIR.65.7.1299
   Bohm A, 2012, CAN J CARDIOL, V28, DOI 10.1016/j.cjca.2011.10.011
   CURRY RC, 1979, CIRCULATION, V59, P307, DOI 10.1161/01.CIR.59.2.307
   FELDMAN RL, 1983, AM HEART J, V106, P1288, DOI 10.1016/0002-8703(83)90036-4
   HANST PL, 1978, AM IND HYG ASSOC J, V39, P772, DOI 10.1080/0002889778507850
   HEUPLER FA, 1978, AM J CARDIOL, V41, P631, DOI 10.1016/0002-9149(78)90810-X
   Lee WS, 2011, KOREAN CIRC J, V41, P220, DOI 10.4070/kcj.2011.41.4.220
   PRINZMETAL M, 1959, AM J MED, V27, P375, DOI 10.1016/0002-9343(59)90003-8
   STEIN I, 1949, AM HEART J, V37, P36, DOI 10.1016/0002-8703(49)91427-1
   STONE PH, 1987, AM J CARDIOL, V59, pB101, DOI 10.1016/0002-9149(87)90089-0
   Sueda S, 2004, ANGIOLOGY, V55, P403, DOI 10.1177/000331970405500407
   Sueda S, 2003, CHEST, V124, P2074, DOI 10.1378/chest.124.6.2074
   WATERS DD, 1983, CIRCULATION, V67, P310, DOI 10.1161/01.CIR.67.2.310
NR 13
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 199
EP 203
DI 10.4070/kcj.2013.43.3.199
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100012
PM 23613700
OA Green Published
DA 2021-04-22
ER

PT J
AU Joo, JC
   Do Seol, M
   Yoon, JW
   Lee, YS
   Kim, DK
   Choi, YH
   Ahn, HS
   Cho, WH
AF Joo, Jung-Chul
   Do Seol, Myung
   Yoon, Jin Won
   Lee, Young Soo
   Kim, Dong-Keun
   Choi, Yong Hoon
   Ahn, Hyo Seong
   Cho, Wook Hyun
TI A Case of Myopathy, Encephalopathy, Lactic Acidosis and Stroke-Like
   Episodes (MEALS) Syndrome with Intracardiac Thrombus
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE MELAS syndrome; Heart; Thrombosis
ID MITOCHONDRIAL MYOPATHY; MELAS; MUTATION; INVOLVEMENT
AB Myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is a multisystem clinical syndrome manifested by mitochondrial myopathy, encephalopathy, lactic acidosis and recurrent stroke-like episodes. A 27-year-old female with MELAS syndrome presented with cerebral infarction. Echocardiography revealed a thrombus attached to the apex of the hypertrophied left ventricle, with decreased systolic function. The embolism of the intracardiac thrombus might have been the cause of stroke. There should be more consideration given to the increased possibility of intracardiac thrombus formation when a MELAS patient with cardiac involvement is encountered.
C1 [Joo, Jung-Chul; Do Seol, Myung; Yoon, Jin Won; Lee, Young Soo; Kim, Dong-Keun; Choi, Yong Hoon; Ahn, Hyo Seong; Cho, Wook Hyun] Seoul Hosp, Sahmyook Med Ctr, Seoul, South Korea.
RP Cho, WH (corresponding author), Sahmyook Seoul Hosp, 82 Mangu Ro, Seoul 130711, South Korea.
EM mulgang@gmail.com
CR Borner GV, 2000, HUM MOL GENET, V9, P467, DOI 10.1093/hmg/9.4.467
   Chae JH, 2004, BRAIN DEV-JPN, V26, P459, DOI 10.1016/j.braindev.2004.01.002
   GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   Kim BS, 2001, YONSEI MED J, V42, P128
   Lam CW, 1997, EUR J PEDIATR, V156, P562, DOI 10.1007/s004310050663
   Oguro H, 2004, INTERNAL MED, V43, P427, DOI 10.2169/internalmedicine.43.427
   Okajima Y, 1998, HEART, V80, P292, DOI 10.1136/hrt.80.3.292
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
   Vydt TCG, 2007, AM J CARDIOL, V99, P264, DOI 10.1016/j.amjcard.2006.07.089
NR 10
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 204
EP 206
DI 10.4070/kcj.2013.43.3.204
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100013
PM 23613701
OA Green Published
DA 2021-04-22
ER

PT J
AU Shim, WS
   Song, JY
   Lee, SY
   Baek, JS
   Jang, SI
   Kim, SH
   Kim, YM
AF Shim, Woo Sup
   Song, Jin Young
   Lee, Sang Yun
   Baek, Jae Suk
   Jang, So Ick
   Kim, Seong Ho
   Kim, Yang Min
TI An Adolescent Patient with Coarctation of Aorta Treated with
   Self-Expandable Nitinol Stent
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic coarctation; Stents
AB Transcatheter treatment of aortic coarctation, with balloon angioplasty or stent implantation, is now an acceptable alternative to surgical repair. However these procedures may result in complications, such as vascular wall injury and re-stenosis of the lesion. A nitinol self-expandable stent, when deployed at the coarctation site, produces low constant radial force, which may result in a gradual widening of the stenotic lesion leaving less tissue injury ('stretching rather than tearing'). For an adolescent with a native aortic coarctation, a self-expandable stent of 20 mm diameter was inserted at the discrete stenotic lesion of 5 mm diameter without previous balloon dilatation procedure. No further balloon dilatation was done immediately after the stent insertion. With the self-expandable stent only, the stenosis of the lesion was partially relieved immediately after the stent deployment. Over several months after the stent insertion, gradual further widening of the stent waist to an acceptable dimension was observed.
C1 [Shim, Woo Sup; Lee, Sang Yun; Baek, Jae Suk; Jang, So Ick; Kim, Seong Ho] Sejong Gen Hosp, Sejong Cardiovasc Ctr, Dept Pediat Cardiol, Puchon 422711, South Korea.
   [Kim, Yang Min] Sejong Gen Hosp, Sejong Cardiovasc Ctr, Dept Radiol, Puchon 422711, South Korea.
   [Song, Jin Young] Samsung Med Ctr, Dept Pediat Cardiol, Seoul, South Korea.
RP Shim, WS (corresponding author), Sejong Gen Hosp, Sejong Cardiovasc Ctr, Dept Pediat Cardiol, 28 Hohyeon Ro 489Beon Gil, Puchon 422711, South Korea.
EM wsshim01@gmail.com
RI Kim, Gi Beom/AAK-3377-2021
OI Kim, Gi Beom/0000-0002-7880-280X
CR Dyet JF, 2000, CARDIOVASC INTER RAD, V23, P47, DOI 10.1007/s002709910007
   Golden AB, 2007, CATHETER CARDIO INTE, V69, P289, DOI 10.1002/ccd.21009
   Kische S, 2010, J VASC SURG, V51, P1550, DOI 10.1016/j.jvs.2009.12.063
   Stoeckel D, 2004, EUR RADIOL, V14, P292, DOI 10.1007/s00330-003-2022-5
NR 4
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 207
EP 211
DI 10.4070/kcj.2013.43.3.207
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100014
PM 23613702
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CW
   Chung, FP
   Wang, KL
   Wu, CL
   Lu, TM
AF Lee, Ching-Wei
   Chung, Fa-Po
   Wang, Kang-Ling
   Wu, Ching-Lan
   Lu, Tse-Min
TI Iceberg in Small Pulmonary Embolism
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Ching-Wei] Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, Tao Yuan Branch, Taoyuan, Taiwan.
   [Lee, Ching-Wei; Chung, Fa-Po; Wang, Kang-Ling; Lu, Tse-Min] Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.
   [Lee, Ching-Wei; Chung, Fa-Po; Wang, Kang-Ling; Wu, Ching-Lan; Lu, Tse-Min] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan.
RP Lu, TM (corresponding author), Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, 201,Sec 2,Shih Pai Rd, Taipei, Taiwan.
EM tmlu@vghtpe.gov.tw
CR Donze J, 2008, THROMB HAEMOSTASIS, V100, P943, DOI 10.1160/TH08-05-0285
   RASCHKE RA, 1993, ANN INTERN MED, V119, P874, DOI 10.7326/0003-4819-119-9-199311010-00002
NR 2
TC 0
Z9 0
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2013
VL 43
IS 3
BP 212
EP 213
DI 10.4070/kcj.2013.43.3.212
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FL
UT WOS:000342384100015
PM 23613703
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SJ
   Park, SH
AF Lee, Seung-Jun
   Park, Sung-Ha
TI Arterial Ageing
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Aging; Arterial stiffness; Pulse wave analysis; Atherosclerosis
ID C-REACTIVE PROTEIN; PULSE-WAVE VELOCITY; ANGIOTENSIN-ALDOSTERONE SYSTEM;
   CONVERTING ENZYME-INHIBITORS; AORTIC STIFFNESS; VASCULAR INFLAMMATION;
   OXIDATIVE STRESS; CORONARY-ARTERY; PROGERIA; DISEASE
AB Arterial ageing is characterized by age associated degeneration and sclerosis of the media layer of the large arteries. However, besides ageing, clinical conditions, which enhance oxidative stress and inflammation act to accelerate the degree of arterial ageing. In this review, we summarized the pathophysiology and contributing factors that accelerate arterial ageing. Among them, we focused on hypertension, the renin-angiotensin-aldosterone system and vascular inflammation which are modifiable causes of the arterial ageing process. Also, novel treatment targets derived from the disease models such as the Hutchinson Gilford Progeria Syndrome were reviewed.
C1 [Lee, Seung-Jun; Park, Sung-Ha] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
RP Park, SH (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM SHPARK0530@yuhs.ac
OI Park, Sungha/0000-0001-5362-478X; Lee, Seung-Jun/0000-0002-9201-4818
CR Aponte MMP, 2012, CURR CARDIOL REP, V14, P433, DOI 10.1007/s11886-012-0275-9
   Benetos A, 2002, CIRCULATION, V105, P1202, DOI 10.1161/hc1002.105135
   Capell BC, 2008, P NATL ACAD SCI USA, V105, P15902, DOI 10.1073/pnas.0807840105
   Cenni V, 2011, EUR J HISTOCHEM, V55, P200, DOI 10.4081/ejh.2011.e36
   Chae CU, 2001, HYPERTENSION, V38, P399, DOI 10.1161/01.HYP.38.3.399
   Damjanov I, 1996, ANDERSONS PATHOLOGY
   Duprez DA, 2006, J HYPERTENS, V24, P983, DOI 10.1097/01.hjh.0000226182.60321.69
   Edwards NC, 2009, J AM COLL CARDIOL, V54, P505, DOI 10.1016/j.jacc.2009.03.066
   EGASHIRA K, 1993, CIRCULATION, V88, P77, DOI 10.1161/01.CIR.88.1.77
   Fishbein GA, 2009, ARCH PATHOL LAB MED, V133, P1309, DOI 10.1043/1543-2165-133.8.1309
   Galarraga B, 2009, RHEUMATOLOGY, V48, P1418, DOI 10.1093/rheumatology/kep251
   Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251
   Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0
   Glynn MW, 2005, HUM MOL GENET, V14, P2959, DOI 10.1093/hmg/ddi326
   Guerin AP, 2001, CIRCULATION, V103, P987
   Guo F, 2009, BIOCHEM BIOPH RES CO, V390, P942, DOI 10.1016/j.bbrc.2009.10.082
   Hongo M, 2011, CIRC J, V75, P2660, DOI 10.1253/circj.CJ-11-0497
   Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761
   Inoue Nobutaka, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P227
   Ishibashi M, 2004, CIRC RES, V94, P1203, DOI 10.1161/01.RES.0000126924.23467.A3
   JIANG YL, 1992, J IMMUNOL, V148, P2423
   Kovacic JC, 2011, CIRCULATION, V123, P1650, DOI 10.1161/CIRCULATIONAHA.110.007021
   Kumar V., 2005, ROBBINS COTRAN PATHO
   Lacolley P, 2002, CIRCULATION, V106, P2848, DOI 10.1161/01.CIR.0000039328.33137.6C
   Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236
   Lefevre C, 2010, ARTERIOSCL THROM VAS, V30, P2611, DOI 10.1161/ATVBAHA.110.213603
   Li ZH, 1999, HYPERTENSION, V33, P116, DOI 10.1161/01.HYP.33.1.116
   Ma TKW, 2010, BRIT J PHARMACOL, V160, P1273, DOI 10.1111/j.1476-5381.2010.00750.x
   Mahmud A, 2005, HYPERTENSION, V46, P1118, DOI 10.1161/01.HYP.0000185463.27209.b0
   Mahmud A, 2004, J RENIN-ANGIO-ALDO S, V5, P102, DOI 10.3317/jraas.2004.025
   MAJESKY MW, 1991, J CLIN INVEST, V88, P904, DOI 10.1172/JCI115393
   Maki-Petaja KM, 2006, CIRCULATION, V114, P1185, DOI 10.1161/CIRCULATIONAHA.105.601641
   Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102
   Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f
   Mancia G, 2007, EUR HEART J, V28, P1462, DOI 10.1093/eurheartj/ehm236
   Mans RA, 2012, NEUROSCIENCE, V202, P1, DOI 10.1016/j.neuroscience.2011.12.007
   Masugata H, 2012, J ATHEROSCLER THROMB, V19, P747
   Mattace-Raso FUS, 2004, ATHEROSCLEROSIS, V176, P111, DOI 10.1016/j.atherosclerosis.2004.04.014
   Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655
   Munakata M, 2004, AM J HYPERTENS, V17, P1050, DOI 10.1016/j.amjhyper.2004.06.028
   Nagano M, 2005, ATHEROSCLEROSIS, V180, P189, DOI 10.1016/j.atherosclerosis.2004.11.019
   Nehme JA, 2005, J MOL CELL CARDIOL, V39, P511, DOI 10.1016/j.yjmcc.2005.05.015
   Park S, 2007, J HYPERTENS, V25, P1279, DOI 10.1097/HJH.0b013e3280f31b6e
   Park S, 2012, YONSEI MED J, V53, P258, DOI 10.3349/ymj.2012.53.2.258
   Pasceri V, 2001, CIRCULATION, V103, P2531
   Provan SA, 2011, J RHEUMATOL, V38, P606, DOI 10.3899/jrheum.100689
   Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056
   Reunert J, 2012, EUR J HUM GENET, V20, P933, DOI 10.1038/ejhg.2012.36
   Rodriguez-Manas L, 2009, AGING CELL, V8, P226, DOI 10.1111/j.1474-9726.2009.00466.x
   Sawabe M, 2010, GERIATR GERONTOL INT, V10, pS213, DOI 10.1111/j.1447-0594.2010.00603.x
   Shahin Y, 2012, ATHEROSCLEROSIS, V221, P18, DOI 10.1016/j.atherosclerosis.2011.12.005
   SMITH EB, 1995, EUR HEART J, V16, P11, DOI 10.1093/eurheartj/16.suppl_A.11
   Takami T, 2003, HYPERTENS RES, V26, P609, DOI 10.1291/hypres.26.609
   TSUJIMOTO G, 1986, J PHARMACOL EXP THER, V239, P411
   van Bussel BC, 2011, HYPERTENSION, V58, P588, DOI 10.1161/HYPERTENSIONAHA.111.174557
   Wang M, 2007, HYPERTENSION, V50, P219, DOI 10.1161/HYPERTENSIONAHA.107.089409
   Yildiz G, 2007, ANN NY ACAD SCI, V1100, P353, DOI 10.1196/annals.1395.038
   Yildiz M, 2008, KARDIOL POL, V66, P1194
NR 58
TC 31
Z9 33
U1 1
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 73
EP 79
DI 10.4070/kcj.2013.43.2.73
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800001
PM 23508642
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, JY
AF Choi, Jae Young
TI Transcatheter Closure of Secundum Atrial Septal Defect in Patients Over
   60 Years Old
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ELDERLY-PATIENTS; DEVICE CLOSURE
C1 Yonsei Univ, Coll Med, Yonsei Univ Hlth Syst, Div Pediat Cardiol,Severance Cardiovasc Hosp, Seoul 120752, South Korea.
RP Choi, JY (corresponding author), Yonsei Univ, Coll Med, Yonsei Univ Hlth Syst, Div Pediat Cardiol,Severance Cardiovasc Hosp, 50 Yonsei Ro, Seoul 120752, South Korea.
EM cjy0122@yuhs.ac
OI Choi, Jae Young/0000-0002-1247-6669
CR Elshershari H, 2008, J INVASIVE CARDIOL, V20, P173
   Ewert P, 2001, CATHETER CARDIO INTE, V52, P177, DOI 10.1002/1522-726X(200102)52:2<177::AID-CCD1043>3.0.CO;2-G
   Holzer R, 2005, CATHETER CARDIO INTE, V64, P513, DOI 10.1002/ccd.20315
   Kim NK, 2011, KOREAN CIRC J, V41, P633, DOI 10.4070/kcj.2011.41.11.633
   Peters B, 2006, Clin Res Cardiol, V95, P88, DOI 10.1007/s00392-006-0329-3
   Schubert S, 2005, CATHETER CARDIO INTE, V64, P333, DOI 10.1002/ccd.20292
   Spies Christian, 2009, Korean Circulation Journal, V39, P47
   Swan L, 2006, INT J CARDIOL, V107, P207, DOI 10.1016/j.ijcard.2005.03.027
   Taniguchi M, 2009, CATHETER CARDIO INTE, V73, P682, DOI 10.1002/ccd.21870
   Woo SB, 2013, KOREAN CIRC J, V43, P110, DOI 10.4070/kcj.2013.43.2.110
NR 10
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 80
EP 81
DI 10.4070/kcj.2013.43.2.80
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800002
PM 23509593
OA Green Published
DA 2021-04-22
ER

PT J
AU Kanat, M
   Vardi, S
   Arinc, H
   Gunduz, H
   Erdem, A
   Karagoz, Y
AF Kanat, Mustafa
   Vardi, Seref
   Arinc, Huseyin
   Gunduz, Huseyin
   Erdem, Alim
   Karagoz, Yalcin
TI Evaluation of Cardiac Functions with Tissue Doppler Imaging in
   Prediabetic Subjects
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Type 2 diabetes mellitus; Diabetic cardiomyopathies; Tissue Doppler
   imaging; Glucose intolerance
ID DIABETIC CARDIOMYOPATHY; HEART-FAILURE; DISEASE; ABNORMALITIES;
   DYSFUNCTION; MORTALITY; MELLITUS; RAT
AB Background and Objectives: The aim of the present study was to evaluate left ventricle systolic and diastolic function, using tissue Doppler echocardiography (TDE), in relation to blood glucose status in prediabetic patients who had no evidence of heart disease by conventional echocardiography (CE).
   Subjects and Methods: We included 60 patients (30 female, 30 male) and 20 healthy controls (10 male, 10 female). All participants were randomised into four groups according to their oral glucose tolerance test. Group-I consisted of those patients who had only impaired fasting glucose (IFG). group-II consisted of patients who had only impaired glucose tolerance (IGT) and group-III consisted of patients who had both IFG and IGT, that is so-called combined glucose intolerance. Group-IV included the healthy controls. All subjects underwent both CE and TDE.
   Results: No significant differences were found among the four groups in terms of CE. There was no significant difference between group-IV and group-I with respect to the early peak diastolic velocity (Ea) of medial mitral annulus (11.65 +/- 0.66 vs. 9.72 +/- 1.58, p>0.05), whereas a statistically significant difference was found between group-IV and group-II (11.65 +/- 0.66 vs. 9.06 +/- 1.07, p<0.001) and between group-IV and group-III (11.65 +/- 0.66 vs. 9.74 +/- 1.09, p<0.05).
   Conclusion: Diastolic myocardial dysfunction in prediabetic patients may be identified by quantitative TDE before the appearance of CE indices of myocardial dysfunction.
C1 [Kanat, Mustafa] Istanbul Medipol Univ, Dept Internal Med, Istanbul, Turkey.
   [Vardi, Seref; Karagoz, Yalcin] Abant Izzet Baysal Univ, Izzet Baysal Med Sch, Dept Internal Med, Bolu, Turkey.
   [Arinc, Huseyin; Gunduz, Huseyin; Erdem, Alim] Abant Izzet Baysal Univ, Izzet Baysal Med Sch, Dept Cardiol, Bolu, Turkey.
RP Kanat, M (corresponding author), Medipol Mega Hosp Complex, Dept Internal Med, TR-34214 Istanbul, Turkey.
EM mustafa.kanat@gmail.com
RI Gunduz, Huseyin/B-2279-2017
CR Astorri E, 1997, CLIN CARDIOL, V20, P536, DOI 10.1002/clc.4960200606
   BELL DSH, 1995, DIABETES CARE, V18, P708, DOI 10.2337/diacare.18.5.708
   Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530
   Dokainish H, 2004, CURR OPIN CARDIOL, V19, P437, DOI 10.1097/01.hco.0000131538.55528.8f
   Fang ZY, 2004, ENDOCR REV, V25, P543, DOI 10.1210/er.2003-0012
   GALDERISI M, 1991, AM J CARDIOL, V68, P85, DOI 10.1016/0002-9149(91)90716-X
   Garcia-Fernandez MA, 1999, EUR HEART J, V20, P496, DOI 10.1053/euhj.1998.1278
   Golfman Leonard S., 1996, Diabetes Research and Clinical Practice, V31, pS73, DOI 10.1016/0168-8227(96)01233-8
   Iozzo P, 2002, DIABETES, V51, P3020, DOI 10.2337/diabetes.51.10.3020
   KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035
   KING H, 1993, DIABETES CARE, V16, P157, DOI 10.2337/diacare.16.1.157
   KLEINMAN JC, 1988, AM J EPIDEMIOL, V128, P389, DOI 10.1093/oxfordjournals.aje.a114979
   LITWIN SE, 1990, J CLIN INVEST, V86, P481, DOI 10.1172/JCI114734
   Mizushige K, 2000, CIRCULATION, V101, P899, DOI 10.1161/01.CIR.101.8.899
   Paulus WJ, 1998, EUR HEART J, V19, P990
   Piccini JP, 2004, AM J MED, V116, P64, DOI 10.1016/j.amjmed.2003.10.021
   POGATSA G, 1979, ACTA DIABETOL LAT, V16, P129, DOI 10.1007/BF02581092
   Poirier P, 2001, DIABETES CARE, V24, P5, DOI 10.2337/diacare.24.1.5
   REGAN TJ, 1981, CIRC RES, V49, P1268, DOI 10.1161/01.RES.49.6.1268
   ROBILLON JF, 1994, DIABETES METAB, V20, P473
   RODRIGUES B, 1995, J MOL CELL CARDIOL, V27, P169, DOI 10.1016/S0022-2828(08)80016-8
   SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072
   Shindler DM, 1996, AM J CARDIOL, V77, P1017, DOI 10.1016/S0002-9149(97)89163-1
   Sutherland G R, 1994, J Am Soc Echocardiogr, V7, P441
   TAHILIANI AG, 1986, LIFE SCI, V38, P959, DOI 10.1016/0024-3205(86)90229-8
NR 25
TC 3
Z9 5
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 82
EP 86
DI 10.4070/kcj.2013.43.2.82
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800003
PM 23508684
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, HJ
   Ahn, Y
   Kim, KH
   Park, JC
   Choi, DJ
   Han, S
   Jeon, ES
   Cho, MC
   Kim, JJ
   Yoo, BS
   Shin, MS
   Seong, IW
   Kang, SM
   Kim, YJ
   Kim, HS
   Chae, SC
   Oh, BH
   Lee, MM
   Ryu, KH
AF Yoon, Hyun Ju
   Ahn, Youngkeun
   Kim, Kye Hun
   Park, Jong Chun
   Choi, Dong-Ju
   Han, Seongwoo
   Jeon, Eun-Seok
   Cho, Myung-Chan
   Kim, Jae-Joong
   Yoo, Byung-Su
   Shin, Mi-Seung
   Seong, In-Whan
   Kang, Seok-Min
   Kim, Yung-Jo
   Kim, Hyung Seop
   Chae, Shung Chull
   Oh, Byung-Hee
   Lee, Myung-Mook
   Ryu, Kyu-Hyung
CA Korea HF Registry
TI The Prognostic Implication of Metabolic Syndrome in Patients with Heart
   Failure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Metabolic syndrome; Heart failure
ID RISK-FACTORS; CARDIOVASCULAR-DISEASE; OBESITY; MORTALITY; DIAGNOSIS;
   UPDATE
AB Background and Objectives: Metabolic syndrome (MetS) increases the risk of heart failure (HF). The purpose of this study was to identify the prevalence of MetS in patients with HF and determine the syndrome's association with HF in clinical and laboratory parameters.
   Subjects and Methods: A total of 3200 HF patients (67.6 +/- 14.5 years) enrolled in a nationwide prospective Korea HF Registry between Jan. 2005 and Oct. 2009. Patients were divided into two groups according to the presence or absence of MetS at admission: group I (presence, n=1141) and group II (absence, n=2059).
   Results: The prevalence of MetS was 35.7% across all subjects and was higher in females (56.0%). The levels of white blood cells, platelets, creatinine, glucose, and cholesterol were significantly higher in group I than in group II. Left ventricular dimension and volume was smaller and ejection fraction was higher in group I than in group II. An ischemic cause of HF was more frequent in group I. The rates of valvular and idiopathic cause were lower in group I than in group II. The rate of mortality was lower in group I than in group II (4.9% vs. 8.3%, p<0.001).
   Conclusion: Despite the increased cardiovascular risks in MetS, MetS was found to be associated with decreased mortality in HF.
C1 [Yoon, Hyun Ju; Ahn, Youngkeun; Kim, Kye Hun; Park, Jong Chun] Chonnam Natl Univ Hosp, Dept Cardiol, Kwangju 501757, South Korea.
   [Choi, Dong-Ju] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Cardiol, Songnam, South Korea.
   [Han, Seongwoo] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Dept Cardiol, Seoul, South Korea.
   [Jeon, Eun-Seok] Sungkyunkwan Univ, Samsung Med Ctr, Coll Med, Dept Cardiol, Seoul, South Korea.
   [Cho, Myung-Chan] Chungbuk Natl Univ, Coll Med, Dept Cardiol, Cheongju, South Korea.
   [Kim, Jae-Joong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul, South Korea.
   [Yoo, Byung-Su] Yonsei Univ, Wonju Christian Hosp, Dept Cardiol, Wonju, South Korea.
   [Shin, Mi-Seung] Gachon Univ, Gil Hosp, Dept Cardiol, Inchon, South Korea.
   [Seong, In-Whan] Chungnam Natl Univ Hosp, Dept Cardiol, Taejon, South Korea.
   [Kang, Seok-Min] Yonsei Univ, Severance Hosp, Dept Cardiol, Seoul 120749, South Korea.
   [Kim, Yung-Jo] Yeungnam Univ, Coll Med, Dept Cardiol, Taegu, South Korea.
   [Kim, Hyung Seop] Keimyung Univ, Coll Med, Dept Cardiol, Taegu, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ, Coll Med, Dept Cardiol, Pusan, South Korea.
   [Oh, Byung-Hee] Seoul Natl Univ, Coll Med, Dept Cardiol, Seoul, South Korea.
   [Lee, Myung-Mook] Dongguk Univ, Coll Med, Dept Cardiol, Ilsan Hosp, Goyang, South Korea.
   [Ryu, Kyu-Hyung] Hallym Univ, Dongtan Sacred Heart Hosp, Coll Med, Dept Cardiol, Seoul, South Korea.
RP Ahn, Y (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiol, 671 Jaebong Ro, Kwangju 501757, South Korea.
EM cecilyk@hanmail.net
RI Oh, Byung-Hee/G-9875-2011
OI Oh, Byung-Hee/0000-0002-9945-4306; Jeong, Jin-Ok/0000-0003-0763-4754;
   Seong, In-Whan/0000-0003-4628-0258
FU National Research Foundation of Korea - Korean Government (MEST),
   Republic of Korea [2010-0020261]; Korea Healthcare Technology R&D
   Project, Ministry for Health, Welfare & Family Affairs, Republic of
   Korea [A084869]
FX This work was supported by a grant from the National Research Foundation
   of Korea funded by the Korean Government (MEST), Republic of Korea
   (2010-0020261), and by a grant from the Korea Healthcare Technology R&D
   Project, Ministry for Health, Welfare & Family Affairs, Republic of
   Korea (A084869).
CR Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Butler J, 2006, J AM COLL CARDIOL, V47, P1595, DOI 10.1016/j.jacc.2005.12.046
   Chen YT, 1999, AM J MED, V106, P605, DOI 10.1016/S0002-9343(99)00126-6
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Denys K, 2009, ACTA CLIN BELG, V64, P23, DOI 10.1179/acb.2009.006
   Dinh W, 2011, ACTA CARDIOL, V66, P167, DOI 10.1080/AC.66.2.2071247
   ERIKSSON H, 1989, EUR HEART J, V10, P647, DOI 10.1093/oxfordjournals.eurheartj.a059542
   Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444
   Horwich TB, 2001, J AM COLL CARDIOL, V38, P789, DOI 10.1016/S0735-1097(01)01448-6
   Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586
   Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68
   Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289
   Kalantar-Zadeh K, 2004, J AM COLL CARDIOL, V43, P1439, DOI 10.1016/j.jacc.2003.11.039
   Kannell WB, 1999, ARCH INTERN MED, V159, P1197, DOI 10.1001/archinte.159.11.1197
   Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245
   Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557
   MARANTZ PR, 1988, CIRCULATION, V77, P607, DOI 10.1161/01.CIR.77.3.607
   McNeill AM, 2006, J AM GERIATR SOC, V54, P1317, DOI 10.1111/j.1532-5415.2006.00862.x
   Mechanick JI, 2005, COMMUNICATION
   하종원, 2005, Korean Circulation Journal, V35, P865
   Oh SW, 2004, OBES RES, V12, P2031, DOI 10.1038/oby.2004.254
   Park HS, 2008, OBES REV, V9, P104, DOI 10.1111/j.1467-789X.2007.00421.x
   Qiao Q, 2007, ANN CLIN BIOCHEM, V44, P232, DOI 10.1258/000456307780480963
   SOUFER R, 1985, AM J CARDIOL, V55, P1032, DOI 10.1016/0002-9149(85)90741-6
   Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204
   Thethi Tina, 2006, Heart Fail Clin, V2, P1, DOI 10.1016/j.hfc.2005.11.006
   Wang JJ, 2007, EUR HEART J, V28, P857, DOI 10.1093/eurheartj/ehl524
   Wang JJ, 2010, ATHEROSCLEROSIS, V210, P237, DOI 10.1016/j.atherosclerosis.2009.10.042
   WHO (World Health Organisation), 1999, DEF DIAGN CLASS DI 1
NR 29
TC 2
Z9 2
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 87
EP 92
DI 10.4070/kcj.2013.43.2.87
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800004
PM 23508725
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, YC
   Yang, TH
   Kim, DI
   Jin, HY
   Chung, SR
   Seo, JS
   Jang, JS
   Kim, DK
   Kim, DK
   Kim, KH
   Seol, SH
   Kim, DS
AF Han, Yang-Chun
   Yang, Tae-Hyun
   Kim, Doo-Il
   Jin, Han-Young
   Chung, Sang-Ryul
   Seo, Jeong-Sook
   Jang, Jae-Sik
   Kim, Dae-Kyeong
   Kim, Dong-Kie
   Kim, Ki-Hun
   Seol, Sang-Hoon
   Kim, Dong-Soo
TI Neutrophil to Lymphocyte Ratio Predicts Long-Term Clinical Outcomes in
   Patients with ST-Segment Elevation Myocardial Infarction Undergoing
   Primary Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Neutrophils; Lymphocytes; Myocardial infarction
ID LEUKOCYTE COUNT; MORTALITY; ASSOCIATION; DISEASE; ATHEROSCLEROSIS; RISK
AB Background and Objectives: A higher neutrophil to lymphocyte ratio (NLR) has been associated with poor clinical outcomes in various cardiac diseases. However, the clinical availability of NLR in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) has not been known. We evaluated the availability of NLR to predict clinical outcomes in patients with STEMI undergoing primary PCI.
   Subjects and Methods: We analyzed 326 consecutive STEMI patients treated with primary PCI. The patients were divided into tertiles according to NLR: NLR <= 3.30 (n=108), 3.31<NLR <= 6.52 (n=108) and NLR>6.53 (n=110). We evaluated the incidence of major adverse cardiac events (MACE), a composite of all causes of death, non-fatal MI, and ischemic stroke at the 12-month follow-up.
   Results: The high NLR group was associated with a significantly higher rate of 12-month MACE (19.1% vs. 3.7%, p<0.001), 12-month death (18.2% vs. 2.8%, p<0.001), in-hospital MACE (12.7% vs. 2.8%, p=0.010) and in-hospital death (12.7% vs. 1.9%, p=0.003) compared to the low NLR group. In the multivariable model, high NLR was an independent predictor of 12-month MACE {hazard ratio (HR) 3.33 (1.09-10.16), p=0.035} and death {HR 4.10 (1.17-14.46), p=0.028} after adjustment for gender, left ventricular ejection fraction, creatinine clearance, angiographic parameters and factors included in the Thrombolysis in Myocardial Infarction risk score for STEMI. There was a significant gradient of 12-month MACE across the NLR tertiles with a markedly increased MACE hazard in the high NLR group (log rank test p=0.002).
   Conclusion: The NLR is a useful marker to predict 12-month MACE and death in patients with STEMI who have undergone primary PCI.
C1 [Han, Yang-Chun] Changwon Fatima Hosp, Dept Internal Med, Div Cardiol, Chang Won, South Korea.
   [Yang, Tae-Hyun; Jin, Han-Young; Chung, Sang-Ryul; Seo, Jeong-Sook; Jang, Jae-Sik; Kim, Dae-Kyeong; Kim, Dong-Soo] Inje Univ, Coll Med, Cardiovasc Res Inst, Div Cardiol,Dept Internal Med,Busan Paik Hosp, Pusan 614735, South Korea.
   [Kim, Doo-Il; Kim, Dong-Kie; Kim, Ki-Hun; Seol, Sang-Hoon] Inje Univ, Coll Med, Haeundae Paik Hosp, Cardiovasc Res Inst, Pusan 614735, South Korea.
RP Yang, TH (corresponding author), Inje Univ, Coll Med, Cardiovasc Res Inst, Div Cardiol,Dept Internal Med,Busan Paik Hosp, 75 Bokji Ro, Pusan 614735, South Korea.
EM yangthmd@naver.com
RI Jang, Jae-Sik/B-4379-2015
OI Jang, Jae-Sik/0000-0001-7865-124X
CR Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062
   Baldus S, 2003, CIRCULATION, V108, P1440, DOI 10.1161/01.CIR.0000090690.67322.51
   Barron HV, 2000, CIRCULATION, V102, P2329, DOI 10.1161/01.CIR.102.19.2329
   BLUM A, 1994, AM HEART J, V127, P1226, DOI 10.1016/0002-8703(94)90040-X
   Cho KH, 2011, AM J CARDIOL, V107, P849, DOI 10.1016/j.amjcard.2010.10.067
   Duffy BK, 2006, AM J CARDIOL, V97, P993, DOI 10.1016/j.amjcard.2005.10.034
   Furman MI, 1996, AM J CARDIOL, V78, P945, DOI 10.1016/S0002-9149(96)00473-0
   Furman MI, 2004, AM HEART J, V147, P42, DOI 10.1016/j.ahj.2003.07.003
   Gibson PH, 2007, AM HEART J, V154, P995, DOI 10.1016/j.ahj.2007.06.043
   Gibson PH, 2010, AM J CARDIOL, V105, P186, DOI 10.1016/j.amjcard.2009.09.007
   Hoffman M, 2004, ATHEROSCLEROSIS, V172, P1, DOI 10.1016/S0021-9150(03)00164-3
   Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054
   Kirtane AJ, 2004, AM J CARDIOL, V93, P532, DOI 10.1016/j.amjcard.2003.11.013
   Lee HY, 2011, KOREAN CIRC J, V41, P68, DOI 10.4070/kcj.2011.41.2.68
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Nunez J, 2008, AM J CARDIOL, V101, P747, DOI 10.1016/j.amjcard.2007.11.004
   Ommen SR, 1997, AM J CARDIOL, V79, P812, DOI 10.1016/S0002-9149(96)00878-8
   Ott I, 1998, AM J CARDIOL, V82, P938, DOI 10.1016/S0002-9149(98)00509-8
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006
   Tousoulis D, 2006, CYTOKINE GROWTH F R, V17, P225, DOI 10.1016/j.cytogfr.2006.04.003
   Uthamalingam S, 2011, AM J CARDIOL, V107, P433, DOI 10.1016/j.amjcard.2010.09.039
   Widmer A, 2003, CARDIOLOGY, V99, P25, DOI 10.1159/000068448
NR 23
TC 50
Z9 53
U1 0
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 93
EP 99
DI 10.4070/kcj.2013.43.2.93
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800005
PM 23508782
OA Green Published
DA 2021-04-22
ER

PT J
AU Sim, DS
   Jeong, MH
   Cho, KH
   Ahn, Y
   Kim, YJ
   Chae, SC
   Hong, TJ
   Seong, IW
   Chae, JK
   Kim, CJ
   Cho, MC
   Rha, SW
   Bae, JH
   Seung, KB
   Park, SJ
AF Sim, Doo Sun
   Jeong, Myung Ho
   Cho, Kyung Hoon
   Ahn, Youngkeun
   Kim, Young Jo
   Chae, Shung Chull
   Hong, Taek Jong
   Seong, In Whan
   Chae, Jei Keon
   Kim, Chong Jin
   Cho, Myeong Chan
   Rha, Seung-Woon
   Bae, Jang Ho
   Seung, Ki Bae
   Park, Seung Jung
CA Other Korea Acute Myocardial
TI Effect of Early Statin Treatment in Patients with Cardiogenic Shock
   Complicating Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angioplasty; Myocardial infarction; Shock
ID ASSOCIATION TASK-FORCE; AUTONOMIC DYSFUNCTION PREDICTS; CORONARY-ARTERY
   DISEASE; IN-HOSPITAL INITIATION; ST-ELEVATION; AMERICAN-COLLEGE; FOCUSED
   UPDATE; MURINE MODEL; THERAPY; MANAGEMENT
AB Background and Objectives: The benefit of early statin treatment following acute myocardial infarction (MI) complicated with cardiogenic shock (CS) has not been well studied. We sought to assess the effect of early statin therapy in patients with CS complicating acute MI.
   Subjects and Methods: We studied 553 statin-naive patients with acute MI and CS (Killip class IV) who underwent revascularization therapy between November 2005 and January 2008 at 51 hospitals in the Korea Acute Myocardial Infarction Registry. Patients were divided into 2 groups: those who received statins during hospitalization (n=280) and those who did not (n=273). The influence of statin treatment on a 12-month clinical outcome was examined using a matched-pairs analysis (n=200 in each group) based on the propensity for receiving statin therapy during hospitalization.
   Results: Before adjustment, patients receiving statin, compared to those not receiving statin, had a more favorable clinical profile, were less likely to suffer procedural complications, and more likely to receive adequate medical therapy. Patients receiving statin had lower unadjusted in-hospital mortality and composite rate of mortality, MI, and repeat revascularization at 12 months, which remained significantly lower after adjustment for patient risk, procedural characteristics, and treatment propensity.
   Conclusion: In CS patients with acute MI undergoing revascularization therapy, early statin treatment initiated during hospitalization was associated with lower rates of in-hospital death and 12-month adverse cardiac events.
C1 [Sim, Doo Sun; Jeong, Myung Ho; Cho, Kyung Hoon; Ahn, Youngkeun] Chonnam Natl Univ, Coll Med, Dept Cardiovasc Med, Kwangju, South Korea.
   [Kim, Young Jo] Yeungnam Univ, Coll Med, Dept Cardiol, Taegu, South Korea.
   [Chae, Shung Chull] Kyungpuk Natl Univ, Coll Med, Dept Cardiol, Taegu, South Korea.
   [Hong, Taek Jong] Busan Natl Univ, Coll Med, Dept Cardiol, Pusan, South Korea.
   [Seong, In Whan] Chungnam Natl Univ, Coll Med, Dept Cardiol, Taejon, South Korea.
   [Chae, Jei Keon] Chonbuk Natl Univ, Coll Med, Dept Cardiol, Jeonju, South Korea.
   [Kim, Chong Jin] Kyung Hee Univ, Coll Med, Dept Cardiovasc Med, Seoul, South Korea.
   [Cho, Myeong Chan] Chungbuk Natl Univ, Coll Med, Dept Cardiol, Cheongju, South Korea.
   [Rha, Seung-Woon] Korea Univ, Coll Med, Guro Hosp, Dept Cardiol, Seoul 136705, South Korea.
   [Bae, Jang Ho] Konyang Univ, Coll Med, Dept Cardiol, Taejon, South Korea.
   [Seung, Ki Bae] Catholic Univ Korea, Coll Med, Dept Cardiovasc Med, Seoul, South Korea.
   [Park, Seung Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul, South Korea.
RP Jeong, MH (corresponding author), Korea Minist Hlth Welf & Family Affairs, Chonnam Natl Univ Hosp, Heart Res Ctr, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
OI Jeong, Jin-Ok/0000-0003-0763-4754; Hur, Seung-Ho/0000-0002-3895-1915;
   Seong, In-Whan/0000-0003-4628-0258; CHO, KYUNG HOON/0000-0002-0377-6352
FU Korean Circulation Society
FX This study was performed with the support of the Korean Circulation
   Society in commemoration of its 50th Anniversary.
CR Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1
   Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209
   Arntz HR, 2000, AM J CARDIOL, V86, P1293, DOI 10.1016/S0002-9149(00)01230-3
   Aronow HD, 2003, ARCH INTERN MED, V163, P2576, DOI 10.1001/archinte.163.21.2576
   D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B
   Fonarow GC, 2005, AM J CARDIOL, V96, P611, DOI 10.1016/j.amjcard.2005.04.029
   Garot P, 2010, EUROINTERVENTION, V6, P350, DOI 10.4244/EIJV6I3A58
   Goldberg RJ, 2009, CIRCULATION, V119, P1211, DOI 10.1161/CIRCULATIONAHA.108.814947
   Gu XS., 1993, J COMPUT GRAPH STAT, V2, P405, DOI DOI 10.1080/10618600.1993.10474623
   Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0
   Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236
   Hochman JS, 2007, JAMA-J AM MED ASSOC, V297, P1657
   Joffe MM, 1999, AM J EPIDEMIOL, V150, P327
   Kim MC, 2011, INT HEART J, V52, P1, DOI 10.1536/ihj.52.1
   Krumholz HM, 2008, CIRCULATION, V118, P2596, DOI 10.1161/CIRCULATIONAHA.108.191099
   Li YH, 2007, INT HEART J, V48, P677, DOI 10.1536/ihj.48.677
   Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195
   Merx MW, 2004, CIRCULATION, V109, P2560, DOI 10.1161/01.CIR.0000129774.09737.5B
   Muhlestein JB, 2001, AM J CARDIOL, V87, P257, DOI 10.1016/S0002-9149(00)01354-0
   Pruefer D, 2002, CIRCULATION, V106, P2104, DOI 10.1161/01.CIR.0000034048.38910.91
   Schmidt H, 2008, CRIT CARE MED, V36, P967, DOI 10.1097/CCM.0B013E3181653263
   Schmidt H, 2006, INTENS CARE MED, V32, P1248, DOI 10.1007/s00134-006-0246-y
   Schmidt H, 2005, CRIT CARE MED, V33, P1994, DOI 10.1097/01.CCM.0000178181.91250.99
   Sim Doo Sun, 2009, Korean Circ J, V39, P297, DOI 10.4070/kcj.2009.39.8.297
   Sim DS, 2010, J CARDIOL, V56, P1, DOI 10.1016/j.jjcc.2010.04.002
   Spencer FA, 2004, ANN INTERN MED, V140, P857, DOI 10.7326/0003-4819-140-11-200406010-00006
   Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321
   Wright RS, 2011, CIRCULATION, V123, P2022, DOI 10.1161/CIR.0b013e31820f2f3e
NR 28
TC 17
Z9 17
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 100
EP 109
DI 10.4070/kcj.2013.43.2.100
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800006
PM 23508129
OA Green Published
DA 2021-04-22
ER

PT J
AU Woo, SB
   Jang, SI
   Kim, SH
   Kim, SJ
   Lee, SY
   Baek, JS
   Shim, WS
AF Woo, Saet Byul
   Jang, So-Ick
   Kim, Seong-Ho
   Kim, Soo-Jin
   Lee, Sang-Yun
   Baek, Jae-Sook
   Shim, Woo-Sup
TI Transcatheter Closure of Secundum Atrial Septal Defect in Patients Over
   60 Years Old
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial septal defect; Septal occluder device; Elderly
ID FOLLOW-UP; SURGICAL CLOSURE; ELDERLY-PATIENTS; DEVICE CLOSURE;
   HEART-FAILURE; ADULTS; FIBRILLATION; OCCLUDERS; REPAIR; TRIAL
AB Background and Objectives: Atrial septal defect (ASD) is the one of most common congenital heart diseases detected in adults. Along with remarkable development of device technology, the first treatment strategy of secundum ASD has been transcatheter closure in feasible cases. However, there are only a few publications regarding the results of transcatheter closure of ASD in elderly patients, especially those over 60 years of age. We report our results of transcatheter closure of ASD in patients over 60 years old.
   Subjects and Methods: Between May 2006 and December 2011, 31 patients over 60 years old (25 female and 6 male; mean 66.7 +/- 5.25 years old, range 61-78 years old) were referred to our center.
   Results: A total of 23 patients underwent therapeutic catheterization to close secundum ASD, and the closure was successful in 22 patients (95.7%). All patients who underwent the procedure survived except for one patient who expired because of left ventricular dysfunction. A small residual shunt was observed in two (9%) of 21 patients before discharge but disappeared at follow-up. All patients eventually had complete closure. There were five patients who had coronary problems. One patient underwent percutaneous coronary intervention using a stent at the same time as transcatheter closure of ASD. Atrial arrhythmias were detected in 6 of 23 patients (26.1%) before the procedure. One patient was successfully treated by radiofrequency ablation before the procedure. No patients displayed new onset arrhythmia during the follow-up period. Follow-up echocardiographic evaluation showed a significantly improved right ventricular geometry.
   Conclusion: We conclude that transcatheter closure of ASD is a safe and an effective treatment method for patients over 60 years old if the procedure is performed under a thorough evaluation of comorbidities and risk factors.
C1 [Woo, Saet Byul] Hallym Univ, Med Ctr, Dept Pediat, Seoul, South Korea.
   [Jang, So-Ick; Kim, Seong-Ho; Lee, Sang-Yun; Baek, Jae-Sook; Shim, Woo-Sup] Sejong Gen Hosp, Sejong Heart Inst, Dept Pediat, Puchon 422711, South Korea.
   [Kim, Soo-Jin] Konkuk Univ Hosp, Dept Pediat, Seoul, South Korea.
RP Jang, SI (corresponding author), Sejong Gen Hosp, Sejong Heart Inst, Dept Pediat, 28 Hohyeon Ro 489beon Gil, Puchon 422711, South Korea.
EM prelud15@korea.com
RI Kim, Soo-Jin/P-2677-2014
OI Kim, Soo-Jin/0000-0001-9671-6019
CR Attie F, 2001, J AM COLL CARDIOL, V38, P2035, DOI 10.1016/S0735-1097(01)01635-7
   BEYER J, 1978, ANN THORAC SURG, V25, P36, DOI 10.1016/S0003-4975(10)63484-4
   BOUTIN C, 1993, CIRCULATION, V88, P621, DOI 10.1161/01.CIR.88.2.621
   Chessa M, 2002, J AM COLL CARDIOL, V39, P1061, DOI 10.1016/S0735-1097(02)01711-4
   Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI 10.1016/S0735-1097(02)01862-4
   Elshershari H, 2008, J INVASIVE CARDIOL, V20, P173
   Ewert P, 2001, CATHETER CARDIO INTE, V52, P177, DOI 10.1002/1522-726X(200102)52:2<177::AID-CCD1043>3.0.CO;2-G
   Giardini A, 2009, INT J CARDIOL, V134, P47, DOI 10.1016/j.ijcard.2008.02.003
   HARJULA A, 1988, J CARDIOVASC SURG, V29, P134
   Holzer R, 2004, CURR OPIN CARDIOL, V19, P84, DOI 10.1097/00001573-200403000-00003
   Kim NK, 2011, KOREAN CIRC J, V41, P633, DOI 10.4070/kcj.2011.41.11.633
   Koenig Peter, 2003, J Interv Cardiol, V16, P51, DOI 10.1046/j.1540-8183.2003.08003.x
   KONSTANTINIDES S, 1995, NEW ENGL J MED, V333, P469, DOI 10.1056/NEJM199508243330801
   Masura J, 2005, J AM COLL CARDIOL, V45, P505, DOI 10.1016/j.jacc.2004.10.066
   Miyaji K, 1997, JPN HEART J, V38, P677
   MURPHY JG, 1990, NEW ENGL J MED, V323, P1645, DOI 10.1056/NEJM199012133232401
   Podnar T, 2001, CATHETER CARDIO INTE, V53, P386, DOI 10.1002/ccd.1187
   Schubert S, 2005, CATHETER CARDIO INTE, V64, P333, DOI 10.1002/ccd.20292
   Spies Christian, 2009, Korean Circulation Journal, V39, P47
   Swan L, 2006, INT J CARDIOL, V107, P207, DOI 10.1016/j.ijcard.2005.03.027
   Taniguchi M, 2009, CATHETER CARDIO INTE, V73, P682, DOI 10.1002/ccd.21870
   Zanchetta M, 2003, J AM COLL CARDIOL, V42, P1677, DOI 10.1016/j.jacc.2003.08.023
NR 22
TC 5
Z9 7
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 110
EP 114
DI 10.4070/kcj.2013.43.2.110
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800007
PM 23508193
OA Green Published
DA 2021-04-22
ER

PT J
AU Finsterer, J
   Stollberger, C
   Steger, C
   Gatterer, E
AF Finsterer, Josef
   Stoellberger, Claudia
   Steger, Christine
   Gatterer, Edmund
TI Catheter Ablation of Multiple Accessory Pathways in Duchenne Muscular
   Dystrophy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Arrhythmia; Tachycardia; supraventricular; Catheter ablation; Muscular
   dystrophies
ID PARKINSON-WHITE-SYNDROME
AB A 23-year-old male with Duchenne muscular dystrophy (DMD) experienced self-limiting palpitations at age 19 years for the first time. Palpitations recurred not earlier than at age 23 years, and were attributed to narrow complex tachycardia, which could be terminated with adenosine. Since electrocardiography showed a delta-wave, Wolff-Parkinson-White (WPW) syndrome was diagnosed, ajmaline prescribed and radio-frequency catheter ablation of three accessory pathways carried out one week later. One day after ablation, however, a relapse of the supraventricular tachycardia occurred and was terminated with ajmaline. Re-entry tachycardia occurred a second time six days after ablation, and as before, it was stopped only with ajmaline. Despite administration of verapamil to prevent tachycardia, it occurred a third time four months after ablation. This case shows that cardiac involvement in DMD may manifest also as WPW-syndrome. In these patients, repeated radio-frequency catheter ablation of accessory pathways may be necessary to completely block the re-entry mechanism.
C1 [Finsterer, Josef] Krankenanstalt Rudolfstiftung Wien, A-1180 Vienna, Austria.
   [Stoellberger, Claudia; Steger, Christine; Gatterer, Edmund] Krankenanstalt Rudolfstiftung Wien, Dept Med 2, A-1180 Vienna, Austria.
RP Finsterer, J (corresponding author), Krankenanstalt Rudolfstiftung Wien, A-1180 Vienna, Austria.
EM fifigs1@yahoo.de
CR Agarwal R K, 1973, Indian Heart J, V25, P346
   Bodalski R, 2008, KARDIOL POL, V66, P1346
   Cay Serkan, 2008, Indian Pacing Electrophysiol J, V8, P141
   Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446
   Finsterer J, 2008, HERZ, V33, P307, DOI 10.1007/s00059-008-3023-6
   Ghosh S, 2008, CIRCULATION, V118, P907, DOI 10.1161/CIRCULATIONAHA.108.781658
   Kirchmann C, 2005, PEDIATR CARDIOL, V26, P66, DOI 10.1007/s00246-004-0689-2
   Light Peter E, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS158, DOI 10.1111/j.1540-8167.2006.00399.x
   Sethi K K, 2007, J Assoc Physicians India, V55 Suppl, P10
   Symons A L, 2002, ASDC J Dent Child, V69, P277
   Tischenko A, 2008, CURR OPIN CARDIOL, V23, P32, DOI 10.1097/HCO.0b013e3282f26d1b
   Weiss C, 2007, MUSCLE NERVE, V35, P396, DOI 10.1002/mus.20705
NR 12
TC 1
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 115
EP 118
DI 10.4070/kcj.2013.43.2.115
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800008
PM 23508228
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, DI
   Park, SW
   Kook, H
   Kim, W
   Kim, DH
   Lee, S
   Oh, SK
   Kim, YH
AF Lee, Dae In
   Park, Sang Weon
   Kook, Hyungdon
   Kim, Woohyeun
   Kim, Dong Hyeok
   Lee, Sunki
   Oh, Suk-Kyu
   Kim, Young-Hoon
TI Unusual Polymorphic Ventricular Tachycardia Originating from the
   Pulmonary Artery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ventricular tachycardia; Pulmonary artery; Radiofrequency catheter
   ablation
ID FIBRILLATION; ABLATION; HEART; QT
AB We report a case about a 27-year-old healthy young male who developed syncope during exercise, which was subsequently identified to be attributable to non-sustained polymorphic ventricular tachycardia (VT). Occurrence of polymorphic VT was neither related to a prolonged QT interval nor a fixed short coupling interval. Standard examinations including echocardiography, coronary angiography, isoproterenol infusion study, and cardiac MRI showed no structural heart disease. On the electrophysiology study, activation mapping revealed that a discrete potential preceded the premature ventricular complex (PVC) triggered polymorphic VT, which was recorded just above the pulmonary valve. After radiofrequency ablation at this area, PVC and polymorphic VT disappeared and did not recur after a 2 month follow up.
C1 [Lee, Dae In; Park, Sang Weon; Kook, Hyungdon; Kim, Woohyeun; Kim, Dong Hyeok; Lee, Sunki; Oh, Suk-Kyu; Kim, Young-Hoon] Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 136705, South Korea.
RP Park, SW (corresponding author), Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, 73 Inchon Ro, Seoul 136705, South Korea.
EM cardio@medimail.co.kr
CR Haissaguerre M, 2002, CIRCULATION, V106, P962, DOI 10.1161/01.CIR.0000027564.55739.B1
   Haissaguerre M, 2003, CIRCULATION, V108, P925, DOI 10.1161/01.CIR.0000088781.99943.95
   Hasdemir C, 2007, PACE, V30, P534, DOI 10.1111/j.1540-8159.2007.00704.x
   Mechleb BK, 2006, PACE, V29, P791, DOI 10.1111/j.1540-8159.2006.00437.x
   Viskin S, 1998, PROG CARDIOVASC DIS, V41, P17, DOI 10.1016/S0033-0620(98)80020-0
   Weerasooriya R, 2003, HERZ, V28, P598, DOI 10.1007/s00059-003-2491-y
   Ya J, 1998, CIRC RES, V82, P464, DOI 10.1161/01.RES.82.4.464
NR 7
TC 5
Z9 6
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 119
EP 122
DI 10.4070/kcj.2013.43.2.119
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800009
PM 23508287
OA Green Published
DA 2021-04-22
ER

PT J
AU Song, SH
   Suh, SE
   Jin, SM
   Moon, JH
   Cho, YK
   Lim, SW
AF Song, Sang Hee
   Suh, Seong Eun
   Jin, Sun Mi
   Moon, Jie Hye
   Cho, Yun Kyung
   Lim, Sang Wook
TI Myocardial Ischemia Caused by Paroxysmal Supraventricular Tachycardia in
   a Patient with Anomalous Origin of Right Coronary Artery Arising from
   Left Sinus of Valsalva
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessel anomalies; Tachycardia; paroxysmal; Myocardial ischemia;
   Multidetector computed tomography
AB Anomalous origin of a coronary artery is rare and does not generally lead to myocardial infarction and paroxysmal supraventricular tachycardia (PSVT). We report an uncommon case of anomalous origin of the right coronary artery (RCA) originating from the left sinus of Valsalva with PSVT and myocardial ischemia. A 58-year-old man presented with PSVT. After arrhythmia subsided, electrocardiogram showed ST and T wave abnormalities, and transient cardiac enzymes were found to be elevated. Coronary CT angiography confirmed that there was anomalous origin of the RCA originating from the left sinus of Valsalva and no intracoronary stenotic lesion. He was managed with conservative treatment, having no symptoms on clinical follow-up for 4 years.
C1 [Song, Sang Hee; Suh, Seong Eun; Jin, Sun Mi; Moon, Jie Hye] CHA Univ, CHA Bundang Med Ctr, Coll Med, Dept Internal Med, Songnam, South Korea.
   [Cho, Yun Kyung] CHA Univ, Gangnam CHA Hosp, Dept Internal Med, Cardiol Div,Coll Med, Seoul 135913, South Korea.
   [Lim, Sang Wook] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Cardiol Div,Coll Med, Songnam, South Korea.
RP Cho, YK (corresponding author), CHA Univ, Gangnam CHA Hosp, Dept Internal Med, Cardiol Div,Coll Med, 566 Nonhyeon Ro, Seoul 135913, South Korea.
EM yunkyung.cho@gmail.com
CR Angelini P, 2002, CIRCULATION, V105, P2449, DOI 10.1161/01.CIR.0000016175.49835.57
   Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0
   Dogan Sait Mesut, 2006, Int J Cardiol, V112, pe57, DOI 10.1016/j.ijcard.2006.03.063
   Earls JP, 2006, TECH VASC INTERV RAD, V9, P210, DOI 10.1053/j.tvir.2007.03.007
   KIMBIRIS D, 1978, CIRCULATION, V58, P606, DOI 10.1161/01.CIR.58.4.606
   Lee Bae Young, 2009, Korean Circ J, V39, P175, DOI 10.4070/kcj.2009.39.5.175
   Mirchandani S, 2005, INT J CARDIOL, V102, P383, DOI 10.1016/j.ijcard.2004.10.010
   Reul RM, 2002, TEX HEART I J, V29, P299
   Tariq R, 2012, EUR J RADIOL, V81, P1790, DOI 10.1016/j.ejrad.2011.05.034
   Turer AT, 2011, J AM COLL CARDIOL, V57, P2398, DOI 10.1016/j.jacc.2010.11.066
   Vincelj J, 2010, INT J CARDIOL, V142, pE35, DOI 10.1016/j.ijcard.2008.11.182
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
   박정수, 2008, Korean Circulation Journal, V38, P627
   김준석, 2004, Korean Circulation Journal, V34, P711
NR 14
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 123
EP 126
DI 10.4070/kcj.2013.43.2.123
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800010
PM 23508331
OA Green Published
DA 2021-04-22
ER

PT J
AU Jeong, EH
   Kim, BJ
   Bang, KB
   So, MS
   Sung, KC
   Kim, JT
   Kong, JH
   Kim, TH
AF Jeong, Eun Haeng
   Kim, Byung Jin
   Bang, Ki Bae
   So, Min Suk
   Sung, Ki Chul
   Kim, Jung Tae
   Kong, Joon Hyuk
   Kim, Tae Ho
TI Saccular Coronary Artery Aneurysm and Fistula with Organized Thrombi
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary aneurysm; Coronary vessels; arterio-arterial fistula
AB Saccular coronary artery aneurysm, associated with coronary artery fistula, is a very rare condition. A 48-year-old woman was referred to our hospital for the evaluation of an abnormal shadow on the left cardiac border from a chest X-ray film during regular medical health examination. A huge saccular aneurysm with organized thrombi in the proximal left anterior descending artery (LAD) and coronary artery fistulae from LAD and conus branch of the right coronary artery to pulmonary artery was diagnosed by transthoracic echocardiography, multi-detector computer tomography (MDCT), and coronary angiography. The patient received surgical treatment, including thrombectomy of aneurysm, ligation of the inlet and outlet of aneurysmal sac, coronary artery bypass graft (left internal mammary artery-to-distal LAD), and ligation of fistulae. The postoperative course was uneventful, and postoperative echocardiography and MDCT revealed patent bypass graft; however, a small fistula from proximal LAD across aneurysmal sac to pulmonary artery was observed.
C1 [Jeong, Eun Haeng; Kim, Byung Jin; Bang, Ki Bae; So, Min Suk; Sung, Ki Chul] Sungkyunkwan Univ, Sch Med, Dept Internal Med, Kangbuk Samsung Hosp, Seoul 110746, South Korea.
   [Kim, Jung Tae; Kong, Joon Hyuk] Sungkyunkwan Univ, Sch Med, Dept Cardiovasc & Thorac Surg, Kangbuk Samsung Hosp, Seoul 110746, South Korea.
   [Kim, Tae Ho] Sungkyunkwan Univ, Sch Med, Dept Cardiovasc & Thorac Surg, Samsung Med Ctr, Seoul 110746, South Korea.
RP Kim, BJ (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Internal Med, Kangbuk Samsung Hosp, 29 Saemunan Ro, Seoul 110746, South Korea.
EM bjjake.kim@samsung.com
RI KIM, JUNG TAE/AAC-8582-2020
CR Anne W, 2000, ACTA CARDIOL, V55, P307, DOI 10.2143/AC.55.5.2005758
   Carr JA, 2006, J CARDIAC SURG, V21, P188, DOI 10.1111/j.1540-8191.2006.00209.x
   DAOUD AS, 1963, AM J CARDIOL, V11, P228, DOI 10.1016/0002-9149(63)90064-X
   Gunduz H, 2004, JPN HEART J, V45, P331, DOI 10.1536/jhj.45.331
   Gziut Aneta I, 2008, Pol Arch Med Wewn, V118, P741
   Hirooka K, 2002, CIRC J, V66, P525, DOI 10.1253/circj.66.525
   Kimura Satoshi, 2006, Asian Cardiovasc Thorac Ann, V14, P422
   Li DY, 2005, J THORAC CARDIOV SUR, V130, P817, DOI 10.1016/j.jtcvs.2005.04.004
   MARKIS JE, 1976, AM J CARDIOL, V37, P217, DOI 10.1016/0002-9149(76)90315-5
   Nakamura K, 2010, ANN THORAC CARDIOVAS, V16, P354
   Nichols L, 2008, ARCH PATHOL LAB MED, V132, P823, DOI 10.1043/1543-2165(2008)132[823:CAAARA]2.0.CO;2
   Syed M, 1997, PROG CARDIOVASC DIS, V40, P77, DOI 10.1016/S0033-0620(97)80024-2
   UENO T, 1992, AM HEART J, V124, P1388, DOI 10.1016/0002-8703(92)90434-W
   Yu W, 2001, ASIAN CARDIOVASC THO, V9, P215
NR 14
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 127
EP 131
DI 10.4070/kcj.2013.43.2.127
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800011
PM 23508346
OA Green Published
DA 2021-04-22
ER

PT J
AU Min, SY
   Shin, JH
   Lee, SW
   Doo, E
   Kim, BK
   Won, YW
   Park, HC
   Choi, SI
   Kim, SG
AF Min, Seung Yeon
   Shin, Jeong Hun
   Lee, Sung-Won
   Doo, Eunyoung
   Kim, Bae Keun
   Won, Young-Woong
   Park, Hwan-Cheol
   Choi, Sung Il
   Kim, Soon Gil
TI A Case of Deep Vein Thrombosis after Coronary Angiography in a Patient
   Using Antidepressants and Anxiolytics
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Venous thrombosis; Coronary angiography; Venous thromboembolism
ID VENOUS THROMBOEMBOLISM; CARDIAC-CATHETERIZATION; PULMONARY-EMBOLISM;
   AMBULATION; RISK
AB Deep vein thrombosis (DVT) is a rare but potentially serious complication of coronary angiography (CAG) affecting just under 5 in 10000 patients. Most of the cases regarding DVT after CAG reported in the literature were associated with procedure-related vascular complications or with risk factors for venous thromboembolism (VTE). Here, we describe the case of a 50-year-old woman during treatment for anxiety disorder, who developed significant DVT after CAG without a history of VTE and with no significant risk factors for VTE, which was treated with an anticoagulant. This case reminds us that clinicians should consider the possible occurrence of VTE after diagnostic CAG even in patients without significant risk factors.
C1 [Min, Seung Yeon; Shin, Jeong Hun; Lee, Sung-Won; Doo, Eunyoung; Kim, Bae Keun; Won, Young-Woong; Park, Hwan-Cheol; Choi, Sung Il; Kim, Soon Gil] Hanyang Univ, Coll Med, Dept Internal Med, Devis Cardiol, Guri 471701, South Korea.
RP Shin, JH (corresponding author), Hanyang Univ, Coll Med, Guri Hosp, Devis Cardiol,Dept Internal Med, 153 Gyeongchun Ro, Guri 471701, South Korea.
EM cardio.hyapex@gmail.com
RI Shin, Jeong Hun/O-1273-2019; Won, Young-Woong/C-9794-2015
OI Shin, Jeong Hun/0000-0002-6718-9763; Choi, Seongil/0000-0001-5927-8574;
   Won, Young-Woong/0000-0001-6209-8339
CR Anderson FA, 2003, CIRCULATION, V107, pI9, DOI 10.1161/01.CIR.0000078469.07362.E6
   Bangalore S, 2011, CIRCULATION, V124, pE147, DOI 10.1161/CIRCULATIONAHA.111.032235
   Chhatriwalla Adnan K, 2006, J Invasive Cardiol, V18, P109
   Chhatriwalla AK, 2006, MAYO CLIN PROC, V81, P1535, DOI 10.4065/81.12.1535
   Doyle BJ, 2006, MAYO CLIN PROC, V81, P1537, DOI 10.4065/81.12.1537
   Elikowski W, 2011, KARDIOL POL, V69, P596
   Filis Konstantinos, 2007, Hellenic J Cardiol, V48, P134
   Jick SS, 2008, PHARMACOTHERAPY, V28, P144, DOI 10.1592/phco.28.2.144
   Lacut K, 2007, FUND CLIN PHARMACOL, V21, P643, DOI 10.1111/j.1472-8206.2007.00515.x
   Merli GJ, 2006, CLIN GERIATR MED, V22, P75, DOI 10.1016/j.cger.2005.09.012
   SHAMMAS RL, 1993, CATHETER CARDIO DIAG, V30, P223, DOI 10.1002/ccd.1810300309
   Tandar Anwar, 2007, EuroIntervention, V3, P345, DOI 10.4244/EIJV3I3A63
NR 12
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 132
EP 134
DI 10.4070/kcj.2013.43.2.132
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800012
PM 23508451
OA Green Published
DA 2021-04-22
ER

PT J
AU Chae, MJ
   Yu, CW
   Lee, SY
   Jang, DH
   Hyun, JY
   Jeong, SJ
   Kim, MH
AF Chae, Myung Joon
   Yu, Cheol Woong
   Lee, Soo Yeon
   Jang, Duck Hyun
   Hyun, Joo Yong
   Jeong, Su Jin
   Kim, Myoung Hwan
TI Takayasu's Disease in a Patient with Ulcerative Colitis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Takayasu arteritis; Colitis; ulcerative; Human leukocyte antigen-B52
   antigen
ID INFLAMMATORY-BOWEL-DISEASE; ARTERITIS; ASSOCIATION
AB A 35-year-old Korean man with a 10-year history of ulcerative colitis (UC) presented with pain and swelling of the right neck. The patient was diagnosed with Takayasu's arteritis (TA) and had human leukocyte antigen (HLA) B-52, which is frequently found in patients having both UC and Takayasu's disease concurrently on HLA analysis. This case is the first report of a patient with both TA and UC in Korea, to the best of our knowledge.
C1 [Chae, Myung Joon; Yu, Cheol Woong; Lee, Soo Yeon; Jang, Duck Hyun; Hyun, Joo Yong] Sejong Gen Hosp, Div Cardiol, Dept Internal Med, Puchon 422711, South Korea.
   [Jeong, Su Jin] Sejong Gen Hosp, Div Endocrinol, Dept Internal Med, Puchon 422711, South Korea.
   [Kim, Myoung Hwan] Sejong Gen Hosp, Div Gastroenterol, Dept Internal Med, Puchon 422711, South Korea.
RP Yu, CW (corresponding author), Sejong Gen Hosp, Div Cardiol, Dept Internal Med, 28 Hohyeon Ro 489beon Gil, Puchon 422711, South Korea.
EM ycw717@naver.com
CR AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129
   Balamtekin N, 2009, ACTA PAEDIATR, V98, P1368, DOI 10.1111/j.1651-2227.2009.01330.x
   Bansal R, 2003, INT J CARDIOL, V88, P91, DOI 10.1016/S0167-5273(02)00371-6
   Choe JW, 1997, KOREAN J GASTROINTES, V17, P860
   Danese S, 2005, WORLD J GASTROENTERO, V11, P7227, DOI 10.3748/wjg.v11.i46.7227
   Eichhorn J, 1996, CIRCULATION, V94, P2396, DOI 10.1161/01.CIR.94.10.2396
   Hokama A, 2003, INTERNAL MED, V42, P897, DOI 10.2169/internalmedicine.42.897
   IKENAGA H, 1989, POSTGRAD MED J, V65, P761, DOI 10.1136/pgmj.65.768.761
   Kim ES, 2010, GUT LIVER, V4, P1, DOI 10.5009/gnl.2010.4.1.1
   Koide K, 1992, Heart Vessels Suppl, V7, P48, DOI 10.1007/BF01744544
   Lee Si Hyung, 2008, Korean J Gastroenterol, V52, P315
   Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063
   Morita Y, 1996, INTERNAL MED, V35, P574, DOI 10.2169/internalmedicine.35.574
   Nishimoto N, 2008, ARTHRITIS RHEUM, V58, P1197, DOI 10.1002/art.23373
   Numano F, 1996, INTERNAL MED, V35, P521, DOI 10.2169/internalmedicine.35.521
   SATO R, 1994, INTERNAL MED, V33, P759, DOI 10.2169/internalmedicine.33.759
NR 16
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 135
EP 138
DI 10.4070/kcj.2013.43.2.135
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800013
PM 23508490
OA Green Published
DA 2021-04-22
ER

PT J
AU Gokdeniz, T
   Aykan, AC
   Celik, S
   Boyaci, F
AF Gokdeniz, Tayyar
   Aykan, Ahmet Cagri
   Celik, Sukru
   Boyaci, Faruk
TI A New Method for Patent Foramen Ovale Closure: Delivering Sheath Over
   Coronary Sinus Catheter into Left Atrium
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Foramen ovale; patent; Amplatzer septal occluder; Coronary sinus
   catheter
AB Patent foramen ovale (PFO) is a frequent condition. It usually does not pose any threat to life, but in certain circumstances, it can open and serve as a conduit for thrombi causing paradoxical embolism. Herein, we report a case of PFO in a patient with ischemic cerebrovascular accident, due to paradoxical embolism, which could not be passed via general practice; hence it was crossed with coronary sinus catheter, through which the delivery sheath was placed into the left atrium, and it was successfully closed.
C1 [Gokdeniz, Tayyar; Aykan, Ahmet Cagri; Celik, Sukru; Boyaci, Faruk] Ahi Evren Chest & Cardiovasc Surg Educ & Res Hosp, Dept Cardiol, TR-61040 Trabzon, Turkey.
RP Aykan, AC (corresponding author), Ahi Evren Chest & Cardiovasc Surg Educ & Res Hosp, Dept Cardiol, Soguksu Mah Camlik Cad, TR-61040 Trabzon, Turkey.
EM ahmetaykan@yahoo.com
RI Aykan, Ahmet C/J-6549-2017
OI Aykan, Ahmet C/0000-0001-5793-7978
CR Calvert PA, 2011, NAT REV CARDIOL, V8, P148, DOI 10.1038/nrcardio.2010.224
   HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X
   Mas JL, 2001, NEW ENGL J MED, V345, P1740, DOI 10.1056/NEJMoa011503
NR 3
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 139
EP 141
DI 10.4070/kcj.2013.43.2.139
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800014
PM 23508551
OA Green Published
DA 2021-04-22
ER

PT J
AU Opolski, MP
   Kotlinski, K
   Wnuk, J
   Kepka, C
   Witkowski, A
AF Opolski, Maksymilian P.
   Kotlinski, Krzysztof
   Wnuk, Jacek
   Kepka, Cezary
   Witkowski, Adam
TI Ischemia-Driven Computed Tomography-Guided Revascularization of Chronic
   Total Occlusion Missed by Conventional Angiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Opolski, Maksymilian P.; Witkowski, Adam] Inst Cardiol, Dept Intervent Cardiol & Angiol, PL-04628 Warsaw, Poland.
   [Kotlinski, Krzysztof] Inst Cardiol, Dept Cardiac Surg & Transplantol, PL-04628 Warsaw, Poland.
   [Wnuk, Jacek] Inst Cardiol, Dept Nucl Med, PL-04628 Warsaw, Poland.
   [Kepka, Cezary] Inst Cardiol, Dept Coronary Artery Dis & Struct Heart Dis, PL-04628 Warsaw, Poland.
RP Opolski, MP (corresponding author), Inst Cardiol, Dept Intervent Cardiol & Angiol, Alpejska 42, PL-04628 Warsaw, Poland.
EM maxopol@gmail.com
OI Opolski, Maksymilian/0000-0001-9577-345X
CR ARNETT EN, 1979, ANN INTERN MED, V91, P350, DOI 10.7326/0003-4819-91-3-350
   Opolski MP, 2012, AM J CARDIOL, V109, P1722, DOI 10.1016/j.amjcard.2012.02.015
   Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626
   Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277
NR 4
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2013
VL 43
IS 2
BP 142
EP 143
DI 10.4070/kcj.2013.43.2.142
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FI
UT WOS:000342383800015
PM 23509594
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, SH
   Choi, BW
AF Hwang, Sung Ho
   Choi, Byoung Wook
TI Advanced Cardiac MR Imaging for Myocardial Characterization and
   Quantification: T1 Mapping
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Magnetic resonance imaging; Myocardium; Gadolinium; Fibrosis; Myocardial
   infarction
ID CARDIOVASCULAR MAGNETIC-RESONANCE; INVERSION-RECOVERY MOLLI; DELAYED
   ENHANCEMENT; DIAGNOSTIC-ACCURACY; CONTRAST AGENTS; HEART-FAILURE;
   INFARCTION; FIBROSIS; VOLUME; DYSFUNCTION
AB Magnetic resonance as an imaging modality provides an excellent soft tissue differentiation, which is an ideal choice for cardiac imaging. Cardiac magnetic resonance (CMR) allows myocardial tissue characterization, as well as comprehensive evaluation of the structures. Although late gadolinium enhancement after injection of the gadolinium extracellular contrast agent has further extended our ability to characterize the myocardial tissue, it also has limitations in the quantification of enhanced myocardial tissue pathology, and the detection of diffuse myocardial disease, which is not easily recognized by enhancement contrast. Recently, the remarkable advances in CMR technique, such as T1 mapping, which can quantitatively evaluate myocardial status, showed potentials to overcome limitations of existing CMR sequences and to expand the application of CMR. This article will review the technical and clinical points to be considered in the practical use of pre-and post-contrast T1 mapping.
C1 [Hwang, Sung Ho; Choi, Byoung Wook] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea.
RP Choi, BW (corresponding author), Yosei Univ, Coll Med, Severance Hosp, Dept Cardiovasc Radiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM bchoi@yuhs.ac
CR Abdel-Aty H, 2004, CIRCULATION, V109, P2411, DOI 10.1161/01.CIR.0000127428.10985.C6
   Abdel-Aty H, 2007, J NUCL MED, V26, P452
   Arai AE, 2011, J CARDIOVASC PHARM T, V16, P313, DOI 10.1177/1074248411412378
   Arheden H, 1999, RADIOLOGY, V211, P698, DOI 10.1148/radiology.211.3.r99jn41698
   Bello D, 2003, CIRCULATION, V108, P1945, DOI 10.1161/01.CIR.0000095029.57483.60
   BOTTOMLEY PA, 1984, MED PHYS, V11, P425, DOI 10.1118/1.595535
   Broberg CS, 2010, CIRC-CARDIOVASC IMAG, V3, P727, DOI 10.1161/CIRCIMAGING.108.842096
   Callot V, 2007, J MAGN RESON IMAGING, V26, P52, DOI 10.1002/jmri.20995
   Croisille P, 2006, EUR RADIOL, V16, P1951, DOI 10.1007/s00330-006-0244-z
   Cummings KW, 2009, RADIOGRAPHICS, V29, P89, DOI 10.1148/rg.291085052
   Dall'Armellina E, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-15
   Ferreira V, 2012, J CARDIOVASC MAGN S1, V14, P179
   Ferreira VM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-42
   Foltz WD, 2006, MAGN RESON MED, V56, P1311, DOI 10.1002/mrm.21079
   Friedrich MG, 2010, NAT REV CARDIOL, V7, P292, DOI 10.1038/nrcardio.2010.28
   Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007
   Gai N, 2011, MAGN RESON MED, V65, P1407, DOI 10.1002/mrm.22716
   JUDD RM, 1991, CIRC RES, V68, P217, DOI 10.1161/01.RES.68.1.217
   JUDD RM, 1995, MAGNET RESON MED, V33, P215, DOI 10.1002/mrm.1910330211
   Karamitsos TD, 2009, J AM COLL CARDIOL, V54, P1407, DOI 10.1016/j.jacc.2009.04.094
   Kawel N, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-27
   Kehr E, 2008, INT J CARDIOVAS IMAG, V24, P61, DOI 10.1007/s10554-007-9223-y
   Kwong RY, 2008, CIRCULATION, V118, P1011, DOI 10.1161/CIRCULATIONAHA.107.727826
   Kwong RY, 2006, CIRCULATION, V113, P2733, DOI 10.1161/CIRCULATIONAHA.105.570648
   Lee JJ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-75
   Maceira AM, 2005, CIRCULATION, V111, P186, DOI 10.1161/01.CIR.0000152819.97857.9D
   Mahrholdt H, 2005, EUR HEART J, V26, P1461, DOI 10.1093/eurheartj/ehi258
   McCrohon A, 2003, CIRCULATION, V108, P54, DOI 10.1161/01.CIR.0000078641.19365.4C
   Messroghli DR, 2007, J MAGN RESON IMAGING, V26, P1081, DOI 10.1002/jmri.21119
   Messroghli DR, 2007, MAGN RESON MED, V58, P34, DOI 10.1002/mrm.21272
   Messroghli DR, 2011, CIRC-CARDIOVASC IMAG, V4, P636, DOI 10.1161/CIRCIMAGING.111.966796
   Messroghli DR, 2006, RADIOLOGY, V238, P1004, DOI 10.1148/radiol.2382041903
   Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110
   Mewton N, 2011, J AM COLL CARDIOL, V57, P891, DOI 10.1016/j.jacc.2010.11.013
   Payne AR, 2011, CIRC-CARDIOVASC IMAG, V4, P210, DOI 10.1161/CIRCIMAGING.110.960450
   Piechnik SK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-69
   Scheffler K, 2001, MAGNET RESON MED, V45, P720, DOI 10.1002/mrm.1097
   Ugander M, 2012, EUR HEART J, V33, P1268, DOI 10.1093/eurheartj/ehr481
   Wansapura J, 2006, MAGN RESON IMAGING, V24, P889, DOI 10.1016/j.mri.2006.04.016
   Willinek WA, 2010, RADIOLOGY, V256, P966, DOI 10.1148/radiol.10092127
   Wong TC, 2012, CIRCULATION, V126, P1206, DOI 10.1161/CIRCULATIONAHA.111.089409
   Zhang YT, 1998, JMRI-J MAGN RESON IM, V8, P675, DOI 10.1002/jmri.1880080324
NR 42
TC 11
Z9 11
U1 1
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2013
VL 43
IS 1
BP 1
EP 6
DI 10.4070/kcj.2013.43.1.1
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FG
UT WOS:000342383600001
PM 23408722
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JH
   Kwon, NH
   Kim, JH
   Ko, YJ
   Ryu, SH
   Ahn, SJ
   Kim, YJ
   Baeg, JY
   Kim, JI
AF Park, Jae Hyun
   Kwon, Nak Hyun
   Kim, Jun Hwan
   Ko, Yu Jin
   Ryu, Seo Hee
   Ahn, Seok Jin
   Kim, Young Jung
   Baeg, Joo Yeong
   Kim, Jung Im
TI Prevalence of Congenital Coronary Artery Anomalies of Korean Men
   Detected by Coronary Computed Tomography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessel anomalies; Multidetector computed tomography; Prevalence
ID SUDDEN-DEATH; ORIGIN; CT; ANGIOGRAPHY; DIAGNOSIS; YOUNG; ADULTS; SINUS
AB Background and Objectives: It has been demonstrated that the anomalous origin of coronary arteries (AOCA) are generally asymptomatic and rare diseases. However, some cases can cause severe life threatening events. To detect these anomalies, coronary angiographies and autopsies were used to detect coronary artery anomalies, but these procedures have limitations because of their invasiveness. The new device, Multidetector Computed Tomography (MDCT), now replaces the method of choice for detecting coronary anomalies. The prevalence of these anomalies in Korea has not been studied yet. This present analysis attempted to determine the prevalence of AOCA in Korean men by MDCT.
   Subjects and Methods: 1582 Korean male police officers underwent coronary MDCT for their health screening voluntarily. After reconstruction of CT images, we could confirm coronary artery anomalies.
   Results: The prevalence of AOCA in Korean men was 1.14% (18 out of 1582 cases). The most common abnormality (11 cases, 0.70%) was the origin of the coronary artery. Anomalies of the coronary artery end point were observed in 5 cases (0.32%). The anomalous location of coronary ostium on the aortic root was observed in 1 case (0.06%). An anomalous collateral vessel was observed in 1 case (0.06%).
   Conclusion: The prevalence of coronary artery anomalies in Korean men was 1.14%. Coronary CT is a safe and noninvasive modality for detecting coronary anomalies.
C1 [Park, Jae Hyun; Kwon, Nak Hyun; Kim, Jun Hwan; Ko, Yu Jin; Ryu, Seo Hee; Ahn, Seok Jin; Kim, Young Jung; Baeg, Joo Yeong] Natl Police Hosp, Dept Internal Med, Seoul 138708, South Korea.
   [Kim, Jung Im] Human Med Imaging & Intervent Ctr, Seoul, South Korea.
RP Kwon, NH (corresponding author), Natl Police Hosp, Dept Internal Med, 123 Songi Ro, Seoul 138708, South Korea.
EM bemasc@naver.com
CR Andreini D, 2010, INT J CARDIOL, V145, P388, DOI 10.1016/j.ijcard.2010.02.057
   Angelini P, 2002, CIRCULATION, V105, P2449, DOI 10.1161/01.CIR.0000016175.49835.57
   Christner JA, 2010, AM J ROENTGENOL, V194, P881, DOI 10.2214/AJR.09.3462
   Duarte R, 2011, HEART LUNG CIRC, V20, P119, DOI 10.1016/j.hlc.2010.09.005
   Eckart RE, 2004, ANN INTERN MED, V141, P829, DOI 10.7326/0003-4819-141-11-200412070-00005
   Erol C, 2011, J COMPUT ASSIST TOMO, V35, P618, DOI 10.1097/RCT.0b013e31822aef59
   Fujimoto S, 2011, J CARDIOL, V57, P69, DOI 10.1016/j.jjcc.2010.10.006
   Gersony WM, 2007, J AM COLL CARDIOL, V50, P2083, DOI 10.1016/j.jacc.2007.08.023
   Ghersin E, 2004, J COMPUT ASSIST TOMO, V28, P293, DOI 10.1097/00004728-200403000-00022
   Kosar P, 2009, DIAGN INTERV RADIOL, V15, P275, DOI 10.4261/1305-3825.DIR.2550-09.1
   Lee HJ, 2012, RADIOLOGY, V262, P101, DOI 10.1148/radiol.11110823
   Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850
   Mayo JR, 2009, AM J ROENTGENOL, V192, P646, DOI 10.2214/AJR.08.2066
   Pelliccia A, 2001, J AM COLL CARDIOL, V37, P598, DOI 10.1016/S0735-1097(00)01122-0
   Sato Y, 2005, HEART VESSELS, V20, P298, DOI 10.1007/s00380-005-0826-8
   Sources and effects of ionizing radiation, 2000, UNSCEAR 2000 REP GEN
   Sundaram B, 2010, RADIOL CLIN N AM, V48, P711, DOI 10.1016/j.rcl.2010.04.006
   Tariq R, 2012, EUR J RADIOL, V81, P1790, DOI 10.1016/j.ejrad.2011.05.034
   Walker MJ, 2009, INT J CARDIOVAS IMAG, V25, P189, DOI 10.1007/s10554-009-9444-3
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
   Zhang LJ, 2010, NETH HEART J, V18, P466, DOI 10.1007/BF03091817
NR 21
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2013
VL 43
IS 1
BP 7
EP 12
DI 10.4070/kcj.2013.43.1.7
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FG
UT WOS:000342383600002
PM 23407877
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, YH
   Lee, CS
   Yuk, HB
   Yang, DJ
   Park, HW
   Kim, KH
   Kim, WH
   Kwon, TG
   Bae, JH
AF Seo, Young Hoon
   Lee, Chung Seop
   Yuk, Hyung Bin
   Yang, Dong Ju
   Park, Hyun Woong
   Kim, Ki Hong
   Kim, Wan Ho
   Kwon, Taek-Geun
   Bae, Jang-Ho
TI Hypercholesterolemia and In-Vivo Coronary Plaque Composition in Patients
   with Coronary Artery Disease: A Virtual Histology - Intravascular
   Ultrasound Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypercholesterolemia; Coronary artery disease; Ultrasonography;
   Interventional plaque; Atherosclerotic
ID RISK; CLASSIFICATION; LESIONS
AB Background and Objectives: Hypercholesterolemia is a key factor in the development of atherosclerosis. We sought to evaluate the relation between hypercholesterolemia and plaque composition in patients with coronary artery disease.
   Subjects and Methods: Study subjects consisted of 323 patients (mean 61.5 years, 226 males) who underwent coronary angiography and virtual histology-intravascular ultrasound examination. Patients were divided into two groups according to total cholesterol level: hypercholesterolemic group (>= 200 mg/dL, n = 114) and normocholesterolemic group (<200 mg/dL, n = 209).
   Results: Hypercholesterolemic patients were younger (59.7 +/- 13.3 years vs. 62.6 +/- 11.5 years, p= 0.036), than normocholesterolemic patients, whereas there were no significant differences in other demographics. Hypercholesterolemic patients had higher corrected necrotic core volume (1.23 +/- 0.85 mm(3)/mm vs. 1.02 +/- 0.80 mm(3)/mm, p = 0.029) as well as percent necrotic core volume (20.5 +/- 8.5% vs. 18.0 +/- 9.2%, p = 0.016) than normocholesterolemic patients. At the minimal lumen area site, percent necrotic core area (21.4 +/- 10.5% vs. 18.4 +/- 11.3%, p = 0.019) and necrotic core area (1.63 +/- 1.09 mm(2) vs. 1.40 +/- 1.20 mm(2), p = 0.088) were also higher than normocholesterolemic patients. Multivariate linear regression analysis showed that total cholesterol level was an independent factor of percent necrotic core volume in the culprit lesion after being adjusted with age, high density lipoprotein-cholesterol, hypertension, diabetes mellitus, smoking and acute coronary syndrome (beta 0.027, 95% confidence interval 0.02-0.053, p = 0.037).
   Conclusion: Hypercholesterolemia was associated with increased necrotic core volume in coronary artery plaque. This study suggests that hypercholesterolemia plays a role in making plaque more complex, which is characterized by a large necrotic core, in coronary artery disease.
C1 [Seo, Young Hoon; Lee, Chung Seop; Yuk, Hyung Bin; Yang, Dong Ju; Park, Hyun Woong; Kim, Ki Hong; Kim, Wan Ho; Kwon, Taek-Geun; Bae, Jang-Ho] Konyang Univ Hosp, Ctr Heart, Div Cardiol, Taejon 371718, South Korea.
RP Bae, JH (corresponding author), Konyang Univ Hosp, Ctr Heart, Div Cardiol, 158 Gwanjeodong Ro, Taejon 371718, South Korea.
EM janghobae@yahoo.co.kr
OI Seo, Young Hoon/0000-0002-7357-2785
CR Assmann G, 1996, ATHEROSCLEROSIS, V124, pS11, DOI 10.1016/0021-9150(96)05852-2
   Barter P, 2000, ARTERIOSCL THROM VAS, V20, P2029, DOI 10.1161/01.ATV.20.9.2029
   Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Fan Jianglin, 2003, J Atheroscler Thromb, V10, P63
   FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406
   Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430
   Hong MK, 2007, AM J CARDIOL, V100, P953, DOI 10.1016/j.amjcard.2007.04.034
   JangHo Bae, 2007, Korean Circulation Journal, V37, P437
   Jellinger PS, 2012, ENDOCR PRACT, V1, P1, DOI DOI 10.4158/EP.18.S1.1
   Kawaguchi R, 2007, J AM COLL CARDIOL, V50, P1641, DOI 10.1016/j.jacc.2007.06.051
   Kroner ESJ, 2011, AM J CARDIOL, V107, P1725, DOI 10.1016/j.amjcard.2011.02.337
   Marso SP, 2012, JACC-CARDIOVASC IMAG, V5, pS42, DOI 10.1016/j.jcmg.2012.01.008
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Missel E, 2008, AM J CARDIOL, V101, P573, DOI 10.1016/j.amjcard.2007.10.018
   Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97
   Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E
   Nair Anuja, 2007, EuroIntervention, V3, P113
   Nasu K, 2006, J AM COLL CARDIOL, V47, P2405, DOI 10.1016/j.jacc.2006.02.044
   Raichlin E, 2009, J AM COLL CARDIOL, V53, P1279, DOI 10.1016/j.jacc.2008.12.041
   Rodriguez-Granillo GA, 2006, AM HEART J, V151, P1020, DOI 10.1016/j.ahj.2005.06.040
   Steinberg D, 1997, CIRCULATION, V95, P1062
   Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065
   Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262
   홍순준, 2003, Korean Circulation Journal, V33, P465
NR 25
TC 3
Z9 5
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2013
VL 43
IS 1
BP 23
EP 28
DI 10.4070/kcj.2013.43.1.23
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FG
UT WOS:000342383600004
PM 23408780
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, MH
   Bae, YJ
   Lee, HK
   Lee, YR
   Lee, DH
   Bae, K
   Koh, SB
   Namgoong, MK
   Cha, BH
   Lee, HY
AF Kim, Mi Hyun
   Bae, Yon Jung
   Lee, Hyun Keun
   Lee, Yeong Ro
   Lee, Dong Hoon
   Bae, Kiho
   Koh, Sang Baek
   Namgoong, Mee Kyung
   Cha, Byung Ho
   Lee, Hae Yong
TI Interleukin-21 Receptor Gene Polymorphisms in Kawasaki Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mucocutaneous lymph node syndrome; Receptor, Interleukin-21;
   Polymorphism, genetic
ID T-CELLS; IL-21; COSTIMULATION; ACTIVATION
AB Background and Objectives: Interleukin-21 receptor (IL-21R) gene polymorphism is related with the development of systemic vasculitis. In this study, we investigated the polymorphisms of IL-21R gene in patients with Kawasaki disease (KD).
   Subjects and Methods: We genotyped the promoter region of IL-21R gene (-2500 bp to +1 bp) in 100 patients with KD and 100 healthy controls. All study subjects were Korean. We designed five pairs of primers and performed polymerase chain reaction (PCR) and direct sequencing. We analyzed whole promoter sequences of 200 individuals with comparison to reference sequences of IL-21R gene (NG_012222.1/NC_000016.9).
   Results: We found five single nucleotide polymorphisms (SNPs) of which minor allele frequency (MAF) > 0.01 in the promoter region of IL-21R gene. Those are -1681 G > T (chromosome site 27411802), -379 G > A (27413104), -332 G > C (27413151, rs2214537), -237 A > T (27413246), and -53 G > A (27413430). There is no significant difference in MAF of each SNP between patients with KD and healthy controls except -237 A > T. Twenty five patients with KD had more than 1 SNP in contrast to only seven healthy controls had. The patients with KD have significantly more IL-21R gene polymorphisms than controls (odds ratio: 3.0, 95% confidence interval: 1.6-5.6, p = 0.0005). There was no significant correlation between IL-21R gene polymorphisms and the serum level of IL-21. The serum level of total IgE was not significantly correlated with the presence of IL-21R gene polymorphisms.
   Conclusion: Our data suggest that the genetic susceptibility profile for KD may include IL-21R gene.
C1 [Kim, Mi Hyun; Bae, Yon Jung; Lee, Hyun Keun; Namgoong, Mee Kyung; Cha, Byung Ho; Lee, Hae Yong] Yonsei Univ, Wonju Coll Med, Dept Pediat, Wonju 220701, South Korea.
   [Koh, Sang Baek] Yonsei Univ, Wonju Coll Med, Dept Prevent Med, Wonju 220701, South Korea.
   [Lee, Yeong Ro; Lee, Dong Hoon; Bae, Kiho] Yonsei Univ, Coll Sci & Technol, Div Biol Sci & Technol, Wonju 220701, South Korea.
   [Lee, Yeong Ro; Lee, Dong Hoon; Bae, Kiho] Yonsei Univ, Coll Sci & Technol, Yonsei Frauhofer Med Device Lab, Wonju 220701, South Korea.
RP Lee, HY (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Pediat, 162 Ilsan Dong, Wonju 220701, South Korea.
EM reehy@yonsei.ac.kr
OI namgoong, mee kyung/0000-0002-8156-8970
FU Leading Foreign Research Institute Recruitment Program through National
   Research Foundation of Korea (NRF) - Ministry of Education, Science and
   Technology (MEST) [2011-00263]
FX This research was supported partly by Leading Foreign Research Institute
   Recruitment Program through the National Research Foundation of Korea
   (NRF) funded by the Ministry of Education, Science and Technology (MEST)
   (2011-00263). We deeply appreciate the valuable comments of Prof. Dong
   Soo Kim about the B cell differentiation and Kawasaki disease.
CR Ahn HM, 2011, KOREAN CIRC J, V41, P321, DOI 10.4070/kcj.2011.41.6.321
   Bae YJ, 2012, ALLERGY ASTHMA IMMUN, V4, P351, DOI 10.4168/aair.2012.4.6.351
   Bennett F, 2003, J IMMUNOL, V170, P711, DOI 10.4049/jimmunol.170.2.711
   Breunis WB, 2007, CLIN EXP IMMUNOL, V150, P83, DOI 10.1111/j.1365-2249.2007.03457.x
   Bucher C, 2009, BLOOD, V114, P5375, DOI 10.1182/blood-2009-05-221135
   Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1
   Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010
   Caprioli F, 2008, J IMMUNOL, V180, P1800, DOI 10.4049/jimmunol.180.3.1800
   Cheung YF, 2008, PEDIATRICS, V122, pE608, DOI 10.1542/peds.2008-0646
   Chun JK, 2010, EUR J PEDIATR, V169, P181, DOI 10.1007/s00431-009-1002-4
   Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017
   Franco A, 2010, AUTOIMMUNITY, V43, P317, DOI 10.3109/08916930903405891
   Furuno K, 2004, J PEDIATR-US, V145, P385, DOI 10.1016/j.jpeds.2004.05.048
   Gomez-Martin D, 2011, AUTOIMMUN REV, V10, P325, DOI 10.1016/j.autrev.2010.11.007
   Hecker M, 2003, GENES IMMUN, V4, P228, DOI 10.1038/sj.gene.6363954
   Huang FY, 2008, J CLIN IMMUNOL, V28, P405, DOI 10.1007/s10875-008-9203-6
   Jin HL, 2004, J IMMUNOL, V173, P657, DOI 10.4049/jimmunol.173.1.657
   Kawasaki T, 1967, Arerugi, V16, P178
   King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6
   Lee Hong Kyu, 1996, Yonsei Medical Journal, V37, P357
   Linterman MA, 2010, SEMIN IMMUNOPATHOL, V32, P183, DOI 10.1007/s00281-009-0194-z
   Nara H, 2010, BIOCHEM BIOPH RES CO, V392, P171, DOI 10.1016/j.bbrc.2010.01.004
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   Onouchi Y, 2009, PEDIATR RES, V65, p46R, DOI 10.1203/PDR.0b013e31819dba60
   Ozaki K, 2000, P NATL ACAD SCI USA, V97, P11439, DOI 10.1073/pnas.200360997
   Pene J, 2006, J IMMUNOL, V177, P5006, DOI 10.4049/jimmunol.177.8.5006
   Quasney MW, 2001, PEDIATR RES, V49, P686, DOI 10.1203/00006450-200105000-00013
   Sohn MH, 2001, GENES IMMUN, V2, P357, DOI 10.1038/sj.gene.6363785
   Sohn Su Ye, 2011, Korean J Pediatr, V54, P157, DOI 10.3345/kjp.2011.54.4.157
   Yeung RSM, 2010, CURR OPIN RHEUMATOL, V22, P551, DOI 10.1097/BOR.0b013e32833cf051
NR 30
TC 1
Z9 1
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2013
VL 43
IS 1
BP 38
EP 43
DI 10.4070/kcj.2013.43.1.38
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FG
UT WOS:000342383600006
PM 23407404
OA Green Published
DA 2021-04-22
ER

PT J
AU Carrizo, S
   Salinas, P
   Jimenez-Valero, S
   Moreno, R
AF Carrizo, Sebastian
   Salinas, Pablo
   Jimenez-Valero, Santiago
   Moreno, Raul
TI Utility of Optical Coherence Tomography to Assess a Hazy Intracoronary
   Image after Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Tomography, optical coherence; Intravascular ultrasonography; Cardiac
   catheterization; Thrombosis; Stents
ID INTRAVASCULAR ULTRASOUND; ABILITY
AB Although its use in daily practice is not common, optical coherence tomography (OCT) is a powerful research tool in invasive cardiology. This report describes a hazy angiography image after percutaneous coronary intervention that has been assessed using OCT. Based on the results of the OCT, the patient underwent an elective coronary angioplasty with standard anticoagulation. After implantation of the stent, an intracoronary hazy image was seen on angiography. The use of OCT permitted a correct diagnosis and a successful treatment. This paper provides a discussion of the advantages and disadvantages of OCT, and a comparison with intravascular ultrasound.
C1 [Carrizo, Sebastian; Salinas, Pablo; Jimenez-Valero, Santiago; Moreno, Raul] Univ Hosp La Paz, Intervent Cardiol Dept, Madrid 28046, Spain.
RP Carrizo, S (corresponding author), Univ Hosp La Paz, Intervent Cardiol Dept, Serv Cardiol, Secc Hemodinam, Paseo Castellana 261, Madrid 28046, Spain.
EM sebastian_carrizo@live.com
RI Moreno, Raul/AAB-9983-2021; Salinas, Pablo/AAD-7107-2021
OI Salinas, Pablo/0000-0003-4040-4029; Moreno, Raul/0000-0001-7179-1426
CR Bourantas CV, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-2
   Grewal J, 2001, AM J CARDIOL, V87, P1246, DOI 10.1016/S0002-9149(01)01513-2
   Iglesias D, 2011, J CARDIOVASC MED, V12, P743, DOI 10.2459/JCM.0b013e32834a138c
   Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5
   Kawamori H, 2010, J INVASIVE CARDIOL, V22, P541
   Kawasaki M, 2006, J AM COLL CARDIOL, V48, P81, DOI 10.1016/j.jacc.2006.02.062
   Kubo T, 2007, J AM COLL CARDIOL, V50, P933, DOI 10.1016/j.jacc.2007.04.082
   Popma JJ, 2004, CHEST, V126, p576S, DOI 10.1378/chest.126.3_suppl.576S
   Prati F, 2011, HEART, V97, P1841, DOI 10.1136/heartjnl-2011-300782
   Raffel OC, 2008, HEART, V94, P1200, DOI 10.1136/hrt.2007.130765
   Rinaldi MJ, 2008, AM HEART J, V155, P654, DOI 10.1016/j.ahj.2007.11.028
   Stamper D, 2006, J AM COLL CARDIOL, V47, pC69, DOI 10.1016/j.jacc.2005.10.067
NR 12
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2013
VL 43
IS 1
BP 44
EP 47
DI 10.4070/kcj.2013.43.1.44
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FG
UT WOS:000342383600007
PM 23407580
OA Green Published
DA 2021-04-22
ER

PT J
AU Rhew, SH
   Ahn, Y
   Cho, EA
   Kim, MS
   Jang, SY
   Lee, KH
   Lee, MG
   Park, KH
   Sim, DS
   Hong, YJ
   Kim, JH
   Jeong, MH
AF Rhew, Shi Hyun
   Ahn, Youngkeun
   Cho, Eun Ae
   Kim, Min Sok
   Jang, Su Young
   Lee, Ki Hong
   Lee, Min Goo
   Park, Keun Ho
   Sim, Doo Sun
   Hong, Young Joon
   Kim, Ju Han
   Jeong, Myung Ho
TI A Patient with Repeated Catastrophic Multi-Vessel Coronary Spasm after
   Zotarolimus-Eluting Stent Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessels; Spasm; Drug-eluting stents
ID MYOCARDIAL-INFARCTION; VARIANT ANGINA; ARTERY SPASM; HYPERSENSITIVITY;
   MAGNESIUM; DEATH
AB Drug-eluting stents (DES) have gained great popularity because of extraordinarily low rates of restenosis. Despite these superior clinical outcomes, several cases regarding the severe multi-vessel coronary spasm, although rare, after the placement of first generation DES have been reported. We report a case of severe, multi-vessel coronary spasm that occurred two occasions after placement of a zotarolimus-eluting stent, one of the second generation DES, in a 42-year-old man with unstable angina. The first incidence was relieved by intracoronary nitroglycerin alone, and second incident, which had combined fixed stenosis was treated with intracoronary nitroglycerin and everolimus-eluting stent.
C1 [Rhew, Shi Hyun; Ahn, Youngkeun; Cho, Eun Ae; Kim, Min Sok; Jang, Su Young; Lee, Ki Hong; Lee, Min Goo; Park, Keun Ho; Sim, Doo Sun; Hong, Young Joon; Kim, Ju Han; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Dept Cardiol, Ctr Cardiovasc, Kwangju 501757, South Korea.
RP Ahn, Y (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiol, Ctr Cardiol, 42 Jebong Ro, Kwangju 501757, South Korea.
EM cecilyk@hanmail.net
CR Brott Brigitta C, 2006, J Invasive Cardiol, V18, P584
   Butt M, 2009, FUTUR CARDIOL, V5, P141, DOI 10.2217/14796678.5.2.141
   Byrne R A, 2009, Minerva Cardioangiol, V57, P567
   Chuang YT, 2009, CIRC J, V73, P1961, DOI 10.1253/circj.CJ-08-0589
   Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030
   Kim JW, 2005, HEART, V91, DOI 10.1136/hrt.2004.049932
   Koh KK, 1996, CATHETER CARDIO DIAG, V37, P132
   Kounis Nicholas G, 2007, J Invasive Cardiol, V19, P200
   Kusama Y, 2011, J NIPPON MED SCH, V78, P4, DOI 10.1272/jnms.78.4
   Kwon TG, 2009, INT J CARDIOL, V133, P173, DOI 10.1016/j.ijcard.2007.12.022
   MIYAGI H, 1989, CIRCULATION, V79, P597, DOI 10.1161/01.CIR.79.3.597
   Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843
   Motoyama T, 1998, J AM COLL CARDIOL, V32, P1672, DOI 10.1016/S0735-1097(98)00447-1
   Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071
   Park YM, 2012, INT J CARDIOL, V154, pE57, DOI 10.1016/j.ijcard.2011.06.034
   Park YM, 2012, INT J CARDIOL
   Sarno G, 2012, INT J CARDIOL, DOI 10.1016/j.ijcard.2011.12.057
   SUGIISHI M, 1993, CIRCULATION, V87, P76, DOI 10.1161/01.CIR.87.1.76
   Suzuki T, 2001, CIRCULATION, V104, P1188, DOI 10.1161/hc3601.093987
   Tan W, 2009, CHINESE MED J-PEKING, V122, P2390, DOI 10.3760/cma.j.issn.0366-6999.2009.19.036
   Teragawa H, 2000, CHEST, V118, P1690, DOI 10.1378/chest.118.6.1690
   Togni M, 2005, J AM COLL CARDIOL, V46, P231, DOI 10.1016/j.jacc.2005.01.062
   Togni Mario, 2006, J Invasive Cardiol, V18, P593
   Tomassini F, 2009, J CARDIOVASC MED, V10, P485, DOI 10.2459/JCM.0b013e32831daf84
   Yasue H, 2008, J AM COLL CARDIOL, V51, P1742, DOI 10.1016/j.jacc.2007.12.049
NR 25
TC 5
Z9 5
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2013
VL 43
IS 1
BP 48
EP 53
DI 10.4070/kcj.2013.43.1.48
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FG
UT WOS:000342383600008
PM 23407605
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SH
   Jeong, SI
   Huh, J
   Kang, IS
   Lee, HJ
AF Kim, Sung Hoon
   Jeong, Soo In
   Huh, June
   Kang, I-Seok
   Lee, Heung Jae
TI Amiodarone and Catheter Ablation as Cardiac Resynchronization Therapy
   for Children with Dilated Cardiomyopathy and Wolff-Parkinson-White
   Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Dilated cardiomyopathy; Wolff-Parkinson-White syndrome; Amiodarone;
   Radiofrequency catheter ablation; Cardiac resynchronization therapy
ID LEFT-VENTRICULAR DYSFUNCTION; PREEXCITATION; TACHYCARDIA; PATIENT;
   INFANTS; PATHWAY
AB Preexcitation by accessory pathways (APs) is known to cause dyssynchrony of the ventricle, related to ventricular dysfunction. Correction of ventricular dyssynchrony can improve heart failure in cases of dilated cardiomyopathy (DCMP) with preexcitation. Here, we report the first case of a child with DCMP and Wolff-Parkinson-White (WPW) syndrome treated with amiodarone and radiofrequency catheter ablation (RFCA) in Korea. A 7-year-old boy, who suffered from DCMP and WPW syndrome, showed improved left ventricular function and clinical functional class after treatment with amiodarone to eliminate preexcitation. QRS duration and left ventricular ejection fraction (LVEF) were inversely correlated with amiodarone dosage. After confirming the reduction of preexcitation effects in DCMP, successful RFCA of the right anterior AP resulted in LVEF improvement, along with the disappearance of preexcitation. Our findings suggest that ventricular dyssynchrony, caused by preexcitation in DCMP with WPW syndrome, can worsen ventricular function and amiodarone, as well as RFCA, which should be considered as a treatment option, even in young children.
C1 [Kim, Sung Hoon] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Pediat, Chang Won, South Korea.
   [Jeong, Soo In] Hallym Univ, Sch Med, Kangdong Sacred Heart Hosp, Dept Pediat, Seoul, South Korea.
   [Huh, June; Kang, I-Seok; Lee, Heung Jae] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat,Cardiac & Vasc Ctr, Seoul 135710, South Korea.
RP Huh, J (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat,Cardiac & Vasc Ctr, 50 Irwon Dong, Seoul 135710, South Korea.
EM herzhuh@skku.edu
OI kim, sunghoon/0000-0002-1570-3230; Huh, June/0000-0003-4523-9632
CR Cadrin-Tourigny J, 2008, HEART RHYTHM, V5, P1320, DOI 10.1016/j.hrthm.2008.05.022
   Campbell RM, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.3.e245
   DEAL BJ, 1985, J AM COLL CARDIOL, V5, P130, DOI 10.1016/S0735-1097(85)80095-4
   Emmel M, 2004, CARDIOL YOUNG, V14, P594, DOI 10.1017/S1047951104006031
   Fazio G, 2008, INT J CARDIOL, V123, pE31, DOI 10.1016/j.ijcard.2006.11.109
   Hirasawa Y, 2009, CIRC J, V73, P639, DOI 10.1253/circj.CJ-08-0794
   Iwasaku T, 2009, EUROPACE, V11, P121, DOI 10.1093/europace/eun318
   Niksch AL, 2006, CURR OPIN CARDIOL, V21, P205, DOI 10.1097/01.hco.0000203182.81534.b0
   PRINZEN FW, 1995, AM HEART J, V130, P1045, DOI 10.1016/0002-8703(95)90207-4
   Schulze OC, 2000, INT J CARDIOL, V74, P99, DOI 10.1016/S0167-5273(00)00270-9
   Tantengco MVT, 2001, J AM COLL CARDIOL, V37, P2093, DOI 10.1016/S0735-1097(01)01302-X
   ten Cate FEAU, 2010, J ELECTROCARDIOL, V43, P146, DOI 10.1016/j.jelectrocard.2009.09.007
   Umana E, 2003, AM J MED, V114, P51, DOI 10.1016/S0002-9343(02)01472-9
   Yamanaka S, 1998, JPN CIRC J, V62, P860, DOI 10.1253/jcj.62.860
NR 14
TC 4
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2013
VL 43
IS 1
BP 57
EP 61
DI 10.4070/kcj.2013.43.1.57
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FG
UT WOS:000342383600010
PM 23407697
OA Green Published
DA 2021-04-22
ER

PT J
AU Pyo, JY
   Joh, DH
   Park, JS
   Lee, SJ
   Lee, H
   Kim, W
   Joung, B
AF Pyo, Jung Yoon
   Joh, Dong Hoo
   Park, Jin Su
   Lee, Seung-Jun
   Lee, Hancheol
   Kim, Wonjin
   Joung, Boyoung
TI Ventricular Tachyarrhythmias in a Patient with Andersen-Tawil Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Andersen-Tawil syndrome; Ventricular tachycardia; Paralysis
ID MUTATIONS; ARRHYTHMIAS
AB Andersen-Tawil syndrome (ATS), a rare autosomal dominant disorder, is characterized by periodic paralysis, dysmorphic features and cardiac arrhythmias. This syndrome is caused by mutations of KCNJ2 gene, which encodes inward rectifying potassium channel. Here, we report an 18-year-old girl who was presented with life-threatening cardiac arrhythmia and acute respiratory distress. She was diagnosed with ATS, based on dysmorphic features, ventricular arrhythmia, and periodic paralysis. This is the first case to be reported in Korea who experienced a fatal cardiac arrest and respiratory failure caused by ATS.
C1 [Pyo, Jung Yoon; Joh, Dong Hoo; Park, Jin Su; Lee, Seung-Jun; Lee, Hancheol; Kim, Wonjin; Joung, Boyoung] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 120752, South Korea.
RP Joung, B (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM cby6908@yuhs.ac
OI Lee, Seung-Jun/0000-0002-9201-4818; Joung, Boyoung/0000-0001-9036-7225
CR ANDERSEN ED, 1971, ACTA PAEDIATR SCAND, V60, P559, DOI 10.1111/j.1651-2227.1971.tb06990.x
   Burge JA, 2012, CURR NEUROL NEUROSCI, V12, P62, DOI 10.1007/s11910-011-0238-3
   Davies NP, 2005, NEUROLOGY, V65, P1083, DOI 10.1212/01.wnl.0000178888.03767.74
   HELFANT RH, 1986, AM J MED, V80, P13, DOI 10.1016/0002-9343(86)90336-0
   MOTTE G, 1984, ARCH MAL COEUR VAISS, V77, P17
   Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7
   Sansone V, 1997, ANN NEUROL, V42, P305, DOI 10.1002/ana.410420306
   Sansone V, 2007, NEUROTHERAPEUTICS, V4, P233, DOI 10.1016/j.nurt.2007.01.005
   Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183
NR 9
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2013
VL 43
IS 1
BP 62
EP 65
DI 10.4070/kcj.2013.43.1.62
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FG
UT WOS:000342383600011
PM 23407770
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Ko, YG
   Yoon, YN
   Choi, D
   Lee, DY
AF Lee, Joong-Hee
   Ko, Young-Guk
   Yoon, Young-Nam
   Choi, Donghoon
   Lee, Do-Yun
TI Hybrid Treatment for Thoracic Aortic Aneurysm Combined with Aberrant
   Right Subclavian Artery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aberrant right subclavian artery; Aortic aneurysm, thoracic;
   Endovascular procedures
ID ENDOVASCULAR TREATMENT; ARCH
AB An aberrant right subclavian artery (ARSA) is the most common vascular abnormality of the aortic arch and is associated with development of aneurysms in 3-8% of these anomalies. In this case report, we describe an 84-year-old man with a symptomatic ARSA treated with staged hybrid procedure combining surgical replacement of the ascending aorta and bilateral carotid-to-subclavian artery bypass with implantation of a stent graft in the aortic arch and descending aorta. Our case suggests that a less invasive hybrid therapy can be performed successfully for the treatment of ARSA with aneurysmal change in patients at high surgical risk.
C1 [Lee, Joong-Hee; Ko, Young-Guk; Choi, Donghoon] Yonsei Univ, Coll Med, Div Cardiol, Severance Cardiovasc Hosp,Yonsei Univ Hlth Syst, Seoul, South Korea.
   [Yoon, Young-Nam] Yonsei Univ, Coll Med, Yonsei Cardiovasc Hosp, Div Cardiovasc Surg, Seoul, South Korea.
   [Lee, Do-Yun] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea.
RP Ko, YG (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM ygko@yuhs.ac
CR Attmann T, 2005, EUR J CARDIO-THORAC, V27, P1125, DOI 10.1016/j.ejcts.2005.02.029
   Corral JS, 2003, J VASC INTERV RADIOL, V14, P789, DOI 10.1097/01.RVI.0000079990.80153.FE
   Daniels L, 2010, ACTA CHIR BELG, V110, P346, DOI 10.1080/00015458.2010.11680631
   Ferrero E, 2011, ANN VASC SURG, V25, P805, DOI 10.1016/j.avsg.2011.02.030
   KIEFFER E, 1994, J VASC SURG, V19, P100, DOI 10.1016/S0741-5214(94)70125-3
   Lacroix V, 2003, J ENDOVASC THER, V10, P190, DOI 10.1583/1545-1550(2003)010<0190:ETOAAA>2.0.CO;2
   Ruddy JM, 2008, J THORAC CARDIOV SUR, V136, P1123, DOI 10.1016/j.jtcvs.2008.06.027
   Shennib H, 2008, J VASC SURG, V47, P1066, DOI 10.1016/j.jvs.2007.12.031
   Stone WM, 2011, ANN VASC SURG, V25, P508, DOI 10.1016/j.avsg.2011.02.012
   Tochii M, 2008, GEN THORAC CARDIOVAS, V56, P22, DOI 10.1007/s11748-007-0181-z
   ZAPATA H, 1993, PEDIATR CARDIOL, V14, P159, DOI 10.1007/BF00795645
NR 11
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2013
VL 43
IS 1
BP 66
EP 69
DI 10.4070/kcj.2013.43.1.66
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FG
UT WOS:000342383600012
PM 23407812
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, DJ
   Lee, SH
   Park, S
   Jang, Y
AF Shin, Dong-Jik
   Lee, Sang-Hak
   Park, Sungha
   Jang, Yangsoo
TI Association between Serine/Threonine Kinase 39 Gene Polymorphism,
   Hypertension, and Other Cardiovascular Risk Factors in Koreans
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE STK39 protein, human; Hypertension; Cholesterol; Waist circumference;
   Glucose
ID GENOME-WIDE ASSOCIATION; STE20/SPS1-RELATED KINASE; BLOOD-PRESSURE;
   SPAK; STK39
AB Background and Objectives: Although the association between single nucleotide polymorphisms (SNPs) of Serine/Threonine Kinase 39 (STK39) and hypertension has been reported, the prior studies have been inconsistent. The aim of this study is to evaluate the association between rs3754777 and rs6749447, the two SNPs of STK39, and hypertension and other cardiovascular risk factors in Koreans, residing in the Republic of Korea.
   Subjects and Methods: We included 238 hypertensive patients and 260 controls. The associations between genotype and haplotype combination and hypertension were examined. In addition, possible SNP-related differences in the adjusted blood pressure and other cardiovascular risk factors were analyzed.
   Results: There was no significant association between the two SNPs and hypertension. However, the carriers of AA genotype of rs3754777 showed lower blood glucose and cholesterol levels, particularly in females. Genotype of rs6749447 was associated with the waist circumference, triglyceride, and high density lipoprotein-cholesterol levels, only in gender-stratified analysis. The effects of haplotype combinations on risk factors were compatible with genotype effects of each SNP.
   Conclusion: Associations between the two SNPs of STK39, rs3754777 and rs6749447, and hypertension were not significant. However, the two SNPs showed genotype-related differences in blood glucose, lipids, and waist circumference, especially in women. Further studies are needed to clarify the effect of STK39 variants in these cardiovascular risk factors.
C1 [Shin, Dong-Jik] Yonsei Univ Hlth Syst, Cardiovasc Genome Ctr, Seoul, South Korea.
   [Lee, Sang-Hak; Park, Sungha; Jang, Yangsoo] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Dept Internal Med,Div Cardiol, Seoul 120752, South Korea.
RP Lee, SH (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Dept Internal Med,Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM shl1106@yuhs.ac
OI Park, Sungha/0000-0001-5362-478X; Jang, Yangsoo/0000-0002-2169-3112
FU Korean Society of Cardiology; Yonsei University College of Medicine
   [6-2012-0086]
FX This study was supported by a grant (2009) from the Korean Society of
   Cardiology and a faculty research grant of Yonsei University College of
   Medicine for 2012 (6-2012-0086).
CR Chen LY, 2012, INT J CARDIOL, V154, P122, DOI 10.1016/j.ijcard.2010.09.007
   Cunnington MS, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-135
   Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324
   Fava C, 2011, J HYPERTENS, V29, P484, DOI 10.1097/HJH.0b013e328342b2c1
   Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784
   Kushiyama A, 2005, J BIOL CHEM, V280, P42016, DOI 10.1074/jbc.M503065200
   Lee J, 2011, NAT MED, V17, P1251, DOI 10.1038/nm.2449
   Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384
   Mooser V, 2009, United States patent, Patent No. [US 0203012 A1, 0203012]
   Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361
   Niu WQ, 2011, J HUM HYPERTENS, V25, P278, DOI 10.1038/jhh.2010.114
   Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200
   Qi H, 2001, MOL CELL ENDOCRINOL, V182, P181, DOI 10.1016/S0303-7207(01)00560-3
   Rhee MY, 2011, HYPERTENS RES, V34, P606, DOI 10.1038/hr.2010.278
   Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106
   Yin RX, 2008, AM J MED, V121, P811, DOI 10.1016/j.amjmed.2008.04.026
NR 16
TC 4
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2013
VL 43
IS 1
BP 13
EP 22
DI 10.4070/kcj.2013.43.1.13
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FG
UT WOS:000342383600003
PM 23408757
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, YM
   Kook, H
   Kim, W
   Lee, SK
   Choi, JI
   Lim, HE
   Park, SW
   Kim, YH
AF Park, Yae Min
   Kook, Hyungdon
   Kim, Woohyeon
   Lee, Son Ki
   Choi, Jong-Il
   Lim, Hong Euy
   Park, Sang Weon
   Kim, Young-Hoon
TI Characteristics and Outcomes of Atrial Tachycardia Originating from the
   Sinus Venosus during Catheter Ablation of Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial tachycardia; Sinus venosus; Atrial fibrillation
ID PULMONARY VEIN ABLATION; P-WAVE MORPHOLOGY; ARRHYTHMIAS; PREDICT; SITE;
   MECHANISMS; ALGORITHM; STATEMENT; FLUTTER
AB Background and Objectives: The sinus venosus (SV) is not a well known source of atrial tachycardia (AT), but it can harbor AT during catheter ablation of atrial fibrillation (AF).
   Subjects and Methods: A total of 1223 patients who underwent catheter ablation for AF were reviewed. Electrophysiological and electrocardiographic characteristics and outcomes after catheter ablation of AT originating from the SV were investigated.
   Results: Ten patients (0.82%) demonstrated AT from the SV (7 males, 53.9 +/- 16.0 years, 6 persistent) during ablation of AF. The mean cycle length was 281 +/- 73 ms. After pulmonary vein isolation and left atrial ablation, AF converted to AT from the SV during right atrial ablation in 2 patients, by rapid atrial pacing after AF termination in 7 patients, and during isoproterenol infusion in 1 patient. Positive P-waves in inferior leads were shown in most patients (90%). The activation sequence of AT was from proximal to distal in the superior vena cava and high to low in the right atrium, which was similar to that of AT from crista terminalis. Fragmented double potentials were recorded during sinus, and a second discrete potential preceded the onset of P wave by 80 +/- 37 ms during AT. Using 4.4 +/- 2.7 radiofrequency focal applications, ATs were terminated and became no longer inducible in all. After ablation procedure, two patients showed transient right phrenic nerve palsy. After 19.9 +/- 14.8 months, all but 1 patient were free of atrial tachyarrhythmia without complications.
   Conclusion: The AT which develops during AF ablation is rarely originated from SV, and its electrophysiologic characteristics may be helpful in guiding effective focal ablation.
C1 [Park, Yae Min; Kook, Hyungdon; Kim, Woohyeon; Lee, Son Ki; Choi, Jong-Il; Lim, Hong Euy; Park, Sang Weon; Kim, Young-Hoon] Korea Univ, Coll Med, Div Cardiol, Seoul 136705, South Korea.
RP Kim, YH (corresponding author), Korea Univ, Coll Med, Div Cardiol, 73 Inchon Ro, Seoul 136705, South Korea.
EM yhkmd@unitel.co.kr
CR Calkins H, 2007, HEART RHYTHM, V4, P816, DOI 10.1016/j.hrthm.2007.04.005
   Chae S, 2007, J AM COLL CARDIOL, V50, P1781, DOI 10.1016/j.jacc.2007.07.044
   Chugh A, 2005, HEART RHYTHM, V2, P464, DOI 10.1016/j.hrthm.2005.01.027
   Gonzalez MD, 2005, J CARDIOVASC ELECTR, V16, P193, DOI 10.1046/j.1540-8167.2004.40483.x
   Haissaguerre MHR, 2005, J CARDIOVASC ELECTR, V16, P1138, DOI 10.1111/j.1540-8167.2005.00308.x
   Harada M, 2009, CIRC J, V73, P647, DOI 10.1253/circj.CJ-08-0748
   Jais P, 2006, HEART RHYTHM, V3, P140, DOI 10.1016/j.hrthm.2005.11.012
   Jais P, 2009, J CARDIOVASC ELECTR, V20, P480, DOI 10.1111/j.1540-8167.2008.01373.x
   Kistler PM, 2006, J AM COLL CARDIOL, V48, P1010, DOI 10.1016/j.jacc.2006.03.058
   Kistler PM, 2005, HEART RHYTHM, V2, P561, DOI 10.1016/j.hrthm.2004.12.013
   Lin YJ, 2009, HEART RHYTHM, V6, P592, DOI 10.1016/j.hrthm.2009.02.019
   Mesas CE, 2004, J AM COLL CARDIOL, V44, P1071, DOI 10.1016/j.jacc.2004.05.072
   Mohamed U, 2007, J CARDIOVASC ELECTR, V18, P1, DOI 10.1111/j.1540-8167.2006.00664.x
   Nam GB, 2010, CIRC J, V74, P434, DOI 10.1253/circj.CJ-09-0622
   Qian ZY, 2011, PACE, V34, P414, DOI 10.1111/j.1540-8159.2010.02980.x
   Rostock T, 2010, CIRC-ARRHYTHMIA ELEC, V3, P160, DOI 10.1161/CIRCEP.109.899021
   Sacher F, 2006, J AM COLL CARDIOL, V47, P2498, DOI 10.1016/j.jacc.2006.02.050
   Sanchez-Quintana D, 2005, J CARDIOVASC ELECTR, V16, P309, DOI 10.1046/j.1540-8167.2005.40759.x
   Saoudi N, 2001, EUR HEART J, V22, P1162, DOI 10.1053/euhj.2001.2658
   Satomi K, 2010, CIRC J, V74, P1051, DOI 10.1253/circj.CJ-10-0248
   Scherr D, 2007, HEART RHYTHM, V4, P1013, DOI 10.1016/j.hrthm.2007.04.021
   TANG CW, 1995, J AM COLL CARDIOL, V26, P1315, DOI 10.1016/0735-1097(95)00307-X
NR 22
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2013
VL 43
IS 1
BP 29
EP 37
DI 10.4070/kcj.2013.43.1.29
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FG
UT WOS:000342383600005
PM 23407327
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, HS
   Lee, IH
   Song, YW
   Choi, BM
   Jang, GY
   Son, CS
   Lee, JW
AF Seo, Hyeon Seok
   Lee, In Hak
   Song, Young Wooh
   Choi, Byung Min
   Jang, Gi Young
   Son, Chang Sung
   Lee, Joo Won
TI A Case of Congenital Hypertrophic Cardiomyopathy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiomyopathy, hypertrophic; Newborns
ID MUTATION
AB Congenital hypertrophic cardiomyopathy (HCMP) is a very rare congenital heart disease. Here, we report a case of neonatal HCMP, which was confirmed by two-dimensional echocardiography and autopsy. The HCMP rapidly progressed and the patient's condition deteriorated, despite the treatment for congestive heart failure.
C1 [Seo, Hyeon Seok; Lee, In Hak; Song, Young Wooh; Choi, Byung Min; Jang, Gi Young; Son, Chang Sung; Lee, Joo Won] Univ Korea Hosp, Dept Pediat, Seoul, South Korea.
RP Jang, GY (corresponding author), Korea Univ, Ansan Hosp, Dept Pediat, 123 Jeokgeum Ro, Ansan 425707, South Korea.
EM jgynhg@naver.com
CR Badertscher A, 2008, ACTA PAEDIATR, V97, P1523, DOI 10.1111/j.1651-2227.2008.00957.x
   Berger S, 2009, CARDIOL YOUNG, V19, P66, DOI 10.1017/S1047951109991648
   Eidem BW, 2000, TEX HEART I J, V27, P289
   Fahrner JA, 2012, AM J MED GENET A, V158A, P1414, DOI 10.1002/ajmg.a.35363
   Kim J, 2011, ANN DERMATOL, V23, P232, DOI 10.5021/ad.2011.23.2.232
   Kim JY, 2007, KOREAN J PEDIAT, V50, P1024
   Kim WW, 2012, J KOREAN ACAD CHILD, V23, P31
   Oh JH, 2011, CIRC J, V75, P2228, DOI 10.1253/circj.CJ-11-0051
   SOMERVILLE J, 1978, BRIT HEART J, V40, P1034
NR 9
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2013
VL 43
IS 1
BP 54
EP 56
DI 10.4070/kcj.2013.43.1.54
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FG
UT WOS:000342383600009
PM 23407623
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HS
   Kim, W
AF Kim, Hyun Soo
   Kim, Weon
TI Full Calcified Jacket of Saphenous Vein Graft
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ATHEROSCLEROSIS; CALCIFICATION
C1 [Kim, Hyun Soo; Kim, Weon] Kyung Hee Univ, Coll Med, Kyung Hee Univ Hosp, Div Cardiovasc,Dept Internal Med, Seoul 130702, South Korea.
RP Kim, W (corresponding author), Kyung Hee Univ, Coll Med, Kyung Hee Univ Hosp, Div Cardiovasc,Dept Internal Med, 23 Kyungheedae Ro, Seoul 130702, South Korea.
EM mylovekw@hanmail.net
CR Berman DS, 2004, J AM COLL CARDIOL, V44, P923, DOI 10.1016/j.jacc.2004.06.042
   Budoff MJ, 2011, AM J KIDNEY DIS, V58, P519, DOI 10.1053/j.ajkd.2011.04.024
   Castagna MT, 2005, CIRCULATION, V111, P1148, DOI 10.1161/01.CIR.0000157160.69812.55
   Kim JK, 2012, ATHEROSCLEROSIS, V220, P208, DOI 10.1016/j.atherosclerosis.2011.07.115
NR 4
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2013
VL 43
IS 1
BP 70
EP 71
DI 10.4070/kcj.2013.43.1.70
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA AP9FG
UT WOS:000342383600013
PM 23408919
OA Green Published
DA 2021-04-22
ER

PT J
AU Ko, J
AF Ko, JaeKon
TI Left Ventricular Dysfunction and Dilated Cardiomyopathy in Infants and
   Children with Wolff-Parkinson-White Syndrome in the Absence of
   Tachyarrhythmias
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Wolff-Parkinson-White syndrome; Ventricular dysfunction, left;
   Cardiomyopathy, dilated
AB Left ventricular (LV) dysfunction and dilated cardiomyopathy (DCM) are rarely attributable to sustained or incessant tachyarrhythmias in infants and children with Wolff-Parkinson-White (WPW) syndrome. However, several recent reports suggested that significant LV dysfunction may develop in WPW syndrome in the absence of tachyarrhythmias. It is assumed that an asynchronous ventricular activation over the accessory pathway, especially right-sided, induces septal wall motion abnormalities, ventricular remodeling and ventricular dysfunction. The prognosis of DCM associated with asymptomatic WPW is excellent. Loss of ventricular pre-excitation results in mechanical resynchronization and reverse remodeling where LV function recovers completely. The reversible nature of LV dysfunction after loss of ventricular pre-excitation supports the causal relationship between LV dysfunction and ventricular pre-excitation. This review summarizes recent clinical and electrophysiological evidence for development of LV dysfunction or DCM in asymptomatic WPW syndrome, and discusses the underlying pathophysiological mechanism.
C1 Univ Ulsan, Coll Med, Asan Med Ctr, Div Pediat Cardiol,Dept Pediat, Seoul 138736, South Korea.
RP Ko, J (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Pediat Cardiol,Dept Pediat, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea.
EM jgko@amc.seoul.kr
CR Cadrin-Tourigny J, 2008, HEART RHYTHM, V5, P1320, DOI 10.1016/j.hrthm.2008.05.022
   De Boeck BWL, 2010, AM J CARDIOL, V106, P539, DOI 10.1016/j.amjcard.2010.03.066
   DEMARIA AN, 1976, CIRCULATION, V53, P249, DOI 10.1161/01.CIR.53.2.249
   Emmel M, 2004, CARDIOL YOUNG, V14, P594, DOI 10.1017/S1047951104006031
   Fazio G, 2008, INT J CARDIOL, V123, pE31, DOI 10.1016/j.ijcard.2006.11.109
   Fenelon G, 1996, PACE, V19, P95, DOI 10.1111/j.1540-8159.1996.tb04796.x
   FRANCIS GS, 1976, CIRCULATION, V54, P174, DOI 10.1161/01.CIR.54.2.174
   GRINES CL, 1989, CIRCULATION, V79, P845, DOI 10.1161/01.CIR.79.4.845
   Horenstein MS, 2003, PEDIATR CARDIOL, V24, P274, DOI 10.1007/s00246-002-0274-5
   Iwasaku T, 2009, EUROPACE, V11, P121, DOI 10.1093/europace/eun318
   Kugler JD, 2002, J CARDIOVASC ELECTR, V13, P336, DOI 10.1046/j.1540-8167.2002.00336.x
   Kwon BS, 2010, J CARDIOVASC ELECTR, V21, P290, DOI 10.1111/j.1540-8167.2009.01612.x
   LEBOVITZ JA, 1977, CHEST, V71, P463, DOI 10.1378/chest.71.4.463
   Marti-Almor J, 2011, REV ESP CARDIOL, V64, P1217, DOI [10.1016/j.recesp.2011.01.013, 10.1016/j.rec.2011.02.009]
   Prinzen FW, 2002, PACE, V25, P484, DOI 10.1046/j.1460-9592.2002.00484.x
   PRINZEN FW, 1995, AM HEART J, V130, P1045, DOI 10.1016/0002-8703(95)90207-4
   SAUL JP, 1994, CIRCULATION, V90, P492, DOI 10.1161/01.CIR.90.1.492
   Tantengco MVT, 2001, J AM COLL CARDIOL, V37, P2093, DOI 10.1016/S0735-1097(01)01302-X
   ten Cate FEAU, 2010, J ELECTROCARDIOL, V43, P146, DOI 10.1016/j.jelectrocard.2009.09.007
   Thambo JB, 2004, CIRCULATION, V110, P3766, DOI 10.1161/01.CIR.0000150336.86033.8D
   TICZON AR, 1976, AM J CARDIOL, V37, P840, DOI 10.1016/0002-9149(76)90107-7
   Tomaske M, 2008, EUROPACE, V10, P181, DOI 10.1093/europace/eun005
   Udink Ten Cate Floris Ea, 2010, Indian Pacing Electrophysiol J, V10, P248
   Yamanaka S, 1998, JPN CIRC J, V62, P860, DOI 10.1253/jcj.62.860
NR 24
TC 9
Z9 13
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2012
VL 42
IS 12
BP 803
EP 808
DI 10.4070/kcj.2012.42.12.803
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IR
UT WOS:000209080600001
PM 23323117
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HS
   Park, MJ
   Oh, MK
   Hong, YM
AF Kim, Hae Soon
   Park, Mi Jung
   Oh, Min Kyung
   Hong, Young Mi
TI Auscultatory Measured Normative Blood Pressure of Korean Adolescents:
   Using the Korean National Health and Nutrition Examination Survey
   2001-2007
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Blood pressure; Adolescent; Auscultation
ID OBESITY-HYPERTENSION; CHILDREN
AB Background and Objectives: In Korea, there hasn't been any previous literature that describes auscultatory blood pressure (BP) normative tables for adolescents. Using BP data, from the Korean National Health and Nutrition Examination Survey (KNHANES), we created normative auscultatory BP percentile tables for Korean adolescents.
   Subjects and Methods: A total of 3508 adolescents (boys 1852, girls 1656), aged 10-17 in 2001, 2005 and 2007 from the KNHANES database years, were included. Auscultatory BP measurement was performed, using a Baumanometer Mercury Gravity Sphygmomanometer.
   Results: The mean systolic BP of boys was higher than that of girls in adolescents older than 13 years of age, and the mean diastolic BP of boys was higher than that of girls in those older than 15 years. Systolic and diastolic BP was correlated with weight, height and age. Age-specific normative auscultatory systolic and diastolic BP percentiles for boys and girls were completed. The graph that showed age-specific prehypertensive and hypertensive systolic and diastolic BP for boys and girls was presented. For adolescents, the height-specific auscultatory BP percentiles for boys and girls were completed. A graph that shows the height-specific prehypertensive and hypertensive BP for boys and girls was also made.
   Conclusion: The auscultatory age-and height-specific BP percentiles for Korean adolescents are established. These can be useful in screening the prehypertension and hypertension of Korean adolescents in a clinical setting.
C1 [Kim, Hae Soon; Hong, Young Mi] Ewha Womans Univ, Sch Med, Dept Pediat, Seoul 158710, South Korea.
   [Park, Mi Jung] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Pediat, Seoul, South Korea.
   [Oh, Min Kyung] Inje Univ, Coll Med, Busan Paik Hosp, Dept Pharmacol, Pusan, South Korea.
RP Hong, YM (corresponding author), Ewha Womans Univ, Sch Med, Mokdong Hosp, Dept Pediat, 1071 Anyangcheon Ro, Seoul 158710, South Korea.
EM hongym@chollian.net
CR [Anonymous], 1987, PEDIATRICS, V79, P1
   BLUMENTHAL S, 1977, PEDIATRICS, V59, P797
   Chio SS, 2011, J AM SOC HYPERTENS, V5, P12, DOI 10.1016/j.jash.2010.10.005
   Chiolero A, 2007, PEDIATRICS, V119, P544, DOI 10.1542/peds.2006-2136
   Falkner B, 1996, PEDIATRICS, V98, P649
   Flynn JT, 2010, CURR OPIN NEPHROL HY, V19, P292, DOI 10.1097/MNH.0b013e3283373016
   Francischetti EA, 2007, INT J CLIN PRACT, V61, P269, DOI 10.1111/j.1742-1241.2006.01262.x
   FROHLICH ED, 1988, CIRCULATION, V77, pA502
   Hansen ML, 2007, JAMA-J AM MED ASSOC, V298, P874, DOI 10.1001/jama.298.8.874
   Harding S, 2006, J HYPERTENS, V24, P1507, DOI 10.1097/01.hjh.0000239285.20315.4d
   Heavenrich R, 1977, PEDIATRICS, V59, pI
   Ippisch HM, 2008, PROG PEDIATR CARDIOL, V25, P177, DOI 10.1016/j.ppedcard.2008.05.002
   Kaelber DC, 2009, PEDIATRICS, V123, pE972, DOI 10.1542/peds.2008-2680
   Lee Chong Guk, 2011, Korean J Pediatr, V54, P463, DOI 10.3345/kjp.2011.54.11.463
   LONDE S, 1984, WESTERN J MED, V141, P193
   Mitchell CK, 2011, J PAEDIATR CHILD H, V47, P22, DOI 10.1111/j.1440-1754.2010.01885.x
   Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555
   Park MK, 2005, PEDIATR CARDIOL, V26, P601, DOI 10.1007/s00246-004-0828-9
   Park MK, 2001, ARCH PEDIAT ADOL MED, V155, P50, DOI 10.1001/archpedi.155.1.50
   Park MK, 2001, AM J CARDIOL, V87, P1305, DOI 10.1016/S0002-9149(01)01528-4
   Sinaiko AR, 1996, NEW ENGL J MED, V335, P1968, DOI 10.1056/NEJM199612263352607
   Sorof J, 2002, HYPERTENSION, V40, P441, DOI 10.1161/01.HYP.0000032940.33466.12
   Sung RYT, 2008, J HYPERTENS, V26, P678, DOI 10.1097/HJH.0b013e3282f42270
   이종국, 2008, Clinical and Experimental Pediatrics, V51, P33
NR 24
TC 1
Z9 1
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2012
VL 42
IS 12
BP 809
EP 815
DI 10.4070/kcj.2012.42.12.809
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IR
UT WOS:000209080600002
PM 23323118
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, IC
   Seo, WW
   Oh, IY
   Choi, EK
   Oh, S
AF Hwang, In-Chang
   Seo, Won-Woo
   Oh, Il-Young
   Choi, Eue-Keun
   Oh, Seil
TI Reversibility of Atrioventricular Block According to Coronary Artery
   Disease: Results of a Retrospective Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrioventricular block; Coronary artery disease; Pacemaker, atrificial
AB Background and Objectives: The causal relationship of clinically-significant atrioventricular block (AVB) and coronary artery disease (CAD) is uncertain. We investigated whether CAD is related to irreversible AVB that requires treatment with a permanent pacemaker.
   Subjects and Methods: We included 188 consecutive patients with new-onset AVB considering pacemaker, who had undergone invasive or noninvasive coronary evaluation. Patients were divided into one of 2 groups: irreversible AVB who underwent implantation of permanent pacemaker {irreversible block (IB) group, n=173} or reversible AVB {reversible block (RB) group, n=15}.
   Results: In IB group, significant CAD was observed in 44 patients (25.4%) and there were 2 (1.2%) patients with acute myocardial infarction (AMI). In RB group, 14 patients (93.3%) had CAD (p<0.001) and 13 patients (86.7%) presented with AMI (p<0.001). On the aspect of CAD type and reversibility of AVB, 13/15 (86.7%) patients of AMI, 0/2 (0%) of unstable angina, and 1/41 (2.4%) of stable angina had reversible AVB.
   Conclusion: AVB in patients with AMI is usually reversible. Therefore, permanent pacemaker implantation should be delayed in cases of AMI. AVB in patients with CAD other than AMI is usually irreversible.
C1 [Hwang, In-Chang; Seo, Won-Woo; Oh, Il-Young; Choi, Eue-Keun; Oh, Seil] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.
RP Oh, S (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM seil@snu.ac.kr
RI Oh, Seil/J-5539-2012; Choi, Eue-Keun/K-3752-2019; Choi,
   Eue-Keun/J-5968-2014
OI Oh, Seil/0000-0002-2504-9615; Choi, Eue-Keun/0000-0002-0411-6372; Seo,
   Won-Woo/0000-0002-4406-5485
CR Cano O, 2011, EUROPACE, V13, P395, DOI 10.1093/europace/euq431
   Dreger H, 2010, PACE, V33, P394, DOI 10.1111/j.1540-8159.2009.02645.x
   FEIGL D, 1984, J AM COLL CARDIOL, V4, P35, DOI 10.1016/S0735-1097(84)80315-0
   Giglioli C, 2006, CAN J CARDIOL, V22, P1047, DOI 10.1016/S0828-282X(06)70320-8
   GUPTA MC, 1978, ANGIOLOGY, V29, P749, DOI 10.1177/000331977802901005
   Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126
   MOSSERI M, 1991, ANN THORAC SURG, V51, P248, DOI 10.1016/0003-4975(91)90796-S
   Mosseri M, 1997, CIRCULATION, V96, P809
   NICOD P, 1988, J AM COLL CARDIOL, V12, P589, DOI 10.1016/S0735-1097(88)80042-1
   Omeroglu SN, 2005, J CARDIAC SURG, V20, P136, DOI 10.1111/j.0886-0440.2005.200369pl.x
   Tandogan Izzet, 2002, Anadolu Kardiyol Derg, V2, P279
   TANS AC, 1980, AM HEART J, V99, P4, DOI 10.1016/0002-8703(80)90308-7
   Tjandrawidjaja MC, 2005, J ELECTROCARDIOL, V38, P271, DOI 10.1016/j.jelectrocard.2005.01.013
   Tompkins C, 2010, J AM COLL CARDIOL, V55, P2376, DOI 10.1016/j.jacc.2009.12.056
   VANDERHAUWAERT LG, 1972, BRIT HEART J, V34, P1045
   Wei SP, 2011, J CARDIOVASC MED, V12, P709, DOI 10.2459/JCM.0b013e328349187c
   Yesil M, 2008, CLIN CARDIOL, V31, P498, DOI 10.1002/clc.20280
   Yesil M, 2008, INT HEART J, V49, P525, DOI 10.1536/ihj.49.525
NR 18
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2012
VL 42
IS 12
BP 816
EP 822
DI 10.4070/kcj.2012.42.12.816
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IR
UT WOS:000209080600003
PM 23323119
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, JH
   Yu, JJ
   Ko, HK
   Choi, HS
   Kim, YH
   Ko, JK
AF Seo, Ji Hye
   Yu, Jeong Jin
   Ko, Hong Ki
   Choi, Hyung Soon
   Kim, Young-Hwue
   Ko, Jae-Kon
TI Diagnosis of Incomplete Kawasaki Disease in Infants Based on an
   Inflammation at the Bacille Calmette-Guerin Inoculation Site
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mucocutaneous Lymph Node Syndrome; Coronary vesseles
AB Background and Objectives: This study was intended to test how the inflammation at the Bacille Calmette-Guerin (BCG) inoculation site (BCGitis) can be a useful a diagnostic feature of Kawasaki disease (KD).
   Subjects and Methods: All subjects were infants at the time of admission, and had received BCG vaccination during their neonatal period. There were 54 patients with complete KD (group 1) and 29 patients with incomplete KD (group 2). All 83 patients had BCGitis during the acute phase of illness. Data regarding the coronary artery diameters in 31 age-matched controls were used for comparison.
   Results: The 2 patient groups did not differ in clinical and laboratory variables. During the acute phase, the median z scores of the left anterior descending coronary artery (LAD) diameter were 0.20, 0.42, and -0.48 in groups 1, 2, and control respectively, and that of right coronary artery (RCA) diameters were -0.15, -0.16, and -1.17 respectively. The z scores in both patient groups were greater than those in controls (p=0.0014 in LAD and p<0.0001 in RCA between group 1 and controls; p=0.0023 in LAD and p<0.0001 in RCA between group 2 and controls). A similar pattern was observed during the subacute and convalescent phases.
   Conclusion: BCGitis is a useful feature in the diagnosis of incomplete KD in infants who received BCG vaccine during neonatal period.
C1 [Seo, Ji Hye; Yu, Jeong Jin; Ko, Hong Ki; Kim, Young-Hwue; Ko, Jae-Kon] Univ Ulsan, Coll Med, Dept Pediat, Seoul 138736, South Korea.
   [Choi, Hyung Soon] Kosin Univ, Gospel Hosp, Dept Pediat, Pusan, South Korea.
RP Yu, JJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pediat, 88 Oylimp Ro 43 Gil, Seoul 138736, South Korea.
EM pediatrist@medimail.co.kr
CR Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x
   Barone SR, 2000, ARCH PEDIAT ADOL MED, V154, P453, DOI 10.1001/archpedi.154.5.453
   BURNS JC, 1986, J PEDIATR-US, V109, P759, DOI 10.1016/S0022-3476(86)80689-8
   Chalmers D, 2008, J PAEDIATR CHILD H, V44, P525, DOI 10.1111/j.1440-1754.2008.01364.x
   Chang FY, 2006, PEDIATR INFECT DIS J, V25, P241, DOI 10.1097/01.inf.0000202067.50975.90
   Cho Min A, 2010, Korean Circ J, V40, P283, DOI 10.4070/kcj.2010.40.6.283
   Chuang Chih-Hsien, 2006, Journal of Microbiology Immunology and Infection, V39, P387
   de Zorzi A, 1998, J PEDIATR-US, V133, P254, DOI 10.1016/S0022-3476(98)70229-X
   HSU YH, 1987, PEDIATR INFECT DIS J, V6, P576, DOI 10.1097/00006454-198706000-00020
   Lee HJ, 2008, J KOREAN MED ASSOC, V51, P104, DOI 10.5124/jkma.2008.51.2.104
   Manlhiot C, 2012, EUR J PEDIATR, V171, P657, DOI 10.1007/s00431-011-1631-2
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   Olivieri L, 2009, J AM SOC ECHOCARDIOG, V22, P159, DOI 10.1016/j.echo.2008.11.003
   Perrin L, 2009, JOINT BONE SPINE, V76, P481, DOI 10.1016/j.jbspin.2008.11.015
   Research Committee on Kawasaki Disease, 1984, REP SUBC STAND DIAGN
   ROWLEY AH, 1987, J PEDIATR-US, V110, P409, DOI 10.1016/S0022-3476(87)80503-6
   Sinha R, 2005, ARCH DIS CHILD, V90, P891, DOI 10.1136/adc.2004.071332
   Sonobe T, 2007, PEDIATR INT, V49, P421, DOI 10.1111/j.1442-200X.2007.02396.x
   Sudo D, 2012, EUR J PEDIATR, V171, P651, DOI 10.1007/s00431-011-1630-3
   Takayama J, 1982, ACTA PEDIAT JPN, V86, P567
   Uehara R, 2010, PEDIATR INFECT DIS J, V29, P430, DOI 10.1097/INF.0b013e3181cacede
   Witt MT, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e10
   YANAGAWA H, 1986, LANCET, V2, P1138
   Yellen ES, 2010, PEDIATRICS, V125, pE234, DOI 10.1542/peds.2009-0606
   Yu JJ, 2011, J PEDIATR-US, V159, P454, DOI 10.1016/j.jpeds.2011.02.029
   Yun SH, 2011, KOREAN CIRC J, V41, P394, DOI 10.4070/kcj.2011.41.7.394
NR 26
TC 15
Z9 16
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2012
VL 42
IS 12
BP 823
EP 829
DI 10.4070/kcj.2012.42.12.823
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IR
UT WOS:000209080600004
PM 23323120
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahmed, K
   Jeong, MH
   Chakraborty, R
   Ahmed, S
   Hong, YJ
   Sim, DS
   Park, KH
   Kim, JH
   Ahn, Y
   Kang, JC
   Cho, MC
   Kim, CJ
   Kim, YJ
AF Ahmed, Khurshid
   Jeong, Myung Ho
   Chakraborty, Rabin
   Ahmed, Sumera
   Hong, Young Joon
   Sim, Doo Sun
   Park, Keun Ho
   Kim, Ju Han
   Ahn, Youngkeun
   Kang, Jung Chaee
   Cho, Myeong Chan
   Kim, Chong Jin
   Kim, Young Jo
CA Korea Acute Myocardial Infarction
TI Coronary Stents in Patients with ST-Elevation Myocardial Infarction and
   Chronic Kidney Disease Undergoing Primary Percutaneous Coronary
   Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Stents; Angioplasty; Kidney failure, chronic
ID STAGE RENAL-DISEASE; CLINICAL-OUTCOMES; ELUTING STENTS; IMPACT;
   INSUFFICIENCY; REVASCULARIZATION; MORTALITY; METAANALYSIS; TRIALS
AB Background and Objectives: Chronic kidney disease (CKD) is associated with poor outcomes after percutaneous coronary intervention (PCI). We sought to compare different coronary stents used during primary PCI in patients with ST-elevation myocardial infarction (STEMI) and CKD.
   Subjects and Methods: We selected 2408 consecutive STEMI patients with CKD (estimated glomerular filtration rate <60 mL/min/1.73 m(2)) undergoing primary PCI and divided them into 5 groups based on the type of stent implanted: 1) bare metal stent (BMS), 2) paclitaxel-eluting stent (PES), 3) sirolimus-eluting stent (SES), 4) zotarolimus-eluting stent (ZES), or 5) everolimus-eluting stent (EES). The study end-point was the number of major adverse cardiac events (MACE) at 12 months.
   Results: There was no significant difference in the incidence of 12-month myocardial infarction, target lesion revascularization, or target vessel revascularization between stent groups; however, the overall rate of repeat revascularization differed significantly between groups. All-cause death differed significantly among the groups. The incidence of 12-month MACE in BMS, PES, SES, ZES, and EES was 8.3%, 9.8%, 8.6%, 5.5%, and 2.6%, respectively (p<0.001). Kaplan-Meier analysis did not show a significant differences in 12-month MACE-free survival among the groups (log-rank p=0.076). This finding remained the same after adjusting for multiple confounders (p=0.147).
   Conclusion: Any of the 5 stents can be used to treat STEMI patients with CKD undergoing primary PCI; all have similar risk of 12-month MACE. This result is hypothesis-generating and warrants further evaluation with a long-term randomized study.
C1 [Ahmed, Khurshid; Jeong, Myung Ho; Hong, Young Joon; Sim, Doo Sun; Park, Keun Ho; Kim, Ju Han; Ahn, Youngkeun; Kang, Jung Chaee] Chonnam Natl Univ, Res Inst Med Sci, Chonnam Natl Univ Hosp, Ctr Heart, Kwangju 501757, South Korea.
   [Ahmed, Khurshid; Chakraborty, Rabin; Ahmed, Sumera] Apollo Gleneagles Hosp, Kolkata, India.
   [Cho, Myeong Chan] Chungbuk Natl Univ Hosp, Dept Internal Med, Chungju, South Korea.
   [Kim, Chong Jin] East West Neo Med Ctr, Dept Internal Med, Seoul, South Korea.
   [Kim, Young Jo] Yeungnam Univ Hosp, Dept Internal Med, Taegu, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ, Res Inst Med Sci, Chonnam Natl Univ Hosp, Ctr Heart, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
OI Seong, In-Whan/0000-0003-4628-0258; Hur, Seung-Ho/0000-0002-3895-1915;
   Jeong, Jin-Ok/0000-0003-0763-4754
CR Abdel-Latif A, 2010, CATHETER CARDIO INTE, V76, P942, DOI 10.1002/ccd.22562
   Ahmed K, 2012, KOREAN CIRC J, V42, P164, DOI 10.4070/kcj.2012.42.3.164
   Apple FS, 2002, AM HEART J, V144, P981, DOI 10.1067/mhj.2002.124048
   Azar RR, 2000, AM J CARDIOL, V86, P485, DOI 10.1016/S0002-9149(00)00998-X
   Barthelemy O, 2011, INT J CARDIOL, V147, P307, DOI 10.1016/j.ijcard.2010.12.061
   Beattie JN, 2001, AM J KIDNEY DIS, V37, P1191, DOI 10.1053/ajkd.2001.24522
   Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X
   Best PJM, 2004, J AM COLL CARDIOL, V44, P1786, DOI 10.1016/j.jacc.2004.07.052
   Bonello L, 2008, AM J CARDIOL, V102, P535, DOI 10.1016/j.amjcard.2008.04.040
   Charytan D, 2006, KIDNEY INT, V70, P2021, DOI 10.1038/sj.ki.5001934
   Das Pranab, 2006, J Invasive Cardiol, V18, P405
   Dumaine R, 2004, AM J CARDIOL, V94, P1543, DOI 10.1016/j.amjcard.2004.08.035
   Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939
   Hachinohe D, 2011, AM J CARDIOL, V108, P206, DOI 10.1016/j.amjcard.2011.03.025
   Halkin Amir, 2006, J Invasive Cardiol, V18, P577
   Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126
   Keeley EC, 2003, AM J CARDIOL, V92, P509, DOI 10.1016/S0002-9149(03)00716-1
   Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479
   Lemos PA, 2005, AM J CARDIOL, V95, P167, DOI 10.1016/j.amjcard.2004.08.089
   LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301
   Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3
   McCullough Peter A, 2002, Rev Cardiovasc Med, V3, P71
   Naidu SS, 2003, AM J CARDIOL, V92, P1160, DOI 10.1016/j.amjcard.2003.07.023
   Rubenstein MH, 2000, CIRCULATION, V102, P2966
   Shenoy C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015070
   Sim Doo Sun, 2009, Korean Circ J, V39, P297, DOI 10.4070/kcj.2009.39.8.297
   Szczech LA, 2002, CIRCULATION, V105, P2253, DOI 10.1161/01.CIR.0000016051.33225.33
   Zhang RY, 2006, CHINESE MED J-PEKING, V119, P1176, DOI 10.1097/00029330-200607020-00007
   이기홍, 2007, Korean Circulation Journal, V37, P64
NR 29
TC 7
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2012
VL 42
IS 12
BP 830
EP 838
DI 10.4070/kcj.2012.42.12.830
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IR
UT WOS:000209080600005
PM 23323121
OA Green Published
DA 2021-04-22
ER

PT J
AU Cha, S
   Kim, GB
   Kwon, BS
   Bae, EJ
   Noh, CI
   Lim, HG
   Kim, WH
   Lee, JR
   Kim, YJ
   Choi, JY
AF Cha, Seulgi
   Kim, Gi Beom
   Kwon, Bo Sang
   Bae, Eun Jung
   Noh, Chung Il
   Lim, Hong Gook
   Kim, Woong Han
   Lee, Jeong Ryul
   Kim, Yong Jin
   Choi, Jung Yun
TI Recent Trends in Indications of Fetal Echocardiography and Postnatal
   Outcomes in Fetuses Diagnosed as Congenital Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Prenatal diagnosis; Echocardiography; Ultrasonography, prenatal; Heart
   defect, congenital
AB Background and Objectives: We hypothesized that fetal echocardiography (echoCG) is an accurate diagnostic tool reflecting well postnatal echoCG findings and outcomes.
   Subjects and Methods: We reviewed the medical records of 290 pregnant women, including 313 fetuses, who were examined by fetal echoCG at the Seoul National University Children's Hospital from January 2008 through April 2011.
   Results: The mean gestational age at diagnosis was 26.2+/-5.2 weeks. The mean age of mothers at diagnosis was 31.7+/-3.8 years. We identified indications for fetal echoCG in 279 cases. The most common indication was abnormal cardiac findings in obstetrical screening sonography (52.0%). Among the 313 echoCG results, 127 (40.6%) were normal, 13 (4.2%) were minor abnormalities, 35 (11.2%) were simple cardiac anomalies, 50 (16.0%) were moderate cardiac anomalies, 60 (19.2%) were complex cardiac anomalies, 16 (5.1%) were arrhythmias, and 12 (3.8%) were twin-to-twin transfusion syndrome. The most common congenital heart disease was tetralogy of Fallot (23 fetuses, 15.9%). One hundred forty-eight neonates were examined by echoCG. We analyzed differences between fetal echoCG and postnatal echoCG. In 131 (88.5%) cases, there was no difference; in 15 (10.1%), there were minor differences; and in only 2 (1.4%) cases, there were major differences.
   Conclusion: There is a recent increase in abnormal cardiac findings of obstetric ultrasonography screenings that indicate fetal echoCG. Fetal echoCG is still a good, accurate diagnostic method for congenital heart disease.
C1 [Cha, Seulgi; Kim, Gi Beom; Kwon, Bo Sang; Bae, Eun Jung; Noh, Chung Il] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul 110744, South Korea.
   [Lim, Hong Gook; Kim, Woong Han; Lee, Jeong Ryul; Kim, Yong Jin] Seoul Natl Univ, Childrens Hosp, Dept Thorac & Cardiovasc Surg, Seoul 110744, South Korea.
   [Choi, Jung Yun] Seoul Natl Univ, Bundang Hosp, Dept Pediat, Songnam, South Korea.
RP Kim, GB (corresponding author), Seoul Natl Univ, Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 110744, South Korea.
EM ped9526@snu.ac.kr
RI Kim, Gi Beom/AAK-3377-2021
OI Kim, Gi Beom/0000-0002-7880-280X; Cha, Seul Gi/0000-0001-7470-9774
CR Acharya G, 2004, ACTA OBSTET GYN SCAN, V83, P1124, DOI 10.1111/j.0001-6349.2004.00404.x
   Apitz C, 2009, LANCET, V374, P1462, DOI 10.1016/S0140-6736(09)60657-7
   Berg C, 2010, ULTRASOUND OBST GYN, V35, P183, DOI 10.1002/uog.7499
   Berkley EMF, 2009, PRENATAL DIAG, V29, P654, DOI 10.1002/pd.2260
   Boldt T, 2002, SCAND CARDIOVASC J, V36, P73, DOI 10.1080/140174302753675339
   Choi EY, 2006, KOREAN J PEDIAT, V49, P1073
   COOPER MJ, 1995, OBSTET GYNECOL, V86, P577, DOI 10.1016/0029-7844(95)00215-D
   Cymbron T, 2006, COMMUNITY GENET, V9, P107, DOI 10.1159/000091488
   Feinstein JA, 2012, J AM COLL CARDIOL, V59, pS1, DOI 10.1016/j.jacc.2011.09.022
   Franklin O, 2002, HEART, V87, P67, DOI 10.1136/heart.87.1.67
   Friedberg MK, 2004, PRENATAL DIAG, V24, P781, DOI 10.1002/pd.981
   Friedman AH, 2002, PRENATAL DIAG, V22, P280, DOI 10.1002/pd.305
   Gedikbasi A, 2008, AM J PERINAT, V25, P427, DOI 10.1055/s-0028-1083840
   Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7
   Jone PN, 2009, PEDIATR CLIN N AM, V56, P709, DOI 10.1016/j.pcl.2009.04.002
   Lee JE, 2010, J OBSTET GYNAECOL RE, V36, P474, DOI 10.1111/j.1447-0756.2010.01222.x
   Martins P, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-27
   Meyer-Wittkopf M, 2001, ULTRASOUND OBST GYN, V17, P392, DOI 10.1046/j.1469-0705.2001.00381.x
   Plesinac Snezana, 2007, Int J Fertil Womens Med, V52, P89
   Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059
   Russo MG, 2008, J CARDIOVASC MED, V9, P910, DOI 10.2459/JCM.0b013e32830212cf
   Schultz AH, 2008, PEDIATRICS, V121, P751, DOI 10.1542/peds.2007-0421
   SMYTHE JF, 1992, AM J CARDIOL, V69, P1471, DOI 10.1016/0002-9149(92)90903-C
   Tennstedt C, 1999, HEART, V82, P34, DOI 10.1136/hrt.82.1.34
   Turner CGB, 2009, CLIN PERINATOL, V36, P439, DOI 10.1016/j.clp.2009.03.015
   Zhang YL, 2011, J ULTRAS MED, V30, P989, DOI 10.7863/jum.2011.30.7.989
NR 26
TC 10
Z9 10
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2012
VL 42
IS 12
BP 839
EP 844
DI 10.4070/kcj.2012.42.12.839
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IR
UT WOS:000209080600006
PM 23323122
OA Green Published
DA 2021-04-22
ER

PT J
AU Oh, JH
   Lee, HW
   Cha, KS
AF Oh, Jun-Hyok
   Lee, Hye Won
   Cha, Kwang Soo
TI Hemodynamic Significance of Coronary Cameral Fistula Assessed by
   Fractional Flow Reserve
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessels; Fistula; Myocardial ischemia; Myocardial bridging
AB Coronary cameral fistula (CCF) is a rare anomaly, where a communication exists between an epicardial coronary artery and a cardiac chamber. Assessing the hemodynamic significance of the fistula is crucial to make a decision concerning the management process. We present two cases of CCF, draining into the left ventricle, in which the hemodynamic significance was assessed by a fractional flow reserve.
C1 [Oh, Jun-Hyok; Lee, Hye Won; Cha, Kwang Soo] Pusan Natl Univ Hosp, Med Res Inst, Dept Cardiol, Pusan 602739, South Korea.
RP Cha, KS (corresponding author), Pusan Natl Univ Hosp, Med Res Inst, Dept Cardiol, 179 Gudeok Ro, Pusan 602739, South Korea.
EM cks@pusan.ac.kr
CR Armsby LR, 2002, J AM COLL CARDIOL, V39, P1026, DOI 10.1016/S0735-1097(02)01742-4
   Bamoshmoosh M, 2007, INT J CARDIOL, V115, pE33, DOI 10.1016/j.ijcard.2006.07.066
   Escaned J, 2003, J AM COLL CARDIOL, V42, P226, DOI 10.1016/S0735-1097(03)00588-6
   LEVIN DC, 1978, CIRCULATION, V58, P25, DOI 10.1161/01.CIR.58.1.25
   LIBERTHSON RR, 1979, CIRCULATION, V59, P849, DOI 10.1161/01.CIR.59.5.849
   Rana O, 2009, EUR J ECHOCARDIOGR, V10, P175, DOI 10.1093/ejechocard/jen215
   SAPIN P, 1990, MEDICINE, V69, P101, DOI 10.1097/00005792-199069020-00004
   Strange JW, 2008, CIRCULATION, V117, P853, DOI 10.1161/CIRCULATIONAHA.107.725515
   VAVURANAKIS M, 1995, CATHETER CARDIO DIAG, V35, P116, DOI 10.1002/ccd.1810350207
NR 9
TC 9
Z9 9
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2012
VL 42
IS 12
BP 845
EP 848
DI 10.4070/kcj.2012.42.12.845
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IR
UT WOS:000209080600007
PM 23323123
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, HY
   Her, SH
   Park, MW
   Choi, MS
   Cho, JS
   Kim, CJ
   Kang, HS
   Choi, YA
   Ju, IN
   Kim, SA
   Lee, JH
   Kwon, JB
   Park, K
AF Lee, Hye Yeon
   Her, Sung-Ho
   Park, Mahn Won
   Choi, Min Seok
   Cho, Jung Sun
   Kim, Chan Joon
   Kang, Hye Seon
   Choi, Yoo A.
   Ju, Il Nam
   Kim, Seon A.
   Lee, Jong-Ho
   Kwon, Jong-Bum
   Park, Kuhn
TI A Case of Patent Ductus Arteriosus with Congestive Heart Failure in a
   80-Year-Old Man
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ductus arteriosus, patent; Heart failure; Aged
AB Patent ductus arteriosus (PDA) is a rare clinical finding in adult patients. Considering the increase in cases of PDA discovered incidentally on echocardiograms at young ages, and the life-shortening effect of PDA, it is rare to diagnose PDA in old patients. We report a case of an 80-year-old patient who experienced symptoms of congestive heart failure showed findings suggestive of PDA in echocardiogram and confirmed the diagnosis through a cardiac catheterization and a coronary angiography. After percutaneous occlusion of PDA with an Amplatzer duct occlusion device, symptoms related to congestive heart failure improved.
C1 [Lee, Hye Yeon; Her, Sung-Ho; Park, Mahn Won; Choi, Min Seok; Cho, Jung Sun; Kim, Chan Joon; Kang, Hye Seon; Choi, Yoo A.; Ju, Il Nam; Kim, Seon A.] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Div Cardiol, Seoul, South Korea.
   [Lee, Jong-Ho; Kwon, Jong-Bum; Park, Kuhn] Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Div Thorac Surg, Seoul, South Korea.
RP Her, SH (corresponding author), Catholic Univ Korea, Coll Med, Daejeon St Marys Hosp, Div Cardiol, 64 Daeheung Ro, Taejon 301723, South Korea.
EM hhhsungho@naver.com
CR Akintunde AA, 2011, AFR HEALTH SCI, V11, P138
   Cassidy HD, 2009, J AM BOARD FAM MED, V22, P214, DOI 10.3122/jabfm.2009.02.070230
   Giliberti P, 2009, J MATERN-FETAL NEO M, V22, P6, DOI 10.1080/14767050903198215
   Harrison DA, 1996, AM J CARDIOL, V77, P1094, DOI 10.1016/S0002-9149(96)00139-7
   Satoh T, 1997, INTERNAL MED, V36, P340, DOI 10.2169/internalmedicine.36.340
   Satoh T, 2008, INTERNAL MED, V47, P263, DOI 10.2169/internalmedicine.47.0445
   Wang JK, 2007, CATHETER CARDIO INTE, V69, P572, DOI 10.1002/ccd.20701
   Zhu Xian-Yang, 2009, Zhonghua Xin Xue Guan Bing Za Zhi, V37, P998
NR 8
TC 6
Z9 6
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2012
VL 42
IS 12
BP 849
EP 852
DI 10.4070/kcj.2012.42.12.849
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IR
UT WOS:000209080600008
PM 23323124
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, MS
   Park, JP
   Yun, SH
   Lee, JU
   Kim, JK
   Lee, NE
   Song, JE
   Lee, SE
   John, SH
   Lim, JH
   Rhew, JY
AF Park, Moon-Sik
   Park, Jong-Pil
   Yun, So-Hee
   Lee, Jae-Un
   Kim, Joong-Keun
   Lee, Na-Eun
   Song, Ji-Eun
   Lee, Shin-Eun
   John, Sung-Hee
   Lim, Ji-Hyun
   Rhew, Jay-Young
TI A Case of Cryptogenic Stroke Associated with Patent Foramen Ovale
   Coexisting with Pulmonary Embolisms, Deep Vein Thromboses, and Renal
   Artery Infarctions
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Paradoxical embolism; Stroke; Patent foramen ovale; Pulmonary
   thromboembolism; Kidney disease
AB A paradoxical embolism is defined as a systemic arterial embolism requiring the passage of a venous thrombus into the arterial circulatory system through a right-to-left shunt, and is commonly related to patent foramen ovale (PFO). However, coexisting pulmonary embolisms, deep vein thromboses (DVT), and multipe systemic arterial embolisms, associated with PFO, are rare. Here, we report a patient who had a cryptogenic ischemic stroke, associated with PFO, which is complicated with a massive pulmonary thromboembolism, DVT, and renal infarctions, and subsequently, the patient was treated using a thrombolytic therapy.
C1 [Park, Moon-Sik; Park, Jong-Pil; Yun, So-Hee; Lee, Jae-Un; Kim, Joong-Keun; Lee, Na-Eun; Song, Ji-Eun; Lee, Shin-Eun; John, Sung-Hee; Lim, Ji-Hyun; Rhew, Jay-Young] Presbyterian Med Ctr, Dept Internal Med, Div Cardiol, Jeonju 560750, South Korea.
RP Park, JP (corresponding author), Presbyterian Med Ctr, Dept Internal Med, Div Cardiol, 365 Seowon Ro, Jeonju 560750, South Korea.
EM jppark74@gmail.com
CR Augustinos P, 2004, CIRCULATION, V110, pI27, DOI 10.1161/01.CIR.0000140900.64198.f4
   Caretta Giorgio, 2009, Cases J, V2, P8358, DOI 10.4076/1757-1626-2-8358
   Clergeau MR, 2009, STROKE, V40, P3758, DOI 10.1161/STROKEAHA.109.559898
   Cramer SC, 2004, STROKE, V35, P46, DOI 10.1161/01.STR.0000106137.42649.AB
   Dao CN, 2011, CATHETER CARDIO INTE, V77, P903, DOI 10.1002/ccd.22884
   Guo Shan, 2007, J Med Case Rep, V1, P104, DOI 10.1186/1752-1947-1-104
   Khairy P, 2003, ANN INTERN MED, V139, P753, DOI 10.7326/0003-4819-139-9-200311040-00010
   Konstantinides S, 1998, CIRCULATION, V97, P1946, DOI 10.1161/01.CIR.97.19.1946
   Kouskov OS, 2011, CLIN APPL THROMB-HEM, V17, pE98, DOI 10.1177/1076029610387123
   LECHAT P, 1988, NEW ENGL J MED, V318, P1148, DOI 10.1056/NEJM198805053181802
   Lim DS, 2011, KOREAN J NEPHROL, V30, P667
   Oh BH, 1993, KOREAN CIRC J, V23, P217
   Pelletier M, 2010, J EMERG MED, V39, P443, DOI 10.1016/j.jemermed.2009.02.033
   Tanislav C, 2011, STROKE, V42, P822, DOI 10.1161/STROKEAHA.110.601575
   Thomas D V, 2005, Australas Radiol, V49, P501, DOI 10.1111/j.1440-1673.2005.01480.x
   WEBSTER MWI, 1988, LANCET, V2, P11
   Windecker S, 2004, J AM COLL CARDIOL, V44, P750, DOI 10.1016/j.jacc.2004.05.044
NR 17
TC 1
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2012
VL 42
IS 12
BP 853
EP 856
DI 10.4070/kcj.2012.42.12.853
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IR
UT WOS:000209080600009
PM 23323125
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, SH
   Im, CH
   Yang, DH
   Kang, JW
   Yoon, JY
   Cho, HJ
   Park, HS
   Cho, Y
   Chae, SC
   Jun, JE
AF Park, Sun Hee
   Im, Churl Hyun
   Yang, Dong Heon
   Kang, Jong Wan
   Yoon, Jae Yong
   Cho, Hyun Jun
   Park, Hun Sik
   Cho, Yongkeun
   Chae, Shung Chull
   Jun, Jae-Eun
TI A Case of Chronic Periaortitis with Retroperitoneal Fibrosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Periaortitis, chronic; Retroperitoneal fibrosis
AB A 73-year-old man with a history of hypertension and ascending aortic dissection was hospitalized for aggravated abdominal pain and general ache for 3 months. Follow-up CT showed aggravated abdominal aortic hematoma with aneurysm, atherosclerotic periaortitis and bilateral hydronephrosis. An initial laboratory finding showed elevated levels of inflammatory markers and renal dysfunction. Positron emission tomography-CT showed an increased standardized uptake values level in the aortic arch, descending thoracic aorta, major branch, abdominal aorta, and common iliac artery. For bilateral hydronephrosis, a double J catheter insertion was performed. Tissue specimens obtained from previous surgery on the aorta indicated the infiltration of lympho-plasma cells without granuloma formation in the aortic wall. After a combined therapy of high dose steroid therapy with azathioprine, the patient's initial complaints of abdominal pain, weakness and azotemia improved. This case was diagnosed as chronic periaortitis based on aortic inflammation at biopsy, which was complicated with retroperitoneal fibrosis and ureteric obstruction.
C1 [Park, Sun Hee; Yang, Dong Heon; Yoon, Jae Yong; Cho, Hyun Jun; Park, Hun Sik; Cho, Yongkeun; Chae, Shung Chull; Jun, Jae-Eun] Kyungpook Natl Univ Hosp, Dept Cardiol, Taegu 700721, South Korea.
   [Im, Churl Hyun; Kang, Jong Wan] Kyungpook Natl Univ Hosp, Dept Rheumatol, Taegu 700721, South Korea.
RP Im, CH (corresponding author), Kyungpook Natl Univ Hosp, Dept Rheumatol, 130 Dongdeok Ro, Taegu 700721, South Korea.
EM ich74@hmail.knu.ac.kr
CR Blockmans D, 2002, CLIN NUCL MED, V27, P211, DOI 10.1097/00003072-200203000-00016
   Iino M, 2002, J COMPUT ASSIST TOMO, V26, P1006, DOI 10.1097/00004728-200211000-00026
   Jois RN, 2004, RHEUMATOLOGY, V43, P1441, DOI 10.1093/rheumatology/keh326
   Kardar AH, 2002, J UROLOGY, V168, P550, DOI 10.1016/S0022-5347(05)64677-0
   MITCHINSON MJ, 1984, HISTOPATHOLOGY, V8, P589, DOI 10.1111/j.1365-2559.1984.tb02371.x
   PARUMS DV, 1990, HISTOPATHOLOGY, V16, P423
   Sakamoto A, 2012, J CARDIOL, V59, P139, DOI 10.1016/j.jjcc.2011.07.014
   Stone JH, 2009, ARTHRITIS RHEUM-US, V60, P3139, DOI 10.1002/art.24798
   Vaglio A, 2003, AM J MED, V114, P454, DOI 10.1016/S0002-9343(03)00056-1
   Vaglio A, 2005, CURR OPIN RHEUMATOL, V17, P34, DOI 10.1097/01.bor.0000145517.83972.40
   Vaglio A, 2006, AUTOIMMUN REV, V5, P458, DOI 10.1016/j.autrev.2006.03.011
   Vaglio A, 2011, CURR OPIN RHEUMATOL, V23, P1, DOI 10.1097/BOR.0b013e328341137d
   van Bommel EFH, 2009, MEDICINE, V88, P193, DOI 10.1097/MD.0b013e3181afc420
NR 13
TC 2
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2012
VL 42
IS 12
BP 857
EP 860
DI 10.4070/kcj.2012.42.12.857
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IR
UT WOS:000209080600010
PM 23323126
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, D
   Kim, S
   Kim, M
   Seo, YH
   Kim, W
   Kang, SH
   Park, SM
   Shim, W
AF Cho, Donghyuk
   Kim, Sua
   Kim, Mina
   Seo, Young Ho
   Kim, Woohyeun
   Kang, Seong Hee
   Park, Sung-Mi
   Shim, Wanjoo
TI Two Cases of High Output Heart Failure Caused by Hereditary Hemorrhagic
   Telangiectasia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart failure; Telangiectasia, hereditary hemorrhagic
ID MANAGEMENT; DIAGNOSIS; LIVER
AB High-output cardiac failure is a rare complication of hereditary hemorrhagic telangiectasia (HHT) usually caused by shunting of blood through atriovenous malformations (AVMs) in the liver. We describe two cases of high output heart failure due to large hepatic AVMs. Clinical suspicion of HHT based on detailed history taking and physical examination is essential for early detection and proper management of heart failure associated with HHT.
C1 [Cho, Donghyuk; Kim, Sua; Kim, Mina; Seo, Young Ho; Kim, Woohyeun; Kang, Seong Hee; Park, Sung-Mi; Shim, Wanjoo] Korea Univ, Coll Med, Dept Cardiol, Seoul 136705, South Korea.
RP Shim, W (corresponding author), Korea Univ, Coll Med, Dept Cardiol, 73 Inchon Ro, Seoul 136705, South Korea.
EM wjshimmd@unitel.co.kr
CR Bayrak-Toydemir P, 2004, GENET MED, V6, P175, DOI 10.1097/01.GIM.0000132689.25644.7C
   Blum A, 2009, CLIN MED INSIGHTS-CA, V3, P121
   Boillot O, 1999, GASTROENTEROLOGY, V116, P187, DOI 10.1016/S0016-5085(99)70243-X
   BRAVERMAN IM, 1990, J INVEST DERMATOL, V95, P422, DOI 10.1111/1523-1747.ep12555569
   Caselitz M, 1998, GUT, V42, P123, DOI 10.1136/gut.42.1.123
   Faughnan ME, 2011, J MED GENET, V48, P73, DOI 10.1136/jmg.2009.069013
   Fleagle JM, 2012, AM J MED SCI, V343, P249, DOI 10.1097/MAJ.0b013e3182429866
   Goussous T, 2009, CARDIOL RES PRACT, V2009, DOI 10.4061/2009/437237
   GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407
   Koscielny A, 2008, J GASTROINTEST SURG, V12, P872, DOI 10.1007/s11605-007-0411-9
   Koyalakonda Shiva Prasad, 2011, JRSM Short Rep, V2, P66, DOI 10.1258/shorts.2011.011057
   McDonald J, 2011, GENET MED, V13, P607, DOI 10.1097/GIM.0b013e3182136d32
   RAZI B, 1971, AM J MED, V50, P809, DOI 10.1016/0002-9343(71)90189-6
NR 13
TC 9
Z9 9
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2012
VL 42
IS 12
BP 861
EP 865
DI 10.4070/kcj.2012.42.12.861
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IR
UT WOS:000209080600011
PM 23323127
OA Green Published
DA 2021-04-22
ER

PT J
AU Won, KB
   Cho, YH
   Cho, DK
AF Won, Ki-Bum
   Cho, Yun-Hyeong
   Cho, Deok-Kyu
TI Sudden Cardiac Arrest with Acute Myocardial Infarction Induced by Left
   Subclavian Artery Occlusion in a Patient with Prior Coronary Artery
   Bypass Surgery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Sudden cardiac arrest; Coronary artery bypass surgery; Atherosclerosis
AB Multivascular preventive and therapeutic approaches are necessary in patients with coronary artery disease because atherosclerosis has a common systemic pathogenesis. We present a rare case of sudden cardiac arrest with acute myocardial infarction induced by the total occlusion of left subclavian artery (LSCA) in a patient with a history of previous coronary artery bypass surgery using the left internal mammary artery. We initially performed blind-puncture of left brachial artery, attempting percutaneous coronary intervention because pulses were absent in both upper and lower extremities. However, the cause of sudden cardiac arrest was atherosclerotic total occlusion of LSCA. The patient was stabilized after successful revascularization of LSCA by percutaneous transluminal angioplasty with stent insertion.
C1 [Won, Ki-Bum; Cho, Yun-Hyeong; Cho, Deok-Kyu] Kwandong Univ, Coll Med, Myongji Hosp, Dept Cardiol,Ctr Cardiovasc, Goyang 412270, South Korea.
RP Cho, DK (corresponding author), Kwandong Univ, Coll Med, Myongji Hosp, Dept Cardiol,Ctr Cardiovasc, 697-24 Hwajeong Dong, Goyang 412270, South Korea.
EM chodk123@paran.com
CR AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129
   Azzarone M, 2000, J ENDOVASC THER, V7, P161, DOI 10.1583/1545-1550(2000)007<0161:SSOOTI>2.3.CO;2
   Cronenwett JL, 2000, VASCULAR SURG, P1140
   FAIRBAIRN JF, 1972, PERIPHERAL VASCULAR
   Hadjipetrou P, 1999, J AM COLL CARDIOL, V33, P1238, DOI 10.1016/S0735-1097(98)00690-1
   KAPPERT A, 1987, LEHRBUCH ATLAS ANGIO
   Rodriguez-Lopez JA, 1999, ANN VASC SURG, V13, P254, DOI 10.1007/s100169900254
   Shadman R, 2004, J AM COLL CARDIOL, V44, P618, DOI 10.1016/j.jacc.2004.04.044
   Singer AJ, 1996, ARCH INTERN MED, V156, P2005, DOI 10.1001/archinte.156.17.2005
NR 9
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2012
VL 42
IS 12
BP 866
EP 868
DI 10.4070/kcj.2012.42.12.866
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IR
UT WOS:000209080600012
PM 23323128
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, Y
   Mori, N
   Nakamura, D
   Yoshimura, T
   Taniike, M
   Makino, N
   Kato, H
   Egami, Y
   Shutta, R
   Tanouchi, J
   Yamada, Y
   Nishino, M
AF Lee, Yasuharu
   Mori, Naoki
   Nakamura, Daisuke
   Yoshimura, Takahiro
   Taniike, Masayuki
   Makino, Nobuhiko
   Kato, Hiroyasu
   Egami, Yasuyuki
   Shutta, Ryu
   Tanouchi, Jun
   Yamada, Yoshio
   Nishino, Masami
TI Valsalva Aneurysm Filled with Thrombi Mimicking a Cardiac Tumor
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Sinus of Valsalva; Cardiac tumor; 2D echocardiography; Magnetic
   resonance imaging
AB A Valsalva aneurysm filled with thrombi can be difficult to diagnose, because it mimics a cardiac tumor. Both cardiac magnetic resonance imaging (MRI) and transesophageal echocardiogram (TEE) were performed on a patient who showed a low-echoic mass located between the atrial septum and the non-coronary sinus. Based on MRI findings allowing tissue characterization and the accurate location of the mass and the TEE findings of an irregular surface of the mass and a partial defect in the edge of the non-coronary sinus, we diagnosed the mass as a thrombosed Valsalva aneurysm that had perforated the inter-atrial septum. The operative findings coincided with the preoperative diagnosis. Both MRI and TEE are useful for diagnosing this condition.
C1 [Lee, Yasuharu; Mori, Naoki; Nakamura, Daisuke; Yoshimura, Takahiro; Taniike, Masayuki; Makino, Nobuhiko; Kato, Hiroyasu; Egami, Yasuyuki; Shutta, Ryu; Tanouchi, Jun; Yamada, Yoshio; Nishino, Masami] Osaka Rosai Hosp, Div Cardiol, Osaka, Japan.
RP Nishino, M (corresponding author), Osaka Rosai Hosp, Div Cardiol, 1179-3 Nagasone Cho, Sakai, Osaka 5918025, Japan.
EM mnishino@orh.go.jp
OI Matsunaga-Lee, Yasuharu/0000-0002-4775-8914
CR COPELAND JG, 1984, CLIN CARDIOL, V7, P449, DOI 10.1002/clc.4960070806
   FLYNN MS, 1993, AM HEART J, V125, P1185, DOI 10.1016/0002-8703(93)90141-U
   Hoey ETD, 2010, AM J ROENTGENOL, V194, pW495, DOI 10.2214/AJR.09.3570
   Lijoi A, 2002, TEX HEART I J, V29, P40
   Meier JH, 1998, J AM SOC ECHOCARDIOG, V11, P729, DOI 10.1053/je.1998.v11.a91047
   Mookadam F, 2005, Eur J Echocardiogr, V6, P221, DOI 10.1016/j.euje.2004.09.008
   Nagueh Sherif F., 1998, Cardiology Clinics, V16, P405, DOI 10.1016/S0733-8651(05)70022-9
   Popescu BA, 2011, J AM COLL CARDIOL, V57, P219, DOI 10.1016/j.jacc.2010.05.062
   Sasaki S, 2009, ANN THORAC SURG, V87, P1619, DOI 10.1016/j.athoracsur.2008.08.044
   SHAHRABANI RM, 1993, BRIT HEART J, V69, P266
   Wang ZJ, 2007, ANN THORAC SURG, V84, P156, DOI 10.1016/j.athoracsur.2007.03.022
NR 11
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2012
VL 42
IS 12
BP 869
EP 871
DI 10.4070/kcj.2012.42.12.869
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IR
UT WOS:000209080600013
PM 23323129
OA Green Published
DA 2021-04-22
ER

PT J
AU Ozyurtlu, F
   Acet, H
   Bilik, MZ
   Ertas, F
AF Ozyurtlu, Ferhat
   Acet, Halit
   Bilik, Mehmet Zihni
   Ertas, Faruk
TI Unreported Coronary Artery Anomaly: Association of Right Coronary Artery
   and Circumflex Coronary Artery with Single Ostium Originate from High
   Left Anterior Aorta
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Ozyurtlu, Ferhat; Acet, Halit] Diyarbakir Training & Res Hosp, Dept Cardiol, Diyarbakir, Turkey.
   [Bilik, Mehmet Zihni; Ertas, Faruk] Dicle Univ, Fac Med, Dept Cardiol, Diyarbakir, Turkey.
RP Acet, H (corresponding author), Diyarbakir Training & Res Hosp, Dept Cardiol, Diyarbakir, Turkey.
EM halitacet@gmail.com
CR Angelini Paolo, 2003, J Invasive Cardiol, V15, P507
   KRAGEL AH, 1988, AM J CARDIOL, V62, P771, DOI 10.1016/0002-9149(88)91220-9
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
NR 3
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2012
VL 42
IS 12
BP 872
EP 873
DI 10.4070/kcj.2012.42.12.872
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IR
UT WOS:000209080600014
PM 23323130
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, HO
AF Jung, Hae-Ok
TI Pericardial Effusion and Pericardiocentesis: Role of Echocardiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Pericardial effusions; Echocardiography; Cardiac tamponade;
   Pericardiocentesis
AB Pericardial effusion can develop from any pericardial disease, including pericarditis and several systemic disorders, such as malignancies, pulmonary tuberculosis, chronic renal failure, thyroid diseases, and autoimmune diseases. The causes of large pericardial effusion requiring invasive pericardiocentesis may vary according to the time, country, and hospital. Transthoracic echocardiography is the most important tool for diagnosis, grading, the pericardiocentesis procedure, and follow up of pericardial effusion. Cardiac tamponade is a kind of cardiogenic shock and medical emergency. Clinicians should understand the tamponade physiology, especially because it can develop without large pericardial effusion. In addition, clinicians should correlate the echocardiographic findings of tamponade, such as right ventricular collapse, right atrial collapse, and respiratory variation of mitral and tricuspid flow, with clinical signs of clinical tamponade, such as hypotension or pulsus paradoxus. Percutaneous pericardiocentesis has been the most useful procedure in many cases of large pericardial effusion, cardiac tamponade, or pericardial effusion of unknown etiology. The procedure should be performed with the guidance of echocardiography.
C1 [Jung, Hae-Ok] Catholic Univ Korea, Div Cardiol, Dept Internal Med, Coll Med, Seoul 137040, South Korea.
RP Jung, HO (corresponding author), Catholic Univ Korea, Div Cardiol, Dept Internal Med, Seoul St Marys Hosp, 505 Banpo Dong, Seoul 137040, South Korea.
EM hojheart@catholic.ac.kr
CR Allen KB, 1999, ANN THORAC SURG, V67, P437, DOI 10.1016/S0003-4975(98)01192-8
   APPLETON CP, 1988, J AM COLL CARDIOL, V11, P1020, DOI 10.1016/S0735-1097(98)90060-2
   Ariyarajah V, 2007, TEX HEART I J, V34, P347
   ARMSTRONG WF, 1982, CIRCULATION, V65, P1491, DOI 10.1161/01.CIR.65.7.1491
   BRAUNWALT E, 2008, HARRISONS INT MED, P1488
   Cho BC, 2004, YONSEI MED J, V45, P462, DOI 10.3349/ymj.2004.45.3.462
   ENGEL PJ, 1982, AM J CARDIOL, V50, P1018, DOI 10.1016/0002-9149(82)90411-8
   GAFFNEY FA, 1984, AM J CARDIOL, V53, P1662, DOI 10.1016/0002-9149(84)90598-8
   GILLAM LD, 1983, CIRCULATION, V68, P294, DOI 10.1161/01.CIR.68.2.294
   Goodman Adam, 2012, J Emerg Trauma Shock, V5, P72, DOI 10.4103/0974-2700.93118
   Halpern Dan G, 2012, Crit Pathw Cardiol, V11, P85, DOI 10.1097/HPC.0b013e318254a5ca
   HOROWITZ MS, 1974, CIRCULATION, V50, P239, DOI 10.1161/01.CIR.50.2.239
   Jung HO, 2010, AM J CARDIOL, V106, P437, DOI 10.1016/j.amjcard.2010.03.044
   Kabukcu M, 2004, TEX HEART I J, V31, P398
   Kil UH, 2008, CLIN CARDIOL, V31, P531, DOI [10.1002/clc.20305, 10.1002/ClC.20305]
   KOCHAR GS, 1990, J AM COLL CARDIOL, V16, P511, DOI 10.1016/0735-1097(90)90613-T
   KRONZON I, 1983, J AM COLL CARDIOL, V1, P913, DOI 10.1016/S0735-1097(83)80208-3
   Levy PY, 2003, MEDICINE, V82, P385, DOI 10.1097/01.md.0000101574.54295.73
   Lindenberger M, 2003, J INTERN MED, V253, P411, DOI 10.1046/j.1365-2796.2003.01103.x
   Little WC, 2006, CIRCULATION, V113, P1622, DOI 10.1161/CIRCULATIONAHA.105.561514
   Loukas M, 2012, CLIN ANAT, V25, P872, DOI 10.1002/ca.22032
   Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002
   Manning WJ, 2008, CECIL MED, P548
   McDonald JM, 2003, ANN THORAC SURG, V76, P811, DOI 10.1016/S0003-4975(03)00665-9
   Merce J, 1999, AM HEART J, V138, P759, DOI 10.1016/S0002-8703(99)70193-6
   Munt BI, 2011, PRACTICE CLIN ECHOCA, P565
   Nagdev A, 2011, RESUSCITATION, V82, P671, DOI 10.1016/j.resuscitation.2011.02.004
   OH JK, 2007, ECHO MANUAL, P289
   Pepi M, 2006, J CARDIOVASC MED, V7, P533, DOI 10.2459/01.JCM.0000234772.73454.57
   Reuter H, 2005, EPIDEMIOL INFECT, V133, P393, DOI 10.1017/S0950268804003577
   REYDEL B, 1990, AM HEART J, V119, P1160, DOI 10.1016/S0002-8703(05)80248-0
   Sagrista-Sauleda J, 2000, AM J MED, V109, P95, DOI 10.1016/S0002-9343(00)00459-9
   Sagrista-Sauleda J, 2011, WORLD J CARDIOL, V3, P135, DOI 10.4330/wjc.v3.i5.135
   Seferovic PM, 2006, HERZ, V31, P891, DOI 10.1007/s00059-006-2937-0
   Spodick DH, 2003, NEW ENGL J MED, V349, P684, DOI 10.1056/NEJMra022643
   SPODICK DH, 2001, HEART DIS TXB CARDIO, V2, P1823
   Tsang TSM, 1998, MAYO CLIN PROC, V73, P647, DOI 10.4065/73.7.647
   Tsang TSM, 2002, MAYO CLIN PROC, V77, P429
   Tsang TSM, 1998, J AM COLL CARDIOL, V32, P1345, DOI 10.1016/S0735-1097(98)00390-8
   Verhaert D, 2010, CIRC-CARDIOVASC IMAG, V3, P333, DOI 10.1161/CIRCIMAGING.109.921791
   김대영, 2008, [The Korean Journal of Medicine, 대한내과학회지], V74, P154
NR 41
TC 25
Z9 26
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 725
EP 734
DI 10.4070/kcj.2012.42.11.725
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500001
PM 23236323
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, YH
   Park, HS
   Hyun, MC
   Kim, YN
AF Kim, Yeo Hyang
   Park, Hyoung-Seob
   Hyun, Myung Chul
   Kim, Yoon-Nyun
TI Pediatric Tachyarrhythmia and Radiofrequency Catheter Ablation: Results
   From 1993 to 2011
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pediatrics; Tachycardia, supraventricular; Catheter ablation
AB Background and Objectives: We performed a retrospective study to elucidate the frequency of tachycardia mechanisms and the characteristics of accessory pathways (APs), confirmed by radiofrequency catheter ablation (RFCA) in pediatric tachycardia. In addition, we analyzed the efficacy and safety of pediatric RFCA.
   Subjects and Methods: The authors retrospectively reviewed the records of a total of 260 patients (aged 2 to 18 years) who had undergone RFCA between August 1993 and July 2011 at two medical centers in Daegu.
   Results: Two hundred and sixty patients underwent 272 RFCAs at less than 18 years of age. Of these 260 patients, 9 patients (3%) were younger than 6 years, and 175 patients (67%) were older than 12 years. The tachycardia mechanisms observed were atrioventricular re-entry tachycardia (AVRT) in 175 patients (65%), atrioventricular nodal re-entry tachycardia (AVNRT) in 83 patients (30%), ventricular tachycardia in 12 patients (4%), and atrial tachycardia in 2 patients (0.7%). Among the patients with AVRT, there were 94 concealed APs and 81 manifest APs. Left-side APs were more common in concealed APs than in manifest APs (72/94, 77% vs. 33/81, 41%, p<0.001). Sixty-six percent (55/83) of AVNRT cases were located at the M1 and/or M2 sites. Four patients had multiple tachycardia mechanisms (AVNRT+AVRT) and 9 patients had multiple APs. The recurrence rate was 5% (13/272). Of these recurrent cases, 12 patients had AVRT. The overall success rate was 95%.
   Conclusion: Pediatric RFCA provides a good success rate and an acceptable recurrence. In addition, we suggest that the APs location may be associated with concealed or manifest property of APs.
C1 [Kim, Yeo Hyang] Keimyung Univ, Dongsan Med Ctr, Dept Pediat, Taegu 700712, South Korea.
   [Park, Hyoung-Seob; Kim, Yoon-Nyun] Keimyung Univ, Dongsan Med Ctr, Div Cardiol, Dept Internal Med, Taegu 700712, South Korea.
   [Hyun, Myung Chul] Kyungpook Natl Univ Hosp, Dept Pediat, Taegu, South Korea.
RP Kim, YH (corresponding author), Keimyung Univ, Dongsan Med Ctr, Dept Pediat, 56 Dalseong Ro, Taegu 700712, South Korea.
EM kimyhped@hanmail.net
CR AKHTAR M, 1993, CIRCULATION, V88, P282, DOI 10.1161/01.CIR.88.1.282
   Bae EJ, 2005, J KOREAN MED SCI, V20, P740, DOI 10.3346/jkms.2005.20.5.740
   Blaufox AD, 2000, PACE, V23, P477, DOI 10.1111/j.1540-8159.2000.tb00830.x
   Brembilia-Perrot B, 2008, ARCH CARDIOVASC DIS, V101, P18, DOI 10.1016/S1875-2136(08)70250-X
   Chiu SN, 2009, CIRC J, V73, P1717, DOI 10.1253/circj.CJ-09-0123
   Cohen MI, 1997, J AM COLL CARDIOL, V29, P403, DOI 10.1016/S0735-1097(96)00487-1
   DICK M, 1991, CIRCULATION, V84, P2318, DOI 10.1161/01.CIR.84.6.2318
   Friedman RA, 2002, PACE, V25, P1000, DOI 10.1046/j.1460-9592.2002.01000.x
   Joung B, 2006, CIRC J, V70, P278, DOI 10.1253/circj.70.278
   Jung Hae Jung, 2011, Korean J Pediatr, V54, P507, DOI 10.3345/kjp.2011.54.12.507
   KO JK, 1992, AM J CARDIOL, V69, P1028, DOI 10.1016/0002-9149(92)90858-V
   Lee PC, 2006, PACE, V29, P490, DOI 10.1111/j.1540-8159.2006.00381.x
   Ludomirsky A, 1990, PEDIAT ARRHYTHMIAS E, P380
   Orejarena LA, 1998, J AM COLL CARDIOL, V31, P150, DOI 10.1016/S0735-1097(97)00422-1
   Silka MJ, 1997, AM J CARDIOL, V80, P1364, DOI 10.1016/S0002-9149(97)00685-1
   SILKA MJ, 1994, PACE, V17, P2129, DOI 10.1111/j.1540-8159.1994.tb03813.x
   VANHARE GF, 1991, J AM COLL CARDIOL, V17, P1613, DOI 10.1016/0735-1097(91)90656-T
   Waki K, 2000, J CARDIOVASC ELECTR, V11, P1144, DOI 10.1111/j.1540-8167.2000.tb01761.x
   Wu MH, 2000, INT J CARDIOL, V72, P221, DOI 10.1016/S0167-5273(99)00183-7
NR 19
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 735
EP 740
DI 10.4070/kcj.2012.42.11.735
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500002
PM 23236324
OA Green Published
DA 2021-04-22
ER

PT J
AU Min, YJ
   Choi, YH
   Hyeon, CW
   Cho, JH
   Kim, KJ
   Kwon, JE
   Kim, EY
   Lee, WS
   Lee, KJ
   Kim, SW
   Kim, TH
   Kim, CJ
AF Min, Yun Joo
   Choi, Young Hwan
   Hyeon, Cheol Won
   Cho, Jun Hwan
   Kim, Kyung Joon
   Kwon, Jee Eun
   Kim, Eun Young
   Lee, Wang-Soo
   Lee, Kwang Je
   Kim, Sang-Wook
   Kim, Tae Ho
   Kim, Chee Jeong
TI Fenofibrate Reduces C-Reactive Protein Levels in Hypertriglyceridemic
   Patients With High Risks for Cardiovascular Diseases
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Fenofibric acid; C-reactive protein; Lipids; Lipoprotein
AB Background and Objectives: The effects of fenofibrate on C-reactive protein (CRP) are under debate. We investigated the effect of fenofibrate on CRP levels and the variables determining changes.
   Subjects and Methods: This case-control study enrolled 280 hypertriglyceridemic patients who were managed either with 200 mg of fenofibrate (Fenofibrate group, n=140) or with standard treatment (comparison group, n=140). CRP levels were measured before and after management for 2 months.
   Results: CRP levels decreased in both the fenofibrate (p=0.003) and comparison (p=0.048) groups. Changes in CRP levels were not significantly different between the two groups (p=0.27) and were negatively associated with baseline CRP levels (r=-0.47, p<0.001). In patients with a baseline CRP level >= 1 mg/L, CRP levels also decreased in both groups (p=0.000 and p=0.001 respectively), however, more in the fenofibrate group than in the comparison group (p=0.025). The reduction of CRP was associated with higher baseline CRP levels (r=-0.29, p=0.001), lower body mass index (BMI, r=0.23, p=0.007), and fenofibrate therapy (r=0.19, p=0.025). CRP levels decreased more in the fenofibrate group than in the comparison group in patients with a BMI <= 26 kg/m(2) with borderline significance (-1.21 +/- 1.82 mg/L vs. -0.89 +/- 1.92 mg/L, p=0.097). In patients with a high density lipoprotein-cholesterol level <40 mg/dL, CRP levels were reduced only in the fenofibrate group (p=0.006).
   Conclusion: Fenofibrate reduced CRP levels in hypertriglyceridemic patients with high CRP and/or low high density lipoprotein-cholesterol levels and without severe overweight. This finding suggests that fenofibrate may have an anti-inflammatory effect in selected patients.
C1 [Min, Yun Joo; Choi, Young Hwan; Hyeon, Cheol Won; Cho, Jun Hwan; Kim, Kyung Joon; Kwon, Jee Eun; Kim, Eun Young; Lee, Wang-Soo; Lee, Kwang Je; Kim, Sang-Wook; Kim, Tae Ho; Kim, Chee Jeong] Chung Ang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 156070, South Korea.
RP Kim, CJ (corresponding author), Chung Ang Univ, Coll Med, Dept Internal Med, Div Cardiol, 102 Heukseok Ro, Seoul 156070, South Korea.
EM cjkim@cau.ac.kr
FU Chung-Ang University
FX This Research was supported by the Chung-Ang University Research Grants
   in 2010.
CR Belfort R, 2010, J CLIN ENDOCR METAB, V95, P829, DOI 10.1210/jc.2009-1487
   Cortellaro M, 2000, THROMB HAEMOSTASIS, V83, P549
   Farnier M, 2005, EUR HEART J, V26, P897, DOI 10.1093/eurheartj/ehi231
   FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001
   Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282
   Gomez-Gerique JA, 2002, ATHEROSCLEROSIS, V162, P245, DOI 10.1016/S0021-9150(01)00708-0
   Haim M, 2007, AM HEART J, V154, P1095, DOI 10.1016/j.ahj.2007.07.026
   Hiukka A, 2008, J AM COLL CARDIOL, V52, P2190, DOI 10.1016/j.jacc.2008.09.049
   Hogue JC, 2008, METABOLISM, V57, P380, DOI 10.1016/j.metabol.2007.10.014
   Jonkers IJ, 2002, AM J MED, V112, P275, DOI 10.1016/S0002-9343(01)01123-8
   Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2
   Kim CJ, 2006, J CARDIOVASC PHARM, V47, P758
   Kim SJ, 2005, KOREAN CIRC J, V35, P30
   Malik J, 2001, CARDIOVASC RES, V52, P290, DOI 10.1016/S0008-6363(01)00382-0
   Muhlestein JB, 2006, J AM COLL CARDIOL, V48, P396, DOI 10.1016/j.jacc.2006.05.009
   Okopien B, 2006, J CLIN ENDOCR METAB, V91, P1770, DOI 10.1210/jc.2005-1615
   Okopien B, 2005, J CARDIOVASC PHARM, V46, P377, DOI 10.1097/01.fjc.0000175455.46245.c8
   Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839
   Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604
   Shah A, 2010, ATHEROSCLEROSIS, V210, P35, DOI 10.1016/j.atherosclerosis.2009.11.010
   Shen J, 2009, CLIN CHEM, V55, P256, DOI 10.1373/clinchem.2008.117754
   SHIN HS, 2005, KOREAN CIRC J, V35, P533
   Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701
   Wang TD, 2003, ATHEROSCLEROSIS, V170, P315, DOI 10.1016/S0021-9150(03)00296-X
   Wu TJ, 2007, ANN CLIN LAB SCI, V37, P158
   Ye P, 2005, CLIN CHIM ACTA, V356, P229, DOI 10.1016/j.cccn.2005.01.023
   2000, CIRCULATION, V102, P21
NR 29
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 741
EP 746
DI 10.4070/kcj.2012.42.11.741
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500003
PM 23236325
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CS
   Seo, YH
   Yang, DJ
   Kim, KH
   Park, HW
   Bin Yuk, H
   Lee, MS
   Kim, WH
   Kwon, TG
   Bae, JH
AF Lee, Chung Seop
   Seo, Young Hoon
   Yang, Dong Ju
   Kim, Ki Hong
   Park, Hyun Woong
   Bin Yuk, Hyung
   Lee, Moo-Sik
   Kim, Wan-Ho
   Kwon, Taek-Geun
   Bae, Jang-Ho
TI Positive Vascular Remodeling in Culprit Coronary Lesion is Associated
   With Plaque Composition: An Intravascular Ultrasound-Virtual Histology
   Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atherosclerosis; Coronary artery; Intravascular ultrasonography
AB Background and Objectives: The relationship between the positive remodeling (PR) of a coronary artery and plaque composition has been studied only in a relatively small number of study population or non-culprit lesion. We evaluated the association between coronary plaque composition and coronary artery remodeling in a relatively large number of culprit lesions.
   Subjects and Methods: The study population consisted of 325 consecutive patients with coronary artery disease that underwent intravascular ultrasound-virtual histology examination in a culprit lesion. The remodeling index (RI) was calculated as the lesion external elastic membrane (EEM) area divided by the average reference EEM area.
   Results: The lesions with PR (RI>1.05, n=97, mean RI=1.19 +/- 0.12) had a higher fibrous volume/lesion length (3.85 +/- 2.12 mm(3)/mm vs. 3.04 +/- 1.79 mm(3)/mm, p=0.003) and necrotic core volume/lesion length (1.26 +/- 0.89 mm(3)/mm vs. 0.90 +/- 0.66 mm(3)/mm, p=0.001) than those with negative remodeling (NR) (RI<0.95, n=132, mean RI=0.82 +/- 0.09). At the minimal luminal area site, the lesions with PR had a higher fibrous area (5.81 +/- 3.17 mm(2) vs. 3.61 +/- 2.30 mm(2), p<0.001), dense calcified area (0.73 +/- 0.69 mm(2) vs. 0.46 +/- 0.43 mm(2), p=0.001), and necrotic core area (1.93 +/- 1.33 mm(2) vs. 1.06 +/- 0.91 mm(2), p<0.001) than those with NR. RI showed significant positive correlation with fibrous volume/lesion length (r=0.173, p=0.002), necrotic core volume/lesion length (r=0.188, p=0.001), fibrous area (r=0.347, p<0.001), fibrofatty area (r=0.111, p=0.036), dense calcified area (r=0.239, p<0.001), and necrotic core area (r=0.334, p<0.001). Multivariate analysis showed that the independent factor for PR was the necrotic core volume/lesion length (beta=0.130, 95% confidence interval; 0.002-0.056, p=0.037) over the entire lesion.
   Conclusion: This study suggests that PR in a culprit lesion is associated with the necrotic core volume in the entire lesion, which is a characteristic of vulnerable plaque.
C1 [Lee, Chung Seop; Seo, Young Hoon; Yang, Dong Ju; Kim, Ki Hong; Park, Hyun Woong; Bin Yuk, Hyung; Kim, Wan-Ho; Kwon, Taek-Geun; Bae, Jang-Ho] Konyang Univ, Coll Med, Dept Cardiol, Taejon 302718, South Korea.
   [Lee, Moo-Sik] Konyang Univ, Coll Med, Dept Prevent Med, Taejon 302718, South Korea.
RP Bae, JH (corresponding author), Konyang Univ, Coll Med, Dept Cardiol, 28 Wonyangmaeul 1 Gil, Taejon 302718, South Korea.
EM janghobae@yahoo.co.kr
OI Seo, Young Hoon/0000-0002-7357-2785
CR Alfonso F, 2008, EUR HEART J, V29, P1701, DOI 10.1093/eurheartj/ehn053
   Bae JH, 2007, KOREAN CIRC J, V37, P437
   Burke AP, 2002, CIRCULATION, V105, P297, DOI 10.1161/hc0302.102610
   Carlier SG, 2006, J NUCL CARDIOL, V13, P831, DOI 10.1016/j.nuclcard.2006.10.013
   Frutkin AD, 2007, EUR HEART J, V28, P1783, DOI 10.1093/eurheartj/ehm145
   Fujii K, 2005, AM J CARDIOL, V96, P1476, DOI 10.1016/j.amjcard.2005.07.054
   GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204
   Granada JF, 2007, ARTERIOSCL THROM VAS, V27, P387, DOI 10.1161/01.ATV.0000253907.51681.0e
   Hiro T, 1997, AM HEART J, V133, P1, DOI 10.1016/S0002-8703(97)70241-2
   Hirose M, 2003, AM J CARDIOL, V92, P141, DOI 10.1016/S0002-9149(03)00528-9
   Jeremias A, 1999, CIRCULATION, V100, P2127, DOI 10.1161/01.CIR.100.21.2127
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Mintz GS, 1997, CIRCULATION, V95, P1791
   Nair Anuja, 2007, EuroIntervention, V3, P113
   Nakamura M, 2001, J AM COLL CARDIOL, V37, P63, DOI 10.1016/S0735-1097(00)01097-4
   Nasu K, 2006, J AM COLL CARDIOL, V47, P2405, DOI 10.1016/j.jacc.2006.02.044
   Rodriguez-Granillo GA, 2006, HEART, V92, P388, DOI 10.1136/hrt.2004.057810
   Schoenhagen P, 2000, CIRCULATION, V101, P598, DOI 10.1161/01.CIR.101.6.598
   Surmely JF, 2007, HEART, V93, P928, DOI 10.1136/hrt.2006.102111
   Varnava AM, 2002, CIRCULATION, V105, P939, DOI 10.1161/hc0802.104327
NR 20
TC 8
Z9 10
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 747
EP 752
DI 10.4070/kcj.2012.42.11.747
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500004
PM 23236326
OA Green Published
DA 2021-04-22
ER

PT J
AU Sohrabi, B
   Habibzadeh, A
   Abbasov, E
AF Sohrabi, Bahram
   Habibzadeh, Afshin
   Abbasov, Eyvaz
TI The Incidence and Pattern of Coronary Artery Anomalies in the North-West
   of Iran: A Coronary Arteriographic Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary arteries; Accept; Angiography
AB Background and Objectives: Coronary artery anomalies are found in approximately 1% of patients undergoing diagnostic coronary angiography (CAG). Angiographic recognition of these vessels is important because of their clinical significance and importance in patients undergoing coronary angioplasty or cardiac surgery. There are fairly enough reports concerning the incidence of coronary anomalies in different geographic areas, but this is the first study among the Iranian population.
   Subjects and Methods: We reviewed the database of the Catheterization Laboratory of Imam Reza and Shahid Madani Hospitals, Tabriz University of Medical Sciences, Iran. Our inquiry included all patients who referred for CAG from other hospitals, between February 2007 and April 2009. Patients with congenital heart diseases, high "take off" of coronary arteries and separate origin of the conus artery from the right coronary sinus (RCS) were excluded. In total, 6065 films were reviewed.
   Results: Seventy nine (1.30%) patients were found to have coronary anomalies. Seventy five (1.24%) patients had anomalies of origin and distribution, while four (0.06%) had coronary artery fistulae. Most common anomaly was separate ostia of the left anterior descending artery and left circumflex artery, which was found in 42 patients (53.16%) with angiographic incidence of 0.69%. The next most common anomalies were anomalous circumflex artery from RCS/right coronary artery (RCA) {n=17 (21.51%)}, and anomalous RCA arising from left coronary sinus {n=6 (7.59%)}.
   Conclusion: In general, the incidence and pattern of coronary anomalies in our study was similar to earlier reports from different parts of the world.
C1 [Sohrabi, Bahram; Habibzadeh, Afshin; Abbasov, Eyvaz] Tabriz Univ Med Sci, Dept Cardiol, Cardiovasc Res Ctr, Tabriz 5166615573, Iran.
RP Sohrabi, B (corresponding author), Tabriz Univ Med Sci, Dept Cardiol, Cardiovasc Res Ctr, Golbad Ave, Tabriz 5166615573, Iran.
EM bahram.sohrabi@ymail.com
RI Habibzadeh, Afshin/U-1046-2017; Habibzadeh, Afshin/O-2228-2019; sohrabi,
   bahram/M-5636-2017
OI Habibzadeh, Afshin/0000-0003-2514-5401; sohrabi,
   bahram/0000-0002-1875-7904
FU Tabriz University of Medical Sciences, Iran; Cardiovascular Research
   Center, Tabriz University of Medical Sciences, Tabriz, Iran
FX This research was financially supported by Vice Chancellor for Research,
   Tabriz University of Medical Sciences, Iran. The authors are indebted to
   Cardiovascular Research Center, Tabriz University of Medical Sciences,
   Tabriz, Iran for its support.
CR Aydinlar A, 2005, INT HEART J, V46, P97, DOI 10.1536/ihj.46.97
   CHAITMAN BR, 1976, CIRCULATION, V53, P122, DOI 10.1161/01.CIR.53.1.122
   CHAN CNS, 1993, AM HEART J, V126, P985, DOI 10.1016/0002-8703(93)90716-M
   CHEITLIN MD, 1974, CIRCULATION, V50, P780, DOI 10.1161/01.CIR.50.4.780
   CIESLINSKI G, 1993, CLIN CARDIOL, V16, P711, DOI 10.1002/clc.4960161005
   Correia E, 2010, REV PORT CARDIOL, V29, P221
   Gambhir D S, 2000, Indian Heart J, V52, P459
   Garg N, 2000, INT J CARDIOL, V74, P39, DOI 10.1016/S0167-5273(00)00243-6
   Gol Mehmet Kamil, 2002, Med Sci Monit, V8, pCR636
   Harikrishnan S, 2002, Indian Heart J, V54, P271
   Hsu L A, 1997, Changgeng Yi Xue Za Zhi, V20, P299
   KRAGEL AH, 1988, AM J CARDIOL, V62, P771, DOI 10.1016/0002-9149(88)91220-9
   KURJIA HZ, 1986, CATHETER CARDIO DIAG, V12, P386, DOI 10.1002/ccd.1810120606
   Lawton J, 1997, CATHETER CARDIO DIAG, V41, P185
   Lee J, 2003, J COMPUT ASSIST TOMO, V27, P289, DOI 10.1097/00004728-200303000-00032
   LIPTON MJ, 1979, RADIOLOGY, V130, P39, DOI 10.1148/130.1.39
   Ohta H, 2003, JPN HEART J, V44, P759, DOI 10.1536/jhj.44.759
   Ouali S, 2009, ARCH CARDIOVASC DIS, V102, P201, DOI 10.1016/j.acvd.2009.01.001
   Stefenelli T, 2001, WIEN KLIN WOCHENSCHR, V113, P138
   TOPAZ O, 1991, AM HEART J, V122, P447, DOI 10.1016/0002-8703(91)90998-W
   Villa RB, 2001, REV ESP CARDIOL, V54, P269
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
NR 22
TC 11
Z9 11
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 753
EP 760
DI 10.4070/kcj.2012.42.11.753
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500005
PM 23236327
OA Green Published
DA 2021-04-22
ER

PT J
AU Cha, JH
   Lee, HR
   Kim, KC
   Cho, MS
   Hong, YM
AF Cha, Ji Hei
   Lee, Hye Ryon
   Kim, Kwan Chang
   Cho, Min-Sun
   Hong, Young Mi
TI Changes of Gene Expressions in Spontaneously Hypertensive Rat Model
   After Losartan Treatment
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Receptors, angiotensin; Angiotensin converting enzyme;
   Gene expression
AB Background and Objectives: The renin angiotensin system seems to play an important role in the development of cardiac and vascular hypertrophy in hypertension. The changes in pathology, and gene expressions of the angiotensin II receptor type 1A (ATIA) and angiotensin converting enzyme (ACE) were investigated in order to explore the effects of losartan in spontaneously hypertensive rat (SHR) models.
   Materials and Methods: Twelve week-old male Wistar rats were grouped as follows: control (C) group, hypertension (H) group, and losartan (L) group in which SHR was treated with losartan (10 mg/kg/day). Western blot and reverse transcription-polymerase chain reaction analysis regarding seven genes such as endothelin-1, ACE, ATIA, neutrophil cytosolic factor, brain natriuretic peptide, troponin I, endothelial nitric oxide synthase were performed.
   Results: Systolic blood pressure was significantly decreased in the L group compared with the H group in weeks 3 and 5. ACE and ATIA proteins in the L group were lower than H group in week 5.
   Conclusion: Losartan reduced blood pressure, cardiac hypertrophy and protein expressions of ACE and ATIA. Changes of protein expressions were more sensitive than changes in pathology. Further study is needed for the differing doses of losartan in SHR models.
C1 [Cha, Ji Hei; Lee, Hye Ryon; Hong, Young Mi] Ewha Womans Univ, Sch Med, Dept Pediat, Seoul 158710, South Korea.
   [Kim, Kwan Chang] Ewha Womans Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Seoul 158710, South Korea.
   [Cho, Min-Sun] Ewha Womans Univ, Sch Med, Dept Pathol, Seoul 158710, South Korea.
RP Hong, YM (corresponding author), Ewha Womans Univ, Sch Med, Dept Pediat, 1071 Anyangcheon Ro, Seoul 158710, South Korea.
EM hongym@chollian.net
FU Korean Medical Institute
FX This research was supported by the Korean Medical Institute (2010).
CR An SJ, 2006, AM J PHYSIOL-HEART C, V290, pH700, DOI 10.1152/ajpheart.00326.2005
   Choi SM, 2009, ARCH PHARM RES, V32, P353, DOI 10.1007/s12272-009-1307-x
   Dai Q, 2007, BRIT J PHARMACOL, V152, P1042, DOI 10.1038/sj.bjp.0707454
   Diep QN, 2002, AM J PHYSIOL-HEART C, V282, pH1635, DOI 10.1152/ajpheart.00984.2001
   Efimova O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016013
   Ferrario CM, 2010, LIFE SCI, V86, P289, DOI 10.1016/j.lfs.2009.11.020
   Fortuno MA, 1998, HYPERTENSION, V32, P280, DOI 10.1161/01.HYP.32.2.280
   FREEMAN EJ, 1995, AM J HYPERTENS, V8, P1105, DOI 10.1016/0895-7061(95)00221-A
   Galzerano D, 2010, VASC HEALTH RISK MAN, V6, P113
   GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081
   Koo HS, 2011, KOREAN CIRC J, V41, P83, DOI 10.4070/kcj.2011.41.2.83
   Koprdova R, 2009, PHYSIOL RES, V58, P327
   Li JJ, 2005, MED HYPOTHESES, V64, P236, DOI 10.1016/j.mehy.2004.06.017
   Lopez B, 2001, HYPERTENSION, V38, P1222, DOI 10.1161/hy1101.098549
   MONDRY A, 1995, EUR HEART J, V16, P64, DOI 10.1093/eurheartj/16.suppl_I.64
   OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282
   Pellman J, 2010, J MOL CELL CARDIOL, V48, P461, DOI 10.1016/j.yjmcc.2009.09.001
   Rizzoni D, 1998, HYPERTENSION, V32, P305, DOI 10.1161/01.HYP.32.2.305
   Rosendorff C, 1996, J AM COLL CARDIOL, V28, P803, DOI 10.1016/S0735-1097(96)00251-3
   Ruiz-Gayo M, 2000, LIFE SCI, V67, P3153, DOI 10.1016/S0024-3205(00)00900-0
   Schillaci G, 2003, J HYPERTENS, V21, P1841, DOI 10.1097/00004872-200310000-00010
   Slaninka-Miceska M, 2003, Bratisl Lek Listy, V104, P342
   Tea BS, 2000, HYPERTENSION, V35, P1069, DOI 10.1161/01.HYP.35.5.1069
   Yokoyama H, 2005, AM J HYPERTENS, V18, P922, DOI 10.1016/j.amjhyper.2005.01.009
   Zhao LL, 2008, J ZHEJIANG UNIV-SC B, V9, P448, DOI 10.1631/jzus.B0820050
NR 25
TC 2
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 761
EP 768
DI 10.4070/kcj.2012.42.11.761
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500006
PM 23236328
OA Green Published
DA 2021-04-22
ER

PT J
AU Bae, JM
   Shin, E
   Heo, DS
AF Bae, Jong-Myon
   Shin, Eunhee
   Heo, Dae Seog
TI Safety of Comprehensive Aortic Root and Valve Repair Surgery: A
   Retrospective Outcomes Research by National Evidence-Based Health Care
   Collaborating Agency, Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic valve; Heart valve diseases; Cardiac valve annuloplasty; Outcome
   assessment
AB Comprehensive aortic root and valve repair (CARVAR) is a recently introduced surgical technique for aortic valve disease. The National Evidence-based Health Care Collaborating Agency was offered by the ministry of Health and Welfare, Korea to perform a restrospective outcome analysis for this surgical procedure. The aims of this study were to evaluate the safety of patients who underwent CARVAR surgery and to provide a rationale for further prospective randomized study. During the period of March 2007 to November 2009, 397 patients received this procedure and enrolled in this study. Clinical events including major bleeding, endocarditis, re-operation and death were followed-up till March 2010 by medical records. During the follow-up periods, 1-year cumulative incidence of major bleeding, re-operation, endocarditis and death were 3.55, 5.65, 5.05 and 5.33%/year respectively. This study showed that the CARVAR technique is not beneficial, and is indeed even more harmful than conventional valve replacement surgery.
C1 [Bae, Jong-Myon; Shin, Eunhee; Heo, Dae Seog] Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea.
   [Bae, Jong-Myon] Jeju Natl Univ, Sch Med, Dept Prevent Med, Cheju 690756, South Korea.
   [Heo, Dae Seog] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.
RP Bae, JM (corresponding author), Jeju Natl Univ, Sch Med, Dept Prevent Med, 102 Jejudaehak Ro, Cheju 690756, South Korea.
EM jmbae@jejunu.ac.kr
FU National Evidence-based Healthcare Collaborating Agency (NECA)
   [NECA-C-10-001]
FX This study was supported by National Evidence-based Healthcare
   Collaborating Agency (NECA) Grant (NECA-C-10-001). All authors as well
   as 6 members of Data Review Board declared not to have any conflict of
   interest in CARVAR procedure. And we appreciated members of the Data
   Review Board and The Korean Society of Thoracic and Cardiovascular
   Surgery and The Korean Society of Cardiology.
CR Bae JM, 2010, RETROSPECTIVE ANAL C
   Hahm SY, 2006, EUR J CARDIO-THORAC, V29, P530, DOI 10.1016/j.ejcts.2006.01.009
   Hahm SY, 2006, KOREAN CIRC J, V36, P140
   Han SW, 2009, EUR J CARDIO-THORAC, V35, P1099, DOI 10.1016/j.ejcts.2008.10.034
   Joo HC, 2012, YONSEI MED J, V53, P915, DOI 10.3349/ymj.2012.53.5.915
   Lim JY, 2012, KOREAN J THORAC CARD, V45, P141
NR 6
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 769
EP 771
DI 10.4070/kcj.2012.42.11.769
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500007
PM 23236329
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CW
   Huang, SS
   Huang, PH
AF Lee, Ching-Wei
   Huang, Shao-Sung
   Huang, Po-Hsun
TI Pulmonary Arterial Thrombosis in a Patient With an Atrial Septal Defect
   and Eisenmenger Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pulmonary embolism; Eisenmenger syndrome
ID ADULTS; HYPERTENSION
AB Pulmonary hypertension is characterized by elevated pulmonary arterial pressure and secondary right ventricular failure. A thromboembolic occlusion of the proximal or distal pulmonary vasculature results in chronic thromboembolic pulmonary hypertension. We report an uncommon case that presented to our hospital with symptoms of dyspnea on exertion over 2 years. The patient had been treated for profound pulmonary thrombosis and right ventricular failure with adequate anticoagulation and sildenafil. Our echocardiography disclosed a large atrial septal defect with severe pulmonary hypertension and right ventricular failure. A diagnosis of Eisenmenger syndrome with pulmonary artery thrombosis was made. Although Eisenmenger syndrome with pulmonary thrombosis is well described in western societies, a huge pulmonary thrombosis is seldom reported in eastern countries. Profound pulmonary thrombosis may obfuscate the actual diagnosis of pulmonary artery hypertension with underlying congenital heart disease. A physical examination and echocardiography are essential in patients with pulmonary hypertension.
C1 Taipei Vet Gen Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.
   Natl Yang Ming Univ, Taipei 112, Taiwan.
RP Huang, PH (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, 201,Sec 2,Shih Pai Rd, Taipei, Taiwan.
EM huangbsvgh@vghtpe.gov.tw
CR Beghetti M, 2009, J AM COLL CARDIOL, V53, P733, DOI 10.1016/j.jacc.2008.11.025
   Broberg C, 2004, HEART, V90, DOI 10.1136/hrt.2004.039198
   Broberg CS, 2007, J AM COLL CARDIOL, V50, P634, DOI 10.1016/j.jacc.2007.04.056
   FUSTER V, 1984, CIRCULATION, V70, P580, DOI 10.1161/01.CIR.70.4.580
   Hassell KL, 1998, BLOOD COAGUL FIBRIN, V9, P107, DOI 10.1097/00001721-199803000-00001
   Jensen AS, 2007, CIRCULATION, V115, pC632, DOI 10.1161/CIRCULATIONAHA.107.695312
   Lopes AA, 2002, CLIN APPL THROMB-HEM, V8, P353, DOI 10.1177/107602960200800407
   MOSER KM, 1995, CIRCULATION, V91, P741, DOI 10.1161/01.CIR.91.3.741
   Niwa K, 1999, J AM COLL CARDIOL, V34, P223, DOI 10.1016/S0735-1097(99)00153-9
   Niwa K, 2001, CIRCULATION, V103, P393
   Piazza G, 2011, NEW ENGL J MED, V364, P351, DOI 10.1056/NEJMra0910203
   RICH S, 1992, NEW ENGL J MED, V327, P76, DOI 10.1056/NEJM199207093270203
   Silversides CK, 2003, J AM COLL CARDIOL, V42, P1982, DOI 10.1016/j.jacc.2003.07.022
NR 13
TC 2
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 772
EP 775
DI 10.4070/kcj.2012.42.11.772
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500008
PM 23236330
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, SW
   Kim, BK
   Hwang, JT
   Kim, JH
   Kim, BO
   Goh, CW
   Rhee, KJ
   Ahn, HS
   Kim, HJ
   Byun, YS
AF Cho, Sung Woo
   Kim, Byung Kyu
   Hwang, Jin Tae
   Kim, Jeong Hoon
   Kim, Byung Ok
   Goh, Choong Won
   Rhee, Kun Joo
   Ahn, Hyo Seung
   Kim, Hyun Jung
   Byun, Young Sup
TI A Case of Primary Cardiac Lymphoma Mimicking Acute Coronary and Aortic
   Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac tumor; Chest pain; Acute coronary syndrome
AB Primary cardiac lymphoma (PCL) is a rare disorder, but the incidence is increasing and its clinical manifestations are various. We report a case of PCL, which mimics an acute coronary and aortic syndrome. A 51 year-old female was presented with chest pain radiating to the back. Her initial electrocardiogram revealed T wave inversion in the leads of V 5-6, II, III and aVF. Additionally, cardiac troponin-T was slightly elevated. Chest radiography showed marked mediastinal widening. Computed tomography scan showed a huge pericardial mass. The histopathologic findings of the mass were compatible with diffuse large B cell lymphoma. She died of refractory ventricular tachycardia, probably, due to an extensive infiltration of PCL to the myocardium.
C1 [Cho, Sung Woo] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea.
   [Cho, Sung Woo; Kim, Byung Kyu; Hwang, Jin Tae; Kim, Jeong Hoon; Kim, Byung Ok; Goh, Choong Won; Rhee, Kun Joo; Ahn, Hyo Seung; Byun, Young Sup] Inje Univ, Coll Med, Dept Internal Med, Sanggye Paik Hosp,Div Cardiol, Seoul 139707, South Korea.
   [Kim, Hyun Jung] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Pathol, Seoul 139707, South Korea.
RP Byun, YS (corresponding author), Inje Univ, Coll Med, Dept Internal Med, Sanggye Paik Hosp,Div Cardiol, 1342 Dongil Ro, Seoul 139707, South Korea.
EM ysbyun@paik.ac.kr
OI Kim, Byung Gyu/0000-0001-5780-9642
CR Burke A, 1996, ATLAS TUMOR PATHOL, P171
   Ceresoli GL, 1997, CANCER-AM CANCER SOC, V80, P1497, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1497::AID-CNCR18>3.0.CO;2-0
   Cho Sung Woo, 2010, Korean Circ J, V40, P94, DOI 10.4070/kcj.2010.40.2.94
   Danbauch S. S., 1995, Central African Journal of Medicine, V41, P169
   Ikeda H, 2004, PATHOL INT, V54, P187, DOI 10.1111/j.1440-1827.2003.01606.x
   Miyashita T, 2000, JPN CIRC J, V64, P135, DOI 10.1253/jcj.64.135
   Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16
   Petrich A, 2011, CANCER-AM CANCER SOC, V117, P581, DOI 10.1002/cncr.25444
   Sankaranarayanan Rajiv, 2009, Clin Cardiol, V32, pE52, DOI 10.1002/clc.20441
   Tanaka Y, 2009, PACE, V32, P816, DOI 10.1111/j.1540-8159.2009.02372.x
NR 10
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 776
EP 780
DI 10.4070/kcj.2012.42.11.776
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500009
PM 23236331
OA Green Published
DA 2021-04-22
ER

PT J
AU Sahin, DY
   Koc, M
   Cakir, H
   Arik, OZ
   Elbasan, Z
   Cayli, M
AF Sahin, Durmus Yildiray
   Koc, Mevlut
   Cakir, Habib
   Arik, Osman Ziya
   Elbasan, Zafer
   Cayli, Murat
TI A Silent and Late Embolization of Atrial Septal Defect Occluder Device
   Into the Right Pulmonary Artery: A Case Report
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial septal defect; Septal occluder device; Pulmonary embolism
AB Percutaneous device closure of atrial septal defect (ASD) is an alternative treatment to surgery. The main advantages of the percutaneous approach include avoidance of surgery, short procedure time and hospital length, in addition to comparable rates of complications. However, percutaneous device closure is associated with infrequent early and late complications including device embolization, air embolism, cardiac tamponade and thrombotic complications. We report a rare complication of silent and late device embolization of the ASD occluder device into the right pulmonary artery, three months after implantation.
C1 [Sahin, Durmus Yildiray; Koc, Mevlut; Arik, Osman Ziya; Elbasan, Zafer; Cayli, Murat] Adana Numune Educ & Res Hosp, Dept Cardiol, Adana, Turkey.
   [Cakir, Habib] Adana Numune Educ & Res Hosp, Dept Cardiovasc Surg, Adana, Turkey.
RP Sahin, DY (corresponding author), Adana Numune Educ & Res Hosp, Dept Cardiol, Adana, Turkey.
EM cardiology79@yahoo.com
RI ELBASAN, ZAFER/W-3376-2018
OI ELBASAN, ZAFER/0000-0001-9422-1995
CR Berdat PA, 2000, J THORAC CARDIOV SUR, V120, P1034, DOI 10.1067/mtc.2000.111054
   Butera G, 2006, AM HEART J, V151, P228, DOI 10.1016/j.ahj.2005.02.051
   Chessa M, 2002, J AM COLL CARDIOL, V39, P1061, DOI 10.1016/S0735-1097(02)01711-4
   Chiappini B, 2008, J CARDIAC SURG, V23, P164, DOI 10.1111/j.1540-8191.2007.00510.x
   Clark EB, 1995, HEART DIS INFANTS CH, P60
   Hopkins RA, 2004, ANN THORAC SURG, V77, P2144, DOI 10.1016/j.athoracsur.2003.10.105
   KING TD, 1974, SURGERY, V75, P383
   Mashman WE, 2005, CATHETER CARDIO INTE, V65, P588, DOI 10.1002/ccd.20429
   Misra Manoranjan, 2007, Interact Cardiovasc Thorac Surg, V6, P384, DOI 10.1510/icvts.2006.141044
   Sinha A, 2004, ECHOCARDIOGR-J CARD, V21, P649, DOI 10.1111/j.0742-2822.2004.04062.x
NR 10
TC 6
Z9 6
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 781
EP 783
DI 10.4070/kcj.2012.42.11.781
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500010
PM 23236332
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, HJ
   Kang, BS
   Cho, YH
AF Han, Hyun-Jeong
   Kang, Byung-Soo
   Cho, Yun-Hyeong
TI Recurrence of Coronary-Subclavian Steal Syndrome After Successful
   Angioplasty of Malfunctioning Arteriovenous Fistula
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary-subclavian steal syndrome; Coronary artery bypass;
   Arteriovenous fistula
AB We report a case of coronary-subclavian steal syndrome, which had been masked by a malfunctioning hemodialysis access vessel and then reappeared after a successful angioplasty of multiple stenoses in the arteriovenous fistula of the left arm in a 61-year-old man. This case suggests that coronary-subclavian steal syndrome should be considered before a coronary artery bypass grafting surgery using internal mammary artery conduit is done, especially when hemodialysis using the left arm vessels is expected.
C1 [Han, Hyun-Jeong; Kang, Byung-Soo; Cho, Yun-Hyeong] Kwandong Univ, Coll Med, Myongji Hosp, Dept Cardiol,Cardiovasc Ctr, Goyang 412270, South Korea.
RP Cho, YH (corresponding author), Kwandong Univ, Coll Med, Myongji Hosp, Dept Cardiol,Cardiovasc Ctr, 697-24 Hwajeong Dong, Goyang 412270, South Korea.
EM princette@paran.com
CR AYRES RW, 1994, CATHETER CARDIO DIAG, V31, P301, DOI 10.1002/ccd.1810310411
   Chavan A, 1996, RADIOLOGY, V200, P433, DOI 10.1148/radiology.200.2.8685338
   SCHMID C, 1990, ANN THORAC SURG, V50, P463, DOI 10.1016/0003-4975(90)90497-T
   SMITH JM, 1994, J CARDIOVASC SURG, V35, P11
   Takach TJ, 2006, ANN THORAC SURG, V81, P386, DOI 10.1016/j.athoracsur.2005.05.071
   WALKER PM, 1985, J VASC SURG, V2, P154, DOI 10.1067/mva.1985.avs0020154
NR 6
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 784
EP 787
DI 10.4070/kcj.2012.42.11.784
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500011
PM 23236333
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, IS
   Ko, YG
   Shin, S
   Shim, JY
   Lee, S
   Chang, BC
   Shim, JK
   Kwak, YR
   Hong, MK
AF Kim, In-Soo
   Ko, Young-Guk
   Shin, Sanghoon
   Shim, Ji-Young
   Lee, Sak
   Chang, Byung-Chul
   Shim, Jae-Kwang
   Kwak, Young-Ran
   Hong, Myeong-Ki
TI The First Case of Successful Transcatheter Aortic Valve Implantation
   Using CoreValve in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic valve stenosis; Catheters; Heart valve prosthesis; Prosthesis
   implantation
AB Surgical replacement of the aortic valve is the standard therapy for severe aortic valve stenosis. However, it is generally associated with increased mortality and morbidities in older individuals. Transcatheter aortic valve implantation (TAVI) is a less invasive procedure and has shown similar clinical outcomes as surgical treatment in elderly patients at high risk for conventional surgery. In this report, we describe the first case of TAVI using a CoreValve in Korea. An 84-year-old man with symptomatic severe aortic valve stenosis was successfully treated by transfemoral TAVI. The patient was discharged without any significant complications and remained free of adverse clinical event for a follow-up duration of 6 months.
C1 [Kim, In-Soo; Ko, Young-Guk; Shin, Sanghoon; Shim, Ji-Young; Hong, Myeong-Ki] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea.
   [Lee, Sak; Chang, Byung-Chul] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.
   [Shim, Jae-Kwang; Kwak, Young-Ran] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea.
RP Hong, MK (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM mkhong61@yuhs.ac
RI Kwak, Young-Lan/AAF-5093-2021; Shim, Chi Young/AAK-1057-2021; Chang,
   Byung/AAP-9674-2020
OI Kwak, Young-Lan/0000-0002-2984-9927; Shim, Chi
   Young/0000-0002-6136-0136; Ko, Young-Guk/0000-0001-7748-5788; Lee,
   Sak/0000-0001-6130-2342; Chang, Byung Chul/0000-0001-5005-8217; Shin,
   Sanghoon/0000-0002-2348-2570; Shim, Jae-Kwang/0000-0001-9093-9692; Hong,
   Myeong-Ki/0000-0002-2090-2031
CR [Anonymous], 2011, AM J CARDIOL, V108, P893
   Azadani AN, 2011, ANN THORAC SURG, V92, P548, DOI 10.1016/j.athoracsur.2011.04.009
   Ben-Dor I, 2011, CARDIOVASC REVASCULA, V12, P345, DOI 10.1016/j.carrev.2011.04.005
   Chu MWA, 2011, INTERACT CARDIOV TH, V13, P251, DOI 10.1510/icvts.2011.274852
   Goncalves A, 2011, INT J CARDIOL
   Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232
   Reynolds MR, 2012, CIRCULATION, V125, P1102, DOI 10.1161/CIRCULATIONAHA.111.054072
   Rodes-Cabau J, 2010, REV ESP CARDIOL, V63, P439, DOI 10.1016/S0300-8932(10)70065-8
   Sarkar K, 2011, CATHETER CARDIO INTE, V78, P485, DOI 10.1002/ccd.23034
   Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510
   Toutouzas K, 2011, INT J CARDIOL, V151, P112, DOI 10.1016/j.ijcard.2011.06.023
   Walther T, 2012, J THORAC CARDIOV SUR, V143, P326, DOI 10.1016/j.jtcvs.2010.10.063
   Webb J, 2011, EUR HEART J, V32, P140, DOI 10.1093/eurheartj/ehq453
NR 13
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 788
EP 791
DI 10.4070/kcj.2012.42.11.788
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500012
PM 23236334
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SY
   Park, YH
   Yeo, HJ
   Sohn, CB
   Han, DC
   Kim, JS
   Kim, J
   Kim, JH
   Chun, KJ
AF Lee, Soo-Yong
   Park, Yong Hyun
   Yeo, Hye-Ju
   Sohn, Chang-Bae
   Han, Dong-Cheul
   Kim, Jeong Su
   Kim, Jun
   Kim, June-Hong
   Chun, Kook-Jin
TI Congenital Giant Right Coronary Artery Aneurysm With Fistula to the
   Coronary Sinus and Persistent Left Superior Vena Cava in an Old Woman
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary aneurysm; Arteriovenous fistula; Coronary sinus
AB The combination of coronary arteriovenous fistula to the coronary sinus (CS), dilatation of the entire length of coronary artery, coronary aneurysm and persistent left superior vena cava (PLSVC) is very rare. We present the case of a 63-year-old female admitted for dyspnea on exertion, orthopnea, and facial edema. Echocardiography detected a giant coronary artery with shunt flow, dilated CS and PLSVC and a coronary angiography reaffirmed these findings. The calculated ratio of pulmonary blood flow to systemic blood flow by cardiac catheterization was 1.53. After multidisciplinary review considering old age, hypoactivity due to underlying Parkinsonism and relatively small amount of shunt flow, medical therapy was chosen. The patient remained asymptomatic for 10 months after discharge without intervention.
C1 [Lee, Soo-Yong; Park, Yong Hyun; Yeo, Hye-Ju; Sohn, Chang-Bae; Han, Dong-Cheul; Kim, Jeong Su; Kim, Jun; Kim, June-Hong; Chun, Kook-Jin] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan 626770, South Korea.
RP Park, YH (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, 20 Geumo Ro, Yangsan 626770, South Korea.
EM nadroj@chol.com
RI ; Yeo, Hye Ju/U-3295-2017
OI Kim, Jun/0000-0002-3573-638X; Yeo, Hye Ju/0000-0002-8403-5790
FU Pusan National University Yangsan HospitalPusan National University
FX This work was supported by 2011 research grant from Pusan National
   University Yangsan Hospital.
CR Bittencourt MS, 2011, EUR J ECHOCARDIOGR, V12, DOI 10.1093/ejechocard/jeq180
   El Watidy AM, 2010, INTERACT CARDIOV TH, V10, P110, DOI 10.1510/icvts.2009.214445
   Gowda RM, 2006, INT J CARDIOL, V107, P7, DOI 10.1016/j.ijcard.2005.01.067
   HALLER JA, 1963, CIRCULATION, V27, P939, DOI 10.1161/01.CIR.27.5.939
   HAMADA M, 1986, AM J CARDIOL, V57, P372, DOI 10.1016/0002-9149(86)90935-5
   Komoda S, 2010, GEN THORAC CARDIOVAS, V58, P78, DOI [10.1007/s11748-010-0758-9, 10.1007/s11748-009-0453-x]
   LIBERTHSON RR, 1979, CIRCULATION, V59, P849, DOI 10.1161/01.CIR.59.5.849
   Loo B, 2010, CIRCULATION, V122, pE447, DOI 10.1161/CIRCULATIONAHA.110.936880
   Mitropoulos F, 2011, INTERACT CARDIOV TH, V13, P672, DOI 10.1510/icvts.2011.283689
   Ozler A, 2008, ANN THORAC SURG, V85, P649, DOI 10.1016/j.athoracsur.2007.08.037
   Tekbas G, 2011, TEX HEART I J, V38, P314
   Tirilomis T, 2005, INT J CARDIOL, V98, P57, DOI 10.1016/j.ijcard.2002.05.001
   Wilkinson JL, 2001, HEART, V85, P113, DOI 10.1136/heart.85.1.113
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
   Yilmaz R, 2005, INT J CARDIOVAS IMAG, V21, P649, DOI 10.1007/s10554-005-3858-3
   Yu L, 2011, J THORAC CARDIOV SUR, V142, P937, DOI 10.1016/j.jtcvs.2011.05.020
NR 16
TC 7
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 792
EP 795
DI 10.4070/kcj.2012.42.11.792
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500013
PM 23236335
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SJ
   Ko, YG
   Shim, JY
   Lee, S
   Chang, BC
   Shim, JK
   Kwak, YR
   Hong, MK
AF Lee, Seung-Jun
   Ko, Young-Guk
   Shim, Ji-Young
   Lee, Sak
   Chang, Byung-Chul
   Shim, Jae-Kwang
   Kwak, Young-Ran
   Hong, Myeong-Ki
TI The First Korean Patient With Severe Aortic Stenosis and Bilateral
   Iliofemoral Artery Disease Treated With Transcatheter Aortic Valve
   Implantation by Transsubclavian Approach
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic valve stenosis; Catheters; Heart valve prosthesis; Prosthesis
   implantation
AB Transcatheter aortic valve implantation (TAVI) is indicated as an alternative treatment modality to surgical aortic valve replacement for high risk patients. The standard retrograde approach through the femoral artery is not feasible in the case of unfavorable iliofemoral anatomy or severe peripheral arterial disease (PAD). However, patients with aortic stenosis (AS) have a higher prevalence of for PAD because both diseases are consequences of atherosclerotic degenerative changes. Transsubclavian, transapical, and direct access to the ascending aorta by thoracotomy are alternative routes for the TAVI procedure. In this report, we present the first Korean patient with symptomatic severe AS and bilateral iliofemoral artery disease who was successfully treated with TAVI using a CoreValve (Medtronic, Minneapolis, MN, USA) by transsubclavian approach.
C1 [Lee, Seung-Jun; Ko, Young-Guk; Shim, Ji-Young; Hong, Myeong-Ki] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
   [Lee, Sak; Chang, Byung-Chul] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Dept Thorac & Cardiovasc Surg, Seoul 120752, South Korea.
   [Shim, Jae-Kwang; Kwak, Young-Ran] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Dept Anesthesiol & Pain Med, Seoul 120752, South Korea.
RP Hong, MK (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM mkhong61@yuhs.ac
RI Shim, Chi Young/AAK-1057-2021; Chang, Byung/AAP-9674-2020; Kwak,
   Young-Lan/AAF-5093-2021
OI Shim, Chi Young/0000-0002-6136-0136; Kwak,
   Young-Lan/0000-0002-2984-9927; Ko, Young-Guk/0000-0001-7748-5788; Hong,
   Myeong-Ki/0000-0002-2090-2031; Lee, Sak/0000-0001-6130-2342; Chang,
   Byung Chul/0000-0001-5005-8217; Lee, Seung-Jun/0000-0002-9201-4818;
   Shim, Jae-Kwang/0000-0001-9093-9692
CR Aronow WS, 2001, AM J CARDIOL, V88, P1046, DOI 10.1016/S0002-9149(01)01990-7
   Bosmans JM, 2011, INTERACT CARDIOV TH, V12, P762, DOI 10.1510/icvts.2010.253773
   Bruschi G, 2010, J THORAC CARDIOV SUR, V140, P715, DOI 10.1016/j.jtcvs.2010.02.030
   Fraccaro C, 2009, JACC-CARDIOVASC INTE, V2, P828, DOI 10.1016/j.jcin.2009.06.016
   Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471
   Moynagh AM, 2011, J AM COLL CARDIOL, V57, P634, DOI 10.1016/j.jacc.2010.08.642
   Petronio AS, 2010, CIRC-CARDIOVASC INTE, V3, P359, DOI 10.1161/CIRCINTERVENTIONS.109.930453
   Ribeiro VD, 2011, INT J CARDIOVAS IMAG, V27, P1235, DOI 10.1007/s10554-011-9900-8
   Witkowski A, 2011, KARDIOL POL, V69, P105
NR 9
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 796
EP 799
DI 10.4070/kcj.2012.42.11.796
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500014
PM 23236336
OA Green Published
DA 2021-04-22
ER

PT J
AU Uysal, OK
   Duran, M
   Ozkan, B
   Tekin, K
   Elbasan, Z
AF Uysal, Onur Kadir
   Duran, Mustafa
   Ozkan, Bugra
   Tekin, Kamuran
   Elbasan, Zafer
TI Asymptomatic Accessory Mitral Valve Tissue Diagnosed by Echocardiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Uysal, Onur Kadir; Duran, Mustafa] Kayseri Educ & Res Hosp, Dept Cardiol, TR-38000 Kayseri, Turkey.
   [Ozkan, Bugra; Tekin, Kamuran; Elbasan, Zafer] Adana Numune Educ & Res Hosp, Dept Cardiol, Adana, Turkey.
RP Uysal, OK (corresponding author), Kayseri Educ & Res Hosp, Dept Cardiol, TR-38000 Kayseri, Turkey.
EM onurkadir@gmail.com
RI Ozkan, Bugra/L-3053-2018; ELBASAN, ZAFER/W-3376-2018
OI ELBASAN, ZAFER/0000-0001-9422-1995
CR Prifti E, 2003, MED SCI MONITOR, V9, pRA126
   Rovner A, 2005, J AM SOC ECHOCARDIOG, V18, P494, DOI 10.1016/j.echo.2005.01.027
   Sharma R, 2006, J AM SOC ECHOCARDIOG, V19, P354
NR 3
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2012
VL 42
IS 11
BP 800
EP 801
DI 10.4070/kcj.2012.42.11.800
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IQ
UT WOS:000209080500015
PM 23236337
OA Green Published
DA 2021-04-22
ER

PT J
AU Youn, HJ
AF Youn, Ho-Joong
TI A Message From the Editor-in-Chief
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.
RP Youn, HJ (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 651
EP 651
DI 10.4070/kcj.2012.42.10.651
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400001
PM 23170090
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, YS
   Lee, HD
AF Lee, Young-Seok
   Lee, Hyoung-Doo
TI Percutaneous Pulmonary Valve Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Catheterization; Pulmonary valve
AB Pulmonary regurgitation (PR) is a frequent sequelae after repair of tetralogy of Fallot, pulmonary atresia, truncus arteriosus, Rastelli and Ross operation. Due to patient growth and conduit degeneration, these conduits have to be changed frequently due to regurgitation or stenosis. However, morbidity is significant in these repeated operations. To prolong conduit longevity, bare-metal stenting in the right ventricular outflow tract (RVOT) obstruction has been performed. Stenting the RVOT can reduce the right ventricular pressure and symptomatic improvement, but it causes PR with detrimental effects on the right ventricle function and risks of arrhythmia. Percutaneous pulmonary valve implantation has been shown to be a safe and effective treatment for patients with pulmonary valve insufficiency, or stenotic RVOTs.
C1 [Lee, Young-Seok] Dong A Univ Hosp, Dept Pediat, Div Pediat Cardiol, Pusan 602715, South Korea.
   [Lee, Hyoung-Doo] Pusan Natl Univ, Childrens Hosp, Ctr Heart, Yangsan, South Korea.
RP Lee, YS (corresponding author), Dong A Univ Hosp, Dept Pediat, Div Pediat Cardiol, 26 Daesingongwon Ro, Pusan 602715, South Korea.
EM lyspedia@dau.ac.kr
CR Batra AS, 2012, AM HEART J, V163, P280, DOI 10.1016/j.ahj.2011.10.017
   Biermann D, 2012, ANN THORAC SURG, V94, pE7, DOI 10.1016/j.athoracsur.2012.01.022
   Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0
   Bonhoeffer P, 2000, CIRCULATION, V102, P813, DOI 10.1161/01.CIR.102.7.813
   Bonhoeffer P, 2002, J AM COLL CARDIOL, V39, P1664, DOI 10.1016/S0735-1097(02)01822-3
   Boone RH, 2010, CATHETER CARDIO INTE, V75, P286, DOI 10.1002/ccd.22250
   Cubeddu RJ, 2011, CATHETER CARDIO INTE, V77, P276, DOI 10.1002/ccd.22653
   Demkow M, 2011, CATHETER CARDIO INTE, V77, P381, DOI 10.1002/ccd.22700
   Eicken A, 2011, EUR HEART J, V32, P1260, DOI 10.1093/eurheartj/ehq520
   Garay F, 2006, CATHETER CARDIO INTE, V67, P659, DOI 10.1002/ccd.20753
   Kenny D, 2011, J AM COLL CARDIOL, V58, P2248, DOI 10.1016/j.jacc.2011.07.040
   Khambadkone S, 2005, CIRCULATION, V112, P1189, DOI 10.1161/CIRCULATIONAHA.104.523266
   Khambadkone S, 2004, CATHETER CARDIO INTE, V62, P401, DOI 10.1002/ccd.20122
   Khambadkone S, 2012, ANN PEDIAT CARDIOL, V5, P53, DOI 10.4103/0974-2069.93713
   Lauten A, 2012, HEART, V98, P623, DOI 10.1136/heartjnl-2011-301399
   Lurz P, 2008, CIRCULATION, V117, P1964, DOI 10.1161/CIRCULATIONAHA.107.735779
   Lurz P, 2011, J AM COLL CARDIOL, V57, P724, DOI 10.1016/j.jacc.2010.07.056
   Lurz P, 2009, CIRCULATION, V119, P2995, DOI 10.1161/CIRCULATIONAHA.108.836312
   Marianeschi SM, 2008, ANN THORAC SURG, V86, P1466, DOI 10.1016/j.athoracsur.2008.06.085
   McElhinney DB, 2011, CIRC-CARDIOVASC INTE, V4, P602, DOI 10.1161/CIRCINTERVENTIONS.111.965616
   McElhinney DB, 2010, CIRCULATION, V122, P507, DOI 10.1161/CIRCULATIONAHA.109.921692
   Momenah TS, 2009, J AM COLL CARDIOL, V53, P1859, DOI 10.1016/j.jacc.2008.08.061
   Nordmeyer J, 2008, EUR HEART J, V29, P810, DOI 10.1093/eurheartj/ehn073
   Nordmeyer J, 2007, CIRCULATION, V115, P1392, DOI 10.1161/CIRCULATIONAHA.106.674259
   Nordmeyer J, 2011, HEART, V97, P118, DOI 10.1136/hrt.2010.198382
   Peng LF, 2006, CIRCULATION, V113, P2598, DOI 10.1161/CIRCULATIONAHA.105.607127
   Sridharan S, 2006, CIRCULATION, V113, pE934, DOI 10.1161/CIRCULATIONAHA.105.599514
   Therrien J, 2005, AM J CARDIOL, V95, P779, DOI 10.1016/j.amjcard.2004.11.037
   Vezmar M, 2010, JACC-CARDIOVASC INTE, V3, P439, DOI 10.1016/j.jcin.2010.02.003
   Zahn EM, 2009, J AM COLL CARDIOL, V54, P1722, DOI 10.1016/j.jacc.2009.06.034
NR 30
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 652
EP 656
DI 10.4070/kcj.2012.42.10.652
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400002
PM 23170091
OA Green Published
DA 2021-04-22
ER

PT J
AU Yang, DH
AF Yang, Dong Heon
TI The Risk Model for Prediction of Survival in Heart Failure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID MORTALITY
C1 Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Taegu 700842, South Korea.
RP Yang, DH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, 680 Gukchaebosang Ro, Taegu 700842, South Korea.
EM ddhyang@knu.ac.kr
CR Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660
   Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028
   Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168
   Aronson D, 2004, AM J MED, V116, P466, DOI 10.1016/j.amjmed.2003.11.014
   Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239
   Kearney MT, 2002, J AM COLL CARDIOL, V40, P1801, DOI 10.1016/S0735-1097(02)02490-7
   Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102
   Oh C, 2012, KOREAN CIRC J, V42, P659, DOI 10.4070/kcj.2012.42.10.659
   SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429
   YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501
NR 10
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 657
EP 658
DI 10.4070/kcj.2012.42.10.657
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400003
PM 23170092
OA Green Published
DA 2021-04-22
ER

PT J
AU Oh, C
   Chang, HJ
   Sung, JM
   Kim, JY
   Yang, W
   Shim, J
   Kang, SM
   Ha, J
   Rim, SJ
   Chung, N
AF Oh, Changmyung
   Chang, Hyuk-Jae
   Sung, Ji Min
   Kim, Ji Ye
   Yang, Wooin
   Shim, Jiyoung
   Kang, Seok-Min
   Ha, Jongwon
   Rim, Se-Joong
   Chung, Namsik
TI Prognostic Estimation of Advanced Heart Failure With Low Left
   Ventricular Ejection Fraction and Wide QRS Interval
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart failure; Prognosis; Cardiac resynchronization therapy
ID CARDIAC-RESYNCHRONIZATION THERAPY; IMPLANTABLE
   CARDIOVERTER-DEFIBRILLATOR; TRANSIENT ISCHEMIC ATTACK; CLINICAL
   CARDIOLOGY; RISK; STROKE; CARE; VALIDATION; STATEMENT; MORTALITY
AB Background and Objectives: Cardiac resynchronization therapy (CRT) has been known to improve the outcome of advanced heart failure (HF) but is still underutilized in clinical practice. We investigated the prognosis of patients with advanced HF who were suitable for CRT but were treated with conventional strategies. We also developed a risk model to predict mortality to improve the facilitation of CRT.
   Subjects and Methods: Patients with symptomatic HF with left ventricular ejection fraction <= 35% and QRS interval >120 ms were consecutively enrolled at cardiovascular hospital. After excluding those patients who had received device therapy, 239 patients (160 males, mean 67 +/- 11 years) were eventually recruited.
   Results: During a follow-up of 308 +/- 236 days, 56 (23%) patients died. Prior stroke, heart rate >90 bpm, serum Na <= 135 mEq/L, and serum creatinine >= 1.5 mg/dL were identified as independent factors using Cox proportional hazards regression. Based on the risk model, points were assigned to each of the risk factors proportional to the regression coefficient, and patients were stratified into three risk groups: low-(0), intermediate-(1-5), and high-risk (>5 points). The 2-year mortality rates of each risk group were 5, 31, and 64 percent, respectively. The C statistic of the risk model was 0.78, and the model was validated in a cohort from a different institution where the C statistic was 0.80.
   Conclusion: The mortality of patients with advanced HF who were managed conventionally was effectively stratified using a risk model. It may be useful for clinicians to be more proactive about adopting CRT to improve patient prognosis.
C1 [Oh, Changmyung; Chang, Hyuk-Jae; Kim, Ji Ye; Yang, Wooin; Shim, Jiyoung; Kang, Seok-Min; Ha, Jongwon; Rim, Se-Joong; Chung, Namsik] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120752, South Korea.
   [Sung, Ji Min] Yonsei Univ, Coll Med, Dept Res Affairs, Seoul 120752, South Korea.
RP Chang, HJ (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, 50 Yonsei Ro, Seoul 120752, South Korea.
EM hjchang@yuhs.ac
RI Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136; Ha, Jong-Won/0000-0002-8260-2958;
   Kang, Seok-Min/0000-0001-9856-9227; Rim, Se Joong/0000-0002-7631-5581;
   Chang, Hyuk-Jae/0000-0002-6139-7545
FU Technology Innovation Program (Industrial Strategic Technology
   Development Program, Intelligent Image Diagnosis and Therapy-Support
   System) - Ministry of Knowledge Economy (MKE, Korea) [10038419]
FX This work was supported by the Technology Innovation Program (Industrial
   Strategic Technology Development Program, 10038419, Intelligent Image
   Diagnosis and Therapy-Support System) funded by the Ministry of
   Knowledge Economy (MKE, Korea).
CR Adams RJ, 2003, CIRCULATION, V108, P1278, DOI 10.1161/01.CIR.0000090444.87006.CF
   Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399
   Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423
   Cleland JGF, 2001, EUR J HEART FAIL, V3, P481, DOI 10.1016/S1388-9842(01)00176-3
   Curtis AB, 2009, AM HEART J, V158, P956, DOI 10.1016/j.ahj.2009.10.011
   Epstein Andrew E, 2008, J Am Coll Cardiol, V51, pe1, DOI 10.1016/j.hrthm.2008.04.014
   Feldman AM, 2005, J AM COLL CARDIOL, V46, P2311, DOI 10.1016/j.jacc.2005.08.033
   Fonarow GC, 2008, CIRC-HEART FAIL, V1, P98, DOI 10.1161/CIRCHEARTFAILURE.108.772228
   Hays AG, 2006, STROKE, V37, P1715, DOI 10.1161/01.STR.0000227121.34717.40
   Iuliano S, 2002, AM HEART J, V143, P1085, DOI 10.1067/mhj.2002.122516
   Jarcho JA, 2006, NEW ENGL J MED, V355, P288, DOI 10.1056/NEJMct055185
   Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064
   Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581
   Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102
   McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9
   Mosterd A, 2001, EUR HEART J, V22, P1318, DOI 10.1053/euhj.2000.2533
   O'Connor CM, 2010, J AM COLL CARDIOL, V55, P872, DOI 10.1016/j.jacc.2009.08.083
   Oren RM, 2005, AM J CARDIOL, V95, p2B
   Patel Jitenbhai J, 2007, Perm J, V11, P50
   Rassi A, 2006, NEW ENGL J MED, V355, P799, DOI 10.1056/NEJMoa053241
   Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80
   Thohan V, 2004, CURR OPIN CARDIOL, V19, P238, DOI 10.1097/00001573-200405000-00009
   Touze E, 2005, STROKE, V36, P2748, DOI 10.1161/01.STR.0000190118.02275.33
   Upadhyay GA, 2008, J AM COLL CARDIOL, V52, P1239, DOI 10.1016/j.jacc.2008.06.043
   van Veldhuisen DJ, 2009, EUR J HEART FAIL, V11, P1143, DOI 10.1093/eurjhf/hfp149
NR 25
TC 7
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 659
EP 667
DI 10.4070/kcj.2012.42.10.659
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400004
PM 23170093
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, BJ
   Heo, JH
   Choi, IS
   Lee, SW
   Kim, HS
   Lee, JW
   Cha, TJ
AF Choi, Byung Joo
   Heo, Jung Ho
   Choi, In-Soo
   Lee, Si-Won
   Kim, Hyun-Soo
   Lee, Jae Woo
   Cha, Tae-Joon
TI Hypoadiponectinemia in Patients With Paroxysmal Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Adiponectin; Atrial fibrillation
ID ADIPONECTIN CONCENTRATIONS; PLASMA ADIPONECTIN; INSULIN-RESISTANCE;
   DISEASE; RISK; ASSOCIATION; MORTALITY; BLOCKADE; PROTEIN
AB Background and Objectives: Adiponectin is an adipose tissue-derived hormone that has beneficial effects on cardiac function and has been reported to be associated with lipid metabolism, glucose metabolism, and insulin resistance. Serum levels of adiponectin are reduced in obese individuals compared with non-obese individuals. Obesity is associated with an increased incidence of atrial fibrillation (AF); however, the role of adiponectin in AF is unclear. The aim of this study is to evaluate the relationship between the plasma adiponectin level and AF.
   Subjects and Methods: Sixty-one consecutive patients were prospectively enrolled for this study. Subjects were divided into two groups: patients with AF (n=30) and controls (n=31). Laboratory evaluation, including levels of plasma adiponectin, was performed and echocardiographic parameters were measured.
   Results: The baseline characteristics were not different between the two groups. The plasma adiponectin level of patients in the AF group was significantly lower than in the control group (14.9 +/- 7.2 vs. 19.+/- 8.9 mu g/mL, p<0.05). In addition, when we divided the AF patients into paroxysmal and chronic AF, the plasma adiponectin level was significantly lower in patients with paroxysmal AF, compared with the control group. In multiple binary logistic regression analysis to evaluate the independent predictors for AF, adiponectin and left atrial diameter were strong independent predictors of AF.
   Conclusion: In this study a lower plasma adiponectin concentration was significantly associated with that of paroxysmal AF. Hypoadiponectinemia can potentially be an important risk factor for AF.
C1 [Choi, Byung Joo; Heo, Jung Ho; Choi, In-Soo; Lee, Si-Won; Kim, Hyun-Soo; Lee, Jae Woo; Cha, Tae-Joon] Kosin Univ, Sch Med, Dept Internal Med, Div Cardiol, Pusan 602703, South Korea.
RP Cha, TJ (corresponding author), Kosin Univ, Sch Med, Dept Internal Med, Div Cardiol, 34 Amnam Dong, Pusan 602703, South Korea.
EM chatjn@gmail.com
CR [Anonymous], 2001, CIRCULATION, V104, P2118
   Celik T, 2009, INT J CARDIOL, V137, P54, DOI 10.1016/j.ijcard.2008.04.088
   Chung MK, 2001, CIRCULATION, V104, P2886, DOI 10.1161/hc4901.101760
   Della Mea P, 2005, AM J HYPERTENS, V18, P30, DOI 10.1016/j.amjhyper.2004.08.029
   Douglas PS, 2007, J AM SOC ECHOCARDIOG, V20, P787, DOI 10.1016/j.echo.2007.06.011
   Echahidi N, 2007, CIRCULATION, V116, pI213, DOI 10.1161/CIRCULATIONAHA.106.681304
   Engeli S, 2000, HYPERTENSION, V35, P1270, DOI 10.1161/01.HYP.35.6.1270
   Engelmann MDM, 2005, EUR HEART J, V26, P2083, DOI 10.1093/eurheartj/ehi350
   Furuhashi M, 2003, HYPERTENSION, V42, P76, DOI 10.1161/01.HYP.0000078490.59735.6E
   George J, 2006, HEART, V92, P1420, DOI 10.1136/hrt.2005.083345
   Goette A, 2000, CIRCULATION, V101, P2678, DOI 10.1161/01.CIR.101.23.2678
   Guebre-Egziabher F, 2005, NEPHROL DIAL TRANSPL, V20, P129, DOI 10.1093/ndt/gfh568
   Guo LL, 2009, NEPHROL DIAL TRANSPL, V24, P1876, DOI 10.1093/ndt/gfn770
   Han SH, 2007, J AM COLL CARDIOL, V49, P531, DOI 10.1016/j.jacc.2006.08.061
   Henningsen KM, 2009, EUROPACE, V11, P1032, DOI 10.1093/europace/eup103
   Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595
   Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245
   Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972
   Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50
   Kumagai Koichiro, 2010, Folia Pharmacologica Japonica, V135, P59
   McEntegart MB, 2007, EUR HEART J, V28, P829, DOI 10.1093/eurheartj/ehm033
   McNamara RL, 2004, J AM COLL CARDIOL, V44, P475, DOI 10.1016/j.jacc.2004.06.041
   Nicolaou VN, 2007, ANGIOLOGY, V58, P21, DOI 10.1177/0003319706297913
   Rienstra M, 2012, AM HEART J, V163, P119, DOI 10.1016/j.ahj.2011.09.029
   Rossi A, 2000, J AM COLL CARDIOL, V35, P1256, DOI 10.1016/S0735-1097(00)00515-5
   Shimano M, 2008, CIRC J, V72, P1120, DOI 10.1253/circj.72.1120
   Tsukamoto O, 2009, J AM COLL CARDIOL, V53, P2070, DOI 10.1016/j.jacc.2009.02.038
   Tsutamoto T, 2007, EUR HEART J, V28, P1723, DOI 10.1093/eurheartj/ehm154
   Yenicesu M, 2005, NEPHRON CLIN PRACT, V99, pC115, DOI 10.1159/000083929
   Zoccali C, 2002, J AM SOC NEPHROL, V13, P134
NR 30
TC 8
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 668
EP 673
DI 10.4070/kcj.2012.42.10.668
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400005
PM 23170094
OA Green Published
DA 2021-04-22
ER

PT J
AU Cetin, M
   Kocaman, SA
   Kiris, T
   Erdogan, T
   Canga, A
   Durakoglugil, ME
   Cicek, Y
   Dogan, S
   Satiroglu, O
AF Cetin, Mustafa
   Kocaman, Sinan Altan
   Kiris, Tuncay
   Erdogan, Turan
   Canga, Aytun
   Durakoglugil, Murtaza Emre
   Cicek, Yuksel
   Dogan, Sitki
   Satiroglu, Omer
TI Absence and Resolution of Fragmented QRS Predict Reversible Myocardial
   Ischemia With Higher Probability of ST Segment Resolution in Patients
   With ST Segment Elevation Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Fragmented QRS; Electrocardiography; Myocardial infarction; Reperfusion;
   Marker
ID BUNDLE-BRANCH BLOCK; PROGNOSTIC-SIGNIFICANCE; CARDIAC EVENTS; ANATOMIC
   BASIS; 12-LEAD ECG; Q-WAVE; COMPLEX; MORTALITY; ABNORMALITIES; SIGN
AB Background and Objectives: Fragmented QRS complexes (fQRS) are associated with increased morbidity and mortality. The causative relationship between fQRS and cardiac fibrosis has been shown, but whether the presence and the number of fQRS on admission of electrocardiogram (ECG) predicts ST segment resolution in patients undergoing primary percutaneous coronary intervention (p-PCI) has not been investigated until now.
   Subjects and Methods: This study included one hundred and eighty-four consecutive patients with ST elevation myocardial infarction (STEMI) who underwent p-PCI. The presence or absence of fQRS on pre and post-PCI ECG and their relation with myocardial infarction and reperfusion parameters were investigated.
   Results: Patients with fQRS on admission of ECG or newly developed fQRS after p-PCI had increased inflammatory markers, higher cardiac enzyme levels, increased pain to balloon time, prolonged QRS time, more extended coronary involvement and more frequent Q waves on ECG in comparison to patients with absence or resolved fQRS. The presence and higher number of fQRS on admission or post-PCI ECGs were significantly related with low percent of ST resolution and myocardial reperfusion parameters. The area under the receiver operating characteristics curve values for the presence and number of fQRS to detect Thrombolysis in Myocardial Infarction Blush Grade 0 and 1, were 0.682 and 0.703.
   Conclusion: In our study, fQRS was significantly related to infarction and myocardial reperfusion parameters before and after p-PCI. Successful myocardial reperfusion by p-PCI caused the reduction in number of fQRS and QRS time with higher ST resolution. fQRS may be useful in identifying the patients at higher cardiac risk with increased ischemic jeopardized or infarcted myocardium, and persistent or newly developed fQRS may predict low percent of ST segment resolution in patients undergoing p-PCI.
C1 [Cetin, Mustafa; Kocaman, Sinan Altan; Canga, Aytun; Dogan, Sitki] Rize Educ & Res Hosp, Dept Cardiol, TR-53020 Rize, Turkey.
   [Kiris, Tuncay] Ordu State Hosp, Dept Cardiol, Ordu, Turkey.
   [Erdogan, Turan; Durakoglugil, Murtaza Emre; Cicek, Yuksel; Satiroglu, Omer] Rize Univ, Fac Med, Dept Cardiol, Rize, Turkey.
RP Kocaman, SA (corresponding author), Rize Educ & Res Hosp, Dept Cardiol, TR-53020 Rize, Turkey.
EM sinanaltan@gmail.com
RI Durakoglugil, Emre/Q-3547-2019; Cetin, Mustafa/A-2919-2016
OI Durakoglugil, Emre/0000-0001-5268-4262; Cetin,
   Mustafa/0000-0001-6342-436X; Erdogan, Turan/0000-0003-2986-5457
CR Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4
   Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209
   Ari H, 2012, HEART VESSELS, V27, P20, DOI 10.1007/s00380-011-0121-9
   Basaran Y, 2011, ECHOCARDIOGR-J CARD, V28, P62, DOI 10.1111/j.1540-8175.2010.01242.x
   Calore C, 2007, J CARDIOVASC MED, V8, P821, DOI 10.2459/JCM.0b013e3280101e3c
   Chatterjee S, 2010, CLIN CARDIOL, V33, P68, DOI 10.1002/clc.20709
   Cheema A, 2010, CIRC-ARRHYTHMIA ELEC, V3, P339, DOI 10.1161/CIRCEP.110.940478
   Das MK, 2006, CIRCULATION, V113, P2495, DOI 10.1161/CIRCULATIONAHA.105.595892
   Das MK, 2009, AM J CARDIOL, V104, P1631, DOI 10.1016/j.amjcard.2009.07.046
   Das MK, 2010, CURR OPIN CARDIOL, V25, P59, DOI 10.1097/HCO.0b013e328333d35d
   Das MK, 2008, CIRC-ARRHYTHMIA ELEC, V1, P258, DOI 10.1161/CIRCEP.107.763284
   Das MK, 2009, HEART RHYTHM, V6, pS8, DOI 10.1016/j.hrthm.2008.10.019
   Das MK, 2010, HEART RHYTHM, V7, P74, DOI 10.1016/j.hrthm.2009.09.065
   Das MK, 2007, HEART RHYTHM, V4, P1385, DOI 10.1016/j.hrthm.2007.06.024
   FLOWERS NC, 1969, CIRCULATION, V39, P531, DOI 10.1161/01.CIR.39.4.531
   FRIEDMAN PL, 1975, CIRC RES, V36, P127, DOI 10.1161/01.RES.36.1.127
   GARDNER PI, 1985, CIRCULATION, V72, P596, DOI 10.1161/01.CIR.72.3.596
   GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2
   Gibson CM, 2000, CIRCULATION, V101, P125, DOI 10.1161/01.CIR.101.2.125
   KILLIP T, 1967, AM J CARDIOL, V20, P457, DOI 10.1016/0002-9149(67)90023-9
   Korhonen P, 2010, ANN NONINVAS ELECTRO, V15, P130, DOI 10.1111/j.1542-474X.2010.00353.x
   LESH MD, 1988, J ELECTROCARDIOL, V21, pS69, DOI 10.1016/0022-0736(88)90061-1
   Mahenthiran J, 2007, J NUCL CARDIOL, V14, P347, DOI 10.1016/j.nuclcard.2007.02.003
   PASSAMANI E, 1985, NEW ENGL J MED, V312, P932
   Pietrasik G, 2007, AM J CARDIOL, V100, P583, DOI 10.1016/j.amjcard.2007.03.063
   Reddy CVR, 2006, ANN NONINVAS ELECTRO, V11, P132, DOI 10.1111/j.1542-474X.2006.00094.x
   Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397
   VARRIALE P, 1992, AM HEART J, V123, P369, DOI 10.1016/0002-8703(92)90648-F
   WEINBERG SL, 1950, AM HEART J, V40, P745, DOI 10.1016/0002-8703(50)90203-1
   WIENER I, 1984, AM HEART J, V107, P86, DOI 10.1016/0002-8703(84)90138-8
NR 30
TC 12
Z9 17
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 674
EP 683
DI 10.4070/kcj.2012.42.10.674
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400006
PM 23170095
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, WJ
   Kim, YH
   Lee, JY
   Park, DW
   Kang, SJ
   Lee, SW
   Lee, CW
   Kim, DH
   Song, JM
   Kang, DH
   Song, JK
   Kim, JB
   Jung, SH
   Choo, SJ
   Chung, CH
   Lee, JW
   Sim, JY
   Choi, IC
   Park, SW
   Park, SJ
AF Kim, Won-Jang
   Kim, Young-Hak
   Lee, Jong-Young
   Park, Duk-Woo
   Kang, Soo-Jin
   Lee, Seung-Whan
   Lee, Cheol Whan
   Kim, Dae-Hee
   Song, Jong-Min
   Kang, Duk-Hyun
   Song, Jae-Kwan
   Kim, Joon Bum
   Jung, Sung Ho
   Choo, Suk Jung
   Chung, Cheol Hyun
   Lee, Jae Won
   Sim, Ji-Yeon
   Choi, In-Cheol
   Park, Seong-Wook
   Park, Seung-Jung
TI Transcatheter Aortic Valve Implantation: Early Experience in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic stenosis; Valve prosthesis
AB Background and Objectives: Transcatheter aortic valve implantation (TAVI) was recently introduced in Korea. The present report describes the experience of early TAVI cases.
   Subjects and Methods: Between March, 2010 and October, 2011, 48 patients with severe symptomatic aortic stenosis (AS) were screened at the Asan Medical Center to determine their suitability for surgical intervention. Of these, 23 were considered unsuitable and underwent TAVI. Procedural success rates, procedure-related complications, and clinical outcomes were evaluated in the TAVI patients.
   Results: Transfemoral (n=20) or transapical (n=3) TAVI was performed. The mean age of patients was 75.9 +/- 5.4 years and 57% were females. The mean logistic European System for Cardiac Operative Risk Evaluation was 25.6 +/- 5.1%. Implantation was successful in 22 patients (19 transfemoral, three transapical). After successful implantation, the mean aortic valve area increased from 0.68 +/- 0.14 cm(2) to 1.45 +/- 0.33 cm(2.) There were no procedure-related complications or mortality. The patients showed no paravalvular aortic regurgitation with >= moderate degree and remained stable without progression during follow-up. During follow-up (interquartile range, 1.1-12.9), all patients were alive without any occurrence of valve failure.
   Conclusion: TAVI procedure is feasible in patients with inoperative symptomatic AS leading to hemodynamic and clinical improvement. With accumulation of experience, proper patient selection and development of device technologies, TAVI should decrease adverse events and expand the indications in the near future.
C1 [Kim, Won-Jang; Kim, Young-Hak; Lee, Jong-Young; Park, Duk-Woo; Kang, Soo-Jin; Lee, Seung-Whan; Lee, Cheol Whan; Kim, Dae-Hee; Song, Jong-Min; Kang, Duk-Hyun; Song, Jae-Kwan; Park, Seong-Wook; Park, Seung-Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul 138736, South Korea.
   [Kim, Joon Bum; Jung, Sung Ho; Choo, Suk Jung; Chung, Cheol Hyun; Lee, Jae Won] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul 138736, South Korea.
   [Sim, Ji-Yeon; Choi, In-Cheol] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul 138736, South Korea.
RP Park, SJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol,Cardiac Ctr, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea.
EM sjpark@amc.seoul.kr
OI Kim, Dae-Hee/0000-0002-8275-4871; Kim, Joon Bum/0000-0001-5801-2395
FU Ministry of Health and Welfare, Republic of KoreaMinistry of Health &
   Welfare, Republic of Korea [A102065]
FX This study was supported by a grant of the Korea Healthcare technology
   R&D Project, Ministry of Health and Welfare, Republic of Korea
   (A102065).
CR Bach DS, 2009, CIRC-CARDIOVASC QUAL, V2, P533, DOI 10.1161/CIRCOUTCOMES.109.848259
   Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857
   Buellesfeld L, 2010, EUR HEART J, V31, P984, DOI 10.1093/eurheartj/ehp570
   Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8
   Gurvitch R, 2011, CATHETER CARDIO INTE, V78, P977, DOI 10.1002/ccd.22961
   Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X
   Kurra V, 2010, JACC-CARDIOVASC INTE, V3, P105, DOI 10.1016/j.jcin.2009.10.014
   Kvidal P, 2000, J AM COLL CARDIOL, V35, P747, DOI 10.1016/S0735-1097(99)00584-7
   Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232
   Lichtenstein SV, 2006, CIRCULATION, V114, P591, DOI 10.1161/CIRCULATIONAHA.106.632927
   Messika-Zeitoun D, 2010, J AM COLL CARDIOL, V55, P186, DOI 10.1016/j.jacc.2009.06.063
   Ng ACT, 2010, CIRC-CARDIOVASC IMAG, V3, P94, DOI 10.1161/CIRCIMAGING.109.885152
   Nkomo Vuyisile T, 2006, Lancet, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8
   OTTO CM, 1994, CIRCULATION, V89, P642, DOI 10.1161/01.CIR.89.2.642
   SCHWARZ F, 1982, CIRCULATION, V66, P1105, DOI 10.1161/01.CIR.66.5.1105
   Serruys PW, 2009, TRANSCATHETER AORTIC, P645
   Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510
   Vassiliades TA, 2005, CATHETER CARDIO INTE, V65, P73, DOI 10.1002/ccd.20281
   Webb JG, 2006, CIRCULATION, V113, P842, DOI 10.1161/CIRCULATIONAHA.105.582882
   Webb JG, 2007, CIRCULATION, V116, P755, DOI 10.1161/CIRCULATIONAHA.107.698258
NR 20
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 684
EP 691
DI 10.4070/kcj.2012.42.10.684
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400007
PM 23170096
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, DH
   Jeong, MH
   Rhee, JA
   Choi, JS
   Lee, KH
   Lee, MG
   Sim, DS
   Park, KH
   Yoon, NS
   Yoon, HJ
   Kim, KH
   Park, HW
   Hong, YJ
   Kim, JH
   Ahn, Y
   Cho, JG
   Park, JC
   Kang, JC
AF Lee, Doo Hwan
   Jeong, Myung Ho
   Rhee, Jung Ae
   Choi, Jin Su
   Lee, Ki Hong
   Lee, Min Goo
   Sim, Doo Sun
   Park, Keun-Ho
   Yoon, Nam Sik
   Yoon, Hyun Ju
   Kim, Kye Hun
   Park, Hyung Wook
   Hong, Young Joon
   Kim, Ju Han
   Ahn, Youngkeun
   Cho, Jeong Gwan
   Park, Jong Chun
   Kang, Jung Chaee
TI Predictors of Long-Term Survival in Acute Coronary Syndrome Patients
   With Left Ventricular Dysfunction After Percutaneous Coronary
   Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Acute coronary syndrome; Prognosis; Heart failure; Angioplasty
ID ACUTE MYOCARDIAL-INFARCTION; EJECTION FRACTION; HEART-FAILURE;
   MORTALITY; PROGNOSIS; ANGIOPLASTY; OUTCOMES; GENDER; IMPACT; WOMEN
AB Background and Objectives: Predictive factors of mortality in acute coronary syndrome (ACS) patients with left ventricular dysfunction were analyzed during 5-year clinical follow-up after percutaneous coronary intervention (PCI).
   Subjects and Methods: A total of 329 ACS consecutive patients (64.6 +/- 11.3 years, 227 males) who underwent PCI from January 2001 to March 2006 were followed for 5 years. All patients had lower than 40% of left ventricular ejection fraction (LVEF). Patients were divided into Group I (survived longer than 5-years: n=130, 101 males) and Group II (survived shorter than 5 years: n=199, 126 males).
   Results: The cumulative survival rate was 88.0% at 1 month, 78.0% at 6 months, 75.0% at 1 year, 67.0% at 2 years, 62.0% at 3 years, 57.0% at 4 years and 40% at 5-years. Group II was older (61.6 +/- 11.2 years vs. 66.4 +/- 11.4 years, p<0.001), and showed higher prevalence of female gender (28.4% vs. 36.7%, p=0.006) and lower LVEF (35.3 +/- 5.2 vs. 33.6 +/- 5.6) than Group I. The independent predictors for mortality were LVEF <30% {odds ratio (OR)=1.793, 95% confidence interval (CI): 1.234-2.452, p=0.002}, serum creatinine >3.0 mg/dL (OR=2.455, 95% CI: 1.306-4.614, p=0.005), older than 65 years (OR=1.594, 95% CI: 1.152-2.206, p=0.005), and female gender (OR=1.524, 95% CI: 1.090-2.130, p=0.014).
   Conclusion: Five-year survival rate was 40% in ACS patients with left ventricular dysfunction, and the predictors for mortality were low LVEF, high serum creatinine, old age, and female gender.
C1 [Lee, Doo Hwan; Jeong, Myung Ho; Lee, Ki Hong; Lee, Min Goo; Sim, Doo Sun; Park, Keun-Ho; Yoon, Nam Sik; Yoon, Hyun Ju; Kim, Kye Hun; Park, Hyung Wook; Hong, Young Joon; Kim, Ju Han; Ahn, Youngkeun; Cho, Jeong Gwan; Park, Jong Chun; Kang, Jung Chaee] Chonnam Natl Univ Hosp, Ctr Heart, Kwangju 501757, South Korea.
   [Lee, Doo Hwan; Jeong, Myung Ho; Lee, Ki Hong; Lee, Min Goo; Sim, Doo Sun; Park, Keun-Ho; Yoon, Nam Sik; Yoon, Hyun Ju; Kim, Kye Hun; Park, Hyung Wook; Hong, Young Joon; Kim, Ju Han; Ahn, Youngkeun; Cho, Jeong Gwan; Park, Jong Chun; Kang, Jung Chaee] Korea Minist Hlth & Welf, Heart Res Ctr, Kwangju, South Korea.
   [Rhee, Jung Ae; Choi, Jin Su] Chonnam Natl Univ, Sch Med, Dept Prevent Med, Kwangju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Korea Minist Hlth & Welf, Heart Res Ctr, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
FU Ministry of Health and WelfareMinistry of Health, Labour and Welfare,
   Japan [A084869]
FX This study was conducted with the support of the Health & Medical
   Technology R&D Program of the Ministry of Health and Welfare (A084869).
CR Antman EM, 2004, J. Am. Coll. Cardiol, V3, pE1, DOI DOI 10.1016/J.JACC.2004.07.014
   Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363
   DEMIROVIC J, 1995, AM J CARDIOL, V75, P1096, DOI 10.1016/S0002-9149(99)80737-1
   FIEBACH NH, 1990, JAMA-J AM MED ASSOC, V263, P1092, DOI 10.1001/jama.263.8.1092
   Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879
   Gwon HC, 1990, KOREAN CIRC J, V20, P687
   Halkin A, 2005, AM J CARDIOL, V96, P325, DOI 10.1016/j.amjcard.2005.03.069
   Halkin A, 2005, J AM COLL CARDIOL, V45, P1397, DOI 10.1016/j.jacc.2005.01.041
   HE J, 1994, AM J EPIDEMIOL, V139, P693, DOI 10.1093/oxfordjournals.aje.a117059
   Holper EM, 2006, AM HEART J, V151, P69, DOI 10.1016/j.ahj.2005.03.053
   KARLSON BW, 1994, AM HEART J, V128, P477, DOI 10.1016/0002-8703(94)90620-3
   Kim JY, 2011, KOREAN CIRC J, V41, P184, DOI 10.4070/kcj.2011.41.4.184
   KOHLI RS, 1990, J AM COLL CARDIOL, V16, P807, DOI 10.1016/S0735-1097(10)80326-2
   Korea National Statistical Office, 2004, 2004 ANN REP COURS D, P32
   KOUVARAS G, 1988, JPN HEART J, V29, P1
   Krumholz HM, 1997, AM J CARDIOL, V80, P11, DOI 10.1016/S0002-9149(97)00299-3
   MAYNARD C, 1992, ARCH INTERN MED, V152, P972, DOI 10.1001/archinte.152.5.972
   PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001
   QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744
   Scanlon PJ, 1999, J AM COLL CARDIOL, V33, P1756, DOI 10.1016/S0735-1097(99)00126-6
   Schuhlen H, 1998, CIRCULATION, V98, P104, DOI 10.1161/01.CIR.98.2.104
   TOFLER GH, 1987, J AM COLL CARDIOL, V9, P473, DOI 10.1016/S0735-1097(87)80038-4
   Walsh CR, 2002, AM HEART J, V144, P1003, DOI 10.1067/mhj.2002.125504
   Zannad F, 1999, J AM COLL CARDIOL, V33, P734, DOI 10.1016/S0735-1097(98)00634-2
NR 24
TC 6
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 692
EP 697
DI 10.4070/kcj.2012.42.10.692
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400008
PM 23170097
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, MY
   Shin, WS
   Shim, BJ
   Lee, SJ
   Park, JH
   Koh, YS
   Lee, JM
AF Park, Mi-Youn
   Shin, Woo-Seung
   Shim, Byung-Ju
   Lee, Seung-Jae
   Park, Jae-Hong
   Koh, Yoon-Seok
   Lee, Jong-Min
TI Exercise-Induced Intranodal Atrioventricular Block
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrioventricular block; Exercise test; Electrophysiologic techniques;
   cardiac
AB Exercise-induced atrioventricular (AV) block in patients with normal AV conduction at rest is rare. Herein, we describe the case of a 67-year-old woman with normal 1 : 1 AV conduction at rest, who developed complete AV block during a treadmill test. Our patient complained of effort-related dizziness and dyspnea, which had been ongoing for 3 months. The patient's physical examination was normal. The resting electrocardiogram showed left anterior fascicular block with a PR interval of 0.19 seconds. The echocardiogram was normal except for mild aortic valve regurgitation. During the treadmill test, the patient developed complete AV block at a sinus rate of 90 beats/min, which was followed by 2 : 1 AV block associated with dyspnea and dizziness. The patient's coronary angiogram was normal, and the ergonovine provocation test was negative. Electrophysiological studies demonstrated rate-dependent intranodal AV block. The patient received implantation of a permanent dual chamber (DDD) pacemaker and had no further symptoms during the follow-up period.
C1 [Park, Mi-Youn; Shim, Byung-Ju; Lee, Seung-Jae] Pohang St Marys Hosp, Dept Internal Med, Div Cardiol, Pohang, South Korea.
   [Shin, Woo-Seung; Park, Jae-Hong; Koh, Yoon-Seok; Lee, Jong-Min] Catholic Univ Korea, Sch Med, Uijeongbu St Marys Hosp, Div Cardiol,Dept Internal Med, Uijongbu 480717, South Korea.
RP Shin, WS (corresponding author), Catholic Univ Korea, Sch Med, Uijeongbu St Marys Hosp, Div Cardiol,Dept Internal Med, 271 Cheonbo Ro, Uijongbu 480717, South Korea.
EM medsws@catholic.ac.kr
RI Koh, Yoon-Seok/AAE-1749-2019
CR Choi JY, 1994, KOREAN CIRC J, V24, P717
   Egred M, 2004, INT J CARDIOL, V97, P559, DOI 10.1016/j.ijcard.2003.06.038
   Hemann Brian A, 2006, J Cardiopulm Rehabil, V26, P314, DOI 10.1097/00008483-200609000-00007
   Kasaoka Y, 2001, J CARDIOVASC ELECTR, V12, P965, DOI 10.1046/j.1540-8167.2001.00965.x
   Marti-Almor J, 2005, REV ESP CARDIOL, V58, P1247
   OZDER AB, 1989, AM HEART J, V117, P1407, DOI 10.1016/0002-8703(89)90451-1
   Pappas LK, 2006, INT J CARDIOL, V111, P461, DOI 10.1016/j.ijcard.2005.06.060
   Sumiyoshi M, 1996, AM HEART J, V132, P1277, DOI 10.1016/S0002-8703(96)90476-7
NR 8
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 698
EP 701
DI 10.4070/kcj.2012.42.10.698
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400009
PM 23170098
OA Green Published
DA 2021-04-22
ER

PT J
AU Jin, X
   Seol, SH
   Park, SH
   Lee, JW
   Park, BM
   Kim, DK
   Kim, KH
   Kim, DI
   Min, HK
   Kim, YM
AF Jin, Xin
   Seol, Sang-Hoon
   Park, Seung-Hyeon
   Lee, Joo-Won
   Park, Bo-Min
   Kim, Dong-Kie
   Kim, Ki-Hun
   Kim, Doo-Il
   Min, Ho-Ki
   Kim, Yeon-Mee
TI An Unusual Case of Left Ventricular Free Wall Rupture Caused by a Silent
   Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Rupture; Pericarditis
AB Left ventricular free wall rupture (LVFWR) is a serious complication of myocardial infarction. It presents with a very high mortality rate and can be rescued by accurate diagnosis and emergency surgery. LVFWR can occur with sudden overt clinical symptoms or present insidiously. This report highlights the case of a man with no prior history of coronary artery disease, who presented with LVFWR and pericardial effusion that evolved to severe bacterial pericarditis.
C1 [Jin, Xin] YanBian Second Peoples Hosp, Dept Internal Med, Div Cardiol, Yanbian, Peoples R China.
   [Seol, Sang-Hoon; Park, Seung-Hyeon; Lee, Joo-Won; Park, Bo-Min; Kim, Dong-Kie; Kim, Ki-Hun; Kim, Doo-Il] Inje Univ, Coll Med, Haeundae Paik Hosp, Div Cardiol,Dept Internal Med, Pusan 612862, South Korea.
   [Min, Ho-Ki] Inje Univ, Coll Med, Haeundae Paik Hosp, Div Chest Surg, Pusan 612862, South Korea.
   [Kim, Yeon-Mee] Inje Univ, Coll Med, Haeundae Paik Hosp, Pusan 612862, South Korea.
RP Seol, SH (corresponding author), Inje Univ, Coll Med, Haeundae Paik Hosp, Div Cardiol,Dept Internal Med, 875 Haeun Daero, Pusan 612862, South Korea.
EM hacemed@hanmail.net
OI Jin, Xin/0000-0002-8250-1444; Kim, Bo-Yeon/0000-0002-3658-2351
CR BATTS KP, 1990, HUM PATHOL, V21, P530, DOI 10.1016/0046-8177(90)90010-3
   David TE., 1993, MECH COMPLICATIONS M, P142
   Exadaktylos NI, 2002, HELL J CARDIOL, V43, P246
   Figueras J, 2000, HEART, V83, P499, DOI 10.1136/heart.83.5.499
   MANN JM, 1988, AM J CARDIOL, V62, P847, DOI 10.1016/0002-9149(88)90881-8
   Park SC, 1999, KOREAN CIRC J, V29, P73
   POHJOLASINTONEN S, 1989, AM HEART J, V117, P809, DOI 10.1016/0002-8703(89)90617-0
   POLLAK H, 1993, EUR HEART J, V14, P640, DOI 10.1093/eurheartj/14.5.640
   Reardon MJ, 1997, ANN THORAC SURG, V64, P1509, DOI 10.1016/S0003-4975(97)00776-5
   SHIRANI J, 1994, AM J CARDIOL, V73, P88, DOI 10.1016/0002-9149(94)90733-1
   Vanezis A. P., 2009, British Journal of Medical Practitioners, V2, P41
   Wehrens XHT, 2004, INT J CARDIOL, V95, P285, DOI 10.1016/j.ijcard.2003.06.006
NR 12
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 702
EP 704
DI 10.4070/kcj.2012.42.10.702
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400010
PM 23170099
OA Green Published
DA 2021-04-22
ER

PT J
AU Yim, SM
   Jang, SW
   Chun, HJ
   Kim, SJ
   Choi, KY
   Kwon, BJ
   Kim, DB
   Cho, EJ
   Lee, MY
   Rho, TH
   Kim, JH
AF Yim, Sun Mie
   Jang, Sung-Won
   Chun, Hyun Ji
   Kim, Su Jung
   Choi, Kyu Young
   Kwon, Beom-June
   Kim, Dong-Bin
   Cho, Eun Joo
   Lee, Man-Young
   Rho, Tai-Ho
   Kim, Jae-Hyung
TI A Case of Left Ventricular Noncompaction Accompanying
   Fasciculo-Ventricular Accessory Pathway and Atrial Flutter
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Isolated noncompaction of the ventricular myocardium; Mitral valve
   insufficiency; Pre-excitation; Mahaim-type; Atrial flutter
AB Left ventricular hypertrabeculation/noncompaction (LVHT) is an uncommon type of genetic cardiomyopathy characterized by trabeculations and recesses within the ventricular myocardium. LVHT is associated with diastolic or systolic dysfunction, thromboembolic complications, and arrhythmias, including atrial fibrillation, ventricular arrhythmias, atrioventricular block and Wolff-Parkinson-White syndrome. Herein, we describe a patient who presented with heart failure and wide-complex tachycardia. Echocardiography showed LVHT accompanied with severe mitral regurgitation. The electrophysiologic study revealed a fasciculo-ventricular accessory pathway and atrial flutter (AFL). The AFL was successfully treated with catheter ablation.
C1 [Yim, Sun Mie; Jang, Sung-Won; Chun, Hyun Ji; Kim, Su Jung; Choi, Kyu Young; Kwon, Beom-June; Kim, Dong-Bin; Cho, Eun Joo; Lee, Man-Young; Rho, Tai-Ho; Kim, Jae-Hyung] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, Seoul 130709, South Korea.
RP Jang, SW (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, 180 Wangsan Ro, Seoul 130709, South Korea.
EM clement@naver.com
CR Ichida F, 1999, J AM COLL CARDIOL, V34, P233, DOI 10.1016/S0735-1097(99)00170-9
   Jenni R, 2001, HEART, V86, P666, DOI 10.1136/heart.86.6.666
   Oechslin E, 2011, EUR HEART J, V32, P1446, DOI 10.1093/eurheartj/ehq508
   Sarma RJ, 2010, PROG CARDIOVASC DIS, V52, P264, DOI 10.1016/j.pcad.2009.11.001
   Sasse-Klaassen S, 2003, AM J MED GENET A, V119A, P162, DOI 10.1002/ajmg.a.20075
   Stollberger C, 2010, CURR PHARM DESIGN, V16, P2880, DOI 10.2174/138161210793176518
NR 6
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 705
EP 708
DI 10.4070/kcj.2012.42.10.705
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400011
PM 23170100
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, IH
   Choi, DY
   Oh, YK
   Kim, JD
   Yu, ST
AF Park, In Ho
   Choi, Du Young
   Oh, Yeon Kyun
   Kim, Jong Duck
   Yu, Seung Taek
TI A Case of Acute Myopericarditis Associated With Mycoplasma Pneumoniae
   Infection in a Child
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mycoplasma pneumoniae; Azithromycin; Clarithromycin; Pericarditis;
   Myocarditis
AB Mycoplasma pneumoniae (M. pneumoniae) primarily causes respiratory tract infections in persons aged 5-20 years. Tracheobronchitis and bronchopneumonia are the most commonly recognized clinical symptoms associated with M. pneumoniae infection. Complications of this infection are unusual; in particular, cardiac involvement is very rare and is generally accompanied by pneumonia. Nonrespiratory illness can therefore involve direct invasion by M. pneumoniae or autoimmune mechanisms, as suggested by the frequency of cross reaction between human antigens and M. pneumoniae. Herein, we report a case of severe acute myopericarditis with pneumonia caused by M. pneumoniae in a healthy young child who presented with fever, lethargy, oliguria and dyspnea. She survived with aggressive therapy including clarithromycin, intravenous immunoglobulin, inotropics, and diuretics. The patient was discharged on the 19th day after admission and followed up 1 month thereafter at the outpatient clinic without sequelae.
C1 [Park, In Ho; Choi, Du Young; Oh, Yeon Kyun; Kim, Jong Duck; Yu, Seung Taek] Wonkwang Univ, Sch Med, Dept Pediat, Iksan 570711, South Korea.
RP Yu, ST (corresponding author), Wonkwang Univ, Sch Med, Dept Pediat, 895 Muwang Ro, Iksan 570711, South Korea.
EM yudoc@wonkwang.ac.kr
FU Wonkwang University
FX This work was supported by a research grant funded by the Wonkwang
   University in 2011.
CR Asher Craig R, 2002, Cardiol Rev, V10, P218, DOI 10.1097/00045415-200207000-00007
   Atkinson TP, 2008, FEMS MICROBIOL REV, V32, P956, DOI 10.1111/j.1574-6976.2008.00129.x
   Defilippi A, 2008, RESP MED, V102, P1762, DOI 10.1016/j.rmed.2008.06.022
   Hawkins S, 2011, CURR OPIN PEDIATR, V23, P126, DOI 10.1097/MOP.0b013e328341579c
   Imazio M, 2008, HEART, V94, P498, DOI 10.1136/hrt.2006.104067
   Imazio M, 2008, INT J CARDIOL, V127, P17, DOI 10.1016/j.ijcard.2007.10.053
   Kim DI, 2009, KOREAN J PEDIAT INFE, V16, P90
   Kim NH, 2007, PEDIATR INFECT DIS J, V26, P897, DOI 10.1097/INF.0b013e31812e4b81
   Kim SH, 2009, INT J CARDIOL, V136, P151, DOI 10.1016/j.ijcard.2008.04.033
   Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9
   MANSEL JK, 1989, CHEST, V95, P639, DOI 10.1378/chest.95.3.639
   Michelow IC, 2004, PEDIATRICS, V113, P701, DOI 10.1542/peds.113.4.701
   Paz A, 2002, CARDIOLOGY, V97, P83, DOI 10.1159/000057677
   PISCITELLI SC, 1992, CLIN PHARMACY, V11, P137
   PONKA A, 1979, ACTA MED SCAND, V206, P77
   Roodpeyma S, 2000, PEDIATR CARDIOL, V21, P363, DOI 10.1007/s002460010081
   Sagrista-Sauleda J, 2004, NEW ENGL J MED, V350, P469, DOI 10.1056/NEJMoa035630
   Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004
   Waites KB, 2003, PEDIATR PULM, V36, P267, DOI 10.1002/ppul.10346
   Waris ME, 1998, J CLIN MICROBIOL, V36, P3155, DOI 10.1128/JCM.36.11.3155-3159.1998
NR 20
TC 5
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 709
EP 713
DI 10.4070/kcj.2012.42.10.709
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400012
PM 23170101
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, Y
   Kim, HJ
   Yoon, CH
AF Jung, Younghee
   Kim, Hyun-Jin
   Yoon, Chang-Hwan
TI Severe Form of Persistent Thebesian Veins Presenting as Ischemic Heart
   Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessel anomalies; Coronary angiography; Arteriovenous fistula;
   Myocardial ischemia
ID MYOCARDIAL-ISCHEMIA; CORONARY; FISTULA
AB Coronary artery fistula is a rare congenital anomaly. Most patients with this anomaly are asymptomatic, but some may develop heart failure, myocardial ischemia or arrhythmias. We report a case of a patient who presented with myocardial ischemia secondary to persistent Thebesian veins. Coronary angiography demonstrated a marked capillary blush draining into the left ventricular cavity through multiple microfistulae from the left anterior descending artery, left circumflex artery and right coronary artery. The patient was discharged without chest pain and was medically maintained with a beta-blocker and angiotensin converting enzyme inhibitor.
C1 [Jung, Younghee; Kim, Hyun-Jin; Yoon, Chang-Hwan] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam 463707, South Korea.
   [Yoon, Chang-Hwan] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.
RP Yoon, CH (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 166 Gumi Ro, Songnam 463707, South Korea.
EM changhwanyoon@gmail.com
OI Yoon, Chang-Hwan/0000-0001-6305-4442
CR ALKHULAIFI AM, 1995, ANN THORAC SURG, V60, P202
   BLAKE HA, 1964, CIRCULATION, V30, P927, DOI 10.1161/01.CIR.30.6.927
   Chattopadhyay S, 2010, CAN J CARDIOL, V26, pE31, DOI 10.1016/S0828-282X(10)70345-7
   Heper G, 2005, TEX HEART I J, V32, P50
   Lisanti P, 1988, G Ital Cardiol, V18, P858
   SHEIKHZADEH A, 1986, JPN HEART J, V27, P533
   SKIMMING JW, 1993, PEDIATR CARDIOL, V14, P174, DOI 10.1007/BF00795649
   Stierle U, 1998, INT J CARDIOL, V63, P47, DOI 10.1016/S0167-5273(97)00280-5
   VOGELBACH KH, 1979, CATHETER CARDIO DIAG, V5, P159, DOI 10.1002/ccd.1810050210
   최종일, 2002, Korean Circulation Journal, V32, P438
   김응주, 2004, Korean Circulation Journal, V34, P107
NR 11
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 714
EP 717
DI 10.4070/kcj.2012.42.10.714
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400013
PM 23170102
OA Green Published
DA 2021-04-22
ER

PT J
AU Namgung, J
   Kwak, JJ
   Choe, H
   Kwon, SU
   Doh, JH
   Lee, SY
   Lee, WR
AF Namgung, June
   Kwak, Jae-Jin
   Choe, Hyunmin
   Kwon, Sung Uk
   Doh, Joon Hyung
   Lee, Sung Yun
   Lee, Won Ro
TI Familial Occurrence of Atrioventricular Nodal Reentrant Tachycardia in a
   Mother and Her Son
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Tachycardia; atrioventricular nodal reentrant
AB Atrioventricular nodal reentrant tachycardia (AVNRT), caused by a reentry circuit involving fast and slow atrioventricular nodal pathways, is one of the most common types of paroxysmal supraventricular tachycardias. While familial Wolff-Parkinson-White syndrome has been well recognized, familial AVNRT has been rarely reported. We report a familial occurrence of AVNRT in a mother and her son, who were symptomatic and successfully treated with radiofrequency catheter ablation of slow pathway.
C1 [Namgung, June; Kwak, Jae-Jin; Choe, Hyunmin; Kwon, Sung Uk; Doh, Joon Hyung; Lee, Sung Yun; Lee, Won Ro] Inje Univ, Coll Med, Ilsan Paik Hosp, Div Cardiol,Dept Internal Med, Goyang 411706, South Korea.
RP Namgung, J (corresponding author), Inje Univ, Coll Med,Ilsan Paik Hosp, Vis Cardiac & Vasc Ctr 21, Div Cardiol,Dept Internal Med, 170 Juhwa Ro, Goyang 411706, South Korea.
EM jnamgung@paik.ac.kr
CR Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302
   Frisch DR, 2006, J CARDIOVASC ELECTR, V17, P1029, DOI 10.1111/j.1540-8167.2006.00522.x
   Gerber TC, 2001, INT J CARDIAC IMAG, V17, P65, DOI 10.1023/A:1010692103831
   Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403
   Hayes JJ, 2004, PACE, V27, P73, DOI 10.1111/j.1540-8159.2004.00388.x
   Kang BH, 2002, KOREAN CIRC J, V32, P715
   VIDAILLET HJ, 1987, NEW ENGL J MED, V317, P65, DOI 10.1056/NEJM198707093170201
   WAN Q, 1992, CHINESE MED J-PEKING, V105, P284
NR 8
TC 4
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 718
EP 721
DI 10.4070/kcj.2012.42.10.718
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400014
PM 23170103
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, J
   Han, D
   Sohn, C
   Kim, JS
   Park, YH
AF Kim, Jun
   Han, Dongcheul
   Sohn, Changbae
   Kim, Jeong Su
   Park, Yong Hyun
TI Alternating Ventricular Preexcitation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Jun; Han, Dongcheul; Sohn, Changbae; Kim, Jeong Su; Park, Yong Hyun] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan 626770, South Korea.
RP Kim, J (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, 20 Geumo Ro, Yangsan 626770, South Korea.
EM mdjunkim@gmail.com
OI Kim, Jun/0000-0002-3573-638X
CR GONZALEZ MD, 1991, CIRCULATION, V83, P1221, DOI 10.1161/01.CIR.83.4.1221
   Kinoshita S, 1998, J ELECTROCARDIOL, V31, P151, DOI 10.1016/S0022-0736(98)90047-4
   KLEIN GJ, 1983, AM J CARDIOL, V52, P292, DOI 10.1016/0002-9149(83)90125-X
   LEHMANN MH, 1985, CIRCULATION, V71, P254, DOI 10.1161/01.CIR.71.2.254
   ROSENBAUM MB, 1982, AM J CARDIOL, V50, P213, DOI 10.1016/0002-9149(82)90169-2
NR 5
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2012
VL 42
IS 10
BP 722
EP 723
DI 10.4070/kcj.2012.42.10.722
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IP
UT WOS:000209080400015
PM 23170104
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, MS
   Flammer, AJ
   Lerman, LO
   Lerman, A
AF Lee, Moo-Sik
   Flammer, Andreas J.
   Lerman, Lilach O.
   Lerman, Amir
TI Personalized Medicine in Cardiovascular Diseases
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Personalized medicine; Cardiovascular diseases; Genomics
ID CORONARY-HEART-DISEASE; ENDOTHELIAL FUNCTION; ASSOCIATION ANALYSIS;
   ATRIAL-FIBRILLATION; GENOMIC MEDICINE; RISK-FACTORS; PHARMACOGENETICS;
   POLYMORPHISMS; GENETICS; SUSCEPTIBILITY
AB Personalized medicine is a novel medical model with all decisions and practices being tailored to individual patients in whatever ways possible. In the era of genomics, personalized medicine combines the genetic information for additional benefit in preventive and therapeutic strategies. Personalized medicine may allow the physician to provide a better therapy for patients in terms of efficiency, safety and treatment length to reduce the associated costs. There was a remarkable growth in scientific publication on personalized medicine within the past few years in the cardiovascular field. However, so far, only very few cardiologists in the USA are incorporating personalized medicine into clinical treatment. We review the concepts, strengths, limitations and challenges of personalized medicine with a particular focus on cardiovascular diseases (CVDs). There are many challenges from both scientific and policy perspectives to personalized medicine, which can overcome them by comprehensive concept and understanding, clinical application, and evidence based practices. Individualized medicine serves a pivotal role in the evolution of national and global healthcare reform, especially, in the CVDs fields. Ultimately, personalized medicine will affect the entire landscape of health care system in the near future.
C1 [Lee, Moo-Sik; Flammer, Andreas J.; Lerman, Amir] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA.
   [Lerman, Lilach O.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN 55905 USA.
   [Lee, Moo-Sik] Konyang Univ, Coll Med, Dept Prevent Med, Taejon, South Korea.
RP Lerman, A (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.
EM lerman.amir@mayo.edu
RI Flammer, Andreas/AAJ-1328-2021; Lerman, Lilach/M-4962-2017
OI Flammer, Andreas/0000-0002-1373-0630
CR Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2
   Aquilante C, 2007, PROMISE PERSONALIZED
   Arnar DO, 2006, EUR HEART J, V27, P708, DOI 10.1093/eurheartj/ehi727
   Arnett DK, 2007, CIRCULATION, V115, P2878, DOI 10.1161/CIRCULATIONAHA.107.183679
   Aspinall MG, 2007, HARVARD BUS REV, V85, P108
   Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989
   Bates S, 2010, DRUG DISCOV TODAY, V15, P115, DOI 10.1016/j.drudis.2009.11.001
   Bonter K, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000110
   Bristow M, 2011, NEW FRONTIERS PERSON
   Califf RM, 2008, JAMA-J AM MED ASSOC, V300, P2300, DOI 10.1001/jama.2008.638
   Chan IS, 2011, ANNU REV GENOM HUM G, V12, P217, DOI 10.1146/annurev-genom-082410-101446
   Collins F, 2010, NATURE, V464, P674, DOI 10.1038/464674a
   Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859
   deGoma EM, 2011, VASC MED, V16, P391, DOI 10.1177/1358863X11422251
   Deng MC, 2006, AM J TRANSPLANT, V6, P150, DOI 10.1111/j.1600-6143.2005.01175.x
   Parguina AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013404
   Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P2851, DOI 10.1001/jama.291.23.2851
   Ganz P, 2003, CIRCULATION, V108, P2049, DOI 10.1161/01.CIR.0000089507.19675.F9
   Genentech USA Inc. PERSONALIZED MEDICINE, 2011, MANAGEDCARE S3, V20
   Ginsburg GS, 2009, TRANSL RES, V154, P277, DOI 10.1016/j.trsl.2009.09.005
   Guttmacher AE, 2002, NEW ENGL J MED, V347, P1512, DOI 10.1056/NEJMra012240
   Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304
   Hamburg NM, 2008, CIRCULATION, V117, P2467, DOI 10.1161/CIRCULATIONAHA.107.748574
   Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842
   Hindorff LA, 2011, CATALOG PUBLISHED GE
   Hudson TJ, 2009, CAN MED ASSOC J, V180, P911, DOI 10.1503/cmaj.090199
   Johnson JA, 2003, PHARMACOGENETICS, V13, P525, DOI 10.1097/00008571-200309000-00001
   Jorgensen JT, 2011, DRUG DISCOV TODAY, V16, P891, DOI 10.1016/j.drudis.2011.09.010
   Kardia SLR, 2003, AM J PREV MED, V24, P143, DOI 10.1016/S0749-3797(02)00587-1
   Kasper D, 2008, HARRISONS PRINCIPLES
   Kongkaew C, 2008, ANN PHARMACOTHER, V42, P1017, DOI 10.1345/aph.1L037
   Kramer BS, 2009, ANNU REV MED, V60, P125, DOI 10.1146/annurev.med.60.101107.134802
   Ku CS, 2010, J HUM GENET, V55, P403, DOI 10.1038/jhg.2010.55
   Lee DS, 2006, NEW ENGL J MED, V355, P138, DOI 10.1056/NEJMoa052948
   Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14
   Lewin J, 2011, YOUR HEART YOUR FUTU
   Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204
   Lunshof JE, 2006, PHARMACOGENOMICS, V7, P237, DOI 10.2217/14622416.7.2.237
   Manace LC, 2009, MT SINAI J MED, V76, P613, DOI 10.1002/msj.20151
   Manolio TA, 2004, ARTERIOSCL THROM VAS, V24, P1567, DOI 10.1161/01.ATV.0000138789.11433.c1
   Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772
   MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503
   Mateos-Caceres PJ, 2004, J AM COLL CARDIOL, V44, P1578, DOI 10.1016/j.jacc.2004.06.073
   McCarthy JJ, 2004, J MED GENET, V41, P334, DOI 10.1136/jmg.2003.016584
   McCrea CE, 2012, VASC MED, V17, P29, DOI 10.1177/1358863X11433188
   McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447
   Munroe J Brian, 2004, Per Med, V1, P9, DOI 10.1517/17410541.1.1.9
   *NAT HEART LUNG BL, 2000, NAT HEART LUNG BLOOD
   Nordlie MA, 2005, J MOL CELL CARDIOL, V39, P667, DOI 10.1016/j.yjmcc.2005.06.006
   O'Donnell CJ, 2008, CIRC-CARDIOVASC GENE, V1, P51, DOI 10.1161/CIRCGENETICS.108.813337
   O'Donnell CJ, 2002, CIRCULATION, V106, P337, DOI 10.1161/01.CIR.0000022663.26468.5B
   Personalized Medicine Coalition, 2009, CAS PERS MED
   Peyser PA, 2002, CIRCULATION, V106, P304, DOI 10.1161/01.CIR.0000022664.21832.5D
   Piquette-Miller M, 2007, CLIN PHARMACOL THER, V81, P311, DOI 10.1038/sj.clpt.6100130
   Roden DM, 2006, ANN INTERN MED, V145, P749, DOI 10.7326/0003-4819-145-10-200611210-00007
   Ruben RJ, 2011, OTOLARYNG HEAD NECK, V145, P707, DOI 10.1177/0194599811419468
   Rubinshtein R, 2010, EUR HEART J, V31, P1142, DOI 10.1093/eurheartj/ehq010
   Rubinshtein R, 2010, EUR HEART J, V31, P936, DOI 10.1093/eurheartj/ehp459
   Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137
   Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366
   Schwartz PJ, 2001, CIRCULATION, V103, P89
   Shapiro SD, 2011, AM J RESP CRIT CARE, V184, P864, DOI 10.1164/rccm.201108-1486ED
   Shimizu W, 2008, CIRC J, V72, P1926, DOI 10.1253/circj.CJ-08-0947
   Spear BB, 2001, TRENDS MOL MED, V7, P201, DOI 10.1016/S1471-4914(01)01986-4
   Tester DJ, 2011, CIRCULATION, V123, P1021, DOI 10.1161/CIRCULATIONAHA.109.914838
   The International HapMap Consortium, INT HAPMAP PROJ
   The National Forum for Heart Disease and Stroke Prevention, 2008, UPD PUBL HLTH ACT PL
   Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921
   Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910
   US Food Drug Administration, 2007, FDA APPR UPD WARF CO
   US Presidents Council of Advisors on Science and Technology (PCAST), 2008, PRIOR PERS MED
   Voora D, 2005, PHARMACOGENOMICS, V6, P503, DOI 10.2217/14622416.6.5.503
   Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021
   Wright CF, 2010, HUM GENET, V127, P125, DOI 10.1007/s00439-009-0767-x
   Zineh I, 2006, ANN PHARMACOTHER, V40, P639, DOI 10.1345/aph.1G464
NR 75
TC 14
Z9 14
U1 3
U2 9
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2012
VL 42
IS 9
BP 583
EP 591
DI 10.4070/kcj.2012.42.9.583
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IO
UT WOS:000209080300001
PM 23091501
OA Green Published
DA 2021-04-22
ER

PT J
AU Joo, SJ
AF Joo, Seung-Jae
TI Anti-Inflammatory Effects of Statins Beyond Cholesterol Lowering
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Jeju Natl Univ Hosp, Dept Internal Med, Div Cardiol, Cheju 690767, South Korea.
RP Joo, SJ (corresponding author), Jeju Natl Univ Hosp, Dept Internal Med, Div Cardiol, 15 Aran 13 Gil, Cheju 690767, South Korea.
EM sejjoo@jejunu.ac.kr
CR [Anonymous], LANCET
   Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1
   Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022
   Cannon CP, 2006, J AM COLL CARDIOL, V48, P438, DOI 10.1016/j.jacc.2006.04.070
   Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804
   Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7
   Kim YR, 2012, KOREAN CIRC J, V42, P595, DOI 10.4070/kcj.2012.42.9.595
   Kinlay S, 2007, J AM COLL CARDIOL, V49, P2003, DOI 10.1016/j.jacc.2007.01.083
   LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461
   Mizuno Y, 2011, J ATHEROSCLER THROMB, V18, P351, DOI 10.5551/jat.7591
   Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000
   Peters SAE, 2010, J INTERN MED, V268, P155, DOI 10.1111/j.1365-2796.2010.02230.x
   Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646
   Ridker PM, 2010, AM J CARDIOL, V106, P204, DOI 10.1016/j.amjcard.2010.03.018
   Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5
   Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378
   Robinson JG, 2005, J AM COLL CARDIOL, V46, P1855, DOI 10.1016/j.jacc.2005.05.085
NR 17
TC 7
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2012
VL 42
IS 9
BP 592
EP 594
DI 10.4070/kcj.2012.42.9.592
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IO
UT WOS:000209080300002
PM 23091502
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, YR
   Park, JH
   Lee, HJ
   Pyun, WB
   Park, SH
AF Kim, Yoo Ri
   Park, Jae Hong
   Lee, Hye-Jin
   Pyun, Wouk Bum
   Park, Si-Hoon
TI The Effect of Doubling the Statin Dose on Pro-Inflammatory Cytokine in
   Patients With Triple-Vessel Coronary Artery Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Statin; C-reactive protein; Interleukin-6
AB Background and Objectives: Statin prevents atherosclerotic progression and helps to stabilize the plaque. According to a recent study, statin reduces inflammation in blood vessels. However, it has not been demonstrated to have any anti-inflammation reaction in patients who have been diagnosed as having a triple-vessel coronary artery disease (CAD).
   Subjects and Methods: This study included a total of thirty (30) patients who had been diagnosed by coronary angiogram as having a triple-vessel CAD. Patients who already had been taking statin were given doubled dosage. An interview, physical examination and blood test were performed at the beginning of this study and three months later.
   Results: After doubling the dose of statin, there was no statistically significant decrease in total cholesterol, low density lipoprotein-cholesterol, (increase in) high density lipoprotein-cholesterol and triglyceride in the blood test. C-reactive protein (CRP), an acute phase reactant, significantly decreased from 0.34 mg/dL at the beginning of the study to 0.12 mg/dL at the end of study (p<0.01). The interleukin-6 concentration also significantly decreased from 8.55 pg/dL to 4.81 pg/dL (p<0.001). No major cardiovascular events occurred and the dosage regimen was not modified during the close observation period. There was no difference in the symptoms of angina pectoris, established by World Health Organization Angina Questionnaires, before and after the dose increase. Liver enzymes remained within normal range with no significant increase before and after conducting this study.
   Conclusion: Doubling the dose of statin alone significantly lowers pro-inflammatory cytokine concentration, which is closely related to the potential acute coronary syndrome, and CRP, a marker of vascular inflammation.
C1 [Kim, Yoo Ri] Univ Ulsan, Coll Med, Dept Cardiol, Asan Med Ctr, Seoul, South Korea.
   [Park, Jae Hong] Han Il Gen Hosp, Dept Cardiol, Seoul, South Korea.
   [Lee, Hye-Jin] Ewha Womans Univ, Sch Med, Dept Endocrinol, Med Ctr, Seoul 158710, South Korea.
   [Pyun, Wouk Bum; Park, Si-Hoon] Ewha Womans Univ, Sch Med, Dept Cardiol, Med Ctr, Seoul 158710, South Korea.
RP Park, SH (corresponding author), Ewha Womans Univ, Sch Med, Dept Cardiol, 1071 Anyangcheon Ro, Seoul 158710, South Korea.
EM sihoon@ewha.ac.kr
CR Alsheikh-Ali AA, 2007, J AM COLL CARDIOL, V50, P409, DOI 10.1016/j.jacc.2007.02.073
   Ambrose JA, 2002, CIRCULATION, V105, P2000, DOI 10.1161/01.CIR.0000012528.89469.8E
   Apple FS, 2005, CLIN CHEM, V51, P810, DOI 10.1373/clinchem.2004.046292
   Biloglav Z, 2004, COLLEGIUM ANTROPOL, V28, P205
   Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804
   Kofler S, 2005, CLIN SCI, V108, P205, DOI 10.1042/CS20040174
   LaRosa JC, 2001, AM J CARDIOL, V88, P291, DOI 10.1016/S0002-9149(01)01643-5
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Libby P, 2006, AM J CARDIOL, V98, p26P, DOI 10.1016/j.amjcard.2006.09.017
   Mills R, 2004, J AM COLL CARDIOL, V44, P50, DOI 10.1016/j.jacc.2004.04.002
   Morrow DA, 2006, CIRCULATION, V114, P281, DOI 10.1161/CIRCULATIONAHA.106.628909
   Murphy NF, 2006, HEART, V92, P1739, DOI 10.1136/hrt.2006.090118
   Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327
   Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646
   Ridker PM, 2005, J AM COLL CARDIOL, V45, P1644, DOI 10.1016/j.jacc.2005.02.080
   Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601
   Shishehbor MH, 2003, CIRCULATION, V108, P426, DOI 10.1161/01.CIR.0000080895.05158.8B
   Shishehbor MH, 2003, CLEV CLIN J MED, V70, P634, DOI 10.3949/ccjm.70.7.634
   Wenger NK, 2007, ANN INTERN MED, V147, P1, DOI 10.7326/0003-4819-147-1-200707030-00002
NR 19
TC 5
Z9 7
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2012
VL 42
IS 9
BP 595
EP 599
DI 10.4070/kcj.2012.42.9.595
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IO
UT WOS:000209080300003
PM 23091503
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JH
   Kim, J
   Park, YH
   Chun, KJ
   Kim, JS
   Jang, YH
   Lee, MY
   Xu, ZL
AF Kim, June Hong
   Kim, Jun
   Park, Yong Hyun
   Chun, Kook Jin
   Kim, Jeong Su
   Jang, Young Ho
   Lee, Mi Young
   Xu, Zhelong
TI Cardiodynamics and Infarct Size in Regional and Global Ischemic Isolated
   Heart Model: Comparison of 1 Hour and 2 Hours Reperfusion
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart; Myocardial ischemia; Myocardial infarction; Myocardial
   reperfusion
AB Background and Objectives: We investigated whether 1 hour reperfusion is enough to assess cardiodynamics and infarct size in both regional ischemia (RI) and global ischemia (GI) in isolated rat heart models.
   Materials and Methods: Hearts were randomly assigned to one of the following groups (each n=14): 1) Sham hearts for 1 hour; 2) Sham hearts for 2 hours; 3) 30 minutes RI followed by 1 hour reperfusion; 4) 30 minutes of RI followed by 2 hours reperfusion; 5) 30 minutes GI followed by 1 hour reperfusion; and 6) 30 minutes GI followed by 2 hours reperfusion.
   Results: There were no significant differences in infarct size between 1 hour and 2 hours reperfusion in both RI and GI. Left ventricular developed pressure was significantly decreased at both 1 hour and 2 hours reperfusion in groups of RI and GI compared to baseline (p<0.01). Rate-pressure product and + dP/dt(max) also significantly decreased compared to baseline level at both 1 hour and 2 hours reperfusion in groups of RI and GI (p<0.05).
   Conclusion: There was no significant difference in infarct size between 1 hour and 2 hours reperfusion in groups of RI and GI. Cardiodynamic variables measured at 1 hour and 2 hours reperfusion significantly decreased compared to baseline level. Our data suggests that reperfusion of 1 hour is sufficient to assess cardiodynamics in both regional and global ischemic isolated hearts model.
C1 [Kim, June Hong; Kim, Jun; Park, Yong Hyun; Chun, Kook Jin; Kim, Jeong Su; Jang, Young Ho] Pusan Natl Univ, Yangsan Hosp, Inst Cardiovasc Res Ctr, Yangsan 626770, South Korea.
   [Lee, Mi Young] Keimyung Univ, Inst Med Sci, Taegu, South Korea.
   [Xu, Zhelong] Univ N Carolina, Dept Anesthesiol, Chapel Hill, NC USA.
RP Jang, YH (corresponding author), Pusan Natl Univ, Yangsan Hosp, Inst Cardiovasc Res, 20 Geumo Ro, Yangsan 626770, South Korea.
EM weonjo@pnuyh.co.kr
OI Kim, Jun/0000-0002-3573-638X
CR Batchu SN, 2009, J MOL CELL CARDIOL, V46, P67, DOI 10.1016/j.yjmcc.2008.09.711
   Bouwman RA, 2010, EUR J PHARMACOL, V647, P132, DOI 10.1016/j.ejphar.2010.08.014
   Chen HT, 2008, ACTA PHARMACOL SIN, V29, P931, DOI 10.1111/j.1745-7254.2008.00824.x
   Dickson EW, 2008, AM J PHYSIOL-HEART C, V294, pH402, DOI 10.1152/ajpheart.00280.2007
   Ferrera R, 2009, CARDIOVASC DRUG THER, V23, P327, DOI 10.1007/s10557-009-6176-5
   Garcia SC, 2007, BASIC RES CARDIOL, V102, P359, DOI 10.1007/s00395-007-0657-0
   Gelpi RJ, 2002, BASIC RES CARDIOL, V97, P40, DOI 10.1007/s395-002-8386-0
   Gross GJ, 2010, AM J PHYSIOL-HEART C, V298, pH2201, DOI 10.1152/ajpheart.00815.2009
   Jang YG, 2008, ANESTHESIOLOGY, V108, P243, DOI 10.1097/01.anes.0000299437.93898.4a
   Kolettis TM, 2010, J PHARM PHARMACOL, V62, P346, DOI 10.1211/jpp.62.03.0009
   Lamberts RR, 2009, CIRCULATION, V120, pS10, DOI 10.1161/CIRCULATIONAHA.108.828426
   Lee DS, 2010, J SURG RES, V164, P175, DOI 10.1016/j.jss.2010.08.050
   Lochner A, 2003, BASIC RES CARDIOL, V98, P337, DOI 10.1007/s00395-003-0427-6
   Maslov LN, 2006, B EXP BIOL MED+, V142, P557, DOI 10.1007/s10517-006-0417-4
   Ofir M, 2008, BIOCHEM PHARMACOL, V75, P1482, DOI 10.1016/j.bcp.2007.12.011
   Rohlicek CV, 2005, CARDIOVASC RES, V65, P861, DOI 10.1016/j.cardiores.2004.12.003
   SAKO EY, 1988, J SURG RES, V44, P430, DOI 10.1016/0022-4804(88)90186-2
   Song DK, 2010, J KOREAN MED SCI, V25, P380, DOI 10.3346/jkms.2010.25.3.380
   STARK G, 1987, BASIC RES CARDIOL, V82, P437, DOI 10.1007/BF01907091
   Taliyan Rajeev, 2010, J Cardiovasc Dis Res, V1, P145, DOI 10.4103/0975-3583.70917
   TANGUAY M, 1991, J CARDIOVASC PHARM, V18, P863, DOI 10.1097/00005344-199112000-00012
   Xi JK, 2009, J MOL CELL CARDIOL, V47, P684, DOI 10.1016/j.yjmcc.2009.08.009
NR 22
TC 6
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2012
VL 42
IS 9
BP 600
EP 605
DI 10.4070/kcj.2012.42.9.600
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IO
UT WOS:000209080300004
PM 23091504
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JK
   Shin, JH
   Kim, SH
   Lim, YH
   Kim, KS
   Kim, SG
   Kim, JH
   Lim, HG
   Shin, J
AF Park, Jin Kyu
   Shin, Jeong Hun
   Kim, Seok Hwan
   Lim, Young-Hyo
   Kim, Kyung-Soo
   Kim, Soon Gil
   Kim, Jeong Hyun
   Lim, Heon Gil
   Shin, Jinho
TI A Comparison of Cornell and Sokolow-Lyon Electrocardiographic Criteria
   for Left Ventricular Hypertrophy in Korean Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Electrocardiography; Echocardiography; Hypertrophy, left ventricular;
   Sensitivity and specificity
AB Background and Objectives: Electrocardiography (ECG) is a cost-effective and useful method for diagnosing left ventricular hypertrophy (LVH) in a large-scale study or in clinical practice. Among ECG criteria, the Cornell product (Cor P) and Sokolow-Lyon criteria were adopted by the European Society of Hypertension-European Society of Cardiology Guidelines but have different performances among races. The aim of this study was to compare the diagnostic performance of two voltage criteria in Korean patients.
   Subjects and Methods: Electrocardiography and echocardiographic LV mass of 332 (159 male, 173 female) consecutive patients were analyzed. Cornell voltage criteria and the Cor P were compared with Sokolow-Lyon voltage (Sok V) and the Sokolow-Lyon product (Sok P). The sensitivities and specificities were estimated using a receiver-operating characteristics (ROC) curve in relation to the LVH diagnosis. The sensitivities and revised cut-off values were derived at specificity levels of 90, 95, and 100%.
   Results: The Cornell-based criteria generally showed better performance than that of the Sok V criteria and Sok P in the area under the ROC curve analysis. The revised cut-off values for the Cornell voltage criteria (20 and 16 mm for males and females, respectively) showed an improved sensitivity (19.7 and 30.3% for males and females, respectively), with a high specificity of 95%.
   Conclusion: The Cornell-based criteria had better performance than that of the Sokolow-Lyon criteria in both Korean men and women. However, revised cut-off values are needed to improve accuracy.
C1 [Park, Jin Kyu; Shin, Jeong Hun; Lim, Young-Hyo; Kim, Kyung-Soo; Kim, Jeong Hyun; Lim, Heon Gil; Shin, Jinho] Hanyang Univ, Med Ctr, Dept Internal Med, Div Cardiol, Seoul 133791, South Korea.
   [Kim, Seok Hwan; Kim, Soon Gil] Hanyang Univ, Guri Hosp, Div Cardiol, Dept Internal Med, Guri, South Korea.
RP Shin, J (corresponding author), Hanyang Univ, Med Ctr, Dept Internal Med, Div Cardiol, 222 Wangsimni Ro, Seoul 133791, South Korea.
EM jhs2003@hanyang.ac.kr
RI Shin, Jeong Hun/O-1273-2019
OI Shin, Jeong Hun/0000-0002-6718-9763
CR Alfakih K, 2004, HYPERTENSION, V44, P175, DOI 10.1161/01.HYP.0000135249.66192.30
   Barrios V, 2010, HEART VESSELS, V25, P51, DOI 10.1007/s00380-009-1154-1
   Bluemke DA, 2008, J AM COLL CARDIOL, V52, P2148, DOI 10.1016/j.jacc.2008.09.014
   CASALE PN, 1987, CIRCULATION, V75, P565, DOI 10.1161/01.CIR.75.3.565
   CASALE PN, 1985, J AM COLL CARDIOL, V6, P572, DOI 10.1016/S0735-1097(85)80115-7
   Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3
   de Simone G, 2005, AM J HYPERTENS, V18, P191, DOI 10.1016/j.amjhyper.2004.08.032
   DEVEREUX RB, 1984, J AM COLL CARDIOL, V3, P82, DOI 10.1016/S0735-1097(84)80433-7
   DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X
   Hancock EW, 2009, J AM COLL CARDIOL, V53, P992, DOI 10.1016/j.jacc.2008.12.015
   Hense HW, 1998, J AM COLL CARDIOL, V32, P451, DOI 10.1016/S0735-1097(98)00240-X
   Hotelling H, 1940, ANN MATH STAT, V11, P271, DOI 10.1214/aoms/1177731867
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Lee YW, 1977, KOREAN CIRC J, V7, P1
   Mancia G, 2007, J HYPERTENS, V25, P1105, DOI 10.1097/HJH.0b013e3281fc975a
   MOLLOY TJ, 1992, J AM COLL CARDIOL, V20, P1180, DOI 10.1016/0735-1097(92)90376-X
   NOBLE LM, 1984, J ELECTROCARDIOL, V17, P157, DOI 10.1016/S0022-0736(84)81090-0
   Okin PM, 2003, CIRCULATION, V108, P684, DOI 10.1161/01.CIR.0000083724.28630.C3
   Okin PM, 2002, AM J HYPERTENS, V15, P663, DOI 10.1016/S0895-7061(02)02945-X
   Okin PM, 2000, HYPERTENSION, V36, P766, DOI 10.1161/01.HYP.36.5.766
   Pewsner D, 2004, BMJ-BRIT MED J, V329, P209, DOI 10.1136/bmj.329.7459.209
   Pewsner D, 2007, BMJ-BRIT MED J, V335, P711, DOI 10.1136/bmj.39276.636354.AE
   Rodrigues SL, 2008, ARQ BRAS CARDIOL, V90, P46, DOI 10.1590/S0066-782X2008000100008
   SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072
   SCHILLACI G, 1994, AM J CARDIOL, V74, P714, DOI 10.1016/0002-9149(94)90316-6
   SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1
   Sundstrom J, 2001, CIRCULATION, V103, P2346
   Truong QA, 2010, J HYPERTENS, V28, P1959, DOI 10.1097/HJH.0b013e32833b49cb
   Verdecchia P, 2000, Ital Heart J, V1, P207
   Xie LD, 2010, HELL J CARDIOL, V51, P391
NR 30
TC 13
Z9 15
U1 1
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2012
VL 42
IS 9
BP 606
EP 613
DI 10.4070/kcj.2012.42.9.606
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IO
UT WOS:000209080300005
PM 23091505
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JY
   Lee, JW
   Youn, YJ
   Ahn, MS
   Ahn, SG
   Yoo, BS
   Lee, SH
   Yoon, J
   Choe, KH
AF Kim, Jang-Young
   Lee, Jun-Won
   Youn, Young-Jin
   Ahn, Min-Soo
   Ahn, Sung-Gyun
   Yoo, Byung-Su
   Lee, Seung-Hwan
   Yoon, Junghan
   Choe, Kyung-Hoon
TI Urinary Levels of 8-Iso-Prostaglandin F2 alpha and 8-Hydroxydeoxyguanine
   as Markers of Oxidative Stress in Patients With Coronary Artery Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Oxidative stress; Coronary artery disease
AB Background and Objectives: The objective of this study was to determine if urinary levels of 8-iso-prostaglandin F2 alpha (8-iso-PGF2 alpha) and 8-hydroxydeoxyguanine (8-OHdG) could be used as markers of the oxidative stress in significant coronary artery disease (CAD).
   Subjects and Methods: We conducted a case-control study in 104 subjects assessed by coronary angiography with the following diagnoses: 35 consecutive cases of significant CAD and 69 cases of non-CAD with stable angina. We compared the urinary levels of 8-iso-PGF 2 alpha and 8-OHdG, as measured by immunoassay between the 2 groups.
   Results: History of hypertension was significantly higher and high density lipoprotein-cholesterol level significantly lower in the CAD group compared with those in the non-CAD group. Median levels of 8-iso-PGF2 alpha were significantly higher in the CAD group compared with the non-CAD group (9.2 vs. 6.0 ng/mg, p=0.001). There were no significant differences in 8-OHdG values between the 2 groups. The odds ratio of 8-iso-PGF2 alpha for CAD in the highest tertile compared with that in the lowest tertile was 7.39 (95% confidence interval; 1.71-31.91). There was no significant difference in median values of 8-iso-PGF2 alpha between single-and multi-vessel CAD.
   Conclusion: Urinary 8-iso-PGF 2 alpha was independently associated with significant CAD in this case-control study.
C1 [Kim, Jang-Young; Lee, Jun-Won; Youn, Young-Jin; Ahn, Min-Soo; Ahn, Sung-Gyun; Yoo, Byung-Su; Lee, Seung-Hwan; Yoon, Junghan; Choe, Kyung-Hoon] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, Wonju 220701, South Korea.
RP Kim, JY (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, 20 Ilsan Ro, Wonju 220701, South Korea.
EM kimjy@yonsei.ac.kr
RI Ahn, Sung Gyun/AAG-5976-2020
OI Ahn, Sung Gyun/0000-0002-1528-2739; Lee, Jun-Won/0000-0001-6206-1704
FU Korean Society of Cardiology
FX This work was supported by grants from the Korean Society of Cardiology
   (2004).
CR Basu S, 2000, CLIN SCI, V99, P511, DOI 10.1042/CS20000116
   Basu S, 2010, PROSTAG LEUKOTR ESS, V82, P219, DOI 10.1016/j.plefa.2010.02.031
   Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976
   Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459
   Galle J, 2006, ATHEROSCLEROSIS, V185, P219, DOI 10.1016/j.atherosclerosis.2005.10.005
   Halliwell B, 2010, ANTIOXID REDOX SIGN, V13, P145, DOI 10.1089/ars.2009.2934
   Jo M, 2011, J GASTROENTEROL, V46, P809, DOI 10.1007/s00535-011-0392-z
   Kono Y, 2006, CIRC J, V70, P1001, DOI 10.1253/circj.70.1001
   Loffredo L, 2006, J VASC SURG, V44, P525, DOI 10.1016/j.jvs.2006.05.023
   Mercer J, 2007, MUTAT RES-FUND MOL M, V621, P75, DOI 10.1016/j.mrfmmm.2007.02.011
   Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev
   Nishikawa T, 2003, DIABETES CARE, V26, P1507, DOI 10.2337/diacare.26.5.1507
   Schulze P Christian, 2005, Curr Atheroscler Rep, V7, P242, DOI 10.1007/s11883-005-0013-5
   Schwedhelm E, 2004, CIRCULATION, V109, P843, DOI 10.1161/01.CIR.0000116761.93647.30
   Singh Uma, 2006, Pathophysiology, V13, P129, DOI 10.1016/j.pathophys.2006.05.002
   Vassalle C, 2004, J INTERN MED, V256, P308, DOI 10.1111/j.1365-2796.2004.01373.x
   Victor VM, 2009, CURR PHARM DESIGN, V15, P2988, DOI 10.2174/138161209789058093
   Wang B, 2006, ATHEROSCLEROSIS, V184, P425, DOI 10.1016/j.atherosclerosis.2005.05.008
   Wu LL, 2004, CLIN CHIM ACTA, V339, P1, DOI 10.1016/j.cccn.2003.09.010
NR 19
TC 15
Z9 16
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2012
VL 42
IS 9
BP 614
EP 617
DI 10.4070/kcj.2012.42.9.614
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IO
UT WOS:000209080300006
PM 23091506
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, EY
   Choi, YH
   Hyeon, CW
   Cho, JH
   Kim, KJ
   Lee, WS
   Lee, KJ
   Kim, SW
   Kim, TH
   Kim, CJ
AF Kim, Eun Young
   Choi, Young Hwan
   Hyeon, Cheol Won
   Cho, Jun Hwan
   Kim, Kyung Joon
   Lee, Wang-Soo
   Lee, Kwang Je
   Kim, Sang-Wook
   Kim, Tae Ho
   Kim, Chee Jeong
TI Relation Between RR Intervals and Early Diastolic Mitral Annular
   Velocities in Atrial Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ventricular function, left; Atrial fibrillation; Electrocardiography;
   Pulsed Doppler echocardiography; Heart rate
AB Background and Objectives: Irregular RR intervals in atrial fibrillation (AF) make beat-to-beat changes in left ventricular (LV) systolic performance. Early diastolic mitral annular velocity (E') is one of the well-established parameters for evaluating LV diastolic function. The relation between RR intervals and E's is unknown. The aim of this study was to observe the influence of continuous changes in RR interval on the parameter for diastolic function in AF.
   Subjects and Methods: Echocardiography was performed in 117 patients with AF. E' was adjusted for the effect of pre-preceding RR interval (RR-2) using the logarithmic equation between RR-2 and E'. The logarithmic equation between adjusted E' and preceding RR interval (RR-1) was calculated.
   Results: The slope in the relation between RR-1 and E' varied from -2.5 to 2.6. The slope was lower (more likely negative) in patients with higher ratio of early diastolic mitral flow velocity (E) to E' (r=-0.21, p=0.023), ischemic heart disease (IHD, r=0.21, p=0.026), and higher systolic blood pressure (r=-0.19, p=0.046). When patients were divided into these 3 groups on the basis of slope, the lowest slope group (<-0.55, n=39) was associated with higher E'/E (p=0.004) and IHD (p=0.018) compared with the highest slope group (>0.57, n=39). The slope with regards to the relationship between RR-2 and E' also varied from -3.4 to 3.1.
   Conclusion: Changes in RR intervals had variable effects on E's according to clinical variables in AF.
C1 [Kim, Eun Young; Choi, Young Hwan; Hyeon, Cheol Won; Cho, Jun Hwan; Kim, Kyung Joon; Lee, Wang-Soo; Lee, Kwang Je; Kim, Sang-Wook; Kim, Tae Ho; Kim, Chee Jeong] Chung Ang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 156755, South Korea.
RP Kim, CJ (corresponding author), Chung Ang Univ, Coll Med, Dept Internal Med, Div Cardiol, 102 Heukseok Ro, Seoul 156755, South Korea.
EM cjkim@cau.ac.kr
FU Chung-Ang University
FX This Research was supported by the Chung-Ang University Research Grant
   in 2010.
CR Al-Omari MA, 2008, AM J CARDIOL, V101, P1759, DOI 10.1016/j.amjcard.2008.02.067
   Daoud EG, 1996, AM J CARDIOL, V78, P1433, DOI 10.1016/S0002-9149(97)89297-1
   De Boeck BWL, 2003, AM HEART J, V146, P411, DOI 10.1016/S0002-8703(03)00322-3
   Effat M, 2000, AM J CARDIOL, V85, P114, DOI 10.1016/S0002-9149(99)00620-7
   Firstenberg MS, 2000, J AM COLL CARDIOL, V36, P1664, DOI 10.1016/S0735-1097(00)00909-8
   Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176
   Graham RJ, 2003, CLIN SCI, V105, P499, DOI 10.1042/CS20030059
   Hasegawa H, 2003, J AM COLL CARDIOL, V41, P1590, DOI 10.1016/S0735-1097(03)00260-2
   최여원, 2008, Korean Circulation Journal, V38, P551
   이광호, 2007, Korean Circulation Journal, V37, P119
   Ko HS, 2002, J KOREAN MED SCI, V17, P743, DOI 10.3346/jkms.2002.17.6.743
   Nagueh SF, 1998, CIRCULATION, V98, P1644, DOI 10.1161/01.CIR.98.16.1644
   Nagueh SF, 2001, J AM COLL CARDIOL, V37, P278, DOI 10.1016/S0735-1097(00)01056-1
   Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6
   Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023
   Oh JK, 2006, J AM COLL CARDIOL, V47, P500, DOI 10.1016/j.jacc.2005.09.032
   SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072
   Sohn DW, 1999, J AM SOC ECHOCARDIOG, V12, P927, DOI 10.1016/S0894-7317(99)70145-8
   Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0
   Van Gelder IC, 2010, NEW ENGL J MED, V362, P1363, DOI 10.1056/NEJMoa1001337
   VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9
   Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289
NR 22
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2012
VL 42
IS 9
BP 618
EP 624
DI 10.4070/kcj.2012.42.9.618
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IO
UT WOS:000209080300007
PM 23091507
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, YH
   Hwang, SH
   Lim, CH
   An, HM
   Kim, HJ
   Moon, SG
   Kang, WY
   Hwang, SH
   Kim, W
   Kim, W
AF Kim, Yeon-Hwa
   Hwang, Seung Hwan
   Lim, Chur Hoan
   An, Hye Mi
   Kim, Hee Jong
   Moon, Se Gwon
   Kang, Won Yu
   Hwang, Sun Ho
   Kim, Weon
   Kim, Wan
TI Reverse Controlled Antegrade and Retrograde Subintimal Tracking in
   Chronic Total Occlusion of Right Coronary Artery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angioplasty; Coronary occlusion; Chronic disease
AB Passage failure of guidewire is still remained most common reason for percutaneous coronary intervention (PCI) failure in chronic total occlusion (CTO). Intravascular ultrasound study (IVUS) and cardiac CT angiography can help identify features that most influence current success rates of PCI. We report our experience using the reverse controlled antegrade and retrograde subintimal tracking technique under the aid of IVUS, cardiac CT angiography for an ambiguous CTO of proximal right coronary artery.
C1 [Kim, Yeon-Hwa; Hwang, Seung Hwan; Lim, Chur Hoan; An, Hye Mi; Kim, Hee Jong; Moon, Se Gwon; Kang, Won Yu; Hwang, Sun Ho; Kim, Wan] Gwangju Vet Hosp, Dept Internal Med, Div Cardiol, Kwangju 506705, South Korea.
   [Kim, Weon] Kyung Hee Univ, Coll Med, Div Cardiol, Dept Internal Med, Seoul, South Korea.
RP Hwang, SH (corresponding author), Gwangju Vet Hosp, Dept Internal Med, Div Cardiol, 99 Cheomdanwolbong Ro, Kwangju 506705, South Korea.
EM h96241085@hanmail.net
CR Hoe J, 2009, INT J CARDIOVAS IMAG, V25, P43, DOI 10.1007/s10554-009-9424-7
   Hoye A, 2005, EUR HEART J, V26, P2630, DOI 10.1093/eurheartj/ehi498
   ISHIZAKA N, 1994, AM HEART J, V127, P8, DOI 10.1016/0002-8703(94)90503-7
   KINOSHITA I, 1995, J AM COLL CARDIOL, V26, P409, DOI 10.1016/0735-1097(95)80015-9
   Olivari Z, 2003, J AM COLL CARDIOL, V41, P1672, DOI 10.1016/S0735-1097(03)00312-7
   Park Y, 2011, INT J CARDIOL, V148, P174, DOI 10.1016/j.ijcard.2009.10.052
   Prasad A, 2007, J AM COLL CARDIOL, V49, P1611, DOI 10.1016/j.jacc.2006.12.040
   Rathore S, 2010, JACC-CARDIOVASC INTE, V3, P155, DOI 10.1016/j.jcin.2009.10.030
   Saito S, 2008, CATHETER CARDIO INTE, V71, P8, DOI 10.1002/ccd.21316
   Suero JA, 2001, J AM COLL CARDIOL, V38, P409, DOI 10.1016/S0735-1097(01)01349-3
NR 10
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2012
VL 42
IS 9
BP 625
EP 628
DI 10.4070/kcj.2012.42.9.625
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IO
UT WOS:000209080300008
PM 23091508
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, H
   Park, TH
   Lee, DY
   Ahn, J
   Baek, HK
   Kim, MH
   Kim, YD
   Park, KJ
   Wu, JS
AF Park, Hyekyong
   Park, Tae-Ho
   Lee, Dong-Yeol
   Ahn, Jihye
   Baek, Hee Kyung
   Kim, Moo-Hyun
   Kim, Young-Dae
   Park, Kwon-Jae
   Wu, Jong-Soo
TI A Case of Aortic Dissection With Fistula From Aorta to Right Ventricle
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Dissection; Heart ventricles; Fistula
AB Aorto-right ventricular fistula is a very rare complication of aortic dissection. We report a case of acute aortic dissection extending into the right ventricle as documented by echocardiography. The patient survived after successful surgical repair.
C1 [Park, Hyekyong; Park, Tae-Ho; Lee, Dong-Yeol; Ahn, Jihye; Baek, Hee Kyung; Kim, Moo-Hyun; Kim, Young-Dae] Dong A Univ, Coll Med, Dept Internal Med, Div Cardiol, Pusan 602715, South Korea.
   [Park, Kwon-Jae; Wu, Jong-Soo] Dong A Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Pusan 602715, South Korea.
RP Park, TH (corresponding author), Dong A Univ, Coll Med, Dept Internal Med, Div Cardiol, 26 Daesingongwon Ro, Pusan 602715, South Korea.
EM thpark65@dau.ac.kr
CR ALAM M, 1993, CHEST, V103, P1907, DOI 10.1378/chest.103.6.1907
   BERMAN AD, 1987, J AM COLL CARDIOL, V9, P228, DOI 10.1016/S0735-1097(87)80106-7
   Boyd LJ, 1924, AM J MED SCI, V168, P654, DOI 10.1097/00000441-192411000-00006
   Caruso A, 2000, J AM SOC ECHOCARDIOG, V13, P69, DOI 10.1016/S0894-7317(00)90047-6
   Davies N J, 1990, J Am Soc Echocardiogr, V3, P140
   Estrera AL, 2010, ANN THORAC SURG, V89, P1467, DOI 10.1016/j.athoracsur.2010.02.015
   Gillinov AM, 1999, J THORAC CARDIOV SUR, V117, P252, DOI 10.1016/S0022-5223(99)70420-4
   Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897
   Jo YJ, 2011, KOREAN CIRC J, V41, P156, DOI 10.4070/kcj.2011.41.3.156
   LINDSAY J, 1993, AM HEART J, V126, P441, DOI 10.1016/0002-8703(93)91064-L
   Marek D, 2009, CARDIOVASC PATHOL, V18, P301, DOI 10.1016/j.carpath.2008.08.002
   MCGOLDRICK JP, 1990, EUR J CARDIO-THORAC, V4, P514, DOI 10.1016/1010-7940(90)90177-2
   PERRYMAN RA, 1972, AM J CARDIOL, V30, P277, DOI 10.1016/0002-9149(72)90072-0
   SPIER LN, 1995, ANN THORAC SURG, V59, P1017, DOI 10.1016/0003-4975(94)00740-X
NR 14
TC 6
Z9 6
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2012
VL 42
IS 9
BP 629
EP 631
DI 10.4070/kcj.2012.42.9.629
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IO
UT WOS:000209080300009
PM 23091509
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, J
   Han, D
   Sohn, C
   Kim, JS
   Park, YH
AF Kim, Jun
   Han, Dongcheul
   Sohn, Changbae
   Kim, Jeong Su
   Park, Yong Hyun
TI Catheter Ablation of Ventricular Arrhythmias via the Radial Artery in a
   Patient With Prior Myocardial Infarction and Peripheral Vascular Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Catheter ablation; Ventricular tachycardia; Ventricular premature
   complexes; Radial artery
AB Herein, we present a case of a successful catheter ablation of ventricular tachycardia (VT) using a radial artery approach in a post-myocardial infarction patient, who had an implantable cardioverter-defibrillator and peripheral artery disease. Although the patient did not use antiarrhythmic drugs, the patient experienced no recurrence of VT during the following 3-year period.
C1 [Kim, Jun; Han, Dongcheul; Sohn, Changbae; Kim, Jeong Su; Park, Yong Hyun] Pusan Natl Univ, Yangsan Hosp, Div Cardiol, Yangsan 626770, South Korea.
RP Kim, J (corresponding author), Pusan Natl Univ, Yangsan Hosp, Div Cardiol, 20 Geumo Ro, Yangsan 626770, South Korea.
EM mdjunkim@yahoo.co.kr
OI Kim, Jun/0000-0002-3573-638X
FU Pusan National University Yangsan HospitalPusan National University
FX This work was supported by a 2012 research grant from Pusan National
   University Yangsan Hospital.
CR Bansch D, 2003, CIRCULATION, V108, P3011, DOI 10.1161/01.CIR.0000103701.30662.5C
   Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180
   Bogun F, 2008, HEART RHYTHM, V5, P367, DOI 10.1016/j.hrthm.2007.11.026
   Bogun F, 2006, J AM COLL CARDIOL, V48, P2500, DOI 10.1016/j.jacc.2006.07.062
   Choussat R, 2000, EUR HEART J, V21, P662, DOI 10.1053/euhj.1999.1945
   Connolly SJ, 2006, JAMA-J AM MED ASSOC, V295, P165, DOI 10.1001/jama.295.2.165
   Credner SC, 1998, J AM COLL CARDIOL, V32, P1909, DOI 10.1016/S0735-1097(98)00495-1
   Exner DV, 2001, CIRCULATION, V103, P2066
   FRIEDMAN PL, 1973, CIRC RES, V33, P597, DOI 10.1161/01.RES.33.5.597
   Hohnloser SH, 2006, EUR HEART J, V27, P3027, DOI 10.1093/eurheartj/ehl276
   Kim JY, 2005, YONSEI MED J, V46, P503, DOI 10.3349/ymj.2005.46.4.503
   Lee DW, 2007, YONSEI MED J, V48, P1048, DOI 10.3349/ymj.2007.48.6.1048
   Reddy VY, 2007, NEW ENGL J MED, V357, P2657, DOI 10.1056/NEJMoa065457
   Sarrazin JF, 2010, J CARDIOVASC ELECTR, V21, P1002, DOI 10.1111/j.1540-8167.2010.01771.x
   Sarrazin JF, 2009, HEART RHYTHM, V6, P1543, DOI 10.1016/j.hrthm.2009.08.004
   Schreieck J, 2005, HEART RHYTHM, V2, P10, DOI 10.1016/j.hrthm.2004.10.037
   Stevenson WG, 1997, J AM COLL CARDIOL, V29, P1180, DOI 10.1016/S0735-1097(97)00065-X
   Szumowski L, 2004, J AM COLL CARDIOL, V44, P1700, DOI 10.1016/j.jacc.2004.08.034
   Takemoto M, 2005, J AM COLL CARDIOL, V45, P1259, DOI 10.1016/j.jacc.2004.12.073
NR 19
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2012
VL 42
IS 9
BP 632
EP 637
DI 10.4070/kcj.2012.42.9.632
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IO
UT WOS:000209080300010
PM 23091510
OA Green Published
DA 2021-04-22
ER

PT J
AU Son, SA
   Lee, YO
   Kim, GJ
   Cho, JY
   Lee, JT
AF Son, Shin-Ah
   Lee, Young-Ok
   Kim, Gun Jik
   Cho, Joon-Yong
   Lee, Jong-Tae
TI Placement of Endovascular Stent Graft in Acute Malperfusion Syndrome
   After Acute Type II Aortic Dissection
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aorta; Dissection; Complications; Stents
AB Acute malperfusion syndrome is a serious complication of acute aortic dissection. A 76-year-old female patient was admitted with acute type B aortic dissection and developed renal malperfusion during medical therapy. We are reporting a clinically successful result from the thoracic endovascular aortic repair used for malperfusion syndrome that occurred by acute type B aortic dissection.
C1 [Son, Shin-Ah; Lee, Young-Ok; Kim, Gun Jik; Cho, Joon-Yong; Lee, Jong-Tae] Kyungpook Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Taegu 700721, South Korea.
RP Kim, GJ (corresponding author), Kyungpook Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, 130 Dongdeok Ro, Taegu 700721, South Korea.
EM straightroot@knu.ac.kr
OI Kim, Gun Jik/0000-0002-8051-2131
CR Chen SL, 2006, CATHETER CARDIO INTE, V68, P319, DOI 10.1002/ccd.20821
   Lauterbach SR, 2001, J VASC SURG, V33, P1185, DOI 10.1067/mva.2001.115377
   Panneton JM, 2000, J VASC SURG, V32, P711, DOI 10.1067/mva.2000.110054
   Suzuki T, 2003, CIRCULATION, V108, P312, DOI 10.1161/01.cir.0000087386.07204.09
   Tsai TT, 2006, CIRCULATION, V114, P2226, DOI 10.1161/CIRCULATIONAHA.106.622340
   Williams DM, 1997, RADIOLOGY, V203, P37, DOI 10.1148/radiology.203.1.9122414
   Williams DM, 1997, J VASC INTERV RADIOL, V8, P605, DOI 10.1016/S1051-0443(97)70619-5
NR 7
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2012
VL 42
IS 9
BP 638
EP 640
DI 10.4070/kcj.2012.42.9.638
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IO
UT WOS:000209080300011
PM 23091511
OA Green Published
DA 2021-04-22
ER

PT J
AU Yurtdas, M
   Aydin, MK
AF Yurtdas, Mustafa
   Aydin, Mehmet Kasim
TI Acute Myocardial Infarction in a Young Man; Fatal Blow of the Marijuana:
   A Case Report
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cannabis; Myocardial infarction
AB Marijuana is known to have been used for medicinal and recreational purposes for thousands of years. Although marijuana has some diverse effects on cardiovascular system, there is insufficient knowledge concerning acute myocardial infarction ( AMI) associated with marijuana and its underlying mechanism. We report the case of a 26 year-old young man suffering from ST-elevated AMI caused by marijuana abuse, which was successfully treating with percutaneous coronary intervention. It should be kept in mind that marijuana could be one of the most probable causes of AMI observed in apparently healthy young persons who use this drug.
C1 [Yurtdas, Mustafa] Hosp Med, Dept Cardiol, Van, Turkey.
   [Aydin, Mehmet Kasim] Mersin Univ, Dept Internal Med, Mersin, Turkey.
RP Yurtdas, M (corresponding author), Med Van Hastanesi, Hosp Med, Dept Cardiol, TR-65200 Van, Turkey.
EM mustafayurtdas@yahoo.com
RI Yurtdas, Mustafa/X-7179-2019
OI Yurtdas, Mustafa/0000-0002-0516-9206
CR Aktas EO, 2006, TURKIYE KLINIKLERI J, V3, P13
   ARONOW WS, 1974, NEW ENGL J MED, V291, P65, DOI 10.1056/NEJM197407112910203
   Bailly C, 2010, INT J CARDIOL, V143, pE4, DOI 10.1016/j.ijcard.2008.11.200
   Basnet S, 2009, PEDIATR CARDIOL, V30, P543, DOI 10.1007/s00246-009-9384-7
   Caldicott DGE, 2005, EUR J EMERG MED, V12, P236, DOI 10.1097/00063110-200510000-00008
   Camaro C, 2009, NETH HEART J, V17, P297, DOI 10.1007/BF03086271
   Canga Y, 2011, ANADOLU KARDIYOL DER, V11, P272, DOI 10.5152/akd.2011.066
   Cappelli F, 2008, J CARDIOVASC MED, V9, P725, DOI 10.2459/JCM.0b013e3282f2cd0d
   Dwivedi S, 2008, INT J CARDIOL, V128, pE54, DOI 10.1016/j.ijcard.2007.04.167
   Karabulut A, 2010, KARDIOL POL, V68, P1266
   Kocabay G, 2009, J CARDIOVASC MED, V10, P669, DOI 10.2459/JCM.0b013e32832bcfbe
   Kosior DA, 2001, INT J CARDIOL, V78, P183, DOI 10.1016/S0167-5273(00)00459-9
   Mach F, 2008, BRIT J PHARMACOL, V153, P290, DOI 10.1038/sj.bjp.0707517
   MACINNES DC, 1984, J ROY COLL GEN PRACT, V34, P575
   Mittleman MA, 2001, CIRCULATION, V103, P2805
   Mukamal KJ, 2008, AM HEART J, V155, P465, DOI 10.1016/j.ahj.2007.10.049
   Rezkalla SH, 2003, ANN EMERG MED, V42, P365, DOI 10.1016/S0196-0644(03)00426-8
   Schmid J, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-22
   Tatli E, 2007, INT J CARDIOL, V120, P420, DOI 10.1016/j.ijcard.2006.08.012
NR 19
TC 20
Z9 21
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2012
VL 42
IS 9
BP 641
EP 645
DI 10.4070/kcj.2012.42.9.641
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IO
UT WOS:000209080300012
PM 23091512
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, HW
   Yoon, HJ
   Choi, SW
   Bae, HJ
   Sohn, JH
   Lee, HM
   Cho, HO
   Cho, YK
   Park, HS
   Kim, H
   Nam, CW
   Hur, SH
   Kim, YN
   Kim, KB
AF Shin, Hong Won
   Yoon, Hyuck Jun
   Choi, Sang Woong
   Bae, Han Jun
   Sohn, Ji Hyun
   Lee, Ho Myung
   Cho, Hyun Ok
   Cho, Yun Kyeong
   Park, Hyoung Seob
   Kim, Hyungseop
   Nam, Chang Wook
   Hur, Seung Ho
   Kim, Yoon Nyun
   Kim, Kwon Bae
TI Acute Stent Thrombosis and Heparin Induced Thrombocytopenia in a Patient
   With ST-Segment Elevation Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heparin; Thrombocytopenia; Thrombosis; Myocardial infarction
AB Heparin is an essential drug in the treatment of acute coronary syndrome and it is used during percutaneous coronary intervention (PCI). Heparin-induced thrombocytopenia (HIT), albeit a serious complication of heparin therapy characterized by thrombocytopenia and high risk for venous and arterial thrombosis, has rarely been previously reported during PCI. We report a case of an acute stent thrombosis due to an unusual cause, HIT during primary PCI, in a patient with acute myocardial infarction.
C1 [Shin, Hong Won; Yoon, Hyuck Jun; Choi, Sang Woong; Bae, Han Jun; Sohn, Ji Hyun; Lee, Ho Myung; Cho, Hyun Ok; Cho, Yun Kyeong; Park, Hyoung Seob; Kim, Hyungseop; Nam, Chang Wook; Hur, Seung Ho; Kim, Yoon Nyun; Kim, Kwon Bae] Keimyung Univ, Coll Med, Dongsan Med Ctr, Div Cardiol,Dept Internal Med, Taegu 700712, South Korea.
RP Yoon, HJ (corresponding author), Keimyung Univ, Coll Med, Dongsan Med Ctr, Div Cardiol,Dept Internal Med, 56 Dalseong Ro, Taegu 700712, South Korea.
EM hippsons@dsmc.or.kr
CR Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002
   Babuin L, 2010, VASC HEALTH RISK MAN, V6, P813, DOI 10.2147/VHRM.S3904
   Brieger DB, 1998, J AM COLL CARDIOL, V31, P1449, DOI 10.1016/S0735-1097(98)00134-X
   Dasari Tarun W, 2011, J Invasive Cardiol, V23, pE5
   Fujii K, 2005, J AM COLL CARDIOL, V45, P995, DOI 10.1016/j.jacc.2004.12.066
   GUPTA BK, 1995, CATHETER CARDIO DIAG, V35, P42, DOI 10.1002/ccd.1810350108
   Hussain F, 2009, INT J CARDIOL, V133, pE11, DOI 10.1016/j.ijcard.2007.08.078
   Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126
   King SB, 2010, POL ARCH MED WEWN, V120, P6, DOI 10.20452/pamw.865
   Lewis BE, 2002, CATHETER CARDIO INTE, V57, P177, DOI 10.1002/ccd.10276
   Matsue H, 2010, INTERACT CARDIOV TH, V11, P188, DOI 10.1510/icvts.2010.232983
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   Rossig L, 2011, INT J CARDIOL, V148, P214, DOI 10.1016/j.ijcard.2010.02.044
   Smith SC, 2006, CATHETER CARDIO INTE, V67, P87, DOI 10.1002/ccd.20606
   van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055
   Warkentin TE, 2003, BRIT J HAEMATOL, V121, P535, DOI 10.1046/j.1365-2141.2003.04334.x
   Wenaweser P, 2005, EUR HEART J, V26, P1180, DOI 10.1093/eurheartj/ehi135
NR 17
TC 6
Z9 6
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2012
VL 42
IS 9
BP 646
EP 649
DI 10.4070/kcj.2012.42.9.646
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IO
UT WOS:000209080300013
PM 23091513
OA Green Published
DA 2021-04-22
ER

PT J
AU Jin, HF
   Yang, JY
   Zhang, QY
   Du, JB
AF Jin, Hongfang
   Yang, Jinyan
   Zhang, Qingyou
   Du, Junbao
TI Epidemiology and Clinical Management of Pulmonary Hypertension in
   Children
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Hypertension, pulmonary; Incidence; Disease management; Child
AB Pulmonary hypertension (PH) is a clinical hemodynamic syndrome characterized by increased pulmonary artery pressure and pulmonary vascular resistance. It can cause right ventricular failure, and even death. Pediatric PH is not very common, but is a greatly hazardous disease that leads to a high mortality rate. Therefore, many registry organizations have been established in the world to strengthen the study of diagnosis and treatment of the disease, and improve the understanding of pediatric PH. This article reviewed recently published researches, as well as presented a comprehensive understanding of PH, including definition, classification, epidemiology, prognosis and treatment.
C1 [Jin, Hongfang; Yang, Jinyan; Zhang, Qingyou; Du, Junbao] Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China.
RP Du, JB (corresponding author), Peking Univ, Hosp 1, Dept Pediat, Beijing 100034, Peoples R China.
EM junbaodu1@126.com
FU Capital Medical Science Development Project [2009-1008]; National
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China (NSFC) [811 21061]
FX The work was supported by Capital Medical Science Development Project
   (2009-1008), and the National Natural Science Foundation of China (811
   21061).
CR Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011
   Barst RJ, 2011, EUR RESPIR J, V37, P665, DOI 10.1183/09031936.00056110
   Barst RJ, 2012, CIRCULATION, V125, P324, DOI 10.1161/CIRCULATIONAHA.110.016667
   Barst RJ, 2012, CIRCULATION, V125, P113, DOI 10.1161/CIRCULATIONAHA.111.026591
   Beghetti M, 2008, PEDIATR RES, V64, P200, DOI 10.1203/PDR.0b013e318179954c
   Berger RMF, 2012, LANCET, V379, P537, DOI 10.1016/S0140-6736(11)61621-8
   Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X
   Fasnacht MS, 2007, SWISS MED WKLY, V137, P510
   Fox BD, 2011, AM J CARDIOL, V108, P1177, DOI 10.1016/j.amjcard.2011.06.021
   Fraisse A, 2010, ARCH CARDIOVASC DIS, V103, P66, DOI 10.1016/j.acvd.2009.12.001
   Fu Li-jun, 2011, Zhonghua Er Ke Za Zhi, V49, P886
   Haworth SG, 2009, HEART, V95, P312, DOI 10.1136/hrt.2008.150086
   Hislop AA, 2011, EUR RESPIR J, V38, P70, DOI 10.1183/09031936.00053510
   Ivy DD, 2008, J AM COLL CARDIOL, V51, P161, DOI 10.1016/j.jacc.2007.09.031
   Ivy DD, 2010, AM J CARDIOL, V106, P1332, DOI 10.1016/j.amjcard.2010.06.064
   Ivy D, 2012, CURR OPIN CARDIOL, V27, P70, DOI 10.1097/HCO.0b013e32835018cd
   Rosenzweig EB, 2011, AM J RESP CRIT CARE, V183
   Simonneau G, 2002, AM J RESP CRIT CARE, V165, P800, DOI 10.1164/ajrccm.165.6.2106079
   Simpson CM, 2006, J HEART LUNG TRANSPL, V25, P469, DOI 10.1016/j.healun.2005.11.438
   Tissot C, 2010, J PEDIATR-US, V157, P528, DOI 10.1016/j.jpeds.2010.06.010
   van Loon RLE, 2007, AM HEART J, V154, P776, DOI 10.1016/j.ahj.2007.06.003
   van Loon RLE, 2011, CIRCULATION, V124, P1755, DOI 10.1161/CIRCULATIONAHA.110.969584
   Xu Zhuo-ming, 2009, Zhonghua Yi Xue Za Zhi, V89, P2106
   Yung D, 2004, CIRCULATION, V110, P660, DOI 10.1161/01.CIR.0000138104.83366.E9
   [张清友 Zhang Qingyou], 2010, [临床儿科杂志, Journal of Chinical Pediatrics], V28, P607
   Zhou Ai-qing, 2011, Zhonghua Er Ke Za Zhi, V49, P881
NR 26
TC 2
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2012
VL 42
IS 8
BP 513
EP 518
DI 10.4070/kcj.2012.42.8.513
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IN
UT WOS:000209080200001
PM 22977445
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, KH
AF Han, Ki Hoon
TI Possible Regulation of Platelets by Native and Modified Low Density
   Lipoprotein-Cholesterol Particles
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul 138736, South Korea.
RP Han, KH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, 88 Olymp Ro 43 Gil, Seoul 138736, South Korea.
EM steadyhan@amc.seoul.kr
CR Akkerman JWN, 2008, INT J BIOCHEM CELL B, V40, P2374, DOI 10.1016/j.biocel.2008.04.002
   Grundtman C, 2011, CURR OPIN LIPIDOL, V22, P327, DOI 10.1097/MOL.0b013e32834aa0c2
   Hackeng CM, 1999, ARTERIOSCL THROM VAS, V19, P239, DOI 10.1161/01.ATV.19.2.239
   Kang DY, 2012, KOREAN CIRC J, V42, P551, DOI 10.4070/kcj.2012.42.8.551
   Maschberger P, 2000, J BIOL CHEM, V275, P19159, DOI 10.1074/jbc.M910257199
   Pontrelli L, 2002, METABOLISM, V51, P334, DOI 10.1053/meta.2002.30510
   Siegel-Axel D, 2008, CARDIOVASC RES, V78, P8, DOI 10.1093/cvr/cvn015
   Siess W, 2006, PATHOPHYSIOL HAEMO T, V35, P292, DOI 10.1159/000093222
   Zimman A, 2010, ARTERIOSCL THROM VAS, V30, P2350, DOI 10.1161/ATVBAHA.110.207498
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2012
VL 42
IS 8
BP 519
EP 520
DI 10.4070/kcj.2012.42.8.519
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IN
UT WOS:000209080200002
PM 22977446
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JH
   Shin, GJ
   Ryu, JI
   Pyun, WB
AF Park, Jae Hong
   Shin, Gil Ja
   Ryu, Jae In
   Pyun, Wook Bum
TI Postoperative B-Type Natriuretic Peptide Levels Associated With
   Prolonged Hospitalization in Hypertensive Patients After Non-Cardiac
   Surgery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Natriuretic peptin, brain; Hospitalization; Postoperative period;
   Hypertension
AB Background and Objectives: B-type natriuretic peptide (BNP) is an important marker for the diagnosis of heart failure and is useful towards predicting morbidity and mortality after non-cardiac surgery. Nevertheless, information on the relationship between postoperative BNP levels and perioperative prognosis after non-cardiac surgery is scarce. The purpose of the study was to assess whether postoperative BNP levels could be used as a predictor of prolonged hospitalization in elderly hypertensive patients after non-cardiac surgery.
   Subjects and Methods: Ninety-seven (97) patients, aged 55 years or older (mean age: 73.12 +/- 10.05 years, M : F=24 : 73) were enrolled in a prospective study from May 2005 through August 2010. All patients underwent total knee or hip replacement. Postoperative BNP and other diagnostic data were recorded within 24 hours of surgery. Patients that required a prolonged hospital stay due to operative causes, such as wound infection and re-operation, were excluded.
   Results: The length of hospital stay was significantly correlated with postoperative BNP levels (p=0.031). Receiver operating characteristic curves demonstrated postoperative BNP levels as predictors of hospital stay >= 30 days with areas under the curve of 0.774 (95% confidence interval: 0.679-0.87, p<0.0001). A BNP cut-off value above 217.5 pg/mL had a sensitivity of 80.6% and a specificity of 66.7% for predicting postoperative hospital stays of 30 days or more.
   Conclusion: Postoperative BNP levels may predict the length of hospital stays after non-cardiac surgery in hypertensive patients. Elevated BNP levels were associated with prolonged hospitalization after elective orthopedic surgery.
C1 [Park, Jae Hong] Kang Nam Gen Hosptial, Dept Internal Med, Div Cardiol, Yongin, South Korea.
   [Shin, Gil Ja; Ryu, Jae In; Pyun, Wook Bum] Ewha Womans Univ, Sch Med, Dept Internal Med, Ctr Cardiovasc, Seoul 158710, South Korea.
RP Pyun, WB (corresponding author), Ewha Womans Univ, Sch Med, Dept Internal Med, Ctr Cardiovasc, 1071 Anyangcheon Ro, Seoul 158710, South Korea.
EM pwb423@ewha.ac.kr
FU Ewha Womans University [2005-0997-1-1]
FX This study was performed by the research fund of Ewha Womans University
   (No. 2005-0997-1-1).
CR Auerbach A, 2006, CIRCULATION, V113, P1361, DOI 10.1161/CIRCULATIONAHA.105.573113
   Berry C, 2006, HEART, V92, P401, DOI 10.1136/hrt.2005.060988
   Bettencourt P, 2004, CIRCULATION, V110, P2168, DOI 10.1161/01.CIR.0000144310.04433.BE
   Cowie MR, 2002, PROG CARDIOVASC DIS, V44, P293, DOI 10.1053/pcad.2002.24599
   Cuthbertson BH, 2007, BRIT J ANAESTH, V99, P170, DOI 10.1093/bja/aem158
   Cuthbertson BH, 2007, AM J CARDIOL, V100, P1310, DOI 10.1016/j.amjcard.2007.05.058
   de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053
   Dernellis J, 2006, HEART, V92, P1645, DOI 10.1136/hrt.2005.085530
   DETSKY AS, 1986, ARCH INTERN MED, V146, P2131, DOI 10.1001/archinte.146.11.2131
   Eagle KA, 2002, CIRCULATION, V105, P1257, DOI 10.1161/hc1002.104956
   EAGLE KA, 1989, ANN INTERN MED, V110, P859, DOI 10.7326/0003-4819-110-11-859
   Goei D, 2011, AM J CARDIOL, V107, P609, DOI 10.1016/j.amjcard.2010.10.021
   Goei D, 2009, CORONARY ARTERY DIS, V20, P219, DOI 10.1097/MCA.0b013e3283219e47
   GOLDMAN L, 1983, ANN INTERN MED, V98, P504, DOI 10.7326/0003-4819-98-4-504
   GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601
   Halm EA, 1996, ANN INTERN MED, V125, P433, DOI 10.7326/0003-4819-125-6-199609150-00001
   Heeschen C, 2004, CIRCULATION, V110, P3206, DOI 10.1161/01.CIR.0000147611.92021.2B
   Hutfless R, 2004, J AM COLL CARDIOL, V43, P1873, DOI 10.1016/j.jacc.2003.12.048
   Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330
   Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043
   Leibowitz D, 2008, CARDIOLOGY, V110, P266, DOI 10.1159/000112411
   MANGANO DT, 1990, ANESTHESIOLOGY, V72, P153, DOI 10.1097/00000542-199001000-00025
   MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601
   NAKAGAWA O, 1995, J CLIN INVEST, V96, P1280, DOI 10.1172/JCI118162
   Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402
   Schutt RC, 2009, AM J CARDIOL, V104, P137, DOI 10.1016/j.amjcard.2009.03.005
NR 26
TC 8
Z9 8
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2012
VL 42
IS 8
BP 521
EP 527
DI 10.4070/kcj.2012.42.8.521
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IN
UT WOS:000209080200003
PM 22977447
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, JR
   Shin, S
   Kim, JS
   Ko, YG
   Hong, MK
   Jang, Y
   Seung, KB
   Park, HS
   Tahk, SJ
   Lim, DS
   Jeon, DW
   Chae, IH
   Kim, DK
   Yoon, J
   Jeong, MH
   Choi, D
AF Cho, Jung Rae
   Shin, Sanghoon
   Kim, Jung-Sun
   Ko, Young-Guk
   Hong, Myeong-Ki
   Jang, Yangsoo
   Seung, Ki Bae
   Park, Hun Sik
   Tahk, Seung-Jea
   Lim, Do-Sun
   Jeon, Dong-Wun
   Chae, In Ho
   Kim, Duk-Kyung
   Yoon, Junghan
   Jeong, Myung Ho
   Choi, Donghoon
TI Clinical Characteristics of Acute Aortic Syndrome in Korean Patients:
   From the Korean Multi-Center Registry of Acute Aortic Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic diseases; Dissection; Hematoma; Population characteristics
AB Background and Objectives: Acute aortic syndrome (AAS) is a heterogeneous group of disorders that often present with severe chest or back pain. It includes acute aortic dissection (AD), intramural hematoma (IMH), dissecting aneurysm, and penetrating aortic ulcer (PAU). The clinical picture of AAS and its prognosis have not been studied in a large number of Korean patients. Therefore, we organized a multi-center registry to identify the clinical characteristics and treatment patterns, as well as long-term outcomes in Korean patients with AAS.
   Subjects and Methods: Five-hundred twenty-eight patients, who had been diagnosed with AAS, were enrolled into this registry from 10 centers. On a retrospective basis, we collected demographic, laboratory, imaging data, as well as follow-up clinical outcomes by reviewing medical records from individual centers. All the data were collected in core lab and analyzed in detail.
   Results: The mean patient age was 60.1 +/- 14.5 years; the male-to-female ratio was M : F=297 : 231. The prevalent risk factors for AAS included hypertension (361, 68.4%) and diabetes (52, 11.1%). The components of AAS that are included in this study are acute AD (446, 84.5%), IMH (57, 10.7%), and PAU (11, 2.1%). By type of AAS, patients diagnosed with Stanford A were 45.6% of enrolled patients, whereas those with Stanford B were 54.4% of enrolled patients. Among nearly half of the patients were treated with medicine (55.7%) alone, whereas 40.0% underwent surgery and 4.3% underwent endovascular treatment. Overall, the in-hospital event rate was 21.2% and the in-hospital death rate was 8.1%. The mean follow-up duration was 42.8 months and there showed 22.9% of total event and 10.1% of death during this period.
   Conclusion: By organizing a multi-center registry of AAS, we could identify the characteristics of AAS in real-world Korean patients. Further, prospective study is warranted with a larger number of patients.
C1 [Cho, Jung Rae] Hallym Univ, Coll Med, Kangnam Sacred Heart Hosp, Div Cardiol, Seoul, South Korea.
   [Shin, Sanghoon; Kim, Jung-Sun; Ko, Young-Guk; Hong, Myeong-Ki; Jang, Yangsoo; Choi, Donghoon] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
   [Seung, Ki Bae] Catholic Univ, Coll Med, Seoul St Marys Hosp, Div Cardiol, Seoul, South Korea.
   [Park, Hun Sik] Kyungpook Natl Univ Hosp, Div Cardiol, Taegu, South Korea.
   [Tahk, Seung-Jea] Ajou Univ, Med Ctr, Div Cardiol, Suwon 441749, South Korea.
   [Lim, Do-Sun] Korea Univ, Anam Hosp, Ctr Cardiovasc, Seoul, South Korea.
   [Jeon, Dong-Wun] Natl Hlth Insurance Coperat, Ilsan Hosp, Div Cardiol, Goyang, South Korea.
   [Chae, In Ho] Seoul Natl Univ, Bundang Hosp, Ctr Cardiovasc, Songnam, South Korea.
   [Kim, Duk-Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Cardiol, Seoul, South Korea.
   [Yoon, Junghan] Yonsei Univ, Wonju Coll Med, Wonju Christian Hosp, Div Cardiol, Wonju, South Korea.
   [Jeong, Myung Ho] Chonnam Natl Univ Hosp, Div Cardiol, Kwangju, South Korea.
RP Choi, D (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM cdhlyj@yuhs.ac
OI Shin, Sanghoon/0000-0002-2348-2570
FU Korean Society of Interventional Cardiology
FX This study was supported by a grant from the Korean Society of
   Interventional Cardiology.
CR Botsios S, 2010, THORAC CARDIOV SURG, V58, P280, DOI 10.1055/s-0030-1249942
   Campbell-Lloyd AJM, 2010, HEART LUNG CIRC, V19, P665, DOI 10.1016/j.hlc.2010.05.009
   Cho Seong Ho, 2009, Korean Circ J, V39, P270, DOI 10.4070/kcj.2009.39.7.270
   Coady Michael A., 1999, Cardiology Clinics, V17, P637, DOI 10.1016/S0733-8651(05)70106-5
   EARNEST F, 1979, MAYO CLIN PROC, V54, P43
   Evangelista A, 2005, CIRCULATION, V111, P1063, DOI 10.1161/01.CIR.0000156444.26393.80
   Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897
   HIRST AE, 1958, MEDICINE, V37, P217, DOI 10.1097/00005792-195809000-00003
   강웅철, 2003, Korean Circulation Journal, V33, P457
   Kaji S, 2002, CIRCULATION, V106, pI248, DOI 10.1161/01.cir.0000032897.55215.e9
   이석, 2006, Korean Circulation Journal, V36, P387
   Lansman SL, 2010, J THORAC CARDIOV SUR, V140, pS92, DOI 10.1016/j.jtcvs.2010.07.062
   Mehta RH, 2002, CIRCULATION, V105, P200, DOI 10.1161/hc0202.102246
   MOHRKAHALY S, 1994, J AM COLL CARDIOL, V23, P658, DOI 10.1016/0735-1097(94)90751-X
   Moizumi Y, 2002, J THORAC CARDIOV SUR, V124, P918, DOI 10.1067/mtc.2002.125637
   NIENABER CA, 1995, CIRCULATION, V92, P1465, DOI 10.1161/01.CIR.92.6.1465
   Song JK, 2009, CIRCULATION, V120, P2046, DOI 10.1161/CIRCULATIONAHA.109.879783
   Song JK, 2001, J AM COLL CARDIOL, V37, P1604, DOI 10.1016/S0735-1097(01)01184-6
   Vilacosta I, 2010, POSTGRAD MED J, V86, P52, DOI 10.1136/hrt.2008.153650
   Vilacosta I, 2001, HEART, V85, P365, DOI 10.1136/heart.85.4.365
   WILSON SK, 1982, ARCH PATHOL LAB MED, V106, P175
NR 21
TC 6
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2012
VL 42
IS 8
BP 528
EP 537
DI 10.4070/kcj.2012.42.8.528
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IN
UT WOS:000209080200004
PM 22977448
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CK
   Yoo, SY
   Hong, MY
   Jang, JK
AF Lee, Chang Kun
   Yoo, Sang Yong
   Hong, Man Yong
   Jang, Jin Kun
TI Antithrombotic or Anti-Platelet Agents in Patients Undergoing Permanent
   Pacemaker Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aspirin; Clopidogrel; Warfarin; Hematoma
AB Background and Objectives: The growing implantations of electrophysiological devices in the context of increasing rates of chronic antithrombotic therapy in cardiovascular disease patients underscore the importance of an effective periprocedural prophylactic strategy for prevention of bleeding complications. We assessed the risk of significant bleeding complications in patients receiving anti-platelet agents or anticoagulants at the time of permanent pacemaker (PPM) implantation.
   Subjects and Methods: We reviewed bleeding complications in patients undergoing PPM implantation. The use of aspirin or clopidogrel was defined as having taking drugs within 5 days of the procedure and warfarin was changed to heparin before the procedure. A significant bleeding complication was defined as a bleeding incident requiring pocket exploration or blood transfusion.
   Results: Permanent pacemaker implantations were performed in 164 men and 96 women. The mean patient age was 73 +/- 11 years old. Among the 260 patients, 14 patients took warfarin (in all of them, warfarin was changed to heparin at least 3 days before procedure), 54 patients took aspirin, 4 patients took clopidogrel, and 25 patients took both. Significant bleeding complications occurred in 8 patients (3.1%), all of them were patients with heparin bridging (p<0.0001). Heparin bridging markedly increased the length of required hospital stay when compare with other groups and the 4 patients (1.5%) that underwent the pocket revision for treatment of hematoma.
   Conclusion: This study suggests that hematoma formation after PPM implantation was rare, even among those who had taken the antiplatelet agents. The significant bleeding complications frequently occurred in patients with heparin bridging therapy. Therefore, heparin bridging therapy was deemed as high risk for significant bleeding complication in PPM implantation.
C1 [Lee, Chang Kun; Yoo, Sang Yong; Hong, Man Yong; Jang, Jin Kun] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Div Cardiol,Dept Internal Med, Kangnung, South Korea.
RP Jang, JK (corresponding author), Univ Ulsan, Coll Med, Gangneung Asan Hosp, Div Cardiol,Dept Internal Med, 38 Bangdong Gil, Sacheon Myeon 210711, Gangneung, South Korea.
EM jinkumc@gmail.com
CR Ahmed I, 2010, ANALOG CIRC SIG PROC, P7, DOI 10.1007/978-90-481-8652-5_2
   Cheng A, 2011, HEART RHYTHM, V8, P536, DOI 10.1016/j.hrthm.2010.12.016
   Daubert JC, 2009, EUR HEART J
   Dreger H, 2010, PACE, V33, P394, DOI 10.1111/j.1540-8159.2009.02645.x
   Eisenberg MJ, 2009, CIRCULATION, V119, P1634, DOI 10.1161/CIRCULATIONAHA.108.813667
   Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082
   Giudici MC, 2004, PACE, V27, P358, DOI 10.1111/j.1540-8159.2004.00441.x
   Grines CL, 2007, J AM COLL CARDIOL, V49, P734, DOI 10.1016/j.jacc.2007.01.003
   Gupta A, 2008, EUROPACE, V10, P1236, DOI 10.1093/europace/eun185
   Hirsh J, 2001, CHEST, V119, p8S, DOI 10.1378/chest.119.1_suppl.8S
   Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994
   Kutinsky IB, 2010, CIRC-ARRHYTHMIA ELEC, V3, P312, DOI 10.1161/CIRCEP.109.917625
   Lee CK, 2011, KOREAN CIRC J, V41, P276, DOI 10.4070/kcj.2011.41.5.276
   Lee Ga Yeon, 2010, Korean Circ J, V40, P99, DOI 10.4070/kcj.2010.40.2.99
   Llau JV, 2009, EUR J ANAESTH, V26, P181, DOI 10.1097/EJA.0b013e328324b79f
   Maree AO, 2007, CIRCULATION, V115, P2196, DOI 10.1161/CIRCULATIONAHA.106.675991
   Mollmann H, 2009, CLIN RES CARDIOL, V98, P8, DOI [10.1007/s00392-008-0718-x, 10.1007/s00392-008-0742-x]
   Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474
   Phan TG, 2000, ARCH NEUROL-CHICAGO, V57, P1710, DOI 10.1001/archneur.57.12.1710
   Tompkins C, 2010, J AM COLL CARDIOL, V55, P2376, DOI 10.1016/j.jacc.2009.12.056
   Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7
   Wiegand UKH, 2004, CHEST, V126, P1177, DOI 10.1378/chest.126.4.1177
NR 22
TC 3
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2012
VL 42
IS 8
BP 538
EP 542
DI 10.4070/kcj.2012.42.8.538
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IN
UT WOS:000209080200005
PM 22977449
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, BS
   Choi, JY
   Kim, JY
   Han, SH
   Park, JE
AF Lee, Bok-Soo
   Choi, Jin Yong
   Kim, Joo Yun
   Han, Seul Hee
   Park, Jeong Euy
TI Simvastatin and Losartan Differentially and Synergistically Inhibit
   Atherosclerosis in Apolipoprotein E-/- Mice
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atherosclerosis; Losartan; Simvastatin; Mice, knockout; Models, animal
AB Background and Objectives: Since statins and angiotensin receptor blockers are a frequently prescribed combination in patients with atherosclerotic cardiovascular diseases, we tested the interactive effects of simvastatin and losartan on atherosclerosis in apolipoprotein E (apoE)(-/-) mice.
   Materials and Methods: Apolipoprotein E-/- mice were fed a high-fat, high-cholesterol (HFHC) diet for 12 weeks, with and without simvastatin (40 mg/kg) and/or losartan (20 mg/kg). The mice were divided into 5 groups and were fed as follows: regular chow (control diet, n=5), HFHC diet (n=6), HFHC diet with losartan (n=6), HFHC diet with simvastatin (n=6), and HFHC diet with both losartan and simvastatin (n=6).
   Results: Losartan treatment in apoE(-/-) mice significantly decreased atherosclerotic lesion areas in whole aortic strips stained with Oil Red O. The plaque area measured at the aortic sinus level was reduced significantly by 17% (HFHC; 346830.9 +/- 52915.8 mu m(2) vs. HFHC plus losartan; 255965.3 +/- 74057.7 mu m(2), p<0.05) in the losartan-treated group. Simvastatin and simvastatin plus losartan treatments reduced macrophage infiltration into lesions by 33% (HFHC; 183575.6 +/- 43211.2 mu m(2) vs. HFHC plus simvastatin; 120556.0 +/- 39282.8 mu m(2), p<0.05) and 44% (HFHC; 183575.6 +/- 43211.2 mu m(2) vs. HFHC plus simvastatin and losartan; 103229.0 +/- 8473.3 mu m(2), p<0.001, respectively). In mice fed the HFHC diet alone, the smooth muscle cell layer in the aortic media was almost undetectable. In mice co-treated with losartan and simvastatin, the smooth muscle layer was more than 60% preserved (p<0.05). Given alone, losartan showed a slightly stronger effect than simvastatin; however, treatment with losartan plus simvastatin induced a greater inhibitory effect on atherosclerosis than either drug given alone. Serum lipid profiles did not differ significantly among the groups.
   Conclusion: Losartan displayed anti-atherosclerotic effects in apoE(-/-) mice that were equivalent to or greater than the effects of simvastatin. Combined treatment with these drugs had greater effect than either drug alone.
C1 [Lee, Bok-Soo; Choi, Jin Yong; Kim, Joo Yun; Han, Seul Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst, Seoul 135710, South Korea.
   [Park, Jeong Euy] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Cardiol, Seoul 135710, South Korea.
RP Park, JE (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Cardiol, 50 Irwon Dong, Seoul 135710, South Korea.
EM jepark39@gmail.com
FU Korean Society of Cardiology; Korea Research Council of Fundamental
   Science and Technology (KRCF) through Basic Research Project
FX This study was supported by grants from the Korean Society of Cardiology
   (2006) and the Korea Research Council of Fundamental Science and
   Technology (KRCF) through Basic Research Project managed by the Korea
   Research Institute of Standards and Science (KRISS).
CR Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64
   Bayorh MA, 2007, CLIN EXP HYPERTENS, V29, P311, DOI 10.1080/10641960701500463
   Chen HJ, 2002, J CARDIOVASC PHARM, V39, P332, DOI 10.1097/00005344-200203000-00003
   Corti R, 2001, CIRCULATION, V104, P249
   Corti R, 2002, CIRCULATION, V106, P2884, DOI 10.1161/01.CIR.0000041255.88750.F0
   Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3
   Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981
   GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141
   Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657
   Han SH, 2007, ATHEROSCLEROSIS, V190, P205, DOI 10.1016/j.atherosclerosis.2006.01.021
   Hayek T, 1999, CARDIOVASC RES, V44, P579, DOI 10.1016/S0008-6363(99)00239-4
   Hernandez-Perera O, 1998, J CLIN INVEST, V101, P2711, DOI 10.1172/JCI1500
   Kim SH, 2010, CIRC RES, V106, P1332, DOI 10.1161/CIRCRESAHA.109.208678
   Koh KK, 2004, CIRCULATION, V110, P3687, DOI 10.1161/01.CIR.0000143085.86697.13
   Koh KK, 2000, CARDIOVASC RES, V47, P648, DOI 10.1016/S0008-6363(00)00146-2
   Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748
   Martin-Ventura JL, 2004, CIRCULATION, V110, P2216, DOI 10.1161/01.CIR.0000136814.87170.B1
   OLIVER MF, 1994, LANCET, V344, P633
   Papakonstantinou E, 2001, J CARDIOVASC PHARM, V38, P715, DOI 10.1097/00005344-200111000-00008
   Park HK, 2006, CIRCULATION, V114, P886, DOI 10.1161/CIRCULATIONAHA.105.541219
   Rezaie-Majd A, 2002, ARTERIOSCL THROM VAS, V22, P1194, DOI 10.1161/01.ATV.0000022694.16328.CC
   Robinson JG, 2005, J AM COLL CARDIOL, V46, P1855, DOI 10.1016/j.jacc.2005.05.085
   Schartl M, 2001, CIRCULATION, V104, P387, DOI 10.1161/hc2901.093188
   Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0
   Sparrow CP, 2001, ARTERIOSCL THROM VAS, V21, P115, DOI 10.1161/01.ATV.21.1.115
   Weber MA, 2004, LANCET, V363, P2049, DOI 10.1016/S0140-6736(04)16456-8
   Yusuf S, 2000, NEW ENGL J MED, V342, P145
NR 27
TC 12
Z9 13
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2012
VL 42
IS 8
BP 543
EP 550
DI 10.4070/kcj.2012.42.8.543
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IN
UT WOS:000209080200006
PM 22977450
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, DY
   Yang, HM
   Park, KW
   Lee, SR
   Lee, MH
   Lee, DW
   Lee, HY
   Kang, HJ
   Koo, BK
   Chae, IH
   Choi, DJ
   Kim, HS
   Kim, CH
AF Kang, Do-Yoon
   Yang, Han-Mo
   Park, Kyung Woo
   Lee, So-Ryoung
   Lee, Min-Ho
   Lee, Dong-Won
   Lee, Hae-Young
   Kang, Hyun-Jae
   Koo, Bon-Kwon
   Chae, In-Ho
   Choi, Dong-Ju
   Kim, Hyo-Soo
   Kim, Cheol-Ho
TI Lack of Association Between Low Density Lipoprotein Particle Size and
   On-Treatment Platelet Reactivity in Patients With Coronary Artery
   Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Lipoproteins; Low-density lipoprotein; Platelet Function Tests
AB Background and Objectives: Small dense low density lipoproteins (sd-LDL) are a risk factor for coronary artery disease and are known to stimulate platelet function in vitro. This study aimed to evaluate whether high proportion of sd-LDL is associated with high on-treatment platelet reactivity (HOPR).
   Subjects and Methods: From January 2009 to March 2010, 439 subjects (mean age: 64.3 +/- 9.7, Male : Female=306 : 133) were enrolled from the low density LIPOProtein-cholesterol Size measurement Registry with coronary artery disease, who had undergone elective percutaneous coronary intervention and measured both LDL particle size and on-treatment platelet reactivity (OPR). Mean LDL particle size was measured by gradient gel electrophoresis (Quantimetrix, Lipoprint (TM)) and OPR by the VerifyNow (TM) system (aspirin and P2Y12).
   Results: Between pattern A (large, buoyant LDL dominant) and B (sd-LDL dominant) population, there were no significant difference in OPR to aspirin (441.3 +/- 71.9 vs. 434.07 +/- 63.45 aspirin reaction units, p=0.351) or clopidogrel (237.9 +/- 87.3 vs. 244.9 +/- 80.7 P2Y12 reaction units, p=0.465). There was no difference in LDL particle size between patients with HOPR compared with non-HOPR patients (aspirin: 26.8 +/- 0.5 vs. 26.7 +/- 0.6 nm, p=0.078, clopidogrel: 26.7 +/- 0.6 vs. 26.8 +/- 0.5 nm, p=0.857). Pearson's correlation coefficients between LDL particle size and platelet reactivity were not statistically significant (aspirin assay: r=0.080, p=0.098, P2Y12 assay: r=-0.027, p=0.568).
   Conclusion: There was no significant association between LDL particle size and OPR in patients with coronary artery disease.
C1 [Kang, Do-Yoon; Yang, Han-Mo; Park, Kyung Woo; Lee, So-Ryoung; Lee, Min-Ho; Lee, Dong-Won; Lee, Hae-Young; Kang, Hyun-Jae; Koo, Bon-Kwon; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Ctr Cardiovasc, Dept Internal Med, Seoul 110744, South Korea.
   [Chae, In-Ho; Choi, Dong-Ju; Kim, Cheol-Ho] Seoul Natl Univ, Bundang Hosp, Ctr Cardiovasc, Dept Internal Med, Songnam, South Korea.
RP Yang, HM (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM hanname@medimail.co.kr
RI Koo, Bon-Kwon/J-5374-2012; Kang, Hyun-Jae/D-6121-2012; Park, Kyung
   Woo/AAX-3046-2020; Lee, Minho/AAJ-6477-2020
OI Kang, Hyun-Jae/0000-0002-3500-1746; Lee, Minho/0000-0003-0748-7766; Lee,
   Hae-Young/0000-0002-9521-4102
FU Korean Society Cardiology; Korean Society of Interventional Cardiology
FX This study was sponsored by a grant from the Korean Society Cardiology
   (2002, Kim) and a grant from the Korean Society of Interventional
   Cardiology (2010, Park).
CR Barth JH, 2010, CLIN CHEM, V56, P1592, DOI 10.1373/clinchem.2010.145631
   Boren J, 2000, CURR OPIN LIPIDOL, V11, P451, DOI 10.1097/00041433-200010000-00002
   Breet NJ, 2011, HEART, V97, P983, DOI 10.1136/hrt.2010.220491
   Carroll JS, 2007, ANAL CHEM, V79, P5133, DOI 10.1021/ac0706271
   Cecchi E, 2009, AM J CARDIOL, V104, P764, DOI 10.1016/j.amjcard.2009.05.005
   Chen LY, 1996, CIRCULATION, V93, P1740, DOI 10.1161/01.CIR.93.9.1740
   Collot-Teixeira S, 2007, ARTERIOSCL THROM VAS, V27, P2491, DOI 10.1161/ATVBAHA.107.154864
   El Harchaoui K, 2007, J AM COLL CARDIOL, V49, P547, DOI 10.1016/j.jacc.2006.09.043
   Hoefner DM, 2001, CLIN CHEM, V47, P266
   Hurt-Camejo E, 2000, CURR OPIN LIPIDOL, V11, P465, DOI 10.1097/00041433-200010000-00004
   Ip S, 2009, ANN INTERN MED, V150, P474, DOI 10.7326/0003-4819-150-7-200904070-00007
   Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992
   Koba Shinji, 2008, J Atheroscler Thromb, V15, P250
   Kwon SW, 2006, YONSEI MED J, V47, P405, DOI 10.3349/ymj.2006.47.3.405
   Lee PY, 2005, AM J MED, V118, P723, DOI 10.1016/j.amjmed.2005.03.041
   Marcucci R, 2009, CIRCULATION, V119, P237, DOI 10.1161/CIRCULATIONAHA.108.812636
   Park KW, 2011, ARTERIOSCL THROM VAS, V31, P665, DOI 10.1161/ATVBAHA.110.217182
   Rizzo M, 2006, INT ANGIOL, V25, P4
   ROSENSON RS, 1993, J AM COLL CARDIOL, V22, P933
   Wang JS, 2000, LIFE SCI, V66, P1937, DOI 10.1016/S0024-3205(00)00519-1
   WEISSER B, 1993, BIOCHEM BIOPH RES CO, V192, P1245, DOI 10.1006/bbrc.1993.1550
   Yoon Y, 2005, CLIN CHEM LAB MED, V43, P431, DOI 10.1515/CCLM.2005.076
   김장영, 2007, Korean Circulation Journal, V37, P135
NR 23
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2012
VL 42
IS 8
BP 551
EP 557
DI 10.4070/kcj.2012.42.8.551
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IN
UT WOS:000209080200007
PM 22977451
OA Green Published
DA 2021-04-22
ER

PT J
AU Kwon, TJ
   Hwang, JY
   Kwak, CH
   Jeong, YH
   Park, YW
   Hwang, SJ
   Park, JR
   Ahn, JH
   Min, JH
AF Kwon, Tae Jung
   Hwang, Jin Yong
   Kwak, Choong Hwan
   Jeong, Young-Hoon
   Park, Yong Whi
   Hwang, Seok-Jae
   Park, Jeong Rang
   Ahn, Jong-Hwa
   Min, Ji Hyun
TI Rupture and Spontaneous Sealing of a Coronary Aneurysm After Deployment
   of Drug-Eluting Stent
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary aneurysm; Drug-eluting stents
AB Lesions with coronary artery aneurysm (CAA) can become complicated during percutaneous coronary intervention. Here, we report a case of a 78-year-old man who developed a rupture, and spontaneous sealing of the CAA occurred after stent implantation, as shown by computed tomography coronary angiography.
C1 [Kwon, Tae Jung; Hwang, Jin Yong; Kwak, Choong Hwan; Jeong, Young-Hoon; Park, Yong Whi; Hwang, Seok-Jae; Park, Jeong Rang; Ahn, Jong-Hwa; Min, Ji Hyun] Gyeongsang Natl Univ Hosp, Dept Internal Med, Jinju 660702, South Korea.
RP Hwang, JY (corresponding author), Gyeongsang Natl Univ Hosp, Dept Internal Med, 79 Gangnam Ro, Jinju 660702, South Korea.
EM jyhwang@nongae.gsnu.ac.kr
RI Jeong, Young-Hoon/F-3476-2015; Jeong, Young-Hoon/AAO-4401-2020
OI Jeong, Young-Hoon/0000-0003-0403-3726; Kwak, Choong
   Hwan/0000-0001-6035-4415
CR ALFORD WC, 1976, ANN THORAC SURG, V22, P317, DOI 10.1016/S0003-4975(10)64961-2
   Cohen P, 2008, CARDIOL REV, V16, P301, DOI 10.1097/CRD.0b013e3181852659
   Gunduz H, 2004, JPN HEART J, V45, P331, DOI 10.1536/jhj.45.331
   Hayat SA, 2009, CATHETER CARDIO INTE, V74, P367, DOI 10.1002/ccd.21937
   Kim HG, 2004, KOREAN CIRC J, V34, P507
   Koshika M, 1999, Kyobu Geka, V52, P924
   Nitschke T, 2002, Z KARDIOL, V91, P187, DOI 10.1007/s003920200010
   Sugimoto K, 2009, CIRC J, V73, P1759, DOI 10.1253/circj.CJ-08-0543
   Syed M, 1997, PROG CARDIOVASC DIS, V40, P77, DOI 10.1016/S0033-0620(97)80024-2
   VIJAYANAGAR R, 1994, J THORAC CARDIOV SUR, V107, P1532, DOI 10.1016/S0022-5223(12)70153-8
   Yokouchi Y, 2010, PATHOL INT, V60, P112, DOI 10.1111/j.1440-1827.2009.02484.x
NR 11
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2012
VL 42
IS 8
BP 558
EP 561
DI 10.4070/kcj.2012.42.8.558
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IN
UT WOS:000209080200008
PM 22977452
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, BS
   Cho, DK
   Koh, WJ
   Yoo, SH
   Won, KB
   Cho, YH
   Hwang, ES
   Koh, JH
AF Kang, Byung-Soo
   Cho, Deok-Kyu
   Koh, Won-Jun
   Yoo, Seung-Hoon
   Won, Ki-Bum
   Cho, Yun-Hyeong
   Hwang, Eui-Seock
   Koh, Jong-Hoon
TI A Case of Severe Pulmonary Thromboembolism in a Young Male With
   Klinefelter Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Klinefelter syndrome; Pulmonary embolism; Venous thrombosis
ID PLASMA
AB A young male patient diagnosed with Klinefelter syndrome was admitted to our hospital via the emergency room with chief complaints of acute chest pain and dyspnea. Pulmonary thromboembolism was diagnosed from his chest CT images. His symptoms improved after he underwent thrombolysis and anticoagulation treatment. Klinefelter syndrome has a tendency towards hypercoagulability due to hormonal imbalance and one or more inherited thromophilic factors. Thus, Klinefelter syndrome patients with a past medical history of venous thromboembolism require continuous oral anticoagulation therapy for a period of at least six months.
C1 [Kang, Byung-Soo; Cho, Deok-Kyu; Koh, Won-Jun; Yoo, Seung-Hoon; Won, Ki-Bum; Cho, Yun-Hyeong; Hwang, Eui-Seock; Koh, Jong-Hoon] Kwandong Univ, Coll Med, Myongji Hosp, Ctr Cardiovasc,Div Cardiol, Goyang 412270, South Korea.
RP Cho, DK (corresponding author), Kwandong Univ, Coll Med, Myongji Hosp, Ctr Cardiovasc,Div Cardiol, 697-24 Hwajeong Dong, Goyang 412270, South Korea.
EM chodk123@paran.com
CR BENNET A, 1987, SCAND J CLIN LAB INV, V47, P23
   Bojesen A, 2003, J CLIN ENDOCR METAB, V88, P622, DOI 10.1210/jc.2002-021491
   CAMPBELL WA, 1981, CLIN GENET, V19, P275
   CARON P, 1989, METABOLISM, V38, P1010, DOI 10.1016/0026-0495(89)90014-0
   Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710
   Lapecorella M, 2003, BLOOD COAGUL FIBRIN, V14, P95, DOI 10.1097/00001721-200301000-00017
   Ratcliffe S, 1999, ARCH DIS CHILD, V80, P192, DOI 10.1136/adc.80.2.192
   문홍주, 2005, Korean Circulation Journal, V35, P474
   SCHWARTZ ID, 1991, ENDOCRIN METAB CLIN, V20, P153, DOI 10.1016/S0889-8529(18)30285-8
   SPRENGERS ED, 1987, BLOOD, V69, P381
   Winkler UH, 1996, MATURITAS, V24, P147, DOI 10.1016/S0378-5122(96)82004-4
NR 11
TC 3
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2012
VL 42
IS 8
BP 562
EP 564
DI 10.4070/kcj.2012.42.8.562
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IN
UT WOS:000209080200009
PM 22977453
OA Green Published
DA 2021-04-22
ER

PT J
AU Ma, SH
   Kim, DH
   Hur, JY
   Kim, KS
   Byun, SJ
   Park, KH
   Yoon, SB
AF Ma, Sung Ho
   Kim, Dong Hyun
   Hur, Jae Young
   Kim, Kwang Seok
   Byun, Se Jin
   Park, Ki Hyun
   Yoon, Seong-Bo
TI Right Ventricular Myocardial Infarction due to Right Coronary Artery
   Total Occlusion Originating From the Distal Left Circumflex Artery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Coronary vessel anomalies
AB An isolated single coronary artery is rare but often associated with other congenital cardiac malformations and myocardial ischemia. We report a rare case of right ventricular myocardial infarction due to total occlusion of the right coronary artery originating from the distal left circumflex artery.
C1 [Ma, Sung Ho; Kim, Dong Hyun; Hur, Jae Young; Kim, Kwang Seok; Byun, Se Jin; Park, Ki Hyun; Yoon, Seong-Bo] Hongik Hosp, Dept Internal Med, Seoul 158738, South Korea.
RP Yoon, SB (corresponding author), Hongik Hosp, Dept Internal Med, 899-1 Sinjeong 4 Dong, Seoul 158738, South Korea.
EM kerveros@chol.com
CR Aziz S, 2004, Heart, V90, P799, DOI 10.1136/hrt.2003.029132
   CHAITMAN BR, 1976, CIRCULATION, V53, P122, DOI 10.1161/01.CIR.53.1.122
   Fraisse A., 2000, Circulation, V101, P1219
   Hsu L A, 1997, Changgeng Yi Xue Za Zhi, V20, P299
   LIPTON MJ, 1979, RADIOLOGY, V130, P39, DOI 10.1148/130.1.39
   OGDEN JA, 1970, YALE J BIOL MED, V43, P11
   Saremi F, 2009, J THORAC IMAG, V24, P34, DOI 10.1097/RTI.0b013e3181883d98
   SHARBAUGH A H, 1974, Journal of the American Medical Association, V230, P243, DOI 10.1001/jama.230.2.243
   Takano M, 2003, JPN HEART J, V44, P271, DOI 10.1536/jhj.44.271
   Voyce Stephen J, 2010, J Invasive Cardiol, V22, pE172
NR 10
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2012
VL 42
IS 8
BP 565
EP 567
DI 10.4070/kcj.2012.42.8.565
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IN
UT WOS:000209080200010
PM 22977454
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, DC
   Choi, JE
   Song, YK
   Lim, AL
   Park, KH
   Choi, YJ
AF Chung, Doo Cheol
   Choi, Jung Eun
   Song, Yong Keun
   Lim, Ah Leum
   Park, Kyoung-Ha
   Choi, Young-Jin
TI Polyarteritis Nodosa Complicated by Chronic Total Occlusion Accompanying
   Aneurysms on All Coronary Arteries
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Polyarteritis nodosa; Coronary aneurysm; Coronary occlusion
AB Polyarteritis nodosa (PAN) is characterized by inflammatory necrosis of medium sized arteries. PAN can also be associated with stenosis or aneurysm of the coronary artery. However, the involvement of PAN at a coronary artery is usually asymptomatic, which makes it difficult to diagnose. In addition, all of the three main coronary arteries involved with chronic total occlusion (CTO) is a rare finding in patients with PAN. We report a patient that presented with PAN complicated by CTO and aneurysms of three main coronary arteries, without typical symptoms of angina.
C1 [Chung, Doo Cheol; Choi, Jung Eun; Song, Yong Keun; Lim, Ah Leum; Park, Kyoung-Ha; Choi, Young-Jin] Hallym Univ, Med Ctr, Dept Internal Med, Div Cardiovasc, Seoul 150719, South Korea.
RP Park, KH (corresponding author), Hallym Univ, Med Ctr, Dept Internal Med, Div Cardiovasc, 94-200 Yeongdeungpo Dong 2 Ga, Seoul 150719, South Korea.
EM pkhmd@naver.com
CR Chang HJ, 2000, KOREAN CIRC J, V30, P227
   Chu KH, 1998, CATHETER CARDIO DIAG, V44, P320, DOI 10.1002/(SICI)1097-0304(199807)44:3<320::AID-CCD16>3.3.CO;2-B
   HOLSINGER DR, 1962, CIRCULATION, V25, P610, DOI 10.1161/01.CIR.25.4.610
   Kastner D, 2000, CAN J CARDIOL, V16, P515
   Kobayashi H, 2010, J RHEUMATOL, V37, P2427, DOI 10.3899/jrheum.100450
   PICK RA, 1982, CHEST, V82, P378, DOI 10.1378/chest.82.3.378
NR 6
TC 8
Z9 8
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2012
VL 42
IS 8
BP 568
EP 570
DI 10.4070/kcj.2012.42.8.568
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IN
UT WOS:000209080200011
PM 22977455
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JM
   Oh, IY
   Choi, DJ
AF Lee, Joo Myung
   Oh, Il-Young
   Choi, Dong-Ju
TI Cardiac Sarcoidosis Presenting With Complete Atrioventricular Block and
   Sustained Monomorphic Ventricular Tachycardia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Sarcoidosis; Heart failure; Magentic resonance imaging; Tachycardia,
   ventricular
AB Sarcoidosis is a rare but potentially fatal multisystem granulomatous disease of unknown etiology. While a number of clinical manifestations may develop, cardiac involvement (prior to or coincident with sarcoidosis of other organs) is an important prognostic factor. Recently, we encountered a patient with cardiac sarcoidosis who presented with complete atrioventricular (AV) block and sustained ventricular tachycardia. An implantable cardioverter-defibrillator was inserted as a precautionary measure for ventricular tachycardia and symptomatic complete AV block. F-18-fluoro-2-deoxyglucose positron emission tomography confirmed a dramatic response to high-dose steroid at four weeks, as demonstrated by a marked decrease in cardiac sarcoid activity from baseline status.
C1 [Lee, Joo Myung] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea.
   [Lee, Joo Myung] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.
   [Oh, Il-Young; Choi, Dong-Ju] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, Songnam 463707, South Korea.
   [Oh, Il-Young; Choi, Dong-Ju] Seoul Natl Univ, Bundang Hosp, Ctr Cardiovasc, Songnam 463707, South Korea.
RP Choi, DJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, 82 Gumi Ro 173beon Gil, Songnam 463707, South Korea.
EM djchoi@snu.ac.kr
OI Lee, Joo Myung/0000-0002-2178-4014
CR BELHASSEN B, 1989, CHEST, V95, P918, DOI 10.1378/chest.95.4.918
   Braun JJ, 2008, EUR J NUCL MED MOL I, V35, P1537, DOI 10.1007/s00259-008-0770-9
   Chapelon-Abric C, 2004, MEDICINE, V83, P315, DOI 10.1097/01.md.0000145367.17934.75
   HAGEMANN GJ, 1980, SARCOIDOSIS OTHER GR, P601
   HILLERDAL G, 1984, AM REV RESPIR DIS, V130, P29
   Hiraga H, 1993, GUIDELINE DIAGNOSIS, P23
   Johns CJ, 1999, MEDICINE, V78, P65, DOI 10.1097/00005792-199903000-00001
   Kim JS, 2009, AM HEART J, V157, P9, DOI 10.1016/j.ahj.2008.09.009
   MATSUI Y, 1976, ANN NY ACAD SCI, V278, P455, DOI 10.1111/j.1749-6632.1976.tb47058.x
   Ohira H, 2011, EUR J NUCL MED MOL I, V38, P1773, DOI 10.1007/s00259-011-1832-y
   Reuhl J, 1997, FORENSIC SCI INT, V89, P145, DOI 10.1016/S0379-0738(97)00106-0
   ROBERTS WC, 1977, AM J MED, V63, P86, DOI 10.1016/0002-9343(77)90121-8
   Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096
   Shimada T, 2001, AM J MED, V110, P520, DOI 10.1016/S0002-9343(01)00677-5
   SILVERMAN KJ, 1978, CIRCULATION, V58, P1204, DOI 10.1161/01.CIR.58.6.1204
   TAKADA K, 1994, SARCOIDOSIS, V11, P113
   Uemura A, 1999, AM HEART J, V138, P299, DOI 10.1016/S0002-8703(99)70115-8
   Vignaux O, 2002, CHEST, V122, P1895, DOI 10.1378/chest.122.6.1895
   WINTERS SL, 1991, J AM COLL CARDIOL, V18, P937, DOI 10.1016/0735-1097(91)90750-4
NR 19
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2012
VL 42
IS 8
BP 571
EP 574
DI 10.4070/kcj.2012.42.8.571
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IN
UT WOS:000209080200012
PM 22977456
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, YR
   Park, JS
AF Cho, Young Rak
   Park, Jong Sung
TI Radiofrequency Catheter Ablation for Unifocal Premature Ventricular
   Complexes Triggering Recurrent Ventricular Fibrillations in a Young Man
   Without Structural Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ventricular fibrillation; Radiofrequency catheter ablation
AB A 17-year-old man was referred for aborted sudden cardiac death. Ventricular fibrillation (VF) was recorded by automated external defibrillator. Post-resuscitation electrocardiograms showed frequent monomorphic premature ventricular complexes (PVCs), with left bundle branch block configuration and inferior axis. Cardiac arrest due to VF recurred twice within the initial 42 hours. Rhythm monitoring revealed multiple episodes of sustained VF triggered by a triplet of monomorphic PVCs having similar morphology with isolated PVCs. Comprehensive cardiologic workup revealed no structural heart disease and ion-channelopathies. With the impression of idiopathic VF triggered by unifocal PVCs of right ventricular outflow tract (RVOT) origin, radiofrequency catheter ablation was performed to prevent frequent VF recurrence before implantable cardioverter-defibrillator (ICD) implantation. After successful ablation of the origin of unifocal PVCs at anterolateral wall of RVOT, the burden of PVCs decreased remarkably and VF did not recur. The patient was discharged after ICD implantation.
C1 [Cho, Young Rak; Park, Jong Sung] Dong A Univ Hosp, Ctr Cardiovasc, Pusan 602715, South Korea.
RP Park, JS (corresponding author), Dong A Univ Hosp, Ctr Cardiovasc, 26 Daesingongwon Ro, Pusan 602715, South Korea.
EM thinkmed@dau.ac.kr
CR [Anonymous], 1997, CIRCULATION, V95, P265
   BUXTON AE, 1983, CIRCULATION, V68, P917, DOI 10.1161/01.CIR.68.5.917
   Haissaguerre M, 2002, CIRCULATION, V106, P962, DOI 10.1161/01.CIR.0000027564.55739.B1
   Knecht S, 2009, J AM COLL CARDIOL, V54, P522, DOI 10.1016/j.jacc.2009.03.065
   Noda T, 2005, J AM COLL CARDIOL, V46, P1288, DOI 10.1016/j.jacc.2005.05.077
   Nogami A, 2005, HEART RHYTHM, V2, P646, DOI 10.1016/j.hrthm.2005.02.006
   Uemura T, 2008, INTERNAL MED, V47, P1799, DOI 10.2169/internalmedicine.47.1211
NR 7
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2012
VL 42
IS 8
BP 575
EP 579
DI 10.4070/kcj.2012.42.8.575
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IN
UT WOS:000209080200013
PM 22977457
OA Green Published
DA 2021-04-22
ER

PT J
AU Kaya, H
   Ertas, F
   Atilgan, ZA
   Demirtas, S
   Caliskan, A
AF Kaya, Hasan
   Ertas, Faruk
   Atilgan, Zuhal Ariturk
   Demirtas, Sinan
   Caliskan, Ahmet
TI Ostial Coronary Stenosis and Severe Aortic Stenosis in a Patient With
   Familial Hypercholesterolemia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kaya, Hasan; Ertas, Faruk; Atilgan, Zuhal Ariturk] Dicle Univ, Fac Med, Dept Cardiol, Diyarbakir, Turkey.
   [Demirtas, Sinan; Caliskan, Ahmet] Dicle Univ, Fac Med, Dept Cardiovasc Surg, Diyarbakir, Turkey.
RP Kaya, H (corresponding author), Dicle Univ, Fac Med, Dept Cardiol, Diyarbakir, Turkey.
EM dr_hasankaya@yahoo.com
RI Demirtas, Sinan/A-4122-2014; Kaya, Hasan/F-8496-2013
OI Demirtas, Sinan/0000-0001-9983-0183; Kaya, Hasan/0000-0003-3923-4026
CR Grenon SM, 2007, CAN J CARDIOL, V23, P1159
   Gulcan O, 2011, ANADOLU KARDIYOL DER, V11, P368, DOI 10.5152/akd.2011.090
   Tsuchida M, 2009, CIRC J, V73, P963, DOI 10.1253/circj.CJ-08-0164
NR 3
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2012
VL 42
IS 8
BP 580
EP 581
DI 10.4070/kcj.2012.42.8.580
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IN
UT WOS:000209080200014
PM 22977458
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JE
   Koo, BK
AF Kim, Jeong-Eun
   Koo, Bon-Kwon
TI Fractional Flow Reserve: The Past, Present and Future
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Coronary artery disease; Fractional flow reserve; myocardiol; Ischemia
ID PERCUTANEOUS CORONARY INTERVENTION; INTRAVENOUS ADENOSINE; PRESSURE
   MEASUREMENTS; FUNCTIONAL SEVERITY; STENOSIS SEVERITY; BLOOD-FLOW;
   TASK-FORCE; FOLLOW-UP; REVASCULARIZATION; ANGIOGRAPHY
AB Revascularization of coronary artery stenosis should be based on the objective evidence of ischemia. It is common practice for physicians to make decisions on revascularization in the cardiac catheterization laboratory based on the results of angiography, despite the fact that angiographic information does not correlate well with the functional significance of a coronary lesion. Fractional flow reserve (FFR) is a physiologic parameter which can be measured easily during the invasive procedure and can assess the functional significance of coronary stenosis. FFR-guided revascularization strategy is reported to be more effective than angiography-guided strategy in patients with coronary artery disease. Moreover, novel technologies based on FFR have been developed and will soon be incorporated into clinical practice.
C1 Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.
   Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea.
RP Koo, BK (corresponding author), Seoul Natl Univ Hosp, Ctr Cardiovasc, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM bkkoo@snu.ac.kr
RI Kim, Jeong Eun/J-5434-2012; Koo, Bon-Kwon/J-5374-2012
CR Bech GJW, 2001, HEART, V86, P547, DOI 10.1136/heart.86.5.547
   Berger A, 2005, J AM COLL CARDIOL, V46, P438, DOI 10.1016/j.jacc.2005.04.041
   De Bruyne B, 2003, CIRCULATION, V107, P1877, DOI 10.1161/01.CIR.0000061950.24940.88
   deBruyne B, 1996, CIRCULATION, V94, P1842, DOI 10.1161/01.CIR.94.8.1842
   DEBRUYNE B, 1994, CIRCULATION, V89, P1013, DOI 10.1161/01.CIR.89.3.1013
   Fearon WF, 2010, CIRCULATION, V122, P2545, DOI 10.1161/CIRCULATIONAHA.109.925396
   Fischer JJ, 2006, CATHETER CARDIO INTE, V68, P544, DOI 10.1002/ccd.20748
   Jang HJ, 2011, KOREAN CIRC J
   KERN MJ, 1991, J AM COLL CARDIOL, V18, P718, DOI 10.1016/0735-1097(91)90795-B
   Kim HJ, 2010, ANN BIOMED ENG, V38, P3195, DOI 10.1007/s10439-010-0083-6
   Koo BK, 2008, EUR HEART J, V29, P726, DOI 10.1093/eurheartj/ehn045
   Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066
   Lindstaedt M, 2009, CLIN RES CARDIOL, V98, P717, DOI 10.1007/s00392-009-0056-7
   Lindstaedt M, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.03.026
   Min JK, 2011, J CARDIOVASC COMPUT, V5, P301, DOI 10.1016/j.jcct.2011.08.003
   Nair PK, 2011, JACC-CARDIOVASC INTE, V4, P1085, DOI 10.1016/j.jcin.2011.07.011
   Nam CW, 2011, J AM COLL CARDIOL, V58, P1211, DOI 10.1016/j.jacc.2011.06.020
   PIJLS NHJ, 1993, CIRCULATION, V87, P1354, DOI 10.1161/01.CIR.87.4.1354
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087
   Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012
   Potvin JM, 2006, AM J CARDIOL, V98, P289, DOI 10.1016/j.amjcard.2006.02.032
   Sen S, 2012, J AM COLL CARDIOL, V59, P1392, DOI 10.1016/j.jacc.2011.11.003
   Seo MK, 2010, CIRCULATION, V122
   Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963
   Shaw LJ, 2004, J NUCL CARDIOL, V11, P171, DOI 10.1016/j.nuclcard.2003.12.004
   Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815
   Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277
   Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096
   Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611
   VOGEL RA, 1988, J AM COLL CARDIOL, V12, P692, DOI 10.1016/S0735-1097(88)80058-5
   WHITE CW, 1984, NEW ENGL J MED, V310, P819, DOI 10.1056/NEJM198403293101304
   WILSON RF, 1990, CIRCULATION, V82, P1595, DOI 10.1161/01.CIR.82.5.1595
   Wongpraparut N, 2005, AM J CARDIOL, V96, P877, DOI 10.1016/j.amjcard.2005.05.040
   Yong ASC, 2011, EUR HEART J, V32, P345, DOI 10.1093/eurheartj/ehq259
NR 35
TC 11
Z9 11
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2012
VL 42
IS 7
BP 441
EP 446
DI 10.4070/kcj.2012.42.7.441
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IM
UT WOS:000209080100001
PM 22870076
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, JH
AF Shin, Joon-Han
TI Is the Measurement of Epicardial Fat in Obese Adolescents Valuable?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Ajou Univ, Med Ctr, Dept Cardiol, Suwon 443721, South Korea.
RP Shin, JH (corresponding author), Ajou Univ, Med Ctr, Dept Cardiol, 164 World Cup Ro, Suwon 443721, South Korea.
EM shinjh@ajou.ac.kr
CR Ahn SG, 2008, HEART, V94, DOI 10.1136/hrt.2007.118471
   August GP, 2008, J CLIN ENDOCR METAB, V93, P4576, DOI 10.1210/jc.2007-2458
   Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515
   Eroglu S, 2009, NUTR METAB CARDIOVAS, V19, P211, DOI 10.1016/j.numecd.2008.05.002
   Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042
   Gorter PM, 2008, AM J CARDIOL, V102, P380, DOI 10.1016/j.amjcard.2008.04.002
   Iacobellis G, 2004, AM J CARDIOL, V94, P1084, DOI 10.1016/j.amjcard.2004.06.075
   Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698
   Kim SJ, 2012, KOREAN CIRC J, V42, P471, DOI 10.4070/kcj.2012.42.7.471
   Park JS, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-29
   Rabkin SW, 2007, OBES REV, V8, P253, DOI 10.1111/j.1467-789X.2006.00293.x
   Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019
   황정원, 2008, Journal of Cardiovascular Imaging, V16, P17
NR 13
TC 2
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2012
VL 42
IS 7
BP 447
EP 448
DI 10.4070/kcj.2012.42.7.447
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IM
UT WOS:000209080100002
PM 22870077
OA Green Published
DA 2021-04-22
ER

PT J
AU Cetin, M
   Kocaman, SA
   Erdogan, T
   Canga, A
   Durakoglugil, ME
   Satiroglu, O
   Akgul, O
   Kiris, T
   Cicek, Y
   Yaylak, B
   Dogan, S
   Sahin, I
   Bostan, M
AF Cetin, Mustafa
   Kocaman, Sinan Altan
   Erdogan, Turan
   Canga, Aytun
   Durakoglugil, Murtaza Emre
   Satiroglu, Omer
   Akgul, Ozgur
   Kiris, Tuncay
   Cicek, Yuksel
   Yaylak, Baris
   Dogan, Sitki
   Sahin, Ismail
   Bostan, Mehmet
TI The Independent Relationship of Systemic Inflammation With Fragmented
   QRS Complexes in Patients With Acute Coronary Syndromes
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Electrocardiography; Coronary artery disease; Inflammation; Acute
   coronary syndrome; Risk assessment
ID BUNDLE-BRANCH BLOCK; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; CARDIAC
   FIBROSIS; ANATOMIC BASIS; HEART-FAILURE; 12-LEAD ECG; Q-WAVE;
   ABNORMALITIES; MORTALITY
AB Background and Objectives: QRS complex fragmentations are frequently seen on routine electrocardiograms with narrow or wide QRS complex. Fragmented QRS complex (fQRS) is associated with increased morbidity and mortality, sudden cardiac death and recurrent cardiovascular events. In this study, we aimed to interrogate the relationship of systemic inflammation with the presence of fQRS in patients with acute coronary syndromes (ACS).
   Subjects and Methods: Two-hundred and twenty eligible patients with ACS that underwent coronary angiography were enrolled consecutively in this study. Patients with significant organic valve disease and those with any QRS morphology that had a QRS duration >= 120 ms as well as patients with permanent pacemakers were excluded from this study.
   Results: Patients with fQRS were of a higher age (p=0.02), had increased C-reactive protein (CRP) levels (p<0.001), prolonged QRS time (p<0.001), extent of coronary artery disease (CAD) (p<0.001), creatine kinase-MB (CK-MB) levels (p=0.006) and Q wave on admission electrocardiography (p<0.001) in comparison to patients with non-fragmented QRS. When we performed multiple logistic regression analysis, fQRS was found to be related to increased CRP levels {odds ratio (OR): 1.2, 95% confidence interval (CI): 1.045-1.316, p=0.007}, QRS duration (OR: 1.1, 95% CI: 1.033-1.098, p<0.001), extent of CAD (OR: 1.5, 95% CI: 1.023-2.144, p=0.037), Q wave (OR: 2.2, 95% CI: 1.084-4.598, p=0.03) and CK-MB levels (OR: 1.0, 95% CI: 1.001-1.037, p=0.04) independently.
   Conclusion: In our study, we found that fQRS was independently related to increased CRP. Fragmented QRS that may result as an end effect of inflammation at cellular level can represent increased cardiac risk by different causative mechanisms in patients with ACS.
C1 [Cetin, Mustafa; Kocaman, Sinan Altan; Canga, Aytun; Dogan, Sitki; Sahin, Ismail] Rize Educ & Res Hosp, Dept Cardiol, TR-53020 Rize, Turkey.
   [Erdogan, Turan; Durakoglugil, Murtaza Emre; Satiroglu, Omer; Cicek, Yuksel; Bostan, Mehmet] Rize Univ, Fac Med, Dept Cardiol, Rize, Turkey.
   [Akgul, Ozgur] Mehmet Akif Ersoy Educ & Res Hosp, Dept Cardiol, Istanbul, Turkey.
   [Kiris, Tuncay] Ordu State Hosp, Dept Cardiol, Ordu, Turkey.
   [Yaylak, Baris] Artvin State Hosp, Dept Cardiol, Artvin, Turkey.
RP Kocaman, SA (corresponding author), Rize Educ & Res Hosp, Dept Cardiol, TR-53020 Rize, Turkey.
EM sinanaltan@gmail.com
RI Durakoglugil, Emre/Q-3547-2019; Cetin, Mustafa/A-2919-2016
OI Durakoglugil, Emre/0000-0001-5268-4262; Cetin,
   Mustafa/0000-0001-6342-436X; Erdogan, Turan/0000-0003-2986-5457
CR Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940
   Basaran Y, 2011, ECHOCARDIOGR-J CARD, V28, P62, DOI 10.1111/j.1540-8175.2010.01242.x
   Bursi F, 2007, AM J MED, V120, P616, DOI 10.1016/j.amjmed.2006.07.039
   Calore C, 2007, J CARDIOVASC MED, V8, P821, DOI 10.2459/JCM.0b013e3280101e3c
   Chatterjee S, 2010, CLIN CARDIOL, V33, P68, DOI 10.1002/clc.20709
   Cheema A, 2010, CIRC-ARRHYTHMIA ELEC, V3, P339, DOI 10.1161/CIRCEP.110.940478
   Das MK, 2006, CIRCULATION, V113, P2495, DOI 10.1161/CIRCULATIONAHA.105.595892
   Das MK, 2009, AM J CARDIOL, V104, P1631, DOI 10.1016/j.amjcard.2009.07.046
   Das MK, 2010, CURR OPIN CARDIOL, V25, P59, DOI 10.1097/HCO.0b013e328333d35d
   Das MK, 2008, CIRC-ARRHYTHMIA ELEC, V1, P258, DOI 10.1161/CIRCEP.107.763284
   Das MK, 2009, HEART RHYTHM, V6, pS8, DOI 10.1016/j.hrthm.2008.10.019
   Das MK, 2010, HEART RHYTHM, V7, P74, DOI 10.1016/j.hrthm.2009.09.065
   Das MK, 2007, HEART RHYTHM, V4, P1385, DOI 10.1016/j.hrthm.2007.06.024
   Eisen A, 2009, SEMIN ARTHRITIS RHEU, V39, P145, DOI 10.1016/j.semarthrit.2008.05.001
   FLOWERS NC, 1969, CIRCULATION, V39, P531, DOI 10.1161/01.CIR.39.4.531
   FRIEDMAN PL, 1975, CIRC RES, V36, P127, DOI 10.1161/01.RES.36.1.127
   GARDNER PI, 1985, CIRCULATION, V72, P596, DOI 10.1161/01.CIR.72.3.596
   GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2
   Kadi H, 2012, MOD RHEUMATOL, V22, P238, DOI 10.1007/s10165-011-0493-9
   Kazumi T, 2003, METABOLISM, V52, P1113, DOI 10.1016/S0026-0495(03)00184-7
   Korhonen P, 2010, ANN NONINVAS ELECTRO, V15, P130, DOI 10.1111/j.1542-474X.2010.00353.x
   LESH MD, 1988, J ELECTROCARDIOL, V21, pS69, DOI 10.1016/0022-0736(88)90061-1
   Mahenthiran J, 2007, J NUCL CARDIOL, V14, P347, DOI 10.1016/j.nuclcard.2007.02.003
   Pietrasik G, 2007, AM J CARDIOL, V100, P583, DOI 10.1016/j.amjcard.2007.03.063
   Reddy CVR, 2006, ANN NONINVAS ELECTRO, V11, P132, DOI 10.1111/j.1542-474X.2006.00094.x
   Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397
   VARRIALE P, 1992, AM HEART J, V123, P369, DOI 10.1016/0002-8703(92)90648-F
   WEINBERG SL, 1950, AM HEART J, V40, P745, DOI 10.1016/0002-8703(50)90203-1
   WIENER I, 1984, AM HEART J, V107, P86, DOI 10.1016/0002-8703(84)90138-8
   Zhang RX, 2010, HYPERTENSION, V55, P953, DOI 10.1161/HYPERTENSIONAHA.109.140608
NR 30
TC 14
Z9 17
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2012
VL 42
IS 7
BP 449
EP 457
DI 10.4070/kcj.2012.42.7.449
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IM
UT WOS:000209080100003
PM 22870078
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, YM
   Ahn, T
   Lee, K
   Shin, KC
   Jung, ES
   Shin, DS
   Kim, MG
   Kang, WC
   Han, SH
   Choi, IS
   Shin, EK
AF Park, Yae Min
   Ahn, Taehoon
   Lee, Kyounghoon
   Shin, Kwen-Chul
   Jung, Eul Sik
   Shin, Dong Su
   Kim, Myeong Gun
   Kang, Woong Chol
   Han, Seung Hwan
   Choi, In Suck
   Shin, Eak Kyun
TI A Comparison of Two Brands of Clopidogrel in Patients With Drug-Eluting
   Stent Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Generic drug; Treatment outcome clopidogrel; Stent thrombosis
AB Background and Objectives: Although generic clopidogrel is widely used, clinical efficacy and safety between generic and original clopidogrel had not been well evaluated. The aim of this study was to evaluate the clinical outcomes of 2 oral formulations of clopidogrel 75 mg tablets in patients with coronary artery disease (CAD) undergoing drug-eluting stent (DES) implantation.
   Subjects and Methods: Between July 2006 and February 2009, 428 patients that underwent implantation with DES for CAD and completed > 1 year of clinical follow-up were enrolled in this study. Patients were divided into the following 2 groups based on treatment formulation, Platless (R) (test formulation, n=211) or Plavix (R) (reference formulation, n=217). The incidence of 1-year major adverse cardiovascular and cerebrovascular event (MACCE) and stent thrombosis (ST) were retrospectively reviewed.
   Results: The baseline demographic and procedural characteristics were not significantly different between two treatment groups. The incidence of 1-year MACCEs was 8.5% {19/211, 2 deaths, 4 myocardial infarctions (MIs), 2 strokes, and 11 target vessel revascularizations (TVRs)} in Platless (R) group vs. 7.4% (16/217, 4 deaths, 1 MI, 2 strokes, and 9 TVRs) in Plavix (R) group (p=0.66). The incidence of 1-year ST was 0.5% (1 definite and subacute ST) in Platless (R) group vs. 0% in Plavix (R) group (p=0.49).
   Conclusion: In this study, the 2 tablet preparations of clopidogrel showed similar rates of MACCEs, but additional prospective randomized studies with pharmacodynamics and platelet reactivity are needed to conclude whether generic clopidgrel may replace original clopidogrel.
C1 [Park, Yae Min; Ahn, Taehoon; Lee, Kyounghoon; Shin, Kwen-Chul; Jung, Eul Sik; Shin, Dong Su; Kim, Myeong Gun; Kang, Woong Chol; Han, Seung Hwan; Choi, In Suck; Shin, Eak Kyun] Gachon Univ Med & Sci, Gil Hosp, Dept Internal Med, Div Cardiol, Inchon 405760, South Korea.
RP Ahn, T (corresponding author), Gachon Univ Med & Sci, Gil Hosp, Dept Internal Med, Div Cardiol, 1198 Guwol Dong, Inchon 405760, South Korea.
EM encore@gilhospital.com
OI Jung, Eul Sik/0000-0003-3898-4693
CR Akin I, 2010, CLIN RES CARDIOL, V99, P393, DOI 10.1007/s00392-010-0136-8
   Applegate RJ, 2002, J AM COLL CARDIOL, V40, P78, DOI 10.1016/S0735-1097(02)01924-1
   Applegate RJ, 2009, CIRC-CARDIOVASC INTE, V2, P35, DOI 10.1161/CIRCINTERVENTIONS.108.805630
   Bahrami G, 2008, J CHROMATOGR B, V864, P168, DOI 10.1016/j.jchromb.2008.01.049
   Barragan P, 2003, CATHETER CARDIO INTE, V59, P295, DOI 10.1002/ccd.10497
   Colombo A, 2003, CIRCULATION, V107, P2178, DOI 10.1161/01.CIR.0000070592.04766.36
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   Di Girolamo G, 2010, CLIN THER, V32, P161, DOI 10.1016/j.clinthera.2010.01.010
   From AM, 2010, EUROINTERVENTION, V6, P269, DOI 10.4244/
   Gomez Y, 2004, J PHARMACEUT BIOMED, V34, P341, DOI 10.1016/S0731-7085(03)00533-8
   Gremmel T, 2010, HEART, V96, P186, DOI 10.1136/hrt.2009.171488
   Jeong Young-Hoon, 2010, Korean Journal of Internal Medicine, V25, P154, DOI 10.3904/kjim.2010.25.2.154
   Katoh M, 2000, EUR J CLIN PHARMACOL, V55, P843, DOI 10.1007/s002280050706
   Kim SD, 2009, CLIN THER, V31, P793, DOI 10.1016/j.clinthera.2009.04.017
   Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4
   Muller I, 2003, THROMB HAEMOSTASIS, V89, P783
   Robinson A, 2007, J CHROMATOGR B, V848, P344, DOI 10.1016/j.jchromb.2006.10.076
   Siller-Matula JM, 2008, J AM COLL CARDIOL, V52, P1557, DOI 10.1016/j.jacc.2008.07.055
   Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516
   Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411
   Suh J, 2010, JACC-CARDIOVASC INTE, V3, P383, DOI 10.1016/j.jcin.2009.10.033
   Weerakkody GJ, 2007, PLATELETS, V18, P428, DOI 10.1080/09537100701206790
   Wood S., 2006, HEARTWIRE MIXED THOU
   Yusuf S, 2001, NEW ENGL J MED, V345, P494
NR 24
TC 4
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2012
VL 42
IS 7
BP 458
EP 463
DI 10.4070/kcj.2012.42.7.458
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IM
UT WOS:000209080100004
PM 22870079
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, BH
   Ko, YG
   Her, AY
   Kim, JS
   Hwang, KC
   Shin, DH
   Kim, BK
   Choi, D
   Ha, JW
   Hong, MK
   Jang, Y
AF Kim, Bo Hyun
   Ko, Young-Guk
   Her, Ae-Young
   Kim, Jung-Sun
   Hwang, Ki-Chul
   Shin, Dong-Ho
   Kim, Byeong-Keuk
   Choi, Donghoon
   Ha, Jong-Won
   Hong, Myeong-Ki
   Jang, Yangsoo
TI Serial Plasma Levels of Angiogenic Factors in Patients With ST-Segment
   Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary
   Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Angiogenesis modulating agents; Vascular
   endothelial growth factor; Angiopoietin-2
AB Background and Objectives: Patients with acute myocardial infarction show varying degrees of collateral development. However, the relationships between angiogenic factors and degree of collaterals are not well known.
   Subjects and Methods: Fifty-nine patients (mean age, 59 +/- 10 years) with ST-segment elevation myocardial infarction (STEMI) underwent primary percutaneous coronary intervention (PCI). Patients were divided into one of 2 groups: group I (Rentrop collateral grade 0/1, n=34) or group II (grade 2/3, n=25). Plasma levels of vascular endothelial growth factor (VEGF), soluble VEGF receptor (sFlt-1), angiopoietin (Ang)-2, and soluble Tie-2 at baseline, 24 and 48 hours after PCI were measured.
   Results: There were fewer diabetic patients and higher incidence of previous angina and multi-vessel disease in group II. Group II had a lower left ventricular ejection fraction and a trend toward longer pain-to-balloon time. Plasma levels of Ang-2, sFlt-1 were elevated prior to primary PCI and decreased after PCI, whereas plasma level of VEGF was relatively low initially, however rose after PCI. sTie-2 levels showed no significant interval change in group I, but decreased over time in group II. VEGF, sFlt-1, and Tie-2 levels did not differ between the groups at each time point. However, plasma levels of Ang-2 were higher in group I than in group II at baseline and at 48 hours.
   Conclusion: Presence of collaterals in STEMI patients undergoing primary PCI was associated with lesser rise in Ang-2 plasma level. VEGF showed a delayed response to acute ischemia compared to Ang-2. Clinical implications of our findings need to be investigated in further studies.
C1 [Kim, Bo Hyun; Ko, Young-Guk; Kim, Jung-Sun; Hwang, Ki-Chul; Shin, Dong-Ho; Kim, Byeong-Keuk; Choi, Donghoon; Ha, Jong-Won; Hong, Myeong-Ki; Jang, Yangsoo] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
   [Her, Ae-Young] Kangwon Natl Univ Hosp, Div Cardiol, Chunchon, South Korea.
RP Ko, YG (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM ygko@yuhs.ac
OI Kim, Byeong-Keuk/0000-0003-2493-066X; Choi,
   Donghoon/0000-0002-2009-9760; Hong, Myeong-Ki/0000-0002-2090-2031; Kim,
   Jung-Sun/0000-0003-2263-3274; Jang, Yangsoo/0000-0002-2169-3112; Ha,
   Jong-Won/0000-0002-8260-2958; Shin, Dong-Ho/0000-0002-7874-5542; Ko,
   Young-Guk/0000-0001-7748-5788
FU Society of Korean Circulation; Korea Healthcare Technology R&D Project,
   Ministry for Health, Welfare & Family Affairs, Republic of Korea
   [A085012, A102064, A110879]; Korea Health 21 R&D Project, Ministry of
   Health & Welfare, Republic of Korea [0412-CR02-0704-0001, A085136];
   Cardiovascular Research Center, Seoul, Republic of Korea
FX This study was partly supported by research grants from the Society of
   Korean Circulation (2008), the Korea Healthcare Technology R&D Project,
   Ministry for Health, Welfare & Family Affairs, Republic of Korea (Nos.
   A085012, A102064 and A110879), the Korea Health 21 R&D Project, Ministry
   of Health & Welfare, Republic of Korea (0412-CR02-0704-0001 and no.
   A085136), and the Cardiovascular Research Center, Seoul, Republic of
   Korea.
CR Berry C, 2007, EUR HEART J, V28, P278, DOI 10.1093/eurheartj/ehl446
   Beygui F, 2003, HEART, V89, P179, DOI 10.1136/heart.89.2.179
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Elsman P, 2004, EUR HEART J, V25, P854, DOI 10.1016/j.ehj.2004.03.005
   Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027
   Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482
   Helisch A, 2003, MICROCIRCULATION, V10, P83, DOI 10.1038/sj.mn.7800173
   Hojo Y, 2000, J AM COLL CARDIOL, V35, P968, DOI 10.1016/S0735-1097(99)00632-4
   Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013
   Iribarren C, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-31
   Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355
   Lee KW, 2004, CIRCULATION, V110, P2355, DOI 10.1161/01.CIR.0000138112.90641.7F
   Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904
   Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899
   Matsunaga T, 2003, AM J PHYSIOL-HEART C, V285, pH352, DOI 10.1152/ajpheart.00621.2002
   Ogawa H, 2000, CARDIOLOGY, V93, P93, DOI 10.1159/000007008
   RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587
   RENTROP KP, 1988, AM J CARDIOL, V61, P677, DOI 10.1016/0002-9149(88)91048-X
   Saharinen P, 2010, CURR OPIN HEMATOL, V17, P198, DOI 10.1097/MOH.0b013e3283386673
   Siemeister G, 1999, CANCER RES, V59, P3185
   Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3
   Tressel SL, 2008, ARTERIOSCL THROM VAS, V28, P1989, DOI 10.1161/ATVBAHA.108.175463
   van Royen N, 2009, J AM COLL CARDIOL, V55, P17, DOI 10.1016/j.jacc.2009.06.058
   Visconti RP, 2002, P NATL ACAD SCI USA, V99, P8219, DOI 10.1073/pnas.122109599
   Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3
NR 25
TC 5
Z9 5
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2012
VL 42
IS 7
BP 464
EP 470
DI 10.4070/kcj.2012.42.7.464
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IM
UT WOS:000209080100005
PM 22870080
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SJ
   Kim, HS
   Jung, JW
   Kim, NS
   Noh, CI
   Hong, YM
AF Kim, Sung Jin
   Kim, Hae Soon
   Jung, Jo Won
   Kim, Nam Su
   Noh, Chung Il
   Hong, Young Mi
TI Correlation Between Epicardial Fat Thickness by Echocardiography and
   Other Parameters in Obese Adolescents
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Epicardial fat; Obesity; Adolescent; Echocardiography
AB Background and Objectives: Obesity has reached epidemic proportions globally and affects people of all ages. Recent studies have shown that visceral adipose tissue measured by magnetic resonance imaging and/or computed tomography correlates positively with epicardial adipose tissue. Epicardial fat, which is correlated to several metabolic parameters, can be assessed by echocardiography. The aim of this study was to evaluate epicardial fat thickness and other metabolic parameters in obese adolescents and investigate the correlation between epicardial fat thickness and other metabolic parameters in obese adolescents.
   Subjects and Methods: We selected 99 subjects, between ages 15-17 years of age, to be enrolled in this study. Sixty five obese adolescents with a body mass index (BMI) >95 percentile and 34 control subjects were included in this study. Echocardiographic measurements including epicardial fat thickness as well as anthropometric and blood pressure (BP) measurements were performed. The following parameters were estimated: blood glucose, total cholesterol, triglyceride, high density lipoprotein-cholesterol, low density lipoprotein-cholesterol, aspartate aminotransferase, alanine aminotransferase, free fatty acid, interleukin-6, tumor necrosis factor-alpha, leptin, adiponectin and high sensitive C reactive protein.
   Results: The obese group showed a statistically significant correlation with echocardiographic epicardial fat thickness and, BMI, waist circumference, obesity index, fat percentage, systolic BP, insulin level, leptin and adiponectin. Multivariate linear regression analysis showed epicardial fat thickness as the most significant independent parameter to correlate with obese adolescents.
   Conclusion: These data suggest that epicardial fat thickness measured by echocardiography is a practical and accurate parameter for predicting visceral obesity.
C1 [Kim, Sung Jin; Kim, Hae Soon; Hong, Young Mi] Ewha Womans Univ, Sch Med, Dept Pediat, Seoul 158710, South Korea.
   [Jung, Jo Won] Ajou Univ, Sch Med, Dept Pediat, Suwon 441749, South Korea.
   [Kim, Nam Su] Hanyang Univ, Coll Med, Dept Pediat, Seoul 133791, South Korea.
   [Noh, Chung Il] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea.
RP Hong, YM (corresponding author), Ewha Womans Univ, Sch Med, Dept Pediat, 1071 Anyangcheon Ro, Seoul 158710, South Korea.
EM hongym@chollian.net
FU Korean Heart Research Foundation
FX This research was supported by a grant from the Korean Heart Research
   Foundation (2009).
CR Alpert BS, 2007, J PEDIATR-US, V150, P219, DOI 10.1016/j.jpeds.2006.12.042
   Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1
   Bettencourt N, 2012, INT J CARDIOL, V158, P26, DOI 10.1016/j.ijcard.2010.12.085
   Bonora E, 1995, METABOLISM, V44, P1617, DOI 10.1016/0026-0495(95)90084-5
   CHA KC, 1995, J APPL PHYSIOL, V79, P1316
   Gil TY, 2008, J KOREAN MED SCI, V23, P35, DOI 10.3346/jkms.2008.23.1.35
   Gormez S, 2011, INTERNAL MED, V50, P805, DOI 10.2169/internalmedicine.50.4753
   Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319
   Iacobellis G, 2005, CYTOKINE, V29, P251, DOI 10.1016/j.cyto.2004.11.002
   Iacobellis G, 2011, INT J CARDIOL, V146, P452, DOI 10.1016/j.ijcard.2010.10.117
   Iacobellis G, 2009, J AM SOC ECHOCARDIOG, V22, P1311, DOI 10.1016/j.echo.2009.10.013
   Im JA, 2007, J PEDIATR-US, V150, P247, DOI 10.1016/j.jpeds.2006.11.038
   Iwao S, 2001, OBES RES, V9, P685, DOI 10.1038/oby.2001.93
   Lee S, 2006, J PEDIATR-US, V148, P188, DOI 10.1016/j.jpeds.2005.10.001
   MARCHINGTON JM, 1989, COMP BIOCHEM PHYS B, V94, P225, DOI 10.1016/0305-0491(89)90337-4
   Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5
   MERCIER JC, 1982, CIRCULATION, V65, P962, DOI 10.1161/01.CIR.65.5.962
   Mookadam Farouk, 2010, Heart Views, V11, P103, DOI 10.4103/1995-705X.76801
   Niboshi A, 2006, EUR J PEDIATR, V165, P625, DOI 10.1007/s00431-006-0135-y
   Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016
   Poirier P, 2007, EUR HEART J, V28, P2047, DOI 10.1093/eurheartj/ehm321
   Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019
   SHIRANI J, 1995, AM J CARDIOL, V76, P414, DOI 10.1016/S0002-9149(99)80116-7
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487
   Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x
NR 25
TC 15
Z9 16
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2012
VL 42
IS 7
BP 471
EP 478
DI 10.4070/kcj.2012.42.7.471
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IM
UT WOS:000209080100006
PM 22870081
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JI
   Kim, IK
AF Kim, Jee In
   Kim, In Kyeom
TI Probing Regulatory Proteins for Vascular Contraction by Deoxyribonucleic
   Acid Microarray
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Contraction; DNA; Microarray; Heat shock; HSP70
AB Background and Objectives: The heat-shock response modulates contractility of vascular smooth muscles. With complementary deoxyribonucleic acid microarray, we tried to identify the novel genes that are involved in the regulation of vascular contraction after heat shock.
   Materials and Methods: Human radial artery strips were mounted in organ baths, exposed at 42 degrees C for 45 minutes, and returned to equilibrate at 37 degrees C. This study examined gene expression profile associated with heat-shock response in radial arteries of patients with hyperlipidemia by using a microarray that contained 5763 human cDNA. The results of microarray hybridization experiments from the radial arteries of 4 different subjects were analyzed and classified by the cluster program.
   Results: Among these differentially-expressed genes, Hsp70, Hsp10, alpha B-crystallin, and Hsp60 were significantly increased by the heat shock response. Of non-HSP genes, 15 genes increased, while 22 genes decreased. Among these 37 genes, alpha B-crystallin (CRYAB) (up 1.92-fold), myosin, light polypeptide kinase transcript variant 8, 6 (up 1.70-fold, up 1.68-fold), catenin (cadherin-associated protein, alpha-like 1) (down-0.57 fold) and tropomyosin 3 (down 0.68-fold) were thought to be related with the contraction. Real-time quantitative polymerase chain reaction showed that Hsp70, Hsp10 and alpha B-crystallin were significantly increased.
   Conclusion: Gene expression profile by heat shock provides information about genes implicated in augmentation of vascular contraction after heat shock.
C1 [Kim, Jee In; Kim, In Kyeom] Kyungpook Natl Univ, Sch Med, Dept Pharmacol, Taegu 700422, South Korea.
   [Kim, In Kyeom] Kyungpook Natl Univ, Sch Med, Cardiovasc Res Inst, Taegu 700422, South Korea.
RP Kim, IK (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Pharmacol, 2-101 Dongin Dong, Taegu 700422, South Korea.
EM inkim@knu.ac.kr
FU Korean Society of Circulation
FX This work was supported by an Industry-Academy Cooperation research
   grant from the Korean Society of Circulation (2006).
CR An Hyo Soon, 2010, Korean Circ J, V40, P131, DOI 10.4070/kcj.2010.40.3.131
   Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648
   Cipolla MJ, 2002, FASEB J, V16, P72, DOI 10.1096/cj.01-0104hyp
   Datta SA, 1999, J BIOL CHEM, V274, P34773, DOI 10.1074/jbc.274.49.34773
   Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Geeves MA, 2005, CELL MOL LIFE SCI, V62, P1462, DOI 10.1007/s00018-005-5015-5
   Gordon AM, 2000, PHYSIOL REV, V80, P853
   GROENEN PJTA, 1994, EUR J BIOCHEM, V225, P1, DOI 10.1111/j.1432-1033.1994.00001.x
   Kim IK, 2004, N-S ARCH PHARMACOL, V369, P402, DOI 10.1007/s00210-004-0880-2
   LEESMILLER JP, 1991, BIOESSAYS, V13, P429, DOI 10.1002/bies.950130902
   Lim Kyoung Ah, 2010, Korean Circ J, V40, P459, DOI 10.4070/kcj.2010.40.9.459
   LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215
   Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806
   Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6
   Morton H, 1998, IMMUNOL CELL BIOL, V76, P483, DOI 10.1046/j.1440-1711.1998.00782.x
   Park Hyun-Woong, 2010, Korean Circ J, V40, P62, DOI 10.4070/kcj.2010.40.2.62
   Seo J, 2000, MOL CELLS, V10, P733, DOI 10.1007/s100590000037
   Silver DL, 1997, J BIOL CHEM, V272, P25353, DOI 10.1074/jbc.272.40.25353
   Snoeckx LHEH, 2001, PHYSIOL REV, V81, P1461
   Tang DD, 2003, AM J PHYSIOL-HEART C, V285, pH1528, DOI 10.1152/ajpheart.00188.2003
   Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8
   Xu QB, 2002, ARTERIOSCL THROM VAS, V22, P1547, DOI 10.1161/01.ATV.0000029720.59649.50
   XU QB, 1995, CIRCULATION, V92, P1223, DOI 10.1161/01.CIR.92.5.1223
   이건, 2004, The Korean Journal of Physiology & Pharmacology, V8, P147
NR 25
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2012
VL 42
IS 7
BP 479
EP 486
DI 10.4070/kcj.2012.42.7.479
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IM
UT WOS:000209080100007
PM 22870082
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JM
   Yoon, CH
AF Lee, Joo Myung
   Yoon, Chang-Hwan
TI Acute Coronary Stent Thrombosis in Cancer Patients: A Case Series Report
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary thrombosis; Thrombosis; Neoplasms; Pancreatic neoplasms; Lung
   neoplasms; Coronary angiography; Stent thrombosis
AB There have been a growing numbers of patients diagnosed with malignancy and coronary artery disease simultaneously or serially. In the era of percutaneous coronary intervention (PCI), stent thrombosis has been a rare but challenging problem. Recently, we experienced two unique cases of acute stent thrombosis in patients with malignancy. The first case showed acute and subacute stent thrombosis after PCI. The second case revealed simultaneous thromboses in stent and non-treated native coronary artery. We believe that we need rigorous precautions in the treatment of patients with coronary artery disease and malignancy, especially with regards to deciding how and whether to revascularize, as well as which anti-platelet agents to select.
C1 [Lee, Joo Myung] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul 110744, South Korea.
   [Yoon, Chang-Hwan] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Cardiol, Songnam 463707, South Korea.
RP Yoon, CH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Cardiol, 173beon Gil, Songnam 463707, South Korea.
EM changhwanyoon@gmail.com
OI Lee, Joo Myung/0000-0002-2178-4014; Yoon, Chang-Hwan/0000-0001-6305-4442
CR Blich M, 2010, J INVASIVE CARDIOL, V22, P461
   Canale ML, 2006, J CARDIOVASC MED, V7, P835, DOI 10.2459/01.JCM.0000250874.09273.9b
   De Cicco M, 2004, CRIT REV ONCOL HEMAT, V50, P187, DOI 10.1016/j.critrevonc.2003.10.003
   Gemici Gokmen, 2009, Clin Cardiol, V32, pE94, DOI 10.1002/clc.20291
   Gurbel PA, 2010, CIRCULATION, V121, P1188, DOI 10.1161/CIRCULATIONAHA.109.919456
   Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126
   Kalapura T, 1999, ANGIOLOGY, V50, P1021, DOI 10.1177/000331979905001208
   Khorana AA, 2009, J CLIN ONCOL, V27, P4839, DOI 10.1200/JCO.2009.22.3271
   Lee AYY, 2010, HEMATOL-AM SOC HEMAT, P144, DOI 10.1182/asheducation-2010.1.144
   Lee SP, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-87
   Montalescot G, 2009, LANCET, V373, P723, DOI 10.1016/S0140-6736(09)60441-4
   NAKAGAWA T, 1994, ANGIOLOGY, V45, P333, DOI 10.1177/000331979404500501
   Wijesinghe Namal, 2006, Heart Lung Circ, V15, P337, DOI 10.1016/j.hlc.2006.03.010
NR 13
TC 8
Z9 10
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2012
VL 42
IS 7
BP 487
EP 491
DI 10.4070/kcj.2012.42.7.487
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IM
UT WOS:000209080100008
PM 22870083
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JH
   Jang, WJ
   Ahn, KJ
   Song, YB
   Hahn, JY
   Choi, JH
   Choi, SH
   Lee, SH
   Gwon, HC
AF Kim, Jung Hyuk
   Jang, Woo Jin
   Ahn, Kyung-Ju
   Song, Young Bin
   Hahn, Joo-Yong
   Choi, Jin Ho
   Choi, Seung-Hyuk
   Lee, Sang Hoon
   Gwon, Hyeon-Cheol
TI Successful Retrieval of Intravascular Stent Remnants With a Combination
   of Rotational Atherectomy and a Gooseneck Snare
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Percutaneous transluminal coronary angioplasty; Stents; Migration;
   Rotational atherectomy
AB Stent migration from the delivery balloon catheter is a rare but serious complication during percutaneous coronary intervention, particularly when a part of the stent stretches into the aorta. We report an unusual case of stent migration treated with a combination of a gooseneck snare and rotablation. A part of the stent was overstretched and unrolled into the aorta and the rest of the stent remained implanted in the coronary artery. The stent was captured with a gooseneck snare but could not be retrieved because it was connected to a stent remnant implanted in the coronary artery. The stent strut was cut with rotablation, and the stent was successfully removed through the femoral sheath.
C1 [Kim, Jung Hyuk; Jang, Woo Jin; Ahn, Kyung-Ju] Han Il Gen Hosp, Div Cardiol, Dept Internal Med, Seoul, South Korea.
   [Song, Young Bin; Hahn, Joo-Yong; Choi, Jin Ho; Choi, Seung-Hyuk; Lee, Sang Hoon; Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Cardiol,Cardiac & Vasc Ctr, Seoul 135710, South Korea.
RP Gwon, HC (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Cardiol,Cardiac & Vasc Ctr, 50 Irwon Dong, Seoul 135710, South Korea.
EM hcgwon@skku.edu
RI Hahn, Joo-Yong/AAU-7250-2020
OI Hahn, Joo-Yong/0000-0002-4412-377X; Choi, Seung-Hyuk/0000-0002-0304-6317
CR Alexiou K, 2006, TEX HEART I J, V33, P139
   Capuano F, 2008, J CARDIOVASC MED, V9, P1140, DOI 10.2459/JCM.0b013e328309c951
   Eggebrecht H, 2000, CATHETER CARDIO INTE, V51, P432, DOI 10.1002/1522-726X(200012)51:4<432::AID-CCD12>3.0.CO;2-1
   Reidemeister JC, 1996, Z KARDIOL S1, V85, pS67
   Sheth R, 2007, CARDIOVASC INTER RAD, V30, P48, DOI 10.1007/s00270-005-0297-4
   Wolf F, 2008, CARDIOVASC INTER RAD, V31, P563, DOI 10.1007/s00270-007-9201-8
NR 6
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2012
VL 42
IS 7
BP 492
EP 496
DI 10.4070/kcj.2012.42.7.492
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IM
UT WOS:000209080100009
PM 22870084
OA Green Published
DA 2021-04-22
ER

PT J
AU Jin, SA
   Seong, SW
   Kim, SS
   Lee, YD
   Choi, UL
   Choi, SW
   Jeong, JO
AF Jin, Seon-Ah
   Seong, Seok-Woo
   Kim, Song Soo
   Lee, Young Dal
   Choi, Ung Lim
   Choi, Si-Wan
   Jeong, Jin-Ok
TI Successful Percutaneous Coronary Intervention in an Anomalous Origin of
   the Right Coronary Artery From the Ascending Aorta Above the Left Sinus
   of the Valsalva
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessel anomalies; Angioplasty
ID CONGENITAL ANEURYSM
AB The anomalous origin of the right coronary artery (RCA) is a rare condition. Most RCA anomalies are usually found incidentally, but these findings have clinical significance because many patients, particularly young ones, present with sudden death, myocardial ischemia and syncope without other symptoms. We describe a case of a 39-year-old male patient that presented with effort chest pain and was diagnosed with anomalous RCA that originated from the ascending aorta with prior history of repairing ruptured sinus valsalva and ventricular septal defect. The anomalous origin of RCA was identified by multidetector computed tomography (MDCT). Successful percutaneous coronary intervention was performed guided by MDCT coronary images and intravascular ultrasound.
C1 [Jin, Seon-Ah; Seong, Seok-Woo; Lee, Young Dal; Choi, Ung Lim; Choi, Si-Wan; Jeong, Jin-Ok] Chungnam Natl Univ, Coll Med, Dept Internal Med, Taejon 301721, South Korea.
   [Kim, Song Soo] Chungnam Natl Univ, Coll Med, Dept Radiol, Taejon 301721, South Korea.
RP Jeong, JO (corresponding author), Chungnam Natl Univ, Coll Med, Dept Internal Med, 282 Munhwa Ro, Taejon 301721, South Korea.
EM jojeong@cnu.ac.kr
OI jin, seon-ah/0000-0001-6895-9101; Seong, In-Whan/0000-0003-4628-0258;
   Kim, Song Soo/0000-0002-3078-2184; Jeong, Jin-Ok/0000-0003-0763-4754;
   Choi, Si Wan/0000-0002-1035-1512
CR Angelini P, 2002, CIRCULATION, V105, P2449, DOI 10.1161/01.CIR.0000016175.49835.57
   Angelini P, 2002, TEX HEART I J, V29, P271
   HUTCHINS GM, 1976, CIRC RES, V38, P572, DOI 10.1161/01.RES.38.6.572
   Kardos A, 1997, CATHETER CARDIO DIAG, V42, P270, DOI 10.1002/(SICI)1097-0304(199711)42:3<270::AID-CCD8>3.0.CO;2-9
   문재연, 2008, Korean Circulation Journal, V38, P390
   Laurence L, 1975, Paroi Arterielle, V3, P55
   Moreno Raul, 2004, J Invasive Cardiol, V16, P159
   SAKAKIBARA S, 1962, AM HEART J, V63, P405, DOI 10.1016/0002-8703(62)90287-9
   SCAGLIOTTI D, 1986, J AM COLL CARDIOL, V7, P443, DOI 10.1016/S0735-1097(86)80520-4
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
   Zhang Man, 2010, Korean Circ J, V40, P251, DOI 10.4070/kcj.2010.40.5.251
NR 11
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2012
VL 42
IS 7
BP 497
EP 500
DI 10.4070/kcj.2012.42.7.497
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IM
UT WOS:000209080100010
PM 22870085
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, WS
   Yoon, YJ
   Park, CW
   Park, SH
   Nam, OO
   Rhee, I
AF Han, Won-Seok
   Yoon, Young-Jin
   Park, Cheol-Woo
   Park, Sung-Hwan
   Nam, Oun-Ouk
   Rhee, Il
TI Staphylococcus aureus Pericardial Abscess Presenting as Severe Sepsis
   and Septic Shock After Acupuncture Therapy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Staphylococcus aureus; Pericarditis; Acupuncture
AB Pericardial abscess is an extremely rare complication of Staphylococcus aureus bacteremia. We report a case of a 72-year-old woman with multiple acupuncture scars on both knees who presented with shortness of breath and general weakness. Transthoracic echocardiography and pericardiocentesis confirmed the presence of pericardial fluid collection. Staphylococcus aureus grew in both pericardial fluid and blood. Although an aggressive medical treatment including intravenous antibiotics and percutaneous drainage, the patient died 2 days after admission.
C1 [Han, Won-Seok; Yoon, Young-Jin; Park, Cheol-Woo; Park, Sung-Hwan; Nam, Oun-Ouk; Rhee, Il] Dong Eui Univ, Coll Oriental Med, Cardiac & Vasc Ctr, Dept Med,Dong Eui Med Ctr, Pusan 614710, South Korea.
RP Rhee, I (corresponding author), Dong Eui Univ, Coll Oriental Med, Cardiac & Vasc Ctr, Dept Med,Dong Eui Med Ctr, 62 Yangjeong Ro, Pusan 614710, South Korea.
EM cormed21@gmail.com
CR Chung HT, 2007, PEDIATR HEMAT ONCOL, V24, P275, DOI 10.1080/08880010701364249
   El-Ahdab F, 2003, SOUTH MED J, V96, P926, DOI 10.1097/01.SMJ.0000072357.15085.0F
   Lin Tsung-Hsien, 2005, Kaohsiung Journal of Medical Sciences, V21, P322
   Mutreja D, 2010, INDIAN J PATHOL MICR, V53, P763, DOI 10.4103/0377-4929.72082
   Park JY, 2011, TUBERC RESPIR DIS, V70, P347, DOI 10.4046/trd.2011.70.4.347
   Perez-Cardona J, 2008, P R HEALTH SCI J, V27, P387
   van de Donk NWCJ, 2010, INTERACT CARDIOV TH, V10, P818, DOI 10.1510/icvts.2009.230904
   김석연, 2007, Infection and Chemotherapy, V39, P314
NR 8
TC 4
Z9 8
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2012
VL 42
IS 7
BP 501
EP 503
DI 10.4070/kcj.2012.42.7.501
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IM
UT WOS:000209080100011
PM 22870086
OA Green Published
DA 2021-04-22
ER

PT J
AU Dahdouh, Z
   Roule, V
   Lognone, T
   Sabatier, R
   Bignon, M
   Malcor, G
   Lemaitre, A
   Blanchart, K
   Wain-Hobson, J
   Saplacan, V
   Cutone, F
   Buklas, D
   Ivascau, C
   Massetti, M
   Grollier, G
AF Dahdouh, Ziad
   Roule, Vincent
   Lognone, Therese
   Sabatier, Remi
   Bignon, Mathieu
   Malcor, Guillaume
   Lemaitre, Adrien
   Blanchart, Katrien
   Wain-Hobson, Julien
   Saplacan, Vladimir
   Cutone, Fabio
   Buklas, Dimitrios
   Ivascau, Calin
   Massetti, Massimo
   Grollier, Gilles
TI Iatrogenic Bidirectional Dissection of the Right Coronary Artery and the
   Ascending Aorta: The Worst Nightmare for an Interventional Cardiologist
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary angioplasty; Coronary dissection; Ascending aorta
AB Although rare, iatrogenic aortocoronary dissection is one of the complications most dreaded by the interventional cardiologist. If not managed promptly, it can have redoubted and serious consequences. Herein, we present the case of a 70 year-old woman who was treated by stenting of the second segment of the right coronary artery (RCA) for recurrent angina but, unfortunately, the procedure was complicated by anterograde dissection of the RCA with a simultaneous retrograde propagation to the proximal part of the ascending aorta. Successful stenting of the entry point was able to recuperate the RCA and to limit the retrograde propagation to the ascending aorta, but there was an extension of the dissection to the aortic valve leaflets resulting in a massive aortic insufficiency. Therefore, an isolated surgical aortic valve replacement was performed.
C1 [Dahdouh, Ziad; Roule, Vincent; Lognone, Therese; Sabatier, Remi; Bignon, Mathieu; Malcor, Guillaume; Lemaitre, Adrien; Blanchart, Katrien; Wain-Hobson, Julien; Grollier, Gilles] CHU Caen, Dept Cardiol, F-14000 Caen, France.
   [Saplacan, Vladimir; Cutone, Fabio; Buklas, Dimitrios; Ivascau, Calin; Massetti, Massimo] CHU Caen, Dept Thorac & Cardiovasc Surg, F-14000 Caen, France.
RP Dahdouh, Z (corresponding author), Univ Hosp Caen, Ave Cote de Nacre, F-14033 Caen, France.
EM ziad_dahdouh@hotmail.com
CR Akgul F, 2006, TEX HEART I J, V33, P515
   Al-Saif SM, 2000, CATHETER CARDIO INTE, V49, P86, DOI 10.1002/(SICI)1522-726X(200001)49:1<86::AID-CCD20>3.0.CO;2-F
   Dunning DW, 2000, CATHETER CARDIO INTE, V51, P387, DOI 10.1002/1522-726X(200012)51:4<387::AID-CCD3>3.3.CO;2-2
   Maiello Luigi, 2003, Ital Heart J, V4, P419
   Wykrzykowska Joanna J, 2006, J Invasive Cardiol, V18, pE217
   Yip HK, 2001, CHEST, V119, P493, DOI 10.1378/chest.119.2.493
NR 6
TC 5
Z9 5
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2012
VL 42
IS 7
BP 504
EP 506
DI 10.4070/kcj.2012.42.7.504
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IM
UT WOS:000209080100012
PM 22870087
OA Green Published
DA 2021-04-22
ER

PT J
AU Islam, AKMM
   Zaman, S
   Doza, F
AF Islam, A. K. M. Monwarul
   Zaman, Shahana
   Doza, Fatema
TI Ortner Syndrome due to Concomitant Mitral Stenosis and Bronchiectasis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mitral stenosis; Recurrent laryngeal nerve; Bronchiectasis
AB Ortner syndrome or cardiovocal syndrome is a rare condition characterized by hoarseness of voice associated with cardiovascular pathology. Compression of the left recurrent laryngeal nerve by the pulmonary artery or left atrium is usually responsible. Recurrent aspiration pneumonia may cause significant morbidity and mortality. Early recognition and treatment along with removal of the underlying cause, if possible, may change an otherwise poor prognosis of the condition. The case presented here describes a 35-year old female with hoarseness of voice in association with mitral stenosis and bronchiectasis. Presence of dual pathology contributed to the overall pathophysiology of the disease, and made its management difficult.
C1 [Islam, A. K. M. Monwarul; Zaman, Shahana; Doza, Fatema] Natl Inst Cardiovasc Dis, Dept Cardiol, Dhaka 1207, Bangladesh.
RP Islam, AKMM (corresponding author), Natl Inst Cardiovasc Dis, Dept Cardiol, Dhaka 1207, Bangladesh.
EM drmonwarbd@yahoo.com
CR ALBERTINI RE, 1972, CHEST, V62, P508, DOI 10.1378/chest.62.4.508
   Escribano Jose F Guijarro, 2006, Vasc Endovascular Surg, V40, P75, DOI 10.1177/153857440604000111
   Graham LVSM, 1999, J VOICE, V13, P414, DOI 10.1016/S0892-1997(99)80046-0
   Gulel O, 2007, CIRCULATION, V115, pE318, DOI 10.1161/CIRCULATIONAHA.106.649814
   Hartl DM, 2005, J CLIN ENDOCR METAB, V90, P3084, DOI 10.1210/jc.2004-2533
   Ishii K, 2004, LARYNGOSCOPE, V114, P2176, DOI 10.1097/01.mlg.0000149453.91005.ab
   Ishimoto S, 2002, CHEST, V121, P1911, DOI 10.1378/chest.121.6.1911
   KAGAL A E, 1975, Journal of Postgraduate Medicine (Bombay), V21, P91
   Lee SI, 2006, DYSPHAGIA, V21, P129, DOI 10.1007/s00455-006-9015-x
   Meyer E, 2008, S AFR J CHILD HEALTH, V2, P170
   Mulpuru SK, 2008, HEART LUNG CIRC, V17, P1, DOI 10.1016/j.hlc.2007.04.007
   MURTY GE, 1989, J LARYNGOL OTOL, V103, P968, DOI 10.1017/S0022215100110643
   NAKAO M, 1985, J AM COLL CARDIOL, V5, P788, DOI 10.1016/S0735-1097(85)80413-7
   Ortner N., 1897, WIEN KLIN WOCHENSCHR, V10, P753
   Pai RK, 2005, HEART RHYTHM, V2, P182, DOI 10.1016/j.hrthm.2004.10.030
   Plastiras Sotiris C, 2010, Clin Cardiol, V33, pE99, DOI 10.1002/clc.20646
   Prada-Delgado O, 2011, NEW ENGL J MED, V365, P939, DOI 10.1056/NEJMicm1014167
   RUBENS F, 1989, CHEST, V95, P1139, DOI 10.1378/chest.95.5.1139
   Solanki S V, 1972, Indian Heart J, V24, P43
   Tewari P, 1996, ANN THORAC SURG, V61, P1721, DOI 10.1016/0003-4975(96)00185-3
NR 20
TC 2
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2012
VL 42
IS 7
BP 507
EP 510
DI 10.4070/kcj.2012.42.7.507
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IM
UT WOS:000209080100013
PM 22870088
OA Green Published
DA 2021-04-22
ER

PT J
AU Jo, YJ
   Lee, EJ
   Oh, JW
   Moon, CM
   Cho, DK
   Cho, YH
   Byun, KH
   Eun, LY
AF Jo, Yun Ju
   Lee, Eun Jeong
   Oh, Jin Won
   Moon, Chang Min
   Cho, Deok Kyu
   Cho, Yun Hyeong
   Byun, Ki Hyun
   Eun, Lucy Youngmin
TI Aortic Dissection and Rupture in a Child (vol 41, pg 156, 2011)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Jo, Yun Ju; Lee, Eun Jeong; Oh, Jin Won; Moon, Chang Min; Eun, Lucy Youngmin] Kwandong Univ, Myongji Hosp, Ctr Cardiovasc, Dept Pediat Cardiol, Goyang, South Korea.
   [Cho, Deok Kyu; Cho, Yun Hyeong; Byun, Ki Hyun] Kwandong Univ, Myongji Hosp, Ctr Cardiovasc, Dept Adult Cardiol, Goyang, South Korea.
RP Jo, YJ (corresponding author), Kwandong Univ, Myongji Hosp, Ctr Cardiovasc, Dept Pediat Cardiol, Goyang, South Korea.
CR Eun Lucy Youngmin, 2011, J Cardiol Cases, V3, pe46, DOI 10.1016/j.jccase.2010.08.001
   Jo YJ, 2011, KOREAN CIRC J, V41, P156, DOI 10.4070/kcj.2011.41.3.156
NR 2
TC 0
Z9 0
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2012
VL 42
IS 7
BP 511
EP 511
DI 10.4070/kcj.2012.42.7.511
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IM
UT WOS:000209080100014
OA Green Published
DA 2021-04-22
ER

PT J
AU Jee, SH
   Jo, J
AF Jee, Sun Ha
   Jo, Jaeseong
TI Linkage of Epidemiologic Evidence With the Clinical Aspects of Metabolic
   Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Metabolic cardiovascular syndrome; Atherosclerosis; Ischemic heart
   disease
ID CORONARY-HEART-DISEASE; FRAMINGHAM RISK SCORE; CARDIOVASCULAR-DISEASE;
   PROVISIONAL REPORT; BLOOD-GLUCOSE; MORTALITY; DEFINITION; PREDICTION;
   ASSOCIATION; PREVALENCE
AB Metabolic syndrome (MetS) is characterized by a cluster of cardiovascular risk factors, such as hypertension, glucose intolerance, high triglycerides, and a low high density lipoprotein-cholesterol level. MetS is known to be associated with cardiovascular diseases. In order to diagnose MetS, definitions such as National Cholesterol Education Program Adult Treatment Panel III, American Heart Association/National Heart Lung and Blood Institute, International Diabetes Federation, World Health Organization, European Group for the Study of Insulin Resistance and American College of Endocrinology are widely used. However, using different criteria may lead to confusion regarding the diagnosis and treatment of patients with MetS in the primary care setting. Our objected was to review 3 aspects concerning MetS using the Metabolic Syndrome Research Initiatives study of 123892 healthy Koreans (1994-2001) that had a maximum follow-up of 12 years. The 3 aspects were reviewed by determination of the association of MetS with the development of atherosclerotic cardiovascular disease (ASCVD) and ischemic heart disease (IHD). Based on our findings, each metabolic factor associated with MetS was not weighted equally. The hazard ratio (HR) was higher in individuals with higher glucose compared with the HR in individuals with higher body mass index. Individuals with pre-MetS (having 1 or 2 metabolic factors) had 1.5-2.3 fold higher risk of developing ASCVD and IHD in both genders. In the presence of MetS, both singly and in combination, precede the development of ASCVD and IHD and individuals with pre-MetS must not be ignored as there is no apparent threshold in defining MetS. Furthermore, MetS may complement the Framingham Risk Score and can be used as the first line approach to treat the ASCVD or IHD.
C1 [Jee, Sun Ha; Jo, Jaeseong] Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Inst Hlth Promot, Seoul 120752, South Korea.
   [Jo, Jaeseong] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul 120752, South Korea.
RP Jee, SH (corresponding author), Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, 50 Yonsei Ro, Seoul 120752, South Korea.
EM jsunha@yuhs.ac
OI Jee, Sun Ha/0000-0001-9519-3068
FU Seoul RAMP;BD program, Republic of Korea [10526]; National RAMP;D
   Program for Cancer Control, Ministry for Health, Welfare and Family
   Affairs, Republic of Korea [0920330]; National Research Foundation of
   Korea (NRF) grant - Korea government (MEST) [2011-0029348]
FX This work was supported by an extramural grant from the Seoul R&BD
   program, Republic of Korea (10526), a grant from the National R&D
   Program for Cancer Control, Ministry for Health, Welfare and Family
   Affairs, Republic of Korea (0920330) and the National Research
   Foundation of Korea (NRF) grant funded by the Korea government (MEST)
   (No. 2011-0029348).
CR Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210
   Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc09-S062, 10.2337/dc12-S064, 10.2337/dc12-s064, 10.2337/dc11-S062]
   Anderson JL, 2004, CARDIOLOGY, V101, P185, DOI 10.1159/000076695
   Andreadis EA, 2007, AM J HYPERTENS, V20, P558, DOI 10.1016/j.amjhyper.2006.12.001
   Aronson D, 2002, CARDIOVASC DIABETOL, V1, DOI 10.1186/1475-2840-1-1
   Balkau B, 1999, DIABETIC MED, V16, P442
   Blake GJ, 2002, CIRCULATION, V106, P1930, DOI 10.1161/01.CIR.0000033222.75187.B9
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180
   De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6
   Dekker JM, 2005, CIRCULATION, V112, P666, DOI 10.1161/CIRCULATIONAHA.104.516948
   Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3
   Einhorn D, 2003, ENDOCR PRACT, V9, P236
   Ford ES, 2004, ATHEROSCLEROSIS, V173, P309, DOI 10.1016/j.atherosclerosis.2003.12.022
   Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769
   Gavin JR, 1997, DIABETES CARE, V20, P1183
   Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372
   Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6
   Haffner SM, 1996, ANN MED, V28, P363, DOI 10.3109/07853899608999094
   Inoue S., 2000, ASIA PACIFIC PERSPEC
   Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683
   Jaquet A, 2008, DIABETES METAB, V34, P177, DOI 10.1016/j.diabet.2007.10.005
   Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017
   Kadota A, 2007, DIABETES CARE, V30, P1533, DOI 10.2337/dc06-2074
   Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289
   Katzmarzyk PT, 2006, DIABETES CARE, V29, P404, DOI 10.2337/diacare.29.02.06.dc05-1636
   Kim HC, 2005, STROKE, V36, P1642, DOI 10.1161/01.STR.0000173404.37692.9b
   Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649
   Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709
   McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385
   Nakanishi N, 2004, DIABETES RES CLIN PR, V64, P59, DOI 10.1016/j.diabres.2003.10.001
   Park JK., 2000, KOREAN J PREV MED, V33, P76
   Stern MP, 2005, DIABETES CARE, V28, P238
   Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644
   World Health Organization, 1992, INT CLASS DIS REL HL
   Yoon YS, 2007, INT J OBESITY, V31, P528, DOI 10.1038/sj.ijo.0803442
NR 38
TC 7
Z9 11
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2012
VL 42
IS 6
BP 371
EP 378
DI 10.4070/kcj.2012.42.6.371
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IL
UT WOS:000209080000001
PM 22787466
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, CS
AF Park, Chul Soo
TI Rho-Associated Kinase 2 Polymorphism of Vasospastic Angina in Korean
   Population
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID NITRIC-OXIDE SYNTHASE; MESSENGER-RNA; PROTEIN; PHOSPHORYLATION;
   ACTIVATION; AKT; INHIBITION; EXPRESSION; MYOSIN; SPASM
C1 Catholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Div Cardiol,Dept Internal Med, Seoul 150713, South Korea.
RP Park, CS (corresponding author), Catholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Div Cardiol,Dept Internal Med, 62 Yeouido Dong, Seoul 150713, South Korea.
EM charlie@catholic.ac.kr
CR Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246
   ARNAL JF, 1994, AM J PHYSIOL-CELL PH, V267, pC1381
   Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200
   Chang KY, 2003, CORONARY ARTERY DIS, V14, P293, DOI 10.1097/01.mca.0000073080.69657.71
   Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8
   Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224
   Eto M, 2001, CIRC RES, V89, P583, DOI 10.1161/hh1901.097084
   Flowers MA, 1995, AM J PHYSIOL-HEART C, V269, pH1988
   Glueck CJ, 2010, AM J CARDIOL, V105, P792, DOI 10.1016/j.amjcard.2009.10.062
   Laufs U, 2000, J CLIN INVEST, V106, P15, DOI 10.1172/JCI9639
   LIAO JK, 1995, J BIOL CHEM, V270, P319, DOI 10.1074/jbc.270.1.319
   Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1002.105938
   Ming XF, 2002, MOL CELL BIOL, V22, P8467, DOI 10.1128/MCB.22.24.8467-8477.2002
   Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3
   Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128
   Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x
   Suzuki S, 2007, PHARMACOGENET GENOM, V17, P919, DOI 10.1097/FPC.0b013e328136bd35
   Takemoto M, 2002, CIRCULATION, V106, P57, DOI 10.1161/01.CIR.0000020682.73694.AB
   Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82
   Yoo SY, 2012, KOREAN CIRC J, V42, P406, DOI 10.4070/kcj.2012.42.6.406
   YOSHIZUMI M, 1993, CIRC RES, V73, P205, DOI 10.1161/01.RES.73.1.205
NR 21
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2012
VL 42
IS 6
BP 379
EP 381
DI 10.4070/kcj.2012.42.6.379
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IL
UT WOS:000209080000002
PM 22787467
OA Green Published
DA 2021-04-22
ER

PT J
AU Yu, LH
   Kim, MH
   Zhang, HZ
   Park, JS
   Park, TH
   Kim, YD
   Cha, KS
   Han, JY
AF Yu, Long Hao
   Kim, Moo Hyun
   Zhang, Hong Zhe
   Park, Jong Seong
   Park, Tae Ho
   Kim, Young Dae
   Cha, Kwang Soo
   Han, Jin Yeong
TI Impact of Platelet Function Test on Platelet Responsiveness and Clinical
   Outcome After Coronary Stent Implantation: Platelet Responsiveness and
   Clinical Outcome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Platelet function tests; Coronary artery disease; Drug-eluting stents
AB Background and Objectives: The aim of this study was to confirm the predictive cut-off values for P2Y12 reaction units (PRU) and aspirin reaction units (ARU) and to evaluate the clinical impact of VerifyNow (R) assays.
   Subjects and Methods: From November 2007 to October 2009, 186 eligible patients were prospectively recruited. Post-treatment platelet reactivity was measured by VerifyNow (R) assays within 12 to 24 hours after intervention, followed by standard dual maintenance dose therapy for 1 year. All patients had scheduled clinical follow-ups at 1, 3, 6, and 12 months.
   Results: The rate of low responders to clopidogrel, aspirin, and both drugs were 41.4%, 10.2%, and 3.8%, respectively. The predictive factors for low responsiveness to clopidogrel (PRU >= 240) were female sex, age, and non-use of cilostazol medication in our univariate analysis and age >= 65 years and non-use cilostazol in the multivariate analysis. The predictors of low responsiveness to aspirin (ARU >= 550) were male sex and age in both univariate and multivariate analyses. There was no significant difference in the clinical event rate with a cut-off value of PRU >= 240 or ARU >= 550 for 30 days and 1-year (p>0.05).
   Conclusion: Hyporesponsiveness to antiplatelet agents (namely aspirin and clopidogrel) was identified in about half of the patients. The cut-off point of PRU >= 240 or ARU >= 550 did not confer predictive value for 30-day or 1-year clinical event rates in patients who had undergone coronary intervention with drug-eluting stents.
C1 [Yu, Long Hao; Kim, Moo Hyun; Zhang, Hong Zhe; Park, Jong Seong; Park, Tae Ho; Kim, Young Dae] Dong A Univ, Coll Med, Dept Cardiol, Pusan 602715, South Korea.
   [Han, Jin Yeong] Dong A Univ, Coll Med, Dept Lab Med, Pusan 602715, South Korea.
   [Yu, Long Hao; Kim, Moo Hyun; Zhang, Hong Zhe] Dong A Univ, Med Ctr, Clin Trial Ctr, Pusan 602715, South Korea.
   [Cha, Kwang Soo] Pusan Natl Univ, Coll Med, Dept Cardiol, Pusan, South Korea.
RP Kim, MH (corresponding author), Dong A Univ, Coll Med, Dept Cardiol, 26 Daesingongwon Ro, Pusan 602715, South Korea.
EM kimmh@dau.ac.kr
FU Research Foundation of The Korean Society of Cardiology
FX This study was financially supported by grants from the Research
   Foundation of The Korean Society of Cardiology (2007), and a part of
   this study was presented as an abstract at The 54th Annual Scientific
   Meeting of The Korean Society of Cardiology in 2010.
CR Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044
   Angiolillo DJ, 2009, REV ESP CARDIOL, V62, P113, DOI 10.1016/S0300-8932(09)70151-4
   Angiolillo DJ, 2009, AM J CARDIOL, V103, p27A, DOI 10.1016/j.amjcard.2008.11.020
   Aradi D, 2010, AM HEART J, V160, P543, DOI 10.1016/j.ahj.2010.06.004
   Bliden KP, 2007, J AM COLL CARDIOL, V49, P657, DOI 10.1016/j.jacc.2006.10.050
   Campo G, 2010, J THROMB THROMBOLYS, V30, P319, DOI 10.1007/s11239-010-0457-5
   Capodanno D, 2009, HAMOSTASEOLOGIE, V29, P376
   Ferreiro JL, 2009, THROMB HAEMOSTASIS, V102, P7, DOI 10.1160/TH09-03-0185
   Geisler T, 2008, J THROMB HAEMOST, V6, P54
   Geisler T, 2006, EUR HEART J, V27, P2420, DOI 10.1093/eurheartj/ehl275
   Gremmel T, 2010, J THROMB HAEMOST, V8, P37, DOI 10.1111/j.1538-7836.2009.03644.x
   Gremmel T, 2011, THROMB HAEMOSTASIS, V106, P211, DOI 10.1160/TH11-03-0137
   Gum PA, 2001, AM J CARDIOL, V88, P230, DOI 10.1016/S0002-9149(01)01631-9
   Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065
   Ko YG, 2011, AM HEART J, V161, P383, DOI 10.1016/j.ahj.2010.10.036
   Lee SP, 2011, J ATHEROSCLER THROMB, V18, P914, DOI 10.5551/jat.9290
   Marcucci R, 2009, CIRCULATION, V119, P237, DOI 10.1161/CIRCULATIONAHA.108.812636
   Patti G, 2008, J AM COLL CARDIOL, V52, P1128, DOI 10.1016/j.jacc.2008.06.038
   Price MJ, 2008, EUR HEART J, V29, P992, DOI 10.1093/eurheartj/ehn046
   Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290
   Price MJ, 2009, AM J CARDIOL, V103, P1339, DOI 10.1016/j.amjcard.2009.01.341
   Slottow TLP, 2009, AM J CARDIOL, V104, P525, DOI 10.1016/j.amjcard.2009.04.015
   Suh JW, 2011, J AM COLL CARDIOL, V57, P280, DOI 10.1016/j.jacc.2010.08.631
   Tantry US, 2009, HAMOSTASEOLOGIE, V29, P368
   Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327
   Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482
   Woo KS, 2010, KOREAN J LAB MED, V30, P460, DOI 10.3343/kjlm.2010.30.5.460
NR 27
TC 9
Z9 13
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2012
VL 42
IS 6
BP 382
EP 389
DI 10.4070/kcj.2012.42.6.382
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IL
UT WOS:000209080000003
PM 22787468
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, HJ
   Kim, JY
   Lee, HJ
   Kim, KH
   Kim, TY
   Lee, CS
   Lee, HC
   Park, TH
   Kim, HS
   Park, YB
AF Kang, Hyun-Jae
   Kim, Ju-Young
   Lee, Ho-Jae
   Kim, Keum-Hyun
   Kim, Tae-Youn
   Lee, Choon-Soo
   Lee, Hyun-Chae
   Park, Tai Hyun
   Kim, Hyo-Soo
   Park, Young-Bae
TI Magnetic Bionanoparticle Enhances Homing of Endothelial Progenitor Cells
   in Mouse Hindlimb Ischemia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Nanoparticles; Stem cells; Ischemia
AB Background and Objectives: Poor homing efficiency is one of the major limitations of current stem cell therapy. Magnetic bionanoparticles (MPs) obtained from Magnetospirillum sp. AMB-1 have a lipid bilayer membrane and ferromagnetic properties. We evaluated a novel priming strategy using MPs to enhance the homing of transplanted progenitor cells to target tissue.
   Materials and Methods: Effects of MP on proliferation, viability, and migration of late human endothelial progenitor cells (EPCs) were examined in vitro. Additionally, effects of MP on gene and protein expression related to survival and adhesion were evaluated. Homing and angiogenic efficiency of MP transferred late EPCs was evaluated in nude mouse hindlimb ischemia model.
   Results: Below threshold concentration, MP transfer did not influence proliferation or survival of late EPCs, but enhanced migration and trans-endothelial migration of late EPCs toward magnet. Below threshold concentration, MP transfer did not influence gene and protein expression related to survival. In the mouse hindlimb ischemia model, late EPCs treated with high dose MP (5 ug/mL) showed enhanced homing of injected late EPCs in the ischemic limb by magnet, compared to low dose MP (1 ug/mL) treated late EPCs. In addition, high dose MP transferred EPC showed significantly better improvement of perfusion in ischemic limb compared to untreated EPC.
   Conclusion: MP transfer with magnet application can be a promising novel strategy to enhance homing efficacy and outcomes of current stem cell therapy.
C1 [Kang, Hyun-Jae; Kim, Ju-Young; Lee, Ho-Jae; Kim, Keum-Hyun; Kim, Tae-Youn; Lee, Choon-Soo; Lee, Hyun-Chae; Kim, Hyo-Soo; Park, Young-Bae] Seoul Natl Univ Hosp, Innovat Res Inst Cell Therapy, Seoul 110744, South Korea.
   [Kang, Hyun-Jae; Kim, Hyo-Soo; Park, Young-Bae] Seoul Natl Univ Hosp, Div Cardiol, Seoul 110744, South Korea.
   [Park, Tai Hyun] Seoul Natl Univ, Inst Bioengn, Sch Chem & Biol Engn, Seoul, South Korea.
RP Kang, HJ (corresponding author), Seoul Natl Univ Hosp, Innovat Res Inst Cell Therapy, Div Cardiol, 101 Daehak Ro, Seoul 110744, South Korea.
EM nowkang@snu.ac.kr
RI Kang, Hyun-Jae/D-6121-2012
OI Kang, Hyun-Jae/0000-0002-3500-1746
FU Korean Society of Cardiology; Innovative Research Institute for Cell
   Therapy, University Hospital - Ministry of Health, Welfare & Family,
   Republic of Korea [A062260]
FX This study was supported by grants from The Korean Society of Cardiology
   (2006) and the Innovative Research Institute for Cell Therapy,
   University Hospital (A062260), sponsored by the Ministry of Health,
   Welfare & Family, Republic of Korea.
CR Agudelo CA, 2011, TISSUE ENG PT A, V17, P2079, DOI [10.1089/ten.tea.2010.0482, 10.1089/ten.TEA.2010.0482]
   Balakumaran A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011462
   Chaudeurge A, 2011, CELL TRANSPLANT, DOI DOI: http://dx. doi. org/10. 3727/096368911x612440
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Han L, 2008, J BIOMATER APPL, V22, P433, DOI 10.1177/0885328207079064
   Hill JM, 2003, CIRCULATION, V108, P1009, DOI 10.1161/01.CIR.0000084537.66419.7A
   Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06
   Kang WJ, 2006, J NUCL MED, V47, P1295
   Kim HS, 2005, FASEB J, V19, P1042, DOI 10.1096/fj.04-2841fje
   Kim JA, 2009, BIOMED MICRODEVICES, V11, P287, DOI 10.1007/s10544-008-9235-y
   Kobayashi T, 2009, ARTHROSCOPY, V25, P1435, DOI 10.1016/j.arthro.2009.06.009
   Komelli A, 2007, ANNU REV BIOCHEM, V76, P351, DOI 10.1146/annurev.biochem.74.082803.133444
   Matuszewski L, 2005, RADIOLOGY, V235, P155, DOI 10.1148/radiol.2351040094
   Templin C, 2006, BASIC RES CARDIOL, V101, P301, DOI 10.1007/s00395-006-0590-7
   Yoo CH, CIRCULATION, V112, P1618
NR 15
TC 13
Z9 13
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2012
VL 42
IS 6
BP 390
EP 396
DI 10.4070/kcj.2012.42.6.390
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IL
UT WOS:000209080000004
PM 22787469
OA Green Published
DA 2021-04-22
ER

PT J
AU Rha, SW
   Chen, KY
   Oh, DJ
   Li, YJ
   Jin, Z
   Poddar, KL
   Ramasamy, S
   Minami, Y
   Elnagar, A
   Choi, BG
   Hong, SP
   Cheon, BW
   Moon, SK
   Im, SI
   Kim, SW
   Na, JO
   Choi, CU
   Lim, HE
   Kim, JW
   Kim, EJ
   Han, SW
   Park, CG
   Seo, HS
   Kim, JH
   Hong, YJ
   Jeong, MH
AF Rha, Seung-Woon
   Chen, Kang-Yin
   Oh, Dong Joo
   Li, Yong-Jian
   Jin, Zhe
   Poddar, Kanhaiya Lal
   Ramasamy, Sureshkumar
   Minami, Yoshiyasu
   Elnagar, Amro
   Choi, Byoung Geol
   Hong, Sang Pyo
   Cheon, Byoung Won
   Moon, Sang Ki
   Im, Sung Il
   Kim, Sun Won
   Na, Jin Oh
   Choi, Cheol Ung
   Lim, Hong Euy
   Kim, Jin Won
   Kim, Eung Ju
   Han, Seong Woo
   Park, Chang Gyu
   Seo, Hong Seog
   Kim, Jung Ha
   Hong, Young Joon
   Jeong, Myung Ho
TI Impact of Heterogeneous Overlapping Drug-Eluting Stents on the Arterial
   Responses of Rabbit Iliac Arteries: A Comparison With Overlapping Bare
   Metal Stents
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Drug-eluting stents; Endothelium; Vasoconstriction
ID INTRAVASCULAR ULTRASOUND; CLINICAL-OUTCOMES; CORONARY; INFLAMMATION;
   IMPLANTATION; RESTENOSIS; THROMBUS; LESIONS; SITES
AB Background and Objectives: Although the use of heterogeneous overlapping drug-eluting stents (DES) is not uncommon in clinical practice, whether the implantation sequences of heterogeneous DES will influence the endothelialization or arterial responses differently remains unclear.
   Materials and Methods: Twenty-one rabbits were randomized to receive overlapping stents in the iliac artery for 3 months {distal sirolimus-eluting stent (SES, Cypher (TM))+ proximal paclitaxel-eluting stent (PES, Taxus (TM)) (C+T, n=7), distal Taxus+proximal Cypher (T+C, n= 7) and bare metal stent (BMS)+ BMS (B+B, n= 7)}. Endothelial function was evaluated by the acetylcholine provocation test during follow-up angiography. Histopathological changes in proximal, overlapped, and distal stented segments were evaluated.
   Results: Although the overall angiographic outcomes were comparable, late loss (mm) in the distal stented segment was higher in the B+B (0.39 +/- 0.07) and C+T (0.40 +/- 0.20) than that in the T+C (0.06 +/- 0.02) group (p<0.001). The incidence of acetylcholine-induced spasm was higher in the DES groups compared with BMS, regardless of the implantation sequences (85.7% in C+T vs. 14.3% in B+B vs. 71.4% in T+C, p=0.017). Notably, only the distal Cypher implantation group (C+T) had three cases of stent fracture. A histopathological analysis showed that despite similar arterial injury scores, Taxus and Cypher stents had higher inflammatory reactions at the overlapped and distal segments compared with those of BMS.
   Conclusion: Despite similar arterial injury, higher inflammatory reactions were observed in overlapping DES segments regardless of the implantation sequence compared with that of BMS. Moreover, DES was associated with impaired endothelial function on the adjacent nonstented segments.
C1 [Rha, Seung-Woon; Chen, Kang-Yin; Oh, Dong Joo; Li, Yong-Jian; Jin, Zhe; Poddar, Kanhaiya Lal; Ramasamy, Sureshkumar; Minami, Yoshiyasu; Elnagar, Amro; Choi, Byoung Geol; Hong, Sang Pyo; Cheon, Byoung Won; Moon, Sang Ki; Im, Sung Il; Kim, Sun Won; Na, Jin Oh; Choi, Cheol Ung; Lim, Hong Euy; Kim, Jin Won; Kim, Eung Ju; Han, Seong Woo; Park, Chang Gyu; Seo, Hong Seog] Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul 152703, South Korea.
   [Chen, Kang-Yin] Tianjin Med Univ, Hosp 2, Dept Cardiol, Tianjin, Peoples R China.
   [Li, Yong-Jian; Jin, Zhe] Tianjin Nankai Hosp, Dept Cardiol, Tianjin, Peoples R China.
   [Kim, Jung Ha; Hong, Young Joon; Jeong, Myung Ho] Chonnam Natl Univ Hosp, Ctr Cardiovasc, Kwangju, South Korea.
RP Oh, DJ (corresponding author), Korea Univ, Guro Hosp, Ctr Cardiovasc, 148 Gurodong Ro, Seoul 152703, South Korea.
EM mddjoh@medimail.co.kr
RI Poddar, Kanhaiya/D-9939-2014
OI Poddar, Kanhaiya/0000-0002-2928-3791; Choi, Byoung
   Geol/0000-0002-6090-869X
FU Korean Society of Cardiology
FX This study was supported by a research grant from the Korean Society of
   Cardiology (2006).
CR Chhatriwalla AK, 2009, CARDIOVASC REVASCULA, V10, P166, DOI 10.1016/j.carrev.2009.02.003
   Chu WW, 2006, AM J CARDIOL, V98, P1563, DOI 10.1016/j.amjcard.2006.07.032
   Colombo A, 2007, CIRCULATION, V116, P1424, DOI 10.1161/CIRCULATIONAHA.106.621359
   Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398
   Finn AV, 2005, CIRCULATION, V112, P270, DOI 10.1161/CIRCULATIONAHA.104.508937
   Her SH, 2011, HEART, V97, P1501, DOI 10.1136/hrt.2011.226308
   Holmes DR, 2010, J AM COLL CARDIOL, V56, P1357, DOI 10.1016/j.jacc.2010.07.016
   Hong YJ, 2007, J KOREAN MED SCI, V22, P802, DOI 10.3346/jkms.2007.22.5.802
   Kang WC, 2007, INT J CARDIOL, V123, P12, DOI 10.1016/j.ijcard.2006.11.104
   Kim JW, 2009, J AM COLL CARDIOL, V53, P1653, DOI 10.1016/j.jacc.2009.01.051
   Lim SY, 2008, CIRC J, V72, P463, DOI 10.1253/circj.72.463
   Lim SY, 2009, J CARDIOL, V54, P375, DOI 10.1016/j.jjcc.2009.06.005
   Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047
   Obata IE, 2007, J AM COLL CARDIOL, V50, P1305, DOI 10.1016/j.jacc.2007.06.031
   SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267, DOI 10.1016/0735-1097(92)90476-4
   Serruys PW, 2002, J AM COLL CARDIOL, V39, P393, DOI 10.1016/S0735-1097(01)01760-0
   Shinke T, 2008, CIRC-CARDIOVASC INTE, V1, P28, DOI 10.1161/CIRCINTERVENTIONS.108.770008
   Tsagalou E, 2005, J AM COLL CARDIOL, V45, P1570, DOI 10.1016/j.jacc.2005.01.049
   Wilson GJ, 2009, CIRCULATION, V120, P141, DOI 10.1161/CIRCULATIONAHA.107.730010
NR 19
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2012
VL 42
IS 6
BP 397
EP 405
DI 10.4070/kcj.2012.42.6.397
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IL
UT WOS:000209080000005
PM 22787470
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoo, SY
   Kim, J
   Cheong, S
   Shin, DH
   Jang, J
   Lee, C
   Tahk, SJ
   Shin, JH
   Choi, SY
   Yoon, MH
AF Yoo, Sang-Yong
   Kim, Jeonguk
   Cheong, Sangsig
   Shin, Dae-Hee
   Jang, Jinkun
   Lee, Changkun
   Tahk, Seung-Jea
   Shin, Joon-Han
   Choi, So-Yeon
   Yoon, Myeong-Ho
TI Rho-Associated Kinase 2 Polymorphism in Patients With Vasospastic Angina
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vasospasm; Rho-associated kinase 2; Polymorphsm; genetic;
   Haplotypes
AB Background and Objectives: Recent studies indicate that in response to vasoconstrictor stimuli, the small GTPase RhoA and its downstream effector, Rho-associated kinase 2 (ROCK)/Rho-kinase, are associated with hypercontraction of the vascular smooth muscle of coronary arteries through augmentation of myosin light chain phosphorylation and Ca2+ sensitization. Expression of ROCK/Rho-kinase mRNA was significantly increased and up-regulated in the spastic coronary artery in a porcine model, and a specific inhibitor of ROCK/Rho-kinase inhibited coronary artery spasm in humans. We therefore explored the role of ROCK2 polymorphisms in the pathogenesis of vasospastic angina (VA).
   Subjects and Methods: We studied 106 patients with VA who exhibited spontaneous or provoked coronary spasm during coronary angiography and compared the prevalence of ROCK2 polymorphisms between this group of patients with VA and controls whose angiograms were normal, and in whom the ergonovine test did not cause spasm (n=107). Five single nucleotide polymorphisms (SNPs) of the ROCK2 gene were selected. SNPs were genotyped by high-resolution melting. Linkage disequilibrium and haplotype analyses were performed using the SHEsis program.
   Results: The prevalence of genotypes of the 5 interesting SNPs in patients with VA was not different from that in the control group. In haplotype analysis, the haplotype G-T-C-T-G (in order of rs978906, rs2271621, rs2230774, rs1515210, and rs3771106) was significantly associated with a decreased risk of VA (p=0.007).
   Conclusion: The haplotype G-T-C-T-G in the ROCK2 gene had a protective effect against VA, suggesting the involvement of ROCK2 in VA pathogenesis.
C1 [Yoo, Sang-Yong; Cheong, Sangsig; Shin, Dae-Hee; Jang, Jinkun; Lee, Changkun] Univ Ulsan, Gangneung Asan Hosp, Coll Med, Div Cardiol,Dept Internal Med, Kangnung, South Korea.
   [Kim, Jeonguk] Univ Ulsan, Gangneung Asan Hosp, Coll Med, Dept Lab Med, Kangnung, South Korea.
   [Tahk, Seung-Jea; Shin, Joon-Han; Choi, So-Yeon; Yoon, Myeong-Ho] Ajou Univ, Coll Med, Dept Internal Med, Div Cardiol, Suwon 441749, South Korea.
RP Kim, J (corresponding author), Univ Ulsan, Gangneung Asan Hosp, Coll Med, Dept Lab Med, 38 Bongdong Gil, Sacheon Myeon 210711, Gangneung, South Korea.
EM jukim@gnah.co.kr
CR CHAHINE RA, 1975, CIRCULATION, V52, P972, DOI 10.1161/01.CIR.52.6.972
   Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0
   Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424
   Kamiunten H, 2004, CIRC J S, V68, P211
   Kandabashi T, 2000, CIRCULATION, V101, P1319, DOI 10.1161/01.CIR.101.11.1319
   Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266
   Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33
   Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136
   Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1002.105938
   Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3
   Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005
   Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751
   Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272
   Shimokawa H, 2000, JPN CIRC J, V64, P1, DOI 10.1253/jcj.64.1
   Shimokawa H, 2002, J CARDIOVASC PHARM, V39, P319, DOI 10.1097/00005344-200203000-00001
   SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0
   Sueda S, 2003, CHEST, V124, P2074, DOI 10.1378/chest.124.6.2074
   SUGIISHI M, 1993, CIRCULATION, V87, P76, DOI 10.1161/01.CIR.87.1.76
   Takai Y, 2001, PHYSIOL REV, V81, P153
   Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853
   Wolfrum S, 2004, ARTERIOSCL THROM VAS, V24, P1842, DOI 10.1161/01.ATV.0000142813.33538.82
   Yasue H, 2008, J CARDIOL, V51, P2, DOI 10.1016/j.jjcc.2008.01.001
   Yoo Sang-Yong, 2009, Korean Circ J, V39, P505, DOI 10.4070/kcj.2009.39.12.505
   Yoo Sang-Yong, 2008, Korean Circulation Journal, V38, P651
NR 26
TC 13
Z9 15
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2012
VL 42
IS 6
BP 406
EP 413
DI 10.4070/kcj.2012.42.6.406
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IL
UT WOS:000209080000006
PM 22787471
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JO
   Kim, YH
   Hyun, MC
AF Kim, Jung Ok
   Kim, Yeo Hyang
   Hyun, Myung Chul
TI Electrocardiography Recordings in Higher Intercostal Space for Children
   With Right Ventricular Outlet Obstruction Reconstruction Operation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart ventricles; Electrocardiography; Thoracic surgery
AB Background and Objectives: We checked traditional and high-level precordial electrocardiogram (ECG) leads in patients who had undergone right ventricular outlet obstruction (RVOT) reconstruction surgery and evaluated the effect of ECG lead position on their QRS duration.
   Subjects and Methods: We enrolled 34 patients who had undergone surgery for congenital heart disease with RVOT obstruction and who had received followed up care that included recorded ECG at a pediatric cardiac out-patient clinic. The control group included 29 patients who did not have hemodynamically significant intracardiac abnormality. We recorded traditional standard 12-leads ECG from the 4th intercostals space, and moved the precordial leads to the 3rd and 2nd intercostals spaces, and recorded ECGs repeatedly.
   Results: In all groups, there was no significant difference of mean QRS duration and QTc interval between traditional standard 12-leads ECGs and ECGs at higher intercostals spaces. There was no significant difference of ECG parameters between groups. In the control group, the degree of the change between the 4th intercostals space (ICS) QRS and 3rd ICS QRS was significant (p=0.031), and although, it was insignificant, ECGs at the 3rd ICS showed decreased QRS duration in group 1 (V1: 3rd ICS 119.21 +/- 21.53 msec vs. 4th ICS 122.80 +/- 31.78 msec. V2: 3rd ICS 113.68 +/- 19.43 msec vs. 4th ICS 118.24 +/- 19.16 msec).
   Conclusion: Although the positional change of ECG leads did not result in a significant effect on measuring QRS duration after surgery, ECG leads at the 3rd ICS rather than at the 4th ICS may cause alteration of ECG readings. Therefore, we suggest that ECGs should be recorded in as accurate a position as possible.
C1 [Kim, Jung Ok] Inje Univ, Busan Paik Hosp, Dept Pediat, Pusan, South Korea.
   [Kim, Yeo Hyang] Keimyung Univ, Sch Med, Dept Pediat, Taegu 700712, South Korea.
   [Hyun, Myung Chul] Kyungpook Natl Univ, Sch Med, Dept Pediat, Taegu, South Korea.
RP Kim, YH (corresponding author), Keimyung Univ, Sch Med, Dept Pediat, 56 Dalseong Ro, Taegu 700712, South Korea.
EM kimyhped@hanmail.net
CR Abd El Rahman MY, 2000, HEART, V84, P416
   Anter E, 2012, HEART RHYTHM, V9, P697, DOI 10.1016/j.hrthm.2011.12.007
   Babu-Narayan SV, 2006, CIRCULATION, V113, P405, DOI 10.1161/CIRCULATIONAHA.105.548727
   Balaji S, 1997, AM J CARDIOL, V80, P160, DOI 10.1016/S0002-9149(97)00311-1
   Batchvarov VN, 2007, EUROPACE, V9, P1081, DOI 10.1093/europace/eum198
   GARSON A, 1983, J AM COLL CARDIOL, V1, P1493, DOI 10.1016/S0735-1097(83)80054-0
   Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8
   Harrison DA, 1997, J AM COLL CARDIOL, V30, P1368, DOI 10.1016/S0735-1097(97)00316-1
   Kugler JD, 1998, J CARDIOVASC ELECTR, V9, P103, DOI 10.1111/j.1540-8167.1998.tb00873.x
   Lee YH, 2010, KOREAN J ORTHOD, V40, P40, DOI 10.4041/kjod.2010.40.1.40
   Lucron H, 1999, AM J CARDIOL, V83, P1369, DOI 10.1016/S0002-9149(99)00102-2
   MARIE PY, 1992, AM J CARDIOL, V69, P785, DOI 10.1016/0002-9149(92)90506-T
   Nanke T, 2002, CIRC J, V66, P549, DOI 10.1253/circj.66.549
   Oreto G, 2010, G ITAL CARDIOL, V11, p3S
   Rudiger A, 2007, AM J EMERG MED, V25, P174, DOI 10.1016/j.ajem.2006.06.018
   Sangwatanaroj S, 2001, CLIN CARDIOL, V24, P776, DOI 10.1002/clc.4960241205
   Sangwatanaroj S, 2001, EUR HEART J, V22, P2290, DOI 10.1053/euhj.2001.2691
   Shimizu W, 2000, J CARDIOVASC ELECTR, V11, P396, DOI 10.1111/j.1540-8167.2000.tb00334.x
   Takagi A, 2002, CIRC J, V66, P1101, DOI 10.1253/circj.66.1101
   Wu Mei-Hwan, 2010, Korean Circ J, V40, P253, DOI 10.4070/kcj.2010.40.6.253
NR 20
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2012
VL 42
IS 6
BP 414
EP 418
DI 10.4070/kcj.2012.42.6.414
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IL
UT WOS:000209080000007
PM 22787472
OA Green Published
DA 2021-04-22
ER

PT J
AU Koo, EH
   Kim, SM
   Park, SM
   Park, JW
   Kim, EK
   Lee, GY
   Chang, SA
   Lee, SC
   Choe, YH
AF Koo, Eun Hee
   Kim, Sung Min
   Park, Sun Mi
   Park, Ji Won
   Kim, Eun Kyoung
   Lee, Ga Yeon
   Chang, Sung-A
   Lee, Sang-Chol
   Choe, Yeon Hyeon
TI Acute Recurrent Pericarditis Accompanied by Graves' Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pericarditis; Graves disease
AB The etiology of acute pericarditis is often thought to be autoimmune, and Graves' disease has been reported in a few series to manifest as acute pericarditis. Since the etiology of recurrent pericarditis is known to be more associated with autoimmune causes, recurrent acute pericarditis may be a potential cardiovascular complication of Graves' disease. We report a case of recurrent acute pericarditis that was presumed to be associated with Graves' disease which was controlled after management of the problem of the thyroid.
C1 [Koo, Eun Hee; Kim, Sung Min; Park, Sun Mi; Park, Ji Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med,Cardiovasc Imaging Ctr, Seoul 135710, South Korea.
   [Kim, Eun Kyoung; Lee, Ga Yeon; Chang, Sung-A; Lee, Sang-Chol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Cardiovasc Imaging Ctr,Dept Med, Seoul 135710, South Korea.
   [Choe, Yeon Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol,Cardiovasc Imaging Ctr, Seoul 135710, South Korea.
   [Choe, Yeon Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci,Cardiovasc Imaging Ctr, Seoul 135710, South Korea.
RP Lee, SC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, 50 Irwon Dong, Seoul 135710, South Korea.
EM chrislee.echo@gmail.com
RI Choe, Yeon Hyeon/F-1422-2010
OI Choe, Yeon Hyeon/0000-0002-9983-048X; Chang, Sung-A/0000-0001-5124-605X
CR Brucato A, 2006, AM J CARDIOL, V98, P267, DOI 10.1016/j.amjcard.2006.01.086
   Clarke NRA, 2002, QJM-INT J MED, V95, P188, DOI 10.1093/qjmed/95.3.188
   Imazio M, 2005, CIRCULATION, V112, P2012, DOI 10.1161/CIRCULATIONAHA.105.542738
   PERMANYERMIRALDA G, 1985, AM J CARDIOL, V56, P623, DOI 10.1016/0002-9149(85)91023-9
   Tsai MS, 2006, AM J EMERG MED, V24, P374, DOI 10.1016/j.ajem.2005.10.020
NR 5
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2012
VL 42
IS 6
BP 419
EP 422
DI 10.4070/kcj.2012.42.6.419
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IL
UT WOS:000209080000008
PM 22787473
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, JW
   Chang, WH
   Hyon, MS
   Youm, W
AF Chung, Jin Wook
   Chang, Won Ho
   Hyon, Min Su
   Youm, Wook
TI Extracorporeal Life Support After Prolonged Resuscitation for
   In-Hospital Cardiac Arrest due to Refractory Ventricular Fibrillation:
   Two Cases Resulting in a Full Recovery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiopulmonary resuscitation; Extracorporeal membrane oxygenation
ID CARDIOPULMONARY-RESUSCITATION
AB Extracorporeal life support (ECLS) has well demonstrated its efficacy in treating in-hospital cardiac arrest and is being used for broader indications. However, ECLS after prolonged cardiopulmonary resuscitation (CPR) has been traditionally contraindicated and is now challenging. Here, we introduce two cases of successful ECLS after prolonged CPR, resulting in a immediate and full recovery. Both these acute ST elevation myocardial infarction patients waiting for primary percutaneous coronary intervention (PCI) suddenly collapsed due to ventricular fibrillation (VF), which was refractory to conventional treatment. After 2 hours of conventional CPR, the ECLS had been implemented and primary PCI could be performed. Subsequent to successful revascularization, the VF was stopped with a single electric shock. In our second case, normal sinus rhythm was spontaneously restored after ECLS implementation, which was completed after 45 minutes of conventional resuscitation. Both patients made a full neurological recovery on the day of the event and were discharged with only minor complications.
C1 [Chung, Jin Wook; Hyon, Min Su] Soonchunhyang Univ Hosp, Dept Internal Med, Seoul, South Korea.
   [Chang, Won Ho; Youm, Wook] Soonchunhyang Univ Hosp, Dept Chest Surg, Seoul, South Korea.
RP Chung, JW (corresponding author), Soonchunhyang Univ, Coll Med, Dept Internal Med, 59 Daesagwan Ro, Seoul 140743, South Korea.
EM jjw25@schmc.ac.kr
CR Chen YS, 2008, LANCET, V372, P554, DOI 10.1016/S0140-6736(08)60958-7
   이일, 2006, Korean Circulation Journal, V36, P11
   Kurusz M, 2002, PERFUSION-UK, V17, P269, DOI 10.1191/0267659102pf581oa
   Mehta RH, 2009, JAMA-J AM MED ASSOC, V301, P1779, DOI 10.1001/jama.2009.600
   Nagao K, 2007, LANCET, V369, P920
   Ong MEH, 2008, RESUSCITATION, V78, P119, DOI 10.1016/j.resuscitation.2008.03.012
   Ramaraj R, 2009, HEART, V95, P1978, DOI 10.1136/hrt.2009.174268
   Ristagno G, 2006, CRIT CARE CLIN, V22, P531, DOI 10.1016/j.ccc.2006.03.011
NR 8
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2012
VL 42
IS 6
BP 423
EP 426
DI 10.4070/kcj.2012.42.6.423
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IL
UT WOS:000209080000009
PM 22787474
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahn, J
   Kim, BS
   Park, H
   Park, K
   Kim, YD
AF Ahn, Jihye
   Kim, Bo-sung
   Park, Hyekyong
   Park, Kyungil
   Kim, Young Dae
TI Cardiogenic Shock From Global Myocardial Ischemia Induced by
   Simultaneous Multivessel Coronary Spasm
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Shock; cardiogenic; Myocardial infarction; Coronary vasospasm
AB Coronary artery spasm is an uncommon, but well recognized, etiology for acute myocardial infarction. However, cardiogenic shock with myocardial infarction resulting from simultaneous multiple coronary artery spasm has been rarely reported, and not in Korea. Recently, we experienced such a case in a 50-year-old Korean man without previous diagnosis of variant angina. The patient, hospitalized for blood sugar control, developed severe chest pain accompanying ST-segment elevation in multiple leads. The patient immediately received cardiac catheterization because of cardiogenic shock. Coronary angiogram revealed the severe and simultaneous spasm of three major epicardial arteries, which was promptly relieved by an intracoronary administration of isosorbide dinitrate. This case highlights the need to rule out the potential mechanism of coronary spasm even in the most severe episodes of acute coronary syndrome.
C1 [Ahn, Jihye; Kim, Bo-sung; Park, Hyekyong; Park, Kyungil; Kim, Young Dae] Dong A Univ, Sch Med, Dept Internal Med, Pusan 602715, South Korea.
RP Kim, YD (corresponding author), Dong A Univ, Sch Med, Dept Internal Med, 26 Daesingongwon Ro, Pusan 602715, South Korea.
EM kimyd@mail.donga.ac.kr
CR Da Costa A, 2001, EUR HEART J, V22, P1459, DOI 10.1053/euhj.2000.2553
   DOO YC, 1999, KOREAN CIRC J, V29, P276
   Golzio Pier-Giorgio, 2004, Ital Heart J, V5, P732
   Jeoung JY, 2002, KOREAN CIRC J, V32, P791
   LANGE RL, 1972, CIRCULATION, V46, P666, DOI 10.1161/01.CIR.46.4.666
   Leary T, 1935, AM HEART J, V10, P338, DOI 10.1016/S0002-8703(35)90315-5
   MARK DB, 1984, CIRCULATION, V69, P880, DOI 10.1161/01.CIR.69.5.880
   Meisel SR, 2002, AM J CARDIOL, V89, P1114, DOI 10.1016/S0002-9149(02)02283-X
   Saito H, 2007, ANGIOLOGY, V58, P112, DOI 10.1177/0003319706297967
   SEVERI S, 1980, AM J CARDIOL, V46, P226, DOI 10.1016/0002-9149(80)90062-4
   VINCENT GM, 1983, NEW ENGL J MED, V309, P220, DOI 10.1056/NEJM198307283090406
   WATERS DD, 1983, CIRCULATION, V68, P258, DOI 10.1161/01.CIR.68.2.258
   WATERS DD, 1982, AM J CARDIOL, V49, P658, DOI 10.1016/0002-9149(82)91943-9
NR 13
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2012
VL 42
IS 6
BP 427
EP 430
DI 10.4070/kcj.2012.42.6.427
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IL
UT WOS:000209080000010
PM 22787475
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, HH
   Moon, KW
   Jung, MH
   Yang, HK
   Park, KS
   Yoo, KD
AF Chung, Han-Hee
   Moon, Keon-Woong
   Jung, Mi-Hyang
   Yang, Hae-Kyung
   Park, Kyung-Seon
   Yoo, Ki-Dong
TI No-Reflow Phenomenon During Treatment of Coronary In-Stent Restenosis
   With a Paclitaxel-Coated Balloon Catheter
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Complications; Coronary restenosis; No-reflow phenomenon
AB Drug-eluting balloon (DEB) with angioplasty a paclitaxel-coated balloon catheter is an effective treatment option in patients with in-stent restenosis (ISR) after a drug-eluting stent (DES). We describe a case in which 'no-reflow' phenomenon developed after DEB angioplasty of a DES ISR lesion. Coronary flow was restored after intracoronary administration of nicorandil.
C1 [Chung, Han-Hee; Moon, Keon-Woong; Jung, Mi-Hyang; Yang, Hae-Kyung; Park, Kyung-Seon; Yoo, Ki-Dong] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Internal Med, Suwon 442723, South Korea.
RP Moon, KW (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Internal Med, 93 Jungbu Daero, Suwon 442723, South Korea.
EM cardiomoon@gmail.com
RI Jung, Mi-Hyang/AAV-2013-2020
OI Jung, Mi-Hyang/0000-0003-0224-5178
CR Iwakura K, 2009, CIRC J, V73, P925, DOI 10.1253/circj.CJ-08-1059
   Limbruno U, 2000, CIRCULATION, V101, P491, DOI 10.1161/01.CIR.101.5.491
   Nakamura T, 2011, JACC-CARDIOVASC INTE, V4, P247, DOI 10.1016/j.jcin.2010.08.028
   Niccoli G, 2009, J AM COLL CARDIOL, V54, P281, DOI 10.1016/j.jacc.2009.03.054
   Rezkalla SH, 2008, CATHETER CARDIO INTE, V72, P950, DOI 10.1002/ccd.21715
   Sakata Y, 1997, JPN CIRC J, V61, P455, DOI 10.1253/jcj.61.455
   Scheller B, 2004, CIRCULATION, V110, P810, DOI 10.1161/01.CIR.0000138929.71660.E0
   Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254
   SKALPE IO, 1983, NEURORADIOLOGY, V24, P219, DOI 10.1007/BF00399775
   Tsubokawa A, 2002, CIRC J, V66, P1119, DOI 10.1253/circj.66.1119
   Unverdorben M, 2010, CLIN RES CARDIOL, V99, P165, DOI 10.1007/s00392-009-0101-6
   Unverdorben M, 2009, CIRCULATION, V119, P2986, DOI 10.1161/CIRCULATIONAHA.108.839282
NR 12
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2012
VL 42
IS 6
BP 431
EP 433
DI 10.4070/kcj.2012.42.6.431
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IL
UT WOS:000209080000011
PM 22787476
OA Green Published
DA 2021-04-22
ER

PT J
AU Gunduz, H
   Demirtas, S
   Vatan, MB
   Cakar, MA
   Akdemir, R
AF Gunduz, Huseyin
   Demirtas, Saadet
   Vatan, Mehmet Bulent
   Cakar, Mehmet Akif
   Akdemir, Ramazan
TI Two Cases of Multivessel Coronary Artery Ectasias Resulting in Acute
   Inferior Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Acute inferior myocardial infarction
AB The incidence of multivessel coronary artery ectasias (CAEs) among patients undergoing coronary artery angiography is very rare. All three coronary vessels can be affected by CAE, but most patients have an isolated arterial ectasia, commonly the right coronary artery. In this report we present two cases with inferior myocardial infarction that was likely caused by thrombotic occlusion of CAEs.
C1 [Gunduz, Huseyin; Demirtas, Saadet; Vatan, Mehmet Bulent; Cakar, Mehmet Akif; Akdemir, Ramazan] Sakarya Univ, Fac Med, Cardiol Dept Korucuk, TR-54100 Sakarya, Turkey.
RP Gunduz, H (corresponding author), Sakarya Univ, Fac Med, Cardiol Dept Korucuk, TR-54100 Sakarya, Turkey.
EM drhuseyingunduz@yahoo.com
RI Gunduz, Huseyin/B-2279-2017
CR ALHARTHI SS, 1991, INT J CARDIOL, V30, P191, DOI 10.1016/0167-5273(91)90094-6
   DAOUD AS, 1963, AM J CARDIOL, V11, P228, DOI 10.1016/0002-9149(63)90064-X
   Ercan E, 2003, INT J CARDIOL, V88, P95, DOI 10.1016/S0167-5273(02)00377-7
   Goz M, 2007, INT J CARDIOL, V119, pE48, DOI 10.1016/j.ijcard.2007.01.112
   HARTNELL GG, 1985, BRIT HEART J, V54, P392
   Inan K, 2009, HEART SURG FORUM, V12, pE294, DOI 10.1532/HSF98.20091082
   Mavrogeni S, 2010, HELL J CARDIOL, V51, P158
   Shimizu M, 2003, CIRC J, V67, P637
   SWAYE PS, 1983, CIRCULATION, V67, P134, DOI 10.1161/01.CIR.67.1.134
NR 9
TC 6
Z9 7
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2012
VL 42
IS 6
BP 434
EP 436
DI 10.4070/kcj.2012.42.6.434
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IL
UT WOS:000209080000012
PM 22787477
OA Green Published
DA 2021-04-22
ER

PT J
AU Moon, J
   Shin, MS
   Lee, HJ
   Chung, WJ
   Park, CH
   Park, KY
AF Moon, Jeonggeun
   Shin, Mi-Seung
   Lee, Hun Jin
   Chung, Wook-Jin
   Park, Chul-Hyun
   Park, Kook-Yang
TI Newly Developed Aortic Dissection After Aorta Cannulation During Mitral
   Valve Surgery in a Patient With Marfan Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Marfan syndrome; Complications; Echocardiography; Operations
AB We report a case of newly developed aortic dissection after aorta cannulation during mitral valve surgery in a patient with Marfan syndrome. An unexpected fatal complication of cardiac surgery detected on postoperative imaging survey in Marfan syndrome patient and its surgical finding are described.
C1 [Moon, Jeonggeun; Shin, Mi-Seung; Lee, Hun Jin; Chung, Wook-Jin] Gachon Univ Med & Sci, Gil Hosp, Dept Internal Med, Div Cardiol, Inchon 405760, South Korea.
   [Park, Chul-Hyun; Park, Kook-Yang] Gachon Univ Med & Sci, Gil Hosp, Dept Thorac & Cardiovasc Surg, Inchon 405760, South Korea.
RP Shin, MS (corresponding author), Gachon Univ Med & Sci, Gil Hosp, Dept Internal Med, Div Cardiol, 1198 Guwol Dong, Inchon 405760, South Korea.
EM miseung@gmail.com
RI Chung, Wook-Jin/AAJ-5613-2021
OI Chung, Wook-Jin/0000-0002-9767-7098
CR Akhyari P, 2009, J THORAC CARDIOV SUR, V137, P1290, DOI 10.1016/j.jtcvs.2008.10.006
   DIETZ H, 1995, NAT GENET, V9, P228, DOI 10.1038/ng0395-228
   Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125
   Kumar Kanwal, 2009, Interact Cardiovasc Thorac Surg, V8, P362, DOI 10.1510/icvts.2008.195867
   MARSALESE DL, 1990, J AM COLL CARDIOL, V16, P68, DOI 10.1016/0735-1097(90)90458-2
   MARSALESE DL, 1989, J AM COLL CARDIOL, V14, P422, DOI 10.1016/0735-1097(89)90197-6
NR 6
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2012
VL 42
IS 6
BP 437
EP 440
DI 10.4070/kcj.2012.42.6.437
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IL
UT WOS:000209080000013
PM 22787478
OA Green Published
DA 2021-04-22
ER

PT J
AU Joo, SJ
AF Joo, Seung-Jae
TI Mechanisms of Platelet Activation and Integrin alpha II beta 3
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Platelet activation; Receptors; G-protein-coupled; Integrin alpha-IIb
   beta-3
AB Platelet aggregation is not only an essential part of hemostasis, but also initiates acute coronary syndrome or ischemic stroke. The precise understanding of the activation mechanism of platelet aggregation is fundamental for the development of more effective agents against platelet aggregation. Adenosine diphosphate, thrombin, and thromboxane A(2) activate platelet integrin alpha IIb beta 3 through G protein-coupled receptors. G protein-mediated signaling pathways, which are initiated by G(q), G(12)/G(13) or G(i), include phospholipase C with calcium signaling, Rho signaling, protein kinase C and phosphatidylinositol 3-kinase. Rap1b, Ca2+ and diacylglycerol-regulated guanine nucleotide exchange factor I, Rap1-GTP-interacting adaptor molecule, and Akt are important proteins involved in G protein-mediated activation of integrin alpha IIb beta 3. Binding of talin-1 and kindlin-3 to cytoplasmic domains of beta 3-integrin triggers a conformational change in the extracellular domains that increases its affinity for ligands, such as fibrinogen or von Willebrand factor. Fibrinogens act as bridges between adjacent platelets to generate a platelet aggregate.
C1 Jeju Natl Univ Hosp, Dept Internal Med, Div Cardiol, Cheju 690767, South Korea.
RP Joo, SJ (corresponding author), Jeju Natl Univ Hosp, Dept Internal Med, Div Cardiol, 15 Aran 13 Gil, Cheju 690767, South Korea.
EM sejjoo@jejunu.ac.kr
CR Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229
   Becker RC, 2009, LANCET, V373, P919, DOI 10.1016/S0140-6736(09)60230-0
   Bennett JS, 2009, J THROMB HAEMOST, V7, P200, DOI 10.1111/j.1538-7836.2009.03378.x
   Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155
   Brass S, 2001, NATURE, V413, P26, DOI 10.1038/35092647
   Braun A, 2009, BLOOD, V113, P2056, DOI 10.1182/blood-2008-07-171611
   Chen JH, 2004, BLOOD, V104, P1703, DOI 10.1182/blood-2003-10-3428
   Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973
   Cifuni SM, 2008, BLOOD, V112, P1696, DOI 10.1182/blood-2008-02-139733
   Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085
   Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098
   Di Virgilio F, 2002, BRIT J PHARMACOL, V135, P831, DOI 10.1038/sj.bjp.0704524
   Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986
   Gachet C, 2006, BLOOD CELL MOL DIS, V36, P223, DOI 10.1016/j.bcmd.2005.12.024
   Giannarelli C, 2010, THROMB HAEMOSTASIS, V104, P949, DOI 10.1160/TH10-03-0195
   Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035
   Joo SJ, 1998, KOREAN CIRC J, V28, P2030
   Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021
   Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202
   Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a
   Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200
   LEFKOVITS J, 1995, NEW ENGL J MED, V332, P1553, DOI 10.1056/NEJM199506083322306
   Li DJ, 2008, BLOOD, V111, P3522, DOI 10.1182/blood-2007-09-111518
   Li RH, 2002, BIOCHEMISTRY-US, V41, P15618, DOI 10.1021/bi026822l
   Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722
   Nguyen TA, 2005, J AM COLL CARDIOL, V45, P1157, DOI 10.1016/j.jacc.2005.01.034
   Nieswandt B, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2009.03370.x
   Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827
   OFFERMANNS S, 1994, P NATL ACAD SCI USA, V91, P504, DOI 10.1073/pnas.91.2.504
   Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16
   Oury C, 2006, CURR PHARM DESIGN, V12, P859, DOI 10.2174/138161206776056029
   Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800
   Quinn MJ, 2003, ARTERIOSCL THROM VAS, V23, P945, DOI 10.1161/01.ATV.0000066686.46338.F1
   Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227
   Smyth SS, 2009, ARTERIOSCL THROM VAS, V29, P449, DOI 10.1161/ATVBAHA.108.176388
   Stojanovic A, 2006, J BIOL CHEM, V281, P16333, DOI 10.1074/jbc.M512378200
   Topol EJ, 1999, LANCET, V353, P227, DOI 10.1016/S0140-6736(98)11086-3
   Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719
   Varga-Szabo D, 2008, J EXP MED, V205, P1583, DOI 10.1084/jem.20080302
   Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094
   Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267
   Zhang W, 2007, BLOOD, V110, P1475, DOI 10.1182/blood-2006-10-052522
NR 42
TC 29
Z9 34
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 295
EP 301
DI 10.4070/kcj.2012.42.5.295
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900001
PM 22701130
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KH
AF Kim, Kye Hun
TI Echocardiographic Measurement of Left Atrial Strain as a Tool for
   Assessing Left Atrial Function and Geometric Change
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Kye Hun] Chonnam Natl Univ, Res Inst Med Sci, Chonnam Natl Univ Hosp, Dept Cardiol, Kwangju, South Korea.
RP Kim, KH (corresponding author), Chonnam Natl Univ Hosp, Ctr Heart, Dept Cardiol, 42 Jebong Ro, Kwangju 501757, South Korea.
EM christiankyehun@hanmail.net
CR Blume GG, 2011, EUR J ECHOCARDIOGR, V12, P421, DOI 10.1093/ejechocard/jeq175
   Cameli M, 2011, ECHOCARDIOGR-J CARD, V28, P327, DOI 10.1111/j.1540-8175.2010.01329.x
   Cameli M, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-14
   Casaclang-Verzosa G, 2008, J AM COLL CARDIOL, V51, P1, DOI 10.1016/j.jacc.2007.09.026
   Her AY, 2012, KOREAN CIRC J, V42, P311, DOI 10.4070/kcj.2012.42.5.311
   Kim DG, 2009, ECHOCARDIOGR-J CARD, V26, P1179, DOI 10.1111/j.1540-8175.2009.00955.x
   Kuppahally SS, 2010, CIRC-CARDIOVASC IMAG, V3, P231, DOI 10.1161/CIRCIMAGING.109.865683
   Shin Mi-Seung, 2009, Korean Circ J, V39, P280, DOI 10.4070/kcj.2009.39.7.280
   Sutherland GR, 2004, J AM SOC ECHOCARDIOG, V17, P788, DOI 10.1016/j.echo.2004.03.027
   Tops LF, 2011, J AM COLL CARDIOL, V57, P324, DOI 10.1016/j.jacc.2010.05.063
   Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077
   Zhang Q, 2008, EUROPACE, V10, P62, DOI 10.1093/europace/eun237
NR 12
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 302
EP 303
DI 10.4070/kcj.2012.42.5.302
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900002
PM 22701131
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, NS
   Jeong, MH
   Ahn, Y
   Kim, JH
   Chae, SC
   Kim, YJ
   Hur, SH
   Seong, IW
   Hong, TJ
   Choi, D
   Cho, MC
   Kim, CJ
   Seung, KB
   Chung, WS
   Jang, YS
   Cho, JG
   Park, SJ
AF Yoon, Nam Sik
   Jeong, Myung Ho
   Ahn, Youngkeun
   Kim, Jong Hyun
   Chae, Shung Chull
   Kim, Young Jo
   Hur, Seung Ho
   Seong, In Whan
   Hong, Taek Jong
   Choi, Donghoon
   Cho, Myeong Chan
   Kim, Chong Jin
   Seung, Ki Bae
   Chung, Wook Sung
   Jang, Yang Soo
   Cho, Jeong Gwan
   Park, Seung Jung
CA Korea Acute Myocardial Infarction
TI Impact of High-Normal Blood Pressure Measured in Emergency Room on
   Adverse Cardiac Events in Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Blood pressure; Prognosis
ID JOINT NATIONAL COMMITTEE; RISK; HYPERTENSION; PREHYPERTENSION; DISEASE
AB Background and Objectives: Prehypertension according to JNC7 is common and is associated with increased vascular mortality. The importance of management in high-normal blood pressure (BP) is underemphasized.
   Subjects and Methods: We analyzed major adverse cardiac events (MACEs) in the Korea Acute Myocardial Infarction Registry in normal BP (group I) and high-normal BP (group II) patients.
   Results: Among 14871 patients, 159 (61 +/- 12.3 years, 122 males) satisfied the study indication. Six-month and one-year clinical follow-up rate was 88.9% and 85.8%, respectively. Group I had 78 patients (60.9 +/- 12.4 years). Group II had 81 patients (61.6 +/- 12.5 years). Demographics of patients were not different between groups. Treatment strategy was not different. Initial Thrombolysis in Myocardial Infarction flow grade 0 was less frequent in group II (n=32, 47.1%) than in group I (n=16, 21.9%) (p=0.001). Successful intervention rate was not different between group II (93.8%) and group I (97.1%) (p=0.590). Six-month MACE occurred in 3 patients in group I (4.4%) and 10 in group II (15.6%) (p=0.031). Compared with normal BP, the odds ratio for patients with high-normal BP was 1.147 (p=0.045, 95% confidence interval 1.011-1.402) for 6-month MACE.
   Conclusion: Even though high-normal BP patients had a better baseline clinical status, the prognosis was poorer than patients with normal BP. Therapeutic BP target goal for the patients with acute myocardial infarction should be <140/90 mm Hg, which is recommended in JNC7.
C1 [Yoon, Nam Sik; Jeong, Myung Ho; Ahn, Youngkeun; Cho, Jeong Gwan] Chonnam Natl Univ Hosp, Heart Res Ctr, Kwangju 501757, South Korea.
   [Kim, Jong Hyun] Hanseo Hosp, Ctr Cardiovasc, Pusan, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ Hosp, Dept Internal Med, Taegu, South Korea.
   [Kim, Young Jo] Yeungnam Univ Hosp, Dept Internal Med, Taegu, South Korea.
   [Hur, Seung Ho] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Taegu, South Korea.
   [Seong, In Whan] Chungnam Natl Univ Hosp, Dept Internal Med, Taejon, South Korea.
   [Hong, Taek Jong] Pusan Natl Univ Hosp, Dept Internal Med, Pusan, South Korea.
   [Choi, Donghoon; Jang, Yang Soo] Yonsei Univ, Severans Hosp, Dept Internal Med, Seoul 120749, South Korea.
   [Cho, Myeong Chan] Chungbuk Natl Univ Hosp, Dept Internal Med, Cheongju, South Korea.
   [Kim, Chong Jin] Kyung Hee Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Seung, Ki Bae; Chung, Wook Sung] Catholic Univ Korea Hosp, Dept Internal Med, Seoul, South Korea.
   [Park, Seung Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Heart Res Ctr, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
OI Hur, Seung-Ho/0000-0002-3895-1915; Seong, In-Whan/0000-0003-4628-0258;
   Jeong, Jin-Ok/0000-0003-0763-4754
FU Korea Healthcare Technology R&D project, Ministry for Health, Welfare
   and Family Affairs, Republic of Korea [A084869]
FX This study was supported by a grant of the Korea Healthcare Technology
   R&D project (A084869), Ministry for Health, Welfare and Family Affairs,
   Republic of Korea.
CR Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   French JK, 2004, HEART, V90, P99, DOI 10.1136/heart.90.1.99
   Kokubo Y, 2008, HYPERTENSION, V52, P652, DOI 10.1161/HYPERTENSIONAHA.108.118273
   Kshirsagar AV, 2006, AM J MED, V119, P133, DOI 10.1016/j.amjmed.2005.08.023
   Lee JH, 2009, AM J CARDIOL, V104, P182, DOI 10.1016/j.amjcard.2009.03.010
   Lee SR, 2008, CIRC J, V72, P392, DOI 10.1253/circj.72.392
   LONATI L, 1993, CARDIOLOGY, V83, P298, DOI 10.1159/000175985
   Majahalme SK, 2003, AM J CARDIOL, V92, P258, DOI 10.1016/S0002-9149(03)00620-9
   Mancia G, 2007, EUR HEART J, V28, P1462, DOI 10.1093/eurheartj/ehm236
   Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217
   Qureshi AI, 2005, STROKE, V36, P1859, DOI 10.1161/01.STR.0000177495.45580.f1
   Richards AM, 2002, J AM COLL CARDIOL, V39, P1182, DOI 10.1016/S0735-1097(02)01737-0
   Sipahi I, 2006, J AM COLL CARDIOL, V48, P833, DOI 10.1016/j.jacc.2006.05.045
   Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417
   Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126
NR 15
TC 6
Z9 6
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 304
EP 310
DI 10.4070/kcj.2012.42.5.304
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900003
PM 22701132
OA Green Published
DA 2021-04-22
ER

PT J
AU Her, AY
   Choi, EY
   Shim, CY
   Song, BW
   Lee, S
   Ha, JW
   Rim, SJ
   Hwang, KC
   Chang, BC
   Chung, N
AF Her, Ae-Young
   Choi, Eui-Young
   Shim, Chi Young
   Song, Byoung Wook
   Lee, Sak
   Ha, Jong-Won
   Rim, Se-Joong
   Hwang, Ki Chul
   Chang, Byung Chul
   Chung, Namsik
TI Prediction of Left Atrial Fibrosis With Speckle Tracking
   Echocardiography in Mitral Valve Disease: A Comparative Study With
   Histopathology
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Echocardiography; Fibrosis; Left atrium
AB Background and Objectives: Left atrial (LA) fibrosis is a main determinant of LA remodeling and development of atrial fibrillation. However, non-invasive prediction of LA fibrosis is challenging. We investigated whether preoperative LA strain as measured by speckle tracking echocardiography could predict the degree of LA fibrosis and LA reverse remodeling after mitral valve (MV) surgery.
   Subjects and Methods: Speckle tracking echocardiography and LA volume measurements were performed in 50 patients one day before MV surgery. LA tissues were obtained during the surgery, and the degrees of their interstitial fibroses were measured. LA volume measurements were repeated within 30 days after surgery (n=50) and 1-year later (n=39).
   Results: Left atrial global strain was significantly correlated with the degree of LA fibrosis (r=-0.55, p<0.001), and its correlation was independent of age, underlying rhythm, presence of rheumatic heart disease and type of predominant MV disease (B=-1.37, 95% confidence interval -2.32 - -0.41, p=0.006). The degree of LA fibrosis was significantly correlated with early (r=-0.337, p=0.017) and 1-year (r=-0.477, p=0.002) percent LA volume reduction after MV surgery, but LA global strain was not significant.
   Conclusion: Left atrial strain as measured by speckle tracking echocardiography might be helpful for predicting the degree of LA fibrosis in patients with MV disease.
C1 [Her, Ae-Young] Kangwon Natl Univ Hosp, Div Cardiol, Chunchon, South Korea.
   [Choi, Eui-Young; Rim, Se-Joong] Yonsei Univ, Coll Med, Ctr Heart, Gangnam Severance Hosp, Seoul 135720, South Korea.
   [Shim, Chi Young; Ha, Jong-Won; Chung, Namsik] Yonsei Univ, Coll Med, Yonsei Cardiovasc Hosp, Div Cardiol, Seoul 135720, South Korea.
   [Song, Byoung Wook; Hwang, Ki Chul] Yonsei Univ, Coll Med, Yonsei Cardiovasc Res Inst, Seoul 135720, South Korea.
   [Lee, Sak; Chang, Byung Chul] Yonsei Univ, Coll Med, Dept Cardiothorac Surg, Seoul 135720, South Korea.
RP Choi, EY (corresponding author), Yonsei Univ, Coll Med, Ctr Heart, Gangnam Severance Hosp, 211 Eonju Ro, Seoul 135720, South Korea.
EM choi0928@yuhs.ac
RI Chang, Byung/AAP-9674-2020; Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136; Ha, Jong-Won/0000-0002-8260-2958;
   Choi, Eui-Young/0000-0003-3732-0190; Rim, Se Joong/0000-0002-7631-5581;
   Chang, Byung Chul/0000-0001-5005-8217; Lee, Sak/0000-0001-6130-2342
FU Korean Society of Cardiology Research Fund
FX This work was supported by the Korean Society of Cardiology Research
   Fund of 2007-13.
CR Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048
   Barnes ME, 2004, MAYO CLIN PROC, V79, P1008, DOI 10.4065/79.8.1008
   BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8
   Cameli M, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-6
   Casaclang-Verzosa G, 2008, J AM COLL CARDIOL, V51, P1, DOI 10.1016/j.jacc.2007.09.026
   Cho DK, 2008, AM J CARDIOL, V101, P374, DOI 10.1016/j.amjcard.2007.09.076
   Di Salvo G, 2005, CIRCULATION, V112, P387, DOI 10.1161/CIRCULATIONAHA.104.463125
   Donal E, 2008, J AM SOC ECHOCARDIOG, V21, P703, DOI 10.1016/j.echo.2007.10.002
   Donal E, 2010, EUR J ECHOCARDIOGR, V11, P845, DOI 10.1093/ejechocard/jeq074
   Eshoo S, 2009, HEART, V95, P1184, DOI 10.1136/hrt.2008.156208
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Langeland S, 2005, CIRCULATION, V112, P2157, DOI 10.1161/CIRCULATIONAHA.105.554006
   Leung DY, 2008, AM HEART J, V156, P1056, DOI 10.1016/j.ahj.2008.07.021
   Nattel S, 1999, J CARDIOVASC ELECTR, V10, P1553, DOI 10.1111/j.1540-8167.1999.tb00214.x
   Sanders P, 2003, CIRCULATION, V108, P1976, DOI 10.1161/01.CIR.0000091408.45747.04
   SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792
   Shin Mi-Seung, 2009, Korean Circ J, V39, P280, DOI 10.4070/kcj.2009.39.7.280
   Spencer KT, 2001, HEART, V85, P272, DOI 10.1136/heart.85.3.272
   Trikas A, 2005, INT J CARDIOL, V99, P111, DOI 10.1016/j.ijcard.2004.01.018
   Vianna-Pinton R, 2009, J AM SOC ECHOCARDIOG, V22, P299, DOI 10.1016/j.echo.2008.12.017
NR 20
TC 48
Z9 52
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 311
EP 318
DI 10.4070/kcj.2012.42.5.311
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900004
PM 22701133
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahmed, K
   Jeong, MH
   Chakraborty, R
   Hong, YJ
   Oh, MS
   Cho, KH
   Kim, MC
   Hachinohe, D
   Hwang, SH
   Lee, MG
   Sim, DS
   Park, KH
   Kim, JH
   Ahn, Y
   Kang, JC
AF Ahmed, Khurshid
   Jeong, Myung Ho
   Chakraborty, Rabin
   Hong, Young Joon
   Oh, Mi Sook
   Cho, Kyung Hoon
   Kim, Min Chol
   Hachinohe, Daisuke
   Hwang, Seung Hwan
   Lee, Min Goo
   Sim, Doo Sun
   Park, Keun Ho
   Kim, Ju Han
   Ahn, Youngkeun
   Kang, Jung Chaee
TI Clinical Impact of Non-High Density Lipoprotein-Cholesterol and
   Apolipoprotein B on Clinical Outcomes in Metabolic Syndrome Patients
   With Acute Myocardial Infarction Undergoing Percutaneous Coronary
   Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Metabolic syndrome; Cholesterol; Apolipoproteins
   B
ID BODY-MASS INDEX; HEART-DISEASE; MORTALITY; OBESITY
AB Background and Objectives: Non-high density lipoprotein-cholesterol (non-HDL-C) and apolipoprotein B (ApoB) are markers of atherosclerotic risk and predictors of cardiovascular events. The aim of this study was to evaluate clinical impact of non-HDL-C and ApoB on clinical outcomes in metabolic syndrome (MS) patients with acute myocardial infarction (AMI) undergoing percuatneous coronary intervetion.
   Subjects and Methods: We analyzed 470 MS patients (64.4 +/- 12.0 years, 53.6% male) with AMI who were followed-up for 12-month after percutaneous coronary intervention (PCI) from December 2005 to January 2008 in a single center. These patients were divided into 2 groups based on median values of non-HDL-C and ApoB. We studied their baseline and follow-up relation with 12-month clinical outcomes, all-cause death and major adverse cardiac events (MACE).
   Results: Mean values of baseline non-HDL-C and ApoB were 141.2 +/- 43.1 mg/dL and 99.3 +/- 29.0 mg/dL respectively. During 12-month follow-up 32 MACE (6.8%) and 12 deaths (2.5%) occurred. We observed significant correlation between non-HDL-C and ApoB. Twelve-month MACE and all-cause death after PCI showed no significant relation as non-HDL-C or ApoB levels increased. Follow-up patients (n=306, rate 65%) also did not show significant relation with clinical outcomes. Twelve-month MACE decreased as non-HDL-C and ApoB reduction rates increased.
   Conclusion: There was no significant association between higher non-HDL-C or ApoB and 12-month clinical outcomes in MS patients with AMI undergoing PCI. ApoB was found to be a better predictor of 12-month MACE than non-HDL-C based on their reduction rates.
C1 [Ahmed, Khurshid; Jeong, Myung Ho; Hong, Young Joon; Oh, Mi Sook; Cho, Kyung Hoon; Kim, Min Chol; Hachinohe, Daisuke; Hwang, Seung Hwan; Lee, Min Goo; Sim, Doo Sun; Park, Keun Ho; Kim, Ju Han; Ahn, Youngkeun; Kang, Jung Chaee] Chonnam Natl Univ, Res Inst Med Sci, Chonnam Natl Univ Hosp, Ctr Heart, Kwangju, South Korea.
   [Ahmed, Khurshid; Chakraborty, Rabin] Apollo Gleneagles Hosp, Kolkata, India.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
OI CHO, KYUNG HOON/0000-0002-0377-6352
FU Korea Ministry of Health WelfareMinistry of Health & Welfare, Republic
   of Korea [A084869]
FX This study was performed with the support of Korea Ministry of Health &
   Welfare (A084869). The authors thank Dr. Sumera K. Ahmed for her
   contribution to this study.
CR [Anonymous], 2003, AM J CARDIOL, V91, P1173
   Apple FS, 2002, AM HEART J, V144, P981, DOI 10.1067/mhj.2002.124048
   Ballantyne CM, 2001, AM J CARDIOL, V88, P265, DOI 10.1016/S0002-9149(01)01638-1
   Cho KH, 2010, AM J CARDIOL, V106, P1061, DOI 10.1016/j.amjcard.2010.06.009
   FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180
   Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Gurm HS, 2002, AM J CARDIOL, V90, P42, DOI 10.1016/S0002-9149(02)02384-6
   Han JH, 2008, ATHEROSCLEROSIS, V197, P333, DOI 10.1016/j.atherosclerosis.2007.05.021
   Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683
   Kereiakes DJ, 2003, CIRCULATION, V108, P1552, DOI 10.1161/01.CIR.0000093203.00632.2B
   Kini AS, 2006, CARDIOL CLIN, V24, P153, DOI 10.1016/j.ccl.2006.04.002
   Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709
   Manginas A, 1999, AM J CARDIOL, V83, P1562, DOI 10.1016/S0002-9149(99)00149-6
   Mehta L, 2007, AM J CARDIOL, V99, P906, DOI 10.1016/j.amjcard.2006.11.038
   Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499
   Prasad A, 2004, AM HEART J, V147, P669, DOI 10.1016/j.ahj.2003.11.010
   Rauchhaus M, 2003, J AM COLL CARDIOL, V42, P1933, DOI 10.1016/j.jacc.2003.07.016
   Reilly MP, 2003, CIRCULATION, V108, P1546, DOI 10.1161/01.CIR.0000088846.10655.E0
   Sattar N, 2004, CIRCULATION, V110, P2687, DOI 10.1161/01.CIR.0000145660.60487.94
   Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94
   Sim Doo Sun, 2009, Korean Circ J, V39, P297, DOI 10.4070/kcj.2009.39.8.297
   Sniderman AD, 2005, CIRCULATION, V112, P3366, DOI 10.1161/CIRCULATIONAHA.105.583336
   Tespili Maurizio, 2003, Ital Heart J, V4, P193
   Wang Tracy Y, 2009, Clin Cardiol, V32, pE22, DOI 10.1002/clc.20518
   이기홍, 2007, Korean Circulation Journal, V37, P64
NR 27
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 319
EP 328
DI 10.4070/kcj.2012.42.5.319
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900005
PM 22701134
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, S
   Kim, NH
   Kim, YK
   Yoo, JH
   Shin, SN
   Ko, JS
   Kim, YK
   Rhee, SJ
   Yun, KH
   Lee, EM
   Yoo, NJ
   Oh, SK
   Jeong, JW
AF Kim, Seunghwan
   Kim, Nam-Ho
   Kim, Yong Kwon
   Yoo, Jong Hyun
   Shin, Seong Nam
   Ko, Jum Suk
   Kim, Yun Kyeong
   Rhee, Sang Jae
   Yun, Kyeong Ho
   Lee, Eun Mi
   Yoo, Nam Jin
   Oh, Seok Kyu
   Jeong, Jin-Won
TI The Number of Endothelial Progenitor Cells is Decreased in Patients With
   Non-Dipper Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Circadian rhythm; Stem cells
ID BLOOD-PRESSURE; RISK
AB Background and Objectives: Circulating endothelial progenitor cells (EPCs) play a key role in the maintenance of endothelial homeostasis and promote vascular repair. A reduced number of EPCs and the functional activity have been associated with several cardiovascular risk factors. However, the relationship between the number of EPCs and circadian rhythm of the blood pressure (BP) remains unclear. The purpose of the present study was to evaluate the relationship between the circadian rhythm of the BP and EPCs in patients with essential hypertension.
   Subjects and Methods: A total of 45 patients with essential hypertension who were newly identified by outpatient BP measurements, underwent 24-hour ambulatory BP monitoring. Among the 45 patients with essential hypertension, 20 were classified as dippers (12 men and 8 women; mean age 48 +/- 14 years) and 25 as non-dippers (14 men and 11 women; mean age 52 +/- 18 years). The EPC count was isolated from the peripheral bloodstream and quantified by flow cytometry.
   Results: The baseline clinical characteristics were similar between the dipper and non-dipper hypertensive patients. The circulating EPCs were statistically reduced in the non-dipper patients as compared to the dippers (104 +/- 60 vs. 66 +/- 47 EPCs per 106 mononuclear cells, p=0.027). The circulating EPC level correlated positively with the circadian changes in the systolic and diastolic BP (r=0.435, p=0.003, and r=0.310, p=0.038, respectively).
   Conclusion: The present study demonstrated that the EPC count was reduced in the peripheral bloodstream in non-dipper hypertensive patients.
C1 [Kim, Seunghwan; Kim, Nam-Ho; Kim, Yong Kwon; Yoo, Jong Hyun; Shin, Seong Nam; Ko, Jum Suk; Kim, Yun Kyeong; Rhee, Sang Jae; Yun, Kyeong Ho; Lee, Eun Mi; Yoo, Nam Jin; Oh, Seok Kyu; Jeong, Jin-Won] Wonkwang Univ Hosp, Reg Cardiocerebrovasc Dis Ctr, Dept Cardiovasc Ctr, Iksan 570711, South Korea.
   [Kim, Nam-Ho; Ko, Jum Suk; Kim, Yun Kyeong; Rhee, Sang Jae; Yun, Kyeong Ho; Lee, Eun Mi; Yoo, Nam Jin; Oh, Seok Kyu; Jeong, Jin-Won] Inst Wonkwang Med Sci, Iksan, South Korea.
RP Kim, NH (corresponding author), Wonkwang Univ Hosp, Inst Wonkwang Med Sci, Dept Internal Med, 895 Muwang Ro, Iksan 570711, South Korea.
EM cardionh@wonkwang.ac.kr
FU Wonkwang University
FX This paper was supported by grants from the Wonkwang University in 2011.
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Bahlmann FH, 2005, HYPERTENSION, V45, P526, DOI 10.1161/01.HYP.0000159191.98140.89
   Chironi G, 2007, ATHEROSCLEROSIS, V191, P115, DOI 10.1016/j.atherosclerosis.2006.02.041
   Choi JH, 2008, KOREAN CIRC J, V38, P411
   Dernbach E, 2004, BLOOD, V104, P3591, DOI 10.1182/blood-2003-12-4103
   Gehling UM, 2000, BLOOD, V95, P3106
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x
   Imanishi T, 2005, J HYPERTENS, V23, P1831, DOI 10.1097/01.hjh.0000183524.73746.1b
   Juonala M, 2006, HYPERTENSION, V48, P424, DOI 10.1161/01.HYP.0000237666.78217.47
   윤경호, 2008, Korean Circulation Journal, V38, P638
   KOHARA K, 1995, HYPERTENSION, V26, P808, DOI 10.1161/01.HYP.26.5.808
   Kong DL, 2004, CIRCULATION, V110, P2039, DOI 10.1161/01.CIR.0000143161.01901.BD
   Oliveras A, 2008, J HUM HYPERTENS, V22, P183, DOI 10.1038/sj.jhh.1002304
   Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953
   VERDECCHIA P, 1994, HYPERTENSION, V24, P793, DOI 10.1161/01.HYP.24.6.793
   Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814
   Yu Y, 2008, AM J HYPERTENS, V21, P72, DOI 10.1038/ajh.2007.5
NR 20
TC 9
Z9 10
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 329
EP 334
DI 10.4070/kcj.2012.42.5.329
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900006
PM 22701498
OA Green Published
DA 2021-04-22
ER

PT J
AU Won, KB
   Chang, HJ
   Park, SH
   Hong, SY
   Jang, Y
   Chung, N
AF Won, Ki-Bum
   Chang, Hyuk-Jae
   Park, Sung-Ha
   Hong, Sung-Yu
   Jang, Yangsoo
   Chung, Namsik
TI High Serum Advanced Glycation End-Products Predict Coronary Artery
   Disease Irrespective of Arterial Stiffness in Diabetic Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Advanced glycation end-products; Coronary artery disease; Pulse wave
   velocity; Diabetes mellitus
AB Background and Objectives: Advanced glycation end-products (AGEs) contribute to the development of atherosclerosis. We investigated whether serum AGEs are related to the presence or severity of coronary artery disease (CAD), and explored the association between serum AGEs and arterial stiffness according to diabetes status in patients suspected of having CAD.
   Subjects and Methods: The measurement of serum AGEs and brachial-ankle pulse wave velocity (baPWV) were performed in 145 consecutive patients (63 +/- 9 years, 58% men) who received a coronary angiogram for evaluation of CAD.
   Results: Forty-four diabetics and 101 non-diabetics were classified into three subgroups based on the number of diseased vessels with obstructive CAD: 0, 1, and 2 or more vessel diseases (VDs). Serum AGEs were significantly higher in diabetics with obstructive CAD than in those without obstructive CAD (2.16 +/- 0.29 vs. 1.85 +/- 0.29 mU/mL, p=0.010) and were significantly correlated with the number of VDs only in diabetics (r=0.504, p<0.001). Serum AGEs were not significantly correlated with baPWV in diabetics or non-diabetics. In receiver operating characteristics analysis, the cut-off value of serum AGEs as a predictor of obstructive CAD was 1.98 mU/mL, with 64% sensitivity and 63% specificity in diabetics. In multiple regression analysis, serum AGEs independently predicted obstructive CAD and were associated with the number of VDs in diabetics.
   Conclusion: Serum AGEs independently predict obstructive CAD and the severity of coronary atherosclerosis irrespective of arterial stiffness only in diabetics. Evaluation of PWV and serum AGEs together may be more effective to identify the risk of CAD in diabetic individuals.
C1 [Won, Ki-Bum; Chang, Hyuk-Jae; Park, Sung-Ha; Hong, Sung-Yu; Jang, Yangsoo; Chung, Namsik] Yonsei Univ, Coll Med, Yonsei Cardiovasc Ctr, Dept Cardiol, Seoul 120752, South Korea.
   [Won, Ki-Bum] Kwandong Univ, Coll Med, Myongji Hosp, Cardiovasc Ctr,Dept Cardiol, Goyang, South Korea.
RP Chang, HJ (corresponding author), Yonsei Univ, Coll Med, Yonsei Cardiovasc Ctr, Dept Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM hjchang@yuhs.ac
OI Park, Sungha/0000-0001-5362-478X; Chang, Hyuk-Jae/0000-0002-6139-7545;
   Jang, Yangsoo/0000-0002-2169-3112
FU Korean Health Technology R&D Project, Ministry for Health Welfare, Korea
   [A102064]
FX This study was supported by a grant from the Korean Health Technology
   R&D Project, Ministry for Health & Welfare, Korea (A102064).
CR Basta G, 2008, ATHEROSCLEROSIS, V196, P9, DOI 10.1016/j.atherosclerosis.2007.07.025
   Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031
   BUCALA R, 1993, P NATL ACAD SCI USA, V90, P6434, DOI 10.1073/pnas.90.14.6434
   BUCALA R, 1994, P NATL ACAD SCI USA, V91, P9441, DOI 10.1073/pnas.91.20.9441
   BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014
   Choi EY, 2005, YONSEI MED J, V46, P78, DOI 10.3349/ymj.2005.46.1.78
   de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249
   Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404
   Kanauchi M, 2001, DIABETES CARE, V24, P1620, DOI 10.2337/diacare.24.9.1620
   KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035
   Kilhovd BK, 1999, DIABETES CARE, V22, P1543, DOI 10.2337/diacare.22.9.1543
   KIRSTEIN M, 1990, P NATL ACAD SCI USA, V87, P9010, DOI 10.1073/pnas.87.22.9010
   Kiuchi K, 2001, HEART, V85, P87, DOI 10.1136/heart.85.1.87
   MAKITA Z, 1991, NEW ENGL J MED, V325, P836, DOI 10.1056/NEJM199109193251202
   Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235
   Najjar SS, 2005, HYPERTENSION, V46, P454, DOI 10.1161/01.HYP.0000177474.06749.98
   Ono Y, 1998, DIABETES RES CLIN PR, V41, P131, DOI 10.1016/S0168-8227(98)00074-6
   Reddy GK, 2004, MICROVASC RES, V68, P132, DOI 10.1016/j.mvr.2004.04.002
   Schleicher ED, 1997, J CLIN INVEST, V99, P457, DOI 10.1172/JCI119180
   Semba RD, 2009, AM J HYPERTENS, V22, P74, DOI 10.1038/ajh.2008.320
   Sugawara J, 2005, J HUM HYPERTENS, V19, P401, DOI 10.1038/sj.jhh.1001838
   Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628
   TANAKA S, 1988, J MOL BIOL, V203, P495, DOI 10.1016/0022-2836(88)90015-0
   Tarchalski J, 2003, MOL CELL BIOCHEM, V246, P25, DOI 10.1023/A:1023443609730
   TSILIBARY EC, 1988, J BIOL CHEM, V263, P4302
   Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823
   Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, pE685
   Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359
   YAN SD, 1994, J BIOL CHEM, V269, P9889
NR 29
TC 15
Z9 16
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 335
EP 340
DI 10.4070/kcj.2012.42.5.335
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900007
PM 22701499
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, MO
   Kim, JH
   Oh, SK
   Lee, MG
   Park, KH
   Sim, DS
   Hong, YJ
   Ahn, Y
   Jeong, MH
AF Jang, Mi Ok
   Kim, Ju Han
   Oh, Sang Ki
   Lee, Min Goo
   Park, Keun Ho
   Sim, Doo Sun
   Hong, Young Joon
   Ahn, Youngkeun
   Jeong, Myung Ho
TI Endovascular Stent in Traumatic Thoracic Aortic Dissection
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aorta, thoracic; Dissection; Aortography; Multidetector computed
   tomography
ID GRAFT REPAIR
AB Traumatic thoracic aortic injury is typically fatal. However, recent improvements in pre-hospital care and diagnostic modalities have resulted in an increased number of patients with traumatic aortic injury arriving alive at the hospital. Also, the morbidity and mortality associated with endovascular repair are significantly lower than with conventional open surgery in traumatic thoracic aorta injury. We experienced two cases of successful management of traumatic thoracic aortic dissection with endovascular stents caused by traffic accidents.
C1 [Jang, Mi Ok; Kim, Ju Han; Oh, Sang Ki; Lee, Min Goo; Park, Keun Ho; Sim, Doo Sun; Hong, Young Joon; Ahn, Youngkeun; Jeong, Myung Ho] Chonnam Natl Univ, Sch Med, Chonnam Natl Univ Hosp, Ctr Heart, Kwangju 501757, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ, Sch Med, Chonnam Natl Univ Hosp, Ctr Heart, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
CR COHEN AM, 1992, AM J ROENTGENOL, V159, P271, DOI 10.2214/ajr.159.2.1632338
   Ferrari Enrico, 2006, Interact Cardiovasc Thorac Surg, V5, P730, DOI 10.1510/icvts.2006.136325
   FINKELMEIER BA, 1982, J THORAC CARDIOV SUR, V84, P257
   강웅철, 2003, Korean Circulation Journal, V33, P457
   Karmy-Jones R, 2009, CURR CARDIOL REV, V5, P187, DOI 10.2174/157340309788970324
   Kasirajan K, 2003, ANN VASC SURG, V17, P589, DOI 10.1007/s10016-003-0066-2
   Shim WH, 1999, KOREAN CIRC J, V29, P907
   Tang GL, 2008, J VASC SURG, V47, P671, DOI 10.1016/j.jvs.2007.08.031
   Wellons ED, 2004, J VASC SURG, V40, P1095, DOI 10.1016/j.jvs.2004.09.003
   Yilmaz O, 2010, ULUS TRAVMA ACIL CER, V16, P575
NR 10
TC 2
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 341
EP 344
DI 10.4070/kcj.2012.42.5.341
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900008
PM 22701500
OA Green Published
DA 2021-04-22
ER

PT J
AU Rahman, A
   Islam, AKMM
   Husnayen, SAM
AF Rahman, Afzalur
   Islam, A. K. M. Monwarul
   Husnayen, S. A. M.
TI Recurrent Deep Vein Thrombosis due to Thrombophilia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Deep vein thrombosis; Thrombophilia
AB Deep vein thrombosis (DVT) is a common condition that is often under-diagnosed. Acquired or hereditary defects of coagulation or a combination of these defects may facilitate the development of DVT. Recurrent DVT, a positive family history or unusual presentation may warrant investigation for hereditary thrombophilia. Investigations are best when conducted at least one month after completion of a course of anticoagulant therapy. Most patients are managed with heparin in the acute stage overlapped by warfarin. The case presented here describes a 40-year old man undergoing three episodes of DVT. Investigations revealed protein C and protein S deficiency. Protein C, protein S and antithrombin deficiency either singly or in combination, are relatively common causes of hereditary thrombophilia. The case presented here serves as a reminder of the need to look into the underlying cause of venous thromboembolism.
C1 [Rahman, Afzalur] Sir Salimullah Med Coll, Dept Cardiol, Dhaka, Bangladesh.
   [Rahman, Afzalur] Mitford Hosp, Dhaka, Bangladesh.
   [Islam, A. K. M. Monwarul] Natl Inst Cardiovasc Dis, Dept Cardiol, Dhaka 1207, Bangladesh.
   [Husnayen, S. A. M.] Zia Heart Fdn Hosp & Res Inst, Dept Cardiol, Dinajpur, Bangladesh.
RP Islam, AKMM (corresponding author), Natl Inst Cardiovasc Dis, Dept Cardiol, Dhaka 1207, Bangladesh.
EM drmonwarbd@yahoo.com
CR Bauer KA, 2001, ANN INTERN MED, V135, P367, DOI 10.7326/0003-4819-135-5-200109040-00013
   CARTER CJ, 1996, DISORDERS THROMBOSIS, P159
   DAngelo A, 1997, BLOOD, V90, P1
   Hao WR, 2008, ACTA CARDIOL SIN, V24, P157
   HEIJBOER H, 1990, NEW ENGL J MED, V323, P1512, DOI 10.1056/NEJM199011293232202
   Maheshwari A, 2004, PERIPHERAL VASCULAR, P452
   Makris M, 1997, THROMB HAEMOSTASIS, V78, P1426
   MILETICH J, 1987, NEW ENGL J MED, V317, P991, DOI 10.1056/NEJM198710153171604
   Murin S, 1998, AM J RESP CRIT CARE, V158, P1369, DOI 10.1164/ajrccm.158.5.9712022
   Nicolaides AN, 2005, INT ANGIOL, V24, P1
   PABINGER I, 1992, BLOOD COAGUL FIBRIN, V3, P547, DOI 10.1097/00001721-199210000-00005
   Price DT, 1997, ANN INTERN MED, V127, P895, DOI 10.7326/0003-4819-127-10-199711150-00007
   Rees CD, 1995, LANCET, V346, P1133
   Schulman S, 2005, POSTGRADUATE HAEMATOLOGY, 5TH EDITION, P912, DOI 10.1002/9780470987056.ch55
   Seligsohn U, 1997, THROMB HAEMOSTASIS, V78, P297
   Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585
   Thomas RH, 2001, ARCH INTERN MED, V161, P2433, DOI 10.1001/archinte.161.20.2433
   Walker ID, 2005, POSTGRADUATE HAEMATOLOGY, 5TH EDITION, P885, DOI 10.1002/9780470987056.ch53
   White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66
NR 19
TC 2
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 345
EP 348
DI 10.4070/kcj.2012.42.5.345
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900009
PM 22701135
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, DY
   Oh, IY
   Lee, SR
   Choe, WS
   Yoon, JH
   Lee, SK
   Choi, EK
   Oh, S
AF Kang, Do-Yoon
   Oh, Il-Young
   Lee, So-Ryoung
   Choe, Won-Seok
   Yoon, Jung-Han
   Lee, Sang-Kun
   Choi, Eue-Keun
   Oh, Seil
TI Recurrent Syncope Triggered by Temporal Lobe Epilepsy: Ictal Bradycardia
   Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Bradycardia; Syncope; Electrocardiography
AB Ictal asystole is potentially lethal, and known to originate from the involvement of limbic autonomic regions. Appropriate treatment must include an antiepileptic drug and the implantation of a pacemaker. We report the case of a 54-year-old male with recurrent syncope secondary to ictal asystole triggered by temporal lobe epilepsy. This was confirmed by combined Holter and video-electroencephalogram monitoring.
C1 [Kang, Do-Yoon; Oh, Il-Young; Lee, So-Ryoung; Choe, Won-Seok; Yoon, Jung-Han; Choi, Eue-Keun; Oh, Seil] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea.
   [Lee, Sang-Kun] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul 110744, South Korea.
RP Oh, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM seil@snu.ac.kr
RI Choi, Eue-Keun/K-3752-2019; Oh, Seil/J-5539-2012; Choi,
   Eue-Keun/J-5968-2014
OI Oh, Seil/0000-0002-2504-9615; Choi, Eue-Keun/0000-0002-0411-6372
CR BLUMHARDT LD, 1986, LANCET, V1, P1051
   Brignole M, 2004, EUR HEART J, V25, P2054, DOI 10.1016/j.ehj.2004.09.004
   Britton JW, 2006, EPILEPSIA, V47, P737, DOI 10.1111/j.1528-1167.2006.00509.x
   Freeman R, 2006, CLIN AUTON RES, V16, P12, DOI 10.1007/s10286-006-0278-y
   FRYSINGER RC, 1989, ELECTROEN CLIN NEURO, V72, P463, DOI 10.1016/0013-4694(89)90222-8
   Kim JS, 1996, KOREAN CIRC J, V26, P855
   Opherk C, 2002, EPILEPSY RES, V52, P117, DOI 10.1016/S0920-1211(02)00215-2
   Park KH, 2007, KOREAN CIRC J, V37, P449
   Reeves AL, 1996, EPILEPSIA, V37, P983, DOI 10.1111/j.1528-1157.1996.tb00536.x
   Rugg-Gunn FJ, 2004, LANCET, V364, P2212, DOI 10.1016/S0140-6736(04)17594-6
NR 10
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 349
EP 351
DI 10.4070/kcj.2012.42.5.349
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900010
PM 22701136
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SH
   Moon, JY
   Sung, JH
   Kim, IJ
   Lim, SW
   Cha, DH
   Cho, SY
AF Kim, Sang-Hoon
   Moon, Jae-Youn
   Sung, Jung-Hoon
   Kim, In Jai
   Lim, Sang-Wook
   Cha, Dong-Hun
   Cho, Seung-Yun
TI Fatal Delayed Coronary Artery Perforation After Coronary Stent
   Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiac tamponade; Complications; Percutaneous transluminal coronary
   angioplasty; Drug-eluting stent
AB Most type I and II perforations are predominately caused by hydrophilic and stiff wires, often presented in the delayed form, and do not require pericardial drainage or surgical interventions. However, we report a type III delayed coronary artery perforation at the site of stent implantation after intervention without any evidence of immediate perforations. To the best of our knowledge, this is the first case report of angiographic documentation and treatment of delayed coronary perforation at the site of stent, presented as a cardiac arrest.
C1 [Kim, Sang-Hoon; Moon, Jae-Youn; Sung, Jung-Hoon; Kim, In Jai; Lim, Sang-Wook; Cha, Dong-Hun; Cho, Seung-Yun] CHA Univ, CHA Bundang Med Ctr, Dept Cardiol, Songnam 463712, South Korea.
RP Moon, JY (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Cardiol, 59 Yatap Ro, Songnam 463712, South Korea.
EM answodus@medimail.co.kr
CR ELLIS SG, 1994, CIRCULATION, V90, P2725, DOI 10.1161/01.CIR.90.6.2725
   Fasseas P, 2004, AM HEART J, V147, P140, DOI 10.1016/S0002-8703(03)00505-2
   Fukutomi T, 2002, CIRC J, V66, P349, DOI 10.1253/circj.66.349
   Gruberg L, 2000, AM J CARDIOL, V86, P680, DOI 10.1016/S0002-9149(00)01053-5
   Gunning MG, 2002, HEART, V88, P495, DOI 10.1136/heart.88.5.495
   Ramana Ravi K, 2005, J Invasive Cardiol, V17, P603
   Shimony A, 2009, AM J CARDIOL, V104, P1674, DOI 10.1016/j.amjcard.2009.07.048
   von Sohsten R, 2000, AM HEART J, V140, P279, DOI 10.1067/mhj.2000.107996
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 352
EP 354
DI 10.4070/kcj.2012.42.5.352
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900011
PM 22701137
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, KH
   Jeong, MH
   Chung, CY
   Kim, D
   Lee, MG
   Park, KH
   Sim, DS
   Yoon, NS
   Yoon, HJ
   Kim, KH
   Hong, YJ
   Kim, JH
   Ahn, Y
   Cho, JG
   Park, JC
   Kang, JC
AF Lee, Ki Hong
   Jeong, Myung Ho
   Chung, Cho Yun
   Kim, Donghan
   Lee, Min Goo
   Park, Keun-Ho
   Sim, Doo Sun
   Yoon, Nam Sik
   Yoon, Hyun Ju
   Kim, Kye Hun
   Hong, Young Joon
   Kim, Ju Han
   Ahn, Youngkeun
   Cho, Jeong Gwan
   Park, Jong Chun
   Kang, Jung Chaee
TI Successful Percutaneous Coronary Intervention in a Centenarian Patient
   With Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Centenarian; Myocardial infarction; Percutaneous transluminal coronary
   angioplasty
ID TRENDS; AGE; MANAGEMENT; OUTCOMES; REGISTRY; IMPACT
AB Despite an increasing prevalence and burden of disease in the elderly, little is known about the management and outcomes of acute coronary syndromes in this group. We report the case of a 101-year-old female patient with a non-ST segment elevation myocardial infarction. Coronary angiography showed a total occlusion of the proximal right coronary artery (RCA), and a significant stenosis in the proximal to mid left anterior descending artery (LAD). Despite a very poor initial clinical status, a percutaneous coronary intervention was successfully performed for the total occlusion in the RCA. The LAD lesion was treated with medical therapy only, on account of the age and general condition of the patient. She was discharged after recovering to a good health status, free of chest pain or dyspnea.
C1 [Lee, Ki Hong; Jeong, Myung Ho; Chung, Cho Yun; Kim, Donghan; Lee, Min Goo; Park, Keun-Ho; Sim, Doo Sun; Yoon, Nam Sik; Yoon, Hyun Ju; Kim, Kye Hun; Hong, Young Joon; Kim, Ju Han; Ahn, Youngkeun; Cho, Jeong Gwan; Park, Jong Chun; Kang, Jung Chaee] Chonnam Natl Univ, Chonnam Natl Univ Hosp, Cardiovasc Res Inst, Heart Res Ctr, Kwangju 501757, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ, Chonnam Natl Univ Hosp, Cardiovasc Res Inst, Heart Res Ctr, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
CR Avezum A, 2005, AM HEART J, V149, P67, DOI 10.1016/j.ahj.2004.06.003
   Batchelor WB, 2000, J AM COLL CARDIOL, V36, P723, DOI 10.1016/S0735-1097(00)00777-4
   Chung WS, 2001, KOREAN CIRC J, V31, P996
   Cohen HA, 2003, AM HEART J, V146, P513, DOI 10.1016/S0002-8703(03)00259-X
   Floyd Kevin C, 2006, J Interv Cardiol, V19, P381, DOI 10.1111/j.1540-8183.2006.00192.x
   From AM, 2008, JACC-CARDIOVASC INTE, V1, P692, DOI 10.1016/j.jcin.2008.07.009
   Galloto A, 2008, EXP GERONTOL, V43, P106, DOI 10.1016/j.exger.2007.06.009
   임상엽, 2005, Korean Circulation Journal, V35, P613
   Klein LW, 2002, J AM COLL CARDIOL, V40, P394, DOI 10.1016/S0735-1097(02)01992-7
   Singh M, 2005, AM J CARDIOL, V96, P907, DOI 10.1016/j.amjcard.2005.05.045
   Singh M, 2007, CIRCULATION, V115, P2835, DOI 10.1161/CIRCULATIONAHA.106.632679
   Skolnick AH, 2007, J AM COLL CARDIOL, V49, P1790, DOI 10.1016/j.jacc.2007.01.066
   이선화, 2007, Korean Circulation Journal, V37, P647
NR 13
TC 0
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 355
EP 359
DI 10.4070/kcj.2012.42.5.355
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900012
PM 22701138
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, KN
   Lee, HC
   Park, JS
   Kim, BW
   Cha, KS
   Kim, SP
   Lee, CW
   Kim, HK
AF Lee, Kyung Nam
   Lee, Han Cheol
   Park, Jin Sup
   Kim, Bo Won
   Cha, Kwang Soo
   Kim, Sang-Pil
   Lee, Chung Won
   Kim, Hae Kyu
TI The Modified Chimney Technique With a Thoracic Aortic Stent Graft to
   Preserve the Blood Flow of the Left Common Carotid Artery for Treating
   Descending Thoracic Aortic Aneurysm and Dissection
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Stents; Aortic rupture; Aortic aneurysm
AB While thoracic endovascular aortic repair is an effective treatment option for descending thoracic aorta pathology, it does have limitations. The main limitation is related to the anatomical difficulties when disease involves the aortic arch. A fenestrated, branched aortic stent graft and hybrid operation has been introduced to overcome this limitation, but it is a custom-made device and is time consuming to manufacture. Furthermore, these devices cannot be used in an emergency setting. We report two patients with massive descending thoracic aortic aneurysm and ruptured aortic dissection very near the aortic arch who underwent a procedure which we named the modified chimney technique. The modified chimney technique can be used as a treatment option in such an emergency situation or as a rescue procedure when aortic pathology is involved near the supra-aortic vessels.
C1 [Lee, Kyung Nam; Lee, Han Cheol; Park, Jin Sup; Kim, Bo Won; Cha, Kwang Soo] Pusan Natl Univ, Coll Med, Dept Cardiol, Pusan 602739, South Korea.
   [Kim, Sang-Pil; Lee, Chung Won] Pusan Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Pusan 602739, South Korea.
   [Kim, Hae Kyu] Pusan Natl Univ, Coll Med, Dept Anesthesia, Pusan 602739, South Korea.
RP Lee, HC (corresponding author), Pusan Natl Univ, Coll Med, Dept Cardiol, 179 Gudeok Ro, Pusan 602739, South Korea.
EM glaraone@hanmail.net
FU Korea Healthcare technology R&D Project, Ministry of Health & Welfare,
   Republic of Korea [A084177]
FX This study was supported by a grant from the Korea Healthcare technology
   R&D Project, Ministry of Health & Welfare, Republic of Korea (A084177).
CR Allaqaband S, 2010, CATHETER CARDIO INTE, V75, P1111, DOI 10.1002/ccd.22390
   Cheng D, 2010, J AM COLL CARDIOL, V55, P986, DOI 10.1016/j.jacc.2009.11.047
   Chuter Timothy A M, 2007, Perspect Vasc Surg Endovasc Ther, V19, P188, DOI 10.1177/1531003507304165
   Criado FJ, 2007, J ENDOVASC THER, V14, P823, DOI 10.1583/07-2247.1
   Feezor RJ, 2007, J ENDOVASC THER, V14, P568, DOI 10.1583/1545-1550(2007)14[568:RFFPSD]2.0.CO;2
   Greenberg RK, 2003, J VASC SURG, V38, P990, DOI 10.1016/S0741-5214(03)00896-6
   Larzon T, 2005, EUR J VASC ENDOVASC, V30, P147, DOI 10.1016/j.ejvs.2005.02.049
   Malina M, 2008, SCAND J SURG, V97, P195, DOI 10.1177/145749690809700226
   Ohrlander T, 2008, J ENDOVASC THER, V15, P427, DOI 10.1583/07-2315.1
   Rizvi AZ, 2009, J VASC SURG, V50, P1159, DOI 10.1016/j.jvs.2009.09.002
   Sonesson B, 2009, J VASC SURG, V49, P1589, DOI 10.1016/j.jvs.2009.02.007
NR 11
TC 5
Z9 6
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 360
EP 365
DI 10.4070/kcj.2012.42.5.360
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900013
PM 22701139
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SH
   Song, PS
   Kim, WS
   Park, KB
   Choi, SH
AF Lee, Sung Ho
   Song, Pil Sang
   Kim, Wook Sung
   Park, Kwang Bo
   Choi, Seung-Hyuk
TI A Case of Stent Graft Infection Coupled With Aorto-Esophageal Fistula
   Following Thoracic Endovascular Aortic Repair in a Complex Patient
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Thoracic aorta; Stents; Complications; Infection; Esophageal fistula
ID MANAGEMENT; ANEURYSMS
AB The incidence of peri-stent graft infection (PGI) following thoracic endovascular aortic repair (TEVAR) is low, but the associated mortality rates are extremely high. The diagnosis of this complication can be difficult due to nonspecific symptoms. Here, we report a case of PGI combined with an aorto-esophageal fistula (AEF) diagnosed by computed tomography (CT) and positron emission tomography (PET) imaging after TEVAR. A 50-year-old woman with a history of diabetes mellitus and chronic hemodialysis had received a stent graft for a contained rupture of a pseudoaneurysm of the descending thoracic aorta. Three months after stent-grafting, she experienced back pain. CT and PET imaging suggested a PGI. The patient underwent surgical treatment for PGI with AEF.
C1 [Lee, Sung Ho; Song, Pil Sang; Choi, Seung-Hyuk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Cardiac & Vasc Ctr, Seoul 135710, South Korea.
   [Kim, Wook Sung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul 135710, South Korea.
   [Park, Kwang Bo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul 135710, South Korea.
RP Choi, SH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Cardiac & Vasc Ctr, 50 Irwon Dong, Seoul 135710, South Korea.
EM sh1214.choi@samsung.com
OI Choi, Seung-Hyuk/0000-0002-0304-6317
CR Blanch M, 2010, ANN VASC SURG, V24, DOI 10.1016/j.avsg.2009.11.003
   Chiesa R, 2010, EUR J VASC ENDOVASC, V39, P273, DOI 10.1016/j.ejvs.2009.12.007
   Christensen JD, 2009, SEMIN ROENTGENOL, V44, P4, DOI 10.1053/j.ro.2008.10.006
   Fattori R, 2006, J THORAC CARDIOV SUR, V132, P332, DOI 10.1016/j.jtcvs.2006.03.055
   Fukuchi K, 2005, J VASC SURG, V42, P919, DOI 10.1016/j.jvs.2005.07.038
   Kitamura T, 2005, ANN VASC SURG, V19, P335, DOI 10.1007/s10016-005-0006-4
   LAWRIE GM, 1994, J CARDIAC SURG, V9, P648, DOI 10.1111/j.1540-8191.1994.tb00899.x
   Orton DF, 2000, RADIOGRAPHICS, V20, P977, DOI 10.1148/radiographics.20.4.g00jl12977
   Perera Ganesha B, 2006, Vasc Endovascular Surg, V40, P1, DOI 10.1177/153857440604000101
   Saleem BR, 2008, J VASC SURG, V47, P635, DOI 10.1016/j.jvs.2007.09.029
   Saleem BR, 2010, AM J SURG, V200, P47, DOI 10.1016/j.amjsurg.2009.05.018
   Seeger JM, 2000, AM SURGEON, V66, P166
NR 12
TC 6
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 366
EP 368
DI 10.4070/kcj.2012.42.5.366
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900014
PM 22701140
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, CG
   Lee, JY
AF Park, Chang Gyu
   Lee, Ju Young
TI The Significance of the J-Curve in Hypertension and Coronary Artery
   Diseases (vol 41, pg 349, 2011)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Correction
C1 [Park, Chang Gyu; Lee, Ju Young] Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul, South Korea.
RP Park, CG (corresponding author), Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul, South Korea.
CR Park CG, 2011, KOREAN CIRC J, V41, P349, DOI 10.4070/kcj.2011.41.7.349
NR 1
TC 0
Z9 0
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2012
VL 42
IS 5
BP 369
EP 369
DI 10.4070/kcj.2012.42.5.369
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IK
UT WOS:000209079900015
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HC
AF Kim, Hyeon Chang
TI Clinical Utility of Novel Biomarkers in the Prediction of Coronary Heart
   Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Biomarkers; Prevention; Risk assessment; Coronary heart disease
AB Coronary heart disease (CHD) is a significant cause of morbidity and mortality worldwide. Many risk prediction models have been developed in an effort to assist clinicians in risk assessment and the prevention of CHD. However, it is unclear whether the existing CHD prediction tools can improve clinical performance, and recently, there has been a lot of effort being made to improve the accuracy of the prediction models. A large number of novel biomarkers have been identified to be associated with cardiovascular risk, and studied with the goal of improving the accuracy and clinical utility of CHD risk prediction. Yet, controversy still remains with regard to the utility of novel biomarkers in CHD risk assessment, and in finding the best statistical methods to assess the incremental value of the biomarkers. This article discusses the statistical approaches that can be used to evaluate the predictive values of new biomarkers, and reviews the clinical utility of novel biomarkers in CHD prediction, specifically in the Korean population.
C1 [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Internal Med, Dept Prevent Med,Div Cardiol, Seoul 120752, South Korea.
   [Kim, Hyeon Chang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
RP Kim, HC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, 50 Yonsei Ro, Seoul 120752, South Korea.
EM hckim@yuhs.ac
RI Kim, Hyeon Chang/F-8796-2019
OI Kim, Hyeon Chang/0000-0001-7867-1240
FU Korea Healthcare technology R&D Project of the Ministry of Health and
   Welfare, Republic of Korea [A102065]
FX This work was supported by a grant from the Korea Healthcare technology
   R&D Project of the Ministry of Health and Welfare, Republic of Korea
   (A102065).
CR Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842
   Blumenthal RS, 2011, PREVENTIVE CARDIOLOG
   Brotman DJ, 2005, ARCH INTERN MED, V165, P138, DOI 10.1001/archinte.165.2.138
   Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009
   Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6
   Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402
   Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128
   Cushman M, 1999, ARTERIOSCL THROM VAS, V19, P493, DOI 10.1161/01.ATV.19.3.493
   D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180
   Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799
   Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804
   De Backer G, 2004, ATHEROSCLEROSIS, V173, P379, DOI 10.1016/j.atherosclerosis.2004.02.014
   Everett BM, 2006, J AM COLL CARDIOL, V48, P2235, DOI 10.1016/j.jacc.2006.09.030
   Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368
   Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010
   Hosmer DW., 2000, APPL LOGISTIC REGRES, V2nd ed
   Jee SH, 2008, ATHEROSCLEROSIS, V197, P318, DOI 10.1016/j.atherosclerosis.2007.05.014
   Kim HC, 2010, J AM COLL CARDIOL, V55, P2080, DOI 10.1016/j.jacc.2009.12.047
   Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3
   Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166
   Mangoni AA, 2002, AM J MED, V112, P556, DOI 10.1016/S0002-9343(02)01021-5
   May M, 2006, HEART, V92, P1396, DOI 10.1136/hrt.2005.085381
   McGeechan K, 2008, ARCH INTERN MED, V168, P2304, DOI 10.1001/archinte.168.21.2304
   Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929
   Pischon T, 2008, ATHEROSCLEROSIS, V197, P392, DOI 10.1016/j.atherosclerosis.2007.06.022
   Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611
   Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05
   Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993
   Shah T, 2009, INT J EPIDEMIOL, V38, P217, DOI 10.1093/ije/dyn217
   Sheridan SL, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-60
   Shlipak MG, 2005, JAMA-J AM MED ASSOC, V293, P1737, DOI 10.1001/jama.293.14.1737
   Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161
   van der Meer IM, 2003, ARCH INTERN MED, V163, P1323, DOI 10.1001/archinte.163.11.1323
   Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373
   Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994
   Wilson PWF, 2005, ARCH INTERN MED, V165, P2473, DOI 10.1001/archinte.165.21.2473
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
   Wood AM, 2009, DIS MARKERS, V26, P199, DOI [10.1155/2009/412947, 10.3233/DMA-2009-0631]
   Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X
   Zethelius B, 2006, CIRCULATION, V113, P1071, DOI 10.1161/CIRCULATIONAHA.105.570762
   Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064
NR 43
TC 11
Z9 11
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2012
VL 42
IS 4
BP 223
EP 228
DI 10.4070/kcj.2012.42.4.223
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IJ
UT WOS:000209079800001
PM 22563333
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, J
AF Shin, Jinho
TI Efonidipine, Another Beauty Relieving the Pressure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 133792, South Korea.
RP Shin, J (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, 222 Wangsimni Ro, Seoul 133792, South Korea.
EM jhs2003@hanyang.ac.kr
OI Shin, Jinho/0000-0001-6706-6504
CR Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1
   Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8
   Komukai M, 2012, KOREAN CIRC J, V42, P231, DOI 10.4070/kcj.2012.42.4.231
   Oh Il-Young, 2010, Korean Circ J, V40, P514, DOI 10.4070/kcj.2010.40.10.514
   Sasaki H, 2009, J ATHEROSCLER THROMB, V16, P568, DOI 10.5551/jat.1628
   Tanaka H, 2002, CARDIOVASC DRUG REV, V20, P81
   Tardif JC, 2009, BRIT MED BULL, V90, P71, DOI 10.1093/bmb/ldp016
   Williams B, 2009, J AM COLL CARDIOL, V54, P705, DOI [10.1016/j.jacc.2009.02.088, 10.1016/j.jacc.2009.06.043]
NR 8
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2012
VL 42
IS 4
BP 229
EP 230
DI 10.4070/kcj.2012.42.4.229
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IJ
UT WOS:000209079800002
PM 22563334
OA Green Published
DA 2021-04-22
ER

PT J
AU Komukai, M
   Tsutsumi, T
   Ebado, M
   Takeyama, Y
AF Komukai, Masae
   Tsutsumi, Takeshi
   Ebado, Mio
   Takeyama, Youichi
TI Effect of an L- and T-Type Calcium Channel Blocker on 24-Hour Systolic
   Blood Pressure and Heart Rate in Hypertensive Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Blood pressure; Calcium channel blockers; Heart rate; Hypertension
ID EFONIDIPINE HYDROCHLORIDE; CA2+ CHANNELS; INHIBITION; DISEASE; PLASMA;
   NZ-105
AB Background and Objectives: The aim of this study was to evaluate the effects of an L-and T-type calcium channel blocker (CCB) on 24-hour systolic blood pressure (24-hour SBP) and heart rate (24-hour HR) profiles in essential hypertensive patients. Subjects and Methods: Thirty-seven consecutive patients were enrolled in this study. The 24-hour SBP and HR were recorded before and after treatment with efonidipine (L-and T-type CCB, 40 mg), after waking. Changes in 24-hour SBP and HR and the diurnal to nocturnal SBP ratio were measured. The best-fit curves of changes in SBP and HR were depicted using a periodic function. Results: The mean 24-hour SBP and HR decreased significantly after treatment. The diurnal to nocturnal SBP ratio in dipper-type hypertension cases decreased from 16.7 +/- 6.1% to 8.3 +/- 9.8% (p<0.05), whereas in non-dipper hypertension cases, it increased from 2.3 +/- 2.9% to 7.7 +/- 5.1% (p<0.01). The antihypertensive effect was minimal at 5.0 hours after drug administration and it slowly recovered at a constant rate (2.1 mm Hg/h) over 12 hours in dipper cases. The median 24-hour changes in HR in the dipper and non-dipper cases were -2.3/min and -5.4/min, respectively. A continuous reduction in the change in HR was seen from 3.5 to 23 hours after drug administration. Conclusion: The antihypertensive action of efonidipine was characterized by a slow recovery of the SBP decrease at a constant rate (2.1 mm Hg/h) and a non-administration time dependent reduction in 24-hour HR.
C1 [Komukai, Masae; Ebado, Mio] Showa Univ, Fujigaoka Hosp, Div Cardiol, Yokohama, Kanagawa 2278501, Japan.
   [Tsutsumi, Takeshi] Univ Tokyo, Dept Ischem Circulatory Physiol, Tokyo, Japan.
   [Takeyama, Youichi] Showa Univ, Fujigaoka Rehabil Hosp, Div Cardiol, Yokohama, Kanagawa 2278501, Japan.
RP Komukai, M (corresponding author), Showa Univ, Fujigaoka Hosp, Div Cardiol, Aoba Ku, 1-30 Fujigaoka, Yokohama, Kanagawa 2278501, Japan.
EM maco21011969@gmail.com
CR Fox K, 2008, LANCET, V372, P817, DOI 10.1016/S0140-6736(08)61171-X
   Ge W, 2009, HYPERTENSION, V53, P592, DOI 10.1161/HYPERTENSIONAHA.108.127548
   Hayashi K, 2007, CIRC RES, V100, P342, DOI 10.1161/01.RES.0000256155.31133.49
   Hermida RC, 2007, ADV DRUG DELIVER REV, V59, P904, DOI 10.1016/j.addr.2006.08.003
   Hermida RC, 2009, CHRONOBIOL INT, V26, P61, DOI 10.1080/07420520802548135
   Ishimitsu T, 2007, HYPERTENS RES, V30, P621, DOI 10.1291/hypres.30.621
   Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA
   Kinoshita H, 2009, CIRCULATION, V120, P743, DOI 10.1161/CIRCULATIONAHA.109.857011
   Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f
   MASUDA Y, 1990, ARCH INT PHARMACOD T, V304, P247
   Masumiya H, 1998, EUR J PHARMACOL, V349, P351, DOI 10.1016/S0014-2999(98)00204-0
   Minami J, 1998, J CARDIOVASC PHARM, V32, P331, DOI 10.1097/00005344-199808000-00023
   Nakabeppu H, 1996, XENOBIOTICA, V26, P229, DOI 10.3109/00498259609046703
   Nold G, 1999, J HUM HYPERTENS, V13, P173, DOI 10.1038/sj.jhh.1000787
   Oh Il-Young, 2010, Korean Circ J, V40, P514, DOI 10.4070/kcj.2010.40.10.514
   Ohtomo N, 1996, JPN J APPL PHYS 1, V35, P5571, DOI 10.1143/JJAP.35.5571
   Ono K, 2005, J PHARMACOL SCI, V99, P197, DOI 10.1254/jphs.FMJ05002X2
   Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002
   Saito T, 1996, ARZNEIMITTEL-FORSCH, V46, P861
   Shin HS, 2006, CELL CALCIUM, V40, P191, DOI 10.1016/j.ceca.2006.04.023
   Tanaka H, 2002, CARDIOVASC DRUG REV, V20, P81
   Tochikubo O, 1996, HYPERTENSION, V27, P1318, DOI 10.1161/01.HYP.27.6.1318
   White WB, 2003, AM J HYPERTENS, V16, P739, DOI 10.1016/S0895-7061(03)00946-4
   YAMASHITA T, 1991, JPN J PHARMACOL, V57, P337, DOI 10.1254/jjp.57.337
NR 24
TC 2
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2012
VL 42
IS 4
BP 231
EP 238
DI 10.4070/kcj.2012.42.4.231
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IJ
UT WOS:000209079800003
PM 22563335
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, HY
   Youn, SW
   Oh, BH
   Kim, HS
AF Lee, Hae-Young
   Youn, Seock-Won
   Oh, Byung-Hee
   Kim, Hyo-Soo
TI Kruppel-Like Factor 2 Suppression by High Glucose as a Possible
   Mechanism of Diabetic Vasculopathy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Diabetes mellitus; Endothelial cells; Kruppel-like factor 2
AB Background and Objectives: Endothelial dysfunction is widely observed in diabetes mellitus, resulting in diabetic vascular complications. Kruppel-like factor 2 (KLF2) is implicated as being a key molecule that maintains endothelial function. We evaluated the expression of KLF2 in endothelial cells cultured in high glucose and investigated its functional implication in a diabetic animal model.
   Subjects and Methods: Human umbilical vein endothelial cells (HUVECs) were cultured in physiologically high glucose (35 mM) condition. The Otsuka Long Evans Tokushima Fatty (OLETF) strain of rat was used as an excellent model of obese type II diabetes, and their lean littermates are Long Evans Tokushima Otsuka (LETO) rats.
   Results: In HUVECs cultured in physiologically high glucose condition, FOXO1 was activated whereas KLF2 and endothelial nitric oxide synthase (eNOS) expression was near completely abolished, which was completely reversed by FOXO1 small interfering ribonucleic acid. In the vessels harvested from the OLETF rats, the animal model of type II diabetes, KLF2 and eNOS expression were found depleted. When vascular remodeling was induced in the left common carotid artery by reduction of blood flow with partial ligation of the distal branches, greater neointimal hypertrophy was observed in OLETF rats compared with the control LETO rats.
   Conclusion: KLF2 suppression in endothelial cells by high glucose is a possible mechanism of diabetic endothelial dysfunction. The strategy of replenishing KLF2 may be effective for preventing diabetic vascular dysfunction.
C1 [Lee, Hae-Young; Youn, Seock-Won; Kim, Hyo-Soo] Seoul Natl Univ Hosp, Clin Res Inst, Cardiovasc Lab, Seoul 110744, South Korea.
   [Lee, Hae-Young; Oh, Byung-Hee; Kim, Hyo-Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea.
RP Lee, HY (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM hylee612@snu.ac.kr
RI Oh, Byung-Hee/G-9875-2011
OI Oh, Byung-Hee/0000-0002-9945-4306; Lee, Hae-Young/0000-0002-9521-4102
FU Korean Society of Cardiology; Seoul National University Hospital;
   National Research Foundation - Korea government (MEST)Ministry of
   Education, Science and Technology, Republic of KoreaKorean Government
   [2010-0020257]
FX This work was supported by research grant for the young investigator
   from the Korean Society of Cardiology (2007) and by research grant from
   the Seoul National University Hospital (Lee HY). This study was also
   partially supported by National Research Foundation grant funded by the
   Korea government (MEST) (2010-0020257, Kim HS).
CR Arslan F, 2008, CIRC RES, V103, P334, DOI 10.1161/CIRCRESAHA.108.182220
   Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a
   Balletshofer BM, 2000, CIRCULATION, V101, P1780, DOI 10.1161/01.CIR.101.15.1780
   Baris N, 2006, CAN J CARDIOL, V22, P935, DOI 10.1016/S0828-282X(06)70312-9
   Beckman JA, 2002, CIRC RES, V90, P107, DOI 10.1161/hh0102.102359
   Buteau J, 2007, DIABETES OBES METAB, V9, P140, DOI 10.1111/j.1463-1326.2007.00782.x
   De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393
   Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404
   HATTORI Y, 1991, AM J PHYSIOL, V261, pH1086
   Hink U, 2001, CIRC RES, V88, pE14
   Hurks R, 2009, EUR J VASC ENDOVASC, V37, P611, DOI 10.1016/j.ejvs.2009.01.015
   Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126
   JOHNSTONE MT, 1993, CIRCULATION, V88, P2510, DOI 10.1161/01.CIR.88.6.2510
   Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JC132914, 10.1172/JCI32914]
   Kanemoto N, 1998, MAMM GENOME, V9, P419, DOI 10.1007/s003359900789
   Kim HS, 2002, J BIOL CHEM, V277, P41888, DOI 10.1074/jbc.M206657200
   Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14
   Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238
   Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787
   Parmar KM, 2005, J BIOL CHEM, V280, P26714, DOI 10.1074/jbc.C500144200
   Rossi J, 2010, LIFE SCI, V87, P92, DOI 10.1016/j.lfs.2010.05.008
   Samatar AA, 2002, J BIOL CHEM, V277, P28118, DOI 10.1074/jbc.M203686200
   Steinberg HO, 1996, J CLIN INVEST, V97, P2601, DOI 10.1172/JCI118709
   Thum T, 2006, CARDIOVASC RES, V72, P193, DOI 10.1016/j.cardiores.2006.08.016
   Wang NP, 2006, BIOCHEM BIOPH RES CO, V341, P1244, DOI 10.1016/j.bbrc.2006.01.089
NR 25
TC 10
Z9 11
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2012
VL 42
IS 4
BP 239
EP 245
DI 10.4070/kcj.2012.42.4.239
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IJ
UT WOS:000209079800004
PM 22563336
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JH
   Jeong, MH
   Hong, YJ
   Lee, KH
   Kim, IS
   Choi, YH
   Lee, MG
   Park, KH
   Sim, DS
   Kim, JH
   Ahn, Y
   Cho, JG
   Park, JC
   Kang, JC
AF Kim, Jeong Hun
   Jeong, Myung Ho
   Hong, Young Joon
   Lee, Ki Hong
   Kim, In Soo
   Choi, Yun Ha
   Lee, Min Goo
   Park, Keun-Ho
   Sim, Doo Sun
   Kim, Ju Han
   Ahn, Youngkeun
   Cho, Jeong Gwan
   Park, Jong Chun
   Kang, Jung Chaee
TI Low Density Lipoprotein-Cholesterol/High Density Lipoprotein-Cholesterol
   Ratio Predicts Plaque Vulnerability in Patients With Stable Angina
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ultrasonography; Plaque, atherosclerotic; Angina pectoris; Cholesterol,
   high density lipoprotein; Cholesterol, low density lipoprotein
AB Background and Objectives: The relationship between lipid profile and coronary plaque tissue characteristics in patients with stable angina pectoris (SAP) is unclear. The aim of this study was to evaluate the relationship between tissue characteristics and lipid profile and predictors of unstable plaques (UPs) in patients with SAP by virtual histology intravascular ultrasonography (VH-IVUS).
   Subjects and Methods: VH-IVUS was performed for target lesions in patients with SAP (61.7 +/- 9.2 years, 174 males, n=266) at the time of coronary angiography. UPs are characterized by thin-cap fibroatheroma, ruptured plaque, or remaining thrombus with VH-IVUS.
   Results: The present study showed that 34 SAP patients had UPs (61.6 +/- 9.2 years, 24 males, 12.8%). The percentage of plaque area in the minimum luminal area in high low density lipoprotein-cholesterol (LDL-C)/high density lipoprotein-cholesterol (HDL-C) ratio patients was significantly higher than in low LDL-C/HDL-C ratio patients (72.7 +/- 9.5% vs. 69.9 +/- 9.3%, p=0.035). An LDL-C/HDL-C ratio >2.0 was an independent predictor for UPs in SAP patients (odds ratio 5.252, 95% confidence interval 1.132-24.372, p=0.034).
   Conclusion: An elevated LDL-C/HDL-C ratio is a positive predictor for coronary plaque vulnerability in patients with SAP.
C1 [Kim, Jeong Hun; Jeong, Myung Ho; Hong, Young Joon; Lee, Ki Hong; Kim, In Soo; Choi, Yun Ha; Lee, Min Goo; Park, Keun-Ho; Sim, Doo Sun; Kim, Ju Han; Ahn, Youngkeun; Cho, Jeong Gwan; Park, Jong Chun; Kang, Jung Chaee] Chonnam Natl Univ Hosp, Ctr Heart, Kwangju 501757, South Korea.
   [Kim, Jeong Hun] Chonnam Natl Univ, Dept Publ Hlth, Sch Med, Kwangju, South Korea.
   [Jeong, Myung Ho] Chonnam Natl Univ, Korea Cardiovasc Stent Res Inst, Kwangju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Ctr Heart, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
FU Korea Healthcare technology R & D Project, Ministry for Health, Welfare
   & Family Affairs, Republic of Korea [A084869]
FX This study was supported by a grant of the Korea Healthcare technology R
   & D Project (A084869), Ministry for Health, Welfare & Family Affairs,
   Republic of Korea.
CR Bae JH, 2006, KOREAN CIRC J, V36, P553
   Bae JH, 2007, KOREAN CIRC J, V37, P437
   Brener SJ, 2006, AM HEART J, V152, P1059, DOI 10.1016/j.ahj.2006.07.022
   ChemarinAlibelli MJ, 1996, AM J CARDIOL, V77, P344, DOI 10.1016/S0002-9149(97)89361-7
   DEFEYTER PJ, 1995, CIRCULATION, V92, P1408, DOI 10.1161/01.CIR.92.6.1408
   Hong MK, 2004, CIRCULATION, V110, P928, DOI 10.1161/01.CIR.0000139858.69915.2E
   Hong MK, 2007, AM J CARDIOL, V100, P953, DOI 10.1016/j.amjcard.2007.04.034
   Hur SH, 2004, KOREAN CIRC J, V34, P548
   KANNEL WB, 1985, AM HEART J, V110, P1100, DOI 10.1016/0002-8703(85)90224-8
   Kimura T, 2010, CIRC J, V74, P1392, DOI 10.1253/circj.CJ-09-0849
   LITTLE WC, 1988, CIRCULATION, V78, P1157, DOI 10.1161/01.CIR.78.5.1157
   Maehara A, 2002, J AM COLL CARDIOL, V40, P904, DOI 10.1016/S0735-1097(02)02047-8
   Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035
   MANNINEN V, 1992, CIRCULATION, V85, P37, DOI 10.1161/01.CIR.85.1.37
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Mintz GS, 2003, AM J CARDIOL, V91, P1333, DOI 10.1016/S0002-9149(03)00323-0
   Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97
   Nair Anuja, 2007, EuroIntervention, V3, P113
   Nakamura H, 2008, CIRCULATION, V118, pS1174
   Nasu K, 2006, J AM COLL CARDIOL, V47, P2405, DOI 10.1016/j.jacc.2006.02.044
   Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499
   Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002
   Pasterkamp G, 2000, J AM COLL CARDIOL, V36, P13, DOI 10.1016/S0735-1097(00)00677-X
   Roberts WL, 2001, CLIN CHEM, V47, P418
   Rodriguez-Granillo GA, 2005, J AM COLL CARDIOL, V46, P2038, DOI 10.1016/j.jacc.2005.07.064
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Sakamoto T, 2010, CIRC J, V74, P1731, DOI 10.1253/circj.CJ-10-0537
   Schoenhagen P, 2006, CIRCULATION, V113, P2826, DOI 10.1161/CIRCULATIONAHA.105.585703
   Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065
NR 29
TC 5
Z9 8
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2012
VL 42
IS 4
BP 246
EP 251
DI 10.4070/kcj.2012.42.4.246
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IJ
UT WOS:000209079800005
PM 22563337
OA Green Published
DA 2021-04-22
ER

PT J
AU Suh, YJ
   Kim, GB
   Kwon, BS
   Bae, EJ
   Noh, CI
   Lim, HG
   Kim, WH
   Lee, JR
   Kim, YJ
AF Suh, Yoon Jung
   Kim, Gi Beom
   Kwon, Bo Sang
   Bae, Eun Jung
   Noh, Chung Il
   Lim, Hong Gook
   Kim, Woong Han
   Lee, Jeong Ryul
   Kim, Yong Jin
TI Clinical Course of Vascular Rings and Risk Factors Associated With
   Mortality
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Vascular rings; Congenital heart disease; Pulmonary artery sling;
   Clinical characteristics; Mortality
AB Background and Objectives: Vascular rings refer to anomalies of the great arteries that cause respiratory or feeding problems. The purpose of this study was to analyze a series of patients with vascular rings and evaluate associated risk factors for mortality.
   Subjects and Methods: A retrospective review of all patients identified with vascular rings between 1997 and 2010 in the Seoul National University Children's Hospital.
   Results: Thirty-five patients were diagnosed with vascular rings (median age at diagnosis, 7 months). The vascular rings of 32 patients were confirmed by cardiac computed tomography or magnetic resonance imaging. The types of vascular rings were: a double aortic arch in ten patients, a right aortic arch with persistent left ligamentum arteriosum in seven, an aberrant subclavian artery in seven, a pulmonary sling in eight, and others types in three patients. Eleven patients were asymptomatic. Gastrointestinal and respiratory symptoms were seen in ten and sixteen patients, respectively. Associated cardiovascular anomalies were present in fifteen patients. Twenty patients with definite symptoms underwent surgical treatment. The median interval between diagnosis and operation was 6 days. Four patients eventually died; three deaths were associated with complex heart diseases, and one had pulmonary artery sling with severe tracheal stenosis. Only the presence of a complex heart disease significantly influenced mortality (p=0.002).
   Conclusion: Vascular rings include several types of anomalies, each with a different prognosis and symptoms. The presence of a complex heart disease was significantly associated with mortality. Early diagnosis and timely surgery in symptomatic patients are essential.
C1 [Suh, Yoon Jung; Kim, Gi Beom; Kwon, Bo Sang; Bae, Eun Jung; Noh, Chung Il] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul 110744, South Korea.
   [Lim, Hong Gook; Kim, Woong Han; Lee, Jeong Ryul; Kim, Yong Jin] Seoul Natl Univ, Childrens Hosp, Dept Thorac & Cardiovasc Surg, Seoul 110744, South Korea.
RP Kim, GB (corresponding author), Seoul Natl Univ, Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 110744, South Korea.
EM ped9526@snu.ac.kr
RI Kim, Gi Beom/AAK-3377-2021
OI Kim, Gi Beom/0000-0002-7880-280X
CR Alsenaidi K, 2006, PEDIATRICS, V118, pE1336, DOI 10.1542/peds.2006-1097
   Banka P, 2009, CIRCULATION, V120, P264, DOI 10.1161/CIRCULATIONAHA.109.851733
   BINET JP, 1977, J THORAC CARDIOV SUR, V73, P248
   Bonnard A, 2003, J PEDIATR SURG, V38, P539, DOI 10.1053/jpsu.2003.50117
   Dodge-Khatami A, 2002, CARDIOL YOUNG, V12, P96, DOI 10.1017/S1047951102000239
   Eichhorn J, 2004, Z KARDIOL, V93, P201, DOI 10.1007/s00392-004-0026-z
   GROSS RE, 1945, NEW ENGL J MED, V233, P586, DOI 10.1056/NEJM194511152332003
   Han BS, 1989, KOREAN CIRC J, V19, P776
   Hernanz-Schulman M, 2005, PEDIATR RADIOL, V35, P961, DOI 10.1007/s00247-005-1529-0
   Humphrey C, 2006, PEDIATRICS, V117, pE903, DOI 10.1542/peds.2005-1674
   Kellenberger CJ, 2010, PEDIATR RADIOL, V40, P876, DOI 10.1007/s00247-010-1607-9
   Kocis KC, 1997, PEDIATR CARDIOL, V18, P127, DOI 10.1007/s002469900130
   Park MK, 2008, PEDIAT CARDIOLOGY PR, P303
   Ruzmetov M, 2009, J PEDIATR SURG, V44, P1328, DOI 10.1016/j.jpedsurg.2008.11.062
   Turner A, 2005, EUR J PEDIATR, V164, P266, DOI 10.1007/s00431-004-1607-6
   Woods RK, 2001, ANN THORAC SURG, V72, P434, DOI 10.1016/S0003-4975(01)02806-5
NR 16
TC 17
Z9 29
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2012
VL 42
IS 4
BP 252
EP 258
DI 10.4070/kcj.2012.42.4.252
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IJ
UT WOS:000209079800006
PM 22563338
OA Green Published
DA 2021-04-22
ER

PT J
AU Ryu, HM
   Kim, JS
   Ko, YG
   Hong, MK
   Jang, Y
   Choi, D
AF Ryu, Hyeon Min
   Kim, Jung-Sun
   Ko, Young Guk
   Hong, Myeong-Ki
   Jang, Yangsoo
   Choi, Donghoon
TI Clinical Outcomes of Infrapopliteal Angioplasty in Patients With
   Critical Limb Ischemia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ischemia; Limb salvage; Tibial arteries; Peroneal arteries; Angioplasty
ID PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; BALLOON ANGIOPLASTY; MORTALITY;
   DISEASE; ARTERY
AB Background and Objectives: With recent advances in equipment and techniques, infrapopliteal angioplasty has shown results that are comparable to those of surgical bypass in patients with critical limb ischemia (CLI). In this study, we evaluated the efficacy and the feasibility of infrapopliteal angioplasty in patients with CLI.
   Subjects and Methods: Between March 2002 and May 2008, infrapopliteal angioplasty was performed on 118 limbs of 101 patients (79 males; mean age 66 years) with CLI (Rutherford category 4, 5 or 6). Freedom from reintervention, limb salvage, and overall survival were analyzed.
   Results: The median follow-up duration was 30 months. Initial technical and clinical success rates were 69.5% and 83.1%, respectively. No major complication requiring surgical intervention developed after angioplasty. Among 82 limbs with initial technical success, the rate of freedom from any reintervention at 2 years was 70.7% and that from limb salvage was 97.6%. Young age and Rutherford category 6 at initial presentation were independent predictors associated with poor 2 year primary patency in these patients with CLI. Overall survival at 1 year was 86.4% and that at 2 years 76.3%. A history of cerebrovascular accident was an independent predictor associated with poor 2 year survival in these patients.
   Conclusion: Infrapopliteal angioplasty as a primary choice of treatment in CLI patients showed favorable clinical outcomes and feasibility.
C1 [Ryu, Hyeon Min] CHA Univ, Gumi CHA Med Ctr, Gumi, South Korea.
   [Kim, Jung-Sun; Ko, Young Guk; Hong, Myeong-Ki; Jang, Yangsoo; Choi, Donghoon] Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, Seoul 120752, South Korea.
RP Choi, D (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Coll Med, 50 Yonsei Ro, Seoul 120752, South Korea.
EM cdhlyj@yuhs.ac
OI Jang, Yangsoo/0000-0002-2169-3112; Hong, Myeong-Ki/0000-0002-2090-2031;
   Ko, Young-Guk/0000-0001-7748-5788; Choi, Donghoon/0000-0002-2009-9760;
   Kim, Jung-Sun/0000-0003-2263-3274
FU Korea Healthcare Technology RD Project [A085012, A102064]; Korea Health
   21 RD Project [A085136]
FX This study was partly supported by grants (No. A085012 and A102064) from
   the Korea Healthcare Technology R&D Project and a grant (No. A085136)
   from the Korea Health 21 R&D Project, both of which are managed by the
   Ministry for Health, Welfare and Family Affairs of the Republic of Korea
   and the Cardiovascular Research Center in Seoul, Korea.
CR Bailey CMH, 2003, EUR J VASC ENDOVASC, V25, P131, DOI 10.1053/ejvs.2002.1817
   Balmer H, 2002, J ENDOVASC THER, V9, P403, DOI 10.1583/1545-1550(2002)009<0403:BAICCL>2.0.CO;2
   BLAIR JM, 1989, J VASC SURG, V9, P698, DOI 10.1067/mva.1989.vs0090698
   Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5
   Clair DG, 2005, ANN VASC SURG, V19, P63, DOI 10.1007/s10016-004-0136-0
   CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605
   Feiring AJ, 2004, J AM COLL CARDIOL, V44, P2307, DOI 10.1016/j.jacc.2004.09.037
   Golomb BA, 2006, CIRCULATION, V114, P688, DOI 10.1161/CIRCULATIONAHA.105.593442
   Hanna GP, 1997, J AM COLL CARDIOL, V30, P664, DOI 10.1016/S0735-1097(97)00216-7
   Krankenberg H, 2005, CATHETER CARDIO INTE, V64, P12, DOI 10.1002/ccd.20237
   Kudo T, 2005, J VASC SURG, V41, P423, DOI 10.1016/j.jvs.2004.11.041
   Lofberg AM, 1996, CARDIOVASC INTER RAD, V19, P317, DOI 10.1007/s002709900067
   Olin JW, 2005, VASCULAR SURG, P404
   Parsons RE, 1998, J VASC SURG, V28, P1066, DOI 10.1016/S0741-5214(98)70033-3
   Rastogi Sachin, 2004, Tech Vasc Interv Radiol, V7, P33, DOI 10.1053/j.tvir.2004.01.001
   Romiti M, 2008, J VASC SURG, V47, P975, DOI 10.1016/j.jvs.2008.01.005
   Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4
   SCHWARTEN DE, 1991, CIRCULATION, V83, P86
   Siablis D, 2005, J ENDOVASC THER, V12, P685, DOI 10.1583/05-1620MR.1
   Soder HK, 2000, J VASC INTERV RADIOL, V11, P1021, DOI 10.1016/S1051-0443(07)61332-3
   TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1
   TREIMAN GS, 1995, J VASC SURG, V22, P457, DOI 10.1016/S0741-5214(95)70015-3
   Tsetis D, 2004, BRIT J RADIOL, V77, P1007, DOI 10.1259/bjr/97382129
NR 23
TC 10
Z9 11
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2012
VL 42
IS 4
BP 259
EP 265
DI 10.4070/kcj.2012.42.4.259
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IJ
UT WOS:000209079800007
PM 22563339
OA Green Published
DA 2021-04-22
ER

PT J
AU Min, GS
   Lee, JH
   Park, JH
   Choi, UL
   Lee, YD
   Seong, SW
   Jin, SA
   Park, SJ
   Kim, JH
   Park, JH
   Choi, SW
   Jeong, JO
   Seong, IW
AF Min, Gye-Sik
   Lee, Jae-Hwan
   Park, Jae-Ho
   Choi, Ung-Lim
   Lee, Young-Dal
   Seong, Seok-Woo
   Jin, Seon-Ah
   Park, Soo-Jin
   Kim, Jun-Hyeong
   Park, Jae-Hyeong
   Choi, Si Wan
   Jeong, Jin-Ok
   Seong, In-Whan
TI Long-Term Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting
   Stents in Patients With Acute Myocardial Infarction: Four-Year
   Observational Study
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Acute myocardial infarction; Percutaneous coronary intervention; Stents
ID BARE-METAL STENTS; RANDOMIZED-TRIALS; CORONARY-ARTERY; METAANALYSIS
AB Background and Objectives: The comparison of long-term clinical effects between Sirolimus-eluting stent (SES) and Paclitaxel-eluting stents (PES) for treatment of acute myocardial infarction (AMI) remains unclear. Seeking to clarify this issue, we performed a retrospective analysis to evaluate four-year clinical outcomes of SES compared to PES treated AMI patients.
   Subjects and Methods: From January 2004 to August 2006, all patients with acute ST-segment elevation myocardial infarction and acute non-ST segment elevation myocardial infarction who underwent percutaneous coronary intervention (PCI) by implantation of either SES or PES were enrolled. The occurrences of cardiac and non-cardiac deaths, recurrent infarction, target vessel revascularization (TVR) and stent thrombosis were analyzed. The composite end points of these major adverse cardiac events (MACE) were also analyzed.
   Results: During the study period, a total of 668 AMI patients had visited, of which 522 patients (299 with SES and 223 with PES) were enrolled. During the four-year clinical follow-up, both groups showed similar occurrences of non-cardiac death (14.6 +/- 2.2% vs. 18.3 +/- 3.0%, p=0.26); cardiac death (6.8 +/- 1.52% vs. 11.2 +/- 2.6%, p=0.39); re-infarction (3.3 +/- 1.1% vs. 6.4 +/- 1.8%, p=0.31); and stent thrombosis (3.2 +/- 1.1% vs. 5.4 +/- 1.7%, p=0.53). However, occurrences of TVR {4.0 +/- 1.2% vs. 10.0 +/- 3.0%, hazard ratio (HR)=0.498, 95% confidence interval (CI)=0.257-0.967, p=0.039} and MACE (19.4 +/- 2.5% vs. 29.4 +/- 3.5%, HR=0.645, 95% CI=0.443-0.940, p=0.021) were significantly lower in the SES population.
   Conclusion: In AMI patients treated with either SES or PES implantation, the former had a significantly lower risk of TVR and MACE during four-year clinical follow-up. Rates of death, cardiac death or recurrent infarction, and stent thrombosis were similar.
C1 [Min, Gye-Sik; Lee, Jae-Hwan; Park, Jae-Ho; Choi, Ung-Lim; Lee, Young-Dal; Seong, Seok-Woo; Jin, Seon-Ah; Park, Soo-Jin; Kim, Jun-Hyeong; Park, Jae-Hyeong; Choi, Si Wan; Jeong, Jin-Ok; Seong, In-Whan] Chungnam Natl Univ, Sch Med, Dept Cardiol, Taejon 301721, South Korea.
RP Lee, JH (corresponding author), Chungnam Natl Univ, Sch Med, Dept Cardiol, 282 Munhwa Ro, Taejon 301721, South Korea.
EM myheart@cnu.ac.kr
RI Park, Soo-Jin/AAQ-9242-2020; Park, Jae-Hyeong/AAD-9015-2021
OI Park, Soo-Jin/0000-0002-6350-6135; Jeong, Jin-Ok/0000-0003-0763-4754;
   Lee, Jae-Hwan/0000-0002-6561-7760; Seong, In-Whan/0000-0003-4628-0258;
   jin, seon-ah/0000-0001-6895-9101; Park, Jae-Hyeong/0000-0001-7035-286X;
   Choi, Si Wan/0000-0002-1035-1512
CR Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA
   Bose R, 2007, AM J CARDIOL, V100, P949, DOI 10.1016/j.amjcard.2007.04.030
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   Daemen J, 2007, AM J CARDIOL, V99, P1027, DOI 10.1016/j.amjcard.2006.11.070
   De Luca G, 2009, INT J CARDIOL, V133, P213, DOI 10.1016/j.ijcard.2007.12.040
   Hao PP, 2010, TEX HEART I J, V37, P516
   Kastrati A, 2005, JAMA-J AM MED ASSOC, V294, P819, DOI 10.1001/jama.294.7.819
   Kastrati A, 2007, EUR HEART J, V28, P2706, DOI 10.1093/eurheartj/ehm402
   Lee CW, 2009, AM J CARDIOL, V104, P1370, DOI 10.1016/j.amjcard.2009.06.059
   Lee JH, 2008, CATHETER CARDIO INTE, V72, P25, DOI 10.1002/ccd.21510
   Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
   Piscione F, 2010, EUROINTERVENTION, V5, P853, DOI 10.4244/EIJV5I7A143
   Sabate M, 2005, CIRCULATION, V112, P2175, DOI 10.1161/CIRCULATIONAHA.105.562421
   Silber S, 2009, CIRCULATION, V120, P1498, DOI 10.1161/CIRCULATIONAHA.109.849877
NR 14
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2012
VL 42
IS 4
BP 266
EP 273
DI 10.4070/kcj.2012.42.4.266
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IJ
UT WOS:000209079800008
PM 22563340
OA Green Published
DA 2021-04-22
ER

PT J
AU Namgung, J
   Kwak, JJ
   Choe, H
   Kwon, SU
   Doh, JH
   Lee, SY
   Ryoo, JY
   Hur, G
   Lee, WR
AF Namgung, June
   Kwak, Jae-Jin
   Choe, Hyunmin
   Kwon, Sung Uk
   Doh, Joon Hyung
   Lee, Sung Yun
   Ryoo, Ji-Yoon
   Hur, Gham
   Lee, Won Ro
TI Late-Onset Postpneumonectomy Empyema Presenting as Right-Sided Heart
   Failure: Extrinsic Right Atrial Compression
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Empyema, pleural; Right-sided heart failure
AB Although it is rare, the right atrium can be encroached on by abnormal mediastinal structures, including aortic aneurysms, carcinomas, hepatic cysts and diaphragmatic paralysis. Extrinsic compression of the right atrium causes significant hemodynamic compromise and can lead to fatal outcomes. We describe the case of a 66-year old man with a past history of pulmonary tuberculosis that had undergone right pneumonectomy 40 years previously. He then presented with signs and symptoms of right-sided heart failure. These new signs and symptoms were recognized to be secondary to extrinsic compression of the right atrium, which was due to late-onset postpneumonectomy empyema, and the signs and symptoms were successfully relieved by performing open drainage of the empyema.
C1 [Namgung, June; Kwak, Jae-Jin; Choe, Hyunmin; Kwon, Sung Uk; Doh, Joon Hyung; Lee, Sung Yun; Lee, Won Ro] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Internal Med,Div Cardiol, Goyang 411706, South Korea.
   [Ryoo, Ji-Yoon] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Thorac Surg, Goyang 411706, South Korea.
   [Hur, Gham] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Radiol, Goyang 411706, South Korea.
RP Namgung, J (corresponding author), Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Internal Med,Div Cardiol, 170 Juhwa Ro, Goyang 411706, South Korea.
EM jnamgung@paik.ac.kr
FU Inje Research and Scholarship Foundation
FX This work was supported by the Inje Research and Scholarship Foundation
   in 2010.
CR DCRUZ IA, 1994, ECHOCARDIOGR-J CARD, V11, P523, DOI 10.1111/j.1540-8175.1994.tb01093.x
   FOWLER NO, 1988, J AM COLL CARDIOL, V12, P187, DOI 10.1016/0735-1097(88)90372-5
   GOLDSTRAW P, 1979, THORAX, V34, P740, DOI 10.1136/thx.34.6.740
   KERR WF, 1977, THORAX, V32, P149, DOI 10.1136/thx.32.2.149
   문재연, 2008, Korean Circulation Journal, V38, P390
   MODEL D, 1983, LANCET, V1, P192
   ROGIERS P, 1991, RESP MED, V85, P333, DOI 10.1016/S0954-6111(06)80108-3
   STAFFORD EG, 1972, J THORAC CARDIOV SUR, V63, P771, DOI 10.1016/S0022-5223(19)41848-5
   van der Berge M, 1999, EUR RESPIR J, V14, P469, DOI 10.1034/j.1399-3003.1999.14b36.x
   Wain J C, 1996, Chest Surg Clin N Am, V6, P529
NR 10
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2012
VL 42
IS 4
BP 274
EP 277
DI 10.4070/kcj.2012.42.4.274
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IJ
UT WOS:000209079800009
PM 22563341
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, EY
   Choi, JO
   Park, HN
   Park, EJ
   Lee, GS
   Park, JY
   Kim, JS
   Jeon, ES
AF Lee, Eun Young
   Choi, Jin-Oh
   Park, Ha Na
   Park, Eun-Jung
   Lee, Gil Sun
   Park, Jun Young
   Kim, Jung-Sun
   Jeon, Eun Seok
TI Malignant Melanoma of Unknown Primary Origin Presenting as Cardiac
   Metastasis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Melanoma; Neoplasma, unknown primary; Unknown primary; Heart neoplasms
AB Malignant melanoma has a very high propensity to metastasize to the heart. However, melanoma may sometimes present as a metastatic lesion in the absence of a primary lesion, which are called melanomas of unknown primary origin. We report a case in which a patient presented with a metastatic maligant melanoma in the right atrium with pericardial effusion and without a primary origin.
C1 [Lee, Eun Young; Choi, Jin-Oh; Park, Ha Na; Park, Eun-Jung; Lee, Gil Sun; Park, Jun Young; Kim, Jung-Sun; Jeon, Eun Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul 135710, South Korea.
RP Jeon, ES (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, 81 Irwon Ro, Seoul 135710, South Korea.
EM esjeon@skku.edu
CR BAAB GH, 1975, ARCH SURG-CHICAGO, V110, P896
   Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622
   Basarici I, 2006, HEART LUNG, V35, P351, DOI 10.1016/j.hrtlng.2005.11.001
   Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G
   Katz KA, 2005, MELANOMA RES, V15, P77, DOI 10.1097/00008390-200502000-00013
   Kim OG, 1999, KOREAN J THORAC CARD, V32, P840
   Lee KS, 2000, KOREAN CIRC J, V30, P1170
   MACGEE W, 1991, VIRCHOWS ARCH A, V419, P183, DOI 10.1007/BF01626346
   Malouf JF, 1996, MAYO CLIN PROC, V71, P1167, DOI 10.4065/71.12.1167
   Manola J, 2000, J CLIN ONCOL, V18, P3782, DOI 10.1200/JCO.2000.18.22.3782
   Ozyuncu N, 2006, EUROPACE, V8, P545, DOI 10.1093/europace/eul058
   Qu GZ, 2003, AM J MED SCI, V325, P157, DOI 10.1097/00000441-200303000-00009
   Savoia P, 2000, J SURG ONCOL, V75, P203, DOI 10.1002/1096-9098(200011)75:3<203::AID-JSO9>3.0.CO;2-X
   Schlagenhauff B, 1997, CANCER-AM CANCER SOC, V80, P60, DOI 10.1002/(SICI)1097-0142(19970701)80:1<60::AID-CNCR8>3.0.CO;2-J
NR 14
TC 7
Z9 7
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2012
VL 42
IS 4
BP 278
EP 280
DI 10.4070/kcj.2012.42.4.278
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IJ
UT WOS:000209079800010
PM 22563342
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HY
   Kwon, SU
   Jang, WI
   Kim, HS
   Kim, JS
   Lee, HS
   Park, MY
   Kim, T
   Lee, SY
   Doh, JH
   Namgung, J
   Lee, WR
AF Kim, Hyung Yoon
   Kwon, Sung Uk
   Jang, Woo-Ik
   Kim, Han-Seong
   Kim, Jin Suk
   Lee, Han Sang
   Park, Min Yong
   Kim, Taewan
   Lee, Sung Yun
   Doh, Joon Hyung
   Namgung, June
   Lee, Won Roo
TI A Rare Case of Aortic Valve Myxoma: Easy to Confuse With Papillary
   Fibroelastoma
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myxoma; Aorta valve
AB Myxoma of the aortic valve is an exceedingly uncommon condition. In this article, we report the case of a 72-year-old man with myxoma arising from the aortic valve. We extirpated the mass and repaired the aortic valve with the patient under cardiopulmonary bypass. The postoperative course was uneventful. Histological examination confirmed that the mass was a myxoma.
C1 [Kim, Hyung Yoon; Kwon, Sung Uk; Kim, Jin Suk; Lee, Han Sang; Park, Min Yong; Kim, Taewan; Lee, Sung Yun; Doh, Joon Hyung; Namgung, June; Lee, Won Roo] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Internal Med,Div Cardiol, Goyang 411706, South Korea.
   [Jang, Woo-Ik] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Thorac Surg, Goyang 411706, South Korea.
   [Kim, Han-Seong] Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Pathol, Goyang 411706, South Korea.
RP Kwon, SU (corresponding author), Inje Univ, Ilsan Paik Hosp, Coll Med, Dept Internal Med,Div Cardiol, 170 Juhwa Ro, Goyang 411706, South Korea.
EM mdksu@paik.ac.kr
CR Azevedo O, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-23
   Blondeau P., 1990, THORAC CARDIOVASC S2, V38, pS192
   CASTELLS E, 1993, J CARDIOVASC SURG, V34, P49
   Chakfe N, 1997, ANN THORAC SURG, V64, P872, DOI 10.1016/S0003-4975(97)00695-4
   EDWARDS FH, 1991, ANN THORAC SURG, V52, P1127, DOI 10.1016/0003-4975(91)91293-5
   Irani AD, 2008, J CARDIAC SURG, V23, P385, DOI 10.1111/j.1540-8191.2007.00545.x
   KENNEDY P, 1995, ANN THORAC SURG, V59, P1221, DOI 10.1016/0003-4975(94)00969-E
   Koyalakonda SP, 2011, CARDIOLOGY, V118, P101, DOI 10.1159/000327081
   MACGOWAN SW, 1993, IRISH J MED SCI, V162, P223, DOI 10.1007/BF02945200
   MELLER J, 1977, AM J MED, V63, P816
   REYNEN K, 1995, NEW ENGL J MED, V333, P1610, DOI 10.1056/NEJM199512143332407
   Rhim HY, 1999, KOREAN CIRC J, V29, P1317
   SELLKE FW, 1990, ANN THORAC SURG, V50, P557, DOI 10.1016/0003-4975(90)90189-D
   SILVERMAN NA, 1980, ANN SURG, V191, P127, DOI 10.1097/00000658-198002000-00001
   WOLD L E, 1980, American Journal of Pathology, V101, P219
   Yu SH, 2006, YONSEI MED J, V47, P367, DOI 10.3349/ymj.2006.47.3.367
   Yuce M, 2007, INT J CARDIOL, V114, P405, DOI 10.1016/j.ijcard.2005.11.086
NR 17
TC 7
Z9 8
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2012
VL 42
IS 4
BP 281
EP 283
DI 10.4070/kcj.2012.42.4.281
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IJ
UT WOS:000209079800011
PM 22563343
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, D
   Jeong, MH
   Lee, KH
   Lee, MG
   Park, KH
   Sim, DS
   Yoon, NS
   Yoon, HJ
   Kim, KH
   Hong, YJ
   Kim, JH
   Ahn, Y
   Cho, JG
   Park, JC
   Kang, JC
AF Kim, Donghan
   Jeong, Myung Ho
   Lee, Ki Hong
   Lee, Min Goo
   Park, Keun-Ho
   Sim, Doo Sun
   Yoon, Nam Sik
   Yoon, Hyun Ju
   Kim, Kye Hun
   Hong, Young Joon
   Kim, Ju Han
   Ahn, Youngkeun
   Cho, Jeong Gwan
   Park, Jong Chun
   Kang, Jung Chaee
TI Successful Primary Percutaneous Coronary Intervention in a Patient With
   Acute Myocardial Infarction and Single Coronary Artery Ostium
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessel anomalies; Myocardial infarction; Percutaneous
   transluminal coronary angioplasty
AB One of the single anomalous origins of coronary artery that has rarely been reported is a congenital anomaly of coronary circulation that occurs in the left coronary artery originating from the right coronary sinus of valsalva. We report a 49-year-old male patient with non-ST segment elevated myocardial infarction that was identified to have an anomalous origin of the left coronary artery from the right coronary artery (RCA) with thrombotic total occlusion of RCA by coronary angiography and cardiac computed tomography. The patient underwent successful percutaneous coronary intervention in total occlusion of the RCA and was discharged after uneventful recovery.
C1 [Kim, Donghan; Jeong, Myung Ho; Lee, Ki Hong; Lee, Min Goo; Park, Keun-Ho; Sim, Doo Sun; Yoon, Nam Sik; Yoon, Hyun Ju; Kim, Kye Hun; Hong, Young Joon; Kim, Ju Han; Ahn, Youngkeun; Cho, Jeong Gwan; Park, Jong Chun; Kang, Jung Chaee] Chonnam Natl Univ, Chonnam Natl Univ Hosp, Korea Cardiovasc Stent Res Inst, Dept Cardiol, Kwangju 501757, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ, Chonnam Natl Univ Hosp, Korea Cardiovasc Stent Res Inst, Dept Cardiol, 42 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
CR ALEXANDER RW, 1956, CIRCULATION, V14, P800, DOI 10.1161/01.CIR.14.5.800
   Angelini P, 2002, CIRCULATION, V105, P2449, DOI 10.1161/01.CIR.0000016175.49835.57
   Gersony WM, 2007, J AM COLL CARDIOL, V50, P2083, DOI 10.1016/j.jacc.2007.08.023
   Jim Man-Hong, 2004, J Invasive Cardiol, V16, P466
   KIMBIRIS D, 1985, AM J CARDIOL, V55, P765, DOI 10.1016/0002-9149(85)90153-5
   Laureti JM, 2005, CLIN CARDIOL, V28, P488, DOI 10.1002/clc.4960281009
   Lee Bae Young, 2009, Korean Circ J, V39, P175, DOI 10.4070/kcj.2009.39.5.175
   Lee KM, 1996, KOREAN CIRC J, V26, P901
   LIBERTHSON RR, 1974, CIRCULATION, V50, P774, DOI 10.1161/01.CIR.50.4.774
   Rudan D, 2010, WIEN KLIN WOCHENSCHR, V122, P508, DOI 10.1007/s00508-010-1420-3
   Samarendra P, 2001, ANGIOLOGY, V52, P521, DOI 10.1177/000331970105200803
   SILVERMAN KJ, 1978, AM J CARDIOL, V41, P1311, DOI 10.1016/0002-9149(78)90891-3
   TAYLOR AJ, 1992, J AM COLL CARDIOL, V20, P640, DOI 10.1016/0735-1097(92)90019-J
   WHITE NK, 1948, ARCH PATHOL, V45, P766
   WILKINS CE, 1988, TEX HEART I J, V15, P166
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
   Yang DK, 2000, KOREAN CIRC J, V30, P1165
   Yildiz A, 2010, CLIN CARDIOL, V33, pE60, DOI 10.1002/clc.20588
   조현오, 2006, Korean Circulation Journal, V36, P817
NR 19
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2012
VL 42
IS 4
BP 284
EP 287
DI 10.4070/kcj.2012.42.4.284
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IJ
UT WOS:000209079800012
PM 22563344
OA Green Published
DA 2021-04-22
ER

PT J
AU Suh, YJ
   Kwon, HW
   Kim, GB
   Kwon, BS
   Bae, EJ
   Noh, CI
   Choi, JY
   Kim, KH
   Kim, YJ
   Park, SS
AF Suh, Yoon Jung
   Kwon, Hye Won
   Kim, Gi Beom
   Kwon, Bo Sang
   Bae, Eun Jung
   Noh, Chung Il
   Choi, Jung Yun
   Kim, Kyung Hwan
   Kim, Yong Jin
   Park, Sung Sup
TI A Case of Near Total Aortic Replacement in an Adolescent With
   Loeys-Dietz Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Loeys-Dietz syndrome; Aortic aneurysm; Craniofacial abnormalities;
   Transforming growth factor-beta type II receptor
ID ANEURYSM; MUTATIONS
AB Loeys-Dietz syndrome is a recently described autosomal dominant disorder caused by mutations in the genes for transforming growth factor-beta receptor type 1 or 2 (TGF-beta R 1/2). The syndrome predisposes patients to aortic aneurysm and dissections, along with craniofacial and musculoskeletal abnormalities. Here we report the case of an adolescent who underwent serial near total aortic replacement, from the aortic valve to the descending aorta. Loeys-Dietz syndrome was confirmed in this case by the detection of a mutation in the TGF-beta R 2 gene.
C1 [Suh, Yoon Jung; Kwon, Hye Won; Kim, Gi Beom; Kwon, Bo Sang; Bae, Eun Jung; Noh, Chung Il; Choi, Jung Yun] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul 110744, South Korea.
   [Kim, Kyung Hwan; Kim, Yong Jin] Seoul Natl Univ, Childrens Hosp, Dept Thorac & Cardiovasc Surg, Seoul 110744, South Korea.
   [Park, Sung Sup] Seoul Natl Univ, Childrens Hosp, Lab Med, Seoul 110744, South Korea.
RP Kim, GB (corresponding author), Seoul Natl Univ, Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 110744, South Korea.
EM ped9526@snu.ac.kr
RI 권, 혜원/Q-1141-2019; Kim, Gi Beom/AAK-3377-2021
OI Kim, Gi Beom/0000-0002-7880-280X; Park, Sung Sup/0000-0003-3754-4848
CR Everitt MD, 2009, J THORAC CARDIOV SUR, V137, P1327, DOI 10.1016/j.jtcvs.2009.02.007
   Jayle C, 2010, J THORAC CARDIOV SUR, V139, P1088, DOI 10.1016/j.jtcvs.2009.11.066
   Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695
   Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511
   Melenovsky V, 2008, J THORAC CARDIOV SUR, V135, P1174, DOI 10.1016/j.jtcvs.2008.01.003
   Neri E, 2010, ANN THORAC SURG, V90, pE88, DOI 10.1016/j.athoracsur.2010.08.077
   Van Hemelrijk C, 2010, CURR OPIN CARDIOL, V25, P546, DOI 10.1097/HCO.0b013e32833f0220
   Williams JA, 2007, ANN THORAC SURG, V83, pS757, DOI 10.1016/j.athoracsur.2006.10.091
   Williams JB, 2011, J CARDIAC SURG, V26, P304, DOI 10.1111/j.1540-8191.2011.01224.x
   Williams ML, 2010, J CARDIAC SURG, V25, P223, DOI 10.1111/j.1540-8191.2009.00956.x
NR 10
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2012
VL 42
IS 4
BP 288
EP 291
DI 10.4070/kcj.2012.42.4.288
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IJ
UT WOS:000209079800013
PM 22563345
OA Green Published
DA 2021-04-22
ER

PT J
AU Roule, V
   Dahdouh, Z
   Lemaitre, A
   Sabatier, R
   Lognone, T
   Bignon, M
   Malcor, G
   Grollier, G
AF Roule, Vincent
   Dahdouh, Ziad
   Lemaitre, Adrien
   Sabatier, Remi
   Lognone, Therese
   Bignon, Mathieu
   Malcor, Guillaume
   Grollier, Gilles
TI Coronary-Pulmonary Fistulas Involving All Three Major Coronary Arteries
   Co-Existing With Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Fistula; Myocardial ischemia
AB We report the case of a man who presented with acute anterior myocardial infarction and in whom the coronary angiogram showed tight stenosis of the left anterior descending coronary artery and the right coronary artery associated with substantial coronary-pulmonary fistulas involving all three major coronary arteries. We discuss the possible links between coronary artery fistulas and myocardial infarction.
C1 [Roule, Vincent; Dahdouh, Ziad; Lemaitre, Adrien; Sabatier, Remi; Lognone, Therese; Bignon, Mathieu; Malcor, Guillaume; Grollier, Gilles] Univ Hosp Caen, Dept Cardiol, F-14033 Caen, France.
RP Roule, V (corresponding author), Univ Hosp Caen, Dept Cardiol, Ave Cote Nacre, F-14033 Caen, France.
EM v.roule@hotmail.fr
CR Abhyankar AD, 1996, INT J CARDIOL, V57, P181, DOI 10.1016/S0167-5273(96)02807-0
   Avramovitch NA, 2002, ISRAEL MED ASSOC J, V4, P1162
   Baden H, 2008, INTERNAL MED, V47, P1945, DOI 10.2169/internalmedicine.47.1465
   BAIM DS, 1982, CIRCULATION, V65, P810, DOI 10.1161/01.CIR.65.4.810
   Gowda RM, 2006, INT J CARDIOL, V107, P7, DOI 10.1016/j.ijcard.2005.01.067
   HACKETT D, 1984, BRIT HEART J, V52, P477
   Valente AM, 2010, CIRC-CARDIOVASC INTE, V3, P134, DOI 10.1161/CIRCINTERVENTIONS.109.883884
NR 7
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2012
VL 42
IS 4
BP 292
EP 293
DI 10.4070/kcj.2012.42.4.292
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IJ
UT WOS:000209079800014
PM 22563346
OA Green Published
DA 2021-04-22
ER

PT J
AU Sohn, DW
AF Sohn, Dae-Won
TI Constrictive Pericarditis as a Never Ending Story: What's New?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Pericarditis; constrictive; Echocardiography; Doppler; Hemodynamics
AB Nowadays, we have a better understanding of the natural history of constrictive pericarditis such as transient constriction. In addition, we have acquired the correct understanding of hemodynamic features that are unique to constrictive pericarditis. This understanding has allowed us to diagnose constrictive pericarditis reliably with Doppler echocardiography and differentiation between constrictive pericarditis and restrictive cardiomyopathy is no longer a clinical challenge. The advent of imaging modalities such as CT or MR is another advance in the diagnosis of constrictive pericarditis. We can accurately measure pericardial thickness and additional information such as the status of coronary artery and the presence of myocardial fibrosis can be obtained. We no longer perform cardiac catheterization for the diagnosis of constrictive pericarditis. However, these advances are useless unless we suspect and undergo work-up for constrictive pericarditis. In constrictive pericarditis, the most important diagnostic tool is clinical suspicion. In a patient with signs and symptoms of increased systemic venous pressure i.e. right sided heart failure, that are disproportionate to pulmonary or left sided heart disease, possibility of constrictive pericarditis should always be included in the differential diagnosis.
C1 Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Cardiovasc Ctr,Dept Internal Med, Seoul 110744, South Korea.
RP Sohn, DW (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Cardiovasc Ctr,Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM dwsohn@snu.ac.kr
CR Bertog SC, 2004, J AM COLL CARDIOL, V43, P1445, DOI 10.1016/j.jacc.2003.11.048
   Breen JF, 2001, J THORAC IMAG, V16, P47, DOI 10.1097/00005382-200101000-00007
   BUSH CA, 1977, CIRCULATION, V56, P924, DOI 10.1161/01.CIR.56.6.924
   CANDELLRIERA J, 1978, CIRCULATION, V57, P1154, DOI 10.1161/01.CIR.57.6.1154
   Choi JH, 2011, JACC-CARDIOVASC IMAG, V4, P567, DOI 10.1016/j.jcmg.2011.01.018
   Chowdhury UK, 2006, ANN THORAC SURG, V81, P522, DOI 10.1016/j.athoracsur.2005.08.009
   CONNOLLY D C, 1957, Trans Am Coll Cardiol, V7, P191
   DEVALERIA PA, 1991, ANN THORAC SURG, V52, P219, DOI 10.1016/0003-4975(91)91339-W
   Feng DL, 2011, CIRCULATION, V124, P1830, DOI 10.1161/CIRCULATIONAHA.111.026070
   FOWLER NO, 1995, CLIN CARDIOL, V18, P341, DOI 10.1002/clc.4960180610
   Garcia MJ, 1996, J AM COLL CARDIOL, V27, P108, DOI 10.1016/0735-1097(95)00434-3
   Ha JW, 2002, J AM SOC ECHOCARDIOG, V15, P1468, DOI 10.1067/mje.2002.127452
   Ha JW, 2001, CIRCULATION, V104, P976, DOI 10.1161/hc3401.095705
   Haley JH, 2004, J AM COLL CARDIOL, V43, P271, DOI 10.1016/j.jacc.2003.08.032
   HATLE LK, 1989, CIRCULATION, V79, P357, DOI 10.1161/01.CIR.79.2.357
   Imazio M, 2007, AM J CARDIOL, V100, P1026, DOI 10.1016/j.amjcard.2007.04.047
   Imazio M, 2011, CIRCULATION, V124, P1270, DOI 10.1161/CIRCULATIONAHA.111.018580
   Kojima S, 1999, NEW ENGL J MED, V341, P373, DOI 10.1056/NEJM199907293410515
   Ling LH, 1999, CIRCULATION, V100, P1380, DOI 10.1161/01.CIR.100.13.1380
   Ling LH, 1997, J AM COLL CARDIOL, V29, P1317, DOI 10.1016/S0735-1097(97)82756-8
   Maisch B, 2004, EUR HEART J, V25, P587, DOI 10.1016/j.ehj.2004.02.002
   MASUI T, 1992, RADIOLOGY, V182, P369, DOI 10.1148/radiology.182.2.1732952
   MEANEY E, 1976, AM J CARDIOL, V38, P547, DOI 10.1016/S0002-9149(76)80001-X
   Oh JK, 1997, CIRCULATION, V95, P796
   OH JK, 1994, J AM COLL CARDIOL, V23, P154, DOI 10.1016/0735-1097(94)90514-2
   PANDIAN NG, 1984, J AM COLL CARDIOL, V4, P1164, DOI 10.1016/S0735-1097(84)80134-5
   Reuss CS, 2009, EUR J ECHOCARDIOGR, V10, P372, DOI 10.1093/ejechocard/jen258
   ROBERTSON R, 1962, CIRCULATION, V26, P525, DOI 10.1161/01.CIR.26.4.525
   Sohn DW, 2004, J AM SOC ECHOCARDIOG, V17, P222, DOI 10.1016/j.echo.2003.11.015
   Sun JP, 2001, J AM SOC ECHOCARDIOG, V14, P1119, DOI 10.1067/mje.2001.115458
   Verhaert D, 2010, CIRC-CARDIOVASC IMAG, V3, P333, DOI 10.1161/CIRCIMAGING.109.921791
NR 31
TC 6
Z9 9
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2012
VL 42
IS 3
BP 143
EP 150
DI 10.4070/kcj.2012.42.3.143
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34II
UT WOS:000209079700001
PM 22493608
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, HS
AF Seo, Hong Seog
TI The Role and Clinical Significance of High-Sensitivity C-Reactive
   Protein in Cardiovascular Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Korea Univ, Coll Med, Guro Hosp, Ctr Cardiovasc, Seoul 152703, South Korea.
RP Seo, HS (corresponding author), Korea Univ, Coll Med, Guro Hosp, Ctr Cardiovasc, 148 Gurodong Ro, Seoul 152703, South Korea.
EM mdhsseo@korea.ac.kr
CR Ahmed K, 2012, KOREAN CIRC J, V42, P164, DOI 10.4070/kcj.2012.42.3.164
   Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804
   Devaraj S, 2011, ARTERIOSCL THROM VAS, V31, P1397, DOI 10.1161/ATVBAHA.111.225508
   Emberson J, 2011, LANCET, V377, P469
   Greenland P, 2010, CIRCULATION, V122, P2748, DOI 10.1161/CIR.0b013e3182051bab
   Hirschfield GM, 2003, QJM-INT J MED, V96, P793, DOI 10.1093/qjmed/hcg134
   Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P2745, DOI 10.1161/01.ATV.0000248096.62495.73
   Lau DCW, 2005, AM J PHYSIOL-HEART C, V288, pH2031, DOI 10.1152/ajpheart.01058.2004
   Lopez-Garcia E, 2005, J NUTR, V135, P562
   Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672
   Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646
   Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601
   Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402
NR 13
TC 16
Z9 17
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2012
VL 42
IS 3
BP 151
EP 153
DI 10.4070/kcj.2012.42.3.151
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34II
UT WOS:000209079700002
PM 22493609
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, W
   Choi, S
   Kim, SH
   Yoon, E
   Lim, HG
   Kim, YJ
AF Jang, Woosung
   Choi, Sunyoung
   Kim, Soo Hwan
   Yoon, Eunjeung
   Lim, Hong-Gook
   Kim, Yong Jin
TI A Comparative Study on Mechanical and Biochemical Properties of Bovine
   Pericardium After Single or Double Crosslinking Treatment
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Bioprosthesis; Glutaraldehyde
AB Background and Objectives: Glutaraldehyde (GA) has been used as a representative method of tissue preservation in cardiovascular surgery. However, GA has showed limited durability including calcification, mechanical failure and toxicity. To overcome those unsolved problems, we analyzed the crosslinking differences of primary amines, GA and genipin in their mechanical and biochemical properties with a single or double crosslinking agent for clinical application.
   Materials and Methods: Samples were divided into 3 groups; control, single crosslinking fixation and double crosslinking fixation after decellurarization using bovine pericardium. For analysis of the biochemical and mechanical properties of each crosslinking method, tensile strength, percentage strain, thermal stability, resistance to pronase, nynhydrin and cytotoxicity test were studied.
   Results: Combined hexamethylene diamine and suberic acid in the carbodiimide hydrochloride/N-hydroxysucinimide solution (EDC/NHS) after decellurarization, tensile strength and strain percentage were not statistically significant compared to the single crosslinking treated groups (p>0.05). Tissue crosslinking stability was weak in single treatment of diphenylphosphoryl azide, suberic acid, low concentration of EDC, hexamethylene diamine and procyanidin groups, but thermal stability and resistance to the pronase and ninhydrin were markedly increased in concentrated EDC/NHS or after combined double treatment with low concentration of GA or genipin (p<0.001).
   Conclusion: Single or double crosslinking with low concentration of carbodiimide, diphenylphosphonyl azide, procyanidin, suberic acid and hexane diamine were not as effective in mechanical, biochemical, cytotoxic and crosslinking properties compared to GA or genipin fixation, but their mechanical and chemical properties were much improved when combined with low concentrations of GA or genipin in the double crosslinking process.
C1 [Jang, Woosung; Choi, Sunyoung; Kim, Soo Hwan; Yoon, Eunjeung; Lim, Hong-Gook; Kim, Yong Jin] Seoul Natl Univ Hosp, Clin Res Inst, Xenotransplantat Res Ctr, Seoul 110744, South Korea.
   [Jang, Woosung; Lim, Hong-Gook; Kim, Yong Jin] Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Seoul 110744, South Korea.
RP Kim, YJ (corresponding author), Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, 101 Daehak Ro, Seoul 110744, South Korea.
EM kyj@plaza.snu.ac.kr
FU Korea Health 21 Research & Development Project, Korean Ministry for
   Health, Welfare & Family Affairs, Republic of Korea [A04004-006]
FX This work was supported by grants from the Korea Health 21 Research &
   Development Project, Korean Ministry for Health, Welfare & Family
   Affairs (A04004-006), Republic of Korea.
CR ANSELME K, 1992, MATRIX, V12, P264, DOI 10.1016/S0934-8832(11)80078-8
   Blazso G, 1997, PHARMAZIE, V52, P380
   Bretti C, 2005, J CHEM ENG DATA, V50, P1761, DOI 10.1021/je0502039
   Cho S, 2009, KOREAN J THORAC CARD, V42, P165
   Cho S, 2009, KOREAN J THORAC CARD, V42, P566
   Damink LHHO, 1996, BIOMATERIALS, V17, P679, DOI 10.1016/0142-9612(96)86737-8
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P429
   Dongmo AB, 2001, J ETHNOPHARMACOL, V77, P137, DOI 10.1016/S0378-8741(01)00296-3
   Gratzer PF, 2001, J BIOMED MATER RES, V58, P172, DOI 10.1002/1097-4636(2001)58:2<172::AID-JBM1004>3.0.CO;2-9
   Hansen DB, 2005, CHEM SOC REV, V34, P408, DOI 10.1039/b315496n
   Hanthamrongwit M, 1996, BIOMATERIALS, V17, P775, DOI 10.1016/0142-9612(96)81414-1
   Jang WS, 2010, KOREAN J THORAC CARD, V43, P1
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Lee CR, 2001, BIOMATERIALS, V22, P3145, DOI 10.1016/S0142-9612(01)00067-9
   Moore MA, 1996, J BIOMED MATER RES, V32, P209, DOI 10.1002/(SICI)1097-4636(199610)32:2<209::AID-JBM9>3.0.CO;2-X
   Nimni ME, 1988, COLLAGEN, VIII, P1
   Packer L, 1999, FREE RADICAL BIO MED, V27, P704, DOI 10.1016/S0891-5849(99)00090-8
   PETITE H, 1995, BIOMATERIALS, V16, P1003, DOI 10.1016/0142-9612(95)94908-4
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   SHEN SH, 1994, J APPL BIOMATER, V5, P159, DOI 10.1002/jab.770050209
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Sung HW, 1997, J BIOMED MATER RES, V35, P147
   Sung SC, 2008, KOREAN J THORAC CARD, V41, P679
   TIMKOVICH R, 1977, ANAL BIOCHEM, V79, P135, DOI 10.1016/0003-2697(77)90387-6
   XI TF, 1992, J BIOMED MATER RES, V26, P1241
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
   Zheng LT, 2008, EUR J PHARMACOL, V588, P106, DOI 10.1016/j.ejphar.2008.04.035
NR 29
TC 13
Z9 13
U1 0
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2012
VL 42
IS 3
BP 154
EP 163
DI 10.4070/kcj.2012.42.3.154
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34II
UT WOS:000209079700003
PM 22493610
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahmed, K
   Jeong, MH
   Chakraborty, R
   Cho, KH
   Sim, DS
   Hong, YJ
   Ahn, Y
   Hachinohe, D
   Cho, MC
   Kim, CJ
   Kim, YJ
AF Ahmed, Khurshid
   Jeong, Myung Ho
   Chakraborty, Rabin
   Cho, Kyung Hoon
   Sim, Doo Sun
   Hong, Young Joon
   Ahn, Youngkeun
   Hachinohe, Daisuke
   Cho, Myeong Chan
   Kim, Chong Jin
   Kim, Young Jo
TI Prognostic Impact of Baseline High-Sensitivity C-Reactive Protein in
   Patients With Acute Myocardial Infarction Undergoing Percutaneous
   Coronary Intervention Based on Body Mass Index
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE C-reactive protein; Overweight; Obesity; Body mass index; Myocardial
   infarction
ID INSULIN-RESISTANCE; INTERLEUKIN-6; CHOLESTEROL; RISK; INFLAMMATION;
   PREVENTION; MORTALITY; ADIPOCYTE; SEVERITY; SIZE
AB Background and Objectives: Serum high sensitivity C-reactive protein (hs-CRP) is a marker of inflammation and may lead to the development of atherosclerosis, adversely affecting mortality. The aim of this study was to evaluate the relationship between baseline hs-CRP level and 12-month clinical outcomes in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) according to their body mass index (BMI) status.
   Subjects and Methods: Using data from the Korea Acute Myocardial Infarction Registry from November 2005 to September 2008, a total of 8174 consecutive AMI patients were studied. Cox proportional hazard model revealed that higher baseline levels of hs-CRP was associated with 12-month all-cause mortality (p=0.045). To further understand this association, patients were divided into 3 groups based on their body mass index: 1) overweight/obese, 2) normal weight, and 3) underweight patients. Then each group was stratified into quartiles based on their hs-CRP.
   Results: In overweight/obese patients, Cox model showed significant association of hs-CRP with 12-month mortality when adjusted for age and gender (p<0.001), however, after adjustment with multiple covariates, mortality was highest in the 4th quartile {HR 2.382, (1.079-5.259), p=0.032} though statistically insignificant (p=0.172). We observed no significant association of serum hs-CRP with 12-month mortality in normal weight (p=0.681) and underweight (p=0.760) patients.
   Conclusion: Higher baseline hs-CRP level (>= 4.08 mg/dL) in overweight/obese AMI patients showed significant association with 12-month all-cause mortality independent of other prognostic markers.
C1 [Ahmed, Khurshid; Jeong, Myung Ho; Cho, Kyung Hoon; Sim, Doo Sun; Hong, Young Joon; Ahn, Youngkeun; Hachinohe, Daisuke] Chonnam Natl Univ, Coll Med, Dept Cardiovasc Med, Kwangju 501757, South Korea.
   [Ahmed, Khurshid; Chakraborty, Rabin] Apollo Gleneagles Hosp, Dept Cardiol, Kolkata, India.
   [Cho, Myeong Chan] Chungbuk Natl Univ, Coll Med, Dept Cardiol, Taejon, South Korea.
   [Kim, Chong Jin] Kyung Hee Univ, Coll Med, Dept Cardiovasc Med, Seoul, South Korea.
   [Kim, Young Jo] Yeungnam Univ, Coll Med, Dept Cardiol, Taegu, South Korea.
   [Jeong, Myung Ho; Hong, Young Joon; Ahn, Youngkeun] Chonnam Natl Univ, Brain Korea 21, Kwangju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ, Coll Med, Dept Cardiovasc Med, 671 Jebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
OI CHO, KYUNG HOON/0000-0002-0377-6352
FU The Korean Society of Circulation
FX This study was performed with the support of The Korean Society of
   Circulation in the memorandum of the 50th anniversary of The Korean
   Society of Circulation. The authors thank Dr. Sumera K. Ahmed for her
   contribution to this study.
CR Alonso-Martinez JL, 2002, EUR J HEART FAIL, V4, P331, DOI 10.1016/S1388-9842(02)00021-1
   Apple FS, 2002, AM HEART J, V144, P981, DOI 10.1067/mhj.2002.124048
   Araujo JP, 2009, J CARD FAIL, V15, P256, DOI 10.1016/j.cardfail.2008.10.030
   Asakura M, 2001, J AM COLL CARDIOL, V37, P1284, DOI 10.1016/S0735-1097(01)01135-4
   Bahceci M, 2007, J ENDOCRINOL INVEST, V30, P210, DOI 10.1007/BF03347427
   Barba C, 2004, LANCET, V363, P157, DOI 10.1016/s0140-6736(03)15268-3
   Bastard JP, 2002, J CLIN ENDOCR METAB, V87, P2084, DOI 10.1210/jc.87.5.2084
   Bursi F, 2007, AM J MED, V120, P616, DOI 10.1016/j.amjmed.2006.07.039
   De Sutter J, 2001, ATHEROSCLEROSIS, V157, P189, DOI 10.1016/S0021-9150(00)00703-6
   DEBEER FC, 1982, BRIT HEART J, V47, P239
   Devaraj S, 2005, J CLIN ENDOCR METAB, V90, P4549, DOI 10.1210/jc.2005-0069
   Kang WY, 2010, J CARDIOL, V55, P84, DOI 10.1016/j.jjcc.2009.10.004
   Kini AS, 2006, CARDIOL CLIN, V24, P153, DOI 10.1016/j.ccl.2006.04.002
   Koenig W, 2008, CLIN CHEM, V54, P335, DOI 10.1373/clinchem.2007.100271
   Lagathu C, 2003, BIOCHEM BIOPH RES CO, V311, P372, DOI 10.1016/j.bbrc.2003.10.013
   Marsik C, 2008, CLIN CHEM, V54, P343, DOI 10.1373/clinchem.2007.091959
   Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000
   Rao AD, 2010, CRIT CARE, V14, DOI 10.1186/cc9006
   Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05
   Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C
   Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993
   Ryu SY, 2005, J KOREAN MED SCI, V20, P379, DOI 10.3346/jkms.2005.20.3.379
   Saito M, 2003, ATHEROSCLEROSIS, V167, P73, DOI 10.1016/S0021-9150(02)00380-5
   Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0
   Sim Doo Sun, 2009, Korean Circ J, V39, P297, DOI 10.4070/kcj.2009.39.8.297
   Sim DS, 2010, J CARDIOL, V56, P1, DOI 10.1016/j.jjcc.2010.04.002
   Tataru MC, 2000, EUR HEART J, V21, P1000, DOI 10.1053/euhj.1999.1981
   Verma S, 2002, CIRCULATION, V105, P1890, DOI 10.1161/01.CIR.0000015126.83143.B4
   Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131
   Wang CH, 2003, CIRCULATION, V107, P1783, DOI 10.1161/01.CIR.0000061916.95736.E5
   Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972
   이기홍, 2007, Korean Circulation Journal, V37, P64
   노혜진, 2006, Korean Circulation Journal, V36, P802
NR 33
TC 13
Z9 14
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2012
VL 42
IS 3
BP 164
EP 172
DI 10.4070/kcj.2012.42.3.164
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34II
UT WOS:000209079700004
PM 22493611
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, J
   Choi, EK
   Lee, MH
   Kang, DY
   Sung, YJ
   Lee, DW
   Oh, I
   Choi, YS
   Oh, S
AF Kim, JiYeong
   Choi, Eue-Keun
   Lee, Min-Ho
   Kang, Do-Yoon
   Sung, Young-Jun
   Lee, Dong-Won
   Oh, Ilyoung
   Choi, Yun-Shik
   Oh, Seil
TI The Relevance of the Primary Prevention Criteria for Implantable
   Cardioverter Defibrillator Implantation in Korean Symptomatic Severe
   Heart Failure Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart failure; Implantable defibrillators; Death; sudden; cardiac
ID CARDIAC-RHYTHM ABNORMALITIES; ACC/AHA/HRS 2008 GUIDELINES; DEVICE-BASED
   THERAPY; MADIT-II CRITERIA; MYOCARDIAL-INFARCTION; MORTALITY; DISEASE;
   APPROPRIATE; DEATH; RISK
AB Background and Objectives: Implantable cardioverter defibrillator (ICD) therapy is recommended as the primary tool for prevention of sudden cardiac death (SCD) in symptomatic patients with severe left ventricular dysfunction. There is a paucity of information on whether this recommendation is appropriate for the Korean population with severe heart failure.
   Subjects and Methods: The study group consisted of 275 consecutive patients (mean age 65 years, 71% male) who met the ICD implantation criteria for primary prevention (left ventricular ejection fraction <= 30% and New York Heart Association functional class II or III). We analyzed the clinical characteristics and outcomes of an ischemic cardiomyopathy (ICMP) group (n=131) and a non-ischemic cardiomyopathy (NICMP) group (n=144). The outcomes of these 2 groups were compared with the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II) conventional and Defibrillators in the Non-ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) standard therapy groups, respectively.
   Results: Eighty patients (29%) died during a follow-up period of 40 +/- 17 months. The NICMP group had better all-cause mortality rates than the ICMP group (19% vs. 40%, p<0.001), however both groups had a similar incidence of SCD (7% vs. 10%, p=0.272). The 2-year all-cause mortality and SCD for the ICMP group were similar to those of the MADIT-II conventional therapy group (20% vs. 20%, 7% vs. 10%, respectively, all p>0.05). All-cause mortality and the incidence of SCD in the NICMP group were comparable to those of the DEFINITE standard therapy group (13% vs. 17%, 6% vs. 6%, respectively, all p>0.05).
   Conclusion: Korean patients with severe heart failure in both the ICMP and NICMP groups had all-caused mortality and risk of SCD comparable to patients in the MADIT-II and DEFINITE standard therapy groups. Therefore, the primary prevention criteria for ICD implantation would be appropriate in both Korean ICMP and NICMP patients.
C1 [Kim, JiYeong; Choi, Eue-Keun; Lee, Min-Ho; Kang, Do-Yoon; Sung, Young-Jun; Lee, Dong-Won; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.
   [Oh, Ilyoung; Choi, Yun-Shik] Seoul Natl Univ, Bundang Hosp, Ctr Cardiovasc, Songnam, South Korea.
RP Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM choiek17@snu.ac.kr
RI Choi, Eue-Keun/J-5968-2014; Choi, Eue-Keun/K-3752-2019; Oh,
   Seil/J-5539-2012; Lee, Minho/AAJ-6477-2020
OI Choi, Eue-Keun/0000-0002-0411-6372; Oh, Seil/0000-0002-2504-9615; Lee,
   Minho/0000-0003-0748-7766
FU SNUH Research Fund [04-2010-1140]
FX This study was supported by grant no 04-2010-1140 from the SNUH Research
   Fund.
CR Ahmed A, 2007, AM J CARDIOL, V99, P393, DOI 10.1016/j.amjcard.2006.08.042
   Bonow RO, 2002, CIRCULATION, V106, P1602, DOI 10.1161/01.CIR.0000035036.22612.2B
   Cesario DA, 2006, J AM COLL CARDIOL, V47, P1507, DOI 10.1016/j.jacc.2005.09.077
   한성우, 2005, Korean Circulation Journal, V35, P357
   Doehner W, 2005, J AM COLL CARDIOL, V46, P1019, DOI 10.1016/j.jacc.2005.02.093
   Epstein AE, 2008, CIRCULATION, V117, P2820, DOI 10.1161/CIRCUALTIONAHA.108.189741
   Greenberg H, 2004, J AM COLL CARDIOL, V43, P1459, DOI 10.1016/j.jacc.2003.11.038
   Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088
   Mason NA, 2005, AM J KIDNEY DIS, V45, P119, DOI 10.1053/j.ajkd.2004.09.025
   McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9
   MOSS AJ, 1983, NEW ENGL J MED, V309, P331, DOI 10.1056/nejm198308113090602
   Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601
   Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474
   Mozaffarian D, 2004, AM J CARDIOL, V93, P1124, DOI 10.1016/j.amjcard.2004.01.039
   Ng ACC, 2008, INT J CARDIOL, V129, P198, DOI 10.1016/j.ijcard.2007.07.014
   Remme WJ, 2008, EUR HEART J, V29, P1739, DOI 10.1093/eurheartj/ehn196
   손장원, 2006, Korean Circulation Journal, V36, P431
   Siu CW, 2010, J CARDIOVASC ELECTR, V21, P231, DOI 10.1111/j.1540-8167.2009.01609.x
   Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938
   성예나, 2009, [Korean Journal of Clinical Pharmacy, 한국임상약학회지], V19, P167
   Tanno K, 2005, CIRC J, V69, P19, DOI 10.1253/circj.69.19
   Vlay SC, 2009, J INVASIVE CARDIOL, V21, P234
   Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254
NR 23
TC 9
Z9 9
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2012
VL 42
IS 3
BP 173
EP 183
DI 10.4070/kcj.2012.42.3.173
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34II
UT WOS:000209079700005
PM 22493612
OA Green Published
DA 2021-04-22
ER

PT J
AU Kwon, HW
   Kwon, BS
   Kim, GB
   Chae, JH
   Park, JD
   Bae, EJ
   Noh, CI
AF Kwon, Hye Won
   Kwon, Bo Sang
   Kim, Gi Beom
   Chae, Jong Hee
   Park, June Dong
   Bae, Eun Jung
   Noh, Chung Il
TI The Effect of Enalapril and Carvedilol on Left Ventricular Dysfunction
   in Middle Childhood and Adolescent Patients With Muscular Dystrophy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiomyopathies; Carvedilol; Echocardiography; Enalapril; Muscular
   dystrophies
AB Background and Objectives: In Duchenne and Becker muscular dystrophies, cardiac function deteriorates with time resulting in heart failure which is often fatal. We prospectively evaluated the effect of enalapril and carvedilol on left ventricular (LV) dysfunction in middle childhood and adolescent patients with muscular dystrophy.
   Subjects and Methods: Twenty-three patients with LV dysfunction (22 with Duchenne muscular dystrophy, 1 with Becker muscular dystrophy) were enrolled. We prescribed enalapril (13 patients) or carvedilol (10 patients) randomly from July 2008 to August 2010 and followed up the patients until September 2011. The changes in LV function parameters before and after the treatment were evaluated by echocardiography.
   Results: The mean age at the start of treatment with enalapril or carvedilol was 12.6 +/- 3.7 years (median 13 years), and mean follow-up duration was 20.1 +/- 8.9 months. In the enalapril group, LV fractional shortening (FS) increased from 25.8 +/- 2.1 to 26.6 +/- 3.0 (p=0.241). In the carvedilol group, LV FS increased from 26.4 +/- 1.1 to 28.6 +/- 4.2 (p=0.110). In all 23 patients, LV FS significantly increased from 26.1 +/- 1.7 (before) to 27.6 +/- 3.7 (after treatment) (p<0.046). Indexed LV dimension at end diastole and LV end-diastolic volume decreased slightly, but without statistical significance by tri-plane volumetry. LV diastolic functional parameters were maintained during follow-up period.
   Conclusion: Enalapril or carvedilol could improve LV systolic function in middle childhood and adolescent patients with muscular dystrophy without significant adverse effects.
C1 [Kwon, Hye Won; Kwon, Bo Sang; Kim, Gi Beom; Chae, Jong Hee; Park, June Dong; Bae, Eun Jung; Noh, Chung Il] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul 110744, South Korea.
RP Noh, CI (corresponding author), Seoul Natl Univ, Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 110744, South Korea.
EM chungnoh@snu.ac.kr
RI Kim, Gi Beom/AAK-3377-2021; 권, 혜원/Q-1141-2019
OI Kim, Gi Beom/0000-0002-7880-280X; 
FU Korean Society of Cardiology [2008-4]
FX The study is supported by a grant (No. 2008-4) from the Korean Society
   of Cardiology.
CR Bahler RC, 2005, J AM SOC ECHOCARDIOG, V18, P666, DOI 10.1016/j.echo.2004.10.003
   Bernal Juan, 2006, Am J Cardiovasc Drugs, V6, P373, DOI 10.2165/00129784-200606060-00004
   Bruns LA, 2001, J PEDIATR-US, V138, P505, DOI 10.1067/mpd.2001.113045
   Cha DH, 1998, KOREAN CIRC J, V28, P523
   DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613
   Duboc D, 2005, J AM COLL CARDIOL, V45, P855, DOI 10.1016/j.jacc.2004.09.078
   Duboc D, 2007, AM HEART J, V154, P596, DOI 10.1016/j.ahj.2007.05.014
   Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U
   Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7
   Finsterer J, 2003, CARDIOLOGY, V99, P1, DOI 10.1159/000068446
   FRANCIS GS, 1990, CIRCULATION, V82, P1724, DOI 10.1161/01.CIR.82.5.1724
   Garcia MJ, 1998, J AM COLL CARDIOL, V32, P865, DOI 10.1016/S0735-1097(98)00345-3
   Giatrakos N, 2006, HEART, V92, P840, DOI 10.1136/hrt.2005.067710
   Giglio V, 2007, AM J CARDIOL, V99, P147, DOI 10.1016/j.amjcard.2006.10.008
   Ishikawa Y, 1999, AM HEART J, V137, P895, DOI 10.1016/S0002-8703(99)70414-X
   Jefferies JL, 2005, CIRCULATION, V112, P2799, DOI 10.1161/CIRCULATIONAHA.104.528281
   Kajimoto H, 2006, CIRC J, V70, P991, DOI 10.1253/circj.70.991
   Kaspar RW, 2009, J AM ACAD NURSE PRAC, V21, P241, DOI 10.1111/j.1745-7599.2009.00404.x
   Klitzner TS, 2005, PEDIATRICS, V116, P1569, DOI 10.1542/peds.2005-2448
   Lamparter S, 1999, CARDIOVASC RES, V43, P165, DOI 10.1016/S0008-6363(99)00111-X
   McNally EM, 2008, HEART, V94, P976, DOI 10.1136/hrt.2007.138461
   Mori K, 2002, PEDIATR CARDIOL, V23, P160, DOI 10.1007/s00246-001-0040-0
   Ogata H, 2007, INT J CARDIOL, V115, P190, DOI 10.1016/j.ijcard.2006.02.013
   Ogata H, 2009, J CARDIOL, V53, P72, DOI 10.1016/j.jjcc.2008.08.013
   Ramaciotti C, 2006, AM J CARDIOL, V98, P825, DOI 10.1016/j.amjcard.2006.04.020
   Reisner SA, 2004, J AM SOC ECHOCARDIOG, V17, P630, DOI 10.1016/j.echo.2004.02.011
   SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072
   Saito T, 2001, Rinsho Shinkeigaku, V41, P691
   Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0
   Tei C, 1995, J Cardiol, V26, P357
   Tsutamoto T, 1997, CIRCULATION, V96, P509
NR 31
TC 18
Z9 19
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2012
VL 42
IS 3
BP 184
EP 191
DI 10.4070/kcj.2012.42.3.184
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34II
UT WOS:000209079700006
PM 22493613
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JS
   Shim, EJ
AF Kim, Joon Sik
   Shim, Eun Jung
TI B-Type Natriuretic Peptide Assay for the Diagnosis and Prognosis of
   Patent Ductus Arteriosus in Preterm Infants
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Patent ductus arteriosus; B-type natriuretic peptide; Echocardiography
ID PERSISTENT PULMONARY-HYPERTENSION; CLINICAL-RELEVANCE; PLASMA-LEVELS;
   MANAGEMENT; INDOMETHACIN; MECHANISMS; BNP
AB Background and Objectives: Patent ductus arteriosus (PDA) is a significant cause of morbidity and mortality in preterm infants. Measurement of plasma B-type natriuretic peptide (BNP) has been reported to be a useful bedside screening tool for the presence of hemodynamically significant PDA (hsPDA) in neonates. This study was conducted to investigate the usefulness of a BNP assay as a biochemical marker for the diagnosis of hsPDA and predictive biomarker of the response to indomethacin in preterm infants.
   Subjects and Methods: Preterm infants born at <37 weeks' gestational age were prospectively enrolled within 24 hours of birth. Plasma BNP levels were measured on days 1, 4, and 7. Significant PDA was diagnosed by large ductal flow with left to right shunt on color Doppler echocardiography, along with clinical features of PDA. Following that, hsPDA was treated with indomethacin.
   Results: A total of 28 preterm infants were prospectively enrolled in this study. Seven infants with PDA had higher on day 4 plasma BNP values (median 654.68 pg/mL; range 428.29-1280.00) compared to the control group (median 124.52 pg/mL; range 37.21-290.49). The area under the receiver operator characteristic curve for the detection of hsPDA was high: 0.998 (95% confidence interval: 0.995-1.002). The cutoff of BNP concentration for the diagnosis of hsPDA was determined to be 412 pg/mL (sensitivity: 100%; specificity: 95%).
   Conclusion: B-type natriuretic peptide can be a useful biomarker for the screening and diagnosis of PDA in preterm infants. Serial BNP measurements are valuable for assessing the clinical course and indomethacin responsiveness of PDA.
C1 [Kim, Joon Sik; Shim, Eun Jung] Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Pediat, Anyang 431070, South Korea.
RP Shim, EJ (corresponding author), Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Pediat, 896 Pyeongchon Dong, Anyang 431070, South Korea.
EM baby4019@hallym.or.kr
CR Attridge JT, 2009, ARCH DIS CHILD-FETAL, V94, pF178, DOI 10.1136/adc.2008.147587
   Bancalari E, 2005, BIOL NEONATE, V88, P192, DOI 10.1159/000087582
   Cantinotti M, 2008, CLIN CHIM ACTA, V390, P12, DOI 10.1016/j.cca.2007.12.020
   Choi BM, 2005, PEDIATRICS, V115, pE255, DOI 10.1542/peds.2004-1837
   CLYMAN RI, 1987, SEMIN PERINATOL, V11, P64
   Clyman RI, 2006, BIOL NEONATE, V89, P330, DOI 10.1159/000092870
   COTTON RB, 1978, J PEDIATR-US, V92, P467, DOI 10.1016/S0022-3476(78)80451-X
   da Graca RL, 2006, PEDIATRICS, V117, P2183, DOI 10.1542/peds.2005-1387
   Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021
   El Hajjar M, 2005, ARCH DIS CHILD-FETAL, V90, pF419, DOI 10.1136/adc.2003.027698
   El-Khuffash A, 2007, ARCH DIS CHILD-FETAL, V92, P320
   EVANS N, 1993, ARCH DIS CHILD-FETAL, V68, P58, DOI 10.1136/adc.68.1_Spec_No.58
   Flynn PA, 2005, J PEDIATR-US, V147, P38, DOI 10.1016/j.jpeds.2005.03.040
   HAMMERMAN C, 1995, CLIN PERINATOL, V22, P457
   HEYMANN MA, 1975, PHYSIOL REV, V55, P62
   Holmstrom H, 2001, ACTA PAEDIATR, V90, P184
   Hsu JH, 2010, J PEDIATR-US, V157, P79, DOI 10.1016/j.jpeds.2009.12.045
   Kluckow M, 2000, J PEDIATR-US, V137, P68, DOI 10.1067/mpd.2000.106569
   Lee HS, 2004, J KOREAN SOC NEONATO, V11, P44
   Levin ER, 1998, NEW ENGL J MED, V339, P321
   Puddy VF, 2002, CLIN SCI, V103, P75, DOI 10.1042/cs1030075
   Reynolds, 2005, PEDIATRICS, V115, P1454, DOI 10.1542/peds.2005-0569
   Reynolds EW, 2004, PEDIATRICS, V114, P1297, DOI 10.1542/peds.2004-0525
   ROJAS MA, 1995, J PEDIATR-US, V126, P605, DOI 10.1016/S0022-3476(95)70362-4
   SKELTON R, 1994, J PAEDIATR CHILD H, V30, P406, DOI 10.1111/j.1440-1754.1994.tb00689.x
   Skinner J, 2001, Semin Neonatol, V6, P49, DOI 10.1053/siny.2000.0037
   Tammela O, 1999, J PEDIATR-US, V134, P552, DOI 10.1016/S0022-3476(99)70239-8
   Tomaru K, 2002, J MOL CELL CARDIOL, V34, P649, DOI 10.1006/jmcc.2002.2005
   Ueda S, 2006, SHOCK, V26, P134, DOI 10.1097/01.shk.0000226266.99960.d0
   WALTHER FJ, 1992, PEDIATRICS, V90, P899
   Young TE, 2007, NEOFAX MANUAL DRUGS
NR 31
TC 9
Z9 12
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2012
VL 42
IS 3
BP 192
EP 196
DI 10.4070/kcj.2012.42.3.192
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34II
UT WOS:000209079700007
PM 22493614
OA Green Published
DA 2021-04-22
ER

PT J
AU Oh, MS
   Kwon, JE
   Kim, KJ
   Jo, JH
   Min, YJ
   Byun, JS
   Kim, KT
   Kim, SW
   Kim, TH
AF Oh, Min Seok
   Kwon, Jee Eun
   Kim, Kyung Jun
   Jo, Joon Hwan
   Min, Yun Ju
   Byun, Jun Soo
   Kim, Kyung Tae
   Kim, Sang Wook
   Kim, Tae Ho
TI Subarachnoid Hemorrhage Mimicking Leakage of Contrast Media After
   Coronary Angiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Subarachnoid hemorrhage; Iodixanol; Coronary angiography
AB We report a patient who developed subarachnoid hemorrhage (SAH) just after coronary angiography (CAG) with non-ionic contrast media (CM) and minimal dose of heparin. The 55-year-old man had a history of acute ST elevation myocardial infarction that had been treated with primary percutaneous coronary intervention and was admitted for a follow-up CAG. The CAG was performed by the transradial approach, using 1000 U of unfractionated heparin for the luminal coating and 70 mL of iodixanol. At the end of CAG, he complained of nausea and rapidly became stuporous. Brain CT showed a diffusely increased Hounsfield unit (HU) in the cisternal space, similar to leakage of CM. The maximal HU was 65 in the cisternal space. No vascular malformations were detected on cerebral angiography. The patient partially recovered his mental status and motor weakness after 2 days. Two weeks later, subacute SAH was evident on magnetic resonance imaging. The patient was discharged after 28 days.
C1 [Oh, Min Seok; Kwon, Jee Eun; Kim, Kyung Jun; Jo, Joon Hwan; Min, Yun Ju; Kim, Sang Wook; Kim, Tae Ho] Chung Ang Univ, Coll Med, Ctr Heart, Dept Cardiol, Seoul 156755, South Korea.
   [Byun, Jun Soo] Chung Ang Univ, Coll Med, Dept Radiol, Seoul 156755, South Korea.
   [Kim, Kyung Tae] Chung Ang Univ, Coll Med, Dept Neurosurg, Seoul 156755, South Korea.
RP Kim, TH (corresponding author), Chung Ang Univ, Coll Med, Ctr Cardiovasc, Dept Cardiol, 224-1 Heukseok Dong, Seoul 156755, South Korea.
EM kdoc97@lycos.co.kr
RI 변, 준수/J-4733-2016
OI 변, 준수/0000-0003-3210-9505
CR CHAKERES DW, 1986, AM J NEURORADIOL, V7, P223
   Culebras A, 1997, STROKE, V28, P1480, DOI 10.1161/01.STR.28.7.1480
   DEWISPELAERE JF, 1992, J COMPUT ASSIST TOMO, V16, P998, DOI 10.1097/00004728-199211000-00035
   Eckel TS, 1998, AM J ROENTGENOL, V170, P503, DOI 10.2214/ajr.170.2.9456974
   Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812
   HAYMAN LA, 1989, AM J ROENTGENOL, V153, P135, DOI 10.2214/ajr.153.1.135
   Kim Do Hoi, 2009, Korean Circulation Journal, V39, P32
   MAY EF, 1993, NEUROLOGY, V43, P836, DOI 10.1212/WNL.43.4.836
   Melton LG, 1996, ACAD RADIOL, V3, P407, DOI 10.1016/S1076-6332(05)80674-9
   MELTON LG, 1995, ACAD RADIOL, V2, P239, DOI 10.1016/S1076-6332(05)80172-2
   RINKEL GJE, 1993, STROKE, V24, P1403, DOI 10.1161/01.STR.24.9.1403
   Schwartz TH, 1996, NEUROSURGERY, V39, P433, DOI 10.1097/00006123-199609000-00001
   Sharp S, 1999, NEUROLOGY, V52, P1503, DOI 10.1212/WNL.52.7.1503
   Sobieraj-Teague M, 2008, CURR OPIN CARDIOL, V23, P327, DOI 10.1097/HCO.0b013e3283021c5b
   Sticherling C, 1998, LANCET, V351, P570, DOI 10.1016/S0140-6736(05)78557-3
   Torvik A, 1995, ACTA RADIOL, V36, P221, DOI 10.1177/0284185195036S39927
   Velden J, 2003, EUR NEUROL, V49, P249, DOI 10.1159/000070198
   WEAVER JP, 1994, J NEUROL SCI, V125, P119, DOI 10.1016/0022-510X(94)90024-8
   Yoon W, 2004, STROKE, V35, P876, DOI 10.1161/01.STR.0000120726.69501.74
NR 19
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2012
VL 42
IS 3
BP 197
EP 200
DI 10.4070/kcj.2012.42.3.197
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34II
UT WOS:000209079700008
PM 22493615
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, JH
   Rha, SW
   Lee, DI
   Kim, S
   Lee, JH
   Kang, SH
   Lim, SY
   Choi, BG
   Elnagar, A
   Kim, SW
   Im, SI
   Han, SW
   Na, JO
   Choi, CU
   Lim, HE
   Kim, JW
   Kim, EJ
   Park, CG
   Seo, HS
   Oh, DJ
AF Kang, Jun Hyuk
   Rha, Seung-Woon
   Lee, Dae In
   Kim, Sua
   Lee, Jae Hyoung
   Kang, Seung Hun
   Lim, Sung Yoon
   Choi, Byoung Geol
   Elnagar, Amro
   Kim, Sun Won
   Im, Sung Il
   Han, Seong Woo
   Na, Jin Oh
   Choi, Cheol Ung
   Lim, Hong Euy
   Kim, Jin Won
   Kim, Eung Ju
   Park, Chang Gyu
   Seo, Hong Seog
   Oh, Dong Joo
TI Successful Retrieval of a Fractured and Entrapped 0.035-Inch Terumo Wire
   in the Femoral Artery Using Biopsy Forceps
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Percutaneous transluminal coronary angioplasty; Complications
AB A 0.035-inch guide wire fracture and entrapment in a peripheral artery is a very rare complication, but when it does occur it may lead to life-threatening complications, such as perforation, thrombus formation, embolization, and subsequent limb ischemia. We describe our experience of successfully retrieving a fractured 0.035-inch Terumo guide wire in the external iliac artery using a biopsy forcep.
C1 [Kang, Jun Hyuk; Rha, Seung-Woon; Lee, Dae In; Kim, Sua; Lee, Jae Hyoung; Kang, Seung Hun; Lim, Sung Yoon; Choi, Byoung Geol; Elnagar, Amro; Kim, Sun Won; Im, Sung Il; Han, Seong Woo; Na, Jin Oh; Choi, Cheol Ung; Lim, Hong Euy; Kim, Jin Won; Kim, Eung Ju; Park, Chang Gyu; Seo, Hong Seog; Oh, Dong Joo] Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul 152703, South Korea.
RP Rha, SW (corresponding author), Korea Univ, Guro Hosp, Ctr Cardiovasc, 80 Guro Dong, Seoul 152703, South Korea.
EM swrha617@yahoo.co.kr
OI Choi, Byoung Geol/0000-0002-6090-869X; Kang, Jun
   Hyuk/0000-0001-8616-4433
CR Chang CP, 2009, INT HEART J, V50, P121, DOI 10.1536/ihj.50.121
   Chang TMT, 2002, TEX HEART I J, V29, P329
   Feldman T, 1999, CATHETER CARDIO INTE, V47, P325, DOI 10.1002/(SICI)1522-726X(199907)47:3<325::AID-CCD17>3.0.CO;2-K
   Li CJ, 2010, J BIOMED RES, V24, P479, DOI 10.1016/S1674-8301(10)60064-4
   MINTZ GS, 1990, CATHETER CARDIO DIAG, V20, P247, DOI 10.1002/ccd.1810200407
   Patel T, 2000, CATHETER CARDIO INTE, V51, P483, DOI 10.1002/1522-726X(200012)51:4<483::AID-CCD24>3.0.CO;2-F
   Sianos G, 2011, HELL J CARDIOL, V52, P79
   van Gaal William J, 2006, Int J Cardiol, V112, pe9, DOI 10.1016/j.ijcard.2006.01.040
NR 8
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2012
VL 42
IS 3
BP 201
EP 204
DI 10.4070/kcj.2012.42.3.201
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34II
UT WOS:000209079700009
PM 22493616
OA Green Published
DA 2021-04-22
ER

PT J
AU Hong, SM
   Yoon, SJ
   Rim, SJ
AF Hong, Suk-Min
   Yoon, Se-Jung
   Rim, Se-Joong
TI Contrast Echo-A Simple Diagnostic Tool for a Coronary Artery Fistula
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery fistula; Echocardiography; Contrast agent
AB Coronary artery fistulas have been diagnosed with aortography, coronary angiography, and coronary computed tomography (CT). A large fistula can be occasionally found as a mass lesion on echocardiography but cannot be easily confirmed. Here, we report a new diagnostic approach to coronary artery fistulas using a contrast agent and transthoracic echocardiography. Transthoracic echocardiography of a 46-year-old female suffering from dyspnea revealed suspicious small turbulent flow in the main pulmonary artery. Following infusion of a contrast agent, we found whitish flow in the main pulmonary artery during the diastolic phase, and aortic CT revealed two huge right coronary artery fistulas in the main pulmonary artery. A simple diagnostic approach to a coronary artery fistula using contrast agent helped us confirm the diagnosis because of the typical diastolic whitish flow in the pulmonary artery.
C1 [Hong, Suk-Min; Yoon, Se-Jung] Natl Hlth Insurance Corp, Ilsan Hosp, Div Cardiol, Goyang 410719, South Korea.
   [Rim, Se-Joong] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Div Cardiol, Seoul, South Korea.
RP Yoon, SJ (corresponding author), Natl Hlth Insurance Corp, Ilsan Hosp, Div Cardiol, 100 Ilsan Ro, Goyang 410719, South Korea.
EM drpuooh@hanmail.net
CR Burch GH, 2001, CORONARY ARTERY DIS, V12, P605, DOI 10.1097/00019501-200112000-00003
   Dresios C, 2010, EUR J ECHOCARDIOGR, V11, DOI 10.1093/ejechocard/jep196
   최성훈, 2003, Korean Circulation Journal, V33, P338
   Kim YH, 1982, KOREAN CIRC J, V12, P189
   Luo L, 2006, AM J MED SCI, V332, P79, DOI 10.1097/00000441-200608000-00005
   MORGAN JR, 1972, AM J CARDIOL, V30, P432, DOI 10.1016/0002-9149(72)90578-4
   Wei K, 2008, J AM SOC ECHOCARDIOG, V21, P1202, DOI 10.1016/j.echo.2008.07.019
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
   Zenooz NA, 2009, RADIOGRAPHICS, V29, P781, DOI 10.1148/rg.293085120
   이승재, 2008, Korean Circulation Journal, V38, P331
NR 10
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2012
VL 42
IS 3
BP 205
EP 207
DI 10.4070/kcj.2012.42.3.205
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34II
UT WOS:000209079700010
PM 22493617
OA Green Published
DA 2021-04-22
ER

PT J
AU Acet, H
   Ozyurtlu, F
   Bilik, MZ
   Ertas, F
AF Acet, Halit
   Ozyurtlu, Ferhat
   Bilik, Mehmet Zihni
   Ertas, Faruk
TI A Rare Coronary Anomaly: Atypical Double Right Coronary Artery With an
   Acute Inferior Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessel anomalies; Myocardial infarction; Atherosclerosis
ID EPICARDIAL ADIPOSE-TISSUE; PATIENT
AB Coronary artery anomalies are uncommon and often asymptomatic. A double right coronary artery (RCA) is an extremely rare coronary artery anomaly, and only a few cases of double RCA have been reported. We report on an atherosclerotic double RCA that appeared after primary percutaneous intervention in a patient with an acute inferior myocardial infarction. This is the second case in the literature in which coronary arteries can be accepted as a double RCA, which were hidden by a total atherosclerotic occlusion in the proximal part of the RCA.
C1 [Acet, Halit; Ozyurtlu, Ferhat; Bilik, Mehmet Zihni] Diyarbakir Training & Res Hosp, Dept Cardiol, TR-21090 Diyarbakir, Turkey.
   [Ertas, Faruk] Dicle Univ, Fac Med, Dept Cardiol, Diyarbakr, Turkey.
RP Acet, H (corresponding author), Diyarbakir Training & Res Hosp, Dept Cardiol, TR-21090 Diyarbakir, Turkey.
EM halitacet@gmail.com
CR Akcay A, 2010, CARDIOL RES PRACT, V2010, DOI 10.4061/2010/123846
   Altun A, 2002, INT J CARDIOL, V82, P99, DOI 10.1016/S0167-5273(01)00595-2
   Garg Naveen, 2002, Indian Heart J, V54, P428
   Iacobellis G, 2003, J CLIN ENDOCR METAB, V88, P5163, DOI 10.1210/jc.2003-030698
   Rohit Manojkumar, 2008, J Invasive Cardiol, V20, pE37
   Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019
   Sari I, 2008, INT J CARDIOL, V130, pE74, DOI 10.1016/j.ijcard.2007.11.073
   Sari I, 2006, INT J CARDIOL, V111, P321, DOI 10.1016/j.ijcard.2005.11.028
   Tatli E, 2007, INT J CARDIOL, V119, pE30, DOI 10.1016/j.ijcard.2007.01.100
   Tuncer C, 2006, CATHETER CARDIO INTE, V68, P574, DOI 10.1002/ccd.20858
   Vural M, 2008, ANATOL J CARDIOL, V8, P303
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
   YOUNGHYMAN PJ, 1984, J AM COLL CARDIOL, V4, P1329, DOI 10.1016/S0735-1097(84)80159-X
NR 13
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2012
VL 42
IS 3
BP 208
EP 211
DI 10.4070/kcj.2012.42.3.208
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34II
UT WOS:000209079700011
PM 22493618
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, C
   Ko, SM
   Kim, N
   Park, SM
   Lee, GY
   Cho, JH
   Kim, JS
AF Kim, Chunghun
   Ko, Sung Min
   Kim, Namjun
   Park, Sun Mi
   Lee, Ga Yeon
   Cho, Jin Hyun
   Kim, June Soo
TI A Case of Swallow Syncope Associated With Cold Beverage Ingestion
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Syncope; Deglutition; Atrioventricular block
AB Swallow syncope (also known as deglutition syncope) is a relatively rare type of syncope that is treatable if diagnosed correctly. We report a case of a 39-year-old man with recurrent swallow syncope. The patient did not have structural heart disease. He developed a complete atrioventricular block upon drinking a cold beverage (Chilsung cider) while undergoing a repeated head-up tilt test. The patient was advised to avoid cold beverages and has been symptom free for 5 months.
C1 [Kim, Chunghun; Ko, Sung Min; Kim, Namjun; Park, Sun Mi; Cho, Jin Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med,Cardiac & Vasc Ctr, Seoul 135710, South Korea.
   [Lee, Ga Yeon; Kim, June Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med,Cardiac & Vasc Ctr, Seoul 135710, South Korea.
RP Kim, JS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Internal Med, 50 Irwon Dong, Seoul 135710, South Korea.
EM juneskim@skku.edu
CR Ammirati F, 2001, CIRCULATION, V104, P52, DOI 10.1161/hc2601.091708
   BORTOLOTTI M, 1982, JAMA-J AM MED ASSOC, V248, P2297, DOI 10.1001/jama.248.18.2297
   DRAKE CE, 1984, AM J CARDIOL, V53, P1408, DOI 10.1016/0002-9149(84)90106-1
   Grubb BP, 2005, NEW ENGL J MED, V352, P1004, DOI 10.1056/NEJMcp042601
   Kakuchi H, 2000, HEART, V83, P702, DOI 10.1136/heart.83.6.702
   Kang Ki Hoon, 2005, Korean Journal of Internal Medicine, V20, P68
   Lee Ga Yeon, 2010, Korean Circ J, V40, P99, DOI 10.4070/kcj.2010.40.2.99
   Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298
   Omi W, 2006, CARDIOLOGY, V105, P75, DOI 10.1159/000089543
   PALMER ED, 1976, AM J GASTROENTEROL, V66, P513
   Spens T., 1978, CLASSIC DESCRIPTIONS, P358
   TOMLINSON IW, 1975, BMJ-BRIT MED J, V2, P315, DOI 10.1136/bmj.2.5966.315
   Trujillo N P, 1974, Med Ann Dist Columbia, V43, P553
NR 13
TC 5
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2012
VL 42
IS 3
BP 212
EP 215
DI 10.4070/kcj.2012.42.3.212
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34II
UT WOS:000209079700012
PM 22493619
OA Green Published
DA 2021-04-22
ER

PT J
AU Heo, WJ
   Kang, JH
   Jeong, WS
   Jeong, MY
   Lee, SH
   Seo, JY
   Jo, SW
AF Heo, Woon Je
   Kang, Jin Ho
   Jeong, Woo Shin
   Jeong, Mi Yeon
   Lee, Sang Hyuk
   Seo, Jeong Yeun
   Jo, Sang Won
TI Subarachnoid Hemorrhage Misdiagnosed as an Acute ST Elevation Myocardial
   Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Subarachnoid hemorrhage
ID ELECTROCARDIOGRAPHIC CHANGES
AB Without significant coronary artery stenosis, ischemic electrocardiographic change including ST segment elevation, segmental wall motion abnormality and elevated serum cardiac-specific markers (creatine kinase-MB, Troponin-T) may develop after central nervous system injuries such as subarachnoid, intracranial or subdural hemorrhage. Misdiagnosing these patients as acute myocardial infarction may result in catastrophic outcomes. By reporting a case of a 55-year old female with subarachnoid hemorrhage mimicking acute ST elevation myocardial infarction, we hope to underline that careful attention of neurologic abnormality is critical in making better prognosis.
C1 [Heo, Woon Je; Kang, Jin Ho; Jeong, Woo Shin; Jeong, Mi Yeon; Lee, Sang Hyuk; Seo, Jeong Yeun] Kangbuk Samsung Med Ctr, Dept Internal Med, Seoul 110746, South Korea.
   [Jo, Sang Won] Kangbuk Samsung Med Ctr, Dept Radiol, Seoul 110746, South Korea.
RP Kang, JH (corresponding author), Kangbuk Samsung Med Ctr, Dept Internal Med, 29 Saemunan Ro, Seoul 110746, South Korea.
EM jinho2.kang@samsung.com
CR Alsamadani H. A., 2011, HEART METAB, V2, P75
   Baroldi G, 1992, HEART BRAIN INTERACT, P43
   BROUWERS PJAM, 1989, STROKE, V20, P1162, DOI 10.1161/01.STR.20.9.1162
   BURCH GE, 1954, CIRCULATION, V9, P719, DOI 10.1161/01.CIR.9.5.719
   Chen YL, 2006, J FORMOS MED ASSOC, V105, P839, DOI 10.1016/S0929-6646(09)60271-0
   CROPP GJ, 1960, CIRCULATION, V22, P25, DOI 10.1161/01.CIR.22.1.25
   DOSHI R, 1977, J NEUROL NEUROSUR PS, V40, P821, DOI 10.1136/jnnp.40.8.821
   Elrifai AM, 1996, STROKE, V27, P737, DOI 10.1161/01.STR.27.4.737
   GREENHOO.JH, 1969, J NEUROSURG, V30, P521, DOI 10.3171/jns.1969.30.5.0521
   Hahn TH, 1995, KOREAN CIRC J, V25, P106
   HERSCH C, 1964, BRIT HEART J, V26, P785
   OPPENHEIMER S, 1995, NEUROLOGY GEN MED NE, P183
   Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X
   YAMOUR BJ, 1980, AM HEART J, V99, P294, DOI 10.1016/0002-8703(80)90343-9
   YUKI K, 1991, J NEUROSURG, V75, P308, DOI 10.3171/jns.1991.75.2.0308
   Zaroff JG, 1999, NEUROSURGERY, V44, P34, DOI 10.1097/00006123-199901000-00013
NR 16
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2012
VL 42
IS 3
BP 216
EP 219
DI 10.4070/kcj.2012.42.3.216
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34II
UT WOS:000209079700013
PM 22493620
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, HC
   Moon, KW
   Kim, HW
   Kim, JH
   Yoo, KD
   Kim, CM
AF Jung, Hee-Chan
   Moon, Keon-Woong
   Kim, Hyung-Woo
   Kim, Ji-Hoon
   Yoo, Ki-Dong
   Kim, Chul-Min
TI Pressure Tracings in Hypertrophic Cardiomyopathy With Dynamic
   Midventricular Obstruction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Jung, Hee-Chan; Moon, Keon-Woong; Kim, Hyung-Woo; Kim, Ji-Hoon; Yoo, Ki-Dong; Kim, Chul-Min] Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Internal Med, Suwon 442723, South Korea.
RP Moon, KW (corresponding author), Catholic Univ Korea, Coll Med, St Vincents Hosp, Dept Internal Med, 93 Jungbu Daero, Suwon 442723, South Korea.
EM cardiomoon@gmail.com
CR Efthimiadis GK, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-26
   Maron MS, 2008, CIRCULATION, V118, P1541, DOI 10.1161/CIRCULATIONAHA.108.781401
NR 2
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2012
VL 42
IS 3
BP 220
EP 221
DI 10.4070/kcj.2012.42.3.220
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34II
UT WOS:000209079700014
PM 22493621
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, YS
   Ahn, Y
AF Kim, Yong Sook
   Ahn, Youngkeun
TI A Long Road for Stem Cells to Cure Sick Hearts: Update on Recent
   Clinical Trials
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Stem cells; Myocardial infarction; Animal experimentation; Clinical
   trial; Peer review, research
ID ACUTE MYOCARDIAL-INFARCTION; BONE-MARROW-CELLS; PERCUTANEOUS CORONARY
   INTERVENTION; LEFT-VENTRICULAR FUNCTION; 5-YEAR FOLLOW-UP; ISCHEMIC
   CARDIOMYOPATHY; MONONUCLEAR-CELLS; PROGENITOR CELLS; DOUBLE-BLIND;
   INTRACORONARY TRANSPLANTATION
AB The contribution of stem cells to cure damaged hearts has finally been unraveled. A large number of preclinical and clinical studies have showed beneficial outcomes after myocardial infarction. In this review, the current understanding of stem cell therapy in preclinical and clinical experiences is summarized. Stem cells from bone marrow have shown a potential to improve cardiac performance after myocardial infarction in animal and early clinical studies. Clinical trials from all over the world have provided safety assessments of stem cell therapy with marginal improvement of clinical outcomes. Thus, further investigations should be encouraged to resolve the discrepancies between studies, clinical issues, and unclear translational findings. This review provides information and commentary on key trials for stem cell-based treatment of cardiovascular disease.
C1 [Kim, Yong Sook; Ahn, Youngkeun] Chonnam Natl Univ Hosp, Heart Res Ctr, Kwangju 501757, South Korea.
   [Ahn, Youngkeun] Chonnam Natl Univ Hosp, Dept Cardiol, Kwangju 501757, South Korea.
   [Ahn, Youngkeun] Chonnam Natl Univ Hosp, Ctr Cardiovasc, Kwangju 501757, South Korea.
RP Ahn, Y (corresponding author), Chonnam Natl Univ Hosp, Dept Cardiol, 42 Jebong Ro, Kwangju 501757, South Korea.
EM cecilyk@hanmail.net
FU National Research Foundation of Korea - Korean Government (MEST),
   Republic of Korea [2010-0020261]; Ministry for Health, Welfare & Family
   Affairs, Republic of KoreaMinistry of Health & Welfare, Republic of
   Korea [A084869]
FX This work was supported by a grant of the National Research Foundation
   of Korea funded by the Korean Government (MEST), Republic of Korea
   (2010-0020261), and by a grant of the Korea Healthcare Technology R&D
   Project, Ministry for Health, Welfare & Family Affairs, Republic of
   Korea (A084869).
CR Abbate A, 2008, J AM COLL CARDIOL, V51, P956, DOI 10.1016/j.jacc.2007.11.062
   Ahmadi H, 2012, ARCH IRAN MED, V15, P32, DOI 012151/AIM.0010
   Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102
   [Anonymous], AM J CARDIOL
   Arnold R, 2010, AM HEART J, V159, P1154, DOI 10.1016/j.ahj.2010.03.030
   Assmus B, 2010, CIRC-HEART FAIL, V3, P89, DOI 10.1161/CIRCHEARTFAILURE.108.843243
   Beitnes JO, 2009, HEART, V95, P1983, DOI 10.1136/hrt.2009.178913
   Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303
   Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0
   Caplan A I, 1986, Prog Clin Biol Res, V217B, P307
   Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8
   Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034
   Chin BB, 2003, NUCL MED COMMUN, V24, P1149, DOI 10.1097/00006231-200311000-00005
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680
   Dubois C, 2010, J AM COLL CARDIOL, V55, P2232, DOI 10.1016/j.jacc.2009.10.081
   Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013
   Feygin J, 2007, AM J PHYSIOL-HEART C, V293, pH1772, DOI 10.1152/ajpheart.00242.2007
   Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818
   FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001
   FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
   Grajek S, 2010, EUR HEART J, V31, P691, DOI 10.1093/eurheartj/ehp536
   Gyongyosi M, 2008, CIRC-CARDIOVASC IMAG, V1, P94, DOI 10.1161/CIRCIMAGING.108.797449
   Hahn JY, 2008, J AM COLL CARDIOL, V51, P933, DOI 10.1016/j.jacc.2007.11.040
   Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055
   Hashemi SM, 2008, EUR HEART J, V29, P251, DOI 10.1093/eurheartj/ehm559
   Hirsch A, 2011, EUR HEART J, V32, P1736, DOI 10.1093/eurheartj/ehq449
   Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801
   Kerkis I, 2006, CELLS TISSUES ORGANS, V184, P105, DOI 10.1159/000099617
   Kim YS, 2010, ARTIF ORGANS, V34, P453, DOI 10.1111/j.1525-1594.2009.00894.x
   Kim YS, 2012, CELLS TISSU IN PRESS
   Konstam MA, 2011, JACC-CARDIOVASC IMAG, V4, P98, DOI 10.1016/j.jcmg.2010.10.008
   Kucia M, 2005, LEUKEMIA, V19, P1118, DOI 10.1038/sj.leu.2403796
   Lim SY, 2006, CARDIOVASC RES, V70, P530, DOI 10.1016/j.cardiores.2006.02.016
   Ly HQ, 2009, EUR HEART J, V30, P2861, DOI 10.1093/eurheartj/ehp322
   Mansour S, 2011, BONE MARROW RES, DOI 10.1155/2011/385124
   Meyer GP, 2009, EUR HEART J, V30, P2978, DOI 10.1093/eurheartj/ehp374
   Moreira RD, 2011, ARQ BRAS CARDIOL, V97, P420
   Moscoso I, 2009, TRANSPL P, V41, P2273, DOI 10.1016/j.transproceed.2009.06.011
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Penn MS, 2012, CIRC RES, V110, P304, DOI 10.1161/CIRCRESAHA.111.253427
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Price MJ, 2006, INT J CARDIOL, V111, P231, DOI 10.1016/j.ijcard.2005.07.036
   Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106
   Roncalli J, 2011, EUR HEART J, V32, P1748, DOI 10.1093/eurheartj/ehq455
   Santoso Teguh, 2011, Acta Med Indones, V43, P112
   Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388
   Schuleri KH, 2008, AM J PHYSIOL-HEART C, V294, pH2002, DOI 10.1152/ajpheart.00762.2007
   Schuleri KH, 2009, EUR HEART J, V30, P2722, DOI 10.1093/eurheartj/ehp265
   Seth S, 2010, J AM COLL CARDIOL, V55, P1643, DOI 10.1016/j.jacc.2009.11.070
   Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8
   Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45
   Solheim S, 2011, THROMB RES
   Song H, 2005, MOL CELLS, V19, P402
   Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1
   Strauer BE, 2001, DEUT MED WOCHENSCHR, V126, P932, DOI 10.1055/s-2001-16579-1
   Strauer BE, 2010, EUR J HEART FAIL, V12, P721, DOI 10.1093/eurjhf/hfq095
   Tendera M, 2009, EUR HEART J, V30, P1313, DOI 10.1093/eurheartj/ehp073
   Thirabanjasak D, 2010, J AM SOC NEPHROL, V21, P1218, DOI 10.1681/ASN.2009111156
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Trachtenberg B, 2011, AM HEART J, V161, P487, DOI 10.1016/j.ahj.2010.11.024
   Traverse JH, 2010, AM HEART J, V160, P428, DOI 10.1016/j.ahj.2010.06.009
   van Ramshorst J, 2009, JAMA-J AM MED ASSOC, V301, P1997, DOI 10.1001/jama.2009.685
   Vulliet PR, 2004, LANCET, V363, P783, DOI 10.1016/S0140-6736(04)15695-X
   WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212
   Wang DG, 2011, INT J CARDIOL, V152, P314, DOI 10.1016/j.ijcard.2010.07.025
   Williams AR, 2011, CIRC RES, V108, P792, DOI 10.1161/CIRCRESAHA.111.242610
   Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02
   Wolf D, 2009, STEM CELLS DEV, V18, P321, DOI 10.1089/scd.2008.0019
   Xu WR, 2004, EXP BIOL MED, V229, P623
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 71
TC 6
Z9 7
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 71
EP 79
DI 10.4070/kcj.2012.42.2.71
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600001
PM 22396692
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HC
AF Kim, Hyeon Chang
TI Knowledge Gap Regarding Low Density Lipoprotein-Cholesterol Levels in
   Koreans
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID ALL-CAUSE MORTALITY; METABOLIC SYNDROME; NATIONAL-HEALTH; PREVALENCE;
   ADULTS; ASSOCIATION; DEFINITION; CORONARY; CRITERIA; OBESITY
C1 [Kim, Hyeon Chang] Yonsei Univ, Coll Med, Dept Prevent Med, Div Cardiol,Dept Internal Med, Seoul 120752, South Korea.
   Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
RP Kim, HC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, 50 Yonsei Ro, Seoul 120752, South Korea.
EM hckim@yuhs.ac
RI Kim, Hyeon Chang/F-8796-2019
OI Kim, Hyeon Chang/0000-0001-7867-1240
CR Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   [Anonymous], AM J CLIN NUTR S
   Choi KM, 2007, METABOLISM, V56, P552, DOI 10.1016/j.metabol.2006.12.003
   Choi SH, 2005, YONSEI MED J, V46, P198, DOI 10.3349/ymj.2005.46.2.198
   Choi SJ, 2012, KOREAN CIRC J, V42, P86, DOI 10.4070/kcj.2012.42.2.86
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Kim HM, 2007, DIABETES RES CLIN PR, V77, P99, DOI 10.1016/j.diabres.2006.10.009
   Kim Hyeon Chang, 2011, Korean Journal of Internal Medicine, V26, P440, DOI 10.3904/kjim.2011.26.4.440
   Kim MH, 2004, J KOREAN MED SCI, V19, P195, DOI 10.3346/jkms.2004.19.2.195
   Kim Y, 2004, OBES RES, V12, P445, DOI 10.1038/oby.2004.50
   Kwon Hyuk Sang, 2005, Korean Journal of Internal Medicine, V20, P310
   Lee MH, 2011, CLIN CHIM ACTA, V412, P1600, DOI 10.1016/j.cca.2011.05.013
   Lim S, 2005, DIABETES CARE, V28, P1810, DOI 10.2337/diacare.28.7.1810
   Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109
   Lindsey CC, 2004, PHARMACOTHERAPY, V24, P167, DOI 10.1592/phco.24.2.167.33142
   Nordestgaard BG, 2009, CLIN CHEM, V55, P845, DOI 10.1373/clinchem.2008.123083
   Park HS, 2008, OBES REV, V9, P104, DOI 10.1111/j.1467-789X.2007.00421.x
   Park HS, 2007, DIABETES OBES METAB, V9, P50, DOI 10.1111/j.1463-1326.2005.00569.x
   Park HS, 2006, DIABETES CARE, V29, P933, DOI 10.2337/diacare.29.04.06.dc06-0069
   Park HS, 2004, INT J EPIDEMIOL, V33, P328, DOI 10.1093/ije/dyh032
   Pedersen TR, 1998, CIRCULATION, V97, P1453, DOI 10.1161/01.CIR.97.15.1453
   RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351
   STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868
   Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311
   Yoon YS, 2004, AM J CLIN NUTR, V80, P217
NR 25
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 80
EP 82
DI 10.4070/kcj.2012.42.2.80
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600002
PM 22396693
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HY
AF Kim, Hee-Yeol
TI The Concurrent Chronic Total Occlusion in a Non-Infarct Artery Strongly
   Associate With Poor Long-Term Prognosis in Patients With Acute
   Myocardial Infarction and Multivessel Coronary Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID LEFT-VENTRICULAR FUNCTION; RECANALIZATION; INTERVENTION; IMPACT;
   MORTALITY; SIZE
C1 Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, Puchon 420717, South Korea.
RP Kim, HY (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, 327 Sisa Ro, Puchon 420717, South Korea.
EM cumckhy@catholic.ac.kr
CR [Anonymous], 1994, NEW ENGL J MED, V330, P516
   Barrett TD, 2002, J PHARMACOL EXP THER, V303, P1007, DOI 10.1124/jpet.102.040600
   Chung CM, 2003, CATHETER CARDIO INTE, V60, P368, DOI 10.1002/ccd.10641
   Claessen BEPM, 2009, JACC-CARDIOVASC INTE, V2, P1128, DOI 10.1016/j.jcin.2009.08.024
   Conde-Vela C, 2007, INT J CARDIOL, V123, P29, DOI 10.1016/j.ijcard.2006.11.102
   Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303
   Joyal D, 2010, AM HEART J, V160, P179, DOI 10.1016/j.ahj.2010.04.015
   Lee JH, 2012, KOREAN CIRC J, V42, P95, DOI 10.4070/kcj.2012.42.2.95
   Lexis CPH, 2011, CATHETER CARDIO INTE, V77, P484, DOI 10.1002/ccd.22664
   Moreno Raul, 2006, J Invasive Cardiol, V18, P16
   ROSS AM, 1993, NEW ENGL J MED, V329, P1615
   Sirnes PA, 1998, EUR HEART J, V19, P273, DOI 10.1053/euhj.1997.0617
   Tajstra M, 2012, AM J CARDIOL, V109, P208, DOI 10.1016/j.amjcard.2011.08.026
   Valenti R, 2008, EUR HEART J, V29, P2336, DOI 10.1093/eurheartj/ehn357
   van der Schaaf R, 2006, AM J CARDIOL, V98, P1165, DOI 10.1016/j.amjcard.2006.06.010
   van der Schaaf RJ, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-89
   van der Schaaf RJ, 2010, AM J CARDIOL, V105, P955, DOI 10.1016/j.amjcard.2009.11.014
   van der Schaaf RJ, 2006, HEART, V92, P117, DOI [10.1136/hrt.2004.059675, 10.1136/hrt.2005.086058]
   Yang Z, 2011, INT J CARDIOL
NR 19
TC 3
Z9 3
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 83
EP 85
DI 10.4070/kcj.2012.42.2.83
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600003
PM 22396694
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, SJ
   Park, SH
   Lee, KS
   Park, HY
AF Choi, Sun-Ja
   Park, Sung-Hee
   Lee, Kwang-Soo
   Park, Hyun-Young
TI The Prevalence, Awareness and Treatment of High Low Density
   Lipoprotein-Cholesterol in Korean Adults Without Coronary Heart Diseases
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Dyslipidemia; Low density lipoprotein-cholesterol; Coronary heart
   disease
ID ALL-CAUSE MORTALITY; RISK-FACTORS; NATIONAL-HEALTH; DYSLIPIDEMIA;
   PLASMA; TRIGLYCERIDE; PREDICTION; MEN
AB Background and Objectives: The purpose of this study was to estimate the prevalence, awareness and treatment of high low density lipoprotein-cholesterol (LDL-C) level in Korean adults without coronary heart disease.
   Subjects and Methods: National representative cross-sectional surveys, data of 5248 Korean adults (2246 men and 3002 women) aged between 20 and 79 years from the Third Korea National Health and Nutrition Examination Survey (KNHANES III, 2005) was used. High LDLC level was defined with the risk prediction algorithm published by the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III).
   Results: The prevalence of the Korean adults with high LDL-C level who need therapeutic lifestyle changes was 19.9%, treatment with lipid-lowing medication was 2.1% and awareness of this condition was 7.9%. Meanwhile, the prevalence of the Korean with very high LDL-C level who should be considered for drug therapy was 13.5%, treatment with lipid-lowing medication was 2.7% and awareness of this condition was 8.1%. Overall, 47.9% (60.3% in male and 39.1% in female) of participants had a single lipid disorder (high LDL-C, high triglycerides: >= 200 mg/dL, low high density lipo-protein-cholesterol: <40 mg/dL), whereas 15.5% (23.5% in male and 9.7% in female) had at least two. Only 1.9% (2.8% in male and 1.2% in female) of all participants had all three lipid abnormalities as defined.
   Conclusion: These findings indicate that continuous efforts are needed to increase awareness and treatment of high LDL-C level in our population to prevent cardiovascular disease.
C1 [Choi, Sun-Ja; Park, Sung-Hee; Lee, Kwang-Soo; Park, Hyun-Young] Natl Inst Hlth, Div Cardiovasc & Rare Dis, Ctr Biomed Sci, Seoul 122701, South Korea.
RP Park, HY (corresponding author), Natl Inst Hlth, Div Cardiovasc & Rare Dis, Ctr Biomed Sci, 194 Tongil Ro, Seoul 122701, South Korea.
EM hypark65@nih.go.kr
OI Park, Hyun-Young/0000-0002-6698-7368
FU National Institute of Health, Korea [4800-4845-300-210, 2007-N63001-00]
FX The study was supported by an intramural grant of the National Institute
   of Health, Korea (4800-4845-300-210, 2007-N63001-00).
CR AUSTIN MA, 1991, ARTERIOSCLER THROMB, V11, P2, DOI 10.1161/01.ATV.11.1.2
   Bersot TP, 2003, AM HEART J, V146, P1052, DOI 10.1016/S0002-8703(03)00516-7
   CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835
   CASTELLI WP, 1984, AM J MED, V76, P4, DOI 10.1016/0002-9343(84)90952-5
   CASTELLI WP, 1986, AM HEART J, V112, P432, DOI 10.1016/0002-8703(86)90296-6
   Committee of treatment guideline for hypercholesterolemia, 2008, TREATM GUID HYP
   FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Ghandehari H, 2008, AM HEART J, V156, P112, DOI 10.1016/j.ahj.2008.03.005
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Hong HS, 2008, KOREAN DIABETES J, V32, P215
   Hyre AD, 2007, ANN EPIDEMIOL, V17, P548, DOI 10.1016/j.annepidem.2007.01.032
   Jun JE, 2001, KOREAN CIRC J, V31, P849
   Kim MK, 2008, KOREAN CIRC J, V38, P36
   성지동, 2005, [The Korean Journal of Medicine, 대한내과학회지], V69, P371
   Ko MJ, 2006, INT J CARDIOL, V110, P184, DOI 10.1016/j.ijcard.2005.07.030
   *KOR CDCP, 2007, IN DEPTH AN 3 KOR NA
   *KOR NAT STAT OFF, 2006, ANN REP CAUS DEATH S
   Lee YW, 2007, J CLIN LAB ANAL, V21, P178, DOI 10.1002/jcla.20165
   Lim S, 2008, J ENDOCRINOL INVEST, V31, P327, DOI 10.1007/BF03346366
   National Health Insurance Corporation, INS STAND DYSL
   Park SH, 2009, CIRC J, V73, P1643, DOI 10.1253/circj.CJ-09-0161
   RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365
   RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351
   Sanghyun Kim, 2006, Korean Circulation Journal, V36, P593
   SCHAEFER EJ, 1978, LANCET, V2, P391
   Siegel D, 2000, Prev Cardiol, V3, P167, DOI 10.1111/j.1520-037X.2000.80381.x
   Smaha LA, 2004, AM HEART J, V148, pS46, DOI 10.1016/j.ahj.2004.09.015
   STAMLER J, 1993, CARDIOLOGY, V82, P191, DOI 10.1159/000175868
   Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311
   Van Ganse E, 2007, CLIN THER, V29, P1671, DOI 10.1016/j.clinthera.2007.08.003
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
NR 32
TC 7
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 86
EP 94
DI 10.4070/kcj.2012.42.2.86
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600004
PM 22396695
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Park, HS
   Ryu, HM
   Lee, H
   Bae, MH
   Lee, JH
   Yang, DH
   Cho, Y
   Chae, SC
   Jun, JE
AF Lee, Ju Hwan
   Park, Hun Sik
   Ryu, Hyeon Min
   Lee, Hyunsang
   Bae, Myung Hwan
   Lee, Jang Hoon
   Yang, Dong Heon
   Cho, Yongkeun
   Chae, Shung Chull
   Jun, Jae-Eun
TI Impact of Multivessel Coronary Disease With Chronic Total Occlusion on
   One-Year Mortality in Patients With Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary occlusion; Myocardial infarction; Chronic disease; Prognosis
ID LEFT-VENTRICULAR FUNCTION; LONG-TERM MORTALITY; INTERVENTION;
   ANGIOPLASTY; OUTCOMES
AB Background and Objectives: The impact of multivessel coronary disease (MVD) with chronic total occlusion (CTO) on one-year mortality in patients with acute myocardial infarction (AMI) is not clearly known. We investigated the impact of MVD with concurrent CTO lesion on one-year mortality in patients with AMI.
   Subjects and Methods: We studied 1008 consecutive patients who underwent coronary angiography between November 2005 and December 2008 with a diagnosis of AMI.
   Results: Among 1008 patients, 432 patients (43%) had MVD, and 88 patients (8.7%) had CTO lesion. The one-year overall mortality was higher in patients with MVD than in patients with single vessel disease (SVD) (10.2% vs. 5.9%, p=0.012). However, the one-year overall mortality was not significantly higher in patients with CTO lesion than in patients without that lesion (12.5% vs. 7.3%, p=0.080). In multivariate analysis, independent predictors of one-year overall mortality were age older than 65 years {hazard ratio (HR) 2.41, 95% confidence interval (CI): 1.43 to 4.08}, Killip class >= III (HR 3.59, 95% CI: 2.24 to 5.77), ST-elevation myocardial infarction (HR 2.45, 95% CI: 1.49 to 4.05) and MVD (HR 1.76, 95% CI: 1.07 to 2.89).
   Conclusion: Patients with MVD showed higher one-year mortality than patients with SVD. However, the presence of CTO was not an independent predictor of one-year mortality in this study that included patients with successfully revascularized CTO lesion.
C1 [Lee, Ju Hwan; Park, Hun Sik; Bae, Myung Hwan; Lee, Jang Hoon; Yang, Dong Heon; Cho, Yongkeun; Chae, Shung Chull; Jun, Jae-Eun] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu 700721, South Korea.
   [Lee, Ju Hwan; Ryu, Hyeon Min; Lee, Hyunsang] Gumi CHA Hosp, Dept Internal Med, Gumi, South Korea.
RP Park, HS (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Internal Med, 130 Dongdeok Ro, Taegu 700721, South Korea.
EM hspark@knu.ac.kr
CR Christofferson RD, 2005, AM J CARDIOL, V95, P1088, DOI 10.1016/j.amjcard.2004.12.065
   Claessen BEPM, 2010, HEART, V96, P1968, DOI 10.1136/hrt.2010.197673
   Claessen BEPM, 2009, JACC-CARDIOVASC INTE, V2, P1128, DOI 10.1016/j.jcin.2009.08.024
   DEBOER MJ, 1994, CIRCULATION, V90, P753, DOI 10.1161/01.CIR.90.2.753
   French JK, 2004, HEART, V90, P99, DOI 10.1136/heart.90.1.99
   Hoye A, 2005, EUR HEART J, V26, P2630, DOI 10.1093/eurheartj/ehi498
   Joyal D, 2010, AM HEART J, V160, P179, DOI 10.1016/j.ahj.2010.04.015
   Moreno R, 2001, J Invasive Cardiol, V13, P202
   OKEEFE JH, 1989, AM J CARDIOL, V64, P1221, DOI 10.1016/0002-9149(89)90558-4
   Parodi G, 2005, HEART, V91, P1541, DOI 10.1136/hrt.2004.054692
   Piscione F, 2005, HEART, V91, P646, DOI 10.1136/hrt.2004.041152
   Schomig A, 2005, JAMA-J AM MED ASSOC, V293, P2865, DOI 10.1001/jama.293.23.2865
   Shihara M, 2002, AM J CARDIOL, V90, P932, DOI 10.1016/S0002-9149(02)02656-5
   Suero JA, 2001, J AM COLL CARDIOL, V38, P409, DOI 10.1016/S0735-1097(01)01349-3
   van der Schaaf R, 2006, AM J CARDIOL, V98, P1165, DOI 10.1016/j.amjcard.2006.06.010
   van der Schaaf RJ, 2006, HEART, V92, P117, DOI [10.1136/hrt.2004.059675, 10.1136/hrt.2005.086058]
   Waldecker B, 1998, J AM COLL CARDIOL, V32, P1320, DOI 10.1016/S0735-1097(98)00405-7
NR 17
TC 12
Z9 17
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 95
EP 99
DI 10.4070/kcj.2012.42.2.95
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600005
PM 22396696
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, KY
   Kim, DB
   Kim, MJ
   Kwon, BJ
   Chang, SY
   Jang, SW
   Cho, EJ
   Rho, TH
   Kim, JH
AF Choi, Kyu-Young
   Kim, Dong-Bin
   Kim, Myung-Jun
   Kwon, Bum-June
   Chang, Seo-Yoon
   Jang, Sung-Won
   Cho, Eun-Joo
   Rho, Tai-Ho
   Kim, Jae-Hyung
TI Higher Plasma Thrombospondin-1 Levels in Patients With Coronary Artery
   Disease and Diabetes Mellitus
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Thrombospondin-1; Coronary artery disease; Diabetes mellitus
ID GROWTH-FACTOR; MESANGIAL CELLS; ANGIOGENESIS; EXPRESSION; GLUCOSE;
   PROTEIN; GENES; PROLIFERATION; POLYMORPHISMS; TISSUE
AB Background and Objectives: Thrombospondin-1 (TSP-1) is associated with atherosclerosis in animals with diabetes mellitus (DM). But, no study has investigated the role of TSP-1 in human atherosclerosis. This study investigated the relationship among plasma TSP-1 concentration, DM, and coronary artery disease (CAD).
   Subjects and Methods: The study involved 374 consecutive subjects with suspected CAD, who had undergone coronary angiography to evaluate effort angina. Patients were divided into four groups as follows: DM(-) and CAD(-), DM(-) and CAD(+), DM(+) and CAD(-), and DM (+) and CAD(+).
   Results: We found that plasma TSP-1 levels were higher in patients with DM(+) and CAD(+) (n=103) than those in other patients (n=271) (p<0.01). A multivariate analysis showed that male gender {odds ratio (OR), 2.728; 95% confidence interval (CI), 1.035-7.187}, high density lipoprotein-cholesterol (OR, 0.925; 95% CI, 0.874-0.980), glycated hemoglobin (OR, 1.373; 95% CI, 1.037-1.817), and plasma TSP-1 (OR, 1.004; 95% CI, 1.000-1.008) levels were independently associated with the presence of CAD in patients with DM.
   Conclusion: Plasma TSP-1 levels were higher in patients with DM(+) and CAD(+) than those in other patients, and plasma TSP-1 levels were independently associated with the presence of CAD in patients with DM. These findings show a possible link between human plasma TSP-1 concentration and CAD in patients with DM.
C1 [Choi, Kyu-Young; Kim, Dong-Bin; Kwon, Bum-June; Jang, Sung-Won; Cho, Eun-Joo; Rho, Tai-Ho; Kim, Jae-Hyung] Catholic Univ Korea, Coll Med, Dept Cardiol, Seoul 130709, South Korea.
   [Kim, Myung-Jun; Chang, Seo-Yoon] Catholic Univ Korea, Coll Med, Dept Physiol, Seoul 130709, South Korea.
RP Kim, DB (corresponding author), Catholic Univ Korea, Coll Med, Dept Cardiol, 180 Wangsan Ro, Seoul 130709, South Korea.
EM dbkimmd@catholic.ac.kr
FU Korean Society of Cardiology
FX This study was supported by a research grant from the Korean Society of
   Cardiology (2008).
CR Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25
   Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5
   BAENZIGE.NL, 1971, P NATL ACAD SCI USA, V68, P240, DOI 10.1073/pnas.68.1.240
   Belmadani S, 2007, AM J PATHOL, V171, P777, DOI 10.2353/ajpath.2007.070056
   BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503
   Carlson CB, 2008, J BIOL CHEM, V283, P20069, DOI 10.1074/jbc.M800223200
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   Frangogiannis NG, 2005, CIRCULATION, V111, P2935, DOI 10.1161/CIRCULATIONAHA.104.510354
   Gavin JR, 1997, DIABETES CARE, V20, P1183
   GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2
   Hsu SC, 1996, CANCER RES, V56, P5684
   Isenberg JS, 2007, CIRC RES, V100, P712, DOI 10.1161/01.RES.0000259579.35787.4e
   Kirma C, 2007, CIRC J, V71, P698, DOI 10.1253/circj.71.698
   MAJACK RA, 1988, J CELL BIOL, V106, P415, DOI 10.1083/jcb.106.2.415
   McGillicuddy FC, 2006, VASC PHARMACOL, V44, P469, DOI 10.1016/j.vph.2006.03.002
   Murphy M, 1999, J BIOL CHEM, V274, P5830, DOI 10.1074/jbc.274.9.5830
   Nor JE, 2000, J VASC RES, V37, P209, DOI 10.1159/000025733
   Poczatek MH, 2000, AM J PATHOL, V157, P1353, DOI 10.1016/S0002-9440(10)64649-4
   Raman P, 2007, J BIOL CHEM, V282, P5704, DOI 10.1074/jbc.M610965200
   Ren B, 2006, BBA-REV CANCER, V1765, P178, DOI 10.1016/j.bbcan.2005.11.002
   Selvin E, 2004, ANN INTERN MED, V141, P421, DOI 10.7326/0003-4819-141-6-200409210-00007
   Stenina OI, 2005, CURR PHARM DESIGN, V11, P2367, DOI 10.2174/1381612054367283
   Stenina OI, 2003, CIRCULATION, V107, P3209, DOI 10.1161/01.CIR.0000074223.56882.97
   Stouffer GA, 1998, CIRCULATION, V97, P907, DOI 10.1161/01.CIR.97.9.907
   Tada H, 1995, TOHOKU J EXP MED, V177, P293, DOI 10.1620/tjem.177.293
   Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910
   Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445
   Yevdokimova N, 2001, J AM SOC NEPHROL, V12, P703
NR 28
TC 26
Z9 28
U1 0
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 100
EP 106
DI 10.4070/kcj.2012.42.2.100
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600006
PM 22396697
OA Green Published
DA 2021-04-22
ER

PT J
AU Song, SW
   Sul, SY
   Lee, HJ
   Yoo, KJ
AF Song, Suk-Won
   Sul, Soon-Young
   Lee, Hee-Jung
   Yoo, Kyung-Jong
TI Comparison of the Radial Artery and Saphenous Vein as Composite Grafts
   in Off-Pump Coronary Artery Bypass Grafting in Elderly Patients: A
   Randomized Controlled Trial
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery bypass grafting; Saphenous vein; Radial artery
AB Background and Objectives: Arterial grafts have a better long-term patency rate than saphenous vein (SV) when used in off-pump coronary artery bypass surgery (OPCAB). However, arterial grafts in elderly patients are often diseased. We sought to compare the early outcomes achieved by using the two different types of composite grafts.
   Subjects and Methods: We conducted a randomized trial to compare radial artery (RA) and SV composite grafts based on the in situ left internal mammary artery in 60 elderly (>70 years old) patients, who were scheduled to undergo OPCAB. Clinical outcomes and 1-year postoperative CT angiography results were compared. The quality of the conduit was evaluated by employing vascular ultrasonography, optical coherence tomography (OCT), and histologic examination.
   Results: No differences in immediate postoperative morbidity and mortality were observed between the two groups. Early postoperative CT angiography revealed a SV patency rate of 100%, which was not different from that of RA composite grafts (99.1%). CT angiography after a year showed an overall patency rate of 96.3%. The overall patency rate of the SV group at 1 year was 94.7%, which was similar to that of the RA group (97.4%). Also, there was no difference in overall survival rate between the two groups. Vascular ultrasonographic images showed strong correlations between OCT and histopathology.
   Conclusion: Our analysis of early outcomes revealed that the SV could be used as an alternative composite graft to the RA in elderly patients. Vascular ultrasonography is an accurate, real-time, and reproducible method for assessing the quality of the RA conduit.
C1 [Song, Suk-Won] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Thorac & Cardiovasc Surg, Seoul 120752, South Korea.
   [Sul, Soon-Young; Lee, Hee-Jung; Yoo, Kyung-Jong] Yonsei Univ, Coll Med, Severance Hosp, Dept Thorac & Cardiovasc Surg, Seoul 120752, South Korea.
RP Yoo, KJ (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Thorac & Cardiovasc Surg, 50 Yonsei Ro, Seoul 120752, South Korea.
EM kjy@yuhs.ac
RI Song, Suk-Won/AAG-3784-2020
OI Song, Suk-Won/0000-0002-9850-9707
FU Korean Society of Cardiology [7-2007-0382]
FX The authors are deeply grateful to Sun-Hee Lim, RN. for collecting the
   data used in this study. This study was supported by a grant from the
   Korean Society of Cardiology for 2007 (7-2007-0382).
CR Burris N, 2007, J THORAC CARDIOV SUR, V133, P419, DOI 10.1016/j.jtcvs.2006.09.056
   Cameron A, 1996, NEW ENGL J MED, V334, P216, DOI 10.1056/NEJM199601253340402
   Fukui T, 2005, ANN THORAC SURG, V80, P579, DOI 10.1016/j.athoracsur.2005.03.053
   Glineur D, 2008, J THORAC CARDIOV SUR, V136, P482, DOI 10.1016/j.jtcvs.2008.01.016
   Halbersma WB, 2009, ANN THORAC SURG, V88, P796, DOI 10.1016/j.athoracsur.2009.04.104
   Kim WS, 2008, ANN THORAC SURG, V86, P1861, DOI 10.1016/j.athoracsur.2008.06.025
   KOBAYASHI H, 1993, SURG TODAY, V23, P697, DOI 10.1007/BF00311708
   LOOP FD, 1986, NEW ENGL J MED, V314, P1, DOI 10.1056/NEJM198601023140101
   Osika W, 2007, ARTERIOSCL THROM VAS, V27, P671, DOI 10.1161/01.ATV.0000256468.95403.6f
   Ozkan S, 2007, J CARDIAC SURG, V22, P385, DOI 10.1111/j.1540-8191.2007.00431.x
   Segarra G, 2000, J THORAC CARDIOV SUR, V120, P729, DOI 10.1067/mtc.2000.109537
   SIMS FH, 1983, AM HEART J, V105, P560, DOI 10.1016/0002-8703(83)90478-7
   SINGH RN, 1983, J THORAC CARDIOV SUR, V86, P359
   Souza DSR, 2006, J THORAC CARDIOV SUR, V132, P373, DOI 10.1016/j.jtcvs.2006.04.002
   Sperti G, 1999, AM J CARDIOL, V83, P592, DOI 10.1016/S0002-9149(98)00920-5
   Tagusari O, 2004, ANN THORAC SURG, V78, P1304, DOI 10.1016/j.athoracsur.2004.03.094
   Tatoulis J, 1999, ANN THORAC SURG, V68, P2093, DOI 10.1016/S0003-4975(99)01150-9
   Tatoulis J, 2009, ANN THORAC SURG, V88, P23, DOI 10.1016/j.athoracsur.2009.03.086
   VANSON JAM, 1990, J THORAC CARDIOV SUR, V99, P703
   Zacharias A, 2009, ANN THORAC SURG, V87, P19, DOI 10.1016/j.athoracsur.2008.09.050
NR 20
TC 30
Z9 32
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 107
EP 112
DI 10.4070/kcj.2012.42.2.107
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600007
PM 22396698
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, HW
   Kim, YN
   Bae, HJ
   Lee, HM
   Cho, HO
   Cho, YK
   Park, HS
   Yoon, HJ
   Kim, H
   Nam, CW
   Hur, SH
   Kim, KB
   Lee, YS
AF Shin, Hong-Won
   Kim, Yoon-Nyun
   Bae, Han-Jun
   Lee, Ho-Myung
   Cho, Hyun-Ok
   Cho, Yun-Kyeong
   Park, Hyoung-Seob
   Yoon, Hyuck-Jun
   Kim, Hyungseop
   Nam, Chang-Wook
   Hur, Seung-Ho
   Kim, Kwon-Bae
   Lee, Young-Soo
CA KORAF Investigator
TI Trends in Oral Anticoagulation Therapy Among Korean Patients With Atrial
   Fibrillation: The KORean Atrial Fibrillation Investigation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; International Normalized Ratio; Anticoagulants
ID ANTITHROMBOTIC THERAPY; STROKE; WARFARIN; PREVENTION; INTENSITY;
   EFFICACY; RISK
AB Background and Objectives: Anticoagulation with vitamin K antagonists (VKAs) such as warfarin provides effective stroke prophylaxis in patients with atrial fibrillation (AF). We conducted a large multicenter survey of Korean patients with AF to determine trends in VKA use.
   Subjects and Methods: Eligible patients were adults with AF that had been prescribed VKAs. Medical records from a total of 5616 patients {mean age 63.6+/-12.2 years, male 3150 (56.1%)} in 27 hospitals from Jan. 2001 to Oct. 2007 were reviewed.
   Results: The mean international normalized ratio (INR) was 2.04+/-0.64, and mean dosage of VKA was 3.66+/-1.50 mg. Individuals in their sixties (1852 patients) accounted for about one third of patients studied. As patients grew older, INR increased and VKA dosage decreased. The dosage of VKA in male patients was larger than that in females for all ages. A total of 2146 (42.4%) patients had an INR of 2-3, and less than 40% patients in their sixties had an INR within optimal range. The dosage of oral anticoagulant for optimal INR level was 3.71 mg.
   Conclusion: In this study, less than half of the Korean patients with AF on VKA reached the therapeutic range of INR. Mean dosage of VKA was 3.66+/-1.50 mg, and the dosage of oral anticoagulant for optimal INR level was 3.71 mg, which decreased with age.
C1 [Shin, Hong-Won; Kim, Yoon-Nyun; Bae, Han-Jun; Lee, Ho-Myung; Cho, Hyun-Ok; Cho, Yun-Kyeong; Park, Hyoung-Seob; Yoon, Hyuck-Jun; Kim, Hyungseop; Nam, Chang-Wook; Hur, Seung-Ho; Kim, Kwon-Bae] Keimyung Univ, Dongsan Med Ctr, Dept Cardiol, Taegu 700712, South Korea.
   [Lee, Young-Soo] Daegu Catholic Univ, Med Ctr, Dept Cardiol, Taegu, South Korea.
RP Kim, YN (corresponding author), Keimyung Univ, Dongsan Med Ctr, Dept Cardiol, 56 Dalseong Ro, Taegu 700712, South Korea.
EM ynkim@dsmc.or.kr
OI Hur, Seung-Ho/0000-0002-3895-1915
FU Korean Society of Circulation
FX This study was performed with the support of the Korean Society of
   Circulation in celebration of the 50th Anniversary of the Korean Society
   of Circulation.
CR Ansell J, 2004, CHEST, V126, p204S, DOI 10.1378/chest.126.3_suppl.204S
   Atarashi H, 2011, CIRC J, V75, P1328, DOI 10.1253/circj.CJ-10-1119
   Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013
   Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913
   LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449
   Lip GYH, 2007, EUR J INTERN MED, V18, P202, DOI 10.1016/j.ejim.2006.11.005
   Miura T, 2009, J CARDIOL, V53, P355, DOI 10.1016/j.jjcc.2008.12.003
   Shen AYJ, 2008, CNS DRUGS, V22, P815, DOI 10.2165/00023210-200822100-00003
   Singer DE, 2008, CHEST, V133, p546S, DOI 10.1378/chest.08-0678
   Stansbury JP, 2005, STROKE, V36, P374, DOI 10.1161/01.STR.0000153065.39325.fd
   van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441
   van Walraven C, 2006, CHEST, V129, P1155, DOI 10.1378/chest.129.5.1155
   Waldo AL, 2005, J AM COLL CARDIOL, V46, P1729, DOI 10.1016/j.jacc.2005.06.077
   WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561
   Yasaka M, 2001, INTERNAL MED, V40, P1183, DOI 10.2169/internalmedicine.40.1183
   이광수, 2008, Korean Circulation Journal, V38, P601
   김영훈, 2003, Korean Circulation Journal, V33, P553
NR 17
TC 16
Z9 16
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 113
EP 117
DI 10.4070/kcj.2012.42.2.113
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600008
PM 22396699
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, DY
   Park, JP
   Ko, SJ
   Lee, SE
   Jhon, SH
   Lim, JH
   Rhew, JY
AF Lee, Dong-Yob
   Park, Jong-Pil
   Ko, Sung-Jun
   Lee, Shin-Eun
   Jhon, Sung-Hee
   Lim, Ji-Hyun
   Rhew, Jay-Young
TI Recurrent Very Late Stent Thrombosis in a Systemic Lupus Erythematous
   Patient
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Lupus erythematosus, systemic; Drug-eluting stents
AB Coronary artery disease is the most important cause of mortality in patients with systemic lupus erythematous (SLE). After stenting for coronary artery disease in SLE patients similar to non-SLE patients, the risk of stent thrombosis is always present. Although there are reports of stent thrombosis in SLE patients, very late recurrent stent thrombosis is rare. We experienced a case of very late recurrent stent thrombosis (4 times) in a patient with SLE.
C1 [Lee, Dong-Yob; Park, Jong-Pil; Ko, Sung-Jun; Lee, Shin-Eun; Jhon, Sung-Hee; Lim, Ji-Hyun; Rhew, Jay-Young] Presbyterian Med Ctr, Dept Internal Med, Div Cardiol, Jeonju 560750, South Korea.
RP Park, JP (corresponding author), Presbyterian Med Ctr, Dept Internal Med, Div Cardiol, 68 Seowon Ro, Jeonju 560750, South Korea.
EM jppark74@gmail.com
CR Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55
   HAIDER YS, 1981, AM J MED, V70, P775, DOI 10.1016/0002-9343(81)90532-5
   Hong MK, 2007, INT J CARDIOL, V114, P78, DOI 10.1016/j.ijcard.2006.01.008
   Kassaian SE, 2008, CARDIOVASC J AFR, V19, P152
   Lee CW, 2010, J AM COLL CARDIOL, V55, P1936, DOI 10.1016/j.jacc.2009.10.077
   Lee CH, 2008, INT J CARDIOL, V126, P430, DOI 10.1016/j.ijcard.2007.01.117
   Lee Kyounghoon, 2009, Korean Circ J, V39, P512, DOI 10.4070/kcj.2009.39.12.512
   Mehta PK, 2008, PEDIATR CARDIOL, V29, P957, DOI 10.1007/s00246-007-9157-0
   Moon YG, 1995, KOREAN CIRC J, V25, P691
   Muir D F, 2003, Int J Cardiovasc Intervent, V5, P44
   Olivier Andre C, 2006, J Invasive Cardiol, V18, pE185
   Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471
   Su Ho-Ming, 2003, Kaohsiung Journal of Medical Sciences, V19, P177
NR 13
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 118
EP 121
DI 10.4070/kcj.2012.42.2.118
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600009
PM 22396700
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JE
   Kim, MK
   Shim, YK
   Kim, JT
   Kim, SM
   Lee, SY
   Bae, JW
   Hwang, KK
   Kim, DW
   Cho, MC
AF Kim, Jeong Eun
   Kim, Mi Kyoung
   Shim, Young Kwang
   Kim, Jeong Tae
   Kim, Sang Min
   Lee, Sang Yeub
   Bae, Jang-Whan
   Hwang, Kyung-Kuk
   Kim, Dong-Woon
   Cho, Myeong-Chan
TI Percutaneous Retrieval of an Embolized Central Venous Chemoport in a
   Patient With Colon Cancer
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Catheters; Complications; Device removal
AB The central access device is commonly used as a route of chemotherapuetic agents in patients with malignant diseases for its convenient and safety for insertion. This report describes a case of 66-year-old man with colon cancer who suffered a rare complication in which a chemoport embolized into the inferior vena cava and it was successfully retrieved by a percutaneous approach using a goose neck snare.
C1 [Kim, Jeong Eun; Kim, Sang Min; Lee, Sang Yeub; Bae, Jang-Whan; Hwang, Kyung-Kuk; Kim, Dong-Woon; Cho, Myeong-Chan] Chungbuk Natl Univ Hosp, Reg Cardiovasc Dis Ctr, Cheongju 361711, South Korea.
   [Kim, Jeong Eun; Kim, Mi Kyoung; Shim, Young Kwang; Kim, Jeong Tae; Kim, Sang Min; Lee, Sang Yeub; Bae, Jang-Whan; Hwang, Kyung-Kuk; Kim, Dong-Woon; Cho, Myeong-Chan] Chungbuk Natl Univ Hosp, Dept Internal Med, Cheongju 361711, South Korea.
RP Bae, JW (corresponding author), Chungbuk Natl Univ Hosp, Dept Internal Med, Reg Cardiovasc Dis Ctr, 776 1Sunhwan Ro, Cheongju 361711, South Korea.
EM drcorazon@hanmail.net
CR AITKEN DR, 1984, AM J SURG, V148, P633, DOI 10.1016/0002-9610(84)90340-4
   Andris D A, 1997, J Intraven Nurs, V20, P233
   ANDRIS DA, 1994, JPEN-PARENTER ENTER, V18, P531, DOI 10.1177/0148607194018006531
   Denny MA, 2003, J EMERG MED, V24, P29, DOI 10.1016/S0736-4679(02)00664-9
   Fazeny-Dorner B, 2003, BONE MARROW TRANSPL, V31, P927, DOI 10.1038/sj.bmt.1704022
   FISHER RG, 1978, AM J ROENTGENOL, V130, P541, DOI 10.2214/ajr.130.3.541
   Gowda MR, 2004, ANGIOLOGY, V55, P557, DOI 10.1177/000331970405500512
   HINKE DH, 1990, RADIOLOGY, V177, P353, DOI 10.1148/radiology.177.2.2217768
   Mirza B, 2004, AM SURGEON, V70, P635
   Nace C S, 1993, Oncol Nurs Forum, V20, P1227
   Rauthe G, 1998, EUR J SURG ONCOL, V24, P192, DOI 10.1016/S0748-7983(98)92963-8
   Whitman E D, 1996, Curr Probl Surg, V33, P309, DOI 10.1016/S0011-3840(96)80008-6
   Yildizeli B, 2005, VASCULAR, V13, P120, DOI 10.1258/rsmvasc.13.2.120
NR 13
TC 3
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 122
EP 124
DI 10.4070/kcj.2012.42.2.122
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600010
PM 22396701
OA Green Published
DA 2021-04-22
ER

PT J
AU An, HM
   Kang, WY
   Kim, YH
   Lim, CH
   Hwang, SH
   Kim, W
   Kim, W
AF An, Hye Mi
   Kang, Won Yu
   Kim, Yeon Hwa
   Lim, Chur Hoan
   Hwang, Sun Ho
   Kim, Weon
   Kim, Wan
TI Below the Knee Intervention Using Multidisciplinary Methods Including an
   Antegrade, Retrograde Approach Without the Use of a Sheath but With a
   Plaque Excision Device
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Peripheal arterial disease; Ischemia; Angioplasty; Atherectomy
AB Below the knee (BTK) interventions are increasing in patients with rest pain or critical limb ischemia, and these interventions are frequently successful in facilitating limb salvage. New intervention techniques and devices allow successful recanalization of occluded BTK arteries. Here, we report a case of successful recanalization of BTK arteries using multidisciplinary methods, including an antegrade approach and retrograde approach without the use of a sheath, but with simple balloon angioplasty, and plaque excision using Silverhawk atherectomy device.
C1 [An, Hye Mi; Kang, Won Yu; Kim, Yeon Hwa; Lim, Chur Hoan; Hwang, Sun Ho; Kim, Wan] Gwangju Vet Hosp, Dept Internal Med, Div Cardiol, Kwangju 506705, South Korea.
   [Kim, Weon] Kyung Hee Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.
RP Kang, WY (corresponding author), Gwangju Vet Hosp, Dept Internal Med, Div Cardiol, 91 Sanwol Gil, Kwangju 506705, South Korea.
EM gpkwy@naver.com
CR Bradbury AW, 2005, LANCET, V366, P1925, DOI 10.1016/S0140-6736(05)67707-5
   Faglia E, 2005, EUR J VASC ENDOVASC, V29, P620, DOI 10.1016/j.ejvs.2005.02.035
   Fusaro M, 2006, Minerva Cardioangiol, V54, P773
   Keeling WB, 2007, J VASC SURG, V45, P25, DOI 10.1016/j.jvs.2006.08.080
   Saito S, 2008, CATHETER CARDIO INTE, V71, P8, DOI 10.1002/ccd.21316
   Staffa R, 2003, Rozhl Chir, V82, P516
NR 6
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 125
EP 128
DI 10.4070/kcj.2012.42.2.125
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600011
PM 22396702
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, NY
   Kang, JK
   Park, SH
   Bae, MH
   Lee, JH
   Yang, DH
   Park, HS
   Chae, SC
   Jun, JE
   Cho, Y
AF Kim, Na Young
   Kang, Jung Kyu
   Park, Sun Hee
   Bae, Myung Hwan
   Lee, Jang Hoon
   Yang, Dong Heon
   Park, Hun Sik
   Chae, Shung Chull
   Jun, Jae Eun
   Cho, Yongkeun
TI Catecholaminergic Polymorphic Ventricular Tachycardia in a Patient With
   Recurrent Exertional Syncope
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Catecholamines; Tachycardia; ventricular; Genetics; Syncope; Exercise
AB A 16-year-old male with a prior history of recurrent syncope was referred to our hospital after being resuscitated from cardiac arrest developed while playing volleyball. His electrocardiogram (ECG) demonstrated ventricular fibrillation at a local emergency department. After referral, an ECG showed bidirectional ventricular tachycardia (VT) and nonsustained Torsade de Pointes. Two days later, his heart rate became regular, and no additional episodes of VT were observed. His ECG showed sinus rhythm with a corrected QT interval of 423 msec, and two-dimensional echocardiography was unremarkable. We made the diagnosis of a catecholaminergic polymorphic VT. However, only premature ventricular complex bigeminy was induced on exercise ECG and epinephrine infusion tests, and the patient showed no episodes of syncope. His father and mother had different missense mutations in the cardiac ryanodine receptor on genetic testing. The proband had both mutations in different alleles and was symptomatic. It was recommended that the patient avoid competitive physical activities, and a beta-blocker was prescribed.
C1 [Kim, Na Young; Kang, Jung Kyu; Park, Sun Hee; Bae, Myung Hwan; Lee, Jang Hoon; Yang, Dong Heon; Park, Hun Sik; Chae, Shung Chull; Jun, Jae Eun; Cho, Yongkeun] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Taegu 700721, South Korea.
RP Cho, Y (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Internal Med, 130 Dongdeok Ro, Taegu 700721, South Korea.
EM choyk@mail.knu.ac.kr
CR di Barletta MR, 2006, CIRCULATION, V114, P1012, DOI 10.1161/CIRCULATIONAHA.106.623793
   George CH, 2003, CIRC RES, V93, P531, DOI 10.1161/01.RES.0000091335.07574.86
   Hayashi M, 2009, CIRCULATION, V119, P2426, DOI 10.1161/CIRCULATIONAHA.108.829267
   Horner JM, 2008, HEART RHYTHM, V5, P1690, DOI 10.1016/j.hrthm.2008.08.038
   Krahn AD, 2009, CIRCULATION, V120, P278, DOI 10.1161/CIRCULATIONAHA.109.853143
   Lahat H, 2001, CIRCULATION, V103, P2822
   LEENHARDT A, 1995, CIRCULATION, V91, P1512, DOI 10.1161/01.CIR.91.5.1512
   Maron BJ, 2004, CIRCULATION, V109, P2807, DOI 10.1161/01.CIR.0000128363.85581.E1
   Nam GB, 2005, CIRCULATION, V111, P2727, DOI 10.1161/CIRCULATIONAHA.104.479295
   Postma AV, 2005, J MED GENET, V42, P863, DOI 10.1136/jmg.2004.028993
   Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8
   Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942
   Wilde AAM, 2008, NEW ENGL J MED, V358, P2024, DOI 10.1056/NEJMoa0708006
NR 13
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 129
EP 132
DI 10.4070/kcj.2012.42.2.129
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600012
PM 22396703
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, S
   Lim, JH
   Kim, Y
   Oh, S
   Choi, WG
AF Kim, Soohyun
   Lim, Joo Han
   Kim, Youngjoong
   Oh, Sewon
   Choi, Woong Gil
TI A Case of Acute Carbon Monoxide Poisoning Resulting in an ST Elevation
   Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Carbon monoxide; Myocardial infarction
AB Carbon monoxide (CO) is a well-known chemical asphyxiant, which causes tissue hypoxia with prominent neurological and cardiovascular injury. After exposure to CO, several cardiac manifestations have been reported, including arrhythmias, acute myocardial infarction, and pulmonary edema. However, an ST elevation myocardial infarction (STEMI) due to CO poisoning is a very rare presentation, and the treatment for STEMI due to CO poisoning is not well established. Here, we report a rare case of STEMI complicated by increased thrombogenicity secondary to acute CO poisoning and complete revascularization after antithrombotic treatment.
C1 [Kim, Soohyun; Kim, Youngjoong; Oh, Sewon; Choi, Woong Gil] Konkuk Univ, Chungju Hosp, Div Cardiol, Chungju 380704, South Korea.
   [Lim, Joo Han] Inha Univ Hosp, Div Hematooncol, Inchon, South Korea.
RP Choi, WG (corresponding author), Konkuk Univ, Chungju Hosp, Div Cardiol, 82 Gugwon Daero, Chungju 380704, South Korea.
EM gilll@paran.com
CR ALLRED EN, 1989, NEW ENGL J MED, V321, P1426, DOI 10.1056/NEJM198911233212102
   ARONOW WS, 1979, PREV MED, V8, P271, DOI 10.1016/0091-7435(79)90003-3
   Chong DY, 1988, KOREAN CIRC J, V18, P69
   Gandini C, 2001, J TOXICOL-CLIN TOXIC, V39, P35, DOI 10.1081/CLT-100102878
   Hampson NB, 2008, AM J EMERG MED, V26, P665, DOI 10.1016/j.ajem.2007.10.005
   Hsu PC, 2010, KAOHSIUNG J MED SCI, V26, P271, DOI 10.1016/S1607-551X(10)70040-1
   MARIUSNUNEZ AL, 1990, CHEST, V97, P491, DOI 10.1378/chest.97.2.491
   MCCABE MJ, 1992, POSTGRAD MED J, V68, P758, DOI 10.1136/pgmj.68.803.758
   MCMEEKIN J D, 1987, Canadian Journal of Cardiology, V3, P118
   Raub JA, 2000, TOXICOLOGY, V145, P1, DOI 10.1016/S0300-483X(99)00217-6
   Satran D, 2005, J AM COLL CARDIOL, V45, P1513, DOI 10.1016/j.jacc.2005.01.044
   Weaver LK, 2009, NEW ENGL J MED, V360, P1217, DOI 10.1056/NEJMcp0808891
NR 12
TC 8
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 133
EP 135
DI 10.4070/kcj.2012.42.2.133
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600013
PM 22396704
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, J
   Kim, SM
   Lee, SY
   Lee, HC
   Bae, JW
   Hwang, KK
   Kim, DW
   Cho, MC
   Byeon, SJ
   Kim, KB
AF Kim, Jeongeun
   Kim, Sang Min
   Lee, Sang Yeub
   Lee, Ho-Chang
   Bae, Jang-Whan
   Hwang, Kyung-Kuk
   Kim, Dong-Woon
   Cho, Myeong-Chan
   Byeon, Sun-Ju
   Kim, Ki-Bong
TI A Case of Severe Aortic Valve Regurgitation Caused by an Ascending
   Aortic Aneurysm in a Young Patient With Autosomal Dominant Polycystic
   Kidney Disease and Normal Renal Function
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic regurgitation; Aortic aneurysm, thoracic; Polycystic kidney,
   autosomal dominant
AB Aortic aneurysm is one several well-known cardiovascular complications in patients with autosomal dominant polycystic kidney disease (ADPCKD). Commonly affected site of aortic aneurysm and its related dissection in ADPCKD is abdominal aorta. Long standing hypertension, haemodialysis, old age are closely related with discovering of aortic aneurysm and dissection in ADPCKD. However, thoracic aortic aneurysms and its related severe aortic regurgitations (ARs) are rare in younger patients suffering from ADPCKD, especially ones who have normal renal function. Here, we report a case involving a 27-year-old Asian male patient with severe AR due to an ascending aneurysm of the thoracic aorta associated with ADPCKD. The patient had normal renal function without Marfan's habitus. The AR and thoracic aortic aneurysm were corrected surgically.
C1 [Kim, Jeongeun; Kim, Sang Min; Lee, Sang Yeub; Bae, Jang-Whan; Hwang, Kyung-Kuk; Kim, Dong-Woon; Cho, Myeong-Chan] Chungbuk Natl Univ, Sch Med, Dept Internal Med, Div Cardiol,Reg Cardiovasc Ctr, Cheongju 361763, South Korea.
   [Lee, Ho-Chang] Chungbuk Natl Univ, Sch Med, Dept Pathol, Cheongju 361763, South Korea.
   [Byeon, Sun-Ju] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea.
   [Kim, Ki-Bong] Seoul Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul 151, South Korea.
RP Bae, JW (corresponding author), Chungbuk Natl Univ, Sch Med, Dept Internal Med, Div Cardiol,Reg Cardiovasc Ctr, 410 Seongbong Ro, Cheongju 361763, South Korea.
EM drcorazon@hanmail.net
OI Byeon, Sun-ju/0000-0002-9599-4970
FU Chungbuk National University
FX This work was supported by a research grant of the Chungbuk National
   University in 2010.
CR Bechtel JFM, 2003, J HEART VALVE DIS, V12, P54
   FICK GM, 1995, J AM SOC NEPHROL, V5, P2048
   GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508
   IGLESIAS CG, 1983, AM J KIDNEY DIS, V2, P630
   Kato A, 2001, NEPHRON, V88, P185, DOI 10.1159/000045984
   LEIER CV, 1984, ANN INTERN MED, V100, P683, DOI 10.7326/0003-4819-100-5-683
   Moon Jeonggeun, 2010, Korean Circ J, V40, P348, DOI 10.4070/kcj.2010.40.7.348
   Nacasch N, 2010, CLIN NEPHROL, V73, P478
   Takagi H, 2005, MED HYPOTHESES, V64, P778, DOI 10.1016/j.mehy.2004.09.023
   Takagi H, 2005, KIDNEY INT, V67, P376, DOI 10.1111/j.1523-1755.2005.091_2.x
   Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1
   VANMAELE R, 1995, NEPHRON, V69, P107, DOI 10.1159/000188378
NR 12
TC 6
Z9 6
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 136
EP 139
DI 10.4070/kcj.2012.42.2.136
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600014
PM 22396705
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Ahn, SG
   Yoon, J
AF Lee, Ji Hyun
   Ahn, Sung Gyun
   Yoon, Junghan
TI Endovascular Stent Grafting via the Left Radial Artery for a Spontaneous
   Isolated Dissecting Rupture of the Superior Mesenteric Artery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Ji Hyun; Ahn, Sung Gyun; Yoon, Junghan] Yonsei Univ, Wonju Coll Med, Div Cardiol, Wonju 220701, South Korea.
RP Ahn, SG (corresponding author), Yonsei Univ, Wonju Coll Med, Div Cardiol, 20 Ilsan Ro, Wonju 220701, South Korea.
EM sgahn@yonsei.ac.kr
RI Ahn, Sung Gyun/AAG-5976-2020
OI Ahn, Sung Gyun/0000-0002-1528-2739
CR Gobble RM, 2009, J VASC SURG, V50, P1326, DOI 10.1016/j.jvs.2009.07.019
   Min SI, 2011, J VASC SURG, V54, P461, DOI 10.1016/j.jvs.2011.03.001
NR 2
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2012
VL 42
IS 2
BP 140
EP U75
DI 10.4070/kcj.2012.42.2.140
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IH
UT WOS:000209079600015
PM 22396706
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, C
AF Lee, Cheul
TI Surgical Management of Chronic Pulmonary Regurgitation After Relief of
   Right Ventricular Outflow Tract Obstruction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Magnetic resonance imaging; Pulmonary regurgitation; Surgery; Tetralogy
   of Fallot
AB Relief of right ventricular (RV) outflow tract obstruction in tetralogy of Fallot or similar physiology often results in pulmonary regurgitation (PR). The resultant chronic volume overload can lead to RV dilatation, biventricular dysfunction, heart failure symptoms, arrhythmias and sudden death. Although pulmonary valve replacement (PVR) can lead to improvement in the functional class and a substantial decrease or normalization of RV volumes, the optimal timing of PVR is not well defined. Benefits of PVR have to be weighed against the risks of this procedure including subsequent reoperation. This article reviews the pathophysiology of chronic PR, evidence-based benefits and risks of PVR, options for valve substitute, and optimal timing of PVR in patients with chronic PR after relief of RV outflow tract obstruction.
C1 Sejong Gen Hosp, Ctr Cardiovasc, Dept Thorac & Cardiovasc Surg, Puchon 422711, South Korea.
RP Lee, C (corresponding author), Sejong Gen Hosp, Ctr Cardiovasc, Dept Thorac & Cardiovasc Surg, 28 Hyohyeon Ro 498 Beon Gil, Puchon 422711, South Korea.
EM tscheul@hanmail.net
RI Lee, Cheul/AAT-2090-2020
OI Lee, Cheul/0000-0002-7772-7035
CR Allen BS, 2002, ANN THORAC SURG, V74, P771, DOI 10.1016/S0003-4975(02)03767-0
   Borger MA, 2006, J HEART VALVE DIS, V15, P49
   Bouzas B, 2005, EUR HEART J, V26, P433, DOI 10.1093/eurheartj/ehi091
   Brown JW, 2007, J THORAC CARDIOV SUR, V133, P1336, DOI 10.1016/j.jtcvs.2006.12.045
   Caldarone CA, 2000, J THORAC CARDIOV SUR, V120, P1022, DOI 10.1067/mtc.2000.110684
   Cheung EWY, 2010, AM J CARDIOL, V106, P552, DOI 10.1016/j.amjcard.2010.03.065
   Dave HH, 2005, ANN THORAC SURG, V80, P1615, DOI 10.1016/j.athoracsur.2005.04.058
   Davlouros PA, 2002, J AM COLL CARDIOL, V40, P2044, DOI 10.1016/S0735-1097(02)02566-4
   Discigil B, 2001, J THORAC CARDIOV SUR, V121, P344, DOI 10.1067/mtc.2001.111209
   Dos L, 2009, J THORAC CARDIOV SUR, V138, P553, DOI 10.1016/j.jtcvs.2009.02.042
   Doughan AR, 2005, AM J CARDIOL, V95, P1511, DOI 10.1016/j.amjcard.2005.01.100
   Fiore AC, 2008, ANN THORAC SURG, V85, P1712, DOI 10.1016/j.athoracsur.2008.02.001
   Frigiola A, 2008, CIRCULATION, V118, pS182, DOI 10.1161/CIRCULATIONAHA.107.756825
   Frigiola A, 2006, EUR J CARDIO-THORAC, V29, pS279, DOI 10.1016/j.ejcts.2006.03.007
   Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8
   GATZOULIS MA, 1995, CIRCULATION, V92, P231, DOI 10.1161/01.CIR.92.2.231
   Gengsakul A, 2007, EUR J CARDIO-THORAC, V32, P462, DOI 10.1016/j.ejcts.2007.06.009
   Geva T, 2004, J AM COLL CARDIOL, V43, P1068, DOI 10.1016/j.jacc.2003.10.045
   Geva T, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-9
   Geva T, 2010, CIRCULATION, V122, pS201, DOI 10.1161/CIRCULATIONAHA.110.951178
   Ghez O, 2007, EUR J CARDIO-THORAC, V31, P654, DOI 10.1016/j.ejcts.2006.12.031
   Harrild DM, 2009, CIRCULATION, V119, P445, DOI 10.1161/CIRCULATIONAHA.108.775221
   Harrison DA, 1997, J AM COLL CARDIOL, V30, P1368, DOI 10.1016/S0735-1097(97)00316-1
   Hawkins JA, 2009, EUR J CARDIO-THORAC, V35, P600, DOI 10.1016/j.ejcts.2008.12.028
   Helbing WA, 1996, J AM COLL CARDIOL, V28, P1827, DOI 10.1016/S0735-1097(96)00387-7
   Helbing WA, 2000, PEDIATR CARDIOL, V21, P70, DOI 10.1007/s002469910009
   Henkens IR, 2007, ANN THORAC SURG, V83, P907, DOI 10.1016/j.athoracsur.2006.09.090
   Kanter KR, 2003, ANN THORAC SURG, V76, P1889, DOI 10.1016/S0003-4975(03)01304-3
   Kanter KR, 2002, ANN THORAC SURG, V73, P1801, DOI 10.1016/S0003-4975(02)03568-3
   Knauth AL, 2008, HEART, V94, P211, DOI 10.1136/hrt.2006.104745
   Konakci KZ, 2005, EUR J CLIN INVEST, V35, P17
   Lee C, 2011, J THORAC CARDIOV SUR, V142, P351, DOI 10.1016/j.jtcvs.2010.12.020
   Lim CO, 2004, EUR J CARDIO-THORAC, V25, P728, DOI 10.1016/j.ejcts.2004.01.036
   Manji RA, 2006, CIRCULATION, V114, P318, DOI 10.1161/CIRCULATIONAHA.105.549311
   McClure RS, 2010, ANN THORAC SURG, V89, P1410, DOI 10.1016/j.athoracsur.2010.01.046
   Morales David L S, 2007, Congenit Heart Dis, V2, P115, DOI 10.1111/j.1747-0803.2007.00083.x
   MURPHY JG, 1993, NEW ENGL J MED, V329, P593, DOI 10.1056/NEJM199308263290901
   Oosterhof T, 2007, CIRCULATION, V116, P545, DOI 10.1161/CIRCULATIONAHA.106.659664
   Oosterhof T, 2006, EUR HEART J, V27, P1478, DOI 10.1093/eurheartj/ehl033
   Park CS, 2010, J HEART VALVE DIS, V19, P124
   Quintessenza JA, 2005, ANN THORAC SURG, V79, P924, DOI 10.1016/j.athoracsur.2004.05.045
   Quintessenza JA, 2009, OPER TECH THORAC CAR, V13, P244
   Quintessenza JA, 2010, WORLD J PEDIATR CONG, V1, P20, DOI 10.1177/2150135110361509
   Rosti L, 1998, J THORAC CARDIOV SUR, V115, P1074, DOI 10.1016/S0022-5223(98)70407-6
   Samyn MM, 2007, J MAGN RESON IMAGING, V26, P934, DOI 10.1002/jmri.21094
   SanchezQuintana D, 1996, HEART, V76, P280, DOI 10.1136/hrt.76.3.280
   Scherptong RWC, 2010, J AM COLL CARDIOL, V56, P1486, DOI 10.1016/j.jacc.2010.04.058
   Silka MJ, 1998, J AM COLL CARDIOL, V32, P245, DOI 10.1016/S0735-1097(98)00187-9
   Stulak JM, 2010, ANN THORAC SURG, V90, P2009, DOI 10.1016/j.athoracsur.2010.07.023
   Therrien J, 2005, AM J CARDIOL, V95, P779, DOI 10.1016/j.amjcard.2004.11.037
   Therrien J, 2001, CIRCULATION, V103, P2489
   Therrien Judith, 2002, Cardiology Clinics, V20, P395
   van de Woestijne PC, 2011, ANN THORAC SURG, V92, P161, DOI 10.1016/j.athoracsur.2011.02.036
   Vliegen HW, 2002, CIRCULATION, V106, P1703, DOI 10.1161/01.CIR.0000030995.59403.F8
   Warnes CA, 2008, CIRCULATION, V118, P2395, DOI 10.1161/CIRCULATIONAHA.108.190811
   Waterbolk TW, 2006, EUR J CARDIO-THORAC, V30, P28, DOI 10.1016/j.ejcts.2006.02.069
   Yemets IM, 1997, ANN THORAC SURG, V64, P526, DOI 10.1016/S0003-4975(97)00577-8
NR 57
TC 9
Z9 9
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2012
VL 42
IS 1
BP 1
EP 7
DI 10.4070/kcj.2012.42.1.1
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IF
UT WOS:000209079400001
PM 22363376
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SH
AF Kim, Seong-Ho
TI Pulmonary Artery Stents-Still "Off Label"
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Cheju Halla Gen Hosp, Dept Pediat, Cheju 690766, South Korea.
RP Kim, SH (corresponding author), Cheju Halla Gen Hosp, Dept Pediat, 65 Doryeong Ro, Cheju 690766, South Korea.
EM shkim24926@hanmail.net
CR Breinholt JP, 2008, CATHETER CARDIO INTE, V72, P977, DOI 10.1002/ccd.21742
   FOGELMAN R, 1995, CIRCULATION, V92, P881, DOI 10.1161/01.CIR.92.4.881
   Ko HK, 2012, KOREAN CIRC J, V42, P40, DOI 10.4070/kcj.2012.42.1.40
   Law MA, 2010, CATHETER CARDIO INTE, V75, P757, DOI 10.1002/ccd.22356
   McMahon CJ, 2001, J AM COLL CARDIOL, V38, P521, DOI 10.1016/S0735-1097(01)01406-1
   OLAUGHLIN MP, 1993, CIRCULATION, V88, P605, DOI 10.1161/01.CIR.88.2.605
   Shaffer KM, 1998, J AM COLL CARDIOL, V31, P661, DOI 10.1016/S0735-1097(97)00535-4
   Stanfill R, 2008, CATHETER CARDIO INTE, V71, P831, DOI 10.1002/ccd.21526
   Stapleton GE, 2009, CATHETER CARDIO INTE, V73, P557, DOI 10.1002/ccd.21838
   Tomita H, 2010, CIRC J, V74, P1676, DOI 10.1253/circj.CJ-10-0157
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2012
VL 42
IS 1
BP 8
EP 9
DI 10.4070/kcj.2012.42.1.8
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IF
UT WOS:000209079400002
PM 22363377
OA Green Published
DA 2021-04-22
ER

PT J
AU Kimm, H
   Yun, JE
   Lee, SH
   Jang, Y
   Jee, SH
AF Kimm, Heejin
   Yun, Ji Eun
   Lee, Sang-Hak
   Jang, Yangsoo
   Jee, Sun Ha
TI Validity of the Diagnosis of Acute Myocardial Infarction in Korean
   National Medical Health Insurance Claims Data: The Korean Heart Study
   (1)
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Acute myocardial infarction; Validity; Reliability; International
   Classification of Diseases
AB Background and Objectives: Medical insurance claims (MIC) data are one of the largest sources of outcome data in the form of International Classification of Diseases (ICD) codes. We evaluated the validity of the ICD codes from the Korean National MIC data with respect to the outcomes from acute myocardial infarction (AMI) in the Korean Heart Study.
   Subjects and Methods: Baseline information was obtained from health examinations conducted from 1994 to 2001. Outcome information regarding the incidence of AMI came from hospital admission discharge records from 1994 to 2007. Structured questionnaires were sent to 98 hospitals. In total, 107 cases of AMI with ICD codes of I21-(93 men, 26-73 years of age) were included in the final analyses. ICD code accuracy and reliability (kappa) for AMI were calculated.
   Results: A large number of AMI cases were from hospitals located in the Seoul area (75.9%). The accuracy of AMI was 71.4%, according to World Health Organization criteria (1997-2000, n= 24, kappa= 0.46) and 73.1% according to the European Society of Cardiology/American College of Cardiology (ESC/ACC) criteria (2001-2007, n= 83, kappa= 0.74). An age of 50 years or older was the only factor related to inaccuracy of codes for AMI (odds ratio, 4.6; 95% confidence interval, 1.2-17.7) in patients diagnosed since January 2001 using ESC/ACC criteria (n= 83).
   Conclusion: The accuracy for diagnosing AMI using the ICD-10 codes in Korean MIC data was > 70%, and reliability was fair to good; however, more attention is required for recoding ICD codes in older patients.
C1 [Kimm, Heejin; Yun, Ji Eun; Lee, Sang-Hak; Jang, Yangsoo; Jee, Sun Ha] Yonsei Univ, Cardiovasc Genome Ctr, Inst Hlth Promot, Seoul 120752, South Korea.
RP Jang, Y (corresponding author), Yonsei Univ, Cardiovasc Genome Ctr, Inst Hlth Promot, 50 Yonsei Ro, Seoul 120752, South Korea.
EM Jangys1212@yuhs.ac
OI Jang, Yangsoo/0000-0002-2169-3112; Jee, Sun Ha/0000-0001-9519-3068;
   Kimm, Heejin/0000-0003-4526-0570
FU Seoul R & BD Program, Republic of KoreaSeoul RBD program [10526]; Korea
   Healthcare Technology R & D Project, Ministry for Health, Welfare, and
   Family Affairs, Republic of Korea [A000385]; Pfizer Inc.Pfizer
FX This study was supported by a grant from the Seoul R & BD Program,
   Republic of Korea (10526), a grant from the Korea Healthcare Technology
   R & D Project, Ministry for Health, Welfare, and Family Affairs,
   Republic of Korea (A000385), and Pfizer Inc.
CR Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4
   김동희, 2008, Korean Circulation Journal, V38, P29
   FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243
   FLEISS JL, 1986, DESIGN ANAL CLIN EXP, P2
   GREENFIELD S, 1988, JAMA-J AM MED ASSOC, V260, P2253, DOI 10.1001/jama.260.15.2253
   Hochholzer W, 2008, AM J MED, V121, P399, DOI 10.1016/j.amjmed.2008.01.033
   Hong Jae Seok, 2009, Korean Circ J, V39, P467, DOI 10.4070/kcj.2009.39.11.467
   HSIA DC, 1992, JAMA-J AM MED ASSOC, V268, P896, DOI 10.1001/jama.268.7.896
   HSIA DC, 1988, NEW ENGL J MED, V318, P352, DOI 10.1056/NEJM198802113180604
   IEZZONI LI, 1986, JAMA-J AM MED ASSOC, V255, P927
   IEZZONI LI, 1988, ANN INTERN MED, V109, P745, DOI 10.7326/0003-4819-109-9-745
   Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017
   JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P2240, DOI 10.1001/jama.260.15.2240
   Kim HC, 2005, STROKE, V36, P1642, DOI 10.1161/01.STR.0000173404.37692.9b
   Kim J. W., 2005, DIABETES KOREA, V1, P42
   김학진, 2007, Korean Circulation Journal, V37, P609
   Park JK., 2000, KOREAN J PREV MED, V33, P76
   Rawson NSB, 1995, STAT MED, V14, P2627, DOI 10.1002/sim.4780142404
   Stausberg J, 2008, INT J MED INFORM, V77, P50, DOI 10.1016/j.ijmedinf.2006.11.005
   Surjan G, 1999, INT J MED INFORM, V54, P77, DOI 10.1016/S1386-5056(98)00171-3
   TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583
   Watzlaf V J, 1987, Top Health Rec Manage, V7, P61
   World Health Organization, 1992, INT CLASS DIS REL HL
NR 23
TC 74
Z9 74
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2012
VL 42
IS 1
BP 10
EP 15
DI 10.4070/kcj.2012.42.1.10
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IF
UT WOS:000209079400003
PM 22363378
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, SY
   Ahn, YG
   Jeong, MH
AF Hwang, Seon Young
   Ahn, Young Geun
   Jeong, Myung Ho
TI Atypical Symptom Cluster Predicts a Higher Mortality in Patients With
   First-Time Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Acute myocardial infarction; Acute coronary syndrome; Symptom; Cluster
   analysis
AB Background and Objectives: Identifying symptom clusters of acute myocardial infarction (AMI) and their clinical significance may be useful in guiding treatment seeking behaviors and in planning treatment strategy. The aim of this study was to identify clusters of acute symptoms and their associated factors that manifested in patients with first-time AMI, and to compare clinical outcomes among cluster groups within 1-year of follow-up.
   Subjects and Methods: A total of 391 AMI patients were interviewed individually using a structured questionnaire for acute and associated symptoms between March 2008 and June 2009 in Korea.
   Results: Among 14 acute symptoms, three distinct clusters were identified by Latent Class Cluster Analysis: typical chest symptom (57.0%), multiple symptom (27.9%), and atypical symptom (15.1%) clusters. The cluster with atypical symptoms was characterized by the least chest pain (3.4%) and moderate frequencies (31-61%) of gastrointestinal symptoms, weakness or fatigue, and shortness of breath; they were more likely to be older, diabetic and to have worse clinical markers at hospital presentation compared with those with other clusters. Cox proportional hazards regression analysis showed that, when age and gender were adjusted for, the atypical symptom cluster significantly predicted a higher risk of 1-year mortality compared to the typical chest pain cluster (hazard ratio 3.288, 95% confidence interval 1.087-9.943, p= 0.035).
   Conclusion: Clusters of symptoms can be utilized in guiding a rapid identification of symptom patterns and in detecting higher risk patients. Intensive treatment should be considered for older and diabetic patients with atypical presentation.
C1 [Hwang, Seon Young] Chosun Univ, Coll Med, Dept Nursing, Kwangju 501759, South Korea.
   [Ahn, Young Geun; Jeong, Myung Ho] Chonnam Natl Univ, Coll Med, Dept Cardiol, Kwangju, South Korea.
RP Hwang, SY (corresponding author), Chosun Univ, Coll Med, Dept Nursing, 309 Pilmun Daero, Kwangju 501759, South Korea.
EM seon9772@chosun.ac.kr
FU Chosun University
FX This study was sponsored by research fund from Chosun University, 2011.
CR Barsevick AM, 2006, J PAIN SYMPTOM MANAG, V31, P85, DOI 10.1016/j.jpainsymman.2005.05.015
   Berg J, 2009, GENDER MED, V6, P454, DOI 10.1016/j.genm.2009.09.007
   Brieger D, 2004, CHEST, V126, P461, DOI 10.1378/chest.126.2.461
   Canto JG, 2000, JAMA-J AM MED ASSOC, V283, P3223, DOI 10.1001/jama.283.24.3223
   Dodd M, 2001, J ADV NURS, V33, P668, DOI 10.1046/j.1365-2648.2001.01697.x
   Fraley C, 1998, COMPUT J, V41, P578, DOI 10.1093/comjnl/41.8.578
   Fukuoka Y, 2007, QUAL LIFE RES, V16, P1655, DOI 10.1007/s11136-007-9272-7
   Horne R, 2000, HEART, V83, P388, DOI 10.1136/heart.83.4.388
   Hwang SY, 2009, J KOREAN ACAD NURS, V39, P888, DOI 10.4040/jkan.2009.39.6.888
   Hwang SY, 2009, J KOREAN MED SCI, V24, P789, DOI 10.3346/jkms.2009.24.5.789
   Leslie WS, 2000, HEART, V84, P137, DOI 10.1136/heart.84.2.137
   Lindgren TG, 2008, NURS RES, V57, P14, DOI 10.1097/01.NNR.0000280654.50642.1a
   McSweeney JC, 2010, J CARDIOVASC NURS, V25, P311, DOI 10.1097/JCN.0b013e3181cfba15
   Miaskowski Christine, 2004, J Natl Cancer Inst Monogr, P17
   Milner KA, 2001, NURS RES, V50, P233, DOI 10.1097/00006199-200107000-00007
   Moser DK, 2006, CIRCULATION, V114, P168, DOI 10.1161/CIRCULATIONAHA.106.176040
   Riegel B, 2010, AM HEART J, V159, P392, DOI 10.1016/j.ahj.2010.01.003
   Ryan CJ, 2007, NURS RES, V56, P72, DOI 10.1097/01.NNR.0000263968.01254.d6
   Then KL, 2001, HEART LUNG, V30, P285, DOI 10.1067/mhl.2001.116010
   Thuresson M, 2007, HEART LUNG, V36, P398, DOI 10.1016/j.hrtlng.2007.02.001
   Vermunt J, 2000, LATENT GOLD USERS GU
NR 21
TC 13
Z9 15
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2012
VL 42
IS 1
BP 16
EP 22
DI 10.4070/kcj.2012.42.1.16
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IF
UT WOS:000209079400004
PM 22363379
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, KJ
   Kim, YJ
   Kim, J
   Kim, SM
   Lee, SY
   Bae, JW
   Hwang, KK
   Kim, DW
   Cho, MC
AF Park, Keon-Jae
   Kim, Yeon-Jeong
   Kim, Jeongeun
   Kim, Sang Min
   Lee, Sang Yeub
   Bae, Jang-Whan
   Hwang, Kyung-Kuk
   Kim, Dong-Woon
   Cho, Myeong-Chan
TI Protective Effects of Peroxiredoxin on Hydrogen Peroxide Induced
   Oxidative Stress and Apoptosis in Cardiomyocytes
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Peroxiredoxins; Myocytes, cardiac; Oxidative stress; Apoptosis
AB Background and Objectives: The redox system is an important anti-oxidative system composed of thioredoxin, thioredoxin reductase, and peroxiredoxin (PRx). The fine details of PRx expression and its protective effects in various cells in cardiovascular tissue under oxidative stress created by hydrogen peroxide have not been fully elucidated.
   Subjects and Methods: Oxidative stress was induced by adding hydrogen peroxide at 0.25 mM for 2 hours to rat neonatal cardiomyocytes (rCMCs), rat vascular smooth muscle cells (rVSMCs), and human umbilical vein endothelial cells (HUVECs). Apoptosis was quantified by flow cytometry and the expression patterns of the six PRx isoforms were evaluated by western blotting in the three cell lines after hydrogen peroxide stimulation. Apoptosis and the cell survival signal pathway were evaluated by PRx1 gene delivery using lentiviral vector in hydrogen peroxide stimulated rCMCs versus green fluorescence protein gene delivery.
   Results: Hydrogen peroxide induced 25% apoptosis in rCMCs. Furthermore, the PRx1 and 5 isoforms were found to be overexpressed in hydrogen peroxide treated rCMCs, and PRx1 overexpression by gene delivery was found to reduce hydrogen peroxide induced rCMCs apoptosis significantly. In addition, this effect was found to originate from cell survival pathway modification.
   Conclusion: Hydrogen peroxide induced significant oxidative stress in rCMCs, rVSMCs, and HUVECs, and PRx1 overexpression using a lentiviral vector system significantly reduced hydrogen peroxide induced rCMCs apoptosis by upregulation of cell survival signals and down-regulation of apoptotic signals. These findings suggest that PRx1 could be used as a treatment strategy for myocardial salvage in conditions of oxidative stress.
C1 [Park, Keon-Jae; Kim, Yeon-Jeong; Kim, Jeongeun; Kim, Sang Min; Lee, Sang Yeub; Bae, Jang-Whan; Hwang, Kyung-Kuk; Kim, Dong-Woon; Cho, Myeong-Chan] Chungbuk Natl Univ, Sch Med, Reg Cardiovasc Dis Ctr, Dept Internal Med, Cheongju 361763, South Korea.
RP Bae, JW (corresponding author), Chungbuk Natl Univ, Sch Med, Reg Cardiovasc Dis Ctr, Dept Internal Med, 62 Gaesin Dong, Cheongju 361763, South Korea.
EM drcorazon@hanmail.net
RI Kim, Dong Woon/W-8254-2018
OI Kim, Dong Woon/0000-0001-7691-1394
FU Korean Society of Cardiology
FX This study was supported by a research grant from the Korean Society of
   Cardiology in 2008. We cordially appreciate Pf. Seung-Taik Kim in
   Chungbuk National University Hospital for providing us with the
   lentiviral vector construct.
CR Boersma E, 2003, LANCET, V361, P847, DOI 10.1016/S0140-6736(03)12712-2
   Byrne JA, 2003, ARCH MAL COEUR VAISS, V96, P214
   CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017
   Chen HW, 2002, BRIT J PHARMACOL, V137, P771, DOI 10.1038/sj.bjp.0704908
   Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x
   Ferrari R, 2004, CURR PHARM DESIGN, V10, P1699, DOI 10.2174/1381612043384718
   Hirotsu S, 1999, P NATL ACAD SCI USA, V96, P12333, DOI 10.1073/pnas.96.22.12333
   Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040
   HOSHI H, 1984, P NATL ACAD SCI-BIOL, V81, P6413, DOI 10.1073/pnas.81.20.6413
   Izumi Y, 2005, ARTERIOSCL THROM VAS, V25, P1877, DOI 10.1161/01.ATV.0000174801.76234.bd
   Kau TR, 2003, CANCER CELL, V4, P463, DOI 10.1016/S1535-6108(03)00303-9
   Kevin LG, 2005, ANESTH ANALG, V101, P1275, DOI 10.1213/01.ANE.0000180999.81013.D0
   Kobayashi S, 2006, FASEB J, V20, P800, DOI 10.1096/fj.05-5426fje
   Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96
   Misra MK, 2009, MED SCI MONITOR, V15, pRA209
   Park Keon-Jae, 2010, Korean Circ J, V40, P651, DOI 10.4070/kcj.2010.40.12.651
   Penna C, 2008, BASIC RES CARDIOL, V103, P368, DOI 10.1007/s00395-007-0695-7
   Poindexter BJ, 2001, CELL CALCIUM, V30, P373, DOI 10.1054/ceca.2001.0249
   PROSPERI MT, 1993, J BIOL CHEM, V268, P11050
   Saraste A, 1997, CIRCULATION, V95, P320
   Tuteja N, 2001, CRIT REV BIOCHEM MOL, V36, P261, DOI 10.1080/20014091074192
   Tuteja N, 2001, CRIT REV BIOCHEM MOL, V36, P337, DOI 10.1080/20014091074219
   Tuteja N, 2009, MUTAT RES-REV MUTAT, V681, P134, DOI 10.1016/j.mrrev.2008.06.004
   Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8
   Zeng LB, 2006, J GENE MED, V8, P18, DOI 10.1002/jgm.825
   Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001
   ZWEIER JL, 1987, P NATL ACAD SCI USA, V84, P1404, DOI 10.1073/pnas.84.5.1404
NR 27
TC 18
Z9 25
U1 1
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2012
VL 42
IS 1
BP 23
EP 32
DI 10.4070/kcj.2012.42.1.23
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IF
UT WOS:000209079400005
PM 22363380
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, WH
   Park, HW
   Kim, KH
   Song, IG
   Yang, DJ
   Lee, CS
   Seo, YH
   Kwon, TG
   Bae, JH
AF Kim, Wan Ho
   Park, Hyun Woong
   Kim, Ki Hong
   Song, In Girl
   Yang, Dong Ju
   Lee, Chung Seop
   Seo, Young Hoon
   Kwon, Taek Geun
   Bae, Jang-Ho
TI Fibro-Fatty Component is Important for the Long-Term Clinical Events in
   Patients Who Have Undergone Primary Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Intravascular ultrasonography; Myocardial infarction; Disease-free
   survival
AB Background and Objectives: We evaluated which plaque components are associated with long-term clinical events in patients who underwent primary percutaneous coronary intervention (PCI).
   Subjects and Methods: The study subjects consisted of 57 consecutive patients (mean age, 58.5 +/- 14.5 years; 45 males) who underwent primary PCI and a virtual histology-intravascular ultrasound examination. Major adverse cardiac events (MACEs) including death, acute myocardial infarction, stroke, and revascularization were evaluated during the mean 28 month follow-up period.
   Results: Patients with high fibro-fatty volume (FFV > 13.4 mm(3), n= 29; mean age, 61.3 years) had a lower ejection fraction (52.7% vs. 59.4%, p= 0.022), a higher incidence of multi-vessel disease (69.0% vs. 28.6%, p= 0.002), larger plaque area (25.7 mm(2) vs. 15.9 mm(2), p< 0.001), and larger plaque volume (315 mm(3) vs. 142 mm(3), p< 0.001) than those with a low FFV (= 13.4 mm(3), n= 28; mean age, 55.6 years). Patients with high FFV had a significantly higher incidence (32.1% vs. 8.3%, p= 0.036) of MACE than those with low FFV. When we divided the study population according to the necrotic core volume (NCV), fibrous volume, or dense calcified volume, no significant findings in terms of demographics and MACE rates were observed. A Cox regression analysis revealed that the independent factor for MACE was FFV (hazard ratio, 6.748; 95% confidence interval, 1.168-38.971, p= 0.033) in this study population.
   Conclusion: The coronary plaque component, particularly FFV, but not NCV, was important in long-term clinical outcomes in patients who underwent primary PCI.
C1 [Kim, Wan Ho; Park, Hyun Woong; Kim, Ki Hong; Song, In Girl; Yang, Dong Ju; Lee, Chung Seop; Seo, Young Hoon; Kwon, Taek Geun; Bae, Jang-Ho] Konyang Univ, Coll Med, Div Cardiol, Taejon 302718, South Korea.
RP Bae, JH (corresponding author), Konyang Univ, Coll Med, Div Cardiol, 685 Gasuwon Dong, Taejon 302718, South Korea.
EM janghobae@yahoo.co.kr
OI Seo, Young Hoon/0000-0002-7357-2785
CR Bae JH, 2008, HEART, V94, P1559, DOI 10.1136/hrt.2007.135822
   Bose D, 2008, BASIC RES CARDIOL, V103, P587, DOI 10.1007/s00395-008-0745-9
   de Gouveia RH, 2002, EUR HEART J, V23, P1433, DOI 10.1053/euhj.2002.3159
   Fujii K, 2005, AM J CARDIOL, V96, P1476, DOI 10.1016/j.amjcard.2005.07.054
   Higashikuni Y, 2008, CIRC J, V72, P1235, DOI 10.1253/circj.72.1235
   Hong MK, 2007, AM J CARDIOL, V100, P953, DOI 10.1016/j.amjcard.2007.04.034
   Hong YJ, 2011, EUR HEART J, V32, P2059, DOI 10.1093/eurheartj/ehp034
   Kataoka T, 2009, JACC-CARDIOVASC IMAG, V2, P327, DOI 10.1016/j.jcmg.2008.08.008
   Kawaguchi R, 2007, J AM COLL CARDIOL, V50, P1641, DOI 10.1016/j.jacc.2007.06.051
   Kawamoto T, 2007, J AM COLL CARDIOL, V50, P1635, DOI 10.1016/j.jacc.2007.05.050
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Missel E, 2008, AM J CARDIOL, V101, P573, DOI 10.1016/j.amjcard.2007.10.018
   Murakami T, 1998, AM J CARDIOL, V82, P839, DOI 10.1016/S0002-9149(98)00489-5
   Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E
   Nakamura Tomohiro, 2007, J Interv Cardiol, V20, P335, DOI 10.1111/j.1540-8183.2007.00282.x
   Nasu K, 2006, J AM COLL CARDIOL, V47, P2405, DOI 10.1016/j.jacc.2006.02.044
   Ramirez-Moreno A, 2004, INT J CARDIOL, V97, P193, DOI 10.1016/j.ijcard.2003.07.031
   Resnic FS, 2003, AM HEART J, V145, P42, DOI 10.1067/mhj.2003.36
   Rodriguez-Granillo GA, 2006, HEART, V92, P388, DOI 10.1136/hrt.2004.057810
   Rodriguez-Granillo GA, 2006, AM HEART J, V151, P1020, DOI 10.1016/j.ahj.2005.06.040
   Surmely JF, 2007, HEART, V93, P928, DOI 10.1136/hrt.2006.102111
   TOBIS JM, 1991, CIRCULATION, V83, P913, DOI 10.1161/01.CIR.83.3.913
   Virmani Renu, 2002, J Interv Cardiol, V15, P439, DOI 10.1111/j.1540-8183.2002.tb01087.x
   Yip HK, 2002, CHEST, V122, P1322, DOI 10.1378/chest.122.4.1322
NR 24
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2012
VL 42
IS 1
BP 33
EP 39
DI 10.4070/kcj.2012.42.1.33
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IF
UT WOS:000209079400006
PM 22363381
OA Green Published
DA 2021-04-22
ER

PT J
AU Ko, HK
   Kim, YH
   Yu, JJ
   Ko, JK
   Park, IS
   Seo, DM
   Yun, TJ
   Park, JJ
   Jang, WS
AF Ko, Hong Ki
   Kim, Young-Hwue
   Yu, Jeong Jin
   Ko, Jae-Kon
   Park, In-Sook
   Seo, Dong-Man
   Yun, Tae-Jin
   Park, Jeong-Jun
   Jang, Wan Sook
TI Effectiveness and Safety of Percutaneous Transcatheter Implantation of
   Pulmonary Arterial Stent in Congenital Heart Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Congenital heart disease; Catheterization
AB Background and Objectives: Pulmonary arterial stenosis is a relatively common complication after corrective operation of congenital heart disease. Unilateral stenosis of pulmonary arteries could result in decrease perfusion of affected lung, pulmonary regurgitation, or elevation of right ventricular pressure. Eventually there are increasing risks of right ventricular failure, arrhythmia, or sudden death. However we have limited data of pulmonary arterial stent in paediatric population as the treatment of branch pulmonary stenosis. This study aimed at validating the effectiveness and investigating complications of pulmonary arterial stent implantation in a single institution during mid-term follow up period.
   Subjects and Methods: A total of 42 patients (50 stents) were implanted for treating branch pulmonary arterial stenosis. We used cardiac catheterization for comparing diameter after stent implantation directly and lung perfusion scan indirectly. We also investigated any adverse effect relating the procedure.
   Results: Percent stenosis of stenotic lesions were decreased from 54.1+/-10.7% to 22.8+/-12.5% (p< 0.001) and degree of decrement in affected lung perfusion was declined from 22.7+/-8.0% to 10.3+/-9.0% (p< 0.001) immediately and lasts during mid-term follow up period. Complication rate relating the procedure was 12% (6 out of 12) and there was no mortality case.
   Conclusion: This series showed immediate and short term effectiveness of pulmonary arterial stent in congenital heart defects. We concluded that percutaneous transcatheter implantation of pulmonary arterial stent was safe and effective during short and mid-term follow up period.
C1 [Ko, Hong Ki; Kim, Young-Hwue; Yu, Jeong Jin; Ko, Jae-Kon; Park, In-Sook; Jang, Wan Sook] Ulsan Unvers, Coll Med, Asan Med Ctr, Dept Pediat Cardiol, Seoul 138736, South Korea.
   [Seo, Dong-Man; Yun, Tae-Jin; Park, Jeong-Jun] Ulsan Unvers, Coll Med, Asan Med Ctr, Dept Pediat Cardiac Surg, Seoul 138736, South Korea.
RP Kim, YH (corresponding author), Ulsan Unvers, Coll Med, Asan Med Ctr, Dept Pediat Cardiol, 88 Olympic Ro 43-Gil, Seoul 138736, South Korea.
EM yhkim@amc.seoul.kr
OI Seo, Dong Man/0000-0002-5831-7954
CR Ashwath R, 2008, PEDIATR CARDIOL, V29, P562, DOI 10.1007/s00246-007-9141-8
   Breinholt JP, 2008, CATHETER CARDIO INTE, V72, P977, DOI 10.1002/ccd.21742
   Chaturvedi RR, 1997, CIRCULATION, V95, P643, DOI 10.1161/01.CIR.95.3.643
   FOGELMAN R, 1995, CIRCULATION, V92, P881, DOI 10.1161/01.CIR.92.4.881
   Forbes TJ, 2003, CATHETER CARDIO INTE, V59, P406, DOI 10.1002/ccd.10547
   Hellenbrand W E, 1988, Cardiol Clin, V6, P421
   Latson LA, 1997, CLIN PEDIATR, V36, P125, DOI 10.1177/000992289703600301
   Latson LA, 2010, CATHETER CARDIO INTE, V75, P765, DOI 10.1002/ccd.22523
   Law MA, 2010, CATHETER CARDIO INTE, V75, P757, DOI 10.1002/ccd.22356
   Li Fen, 2009, Zhonghua Er Ke Za Zhi, V47, P255
   Maglione J, 2009, CIRC-CARDIOVASC INTE, V2, P52, DOI 10.1161/CIRCINTERVENTIONS.108.826263
   Moszura T, 2010, CARDIOL J, V17, P149
   MULLINS CE, 1988, CIRCULATION, V77, P188, DOI 10.1161/01.CIR.77.1.188
   OYEN WJG, 1995, J NUCL MED, V36, P2006
   Petit CJ, 2009, J THORAC CARDIOV SUR, V138, P382, DOI 10.1016/j.jtcvs.2009.02.030
   Rath P C, 1986, J Assoc Physicians India, V34, P199
   Recto MR, 2001, CATHETER CARDIO INTE, V53, P499, DOI 10.1002/ccd.1209
   Rutledge JM, 2002, CATHETER CARDIO INTE, V56, P541, DOI 10.1002/ccd.10251
   Tomita H, 2010, CIRC J, V74, P1676, DOI 10.1253/circj.CJ-10-0157
NR 19
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2012
VL 42
IS 1
BP 40
EP 45
DI 10.4070/kcj.2012.42.1.40
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IF
UT WOS:000209079400007
PM 22363382
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, JS
   Her, SH
   Park, MW
   Kim, HD
   Baek, JY
   Youn, HJ
   Seung, KB
   Kim, JH
AF Cho, Jung Sun
   Her, Sung-Ho
   Park, Mahn-Won
   Kim, Hyoung Doo
   Baek, Ju Yeal
   Youn, Ho-Joong
   Seung, Ki-Bae
   Kim, Jae-Hyung
TI A Butterfly-Shaped Primary Cardiac Lymphoma That Showed Bi-Atrial
   Involvement
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Lymphoma; Large B-cell, diffuse; Cardiac tumor; Heart atria; Pericardium
AB We described here a patient who presented with symptoms of heart failure who was found to have severe bilateral impairment of atrioventricular inflow. Primary cardiac lymphoma (PCL) with extensive involvement of the two atria, pericardium and myocardium is an extremely rare tumor in immunocompetent patients. We report here a case of PCL in an immunocompetent patient with involvement of both atria and the atrial septum. The tumor had a butterfly shape. We could not do surgical excision because of the massive pericardiac invasion. The diagnosis was B-cell lymphoma and this was confirmed by the pericardiac biopsy.
C1 [Cho, Jung Sun; Her, Sung-Ho; Park, Mahn-Won; Kim, Hyoung Doo; Baek, Ju Yeal; Youn, Ho-Joong; Seung, Ki-Bae; Kim, Jae-Hyung] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea.
RP Her, SH (corresponding author), Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Internal Med, 520-2 Daeheung Dong, Taejon 301723, South Korea.
EM hhhsungho@hanmail.net
CR Antoniades L, 2009, ECHOCARDIOGR-J CARD, V26, P214, DOI 10.1111/j.1540-8175.2008.00757.x
   Chalabreysse L, 2002, VIRCHOWS ARCH, V441, P456, DOI 10.1007/s00428-002-0711-0
   CHAO TY, 1995, ACTA CYTOL, V39, P955
   Fujita Y, 2009, CIRC J, V73, P967, DOI 10.1253/circj.CJ-08-0064
   Ikeda H, 2004, PATHOL INT, V54, P187, DOI 10.1111/j.1440-1827.2003.01606.x
   Jurkovich D, 2000, CATHETER CARDIO INTE, V50, P226, DOI 10.1002/(SICI)1522-726X(200006)50:2<226::AID-CCD19>3.0.CO;2-A
   Kim JY, 2004, KOREAN CIRC J, V34, P808
   LAM KY, 1993, ARCH PATHOL LAB MED, V117, P1027
   Lucas EMT, 2004, CARDIOVASC INTER RAD, V27, P190, DOI 10.1007/s00270-003-2680-3
   MCALLISTER HA, 1978, TUMORS CARDIOVASCULA, P99
   Mejhert M, 2000, SCAND CARDIOVASC J, V34, P606
   MONSUEZ JJ, 1991, EUR HEART J, V12, P464, DOI 10.1093/oxfordjournals.eurheartj.a059918
   MOORE JA, 1992, AM HEART J, V124, P514, DOI 10.1016/0002-8703(92)90623-4
   Nascimento AF, 2007, AM J SURG PATHOL, V31, P1344, DOI 10.1097/PAS.0b013e3180317341
   Saotome M, 2002, ANGIOLOGY, V53, P239, DOI 10.1177/000331970205300218
   SOMERS K, 1960, CANCER, V13, P449, DOI 10.1002/1097-0142(196005/06)13:3<449::AID-CNCR2820130306>3.0.CO;2-V
   YUH DD, 1994, J HEART LUNG TRANSPL, V13, P538
NR 17
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2012
VL 42
IS 1
BP 46
EP 49
DI 10.4070/kcj.2012.42.1.46
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IF
UT WOS:000209079400008
PM 22363383
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, KY
   Kang, TS
AF Jung, Kyong Yeun
   Kang, Tae Soo
TI A Case of Acute Myocardial Infarction With ST-Segment Elevation in a
   Lead Augmented Right Vector Caused by a Left Main Coronary Artery
   Vasospasm
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery vasospasm; Electrocardiography; Acute coronary syndrome
AB Diagnosing and selecting an appropriate treatment strategy for left main coronary artery (LMCA) obstruction is very important. Although this disease is not frequently encountered, it can cause severe hemodynamic deterioration resulting in a less favorable prognosis without a suitable management approach. Another aspect of LMCA that we must not overlook is coronary artery spasm, which can be an infrequent but important cause of acute coronary syndrome. Although it is rare, LMCA can cause critical complications. In this study, we report the case of a 35-year-old female who was admitted to the hospital with a diagnosis of acute myocardial infarction with ST-segment elevation in the aVR lead caused by a left main coronary spasm that was examined on intravascular ultrasound.
C1 [Jung, Kyong Yeun; Kang, Tae Soo] Dankook Univ, Coll Med, Dept Internal Med, Div Cardiovasc Med, Cheonan 330715, South Korea.
RP Kang, TS (corresponding author), Dankook Univ, Coll Med, Dept Internal Med, Div Cardiovasc Med, 16-5 Anseo Dong, Cheonan 330715, South Korea.
EM neosoo70@dankook.ac.kr
CR Barrabes JA, 2003, CIRCULATION, V108, P814, DOI 10.1161/01.CIR.0000084553.92734.83
   Duygu H, 2008, CLIN CARDIOL, V31, P179, DOI 10.1002/clc.20166
   Edris A, 2010, CATHETER CARDIO INTE, V76, P304, DOI 10.1002/ccd.22462
   Engelen DJ, 1999, J AM COLL CARDIOL, V34, P389, DOI 10.1016/S0735-1097(99)00197-7
   Kosuge M, 2006, AM J CARDIOL, V97, P334, DOI 10.1016/j.amjcard.2005.08.049
   Kosuge M, 2005, AM J CARDIOL, V95, P1366, DOI 10.1016/j.amjcard.2005.01.085
   KUGA T, 1993, CIRCULATION, V87, P573, DOI 10.1161/01.CIR.87.2.573
   Nikus KC, 2008, J ELECTROCARDIOL, V41, P626, DOI 10.1016/j.jelectrocard.2008.06.020
   NOBUYOSHI M, 1991, J AM COLL CARDIOL, V18, P904, DOI 10.1016/0735-1097(91)90745-U
   Ong P, 2008, J AM COLL CARDIOL, V52, P523, DOI 10.1016/j.jacc.2008.04.050
   Wakabayashi K, 2008, J AM COLL CARDIOL, V52, P518, DOI 10.1016/j.jacc.2008.01.076
   Yamaji H, 2001, J AM COLL CARDIOL, V38, P1348, DOI 10.1016/S0735-1097(01)01563-7
NR 12
TC 3
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2012
VL 42
IS 1
BP 50
EP 53
DI 10.4070/kcj.2012.42.1.50
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IF
UT WOS:000209079400009
PM 22363384
OA Green Published
DA 2021-04-22
ER

PT J
AU Shin, HS
   Kang, TS
AF Shin, Hyun-Sung
   Kang, Tae Soo
TI A Case of Late Stent Thrombosis Following Platelet Transfusion in a
   Patient With Aplastic Anemia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Stent; Thrombosis; Platelet transfusion; Aplastic, anemia
AB Aplastic anemia is a condition in which the bone marrow fails to produce adequate numbers of peripheral blood elements. The incidences of atherosclerosis and myocardial infarction in patients with congenital coagulation disorders and chronic thrombocytopenia are very low. In this paper, a case of late stent thrombosis within a drug-eluting stent occurring after platelet transfusion in a patient with aplastic anemia is presented. The authors' observations emphasize the risks of platelet transfusion and the authors' support withholding such a treatment unless vitally indicated, in patients with coronary artery stent implantation and even in those on dual antiplatelet therapy.
C1 [Shin, Hyun-Sung; Kang, Tae Soo] Dankook Univ, Coll Med, Dept Internal Med, Div Cardiovasc Med, Cheonan 330715, South Korea.
RP Kang, TS (corresponding author), Dankook Univ, Coll Med, Dept Internal Med, Div Cardiovasc Med, 16-5 Anseo Dong, Cheonan 330715, South Korea.
EM neosoo70@dankook.ac.kr
CR Anderson D, 2007, TRANSFUS MED REV, V21, pS9, DOI 10.1016/j.tmrv.2007.01.001
   Andrade J, 2008, CAN J CARDIOL, V24, pE25, DOI 10.1016/S0828-282X(08)70186-7
   Cornet Alexander D, 2007, J Invasive Cardiol, V19, pE297
   Emerson GG, 2002, PHARMACOTHERAPY, V22, P1638, DOI 10.1592/phco.22.17.1638.34125
   Fisher M, 1996, BRIT J CLIN PRACT, V50, P222
   JUHANVAGUE I, 1993, THROMB HAEMOSTASIS, V70, P138
   Mendez TC, 2004, REV ESP CARDIOL, V57, P789, DOI 10.1157/13064833
   Paolini R, 2000, AM J HEMATOL, V65, P177, DOI 10.1002/1096-8652(200010)65:2<177::AID-AJH17>3.0.CO;2-K
   Sabovic M, 2003, HEART VESSELS, V18, P47, DOI 10.1007/s003800300008
   TOYAMA M, 1994, JPN HEART J, V35, P369
   URANO T, 1990, THROMB HAEMOSTASIS, V63, P82
NR 11
TC 7
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2012
VL 42
IS 1
BP 54
EP 57
DI 10.4070/kcj.2012.42.1.54
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IF
UT WOS:000209079400010
PM 22363385
OA Green Published
DA 2021-04-22
ER

PT J
AU Won, H
   Oh, J
   Yang, Y
   Kim, M
   Kim, C
   Park, J
   Kim, BK
   Choi, D
   Hong, MK
AF Won, Hoyoun
   Oh, Jaewon
   Yang, Youngjun
   Kim, Mihyun
   Kim, Choongki
   Park, Junbeom
   Kim, Byeong-Keuk
   Choi, Donghoon
   Hong, Myeong-Ki
TI Successful Management of a Rare Case of Stent Fracture and Subsequent
   Migration of the Fractured Stent Segment Into the Ascending Aorta in
   In-Stent Restenotic Lesions of a Saphenous Vein Graft
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Drug-Eluting stents; Complications
AB Stent fracture is a complication following implantation of drug eluting stents and is recognized as one of the risk factors for in-stent restenosis. We present the first case of successfully managing a stent fracture and subsequent migration of the fractured stent into the ascending aorta that occurred during repeat revascularization for in-stent restenosis of an ostium of saphenous vein graft after implantation of a zotarolimus-eluting stent. Although the fractured stent segment had migrated into the ascending aorta with a pulled balloon catheter, it was successfully repositioned in the saphenous vein graft using an inflated balloon catheter. Then, the fractured stent segment was successfully connected to the residual segment of the zotarolimus-eluting stent by covering it with an additional sirolimuseluting stent.
C1 [Won, Hoyoun; Oh, Jaewon; Yang, Youngjun; Kim, Mihyun; Kim, Choongki; Park, Junbeom; Kim, Byeong-Keuk; Choi, Donghoon; Hong, Myeong-Ki] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
   [Hong, Myeong-Ki] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 120752, South Korea.
RP Hong, MK (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Severance Biomed Sci Inst,Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM mkhong61@yuhs.ac
OI Won, Hoyoun/0000-0001-7880-3477; Choi, Donghoon/0000-0002-2009-9760; Oh,
   Jaewon/0000-0002-4585-1488; Kim, Byeong-Keuk/0000-0003-2493-066X; Hong,
   Myeong-Ki/0000-0002-2090-2031
CR Aoki J, 2007, CATHETER CARDIO INTE, V69, P380, DOI 10.1002/ccd.20950
   Canan T, 2010, CATHETER CARDIO INTE, V75, P237, DOI 10.1002/ccd.22212
   Chakravarty T, 2010, AM J CARDIOL, V106, P1075, DOI 10.1016/j.amjcard.2010.06.010
   Nakazawa G, 2009, J AM COLL CARDIOL, V54, P1924, DOI 10.1016/j.jacc.2009.05.075
   Sianos G, 2004, CATHETER CARDIO INTE, V61, P111, DOI 10.1002/ccd.10709
NR 5
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2012
VL 42
IS 1
BP 58
EP 61
DI 10.4070/kcj.2012.42.1.58
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IF
UT WOS:000209079400011
PM 22363386
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JH
   Chun, KJ
   Song, SG
   Kim, JS
   Park, YH
   Kim, J
   Choo, KS
   Kim, JH
   Lee, SK
AF Park, Ju Hyun
   Chun, Kook Jin
   Song, Sung Gook
   Kim, Jeong Su
   Park, Yong Hyun
   Kim, Jun
   Choo, Ki Seuk
   Kim, June Hong
   Lee, Sang Kwon
TI Severe Aortic Coarctation in a 75-Year-Old Woman: Total Simultaneous
   Repair of Aortic Coarctation and Severe Aortic Stenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic coarctation; Aged; Thoracic surgical procedures
AB Aortic coarctation is usually diagnosed and repaired in childhood and early adulthood. Survival of a patient with an uncorrected coarctation to more than 70 years of age is extremely unusual, and management strategies for these cases remain controversial. We present a case of a 75-year-old woman who was first diagnosed with aortic coarctation and severe aortic valve stenosis 5 years ago and who underwent a successful one-stage repair involving valve replacement and insertion of an extra-anatomical bypass graft from the ascending to the descending aorta.
C1 [Park, Ju Hyun] Busan St Marys Med Ctr, Dept Cardiol, Pusan, South Korea.
   [Chun, Kook Jin; Song, Sung Gook; Kim, Jeong Su; Park, Yong Hyun; Kim, Jun; Kim, June Hong] Pusan Natl Univ, Yangsan Hosp, Coll Med, Dept Cardiol, Yangsan 626770, South Korea.
   [Choo, Ki Seuk] Pusan Natl Univ, Yangsan Hosp, Coll Med, Dept Diagnost Radiol, Yangsan 626770, South Korea.
   [Lee, Sang Kwon] Pusan Natl Univ, Yangsan Hosp, Coll Med, Dept Thorac & Cardiovasc Surg, Yangsan 626770, South Korea.
RP Chun, KJ (corresponding author), Pusan Natl Univ, Yangsan Hosp, Coll Med, Dept Cardiol, 20 Geumo Ro, Yangsan 626770, South Korea.
EM ptca82@gmail.com
OI Kim, Jun/0000-0002-3573-638X
FU Pusan National University Research GrantPusan National University
FX This work was supported for two years by Pusan National University
   Research Grant.
CR BARTLETT LC, 1983, CAN MED ASSOC J, V129, P529
   Bauer M, 2001, ANN THORAC SURG, V72, P2060, DOI 10.1016/S0003-4975(01)03094-6
   BOBBY JJ, 1991, BRIT HEART J, V65, P271
   CAMPBELL M, 1970, BRIT HEART J, V32, P633
   Cevik S, 2004, TEX HEART I J, V31, P429
   Convens C, 1996, CATHETER CARDIO DIAG, V39, P71, DOI 10.1002/(SICI)1097-0304(199609)39:1<71::AID-CCD15>3.0.CO;2-R
   Grech V, 1999, INT J CARDIOL, V68, P197, DOI 10.1016/S0167-5273(98)00352-0
   HALDANE JH, 1983, CAN MED ASSOC J, V128, P1298
   Jenkins NP, 1999, QJM-MON J ASSOC PHYS, V92, P365, DOI 10.1093/qjmed/92.7.365
   Kountouris Evaggelos, 2009, Cases J, V2, P6308, DOI 10.4076/1757-1626-2-6308
   LIBERTHSON RR, 1979, AM J CARDIOL, V43, P835, DOI 10.1016/0002-9149(79)90086-9
   Morris RJ, 1998, ANN THORAC SURG, V65, P1698, DOI 10.1016/S0003-4975(98)00291-4
   OByrne E, 1997, INT J CLIN PRACT, V51, P466
   Patel Y, 1998, THORAC CARDIOV SURG, V46, P158, DOI 10.1055/s-2007-1010216
NR 14
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2012
VL 42
IS 1
BP 62
EP 64
DI 10.4070/kcj.2012.42.1.62
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IF
UT WOS:000209079400012
PM 22363387
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, JH
   Jung, DH
   Park, SK
   Park, JS
   Kim, JY
   Min, PK
   Lee, BK
   Yoon, YW
   Hong, BK
   Kwon, HM
   Rim, SJ
AF Yoon, Ji Hyun
   Jung, Da Hyun
   Park, Seung Kyo
   Park, Ji Soo
   Kim, Jong-Youn
   Min, Pil-Ki
   Lee, Byung-Kwon
   Yoon, Young-Won
   Hong, Bum-Kee
   Kwon, Hyuck-Moon
   Rim, Se-Joong
TI Spontaneous Sinus Conversion of Permanent Atrial Fibrillation During
   Treatment of Hyperkalemia
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hyperkalemia; Atrial fibrillation; Electrocardiography
ID INDUCED FAILURE; AMIODARONE; RHYTHM; RESTORATION
AB Hyperkalemia is a common adverse effect of treatment for heart failure and is associated with high mortality and morbidity. The cardiac manifestations of hyperkalemia include various electrocardiogram changes. We describe a case of a 74-year-old woman with heart failure and permanent atrial fibrillation who reverted to normal sinus rhythm during recovery from hyperkalemia.
C1 [Yoon, Ji Hyun; Jung, Da Hyun; Park, Seung Kyo; Park, Ji Soo; Kim, Jong-Youn; Min, Pil-Ki; Lee, Byung-Kwon; Yoon, Young-Won; Hong, Bum-Kee; Kwon, Hyuck-Moon; Rim, Se-Joong] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 135720, South Korea.
RP Rim, SJ (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, 211 Eonju Ro, Seoul 135720, South Korea.
EM sejoong@yuhs.ac
OI Kim, Jong-Youn/0000-0001-7040-8771; Rim, Se Joong/0000-0002-7631-5581;
   Hong, Bum Kee/0000-0002-6456-0184; Lee, Byoung Kwon/0000-0001-9259-2776;
   Min, Pil-Ki/0000-0001-7033-7651; Park, Ji Soo/0000-0002-0023-7740; Kwon,
   Hyuck Moon/0000-0001-9901-5015
CR Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]
   Capucci A, 2000, EUR HEART J, V21, P66, DOI 10.1053/euhj.1999.1734
   Diercks DB, 2004, J EMERG MED, V27, P153, DOI 10.1016/j.jemermed.2004.04.006
   Evans Kimberley J, 2005, J Intensive Care Med, V20, P272, DOI 10.1177/0885066605278969
   Fisch C, 1966, Prog Cardiovasc Dis, V8, P387, DOI 10.1016/S0033-0620(66)80029-4
   Gogas BD, 2011, INT J CARDIOL, V148, pE40, DOI 10.1016/j.ijcard.2009.05.004
   GOMES JAC, 1984, AM HEART J, V107, P214, DOI 10.1016/0002-8703(84)90367-3
   Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135
   Kahloon MU, 2005, INT J CARDIOL, V105, P224, DOI 10.1016/j.ijcard.2004.11.028
   Kamiya K, 2001, CIRCULATION, V103, P1317
   MATHEW PK, 1979, ANGIOLOGY, V30, P143, DOI 10.1177/000331977903000210
   MIDDLEKAUFF HR, 1993, AM J CARDIOL, V72, pF75, DOI 10.1016/0002-9149(93)90967-H
   MOORE ML, 1989, NEW ZEAL MED J, V102, P557
   Naccarelli GV, 2005, CLIN CARDIOL, V28, P165, DOI 10.1002/clc.4960280403
   Nyirenda MJ, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4114
   PAICE B, 1983, BRIT MED J, V286, P1189, DOI 10.1136/bmj.286.6372.1189
   Romeo E, 2011, J CARDIOVASC MED, V12, P678, DOI 10.2459/JCM.0b013e32833ce871
   Schiraldi F, 2008, RESUSCITATION, V79, P161, DOI 10.1016/j.resuscitation.2008.04.023
   SHEMER J, 1983, ISRAEL J MED SCI, V19, P659
   Webster A, 2002, EMERG MED J, V19, P74, DOI 10.1136/emj.19.1.74
NR 20
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2012
VL 42
IS 1
BP 65
EP 68
DI 10.4070/kcj.2012.42.1.65
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IF
UT WOS:000209079400013
PM 22363388
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CW
   Sung, SH
   Yu, WC
AF Lee, Ching-Wei
   Sung, Shih-Hsien
   Yu, Wen-Chung
TI Coronary Artery Fistula With a Huge Aneurysm Formation Presenting as
   Heart Failure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Lee, Ching-Wei; Sung, Shih-Hsien; Yu, Wen-Chung] Taipei Vet Gen Hosp, Dept Med, Taipei 112, Taiwan.
   [Lee, Ching-Wei; Sung, Shih-Hsien; Yu, Wen-Chung] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan.
   [Sung, Shih-Hsien] Natl Yang Ming Univ, Dept Publ Hlth, Taipei 112, Taiwan.
RP Sung, SH (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, 201 Sec 2,Shih Pai Rd, Taipei 112, Taiwan.
EM mr.sungsh@gmail.com
CR Athanasias DA, 2002, HELL J CARDIOL, V43, P78
   Cheung DLC, 2001, ANN THORAC SURG, V71, P190, DOI 10.1016/S0003-4975(00)01862-2
   Roncalli J, 2007, CARDIOVASC REVASCULA, V8, P114, DOI 10.1016/j.carrev.2006.11.006
NR 3
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2012
VL 42
IS 1
BP 69
EP 70
DI 10.4070/kcj.2012.42.1.69
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IF
UT WOS:000209079400014
PM 22363389
OA Green Published
DA 2021-04-22
ER

PT J
AU Jo, SH
AF Jo, Sang-Ho
TI N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A
   Narrative Review
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Acetylcysteine; Renal insufficiency; Contrast media; Angiography;
   Prevention
ID RADIOCONTRAST-INDUCED NEPHROPATHY; ACUTE MYOCARDIAL-INFARCTION;
   ACUTE-RENAL-FAILURE; ACETYL-L-CYSTEINE; CORONARY-ANGIOGRAPHY; PRIMARY
   ANGIOPLASTY; SODIUM-BICARBONATE; MEDIA; INSUFFICIENCY; METAANALYSIS
AB Contrast-induced nephropathy (CIN) affects in-hospital, short-and long-term morbidity and mortality. It also leads to prolonged hospital stay and increased medical cost. Given the potential clinical severity of CIN, there has been considerable interest in the development of preventative strategies to reduce the risk of contrast-induced renal deterioration in at-risk populations. A number of pharmacologic and mechanical preventive measures have been attempted, but no method other than adequate periprocedural hydration has been conclusively successful. Since its introduction in 2000, N-acetylcysteine (NAC) has been widely investigated, albeit with conflicting findings for its nephroprotection capability in patients receiving contrast media procedures. However, there is still virtually no definitive evidence of effectiveness of NAC. Although the exact mechanism responsible for the protective action of NAC from renal function deterioration remains unclear, the antioxidant and vasodilatory properties of NAC have been suggested as the main mechanisms. This review summarizes the current status of NAC as a potential agent to prevent renal functional deterioration and its limitations.
C1 Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Cardiol, Anyang 431070, South Korea.
RP Jo, SH (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Cardiol, 896 Pyeongchon Dong, Anyang 431070, South Korea.
EM sophi5@medimail.co.kr
CR ARSTALL MA, 1995, CIRCULATION, V92, P2855, DOI 10.1161/01.CIR.92.10.2855
   BAKRIS GL, 1990, AM J PHYSIOL, V258, pF115
   Baliga R, 1997, AM J KIDNEY DIS, V29, P465, DOI 10.1016/S0272-6386(97)90212-2
   Barrett BJ, 2006, NEW ENGL J MED, V354, P379, DOI 10.1056/NEJMcp050801
   BARRETT BJ, 1994, NEW ENGL J MED, V331, P1449, DOI 10.1056/NEJM199411243312111
   BARRETT BJ, 1994, J AM SOC NEPHROL, V5, P125
   Berwanger O, 2011, CIRCULATION, V124, P1250, DOI 10.1161/CIRCULATIONAHA.111.038943
   Birck R, 2003, LANCET, V362, P598, DOI 10.1016/S0140-6736(03)14189-X
   BRADY HR, 1995, LANCET, V346, P1533, DOI 10.1016/S0140-6736(95)92057-9
   Briguori C, 2004, EUR HEART J, V25, P206, DOI 10.1016/j.ehj.2003.11.016
   Briguori C, 2007, CIRCULATION, V115, P1211, DOI 10.1161/CIRCULATIONAHA.106.687152
   COTGREAVE I, 1991, BIOCHEM PHARMACOL, V42, P13, DOI 10.1016/0006-2952(91)90674-T
   DiMari J, 1997, AM J PHYSIOL-RENAL, V272, pF292
   Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470
   Gare M, 1999, J AM COLL CARDIOL, V34, P1682, DOI 10.1016/S0735-1097(99)00422-2
   Gonzales DA, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-32
   Haase M, 2008, NEPHROL DIAL TRANSPL, V23, P1581, DOI 10.1093/ndt/gfm818
   Heyman SN, 1999, INVEST RADIOL, V34, P685, DOI 10.1097/00004424-199911000-00004
   Hoffmann U, 2004, J AM SOC NEPHROL, V15, P407, DOI 10.1097/01.ASN.0000106780.14856.55
   Holt S, 1999, LANCET, V353, P294, DOI 10.1016/S0140-6736(05)74933-3
   Huber W, 2003, AM J CARDIOL, V91, P1157, DOI 10.1016/S0002-9149(03)00259-5
   Izzedine H, 2009, J HEPATOL, V50, P1055, DOI 10.1016/j.jhep.2009.02.002
   Jaffery Z, 2011, CATHETER CARDIOVASC
   Jo SH, 2006, J AM COLL CARDIOL, V48, P924, DOI 10.1016/j.jacc.2006.06.047
   Jo SH, 2009, AM HEART J, V157, P576, DOI 10.1016/j.ahj.2008.11.010
   Katholi RE, 1998, AM J KIDNEY DIS, V32, P64, DOI 10.1053/ajkd.1998.v32.pm9669426
   Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007
   Khachigian LM, 1997, AM J PATHOL, V151, P1225
   Kshirsagar AV, 2004, J AM SOC NEPHROL, V15, P761, DOI 10.1097/01.ASN.0000116241.47678.49
   Lee HC, 2011, J NEPHROL
   Liu R, 2005, J GEN INTERN MED, V20, P193, DOI 10.1111/j.1525-1497.2005.30323.x
   MANSKE CL, 1990, AM J MED, V89, P615, DOI 10.1016/0002-9343(90)90180-L
   Marenzi G, 2006, NEW ENGL J MED, V354, P2773, DOI 10.1056/NEJMoa054209
   McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2
   McCullough PA, 2006, J AM COLL CARDIOL, V48, P692, DOI 10.1016/j.jacc.2006.02.073
   McCullough PA, 2011, CIRCULATION, V124, P1210, DOI 10.1161/CIRCULATIONAHA.111.054502
   Mehta A, 2002, MOL CELL BIOCHEM, V240, P19, DOI 10.1023/A:1020675721351
   Merten GJ, 2004, JAMA-J AM MED ASSOC, V291, P2328, DOI 10.1001/jama.291.19.2328
   MESSANA JM, 1990, RENAL FAILURE, V12, P75, DOI 10.3109/08860229009087121
   Mueller C, 2002, ARCH INTERN MED, V162, P329, DOI 10.1001/archinte.162.3.329
   Murphy SW, 2000, J AM SOC NEPHROL, V11, P177
   Nallamothu BK, 2004, AM J MED, V117, P938, DOI 10.1016/j.amjmed.2004.06.046
   Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766
   Ozcan EE, 2007, AM HEART J, V154, P539, DOI 10.1016/j.ahj.2007.05.012
   Pannu N, 2004, KIDNEY INT, V65, P1366, DOI 10.1111/j.1523-1755.2004.00516.x
   Pannu N, 2006, JAMA-J AM MED ASSOC, V295, P2765, DOI 10.1001/jama.295.23.2765
   Poletti PA, 2007, AM J ROENTGENOL, V189, P687, DOI 10.2214/AJR.07.2356
   Pollman MJ, 1999, CIRC RES, V84, P113
   Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33
   Ristikankare A, 2006, BRIT J ANAESTH, V97, P611, DOI 10.1093/bja/ael224
   Romano G, 2008, EUR HEART J, V29, P2569, DOI 10.1093/eurheartj/ehn197
   RUDNICK MR, 1995, KIDNEY INT, V47, P254, DOI 10.1038/ki.1995.32
   RUSSO D, 1990, NEPHRON, V55, P254, DOI 10.1159/000185971
   Sadeghi HM, 2003, CIRCULATION, V108, P2769, DOI 10.1161/01.CIR.0000103623.63687.21
   Salom MG, 1998, TRANSPLANTATION, V65, P1315, DOI 10.1097/00007890-199805270-00006
   Solomon R, 1998, KIDNEY INT, V53, P230, DOI 10.1038/sj.ki.4495510
   SOLOMON R, 1994, NEW ENGL J MED, V331, P1416, DOI 10.1056/NEJM199411243312104
   Stevens NA, 1999, J AM COLL CARDIOL, V33, P403
   Stone GW, 2003, JAMA-J AM MED ASSOC, V290, P2284, DOI 10.1001/jama.290.17.2284
   Tanaka A, 2011, INTERNAL MED, V50, P673, DOI 10.2169/internalmedicine.50.4226
   Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277
   Tepel M, 2006, CIRCULATION, V113, P1799, DOI 10.1161/CIRCULATIONAHA.105.595090
   Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304
   Thiele H, 2010, J AM COLL CARDIOL, V55, P2201, DOI 10.1016/j.jacc.2009.08.091
   Trivedi H, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.01.035
   VALE JA, 1995, LANCET, V346, P547, DOI 10.1016/S0140-6736(95)91385-8
   WEINSTEIN JM, 1992, NEPHRON, V62, P413, DOI 10.1159/000187090
   YOSHIOKA T, 1992, KIDNEY INT, V41, P1008, DOI 10.1038/ki.1992.153
   ZHANG H, 1995, EUR SURG RES, V27, P292, DOI 10.1159/000129412
NR 69
TC 9
Z9 9
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 695
EP 702
DI 10.4070/kcj.2011.41.12.695
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300001
PM 22259598
OA Green Published
DA 2021-04-22
ER

PT J
AU Lim, DS
AF Lim, Do-Sun
TI Staged Complete Revascularization in ST-Segment Elevation Myocardial
   Infarction Should Be the Treatment of Choice Compared to Primary
   Complete Revascularization
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Korea Univ, Coll Med, Anam Hosp, Dept Cardiol,Cardiovasc Ctr, Seoul 136705, South Korea.
RP Lim, DS (corresponding author), Korea Univ, Coll Med, Anam Hosp, Dept Cardiol,Cardiovasc Ctr, 73 Inchon Ro, Seoul 136705, South Korea.
EM dslmd@kumc.or.kr
CR Brener SJ, 2002, AM J CARDIOL, V90, P631, DOI 10.1016/S0002-9149(02)02569-9
   Hannan EL, 2010, JACC-CARDIOVASC INTE, V3, P22, DOI 10.1016/j.jcin.2009.10.017
   Jo HS, 2011, KOREAN CIRC J, V41, P718, DOI 10.4070/kcj.2011.41.12.718
   Kornowski R, 2011, J AM COLL CARDIOL, V58, P704, DOI 10.1016/j.jacc.2011.02.071
   Shishehbor MH, 2007, J AM COLL CARDIOL, V49, P849, DOI 10.1016/j.jacc.2006.10.054
   Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220
   Smith SC, 2006, CIRCULATION, V113, P156, DOI 10.1161/CIRCULATIONAHA.105.170815
   Varani E, 2008, CATHETER CARDIO INTE, V72, P927, DOI 10.1002/ccd.21722
   Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046
NR 9
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 703
EP 704
DI 10.4070/kcj.2011.41.12.703
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300002
PM 22259599
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, K
   Kim, TE
   Park, KW
   Kang, HJ
   Koo, BK
   Kim, HS
AF Park, Kyungil
   Kim, Tae-Eun
   Park, Kyung-Woo
   Kang, Hyun-Jae
   Koo, Bon-Kwon
   Kim, Hyo-Soo
TI Analysis of Potential Cost-Savings After Introduction of Drug-Eluting
   Balloon Angioplasty for In-Stent Restenosis or Small Vessel Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angioplasty, balloon; Coronary restenosis
ID PACLITAXEL-COATED BALLOON; CORONARY; PREVENTION; DELIVERY
AB Background and Objectives: The drug-eluting balloon (DEB) catheter system was developed to treat restenosis. Furthermore, DEB angioplasty has been shown to reduce restenosis risk when compared to drug-eluting stents (DES) in patients with in-stent restenosis (ISR) or small vessel disease (SVD). In addition, DEB angioplasty reduces costs due to fewer revascularizations and reduced clopidogrel treatment length. The objective of this study was to predict the expected cost-savings when DEB is substituted for DES in patients with ISR or SVD. Subjects and Methods: The subjects included were patients treated by DES at Seoul National University Hospital from January 2006 to June 2009, with clinical data after percutaneous coronary intervention, were. A model was developed to allow the costs of DES and the calculated costs of DEB incurred by patients with ISR or SVD to be compared. The overall cost of DEB was calculated to be 1,256,150 won and the overall cost of DES was 2,102,500 won, and the cost of clopidogrel was 2,168 won. Expected repeat revascularizations within 12 months of DEB were calculated based on information provided by the Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery (PEPCAD) I and II trials. Results: By substituting DEB for DES, total cost (including the cost of initial DEB treatment, the cost of repeat revascularization after DEB treatment, and the cost of clopidogrel treatment) was found to be 34% lower in ISR patients and 48% lower in SVD patients. Conclusion: DEB angioplasty will significantly reduce costs as compared to DES in ISR and in SVD patients.
C1 [Park, Kyungil; Kim, Tae-Eun; Park, Kyung-Woo; Kang, Hyun-Jae; Koo, Bon-Kwon; Kim, Hyo-Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Ctr Cardiovasc, Seoul 110744, South Korea.
RP Kim, HS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Ctr Cardiovasc, 101 Daehak Ro, Seoul 110744, South Korea.
EM hyosoo@snu.ac.kr
RI Park, Kyung Woo/AAX-3046-2020; Kang, Hyun-Jae/D-6121-2012
OI Kang, Hyun-Jae/0000-0002-3500-1746
FU Center of Ischemic Heart Disease - Ministry of Health & Welfare, the
   Republic of Korea [0412-CR02-0704-0001]
FX This study was supported by a grant from the Center of Ischemic Heart
   Disease (0412-CR02-0704-0001) sponsored by the Ministry of Health &
   Welfare, the Republic of Korea.
CR Ardissino D, 2004, JAMA-J AM MED ASSOC, V292, P2727, DOI 10.1001/jama.292.22.2727
   Bauters C, 1998, J AM COLL CARDIOL, V31, P1291, DOI 10.1016/S0735-1097(98)00076-X
   Cortese B, 2010, HEART, V96, P1291, DOI 10.1136/hrt.2010.195057
   Cremers B, 2009, THROMB HAEMOSTASIS, V101, P201, DOI 10.1160/TH08-06-0387
   Elezi S, 1998, CIRCULATION, V98, P1875, DOI 10.1161/01.CIR.98.18.1875
   홍순준, 2007, Korean Circulation Journal, V37, P530
   황유정, 2006, Korean Circulation Journal, V36, P450
   Iofina E, 2005, CATHETER CARDIO INTE, V64, P28, DOI 10.1002/ccd.20212
   이철환, 2007, Korean Circulation Journal, V37, P97
   Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165
   KUNTZ RE, 1992, CIRCULATION, V86, P1827, DOI 10.1161/01.CIR.86.6.1827
   Novack V, 2010, AM J CARDIOL, V106, P774, DOI 10.1016/j.amjcard.2010.04.039
   Posa A, 2008, CORONARY ARTERY DIS, V19, P243, DOI 10.1097/MCA.0b013e3283030b26
   Savage MP, 1998, J AM COLL CARDIOL, V31, P307, DOI 10.1016/S0735-1097(97)00511-1
   Scheller B, 2004, CIRCULATION, V110, P810, DOI 10.1161/01.CIR.0000138929.71660.E0
   Scheller B, 2003, EUR HEART J, V24, P1462, DOI 10.1016/S0195-668X(03)00317-8
   Scheller B, 2008, CLIN RES CARDIOL, V97, P773, DOI 10.1007/s00392-008-0682-5
   Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254
   Stone GW, 2005, JAMA-J AM MED ASSOC, V294, P1215, DOI 10.1001/jama.294.10.1215
   Unverdorben M, 2010, CLIN RES CARDIOL, V99, P165, DOI 10.1007/s00392-009-0101-6
   Unverdorben M, 2009, CIRCULATION, V119, P2986, DOI 10.1161/CIRCULATIONAHA.108.839282
   Virmani R, 2004, CIRCULATION, V109, P701, DOI 10.1161/01.CIR.0000116202.41966.D4
NR 22
TC 5
Z9 5
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 705
EP 711
DI 10.4070/kcj.2011.41.12.705
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300003
PM 22259600
OA Green Published
DA 2021-04-22
ER

PT J
AU Ko, SK
   Yoon, SJ
   Oh, IH
   Seo, HY
   Kim, EJ
AF Ko, Seul-Ki
   Yoon, Seok-Jun
   Oh, In-Hwan
   Seo, Hye-Young
   Kim, Eun-Jung
TI The Economic Burden of Inflammatory Heart Disease in Korea
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Inflammation; Cost of illness; Endocarditis
AB Background and Objectives: The incidence of inflammatory heart diseases is not yet as high as those of other cardiovascular diseases; however, inflammatory heart diseases do have relatively high mortality rate. Therefore, update information on the economic burden of inflammatory heart diseases are necessary in order to appropriate policy making on these diseases. Materials and Methods: This study used a number of resources to obtain data, national health insurance statistics, the Korean Health Panel, and the causes of death report by the Korean National Statistical Office. The total costs of inflammatory heart diseases were estimated as the sum of direct medical care costs, direct non-medical care and indirect costs. Results: The total direct cost of inflammatory heart disease was higher in Korean men than that of Korean women and cost due to inpatient was higher than that of outpatients cost. The costs to cover premature death were highest among all of the components used to determine the total costs for inflammatory heart disease, representing 66.3% of these costs in Korea. Conclusion: Inflammatory heart disease has a relatively high mortality rate, and the costs that are associated with premature deaths consume the greatest proportion of the costs associated with this disease. In spite of some limitations of study, this could be a reliable evidence of economic burden of inflammatory heart disease.
C1 [Ko, Seul-Ki] Korea Univ, Sch Med, Korea Univ 136705, Coll Med, South Korea.
   [Yoon, Seok-Jun; Oh, In-Hwan] Korea Univ, Coll Med, Dept Prevent Med, Korea Univ 136705, Coll Med, South Korea.
   [Seo, Hye-Young] Korea Univ, Grad Sch, Dept Publ Hlth, Korea Univ 136705, Coll Med, South Korea.
   [Kim, Eun-Jung] Cheju Halla Coll, Dept Nursing, Cheju, South Korea.
RP Yoon, SJ (corresponding author), Korea Univ, Coll Med, Dept Prevent Med, 126-1 Anam Dong 5 Ga, Korea Univ 136705, Coll Med, South Korea.
EM yoonsj02@korea.ac.kr
RI Oh, In Hwan/AAI-9070-2020
OI Oh, In Hwan/0000-0002-5450-9887; Kim, Eun-Jung/0000-0003-2352-5267
FU Korea Centers for Disease Control and Prevention [R1006511]
FX This research was supported by a fund (code R1006511) by Research of
   Korea Centers for Disease Control and Prevention.
CR Ariza MA, 2010, REV ENDOCR METAB DIS, V11, P1, DOI 10.1007/s11154-010-9128-2
   Blauwet LA, 2010, PROG CARDIOVASC DIS, V52, P274, DOI 10.1016/j.pcad.2009.11.006
   Dec GW, 2003, MYOCARDITIS: FROM BENCH TO BEDSIDE, P257
   DRORY Y, 1991, AM J CARDIOL, V68, P1388, DOI 10.1016/0002-9149(91)90251-F
   Fairweather D, 2005, LUPUS, V14, P646, DOI 10.1191/0961203305lu2192oa
   Hufnagel G, 2000, HERZ, V25, P279, DOI 10.1007/s000590050021
   hyun PARK，Bo, 2010, [Health Policy and Mangemnet, 보건행정학회지], V20, P103
   Jung Young-Ho, 2004, 재정논집, V18, P77
   Kim JH, 2006, SURVEY BENEFIT COVER, P131
   Kim Jinhee, 2009, J Prev Med Public Health, V42, P190, DOI 10.3961/jpmph.2009.42.3.190
   Kim SY, 2010, AM J RHINOL ALLERGY, V24, pE110, DOI 10.2500/ajra.2010.24.3513
   Korea Institute for Health and Social Affairs and National Health Insurance Corporation, KOR HLTH PAN
   Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308
   Mathers CD., 2001, NATL BURDEN DIS STUD
   Ministry of Labor, SURV REP WAG STRUCT
   National Health Insurance Corporation, 2007, NAT HLTH INS STAT YB, P488
   National Statistical Office, 2009, CAUS DEATH STAT 2008
   World Health Organization (WHO), GLOB BURD DIS 2004 U
   World Heart Federation, WORLD HEART FED DIFF
   Yoon SJ, 2011, STUDY MEASURING EC B
NR 20
TC 0
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 712
EP 717
DI 10.4070/kcj.2011.41.12.712
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300004
PM 22259601
OA Green Published
DA 2021-04-22
ER

PT J
AU Jo, HS
   Park, JS
   Sohn, JW
   Yoon, JC
   Sohn, CW
   Lee, SH
   Hong, GR
   Shin, DG
   Kim, YJ
   Jeong, MH
   Chae, SC
   Hur, SH
   Hong, TJ
   Seong, IW
   Chae, JK
   Rhew, JY
   Chae, IH
   Cho, MC
   Bae, JH
   Rha, SW
   Kim, CJ
   Choi, DH
   Jang, YS
   Yoon, JH
   Chung, WS
   Seung, KB
   Park, SJ
AF Jo, Hyun Su
   Park, Jong Seon
   Sohn, Jang Won
   Yoon, Joon Cheol
   Sohn, Chang Woo
   Lee, Sang Hee
   Hong, Geu Ru
   Shin, Dong Gu
   Kim, Young Jo
   Jeong, Myung Ho
   Chae, Shung Chull
   Hur, Seung Ho
   Hong, Taek Jong
   Seong, In Whan
   Chae, Jei Keon
   Rhew, Jay Young
   Chae, In Ho
   Cho, Myeong Chan
   Bae, Jang Ho
   Rha, Seung Woon
   Kim, Chong Jin
   Choi, Dong Hoon
   Jang, Yang Soo
   Yoon, Jung Han
   Chung, Wook Sung
   Seung, Ki Bae
   Park, Seung Jung
TI Culprit-Lesion-Only Versus Multivessel Revascularization Using
   Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial
   Infarction: A Korean Acute Myocardial Infarction Registry-Based Analysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Coronary artery disease; Angioplasty
AB Background and Objectives: In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, complete revascularization (CR) for non-culprit lesions is not routinely recommended. The aim of this study was to compare the clinical outcomes of multivessel compared with infarct-related artery (IRA)-only revascularization in patients undergoing primary percutaneous coronary intervention (PCI) for STEMI. Subjects and Methods: From the Korean Acute Myocardial Infarction Registry (KAMIR) database, 1,094 STEMI patients with multivessel disease who underwent primary PCI with drug-eluting stents were enrolled in this study. The patients were divided into two groups: culprit-vessel-only revascularization (COR, n=827) group; multivessel revascularization, including non-IRA (MVR, n=267) group. The primary endpoint of this study included major adverse cardiac events (MACEs), such as death, myocardial infarction, or target or nontarget lesion revascularization at one year. Results: There was no difference in clinical characteristics between the two groups. During the one-year follow-up, 102 (15.2%) patients in the COR group and 32 (14.2%) in the MVR group experienced at least one MACE (p=0.330). There were no differences between the two groups in terms of rates of death, myocardial infarction, or revascularization (2.1% vs. 2.0%, 0.7% vs. 0.8%, and 11.7% vs. 10.1%, respectively; p=0.822, 0.910, and 0.301, respectively). The MACE rate was higher in the incompletely revascularized patients than in the completely revascularized patients (15% vs. 9.5%, p=0.039), and the difference was attributable to a higher rate of nontarget vessel revascularization (8.6% vs. 1.8%, p=0.002). Conclusion: Although multivessel angioplasty during primary PCI for STEMI did not reduce the MACE rate compared with culprit-vessel-only PCI, CR was associated with a lower rate of repeat revascularization after multivessel PCI.
C1 [Jo, Hyun Su; Park, Jong Seon; Sohn, Jang Won; Yoon, Joon Cheol; Sohn, Chang Woo; Lee, Sang Hee; Hong, Geu Ru; Shin, Dong Gu; Kim, Young Jo] Yeungnam Univ Hosp, Dept Internal Med, Div Cardiol, Taegu 705717, South Korea.
   [Jeong, Myung Ho] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ, Coll Med, Dept Internal Med, Taegu, South Korea.
   [Hur, Seung Ho] Keimyung Univ, Coll Med, Dept Internal Med, Taegu, South Korea.
   [Hong, Taek Jong] Pusan Natl Univ, Sch Med, Dept Internal Med, Pusan, South Korea.
   [Seong, In Whan] Chungnam Natl Univ, Coll Med, Dept Internal Med, Taejon, South Korea.
   [Chae, Jei Keon] Chonbuk Natl Univ, Coll Med, Dept Internal Med, Jeonju, South Korea.
   [Rhew, Jay Young] Jeonju Presbyterian Med Ctr, Dept Internal Med, Jeonju, South Korea.
   [Chae, In Ho] Seoul Natl Univ, Coll Med, Dept Internal Med, Songnam, South Korea.
   [Cho, Myeong Chan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea.
   [Bae, Jang Ho] Konyang Univ, Coll Med, Dept Internal Med, Taejon, South Korea.
   [Rha, Seung Woon] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea.
   [Kim, Chong Jin] Kyung Hee Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Choi, Dong Hoon; Jang, Yang Soo] Yonsei Univ, Severans Hosp, Dept Internal Med, Seoul 120749, South Korea.
   [Yoon, Jung Han] Yonsei Univ, Wonju Christian Hosp, Dept Internal Med, Wonju, South Korea.
   [Chung, Wook Sung; Seung, Ki Bae] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea.
   [Park, Seung Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea.
RP Park, JS (corresponding author), Yeungnam Univ Hosp, Dept Internal Med, Div Cardiol, 170 Hyeonchung Ro, Taegu 705717, South Korea.
EM pjs@med.yu.ac.kr
OI Hur, Seung-Ho/0000-0002-3895-1915; Jeong, Jin-Ok/0000-0003-0763-4754;
   Seong, In-Whan/0000-0003-4628-0258
CR Antman EM, 2004, J. Am. Coll. Cardiol, V3, pE1, DOI DOI 10.1016/J.JACC.2004.07.014
   Brener SJ, 2008, AM HEART J, V155, P140, DOI 10.1016/j.ahj.2007.09.007
   Cavender MA, 2009, AM J CARDIOL, V104, P507, DOI 10.1016/j.amjcard.2009.04.016
   Corpus RA, 2004, AM HEART J, V148, P493, DOI 10.1016/j.ahj.2004.03.051
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   ELLIS SG, 1988, CIRCULATION, V77, P372, DOI 10.1161/01.CIR.77.2.372
   Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303
   Hong Jae Seok, 2009, Korean Circ J, V39, P467, DOI 10.4070/kcj.2009.39.11.467
   Ijsselmuiden AJJ, 2004, AM HEART J, V148, P467, DOI 10.1016/j.ahj.2004.03.026
   Kim MC, 2010, INT J CARDIOL
   Kornowski R, 1999, J AM COLL CARDIOL, V33, P420, DOI 10.1016/S0735-1097(98)00566-X
   Kwon TG, 2009, INT J CARDIOL, V133, P173, DOI 10.1016/j.ijcard.2007.12.022
   Lee KH, 2008, INT J CARDIOL, V130, P227, DOI 10.1016/j.ijcard.2007.08.044
   Lee MG, 2010, J KOREAN MED SCI, V25, P1456, DOI 10.3346/jkms.2010.25.10.1456
   Lee SR, 2008, CIRC J, V72, P392, DOI 10.1253/circj.72.392
   Marenzi G, 2009, ANN INTERN MED, V150, P170, DOI 10.7326/0003-4819-150-3-200902030-00006
   Moussa I, 1997, CIRCULATION, V96, P3873
   MULLER DWM, 1991, AM HEART J, V121, P1042, DOI 10.1016/0002-8703(91)90661-Z
   Parodi G, 2005, HEART, V91, P1541, DOI 10.1136/hrt.2004.054692
   Politi L, 2010, HEART, V96, P662, DOI 10.1136/hrt.2009.177162
   Roe MT, 2001, AM J CARDIOL, V88, P170, DOI 10.1016/S0002-9149(01)01615-0
   Shishelibor MH, 2006, AM J CARDIOL, V97, P1585, DOI 10.1016/j.amjcard.2005.12.049
   Sim Doo Sun, 2009, Korean Circ J, V39, P297, DOI 10.4070/kcj.2009.39.8.297
   Smith SC, 2006, CIRCULATION, V113, pE166, DOI 10.1161/CIRCULATIONAHA.106.173220
   Thygesen K, 2007, EUR HEART J, V28, P2525
NR 25
TC 25
Z9 25
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 718
EP 725
DI 10.4070/kcj.2011.41.12.718
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300005
PM 22259602
OA Green Published
DA 2021-04-22
ER

PT J
AU Youn, YJ
   Kim, WT
   Lee, JW
   Ahn, SG
   Ahn, MS
   Kim, JY
   Yoo, BS
   Lee, SH
   Yoon, J
   Choe, KH
AF Youn, Young Jin
   Kim, Woo-Taek
   Lee, Jun-Won
   Ahn, Sung-Gyun
   Ahn, Min-Soo
   Kim, Jang-Young
   Yoo, Byung-Su
   Lee, Seung-Hwan
   Yoon, Junghan
   Choe, Kyung-Hoon
TI Eutectic Mixture of Local Anesthesia Cream Can Reduce Both the Radial
   Pain and Sympathetic Response During Transradial Coronary Angiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Anesthesia, local; Coronary angiography; Radial artery
AB Background and Objectives: Radial artery spasm is one of the most common complications of transradial coronary angiography (TRA): the radial artery is prone to cathecholamine-induced contraction and radial pain during TRA could increase the sympathetic tone. The object of this study was to evaluate whether the eutectic mixture of local anesthesia (EMLA) cream, in addition to lidocaine infiltration, could reduce the sympathetic response by reducing radial pain during TRA. Subjects and Methods: Seventy-six patients were randomized 1 : 1 to either EMLA or control groups. Radial pain was measured by the visual analogue scale (VAS) and the verbal rating scale (VRS-4). Sympathetic response, including systolic (SBP) and diastolic blood pressure (DBP), pulse rate (PR), stroke volume (SV) and total peripheral resistance (TPR), was measured by photoplethysmography. Results: Radial pain measured during lidocaine infiltration was significantly lower in the EMLA group (VAS: 3.1 vs. 4.0, p=0.04; VRS-4: 2.0 vs. 2.2, p=0.03) and the sympathetic response was significantly blunted in the EMLA group from baseline to lidocaine infiltration (Delta SBP, mm Hg: 5 vs. 13, p<0.01; Delta DBP, mm Hg: 2 vs. 7, p= 0.03; Delta PR, beat/min: 2 vs. 8, p<0.01, Delta SV, mL: 3 vs. 21, p<0.01; Delta TPR, mm Hg . L/min: 1.0 vs. 5.9, p<0.01). Conclusion: In patients undergoing TRA, the EMLA cream, in addition to lidocaine infiltration, effectively reduces the radial pain and thereby the sympathetic response, during lidocaine infiltration.
C1 [Youn, Young Jin; Kim, Woo-Taek; Lee, Jun-Won; Ahn, Sung-Gyun; Ahn, Min-Soo; Kim, Jang-Young; Yoo, Byung-Su; Lee, Seung-Hwan; Yoon, Junghan; Choe, Kyung-Hoon] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, Wonju 220060, South Korea.
RP Yoon, J (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, 162 Ilsan Dong, Wonju 220060, South Korea.
EM jyoon@yonsei.ac.kr
RI Ahn, Sung Gyun/AAG-5976-2020
OI Ahn, Sung Gyun/0000-0002-1528-2739; Lee, Jun-Won/0000-0001-6206-1704
CR Agostoni P, 2004, J AM COLL CARDIOL, V44, P349, DOI 10.1016/j.jacc.2004.04.034
   Bogert LWJ, 2005, EXP PHYSIOL, V90, P437, DOI 10.1113/expphysiol.2005.030262
   Fukuda N, 2004, JPN HEART J, V45, P723, DOI 10.1536/jhj.45.723
   Goldberg SL, 1998, CATHETER CARDIO DIAG, V44, P147, DOI 10.1002/(SICI)1097-0304(199806)44:2<147::AID-CCD5>3.0.CO;2-6
   Guelen I, 2003, BLOOD PRESS MONIT, V8, P27, DOI 10.1097/00126097-200302000-00006
   He GW, 1998, J THORAC CARDIOV SUR, V115, P1136, DOI 10.1016/S0022-5223(98)70414-3
   Hildick-Smith DJR, 2004, CATHETER CARDIO INTE, V61, P60, DOI 10.1002/ccd.10708
   Hildick-Smith DJR, 1998, INT J CARDIOL, V64, P231, DOI 10.1016/S0167-5273(98)00074-6
   HJEMDAHL P, 1993, BAILLIERE CLIN ENDOC, V7, P307, DOI 10.1016/S0950-351X(05)80179-X
   Imholz BPM, 1998, CARDIOVASC RES, V38, P605, DOI 10.1016/S0008-6363(98)00067-4
   Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023
   Joly LM, 1998, ANESTH ANALG, V87, P403, DOI 10.1097/00000539-199808000-00032
   Kiemeneij F, 2003, CATHETER CARDIO INTE, V58, P281, DOI 10.1002/ccd.10445
   Kim Jang-Young, 2007, J Invasive Cardiol, V19, P6
   Olday SJ, 2002, BRIT J ANAESTH, V88, P580, DOI 10.1093/bja/88.4.580
   Ruiz-Salmeron RJ, 2005, REV ESP CARDIOL, V58, P504, DOI 10.1016/S1885-5857(06)60730-5
   SMITH M, 1990, BRIT J ANAESTH, V65, P240, DOI 10.1093/bja/65.2.240
   Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X
NR 18
TC 7
Z9 7
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 726
EP 732
DI 10.4070/kcj.2011.41.12.726
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300006
PM 22259603
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Bae, JW
   Park, JB
   Park, CG
   Youn, HJ
   Choi, DJ
   Ahn, YK
   Shin, JH
   Rim, SJ
   Bae, JH
   Kim, DW
AF Lee, Ju-Hee
   Bae, Jang-Whan
   Park, Jung Bae
   Park, Chang Gyu
   Youn, Ho-Joong
   Choi, Dong Ju
   Ahn, Young Keun
   Shin, Joon-Han
   Rim, Se-Joong
   Bae, Jang-Ho
   Kim, Dong-Woon
TI Morning Hypertension in Treated Hypertensives: Baseline Characteristics
   and Clinical Implications
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Home Blood Pressure Monitoring
ID HOME BLOOD-PRESSURE; LEFT-VENTRICULAR HYPERTROPHY; EXAGGERATED
   DIFFERENCE; SURGE; SELF; DETERMINANTS; ASSOCIATION; PREDICTION;
   GUIDELINES; STROKE
AB Background and Objectives: Morning hypertension is closely related to target organ damage and cardiovascular events. Little data is available concerning the baseline characteristics and comprehensive blood pressure analysis of hypertensive patients on treatment with morning hypertension. Subjects and Methods: We evaluated 1,087 hypertensive patients who had taken stable anti-hypertensive medication at least 6 months. The enrolled patients measured their home blood pressure for 7 days. Baseline characteristics and the laboratory data were analyzed. Morning hypertension was defined as a morning blood pressure >= 135/85 mm Hg and systolic or diastolic blood pressure difference between morning and evening exceeding 10 mm Hg. Results: One hundred seventy three patients with morning hypertension showed a preponderance of males, older patients, alcohol consumers, and greater waist circumference and waist-to-hip ratio despite the same body mass index. Impaired fasting glucose and metabolic syndrome were more prevalent in the patients with morning hypertension. The morning hypertensives took more anti-hypertensive drugs and displayed higher blood pressure in the clinic and at home. Conclusion: The worse clinical variables and relatively poorly controlled blood pressure of those with morning hypertension supports a potential relationship of morning hypertension with poor cardiovascular outcome. Morning blood pressure should be monitored at home for the optimal treatment of hypertension.
C1 [Lee, Ju-Hee; Bae, Jang-Whan; Kim, Dong-Woon] Chungbuk Natl Univ Hosp, Ctr Cardiovasc, Cheongju 361711, South Korea.
   [Park, Jung Bae] Kwandong Univ, Coll Med, Cheil Gen Hosp, Div Med Cardiol, Seoul, South Korea.
   [Park, Chang Gyu] Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul, South Korea.
   [Youn, Ho-Joong] Catholic Univ Korea, Coll Med, Ctr Cardiovasc, Seoul, South Korea.
   [Youn, Ho-Joong] Catholic Univ Korea, Coll Med, Div Cardiol, Seoul, South Korea.
   [Choi, Dong Ju] Seoul Natl Univ, Bundang Hosp, Ctr Cardiovasc, Songnam, South Korea.
   [Ahn, Young Keun] Chonnam Natl Univ Hosp, Ctr Heart, Kwangju, South Korea.
   [Shin, Joon-Han] Ajou Univ, Sch Med, Dept Cardiol, Suwon 441749, South Korea.
   [Rim, Se-Joong] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.
   [Bae, Jang-Ho] Konyang Univ, Coll Med, Ctr Heart, Dept Cardiol, Taejon, South Korea.
RP Kim, DW (corresponding author), Chungbuk Natl Univ Hosp, Dept Internal Med, Div Cardiol, 776 1Sunhwan Ro, Cheongju 361711, South Korea.
EM kdwoon@chungbuk.ac.kr
FU Chungbuk National University
FX This work was supported by the research grant of the Chungbuk National
   University in 2009.
CR Asayama K, 2006, HYPERTENSION, V48, P737, DOI 10.1161/01.HYP.0000240332.01877.11
   임수, 2005, Diabetes and Metabolism Journal, V29, P432
   Giles TD, 2006, J HYPERTENS, V24, pS11, DOI 10.1097/01.hjh.0000220098.12154.88
   Gosse P, 2004, J HYPERTENS, V22, P1113, DOI 10.1097/00004872-200406000-00011
   Gosse P, 2001, J HUM HYPERTENS, V15, P413, DOI 10.1038/sj.jhh.1001187
   Ikeda T, 2004, HYPERTENS RES, V27, P939, DOI 10.1291/hypres.27.939
   Imai Y, 2003, HYPERTENS RES, V26, P771, DOI 10.1291/hypres.26.771
   Ishikawa J, 2005, AM J HYPERTENS, V18, P958, DOI 10.1016/j.amjhyper.2005.01.013
   Ishikawa J, 2008, J CLIN HYPERTENS, V10, P34, DOI 10.1111/j.1524-6175.2007.07250.x
   Ishikawa J, 2006, HYPERTENS RES, V29, P679, DOI 10.1291/hypres.29.679
   Kamoi K, 2002, DIABETES CARE, V25, P2218, DOI 10.2337/diacare.25.12.2218
   Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA
   Kario K, 2006, HYPERTENS RES, V29, P581, DOI 10.1291/hypres.29.581
   Kario K, 2008, J AM SOC HYPERTENS, V2, P397, DOI 10.1016/j.jash.2008.05.004
   Kawabe H, 2009, HYPERTENS RES, V32, P1028, DOI 10.1038/hr.2009.138
   Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f
   Manfredini R, 1996, ANN NY ACAD SCI, V783, P141, DOI 10.1111/j.1749-6632.1996.tb26713.x
   Marfella R, 2005, AM J HYPERTENS, V18, P308, DOI 10.1016/j.amjhyper.2004.09.013
   Mengden T, 2000, BLOOD PRESS MONIT, V5, P111
   Ohkubo T, 1997, J HYPERTENS, V15, P357, DOI 10.1097/00004872-199715040-00006
   Pickering T, 1996, AM J HYPERTENS, V9, P1, DOI 10.1016/0895-7061(95)00341-X
   Polonia Jorge, 2005, Rev Port Cardiol, V24, P65
   Shibuya Y, 2007, HYPERTENS RES, V30, P903, DOI 10.1291/hypres.30.903
   Shimizu M, 2009, AM J HYPERTENS, V22, P611, DOI 10.1038/ajh.2009.61
   Tamaki S, 2006, HYPERTENS RES, V29, P783, DOI 10.1291/hypres.29.783
NR 25
TC 5
Z9 12
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 733
EP 743
DI 10.4070/kcj.2011.41.12.733
PG 11
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300007
PM 22259604
OA Green Published
DA 2021-04-22
ER

PT J
AU Bang, S
   Ko, HK
   Yu, JJ
   Han, MK
   Kim, YH
   Ko, JK
   Park, IS
AF Bang, Sunhee
   Ko, Hong Ki
   Yu, Jeong Jin
   Han, Myung-Ki
   Kim, Young-Hwue
   Ko, Jae-Kon
   Park, In-Sook
TI Right Ventricular Outflow Tract Stenting in a Low Birth Weight Infant
   Born With Tetralogy of Fallot and Prostaglandin E1 Dependency
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Tetralogy of Fallot; Infant, Low birth weight; Ventricular outflow
   obstruction; Stents
AB Surgical skill and strategy for the correction of tetralogy of Fallot (TOF) have improved and resulted in satisfactory outcomes. However, prematurity and low birth weight continue to remain risk factors for poor outcomes. We present a case of a 2,150 g neonate born with TOF, in whom palliation was achieved with right ventricular outflow tract (RVOT) stenting. Seventy-seven days after the procedure, stenosis of RVOT below the stent was identified. At that time his body weight was 4.9 kg and total corrective surgery was deemed feasible. Eight months following surgical repair, the patient remained well without medical intervention. RVOT stenting may be a viable interim procedure while waiting for a low birth weight neonate born with TOF and prostaglandin E1 dependency to reach optimal weight to undergo corrective surgery.
C1 [Bang, Sunhee; Ko, Hong Ki; Yu, Jeong Jin; Han, Myung-Ki; Kim, Young-Hwue; Ko, Jae-Kon; Park, In-Sook] Univ Ulsan, Coll Med, Dept Pediat, Seoul 138736, South Korea.
RP Yu, JJ (corresponding author), Univ Ulsan, Asan Med Ctr, Coll Med, Dept Pediat, 86 Asanbyeongwon Gil, Seoul 138736, South Korea.
EM pediatrist@medimail.co.kr
CR CHANG AC, 1994, J PEDIATR-US, V124, P461, DOI 10.1016/S0022-3476(94)70376-0
   Dohlen G, 2009, HEART, V95, P142, DOI 10.1136/hrt.2007.135723
   Gibbs JL, 1997, HEART, V77, P176, DOI 10.1136/hrt.77.2.176
   Gladman G, 1997, J THORAC CARDIOV SUR, V114, P25, DOI 10.1016/S0022-5223(97)70113-2
   Jonas Richard A, 2009, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, P39, DOI 10.1053/j.pcsu.2009.01.021
   Laudito A, 2006, ANN THORAC SURG, V81, P744, DOI 10.1016/j.athoracsur.2004.10.068
   Lee Y, 1971, KOREAN CIRC J, V1, P17
   Morales DL, 2009, SEMIN THORAC CARDIOV, V12, P54, DOI DOI 10.1053/J.PCSU.2009.02.001
   Reddy VM, 1999, J THORAC CARDIOV SUR, V117, P324, DOI 10.1016/S0022-5223(99)70430-7
   Song JY, 2000, KOREAN CIRC J, V30, P745
   Van Arsdell GS, 2000, CIRCULATION, V102, P123
   Wernovsky G, 2001, CLIN PERINATOL, V28, P249, DOI 10.1016/S0095-5108(05)70078-6
NR 12
TC 5
Z9 6
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 744
EP 746
DI 10.4070/kcj.2011.41.12.744
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300008
PM 22259605
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SM
   Gwon, HC
   Lee, HJ
   Choi, JH
   Choi, SH
   Yang, JH
   Lee, SY
   Song, YB
   Hahn, JY
   Choi, JH
   Choi, SH
   Lee, SH
AF Kim, Sang Min
   Gwon, Hyeon-Cheol
   Lee, Hyun Jong
   Choi, Joon Hyouk
   Choi, Soo Hee
   Yang, Ji Hyun
   Lee, Sang Yeub
   Song, Young Bin
   Hahn, Joo-Yong
   Choi, Jin Ho
   Choi, Seung-Hyuk
   Lee, Sang Hoon
TI Periprocedural Myocardial Infarction After Retrograde Approach for
   Chronic Total Occlusion of Coronary Artery: Demonstrated by Cardiac
   Magnetic Resonance Imaging
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary occlusion; Percutaneous transluminal coronary angioplasty;
   Complications; Myocardial infarction
AB A retrograde approach through the collateral channels was recently proposed as one of the most promising current techniques for percutaneous coronary intervention of chronic total occlusion in coronary arteries (CTO). This report describes the case of a 68-year-old man in whom CTO was successfully crossed with a wire by the retrograde approach using septal collateral, but the patient suffered from a complication with septal myocardial infarction demonstrated by cardiac magnetic resonance imaging.
C1 [Kim, Sang Min; Lee, Sang Yeub] Chungbuk Natl Univ Hosp, Ctr Cardiovasc, Cheongju, South Korea.
   [Gwon, Hyeon-Cheol; Choi, Soo Hee; Yang, Ji Hyun; Song, Young Bin; Hahn, Joo-Yong; Choi, Jin Ho; Choi, Seung-Hyuk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Cardiac & Vasc Ctr, Seoul 135710, South Korea.
   [Lee, Hyun Jong] Sejong Gen Hosp, Ctr Cardiovasc, Puchon, South Korea.
   [Choi, Joon Hyouk; Lee, Sang Hoon] Jeju Hanmaum Hosp, Ctr Cardiovasc, Cheju, South Korea.
RP Gwon, HC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Cardiac & Vasc Ctr, 50 Irwon Dong, Seoul 135710, South Korea.
EM hcgwon@skku.edu
RI Hahn, Joo-Yong/AAU-7250-2020
OI Hahn, Joo-Yong/0000-0002-4412-377X; Yang, Ji Hyun/0000-0003-0102-8489;
   Choi, Seung-Hyuk/0000-0002-0304-6317
CR Chung Suk Hwan, 2009, Korean Circ J, V39, P228, DOI 10.4070/kcj.2009.39.6.228
   HAMM CW, 1990, AM J CARDIOL, V66, P1459, DOI 10.1016/0002-9149(90)90534-8
   SAFIAN RD, 1988, AM J CARDIOL, V61, pG23, DOI 10.1016/S0002-9149(88)80028-6
   Saito S, 2008, CATHETER CARDIO INTE, V71, P8, DOI 10.1002/ccd.21316
   Surmely JF, 2007, CATHETER CARDIO INTE, V69, P826, DOI 10.1002/ccd.20816
   Surmely Jean-Francois, 2006, J Invasive Cardiol, V18, P334
   Werner GS, 2003, CIRCULATION, V107, P1972, DOI 10.1161/01.CIR.0000061953.72662.3A
NR 7
TC 7
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 747
EP 749
DI 10.4070/kcj.2011.41.12.747
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300009
PM 22259606
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SM
   Park, SJ
   Park, JR
   Choi, JH
   Yang, JH
   Noh, HJ
   Jo, HC
   Choi, SH
   Choe, YH
   Park, SW
AF Kim, Sang Min
   Park, Sung-Ji
   Park, Jeong Rang
   Choi, Joon Hyouk
   Yang, Ji Hyun
   Noh, Hye Jin
   Jo, Hyun Chul
   Choi, Soo Hee
   Choe, Yeon Hyeon
   Park, Seung Woo
TI A Newly Developed Pericardial Tuberculoma During Antituberculous Therapy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Tuberculosis; Magnetic resonance imaging
AB Tuberculosis generally affects the respiratory tract. In developing nations, the pericardium is the most common location of extrapulmonary tuberculosis; however, tuberculous pericarditis rarely appears as a localized mass or tuberculoma. We present here a case of a 62-year-old woman with pericardial tuberculoma. She had a history of effusive tuberculous pericarditis and drainage. Because she had taken regular medication over a period of six months, the pericardial mass with an adjacent lung nodule newly detected on the chest radiogram was initially suspected of being invasive lung cancer. Prior to pathologic confirmation, precise information from imaging tests, including computed tomography, magnetic resonance imaging, and positron emission tomography-computed tomography are helpful when making decisions regarding which methods should be used for surgical approach and treatment. Through imaging, our case showed typical features of pericardial tuberculoma and a favorable clinical course after two months with a change in antituberculous therapy.
C1 [Kim, Sang Min] Chungbuk Natl Univ Hosp, Ctr Cardiovasc, Cheongju, South Korea.
   [Park, Sung-Ji; Yang, Ji Hyun; Noh, Hye Jin; Jo, Hyun Chul; Choi, Soo Hee; Park, Seung Woo] Samsung Med Ctr, Cardiac & Vasc Ctr, Cardiovasc Imaging Ctr, Seoul 135710, South Korea.
   [Park, Jeong Rang] Gyeongsang Natl Univ Hosp, Dept Cardiol, Jinju, South Korea.
   [Choi, Joon Hyouk] Jeju Hanmaum Hosp, Cheju, South Korea.
   [Choe, Yeon Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci,Dept Radiol, Seoul, South Korea.
RP Park, SJ (corresponding author), Samsung Med Ctr, Cardiac & Vasc Ctr, Cardiovasc Imaging Ctr, Dept Med,Div Cardiol, 50 Irwon Dong, Seoul 135710, South Korea.
EM sungji.park@samsung.com
RI Choe, Yeon Hyeon/F-1422-2010
OI Choe, Yeon Hyeon/0000-0002-9983-048X; Yang, Ji Hyun/0000-0003-0102-8489
CR Bury T, 1997, THORAX, V52, P187, DOI 10.1136/thx.52.2.187
   Gulati GS, 2004, CLIN RADIOL, V59, P514, DOI 10.1016/j.crad.2003.12.005
   Jagia P, 2004, PEDIATR RADIOL, V34, P904, DOI 10.1007/s00247-004-1222-8
   KIM TK, 1995, AM J NEURORADIOL, V16, P1903
   Mayosi BM, 2005, CIRCULATION, V112, P3608, DOI 10.1161/CIRCULATIONAHA.105.543066
NR 5
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 750
EP 753
DI 10.4070/kcj.2011.41.12.750
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300010
PM 22259607
OA Green Published
DA 2021-04-22
ER

PT J
AU Kee, WJ
   Jeong, MH
   Jang, SY
   Lee, MG
   Park, KH
   Sim, DS
   Hong, YJ
   Kim, JH
   Ahn, Y
   Kang, JC
AF Kee, Won Ju
   Jeong, Myung Ho
   Jang, Soo Young
   Lee, Min Goo
   Park, Keun-Ho
   Sim, Doo Sun
   Hong, Young Joon
   Kim, Ju Han
   Ahn, Youngkeun
   Kang, Jung Chaee
TI Very Late Stent Thrombosis due to Neointimal Rupture After
   Paclitaxel-Eluting Stent Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary thrombosis; Paclitaxel; Ultrasonics; Clopidogrel
AB We report our experience of very late stent thrombosis (VLST) in a young male patient who underwent implantation of two paclitaxel-eluting stents (PES) six years ago. The patient was compliant with standard dual antiplatelet therapy, but he presented with acute myocardial infarction which was associated with VLST. Intravascular ultrasound showed neointimal rupture with thrombus within the PES implanted in the right coronary artery. The lesion was successfully treated with balloon angioplasty without complications, however he was found to be hyporesponsive to clopidogrel when tested for adenosine diphosphate-induced platelet aggregation. The patient was discharged after uneventful recovery with triple anti-platelet therapy using aspirin, clopidogrel and cilostazol. To the best of our knowledge, a time interval of 2,223 days is the longest reported time interval between PES deployment and VLST occurrence. VLST may indeed occur in clinically stable patients, as multiple factors can influence the pathological mechanisms of VLST.
C1 [Kee, Won Ju; Jeong, Myung Ho; Jang, Soo Young; Lee, Min Goo; Park, Keun-Ho; Sim, Doo Sun; Hong, Young Joon; Kim, Ju Han; Ahn, Youngkeun; Kang, Jung Chaee] Chonnam Natl Univ Hosp, Heart Res Ctr, Korea Minist Hlth & Welf, Kwangju 501757, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Heart Res Ctr, 167 Jaebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
CR Ahn YS, 2008, KOREAN CIRC J, V38, P564
   Angiolillo DJ, 2005, THROMB RES, V115, P101, DOI 10.1016/j.thromres.2004.07.007
   Ellis SG, 2007, J AM COLL CARDIOL, V49, P1043, DOI 10.1016/j.jacc.2007.01.015
   Farb A, 2001, CIRCULATION, V104, P473, DOI 10.1161/hc3001.092037
   Higo T, 2009, JACC-CARDIOVASC IMAG, V2, P616, DOI 10.1016/j.jcmg.2008.12.026
   Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126
   Jensen LO, 2007, J AM COLL CARDIOL, V50, P463, DOI 10.1016/j.jacc.2007.06.002
   Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042
   Kim Sung Soo, 2009, Korean Circ J, V39, P205, DOI 10.4070/kcj.2009.39.5.205
   Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731
   Muller I, 2003, THROMB HAEMOSTASIS, V89, P783
   Rogers C, 1996, CIRCULATION, V94, P2909, DOI 10.1161/01.CIR.94.11.2909
   Seol Sang-Hoon, 2009, Korean Circ J, V39, P439, DOI 10.4070/kcj.2009.39.10.439
   Wenaweser P, 2008, J AM COLL CARDIOL, V52, P1134, DOI 10.1016/j.jacc.2008.07.006
   Yokoyama S, 2010, INT HEART J, V51, P7, DOI 10.1536/ihj.51.7
   남창욱, 2007, Korean Circulation Journal, V37, P385
NR 16
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 754
EP 758
DI 10.4070/kcj.2011.41.12.754
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300011
PM 22259608
OA Green Published
DA 2021-04-22
ER

PT J
AU Yang, SM
   Kang, SH
   Kim, KT
   Park, SW
   Lee, WS
AF Yang, Seung-Min
   Kang, Suk-Hyung
   Kim, Kyoung-Tae
   Park, Seung Won
   Lee, Wang-Soo
TI Spontaneous Spinal Epidural Hematomas Associated With Acute Myocardial
   Infarction Treatment
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Acute myocardial infarction; Hematoma, epidural, spinal; Paraplegia;
   Thrombolytic therapy; Anticoagulants
AB Many studies have reported spontaneous spinal epidural hematoma (SSEH). Although most cases are idiopathic, several are associated with thrombolytic therapy or anticoagulants. We report a case of SSEH coincident with acute myocardial infarction (AMI), which caused serious neurological deficits. A 56 year old man presented with chest pain accompanied with back and neck pain, which was regarded as an atypical symptom of AMI. He was treated with nitroglycerin, aspirin, low molecular weight heparin, and clopidogrel. A spinal magnetic resonance image taken after paraplegia developed 3 days after the initial symptoms revealed an epidural hematoma at the cervical and thoracolumbar spine. Despite emergent decompressive surgery, paraplegia has not improved 7 months after surgery. A SSEH should be considered when patients complain of abrupt, strong, and non-traumatic back and neck pain, particularly if they have no spinal pain history.
C1 [Yang, Seung-Min; Park, Seung Won] Chung Ang Univ, Coll Med, Dept Neurol Surg, Seoul 156756, South Korea.
   [Yang, Seung-Min; Kang, Suk-Hyung; Park, Seung Won] Chung Ang Univ, Grad Sch, Dept Neurol Surg, Seoul 156756, South Korea.
   [Kang, Suk-Hyung] Hallym Univ, Coll Med, Med Ctr, Chuncheon Sacred Heart Hosp,Spine Ctr,Dept Neuros, Chunchon 200704, South Korea.
   [Kim, Kyoung-Tae] Kyungpook Natl Univ Hosp, Dept Neurosurg, Taegu, South Korea.
   [Lee, Wang-Soo] Chung Ang Univ, Coll Med, Div Cardiol, Seoul 156756, South Korea.
RP Kang, SH (corresponding author), Hallym Univ, Coll Med, Med Ctr, Chuncheon Sacred Heart Hosp,Spine Ctr,Dept Neuros, 153 Gyo Dong, Chunchon 200704, South Korea.
EM nscharisma@hanmail.net
RI Kang, Sukhyung/R-6333-2019; Won, Park Seung/F-2877-2014
OI Won, Park Seung/0000-0001-8305-7501; Kang, Sukhyung/0000-0002-1130-9754
CR Akhtar Mohammed Majid, 2010, Practitioner, V254, P25
   Chan KC, 2002, JPN HEART J, V43, P417, DOI 10.1536/jhj.43.417
   Cultrera F, 2004, J Neurosurg Sci, V48, P43
   Kitagawa RS, 2009, J NEUROSURG-PEDIATR, V3, P425, DOI 10.3171/2009.2.PEDS08427
   Kumar A, 2009, MAYO CLIN PROC, V84, P917, DOI 10.1016/S0025-6196(11)60509-0
   Lee H, 2001, Crit Care Nurs Clin North Am, V13, P531
   Lee H O, 1997, Am J Crit Care, V6, P7
   Liu Z, 2008, SURG NEUROL, V69, P253, DOI 10.1016/j.surneu.2007.02.019
   Lovlien M, 2006, SCAND CARDIOVASC J, V40, P342, DOI 10.1080/14017430600913199
   McSweeney JC, 2003, CIRCULATION, V108, P2619, DOI 10.1161/01.CIR.0000097116.29625.7C
   Riegel B, 2010, AM HEART J, V159, P392, DOI 10.1016/j.ahj.2010.01.003
   Subbiah M, 2010, Spine J, V10, pe11, DOI 10.1016/j.spinee.2010.04.011
   Sung JH, 2007, J KOREAN MED SCI, V22, P577, DOI 10.3346/jkms.2007.22.3.577
   Tagaya A, 2010, PEDIATR INT, V52, P296, DOI 10.1111/j.1442-200X.2010.03033.x
NR 14
TC 4
Z9 5
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 759
EP 762
DI 10.4070/kcj.2011.41.12.759
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300012
PM 22259609
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Seo, SM
   Kim, EO
   Ahn, HJ
   Lee, YW
   Cho, YH
   Baek, I
   Oh, YS
   Yu, J
   Seung, KB
AF Lee, Jae Ho
   Seo, Suk Min
   Kim, Eun Oh
   Ahn, Hyo Jun
   Lee, Yang Won
   Cho, Yul-Hee
   Baek, Inwoon
   Oh, You Suk
   Yu, Jihyun
   Seung, Ki-Bae
TI Stent Fracture at the Proximal Shaft of the Left Main Stem
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Stent fracture; Left main stem; Acute myocardial infarction
ID CORONARY STENT
AB Stent fracture is likely to be caused due to mechanical stress at the hinge point or kinking movement at the point of aneurysm formation with stent malapposition. To our knowledge, this is the first published report of stent fracture at the proximal shaft of the left main stem in a patient with acute myocardial infarction.
C1 [Lee, Jae Ho; Seo, Suk Min; Kim, Eun Oh; Ahn, Hyo Jun; Lee, Yang Won; Cho, Yul-Hee; Baek, Inwoon; Oh, You Suk; Yu, Jihyun; Seung, Ki-Bae] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Internal Med, Seoul 137701, South Korea.
   [Seo, Suk Min; Seung, Ki-Bae] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Ctr Cardiovasc, Seoul 137701, South Korea.
   [Seo, Suk Min; Seung, Ki-Bae] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Div Cardiol, Seoul 137701, South Korea.
RP Seung, KB (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Internal Med, 222 Banpodaero, Seoul 137701, South Korea.
EM kbseung@catholic.ac.kr
RI Seo, Suk Min/AAB-8238-2021
CR Adlakha S, 2010, INT J CARDIOL, V141, pE23, DOI 10.1016/j.ijcard.2008.11.135
   Aoki J, 2008, JACC-CARDIOVASC INTE, V1, P14, DOI 10.1016/j.jcin.2007.10.004
   Aoki J, 2007, CATHETER CARDIO INTE, V69, P380, DOI 10.1002/ccd.20950
   BERGELSON BA, 1995, AM HEART J, V129, P350, DOI 10.1016/0002-8703(95)90018-7
   Doi H, 2009, AM J CARDIOL, V103, P818, DOI 10.1016/j.amjcard.2008.11.051
   Hong MK, 2006, CIRCULATION, V113, P414, DOI 10.1161/CIRCULATIONAHA.105.563403
   Kim EJ, 2007, INT J CARDIOL, V120, P417, DOI 10.1016/j.ijcard.2006.08.019
   이승율, 2008, Korean Circulation Journal, V38, P69
   Lee MS, 2007, CATHETER CARDIO INTE, V69, P387, DOI 10.1002/ccd.20942
   Liao R, 2004, INT J CARDIOVAS IMAG, V20, P305, DOI 10.1023/B:CAIM.0000041950.84736.e6
   Tizon-Marcos H, 2009, J INTERV CARDIOL, V22, P362, DOI 10.1111/j.1540-8183.2009.00484.x
NR 11
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 763
EP 765
DI 10.4070/kcj.2011.41.12.763
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300013
PM 22259610
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, J
   Kim, JS
   Park, YH
   Kim, JH
   Chun, KJ
AF Kim, Jun
   Kim, Jeong Su
   Park, Yong Hyun
   Kim, June Hong
   Chun, Kook Jin
TI Catheter Ablation of Parahisian Premature Ventricular Complex
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Premature ventricular complexes; Bundle of His; Catheter ablation
AB Catheter ablation is performed in selected patients with a symptomatic premature ventricular complex (PVC) or PVC-induced cardiomyopathy. Ablation of PVC from the His region has a high risk of inducing a complete atrioventricular block. Here we report successful catheter ablation of a parahisian PVC in a 63-year-old man.
C1 [Kim, Jun; Kim, Jeong Su; Park, Yong Hyun; Kim, June Hong; Chun, Kook Jin] Pusan Natl Univ, Sch Med, Ctr Cardiovasc, Dept Internal Med,Yangsan Hosp, Yangsan 626770, South Korea.
RP Kim, J (corresponding author), Pusan Natl Univ, Sch Med, Ctr Cardiovasc, 20 Geumo Ro, Yangsan 626770, South Korea.
EM mdjunkim@yahoo.co.kr
OI Kim, Jun/0000-0002-3573-638X
FU Pusan National University Yangsan HospitalPusan National University
FX This work was supported by a 2011 research grant from Pusan National
   University Yangsan Hospital.
CR Anderson RH, 2000, ANAT REC, V260, P81, DOI 10.1002/1097-0185(20000901)260:1<81::AID-AR90>3.0.CO;2-3
   Ashikaga K, 2007, EUROPACE, V9, P781, DOI 10.1093/europace/eum085
   Bogun F, 2007, HEART RHYTHM, V4, P863, DOI 10.1016/j.hrthm.2007.03.003
   Callans DJ, 1997, J AM COLL CARDIOL, V29, P1023, DOI 10.1016/S0735-1097(97)00004-1
   Choi YS, 1999, KOREAN CIRC J, V29, P1089
   Di Biase L, 2011, HEART RHYTHM, V8, P968, DOI 10.1016/j.hrthm.2011.02.038
   HAISSAGUERRE M, 1994, CIRCULATION, V90, P1124, DOI 10.1161/01.CIR.90.3.1124
   Haissaguerre M, 2003, CIRCULATION, V108, P925, DOI 10.1161/01.CIR.0000088781.99943.95
   Ito S, 2003, J CARDIOVASC ELECTR, V14, P1280, DOI 10.1046/j.1540-8167.2003.03211.x
   Kanei Y, 2008, ANN NONINVAS ELECTRO, V13, P81, DOI 10.1111/j.1542-474X.2007.00204.x
   Noda T, 2005, J AM COLL CARDIOL, V46, P1288, DOI 10.1016/j.jacc.2005.05.077
   Seidl K, 1999, J CARDIOVASC ELECTR, V10, P924, DOI 10.1111/j.1540-8167.1999.tb01263.x
   Takemoto M, 2005, J AM COLL CARDIOL, V45, P1259, DOI 10.1016/j.jacc.2004.12.073
   Yamauchi Y, 2005, J CARDIOVASC ELECTR, V16, P1041, DOI 10.1111/j.1540-8167.2005.40787.x
   Yarlagadda RK, 2005, CIRCULATION, V112, P1092, DOI 10.1161/CIRCULATIONAHA.105.546432
   ZHU DWX, 1995, J AM COLL CARDIOL, V26, P843, DOI 10.1016/0735-1097(95)00287-7
NR 16
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 766
EP 769
DI 10.4070/kcj.2011.41.12.766
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300014
PM 22259611
OA Green Published
DA 2021-04-22
ER

PT J
AU Islam, AKMM
   Rahman, MT
   Paul, TK
AF Islam, A. K. M. Monwarul
   Rahman, Md. Toufiqur
   Paul, Tapesh Kumar
TI Biatrial Myxoma in a Young Male Patient
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Islam, A. K. M. Monwarul; Rahman, Md. Toufiqur] Natl Inst Cardiovasc Dis, Dhaka 1207, Bangladesh.
   [Paul, Tapesh Kumar] Delta Med Coll & Hosp, Dhaka, Bangladesh.
RP Islam, AKMM (corresponding author), Natl Inst Cardiovasc Dis, Dept Cardiol, Dhaka 1207, Bangladesh.
EM drmonwarbd@yahoo.com
CR Bojar RM, 1992, ADULT CARDIAC SURG, P358
   ETH Yeh, 2011, HURSTS HEART, P2011
   Grasso AW, 2009, MANUAL CARDIOVASCULA, P288
   Roy ANS, 2011, CLIN CARDIOL, V34, P83, DOI 10.1002/clc.20845
NR 4
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD DEC
PY 2011
VL 41
IS 12
BP 770
EP 771
DI 10.4070/kcj.2011.41.12.770
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IE
UT WOS:000209079300015
PM 22259612
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, NK
   Park, SJ
   Choi, JY
AF Kim, Nam Kyun
   Park, Su-Jin
   Choi, Jae Young
TI Transcatheter Closure of Atrial Septal Defect: Does Age Matter?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Atrial septal defect; Septal occluder device; Child; Aged
AB Atrial septal defect (ASD) is the most common type of common congenital heart disease (CHD) in adults. During the last decade, there has been a remarkable change in the treatment strategy of ASD, shifting the therapeutic gold standard from surgery to transcatheter closure, along with refinements and the evolution of device technology. Reports on the outcome of transcatheter ASD closure have shown an excellent efficacy as well as a low complication rate. However, the procedural details and/or outcomes of this procedure may be influenced by several factors including morphologic characteristics of the defect, comorbid diseases, as well as individual factors including age and weight of the patient. Because the risk-benefit relationship in both the very young and the elderly subsets of the patients has not been clearly defined yet, closure of an ASD with device may be potentially subtracted from the treatment option in these patient groups. In this article, we will review the basis for device closure in small children and elderly patients with ASD and provide an overview of the frequently encountered problems.
C1 [Kim, Nam Kyun; Park, Su-Jin; Choi, Jae Young] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Pediat Cardiol, Seoul 120752, South Korea.
RP Choi, JY (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Pediat Cardiol, 250 Seongsan Ro, Seoul 120752, South Korea.
EM cjy0122@yuhs.ac
OI Choi, Jae Young/0000-0002-1247-6669
CR Amin Z, 2006, CATHETER CARDIO INTE, V68, P778, DOI 10.1002/ccd.20872
   Attie F, 2001, J AM COLL CARDIOL, V38, P2035, DOI 10.1016/S0735-1097(01)01635-7
   BULL C, 1981, ARCH DIS CHILD, V56, P784, DOI 10.1136/adc.56.10.784
   Cardenas L, 2007, CATHETER CARDIO INTE, V69, P447, DOI 10.1002/ccd.21030
   Choi JY, 2008, CATHETER CARDIOVASC, V1, pS10
   Diab KA, 2007, J THORAC CARDIOV SUR, V134, P960, DOI 10.1016/j.jtcvs.2007.06.018
   Elshershari H, 2008, J INVASIVE CARDIOL, V20, P173
   Ewert P, 2001, CATHETER CARDIO INTE, V52, P177, DOI 10.1002/1522-726X(200102)52:2<177::AID-CCD1043>3.0.CO;2-G
   Gatzoulis MA, 1999, NEW ENGL J MED, V340, P839, DOI 10.1056/NEJM199903183401103
   Hijazi Ziyad M, 2005, Anadolu Kardiyol Derg, V5, P331
   Holzer R, 2004, CURR OPIN CARDIOL, V19, P84, DOI 10.1097/00001573-200403000-00003
   Keane JFLJ, 2006, NADAS PEDIAT CARDIOL, V2, P603, DOI [10.1016/B978-1-4160-2390-6.50039-8, DOI 10.1016/B978-1-4160-2390-6.50039-8]
   Lammers A, 2005, J THORAC CARDIOV SUR, V129, P1353, DOI 10.1016/j.jtcvs.2004.10.007
   McMahon CJ, 2002, HEART, V87, P256, DOI 10.1136/heart.87.3.256
   Miyaji K, 1997, JPN HEART J, V38, P677
   Oliver JM, 2002, AM J CARDIOL, V89, P39
   Park M, 2008, PEDIAT CARDIOLOGY PR, P161
   Schubert S, 2005, CATHETER CARDIO INTE, V64, P333, DOI 10.1002/ccd.20292
   SHAH D, 1994, BRIT HEART J, V71, P224
   Shibata Y, 1996, ANN THORAC SURG, V62, P1096, DOI 10.1016/0003-4975(96)00395-5
   Silversides CK, 2004, HEART, V90, P1194, DOI 10.1136/hrt.2003.022475
   Spies Christian, 2009, Korean Circulation Journal, V39, P47
   Swan L, 2006, INT J CARDIOL, V107, P207, DOI 10.1016/j.ijcard.2005.03.027
   Taniguchi M, 2009, CATHETER CARDIO INTE, V73, P682, DOI 10.1002/ccd.21870
   Verma A, 2005, CIRCULATION, V112, P1214, DOI 10.1161/CIRCULATIONAHA.104.478263
   Vogel M, 2000, CARDIOL YOUNG, V10, P534
   Wood AM, 2011, CONGENIT HEART DIS, V6, P330, DOI 10.1111/j.1747-0803.2011.00540.x
   Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328
   Yalonetsky S, 2009, CONGENIT HEART DIS, V4, P17, DOI 10.1111/j.1747-0803.2008.00245.x
NR 29
TC 15
Z9 17
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2011
VL 41
IS 11
BP 633
EP 638
DI 10.4070/kcj.2011.41.11.633
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34ID
UT WOS:000209079200001
PM 22194756
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, JW
AF Jung, Jo Won
TI Do We Have to Close Residual Patent Ductus Arteriosus After Surgery or
   Transcatheter Intervention?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Ajou Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, Suwon 443749, South Korea.
RP Jung, JW (corresponding author), Ajou Univ, Sch Med, Dept Pediat, Div Pediat Cardiol, San 5 Woncheon Dong, Suwon 443749, South Korea.
EM jwjung@ajou.ac.kr
CR Abadir S, 2009, ARCH CARDIOVASC DIS, V102, P533, DOI 10.1016/j.acvd.2009.04.004
   Baspinar O, 2011, KOREAN CIRC J, V41, P654, DOI 10.4070/kcj.2011.41.11.654
   Brunetti MA, 2010, CATHETER CARDIO INTE, V76, P696, DOI 10.1002/ccd.22538
   Burke RP, 1999, PEDIATRICS, V104, P227, DOI 10.1542/peds.104.2.227
   Chuang YC, 2011, ECHOCARDIOGR-J CARD, V28, pE101, DOI 10.1111/j.1540-8175.2010.01343.x
   Fortescue EB, 2010, CONGENIT HEART DIS, V5, P354, DOI 10.1111/j.1747-0803.2010.00435.x
   Galal MO, 2006, CARDIOL YOUNG, V16, P522, DOI 10.1017/S1047951106001314
   Gross RE, 1939, J AMER MED ASSOC, V112, P729, DOI 10.1001/jama.1939.02800080049011
   Jung Jo Won, 2010, Korean Circ J, V40, P216, DOI 10.4070/kcj.2010.40.5.216
   LABORDE F, 1993, J THORAC CARDIOV SUR, V105, P278, DOI 10.1016/S0022-5223(19)33812-7
   Magee AG, 2001, EUR HEART J, V22, P1817, DOI 10.1053/euhj.2001.2605
   MAVROUDIS C, 1994, ANN SURG, V220, P402
   Ng B, 2011, CONGENIT HEART DIS, V6, P64, DOI 10.1111/j.1747-0803.2010.00466.x
   RASHKIND WJ, 1987, CIRCULATION, V75, P583, DOI 10.1161/01.CIR.75.3.583
   Schneider DJ, 2006, CIRCULATION, V114, P1873, DOI 10.1161/CIRCULATIONAHA.105.592063
   WIERNY L, 1986, CARDIOVASC INTER RAD, V9, P279, DOI 10.1007/BF02577958
NR 16
TC 0
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2011
VL 41
IS 11
BP 639
EP 640
DI 10.4070/kcj.2011.41.11.639
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34ID
UT WOS:000209079200002
PM 22194757
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, K
   Ahn, TH
   Kang, WC
   Han, SH
   Choi, IS
   Shin, EK
AF Lee, Kyounghoon
   Ahn, Tae Hoon
   Kang, Woong Chol
   Han, Seung Hwan
   Choi, In Suck
   Shin, Eak Kyun
TI The Effects of Statin and Niacin on Plaque Stability, Plaque Regression,
   Inflammation and Oxidative Stress in Patients With Mild to Moderate
   Coronary Artery Stenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Niacin; HMG-CoA reductase; Coronary stenosis; Inflammation;
   Intravascular ultrasonography
ID EXTENDED-RELEASE NIACIN; REACTIVE PROTEIN-LEVELS; INTIMA-MEDIA
   THICKNESS; CHOLESTEROL; PREVENTION; ATHEROSCLEROSIS; VASOREACTIVITY;
   COMBINATION; PROGRESSION; PRAVASTATIN
AB Background and Objectives: The aim of this study was to compare the effects of a combination of niacin and simvastatin to simvastatin alone, on plaque regression and inflammatory makers. Subjects and Methods: The study had a prospective, randomized design. Subjects were patients with intermediate coronary artery stenosis. A total of 28 patients received a combination of niacin 1,000 mg plus simvastatin 40 mg (N+S group, n=14); the other group received simvastatin 40 mg alone (S group, n=14). All patients had a baseline and a 9-month follow-up coronary angiogram and an intravascular ultrasound procedure. Parameters such as normalized total atheroma volume (nTAV) and percent atheroma volume (PAV) were analyzed before and after treatment as were inflammatory markers such as high sensitivity C-reactive protein (hs-CRP), Matrix metalloproteinase-9 (MMP-9) and soluble CD40 ligand (sCD40L). Results: There was no difference in baseline characteristics between the two groups. The nTAV and PAV in the N+S group before and after treatment were not different than those in the S group. But the degree of changes (delta) in nTAV in the N+S group was greater than that in the S group (-21.6 +/- 10.68 vs. 5.25 +/- 42.19, respectively, p=0.024). Also, the change in PAV in the NS group was higher than that in the S group (-1.2 +/- 2.5 vs. -0.6 +/- 5, respectively, p=0.047. Changes in hs-CRP, MMP-9, and sCD40L in the NS group were significantly greater than those of the S group (-0.71 +/- 1.25, 73.5 +/- 64.9, -1,970 +/- 1,925 vs. -0.32 +/- 0.96, 62.5 +/- 30.6, -1,673 +/- 2,628, respectively). Conclusion: The combination of niacin plus simvastatin decreases coronary plaque volume and attenuates the inflammatory response in patients with intermediate coronary artery stenosis.
C1 [Lee, Kyounghoon; Ahn, Tae Hoon; Kang, Woong Chol; Han, Seung Hwan; Choi, In Suck; Shin, Eak Kyun] Gachon Univ Med & Sci, Gil Hosp, Dept Cardiol, Inchon 405760, South Korea.
RP Ahn, TH (corresponding author), Gachon Univ Med & Sci, Gil Hosp, Dept Cardiol, 1198 Guwol Dong, Inchon 405760, South Korea.
EM encore@gilhospital.com
FU Korean Society of Circulation
FX This study was supported by a grant from the Korean Society of
   Circulation (Industrial-Educational Cooperation 2006).
CR Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090
   Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x
   Cipollone F, 2002, CIRCULATION, V106, P399, DOI 10.1161/01.CIR.0000025419.95769.F0
   Fernandez-Patron C, 1999, THROMB HAEMOSTASIS, V82, P1730
   Fichtlscherer S, 2000, CIRCULATION, V102, P1000, DOI 10.1161/01.CIR.102.9.1000
   Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1
   GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8
   Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143
   Hong YJ, 2007, KOREAN CIRC J, V37, P483
   Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102
   KANNEL WB, 1995, AM J CARDIOL, V76, pC69, DOI 10.1016/S0002-9149(99)80474-3
   홍영준, 2003, Korean Circulation Journal, V33, P891
   Lelongt B, 2001, J EXP MED, V193, P793, DOI 10.1084/jem.193.7.793
   Meyers CD, 2004, CURR OPIN LIPIDOL, V15, P659, DOI 10.1097/00041433-200412000-00006
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002
   PEDERSEN TR, 1994, LANCET, V344, P1383
   Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401
   Sakai T, 2001, ARTERIOSCL THROM VAS, V21, P1783, DOI 10.1161/hq1001.096624
   SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001
   Son JW, 2003, INT J CARDIOL, V88, P77, DOI 10.1016/S0167-5273(02)00368-6
   Son JW, 1999, KOREAN CIRC J, V29, P1016
   Tang JP, 2004, J CEREBR BLOOD F MET, V24, P1133, DOI 10.1097/01.WCB.0000135593.05952.DE
   Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D
   Taylor AJ, 2007, VASC HEALTH RISK MAN, V3, P159
   Taylor AJ, 2006, CURR MED RES OPIN, V22, P2243, DOI 10.1185/030079906X148508
   Tomai F, 2001, CIRCULATION, V104, P1471, DOI 10.1161/hc3801.096354
   Tonkin A, 1998, NEW ENGL J MED, V339, P1349
   박사윤, 2003, Korean Circulation Journal, V33, P663
NR 29
TC 16
Z9 16
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2011
VL 41
IS 11
BP 641
EP 648
DI 10.4070/kcj.2011.41.11.641
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34ID
UT WOS:000209079200003
PM 22194758
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, JS
   Kang, DH
   Kim, DH
   Song, JM
   Song, JK
AF Seo, Jeong-Sook
   Kang, Duk-Hyun
   Kim, Dae-Hee
   Song, Jong-Min
   Song, Jae-Kwan
TI Predictors of Echocardiographic Progression in Patients With Mild Aortic
   Stenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic stenosis; Predictors; Prognosis
AB Background and Objectives: The factors related to the progression of mild aortic stenosis (AS) remain unknown. We wanted to evaluate the long-term outcomes and predictors of echocardiographic progression in patients with mild AS. Subjects and Methods: We prospectively included 103 consecutive asymptomatic patients (62.1 +/- 11.9 years, 31 males) with mild AS. Mild AS was defined as aortic valve (AV) thickening accompanied by a peak aortic jet velocity (AV Vmax) >= 2.0 and <3.0 m/sec, and rapid progression of AS was defined as an average annual increase in the AV Vmax >= 0.2 m/sec, and cardiac events were defined as cardiac death or AV replacement. Results: During a median echocardiographic follow-up time of 6.0 years, the average change in the AV Vmax was 0.08 +/- 0.10 m/sec per year. The rate of progression was significantly associated with age, moderate-to-severe AV calcification and the baseline AV Vmax, but not with the serum cholesterol level. The baseline AV Vmax (2.6 +/- 0.3 m/sec vs. 2.2 +/- 0.3 m/sec, respectively, p<0.001) and the incidence of moderate-to-severe AV calcification (92.9% vs. 36.5%, respectively, p<0.001) were significantly higher in the rapid progression group than in the slow progression group. The 7-year cardiac event-free survival rate was lower in the rapid progression group than in the slow progression group (87.5 +/- 8.3% vs. 100%, respectively). Conclusion: The progression of AS was slower than expected and it was related to age, the baseline AV Vmax and AV calcification. Because of the marked individual variability in progression, the patients showing rapid progression of AS need closer follow-up.
C1 [Seo, Jeong-Sook] Inje Univ, Pusan Paik Hosp, Coll Med, Dept Cardiol, Pusan, South Korea.
   [Kang, Duk-Hyun; Kim, Dae-Hee; Song, Jong-Min; Song, Jae-Kwan] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul 138736, South Korea.
RP Kang, DH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, 86 Asanbyeongwon Gil, Seoul 138736, South Korea.
EM dhkang@amc.seoul.kr
OI Kim, Dae-Hee/0000-0002-8275-4871
CR Aronow WS, 2001, AM J CARDIOL, V88, P693, DOI 10.1016/S0002-9149(01)01821-5
   Bellamy MF, 2002, J AM COLL CARDIOL, V40, P1723, DOI 10.1016/S0735-1097(02)02496-8
   Caira FC, 2006, J AM COLL CARDIOL, V47, P1707, DOI 10.1016/j.jacc.2006.02.040
   Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027
   Cowell SJ, 2005, NEW ENGL J MED, V352, P2389, DOI 10.1056/NEJMoa043876
   DEUTSCHER S, 1984, J CHRON DIS, V37, P407, DOI 10.1016/0021-9681(84)90108-5
   DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X
   Kang DH, 2010, CIRCULATION, V121, P1502, DOI 10.1161/CIRCULATIONAHA.109.909903
   Messika-Zeitoun D, 2004, CIRCULATION, V110, P356, DOI 10.1161/01.CIR.0000135469.82545.D0
   Mohty D, 2008, ARTERIOSCL THROM VAS, V28, P187, DOI 10.1161/ATVBAHA.107.154989
   Ngo DTM, 2009, JACC-CARDIOVASC IMAG, V2, P919, DOI 10.1016/j.jcmg.2009.03.016
   Novaro GM, 2001, CIRCULATION, V104, P2205, DOI 10.1161/hc4301.098249
   OBrien KD, 1996, ARTERIOSCL THROM VAS, V16, P523, DOI 10.1161/01.ATV.16.4.523
   OLSSON M, 1994, J AM COLL CARDIOL, V23, P1162, DOI 10.1016/0735-1097(94)90606-8
   Olsson M, 1999, ARTERIOSCL THROM VAS, V19, P1218, DOI 10.1161/01.ATV.19.5.1218
   OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844
   Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262
   Owens DS, 2009, JACC-CARDIOVASC IMAG, V2, P928, DOI 10.1016/j.jcmg.2009.02.016
   Rosenhek R, 2004, CIRCULATION, V110, P1291, DOI 10.1161/01.CIR.0000140723.15274.53
   Rosenhek R, 2004, EUR HEART J, V25, P199, DOI 10.1016/j.ehj.2003.12.002
   Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903
   Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602
   Ryu Dong Ryeol, 2010, J Cardiovasc Ultrasound, V18, P127, DOI 10.4250/jcu.2010.18.4.127
   Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358
   SKJAERPE T, 1985, CIRCULATION, V72, P810, DOI 10.1161/01.CIR.72.4.810
NR 25
TC 5
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2011
VL 41
IS 11
BP 649
EP 653
DI 10.4070/kcj.2011.41.11.649
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34ID
UT WOS:000209079200004
PM 22194759
OA Green Published
DA 2021-04-22
ER

PT J
AU Baspinar, O
   Kilinc, M
   Kervancioglu, M
   Irdem, A
AF Baspinar, Osman
   Kilinc, Metin
   Kervancioglu, Mehmet
   Irdem, Ahmet
TI Transcatheter Closure of a Residual Patent Ductus Arteriosus After
   Surgical Ligation in Children
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Child
AB Background and Objectives: To assess the safety and efficacy of transcatheter closure of residual ductal flow after initial surgical ligation of the arterial duct. Subjects and Methods: Between June 2005 and December 2009, transcatheter occlusion of residual postsurgical ductus arteriosus was performed in six children. Results: The mean patient age was 10 +/- 5.5 years; mean post-procedural time since the initial surgical closure was 6.3 +/- 4.5 years. The mean diameter of the patent ductus arteriosus on angiography was 1.3 +/- 0.5 mm (range, 0.8 to 2.4 mm). Three different types of coils were used successfully without any complications. Conclusion: Transcatheter occlusion of residual postsurgical arterial duct is a safe and successful procedure. However, attention should be paid due to the distorting shape of the arterial duct.
C1 [Baspinar, Osman; Kilinc, Metin; Kervancioglu, Mehmet; Irdem, Ahmet] Gaziantep Univ, Fac Med, Dept Pediat Cardiol, TR-27310 Gaziantep, Turkey.
RP Baspinar, O (corresponding author), Gaziantep Univ, Fac Med, Dept Pediat Cardiol, TR-27310 Gaziantep, Turkey.
EM osmanbaspinar@hotmail.com
RI Kervancioglu, Mehmet/AAG-8104-2020; KILINC, Metin/AAG-6503-2020; IRDEM,
   Ahmet/ABD-4409-2020
OI Kervancioglu, Mehmet/0000-0001-6207-0985; KILINC,
   Metin/0000-0003-1385-6492; Baspinar, Osman/0000-0002-9307-0344
CR Demir T, 2007, CARDIOL YOUNG, V17, P48, DOI 10.1017/S1047951106001405
   JONES JC, 1965, J THORAC CARDIOV SUR, V50, P149, DOI 10.1016/S0022-5223(19)33203-9
   Kusa Jacek, 2008, EuroIntervention, V3, P584, DOI 10.4244/EIJV3I5A105
   LLOYD TR, 1994, AM HEART J, V127, P1664, DOI 10.1016/0002-8703(94)90415-4
   Moore JW, 2005, CATHETER CARDIO INTE, V64, P91, DOI 10.1002/ccd.20243
   Ovaert C, 2003, CAN J CARDIOL, V19, P1493
   Podnar T, 1999, PEDIATR CARDIOL, V20, P126, DOI 10.1007/s002469900418
   SORENSEN KE, 1991, AM J CARDIOL, V67, P653, DOI 10.1016/0002-9149(91)90911-4
   ZUCKER N, 1993, CARDIOL YOUNG, V3, P216
NR 9
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2011
VL 41
IS 11
BP 654
EP 657
DI 10.4070/kcj.2011.41.11.654
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34ID
UT WOS:000209079200005
PM 22194760
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, S
   Park, H
   Hwang, HJ
   Shim, J
   Sung, JH
   Kim, JY
   Pak, HN
   Lee, MH
   Joung, B
AF Park, Sanghoon
   Park, Hyerim
   Hwang, Hye Jin
   Shim, Jaemin
   Sung, Jung-Hoon
   Kim, Jong-Youn
   Pak, Hui-Nam
   Lee, Moon-Hyoung
   Joung, Boyoung
TI Heart Rate Acceleration of a Subsidiary Pacemaker by beta-Adrenergic
   Stimulation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Calcium channel; Sympathetic nervous system; Sinoatrial node
AB Background and Objectives: Recent evidence indicates that the membrane voltage and Ca2+ clocks jointly regulate sinoatrial node (SAN) automaticity. However, the mechanism of heart rhythm acceleration of the subsidiary pacemaker (SP) during beta-adrenergic stimulation is still unknown. Here we tested the hypothesis that the heart rate acceleration of the SP by beta-adrenergic stimulation involves synergistic interactions between both clock mechanisms. Materials and Methods: We performed optical mapping and pharmacological interventions in 15 isolated Langendorff-perfused canine right atriums (RA). The SP model was produced by ligation of the SAN artery at the mid portion of the sulcus terminalis. Results: In the 6 RAs with an intact SAN, 1 mu mol/L isoproterenol infusion increased the heart rate from 82 +/- 9 to 166 +/- 18 bpm (102%) with late diastolic Ca-i elevation (LDCAE) at the superior SAN. However, in the 6 SP models, the heart rate increased from 55 +/- 10 bpm to 106 +/- 11 bpm (92%, p=0.005) without LDCAE at the earliest activation site. The isoproterenol induced heart rate increase was reversed to 74 +/- 5 bpm (33% from baseline) by administering an infusion of the funny current blocker ZD 7288 (3 mu mol/L, n=3), whereas, it was suppressed to 69 +/- 7 bpm (24% from baseline) by sarcoplasmic reticulum (SR) Ca2+ emptying with administering ryanodine (10 mu mol/L) plus thapsigargin (200 nmol/L, n=3). The isoproterenol induced heart rate increase was completely abolished by combined treatment with funny current blocker and SR Ca2+ emptying (n=3). Conclusion: Acceleration of the Ca2+ clock in the SP plays an important role in the heart rate acceleration during beta-adrenergic stimulation, and this interacts synergistically with the voltage clock to increase the heart rate.
C1 [Park, Sanghoon; Park, Hyerim; Hwang, Hye Jin; Shim, Jaemin; Kim, Jong-Youn; Pak, Hui-Nam; Lee, Moon-Hyoung; Joung, Boyoung] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 120752, South Korea.
   [Sung, Jung-Hoon] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Div Cardiol, Songnam, South Korea.
RP Joung, B (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol, 250 Seongsan Ro, Seoul 120752, South Korea.
EM cby6908@yuhs.ac
RI Pak, Hui-Nam/C-4266-2015
OI Pak, Hui-Nam/0000-0002-3256-3620
FU Korean Circulation Society [7-2009-0545]; Yonsei University College of
   Medicine [6-2009-0176, 6-2010-0059, 7-2009-0583]; Basic Science Research
   Program through the National Research Foundation of Korea - Ministry of
   Education, Science and Technology [2010-0021993]; Korean Healthcare
   Technology Research and Development grant [A085136]
FX This study was supported by funding from the Korean Circulation Society
   (7-2009-0545), a faculty research grant of Yonsei University College of
   Medicine (6-2009-0176, 6-2010-0059, 7-2009-0583), the Basic Science
   Research Program through the National Research Foundation of Korea as
   funded by the Ministry of Education, Science and Technology
   (2010-0021993) and a Korean Healthcare Technology Research and
   Development grant (number A085136).
CR Adan V, 2003, AM FAM PHYSICIAN, V67, P1725
   Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095
   BOINEAU JP, 1984, CIRC RES, V54, P332, DOI 10.1161/01.RES.54.3.332
   BOINEAU JP, 1978, CIRCULATION, V58, P1036, DOI 10.1161/01.CIR.58.6.1036
   DIFRANCESCO D, 1995, CARDIOVASC RES, V30, P307, DOI 10.1016/S0008-6363(95)00029-1
   DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455
   Dobrzynski H, 2007, CIRCULATION, V115, P1921, DOI 10.1161/CIRCULATIONAHA.106.616011
   Efimov IR, 2010, CIRC RES, V106, P255, DOI 10.1161/CIRCRESAHA.109.209841
   Efimov IR, 2004, CIRC RES, V95, P21, DOI 10.1161/01.RES.0000130529.18016.35
   Fedorov VV, 2009, CIRC RES, V104, P915, DOI 10.1161/CIRCRESAHA.108.193193
   Hata T, 1996, HEART VESSELS, V11, P234, DOI 10.1007/BF01746203
   Joung Boyoung, 2005, Korean Circulation Journal, V35, P183
   Joung B, 2010, AM J PHYSIOL-HEART C, V299, pH634, DOI 10.1152/ajpheart.00347.2010
   Joung Boyoung, 2009, Korean Circ J, V39, P217, DOI 10.4070/kcj.2009.39.6.217
   Joung B, 2009, CIRCULATION, V119, P788, DOI 10.1161/CIRCULATIONAHA.108.817379
   Ju YK, 1998, J PHYSIOL-LONDON, V508, P153, DOI 10.1111/j.1469-7793.1998.153br.x
   Lancaster MK, 2004, J PHYSIOL-LONDON, V556, P481, DOI 10.1113/jphysiol.2003.057372
   Lei M, 2004, J PHYSIOL-LONDON, V559, P835, DOI 10.1113/jphysiol.2004.068643
   RANDALL WC, 1978, AM J PHYSIOL, V234, pH465
   ROZANSKI GJ, 1983, CIRCULATION, V67, P1378, DOI 10.1161/01.CIR.67.6.1378
   RUBENSTEIN DS, 1989, CIRC RES, V64, P648, DOI 10.1161/01.RES.64.4.648
   Tellez JO, 2006, CIRC RES, V99, P1384, DOI 10.1161/01.RES.0000251717.98379.69
   Verheijck EE, 2001, CARDIOVASC RES, V52, P40, DOI 10.1016/S0008-6363(01)00364-9
   Vinogradova TM, 2006, CIRC RES, V98, P505, DOI 10.1161/01.RES.0000204575.94040.d1
   Vinogradova TM, 2004, CIRC RES, V94, P802, DOI 10.1161/01.RES.0000122045.55331.0F
   Vinogradova TM, 2002, CIRC RES, V90, P73, DOI 10.1161/hh0102.102271
   1997, N ENGL J MED, V337, P1576
NR 27
TC 2
Z9 2
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2011
VL 41
IS 11
BP 658
EP 665
DI 10.4070/kcj.2011.41.11.658
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34ID
UT WOS:000209079200006
PM 22194761
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, BS
   Kim, HJ
   Han, SW
   Kim, SH
   Suh, SY
   Chung, SM
   Ryu, KH
AF Kim, Bum Sung
   Kim, Hyun-Joong
   Han, Seong Woo
   Kim, Sung Hea
   Suh, Soon Yong
   Chung, Sang Man
   Ryu, Kyu Hyung
TI Slow Coronary Flow is Related to Increased Carotid Intima-Media
   Thickness but Not Pulse Wave Velocity
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Microcirculation; Slow coronary flow; Carotid intima-media thickness
AB Background and Objectives: Slow coronary flow (SCF) is characterized by delayed contrast dye opacification without significant stenosis of epicardial coronary arteries. However, the pathophysiology and clinical implications of SCF are not fully understood. Some reports have suggested that SCF might be caused by atherosclerosis in the coronary artery microvasculature. Measuring carotid intima-media thickness (IMT) and pulse wave velocity (PWV), which are non-invasive and simple diagnostic tools, was developed to detect subclinical atherosclerosis. Thus, we determined IMT and PWV, and their possible relationship in a SCF group and a normal coronary flow (NCF) group of patients. Subjects and Methods: We included 101 patients who complained of chest pain but had a normal coronary angiogram. Thrombolysis in Myocardial Infarction frame count (TIMI frame count, TFC) was evaluated in the left and right coronary arteries. We defined SCF as a TFC of more than 25. Carotid IMT was measured by ultrasonography in both common carotid arteries. PWV was calculated from pulse transit time between the brachial and ankle arteries. Results: Fifteen patients were included in the SCF group and 86 patients in the NCF group. Male patients (n = 11, 73.3%) were significantly more common in the SCF group than in the NCF group (n = 37, 43.0%, p<0.05). The TFC of the SCF and NCF groups were 28.8 +/- 3.5 and 15.7 +/- 4.5, respectively. The carotid IMT in the SCF group increased significantly compared to that in the NCF group (1.2 +/- 0.3 mm vs. 0.8 +/- 0.1 mm, p<0.01). However, no significant difference in PWV was observed between the two groups. Conclusion: SCF may reflect early atherosclerotic changes in the coronary artery microvasculature.
C1 [Kim, Bum Sung; Kim, Hyun-Joong; Han, Seong Woo; Kim, Sung Hea; Suh, Soon Yong; Chung, Sang Man; Ryu, Kyu Hyung] Konkuk Univ, Sch Med, Dept Cardiovasc Med, Seoul 143729, South Korea.
RP Ryu, KH (corresponding author), Konkuk Univ, Sch Med, Dept Cardiovasc Med, 4-12 Hwayang Dong, Seoul 143729, South Korea.
EM khryumd@hanmail.net
OI Kim, Bum Sung/0000-0002-3864-419X
CR Beltrame JF, 2002, CARDIOLOGY, V97, P197, DOI 10.1159/000063121
   Cakmak M, 2008, CARDIOLOGY, V110, P39, DOI 10.1159/000109405
   Camsari A, 2008, ATHEROSCLEROSIS, V200, P310, DOI 10.1016/j.atherosclerosis.2007.12.028
   Cin VG, 2003, JPN HEART J, V44, P907, DOI 10.1536/jhj.44.907
   CRAVEN TE, 1990, CIRCULATION, V82, P1230, DOI 10.1161/01.CIR.82.4.1230
   EGASHIRA K, 1993, NEW ENGL J MED, V328, P1659, DOI 10.1056/NEJM199306103282302
   Gibson CM, 1996, CIRCULATION, V93, P879, DOI 10.1161/01.CIR.93.5.879
   Kurtoglu N, 2001, AM J CARDIOL, V87, P777, DOI 10.1016/S0002-9149(00)01503-4
   Matsushima Y, 2004, CLIN CARDIOL, V27, P629, DOI 10.1002/clc.4960271110
   Megnien JL, 1998, AM J HYPERTENS, V11, P293, DOI 10.1016/S0895-7061(97)00477-9
   MOTZ W, 1991, AM J CARDIOL, V68, P996, DOI 10.1016/0002-9149(91)90485-4
   Olivotto I, 2006, J AM COLL CARDIOL, V47, P1043, DOI 10.1016/j.jacc.2005.10.050
   QUYYUMI AA, 1992, CIRCULATION, V86, P1864, DOI 10.1161/01.CIR.86.6.1864
   Saya S, 2008, CLIN CARDIOL, V31, P352, DOI 10.1002/clc.20266
   Seo Won-Woo, 2010, Korean Circ J, V40, P224, DOI 10.4070/kcj.2010.40.5.224
   TAMBE AA, 1972, AM HEART J, V84, P66, DOI 10.1016/0002-8703(72)90307-9
   Tanriverdi H, 2006, CORONARY ARTERY DIS, V17, P331, DOI 10.1097/00019501-200606000-00002
   van Popele NM, 2001, STROKE, V32, P454, DOI 10.1161/01.STR.32.2.454
   VRINTS C, 1991, ACTA CARDIOL, V46, P399
   WOFFORD JL, 1991, ARTERIOSCLER THROMB, V11, P1786, DOI 10.1161/01.ATV.11.6.1786
   Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359
   Yigit F, 2006, TOHOKU J EXP MED, V209, P41, DOI 10.1620/tjem.209.41
   ZEIHER AM, 1995, CIRCULATION, V91, P2345, DOI 10.1161/01.CIR.91.9.2345
NR 23
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2011
VL 41
IS 11
BP 666
EP 670
DI 10.4070/kcj.2011.41.11.666
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34ID
UT WOS:000209079200007
PM 22194762
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, HJ
   Hur, SH
   Kim, SK
   Kim, H
   Park, HS
   Cho, YK
   Nam, CW
   Kim, YN
   Kim, KB
AF Yoon, Hyuck-Jun
   Hur, Seung-Ho
   Kim, Shin-Keun
   Kim, Hyungseop
   Park, Hyoung-Seob
   Cho, Yun-Kyeong
   Nam, Chang-Wook
   Kim, Yoon-Nyun
   Kim, Kwon-Bae
TI A Case of In-Stent Neointimal Plaque Rupture 10 Years After Bare Metal
   Stent Implantation: Intravascular Ultrasound and Optical Coherence
   Tomographic Findings
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary restenosis; Stents; Neointima; Ultrasonography; Tomography
AB Neointimal hyperplasia mainly develops within several months of coronary stent deployment, after which it stabilizes. Although it was widely accepted, particularly during the bare-metal stent (BMS) era, that in-stent restenosis (ISR) generally does not present as an acute coronary syndrome (ACS), but rather as a gradual recurrence of angina symptoms, recent data have shown that a substantial number of patients with ISR present as ACS. There has also been consistent postmortem evidence of plaque rupture secondary to atherosclerotic change within the neointima of a BMS. We report here a case of ACS in which intravascular ultrasound and optical coherent tomographic assessments revealed neointimal atherosclerotic change and ruptured plaque 10 years after BMS deployment.
C1 [Yoon, Hyuck-Jun; Hur, Seung-Ho; Kim, Shin-Keun; Kim, Hyungseop; Park, Hyoung-Seob; Cho, Yun-Kyeong; Nam, Chang-Wook; Kim, Yoon-Nyun; Kim, Kwon-Bae] Keimyung Univ, Dongsan Med Ctr, Div Cardiol, Dept Internal Med, Taegu 700712, South Korea.
RP Hur, SH (corresponding author), Keimyung Univ, Dongsan Med Ctr, Div Cardiol, 194 Dongsan Dong, Taegu 700712, South Korea.
EM shur@dsmc.or.kr
OI Hur, Seung-Ho/0000-0002-3895-1915
CR Baek EK, 2008, KOREAN CIRC J, V38, P432
   Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011
   Chung IM, 2002, J AM COLL CARDIOL, V40, P2072, DOI 10.1016/S0735-1097(02)02598-6
   Doyle B, 2007, CIRCULATION, V116, P2391, DOI 10.1161/CIRCULATIONAHA.107.707331
   Fineschi M, 2009, J CARDIOVASC MED, V10, P572, DOI 10.2459/JCM.0b013e32832bca4e
   Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5
   Komatsu R, 1998, CIRCULATION, V98, P224, DOI 10.1161/01.CIR.98.3.224
   Kume T, 2006, AM J CARDIOL, V97, P1172, DOI 10.1016/j.amjcard.2005.11.035
   Lee CW, 2010, J AM COLL CARDIOL, V55, P1936, DOI 10.1016/j.jacc.2009.10.077
   Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011
   Sangiorgi G, 1999, AM HEART J, V138, P681, DOI 10.1016/S0002-8703(99)70183-3
NR 11
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2011
VL 41
IS 11
BP 671
EP 673
DI 10.4070/kcj.2011.41.11.671
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34ID
UT WOS:000209079200008
PM 22194763
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, MH
   Sung, YJ
   Yoon, JH
   Kim, J
   Oh, IY
   Choi, EK
   Oh, S
AF Lee, Min-Ho
   Sung, Young-Jun
   Yoon, Jung-Han
   Kim, Jiyeong
   Oh, Il-Young
   Choi, Eue-Keun
   Oh, Seil
TI Wolff-Parkinson-White Syndrome in a Patient With Mitochondrial
   Encephalopathy, Lactic Acidosis and Stroke-Like Episodes Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE MELAS syndrome; Wolff-Parkinson-White syndrome
AB Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome is a multisystem disorder, which is clinically characterized by encephalopathy, dementia, seizures and stroke-like episodes. Multiple organs can be affected and cardiac involvement often dominates the clinical picture because of its high energy requirement. We report a case of a 21-year-old woman with MELAS syndrome who had pre-excitation ECG and one episode of tachycardia attack.
C1 [Oh, Seil] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea.
   Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea.
RP Oh, S (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM seil@snu.ac.kr
RI Choi, Eue-Keun/J-5968-2014; Oh, Seil/J-5539-2012; Choi,
   Eue-Keun/K-3752-2019; Lee, Minho/AAJ-6477-2020
OI Choi, Eue-Keun/0000-0002-0411-6372; Oh, Seil/0000-0002-2504-9615; Lee,
   Minho/0000-0003-0748-7766
CR Abu-Amero Khaled K, 2009, J Med Case Rep, V3, P77, DOI 10.1186/1752-1947-3-77
   CIAFALONI E, 1992, ANN NEUROL, V31, P391, DOI 10.1002/ana.410310408
   HIRANO M, 1994, J CHILD NEUROL, V9, P4, DOI 10.1177/088307389400900102
   HIRANO M, 1992, NEUROMUSCULAR DISORD, V2, P125, DOI 10.1016/0960-8966(92)90045-8
   Kim WH, 2004, KOREAN J MED, V67, P727
   PAVLAKIS SG, 1984, ANN NEUROL, V16, P481, DOI 10.1002/ana.410160409
   Shanske S, 2004, AM J MED GENET A, V130A, P134, DOI 10.1002/ajmg.a.30220
   Son SW, 2008, KOREAN CIRC J, V38, P491
   Sproule DM, 2008, ANN NY ACAD SCI, V1142, P133, DOI 10.1196/annals.1444.011
   Sproule DM, 2007, ARCH NEUROL-CHICAGO, V64, P1625, DOI 10.1001/archneur.64.11.1625
NR 10
TC 2
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2011
VL 41
IS 11
BP 674
EP 676
DI 10.4070/kcj.2011.41.11.674
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34ID
UT WOS:000209079200009
PM 22194764
OA Green Published
DA 2021-04-22
ER

PT J
AU Hachinohe, D
   Jeong, MH
   Kim, MC
   Cho, KH
   Ahmed, K
   Hwang, SH
   Lee, MG
   Sim, DS
   Park, KH
   Kim, JH
   Hong, YJ
   Ahn, Y
   Kang, JC
AF Hachinohe, Daisuke
   Jeong, Myung Ho
   Kim, Min Chol
   Cho, Kyung Hoon
   Ahmed, Khurshid
   Hwang, Seung Hwan
   Lee, Min Goo
   Sim, Doo Sun
   Park, Keun-Ho
   Kim, Ju Han
   Hong, Young Joon
   Ahn, Youngkeun
   Kang, Jung Chaee
TI Drug-Eluting Stent as an Option for Intractable In-Stent Coronary
   Restenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Drug-eluting stents; Coronary restenosis; Brachytherapy; Angioplasty
AB A 51-year-old man was admitted due to an acute anterior ST-segment elevation myocardial infarction. After thrombolytic therapy using recombinant tissue plasminogen activator, stent implantation was performed from the proximal left anterior descending artery (LAD) to the mid LAD using a bare-metal stent (BMS). Since then, the patient suffered five repeated episodes of in-stent restenosis (ISR). At the first ISR, he was treated with plain old balloon angioplasty (POBA). At the second ISR, he was treated with brachytherapy, and at the third ISR, he was treated with POBA and one more BMS distal to the previously implanted stent. At the forth, only POBA was performed, and finally, at the fifth ISR, a sirolimus-eluting stent was implanted. Following that, the patient remained asymptomatic and follow-up coronary angiography showed no ISR.
C1 [Hachinohe, Daisuke] Sapporo Higashi Tokushukai Hosp, Ctr Heart, Sapporo, Hokkaido, Japan.
   [Hachinohe, Daisuke; Jeong, Myung Ho; Kim, Min Chol; Cho, Kyung Hoon; Ahmed, Khurshid; Hwang, Seung Hwan; Lee, Min Goo; Sim, Doo Sun; Park, Keun-Ho; Kim, Ju Han; Hong, Young Joon; Ahn, Youngkeun; Kang, Jung Chaee] Chonnam Natl Univ Hosp, Ctr Heart, Kwangju 501757, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Ctr Heart, 671 Jeabong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
OI CHO, KYUNG HOON/0000-0002-0377-6352
CR Ahmed JM, 2000, CIRCULATION, V102, P7, DOI 10.1161/01.CIR.102.1.7
   Alfonso F, 2006, J AM COLL CARDIOL, V47, P2152, DOI 10.1016/j.jacc.2005.10.078
   Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Hong YJ, 2003, KOREAN CIRC J, V33, P967
   Kastrati A, 2001, AM J CARDIOL, V87, P34, DOI 10.1016/S0002-9149(00)01268-6
   Kastrati A, 2005, JAMA-J AM MED ASSOC, V293, P165, DOI 10.1001/jama.293.2.165
   Kim SH, 2005, KOREAN CIRC J, V35, P591
   Popma JJ, 2002, CIRCULATION, V106, P1090, DOI 10.1161/01.CIR.0000027814.96651.72
   Radke PW, 2003, EUR HEART J, V24, P266, DOI 10.1016/S0195-668X(02)00202-6
   Schuhlen H, 2004, AM HEART J, V147, P317, DOI 10.1016/j.ahj.2003.10.002
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   Stone GW, 2007, CIRCULATION, V115, P2842, DOI 10.1161/CIRCULATIONAHA.106.687186
   Stone GW, 2006, JAMA-J AM MED ASSOC, V295, P1253, DOI 10.1001/jama.295.11.1253
   Waksman R, 2000, CIRCULATION, V101, P1895, DOI 10.1161/01.CIR.101.16.1895
NR 15
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2011
VL 41
IS 11
BP 677
EP 680
DI 10.4070/kcj.2011.41.11.677
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34ID
UT WOS:000209079200010
PM 22194765
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, J
   Shin, JH
   Kim, SH
   Lim, YH
   Lee, JU
   Kim, KS
   Kim, SK
   Kim, JH
   Lim, HK
   Shin, J
AF Park, Jinkyu
   Shin, Jeong Hun
   Kim, Seok Hwan
   Lim, Young-Hyo
   Lee, Jae Ung
   Kim, Kyung-Soo
   Kim, Soon-Kil
   Kim, Jeong Hyun
   Lim, Heon Kil
   Shin, Jinho
TI Type 2 Myocardial Infarction Following Generalized Tonic-Clonic Seizure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Epilepsy; Myocardial infarction; Troponin I; Coronary angiography
AB Myocardial infarction is diagnosed when blood levels of biomarkers are increased in the clinical setting of acute myocardial ischemia. Among the biomarkers, troponin I is the preferred biomarker indicative of myocardial necrosis. It is tissue specific for the heart. Myocardial infarction is rarely reported following seizure. We report a case of elevated troponin I in a patient after an episode of generalized tonic-clonic seizure. The diagnosis was type 2 myocardial infarction.
C1 [Park, Jinkyu; Shin, Jeong Hun; Lim, Young-Hyo; Kim, Kyung-Soo; Kim, Jeong Hyun; Lim, Heon Kil; Shin, Jinho] Hanyang Univ, Med Ctr, Dept Internal Med, Div Cardiol, Seoul 133070, South Korea.
   [Kim, Seok Hwan; Lee, Jae Ung; Kim, Soon-Kil] Hanyang Univ, Guri Hosp, Dept Internal Med, Div Cardiol, Guri, South Korea.
RP Shin, J (corresponding author), Hanyang Univ, Med Ctr, Dept Internal Med, Div Cardiol, 222 Wangsimni Ro, Seoul 133070, South Korea.
EM jhs2003@hanyang.ac.kr
RI Shin, Jeong Hun/O-1273-2019
OI Shin, Jeong Hun/0000-0002-6718-9763; Shin, Jinho/0000-0001-6706-6504
CR Brobbey A, 2004, AM J MED SCI, V328, P189, DOI 10.1097/00000441-200409000-00012
   Chin PS, 2004, NEUROLOGY, V63, P2453, DOI 10.1212/01.WNL.0000148608.92290.EB
   Ficker DM, 1998, NEUROLOGY, V51, P1270, DOI 10.1212/WNL.51.5.1270
   Hajsadeghi S, 2009, ARCH MED RES, V40, P24, DOI 10.1016/j.arcmed.2008.10.002
   Jaffe AS, 2006, J AM COLL CARDIOL, V48, P1, DOI 10.1016/j.jacc.2006.02.056
   Jaffe AS, 2000, CIRCULATION, V102, P1216, DOI 10.1161/01.CIR.102.11.1216
   KANNEL WB, 1987, CIRCULATION, V75, P4
   Khan IA, 1999, AM J EMERG MED, V17, P225, DOI 10.1016/S0735-6757(99)90110-9
   Kim SK, 2006, KOREAN CIRC J, V36, P381
   Lim SY, 2003, KOREAN CIRC J, V33, P385
   Montepietra S, 2009, SEIZURE-EUR J EPILEP, V18, P379, DOI 10.1016/j.seizure.2008.11.004
   Natelson BH, 1998, ARCH NEUROL-CHICAGO, V55, P857, DOI 10.1001/archneur.55.6.857
   Parvulescu-Codrea S, 2006, CLIN CARDIOL, V29, P325, DOI 10.1002/clc.4960290713
   Samuels MA, 2007, CIRCULATION, V116, P77, DOI 10.1161/CIRCULATIONAHA.106.678995
   Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397
   Tomson T, 2005, EPILEPSIA, V46, P54, DOI 10.1111/j.1528-1167.2005.00411.x
   TURI ZG, 1985, AM J CARDIOL, V55, P1463, DOI 10.1016/0002-9149(85)90954-3
   Wagner A, 2003, LANCET, V361, P374, DOI 10.1016/S0140-6736(03)12389-6
   Welch RD, 2001, JAMA-J AM MED ASSOC, V286, P1977, DOI 10.1001/jama.286.16.1977
   Woodruff BK, 2003, NEUROLOGY, V60, P1690, DOI 10.1212/01.WNL.0000065881.46964.4F
NR 20
TC 7
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2011
VL 41
IS 11
BP 681
EP 684
DI 10.4070/kcj.2011.41.11.681
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34ID
UT WOS:000209079200011
PM 22194766
OA Green Published
DA 2021-04-22
ER

PT J
AU Uhm, JS
   Chung, WS
   Lee, SJ
   Shin, AY
   Jung, SY
   Kim, CJ
   Seo, SM
   Park, HJ
   Kim, PJ
   Chang, K
   Seung, KB
AF Uhm, Jae-Sun
   Chung, Wook-Sung
   Lee, Seok Jong
   Shin, Ah Young
   Jung, Soo-Yeon
   Kim, Chan-Joon
   Seo, Suk-Min
   Park, Hun-Jun
   Kim, Pum-Joon
   Chang, Kiyuk
   Seung, Ki-Bae
TI Two Cases of Percutaneous Intervention for Coronary Artery Bypass Graft
   Anastomoses With Paclitaxel-Eluting Balloon Catheters
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery bypass surgery; Angioplasty; balloon; coronary
ID COATED BALLOON; STENT
AB Coronary artery bypass graft (CABG) intervention, particularly anastomosis site intervention, is challenging for interventional cardiologists. A paclitaxel-eluting balloon catheter (SeQuent Please) is a recently-introduced device capable of delivering paclitaxel homogeneously into the targeted vessel wall. We herein report our experience with two cases. In the first case, coronary angiography showed significant stenosis at the site of anastomosis between the saphenous vein graft and the left anterior descending artery (LAD). In the second case, coronary angiography showed significant stenosis at the site of anastomosis between the left internal mammary artery and the LAD. We performed percutaneous intervention of these CABG anastomoses using paclitaxel-eluting balloon catheters, and obtained favorable angiographic and clinical outcomes.
C1 [Uhm, Jae-Sun; Chung, Wook-Sung; Lee, Seok Jong; Shin, Ah Young; Jung, Soo-Yeon; Kim, Chan-Joon; Seo, Suk-Min; Park, Hun-Jun; Kim, Pum-Joon; Chang, Kiyuk; Seung, Ki-Bae] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul 137701, South Korea.
RP Chung, WS (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, 505 Banpo Dong, Seoul 137701, South Korea.
EM chungws@catholic.ac.kr
RI Seo, Suk Min/AAB-8238-2021
CR Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940
   Buxton BF, 2003, J THORAC CARDIOV SUR, V125, P1363, DOI 10.1016/S0022-5223(02)73241-8
   Cortese B, 2010, HEART, V96, P1291, DOI 10.1136/hrt.2010.195057
   Fanggiday JC, 2008, CATHETER CARDIO INTE, V71, P629, DOI 10.1002/ccd.21452
   Hiscock Martin, 2007, Heart Lung Circ, V16 Suppl 3, pS51, DOI 10.1016/j.hlc.2007.03.016
   Keeley EC, 2001, J AM COLL CARDIOL, V38, P659, DOI 10.1016/S0735-1097(01)01420-6
   Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663
   Lee MS, 2010, AM J CARDIOL, V105, P1076, DOI 10.1016/j.amjcard.2009.12.006
   Morrison DA, 2006, CATHETER CARDIO INTE, V67, P571, DOI 10.1002/ccd.20641
   Scheller B, 2006, NEW ENGL J MED, V355, P2113, DOI 10.1056/NEJMoa061254
   Tatoulis J, 2004, ANN THORAC SURG, V77, P93, DOI 10.1016/S0003-4975(03)01331-6
   Unverdorben M, 2010, CLIN RES CARDIOL, V99, P165, DOI 10.1007/s00392-009-0101-6
   Unverdorben M, 2009, CIRCULATION, V119, P2986, DOI 10.1161/CIRCULATIONAHA.108.839282
   WEINTRAUB WS, 1995, CIRCULATION, V92, P50, DOI 10.1161/01.CIR.92.9.50
   Yoo Sun Hong, 2009, Korean Circ J, V39, P251, DOI 10.4070/kcj.2009.39.6.251
NR 15
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2011
VL 41
IS 11
BP 685
EP 688
DI 10.4070/kcj.2011.41.11.685
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34ID
UT WOS:000209079200012
PM 22194767
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoshimori, A
   Kobori, A
   Michihiro, N
   Furukawa, Y
AF Yoshimori, An
   Kobori, Atsushi
   Michihiro, Nasu
   Furukawa, Yutaka
TI Delayed Perforation of the Right Ventricular Wall by a Single
   Standard-Caliber Implantable Cardioverter-Defibrillator Lead Detected by
   Multidetector Computed Tomography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Implantable cardioverter-defibrillator; Complications; Computed
   tomography; sprial
AB We present an unusual case of a delayed right ventricular perforation by a single standard-caliber implantable cardioverter-defibrillator lead, which manifested 14 days after implantation. Multidetector computed tomography could clearly display the lead perforation, and allow for identification of the associated sequelae such as pericardial effusion and planning the lead extraction strategy.
C1 [Yoshimori, An; Kobori, Atsushi; Furukawa, Yutaka] Kobe City Med Ctr, Gen Hosp, Dept Cardiovasc Med, Kobe, Hyogo 6500046, Japan.
   [Michihiro, Nasu] Kobe City Med Ctr, Gen Hosp, Dept Cardiovasc Surg, Kobe, Hyogo 6500046, Japan.
RP Yoshimori, A (corresponding author), Kobe City Med Ctr, Gen Hosp, Dept Cardiovasc Med, 4-6 Minatojimanakamachi, Kobe, Hyogo 6500046, Japan.
EM yan527@hotmail.com
CR Danik SB, 2007, HEART RHYTHM, V4, P439, DOI 10.1016/j.hrthm.2006.12.044
   Eltis CR, 2009, HEART RHYTHM, V6, P619, DOI 10.1016/j.hrthm.2009.02.020
   Henrikson CA, 2006, PACE, V29, P509, DOI 10.1111/j.1540-8159.2006.00385.x
   Hirschl DA, 2007, PACE, V30, P28
   Lee DS, 2010, J AM COLL CARDIOL, V55, P774, DOI 10.1016/j.jacc.2009.11.029
   Polin GM, 2006, AM J CARDIOL, V98, P223, DOI 10.1016/j.amjcard.2006.01.078
   SCHWARTZMAN D, 1995, J AM COLL CARDIOL, V26, P776, DOI 10.1016/0735-1097(95)00244-X
   Takahashi T, 2002, CIRC J, V66, P746, DOI 10.1253/circj.66.746
   Turakhia M, 2009, J INTERV CARD ELECTR, V24, P47, DOI 10.1007/s10840-008-9308-0
NR 9
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2011
VL 41
IS 11
BP 689
EP 691
DI 10.4070/kcj.2011.41.11.689
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34ID
UT WOS:000209079200013
PM 22194768
OA Green Published
DA 2021-04-22
ER

PT J
AU Pavlidis, AN
   Poulimenos, LE
   Giannakopoulos, AK
   Tsoukas, A
   Kallistratos, MS
   Manolis, AJ
AF Pavlidis, Antonios N.
   Poulimenos, Leonidas E.
   Giannakopoulos, Antreas K.
   Tsoukas, Athanasios
   Kallistratos, Manolis S.
   Manolis, Athanasios J.
TI Electrocardiographic Changes in a Patient With Pulmonary Embolism and
   Septic Shock
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
DE Pulmonary embolism; Electrocardiogram; Sepsis
AB Various electrocardiography (ECG) abnormalities have been reported in patients who present with pulmonary embolism (PE). Severe sepsis is also associated with ECG changes that may mimic ST elevation myocardial infarction. We report a case of an elderly patient with PE and septic shock associated with striking ECG changes.
C1 [Pavlidis, Antonios N.; Poulimenos, Leonidas E.; Giannakopoulos, Antreas K.; Tsoukas, Athanasios; Kallistratos, Manolis S.; Manolis, Athanasios J.] Asklepeion Gen Hosp, Dept Cardiol, Athens 16673, Greece.
   [Manolis, Athanasios J.] Emory Univ, Sch Med, Atlanta, GA USA.
RP Pavlidis, AN (corresponding author), Asklepeion Gen Hosp, Dept Cardiol, V Pavlou 1 St, Athens 16673, Greece.
EM antonispav@yahoo.com
RI Kallistratos, Manolis S/E-1343-2019
OI Kallistratos, Manolis S/0000-0002-8256-4218
CR Goslar T, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-50
   Lin JF, 2009, CIRC J, V73, P1157, DOI 10.1253/circj.CJ-08-0474
   Martinez JD, 2009, POSTGRAD MED, V121, P102, DOI 10.3810/pgm.2009.03.1981
   Ryu Hyeon Min, 2010, Korean Circ J, V40, P499, DOI 10.4070/kcj.2010.40.10.499
   TERRADELLAS JB, 1982, CHEST, V81, P444, DOI 10.1378/chest.81.4.444
NR 5
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD NOV
PY 2011
VL 41
IS 11
BP 692
EP 693
DI 10.4070/kcj.2011.41.11.692
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34ID
UT WOS:000209079200014
PM 22194769
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, SW
   Ryu, KH
AF Han, Seong Woo
   Ryu, Kyu Hyung
TI Renal Dysfunction in Acute Heart Failure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Acute heart failure; Kidney function; Cardiorenal syndrome
ID BLOOD UREA NITROGEN; ACUTE KIDNEY INJURY; GELATINASE-ASSOCIATED
   LIPOCALIN; CENTRAL VENOUS-PRESSURE; QUALITY-OF-CARE; PROGNOSTIC
   IMPORTANCE; HOSPITALIZED-PATIENTS; CYSTATIN-C; MORTALITY; OUTCOMES
AB During treatment of acute heart failure (AHF), worsening renal function is often complicated and results in a complex clinical course. Furthermore, renal dysfunction is a strong independent predictor of long-term adverse outcomes in patients with AHF. Traditionally, the predominant cause of renal dysfunction has been attributed to impairment of cardiac output and relative underfilling of arterial perfusion. Recently, emerging data have led to the importance of venous congestion and elevated intra-abdominal pressure rather than confining it to impaired forward cardiac output as the primary driver of renal impairment. Relief of congestion is a major objective of AHF treatment but therapy is still based on the administration of loop diuretics. The results of the recently performed controlled studies for the assessment of new treatments to overcome resistance to diuretic treatment to protect kidneys from untoward effects have been mostly neutral. Better treatment of congestion in heart failure remains a major problem.
C1 [Han, Seong Woo] Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul, South Korea.
   [Ryu, Kyu Hyung] Konkuk Univ, Med Ctr, Dept Cardiovasc Med, Seoul 143729, South Korea.
RP Ryu, KH (corresponding author), Konkuk Univ, Med Ctr, Dept Cardiovasc Med, 4-12 Hwayang Dong, Seoul 143729, South Korea.
EM khryumd@hanmail.net
CR Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005
   Aghel A, 2010, J CARD FAIL, V16, P49, DOI 10.1016/j.cardfail.2009.07.003
   Aronson D, 2004, AM J MED, V116, P466, DOI 10.1016/j.amjmed.2003.11.014
   Blankstein Ron, 2008, Heart Fail Clin, V4, P411, DOI 10.1016/j.hfc.2008.03.006
   Bonventre JV, 2010, NAT BIOTECHNOL, V28, P436, DOI 10.1038/nbt0510-436
   Bourge RC, 2005, J AM COLL CARDIOL, V46, P2052, DOI 10.1016/j.jacc.2005.09.014
   Cauthen CA, 2008, AM J CARDIOL, V101, P1643, DOI 10.1016/j.amjcard.2008.01.047
   Chakeabarti S, 2010, J CARD FAIL, V16, pS53, DOI 10.1016/j.cardfail.2010.04.004
   Chen HH, 2006, AM J MED, V119, P11, DOI 10.1016/j.amjmed.2006.09.012
   Choi DJ, 2011, KOREAN CIRC J, V41, P363, DOI 10.4070/kcj.2011.41.7.363
   Cleland JGF, 2000, EUR J HEART FAIL, V2, P123, DOI 10.1016/S1388-9842(00)00081-7
   Costanzo MR, 2007, J AM COLL CARDIOL, V49, P675, DOI 10.1016/j.jacc.2006.07.073
   Costello-Boerrigter LC, 2006, AM J PHYSIOL-RENAL, V290, pF273, DOI 10.1152/ajprenal.00195.2005
   Cowie MR, 2006, EUR HEART J, V27, P1216, DOI 10.1093/eurheartj/ehi859
   Damman K, 2007, J CARD FAIL, V13, P599, DOI 10.1016/j.cardfail.2007.04.008
   Damman K, 2007, EUR J HEART FAIL, V9, P872, DOI 10.1016/j.ejheart.2007.05.010
   Damman K, 2010, EUR J HEART FAIL, V12, P974, DOI 10.1093/eurjhf/hfq118
   Damman K, 2010, HEART, V96, P1297, DOI 10.1136/hrt.2010.194878
   Damman K, 2009, J AM COLL CARDIOL, V53, P582, DOI 10.1016/j.jacc.2008.08.080
   den Uil CA, 2009, EUR J HEART FAIL, V11, P386, DOI 10.1093/eurjhf/hfp021
   Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309
   Drazner MH, 2001, NEW ENGL J MED, V345, P574, DOI 10.1056/NEJMoa010641
   Felker GM, 2011, NEW ENGL J MED, V364, P797, DOI 10.1056/NEJMoa1005419
   Filippatos G, 2007, J CARD FAIL, V13, P360, DOI 10.1016/j.cardfail.2007.02.005
   Fonarow GC, 2007, ARCH INTERN MED, V167, P1493, DOI 10.1001/archinte.167.14.1493
   Forman DE, 2004, J AM COLL CARDIOL, V43, P61, DOI 10.1016/j.jacc.2003.07.031
   FRANCIS GS, 1990, CIRCULATION, V82, P1724, DOI 10.1161/01.CIR.82.5.1724
   FRANCIS GS, 1985, ANN INTERN MED, V103, P1, DOI 10.7326/0003-4819-103-1-1
   Friedrich JO, 2005, ANN INTERN MED, V142, P510, DOI 10.7326/0003-4819-142-7-200504050-00010
   Funaya H, 1997, CIRCULATION, V95, P1363
   Giamouzis G, 2010, J CARD FAIL, V16, P922, DOI 10.1016/j.cardfail.2010.07.246
   Gottlieb SS, 2002, J CARD FAIL, V8, P136, DOI 10.1054/jcaf.2002.125289
   GRUBB A, 1992, CLIN NEPHROL, V38, pS20
   Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e
   Herget-Rosenthal S, 2000, AM J NEPHROL, V20, P97, DOI 10.1159/000013564
   Heywood JT, 2007, J CARD FAIL, V13, P422, DOI 10.1016/j.cardfail.2007.03.011
   Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013
   Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135
   Klein L, 2008, CIRC-HEART FAIL, V1, P25, DOI 10.1161/CIRCHEARTFAILURE.107.746933
   Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319
   Lassus JPE, 2010, EUR HEART J, V31, P2791, DOI 10.1093/eurheartj/ehq293
   LEIER CV, 1978, CIRCULATION, V58, P466, DOI 10.1161/01.CIR.58.3.466
   Lindenfeld J, 2011, J AM COLL CARDIOL, V58, P383, DOI 10.1016/j.jacc.2011.01.054
   LJUNGMAN S, 1992, AM J CARDIOL, V70, P479, DOI 10.1016/0002-9149(92)91194-9
   MASKIN CS, 1985, CIRCULATION, V72, P846, DOI 10.1161/01.CIR.72.4.846
   Masuo K, 2010, HYPERTENS RES, V33, P521, DOI 10.1038/hr.2010.35
   McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9
   McCullough PA, 2011, WORLD J CARDIOL, V3, P1, DOI 10.4330/wjc.v3.i1.1
   Mebazaa A, 2007, JAMA-J AM MED ASSOC, V297, P1883, DOI 10.1001/jama.297.17.1883
   Metra M, 2008, EUR J HEART FAIL, V10, P188, DOI 10.1016/j.ejheart.2008.01.011
   Metra M, 2011, EUR HEART J, V32, P1519, DOI 10.1093/eurheartj/ehr042
   Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6
   Mullens W, 2008, J AM COLL CARDIOL, V52, P200, DOI 10.1016/j.jacc.2008.02.083
   Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068
   Nohria A, 2008, J AM COLL CARDIOL, V51, P1268, DOI 10.1016/j.jacc.2007.08.072
   O'Connor CM, 2011, NEW ENGL J MED, V365, P32, DOI 10.1056/NEJMoa1100171
   O'Meara E, 2006, EUR J HEART FAIL, V8, P63, DOI 10.1016/j.ejheart.2005.04.013
   Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051
   Sarraf M, 2009, CLIN J AM SOC NEPHRO, V4, P2013, DOI 10.2215/CJN.03150509
   Schrier RW, 2008, CIRC-HEART FAIL, V1, P2, DOI 10.1161/CIRCHEARTFAILURE.108.770834
   SCHRIER RW, 1975, NEW ENGL J MED, V292, P141, DOI 10.1056/NEJM197501162920306
   Schrier RW, 2006, J AM COLL CARDIOL, V47, P1, DOI 10.1016/j.jacc.2005.07.067
   SCHRIER RW, 1979, AM J PHYSIOL, V236, pF321
   SCHRIER RW, 1975, NEW ENGL J MED, V292, P81, DOI 10.1056/NEJM197501092920207
   Smith GL, 2006, J AM COLL CARDIOL, V47, P1987, DOI 10.1016/j.jacc.2005.11.084
   Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415
   Teichman SL, 2009, HEART FAIL REV, V14, P321, DOI 10.1007/s10741-008-9129-3
   Testani JM, 2011, J AM COLL CARDIOL, V58, P375, DOI 10.1016/j.jacc.2011.01.052
   Uthoff H, 2011, EUR J HEART FAIL, V13, P432, DOI 10.1093/eurjhf/hfq195
   Waikar SS, 2009, J AM SOC NEPHROL, V20, P672, DOI 10.1681/ASN.2008070669
   Yilmaz MB, 2007, CARDIOVASC DRUG THER, V21, P431, DOI 10.1007/s10557-007-6066-7
   Zannad F, 2006, EUR J HEART FAIL, V8, P697, DOI 10.1016/j.ejheart.2006.01.001
   Zappitelli M, 2007, CRIT CARE, V11, DOI 10.1186/cc6089
NR 73
TC 9
Z9 10
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2011
VL 41
IS 10
BP 565
EP 574
DI 10.4070/kcj.2011.41.10.565
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IC
UT WOS:000209079100001
PM 22125554
OA Green Published
DA 2021-04-22
ER

PT J
AU Bae, JW
AF Bae, Jang-Whan
TI Hypertension, Vascular Rarefaction and Angiopoietin-1
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Chungbuk Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, Cheongju 361711, South Korea.
RP Bae, JW (corresponding author), Chungbuk Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, 62 Gaesin Dong, Cheongju 361711, South Korea.
EM drcorazon@hanmail.net
CR Antonios TFT, 2003, HEART, V89, P175, DOI 10.1136/heart.89.2.175
   Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12
   Kim HZ, 2009, BBA-MOL CELL RES, V1793, P772, DOI 10.1016/j.bbamcr.2009.01.018
   Koller A, 2002, MICROCIRCULATION, V9, P277, DOI 10.1038/sj.mn.7800142
   Lee JS, 2008, CARDIOVASC RES, V78, P572, DOI 10.1093/cvr/cvn048
   Redon J, 2005, CURR OPIN NEPHROL HY, V14, P448, DOI 10.1097/01.mnh.0000168935.95527.0a
   Rizzoni D, 2000, J HYPERTENS, V18, P885, DOI 10.1097/00004872-200018070-00010
   Sane David C., 2004, Angiogenesis, V7, P193, DOI 10.1007/s10456-004-2699-3
   Suh W, 2011, KOREAN CIRC J, V41, P590, DOI 10.4070/kcj.2011.41.10.590
   Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511
NR 10
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2011
VL 41
IS 10
BP 575
EP 577
DI 10.4070/kcj.2011.41.10.575
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IC
UT WOS:000209079100002
PM 22125555
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, SW
   Rho, TH
   Kim, DB
   Cho, EJ
   Kwon, BJ
   Park, HJ
   Shin, WS
   Kim, JH
   Lee, JM
   Moon, KW
   Oh, YS
   Yoo, KD
   Youn, HJ
   Lee, MY
   Chung, WS
   Seung, KB
   Kim, JH
AF Jang, Sung-Won
   Rho, Tai-Ho
   Kim, Dong-Bin
   Cho, Eun Joo
   Kwon, Beom-June
   Park, Hun-Jun
   Shin, Woo-Seung
   Kim, Ji-Hoon
   Lee, Jong-Min
   Moon, Keon-Woong
   Oh, Yong-Seog
   Yoo, Ki-Dong
   Youn, Ho-Joong
   Lee, Man-Young
   Chung, Wook-Sung
   Seung, Ki-Bae
   Kim, Jae-Hyung
TI Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation
   After Coronary Stent Implantation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Angioplasty; Stents; Anticoagulants; Platelet
   aggregation inhibitors
AB Background and Objectives: Little evidence is available on the optimal antithrombotic therapy following percutaneous coronary intervention (PCI) in patients with atrial fibrillation (AF). We investigated the outcomes of antithrombotic treatment strategies in AF patients who underwent PCI. Subjects and Methods: Three hundred sixty-two patients (68.0% men, mean age: 68.3 +/- 7.8 years) with AF and who had undergone PCI with stent implantation between 2005 and 2007 were enrolled. The clinical, demographic and procedural characteristics were reviewed and the stroke risk factors as well as antithrombotic regimens were analyzed. Results: The accompanying comorbidities were as follows: hypertension (59.4%), diabetes (37.3%) and congestive heart failure (16.6%). The average number of stroke risk factors was 1.6. At the time of discharge after PCI, warfarin was prescribed for 84 patients (23.2%). Cilostazol was used in addition to dual antiplatelet therapy in 35% of the patients who did not receive warfarin. The mean follow-up period was 615 +/- 385 days. The incidences of major adverse cardiac events (MACE), stroke and major bleeding were 11.3%, 3.6% and 4.1%, respectively. By Kaplan-Meier survival analysis, warfarin treatment was not associated with a lower risk of MACE (p=0.886), but it was associated with an increased risk of major bleeding (p=0.002). Conclusion: Oral anticoagulation therapy after PCI may increase hemorrhagic events in Korean AF patients.
C1 [Jang, Sung-Won; Rho, Tai-Ho; Kim, Dong-Bin; Cho, Eun Joo; Kwon, Beom-June; Park, Hun-Jun; Shin, Woo-Seung; Kim, Ji-Hoon; Lee, Jong-Min; Moon, Keon-Woong; Oh, Yong-Seog; Yoo, Ki-Dong; Youn, Ho-Joong; Lee, Man-Young; Chung, Wook-Sung; Seung, Ki-Bae; Kim, Jae-Hyung] Catholic Univ Korea, Sch Med, Dept Internal Med, Div Cardiol, Seoul 137040, South Korea.
RP Rho, TH (corresponding author), Catholic Univ Korea, Sch Med, Dept Internal Med, Div Cardiol, 505 Banpo Dong, Seoul 137040, South Korea.
EM tairho@catholic.ac.kr
CR Aguilar MI, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006186.pub2
   Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4
   Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000
   Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009
   Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864
   Han YL, 2009, AM HEART J, V157, P733, DOI 10.1016/j.ahj.2009.01.006
   Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690
   Lee SW, 2007, AM J CARDIOL, V100, P1103, DOI 10.1016/j.amjcard.2007.05.032
   Li T, 2006, J MED GENET, V43, P740, DOI 10.1136/jmg.2005.040410
   Lip GYH, 2006, CHEST, V130, P1823, DOI 10.1378/chest.130.6.1823
   Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503
   Ruiz-Nodar JM, 2008, J AM COLL CARDIOL, V51, P818, DOI 10.1016/j.jacc.2007.11.035
   Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098
   Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7
   Suzuki S, 2007, CIRC J, V71, P761, DOI 10.1253/circj.71.761
   van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441
   Yang Tae-Hyun, 2009, Korean Circ J, V39, P462, DOI 10.4070/kcj.2009.39.11.462
NR 17
TC 8
Z9 9
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2011
VL 41
IS 10
BP 578
EP 582
DI 10.4070/kcj.2011.41.10.578
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IC
UT WOS:000209079100003
PM 22125556
OA Green Published
DA 2021-04-22
ER

PT J
AU Lim, SY
   Kim, SW
   Kim, EJ
   Kang, JH
   Kim, SA
   Kim, YK
   Na, JO
   Choi, CU
   Lim, HE
   Han, SW
   Rha, SW
   Park, CG
   Seo, HS
   Oh, DJ
AF Lim, Sung Yoon
   Kim, Sun Won
   Kim, Eung Ju
   Kang, Jun Hyuk
   Kim, Su A.
   Kim, Yun Kyung
   Na, Jin Oh
   Choi, Cheol Ung
   Lim, Hong Euy
   Han, Seong Woo
   Rha, Seung-Woon
   Park, Chang Gyu
   Seo, Hong Seog
   Oh, Dong Joo
TI Telmisartan Versus Valsartan in Patients With Hypertension: Effects on
   Cardiovascular, Metabolic, and Inflammatory Parameters
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Valsartan
ID CONVERTING-ENZYME-INHIBITOR; BLOOD-PRESSURE; MYOCARDIAL FIBROSIS;
   ARTERIAL STIFFNESS; RECEPTOR BLOCKER; EUROPEAN-SOCIETY; ANGIOTENSIN;
   GUIDELINES; LOSARTAN; ULTRASOUND
AB Background and Objectives: Angiotensin-receptor blockers (ARBs) have beneficial effects on cardiovascular, metabolic, and inflammatory parameters in addition to controlling blood pressure (BP). However, few comparative clinical studies have been conducted with different ARBs. We compared these effects in patients with uncomplicated hypertension who were receiving telmisartan or valsartan. Subjects and Methods: The subjects were patients with essential hypertension (48.4 +/- 9.6 years) who were randomly assigned to take either telmisartan (80 mg/day, n=30) or valsartan (160 mg/day, n=30) for 12 weeks. Their anthropometric, laboratory, vascular, and echocardiographic data were measured at baseline and at the end of the study. Results: Baseline characteristics were not significantly different between the two groups, except for the carotidfemoral pulse wave velocity (cfPWV; telmisartan group vs. valsartan group; 841.2 +/- 131.0 vs. 761.1 +/- 104.4 cm/s, p<0.05). After 12 weeks, BP had fallen to a similar extent with mean reductions in the systolic and diastolic BP of 20.7 +/- 18.1 and 16.3 +/- 13.0 mm Hg (p<0.001, respectively) for the telmisartan and 22.5 +/- 17.0 and 16.8 +/- 9.3 mm Hg (p<0.001, respectively) for the valsartan group. Although the cfPWV and left ventricular mass index (LVMI) fell significantly only with the administration of telmisartan, they were not significantly different when baseline cfPWV was considered. The differences in the cfPWV and LVMI changes from baseline between the two groups were also not significant after adjusting for baseline cfPWV. No significant changes in other vascular, metabolic, or inflammatory parameters were observed with either treatment. Conclusion: The effects of a 12-week treatment with the two ARBs, telmisartan and valsartan, on cardiovascular, metabolic, and inflammatory parameters were not different in patients with uncomplicated hypertension.
C1 [Lim, Sung Yoon; Kim, Sun Won; Kim, Eung Ju; Kang, Jun Hyuk; Kim, Su A.; Kim, Yun Kyung; Na, Jin Oh; Choi, Cheol Ung; Lim, Hong Euy; Han, Seong Woo; Rha, Seung-Woon; Park, Chang Gyu; Seo, Hong Seog; Oh, Dong Joo] Korea Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 152703, South Korea.
RP Kim, EJ (corresponding author), Korea Univ, Coll Med, Guro Hosp, Dept Internal Med,Div Cardiol, 80 Guro Dong, Seoul 152703, South Korea.
EM withnoel@empal.com
FU Korean Society of Cardiology
FX This work was supported by grants from the Korean Society of Cardiology
   (2006). Part of this study was presented as an abstract at the 52nd
   Annual Scientific Meeting of the Korean Society of Cardiology in 2008
   and the ESH Congress in 2010.
CR Benson SC, 2004, HYPERTENSION, V43, P993, DOI 10.1161/01.HYP.0000123072.34629.57
   Brooks WW, 1997, CIRCULATION, V96, P4002
   Ciulla MM, 2004, CIRCULATION, V110, P552, DOI 10.1161/01.CIR.0000137118.47943.5C
   Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6
   Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3
   DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X
   Dhakam Z, 2006, AM J HYPERTENS, V19, P214, DOI 10.1016/j.amjhyper.2005.08.007
   Fliser D, 2004, CIRCULATION, V110, P1103, DOI 10.1161/01.CIR.0000140265.21608.8E
   Hirata K, 2005, J HYPERTENS, V23, P551, DOI 10.1097/01.hjh.0000160211.56103.48
   황원민, 2005, Korean Circulation Journal, V35, P131
   Jung An Doc, 2009, Korean Circ J, V39, P180, DOI 10.4070/kcj.2009.39.5.180
   Karalliedde J, 2008, HYPERTENSION, V51, P1617, DOI 10.1161/HYPERTENSIONAHA.108.111674
   Kim KI, 2008, AM J HYPERTENS, V21, P884, DOI 10.1038/ajh.2008.191
   Koh KK, 2003, J AM COLL CARDIOL, V42, P905, DOI 10.1016/S0735-1097(03)00846-5
   Lacourciere Y, 2004, BLOOD PRESS MONIT, V9, P203, DOI 10.1097/00126097-200408000-00005
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Mancia G, 2007, EUR HEART J, V28, P1462, DOI 10.1093/eurheartj/ehm236
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Neutel JM, 2010, CURR MED RES OPIN, V26, P213, DOI 10.1185/03007990903444434
   Safar ME, 2008, CURR CARDIOVASC RISK, V2, P268, DOI 10.1007/s12170-008-0050-z
   Schupp M, 2004, CIRCULATION, V109, P2054, DOI 10.1161/01.CIR.0000127955.36250.65
   Sierra C, 2005, CURR OPIN NEPHROL HY, V14, P435, DOI 10.1097/01.mnh.0000174397.59100.89
   Smith DHG, 2003, BLOOD PRESS MONIT, V8, P111, DOI 10.1097/00126097-200306000-00004
   Song HG, 2010, INT J CARDIOL, V139, P263, DOI 10.1016/j.ijcard.2008.10.032
   Weiss D, 2001, CIRCULATION, V103, P448
   Yamamoto K, 2005, J HYPERTENS, V23, P393, DOI 10.1097/00004872-200502000-00022
   Yusuf S, 2000, NEW ENGL J MED, V342, P145
NR 27
TC 7
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2011
VL 41
IS 10
BP 583
EP 589
DI 10.4070/kcj.2011.41.10.583
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IC
UT WOS:000209079100004
PM 22125557
OA Green Published
DA 2021-04-22
ER

PT J
AU Suh, W
   Lee, JS
   Kim, KL
   Song, SH
   Koh, GY
   Kim, DK
AF Suh, Wonhee
   Lee, Jung-Sun
   Kim, Koung Li
   Song, Sun-Hwa
   Koh, Gou Young
   Kim, Duk-Kyung
TI Angiopoietin-1 Gene Therapy Attenuates Hypertension and Target Organ
   Damage in Nitric Oxide Synthase Inhibited Spontaneously Hypertensive
   Rats
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angiopoietin-1; Endothelium; Hypertension; Nitric oxide
AB Background and Objectives: In our previous study, we found that the gene transfer of a potent derivative of cartilage oligomeric matrix protein Angiopoietin-1 (COMP-Ang-1) substantially prevented hypertension, microvascular rarefaction, and target organ damage in spontaneously hypertensive rats (SHRs). The purpose of the present study was to examine the role of nitric oxide (NO) in the therapeutic effects observed after COMP-Ang-1 gene transfer. Materials and Methods: To exclude the NO-mediated effects in COMP-Ang-1 gene therapy, the SHRs were treated with an NO synthase (NOS) inhibitor, N-w-nitro-L-arginine methyl ester (L-NAME) before the electrophoretic gene transfer. Results: The pretreatment with L-NAME induced a severe and sustained increase in systolic blood pressure (BP) in a LacZ plasmid transferred control SHR. However, the electrophoretic transfer of a COMP-Ang-1 plasmid instead of LacZ plasmid in L-NAME-pretreated SHRs substantially blocked the development of hypertension without any significant difference in comparison with L-NAME-untreated COMP-Ang-1 plasmid transferred groups. In addition, the COMP-Ang-1 plasmid transfer substantially attenuated microvascular rarefaction and arteriole remodeling in the heart and kidney, which might account for the mild histological alterations observed in the COMP-Ang-1 plasmid transferred group, in contrast to the severe fibrosis and necrosis seen in the LacZ plasmid controls. Conclusion: These therapeutic outcomes of COMP-Ang-1 gene transfer even in NOS inhibited SHRs suggested that the antihypertensive effect of COMP-Ang-1 was not merely secondary to NO-mediated vasorelaxation, but it may be associated with its ability to protect the vascular endothelium probably via an NO-independent mechanism which serves to attenuate microvascular rarefaction and target organ damage, and also to prevent hypertension by reducing peripheral vascular resistance.
C1 [Suh, Wonhee; Kim, Koung Li; Song, Sun-Hwa] Ajou Univ, Coll Pharm, Suwon 441749, South Korea.
   [Lee, Jung-Sun; Kim, Koung Li; Kim, Duk-Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Samsung Biomed Res Inst, Seoul, South Korea.
   [Koh, Gou Young] Korea Adv Inst Sci & Technol, Biomed Res Inst, Taejon 305701, South Korea.
   [Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.
RP Kim, DK (corresponding author), Samsung Med Ctr, Dept Med, 50 Irwon Dong, Seoul 135710, South Korea.
EM dkkim@skku.edu
FU National Research Foundation of Korea (NRF) - Ministry of Education,
   Science and TechnologyMinistry of Education, Science and Technology,
   Republic of KoreaNational Research Foundation of Korea [2010-0017233];
   Ministry for Health, Welfare & Family Affairs, Republic of KoreaMinistry
   of Health & Welfare, Republic of Korea [A084072]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science and Technology (2010-0017233) and by a grant of
   the Korea Healthcare Technology R & D Project, Ministry for Health,
   Welfare & Family Affairs, Republic of Korea (A084072). All authors
   confirm that there is no conflict of interest associated with this
   publication.
CR Antonios TFT, 1999, HYPERTENSION, V34, P655, DOI 10.1161/01.HYP.34.4.655
   Antonios TFT, 2003, HEART, V89, P175, DOI 10.1136/heart.89.2.175
   Battegay EJ, 2007, CURR OPIN PHARMACOL, V7, P151, DOI 10.1016/j.coph.2006.09.007
   Cho CH, 2006, P NATL ACAD SCI USA, V103, P4946, DOI 10.1073/pnas.0506352103
   Cho CH, 2004, P NATL ACAD SCI USA, V101, P5553, DOI 10.1073/pnas.0307575101
   Du WM, 2003, J CARDIOVASC PHARM, V41, P233, DOI 10.1097/00005344-200302000-00012
   Jung An Doc, 2009, Korean Circ J, V39, P180, DOI 10.4070/kcj.2009.39.5.180
   Kim W, 2006, NY TIMES BK REV, P1
   Kobori H, 2005, J AM SOC NEPHROL, V16, P2073, DOI 10.1681/ASN.2004080676
   Kubis N, 2002, J HYPERTENS, V20, P1581, DOI 10.1097/00004872-200208000-00021
   Kubis N, 2002, J HYPERTENS, V20, P273, DOI 10.1097/00004872-200202000-00017
   Lee JS, 2008, CARDIOVASC RES, V78, P572, DOI 10.1093/cvr/cvn048
   Levy BI, 2001, CIRCULATION, V104, P735, DOI 10.1161/hc3101.091158
   Mourad JJ, 2006, J HYPERTENS, V24, pS10, DOI 10.1097/01.hjh.0000240041.43214.8a
   Nakamura Y, 2001, HYPERTENSION, V37, P1262, DOI 10.1161/01.HYP.37.5.1262
   Noon JP, 1997, J CLIN INVEST, V99, P1873, DOI 10.1172/JCI119354
   Olzinski AR, 2005, CARDIOVASC RES, V66, P170, DOI 10.1016/j.cardiores.2004.12.021
   Redon J, 2005, CURR OPIN NEPHROL HY, V14, P448, DOI 10.1097/01.mnh.0000168935.95527.0a
NR 18
TC 5
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2011
VL 41
IS 10
BP 590
EP 595
DI 10.4070/kcj.2011.41.10.590
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IC
UT WOS:000209079100005
PM 22125558
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Cho, KI
   Kim, SM
   Lee, HG
   Kim, TI
AF Lee, Ji Hyun
   Cho, Kyoung Im
   Kim, Seong Man
   Lee, Hyeon Gook
   Kim, Tae Ik
TI Arterial Stiffness in Female Patients With Fibromyalgia and Its
   Relationship to Chronic Emotional and Physical Stress
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Fibromyalgia; Compliance; Stress; Pulse wave velocity
AB Background and Objectives: In patients with fibromyalgia (FM) syndrome, stress and pain may chronically enhance sympathetic activity, altering cardiovascular responses and inducing the arterial wall-stiffening process. We investigated arterial stiffness in FM patients using pulse wave velocity (PWV) and analyzed whether arterial stiffness was affected by the clinical parameters of FM. Subjects and Methods: This study included 108 female FM patients (51.5 +/- 8.9 years) without any known cardiovascular diseases and 76 healthy female controls (50.1 +/- 8.9 years). FM patients underwent a manual tender point survey for tender point counts, and completed the visual analogue scale (VAS) of pain and fibromyalgia impact questionnaire (FIQ), which were composed of a physical and feel score. Brachial-ankle pulse-wave velocity (baPWV) was measured with an automated device. The study participants were subdivided into 2 groups based on the sum of the FIQ score (group A: FIQ >= 50, group B: <50). Results: Patients with FM had significantly higher baPWV than the controls, and significant increase were noted in baPWV values of group A compared with those of group B. BaPWV showed a significant positive correlation (correlation coefficient=6.83, p=0.022) with severity of disease assessed by FIQ. Conclusion: The patients with FM showed significantly increased arterial stiffness, suggesting a pathophysiologic link between FM and endothelial dysfunction. This study provides a basis for clarifying the mechanism by which chronic pain syndrome is associated with an increased risk of vascular stiffness.
C1 [Lee, Ji Hyun] Maryknoll Med Ctr, Div Rheumatol, Pusan 600730, South Korea.
   [Cho, Kyoung Im; Kim, Seong Man; Lee, Hyeon Gook; Kim, Tae Ik] Maryknoll Med Ctr, Div Cardiol, Pusan 600730, South Korea.
RP Cho, KI (corresponding author), Maryknoll Med Ctr, Div Cardiol, 4-12 Daecheong Dong, Pusan 600730, South Korea.
EM kyoungim74@gmail.com
CR Bae SC, 2004, QUAL LIFE RES, V13, P857, DOI 10.1023/B:QURE.0000021688.92614.60
   Baron R, 1999, MUSCLE NERVE, V22, P678, DOI 10.1002/(SICI)1097-4598(199906)22:6<678::AID-MUS4>3.0.CO;2-P
   Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031
   Cho Kyoung Im, 2010, Korean Circ J, V40, P74, DOI 10.4070/kcj.2010.40.2.74
   Cho KI, 2011, CLIN RHEUMATOL, V30, P647, DOI 10.1007/s10067-010-1599-8
   Cooke WH, 2002, CLIN SCI, V102, P639, DOI 10.1042/CS20010326
   FISHBANE S, 1995, AM J KIDNEY DIS, V25, P34, DOI 10.1016/0272-6386(95)90622-3
   Giske L, 2008, EUR J PAIN, V12, P351, DOI 10.1016/j.ejpain.2007.07.007
   Harris KF, 2003, PSYCHOSOM MED, V65, P402, DOI 10.1097/01.PSY.0000035720.08842.9F
   Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317
   JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314
   Lee Young Soo, 2005, Korean Circulation Journal, V35, P424
   Leicht AS, 2003, EXP PHYSIOL, V88, P441, DOI 10.1113/eph8802535
   MANUCK SB, 1988, AM HEART J, V116, P328, DOI 10.1016/0002-8703(88)90110-X
   Martinez-Lavin M, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2146
   Mohri M, 1998, LANCET, V351, P1165, DOI 10.1016/S0140-6736(97)07329-7
   Newman AB, 1997, J AM GERIATR SOC, V45, P1472, DOI 10.1111/j.1532-5415.1997.tb03198.x
   Rajagopalan S, 2001, AM J CARDIOL, V88, P196, DOI 10.1016/S0002-9149(01)01623-X
   STRAWN WB, 1991, CIRC RES, V68, P1270, DOI 10.1161/01.RES.68.5.1270
   Tomiyama H, 2005, CIRC J, V69, P815, DOI 10.1253/circj.69.815
   Tomiyama H, 2003, ATHEROSCLEROSIS, V166, P303, DOI 10.1016/S0021-9150(02)00332-5
   VITA JA, 1992, CIRCULATION, V85, P1390, DOI 10.1161/01.CIR.85.4.1390
   Wallace J, 2005, FIBROMYALGIA OTHER C, P127
   Wallace J, 2005, FIBROMYALGIA OTHER C, P17
   Wilkinson IB, 2002, CIRCULATION, V105, P213, DOI 10.1161/hc0202.101970
   Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046
   WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203
   Yamashina A, 2002, HYPERTENS RES, V25, P359, DOI 10.1291/hypres.25.359
   Zaroff JG, 2000, STROKE, V31, P1136, DOI 10.1161/01.STR.31.5.1136
   이무용, 2008, Korean Circulation Journal, V38, P343
NR 30
TC 21
Z9 21
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2011
VL 41
IS 10
BP 596
EP 602
DI 10.4070/kcj.2011.41.10.596
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IC
UT WOS:000209079100006
PM 22125559
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KH
   Kim, YJ
   Lee, SP
   Kim, HK
   Seo, JW
   Sohn, DW
   Oh, BH
   Park, YB
AF Kim, Kyung-Hee
   Kim, Yong-Jin
   Lee, Seung-Pyo
   Kim, Hyung-Kwan
   Seo, Jeong-Wook
   Sohn, Dae-Won
   Oh, Byung-Hee
   Park, Young-Bae
TI Survival, Exercise Capacity, and Left Ventricular Remodeling in a Rat
   Model of Chronic Mitral Regurgitation: Serial Echocardiography and
   Pressure-Volume Analysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mitral regurgitation; Hemodynamic study; Exercise test; Rat model
AB Background and Objectives: The aims of this study were to establish a reliable model of chronic mitral regurgitation (MR) in rats and verify the pathophysiological features of this model by evaluating cardiac function using serial echocardiography and a pressure-volume analysis. Materials and Methods : MR was created in 37 Sprague-Dawley rats by making a hole with a 23 gauge needle on the mitral leaflet through the left ventricular (LV) apex under the guidance of transesophageal echocardiography. Results: Serial echocardiograms revealed that the LV began to dilate immediately after the MR operation and showed progressive dilation until the 14th week (LV end-systolic dimension at 14 weeks, 4.71 +/- 0.25 mm vs. 6.81 +/- 0.50 mm for sham vs. MR, p<0.01; LV end-diastolic dimension, 8.32 +/- 0.42 mm vs. 11.01 +/- 0.47 mm, p<0.01). The LV ejection fraction tended to increase immediately after the MR operation but started to decrease thereafter and showed a significant difference with the sham group from the 14th week (70.0 +/- 2.2% vs. 62.1 +/- 3.1% for sham vs. MR). In a pressure-volume analysis performed at the 14th week, the LV end-systolic pressure-volume relationship and +dp/dt decreased significantly in the MR group. A serial treadmill test revealed that exercise capacity remained in the normal range until the 14th week when it began to decrease (exercise duration, 406 +/- 45 seconds vs. 330 +/- 27 seconds, p<0.01). A pathological analysis showed no significance difference in interstitial fibrosis between the two groups. Conclusion: We established a small animal model of chronic MR and verified its pathophysiological features. This model may provide a useful tool for future research on MR and volume overload heart failure.
C1 [Kim, Kyung-Hee; Kim, Yong-Jin; Lee, Seung-Pyo; Kim, Hyung-Kwan; Seo, Jeong-Wook; Sohn, Dae-Won; Oh, Byung-Hee; Park, Young-Bae] Seoul Natl Univ, Coll Med, Ctr Cardiovasc, Dept Internal Med, Seoul 110744, South Korea.
RP Kim, YJ (corresponding author), Seoul Natl Univ, Coll Med, Ctr Cardiovasc, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM kimdamas@snu.ac.kr
RI Oh, Byung-Hee/G-9875-2011; Kim, Hyung-Kwan/R-8375-2019
OI Oh, Byung-Hee/0000-0002-9945-4306; Kim, Kyung-Hee/0000-0003-0214-0296;
   Seo, Jeong-Wook/0000-0003-0242-1805
FU Korea Institute of Medicine and the Korea Healthcare Technology R&D
   Project, Ministry for Health, Welfare, and Family Affairs, Republic of
   Korea [A090458, A080659]
FX This study was supported by a grant from the Korea Institute of Medicine
   and the Korea Healthcare Technology R&D Project, Ministry for Health,
   Welfare, and Family Affairs, Republic of Korea (A090458 and A080659).
CR Batkai S, 2004, CIRCULATION, V110, P1996, DOI 10.1161/01.CIR.0000143230.23252.D2
   Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005
   Chang SA, 2009, HYPERTENSION, V54, P591, DOI 10.1161/HYPERTENSIONAHA.109.131243
   Chaput M, 2009, CIRCULATION, V120, pS99, DOI 10.1161/CIRCULATIONAHA.109.844019
   CORIN WJ, 1991, CIRCULATION, V83, P797, DOI 10.1161/01.CIR.83.3.797
   Daimon M, 2005, CIRCULATION, V111, P2183, DOI 10.1161/01.CIR.0000163547.03188.AC
   ERIKSSON H, 1995, J INTERN MED, V237, P135, DOI 10.1111/j.1365-2796.1995.tb01153.x
   HELMCKE F, 1987, CIRCULATION, V75, P175, DOI 10.1161/01.CIR.75.1.175
   Ichihara S, 2001, CIRCULATION, V104, P346
   Lips DJ, 2004, BASIC RES CARDIOL, V99, P351, DOI 10.1007/s00395-004-0476-5
   LITWIN SE, 1995, CIRCULATION, V91, P2642, DOI 10.1161/01.CIR.91.10.2642
   MICHEL JB, 1986, BASIC RES CARDIOL, V81, P142, DOI 10.1007/BF01907379
   Mishra YK, 2006, ANN THORAC SURG, V81, P42, DOI 10.1016/j.athoracsur.2005.06.023
   Monnet E, 2005, ANN THORAC SURG, V79, P1445, DOI 10.1016/j.athoracsur.2004.04.002
   Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270
   Nkomo Vuyisile T, 2006, Lancet, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8
   Pacher P, 2004, AM J PHYSIOL-HEART C, V287, pH2132, DOI 10.1152/ajpheart.00405.2004
   Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138
   Patten RD, 2009, CIRC-HEART FAIL, V2, P138, DOI 10.1161/CIRCHEARTFAILURE.108.839761
   Pu M, 2005, J AM SOC ECHOCARDIOG, V18, P468, DOI 10.1016/j.echo.2004.10.005
   Pu M, 2009, AM J PHYSIOL-HEART C, V296, pH1727, DOI 10.1152/ajpheart.00882.2008
   Reffelmann T, 2003, BASIC RES CARDIOL, V98, P275, DOI 10.1007/s00395-003-0401-3
   Ryan TD, 2007, J AM COLL CARDIOL, V49, P811, DOI 10.1016/j.jacc.2006.06.083
   Singh JP, 1999, AM J CARDIOL, V83, P897, DOI 10.1016/S0002-9149(98)01064-9
   WEBER KT, 1990, CIRCULATION, V82, P1387, DOI 10.1161/01.CIR.82.4.1387
   Zheng JY, 2009, CIRCULATION, V119, P2086, DOI 10.1161/CIRCULATIONAHA.108.826230
   ZILE MR, 1991, AM J PHYSIOL, V261, pH1471
NR 27
TC 7
Z9 7
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2011
VL 41
IS 10
BP 603
EP 611
DI 10.4070/kcj.2011.41.10.603
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IC
UT WOS:000209079100007
PM 22125560
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JH
   Ha, GJ
   Seong, MJ
   Jung, JW
   Kim, SY
   Moon, SH
   Lee, YS
AF Kim, Jung Hyun
   Ha, Geun Jin
   Seong, Myung Jun
   Jung, Jin Wook
   Kim, So Yeon
   Moon, Sung Hee
   Lee, Young Soo
TI Anomalous Origin of the Left Circumflex Coronary Artery From the First
   Diagonal Branch Presented as Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessel anomalies
AB Coronary artery anomalies are diagnosed in 0.6 to 1.5% of patients who undergo coronary angiography (CAG). They may present with life threatening conditions but are generally asymptomatic. Recognition and adequate visualization of the anomaly is essential for correct management of the condition. However, in some cases the exact orifice and course of an anomalous coronary vessel cannot be selectively identified by CAG. In this report, a 54-year-old man was admitted to the hospital with acute inferior myocardial infarction and had an anomalous origin of the left circumflex coronary artery (LCX) from the first diagonal branch (D1). In CAG, the right CAG showed no significant stenosis and fortunately we found an anomalous origin of the LCX from the D1. The course of LCX was precisely established by 64-slice multi-detector computed tomography.
C1 [Kim, Jung Hyun] Gimcheon Jeil Hosp, Div Cardiol, Gimcheon, South Korea.
   [Ha, Geun Jin; Seong, Myung Jun; Lee, Young Soo] Daegu Catholic Univ, Med Ctr, Div Cardiol, Taegu 705718, South Korea.
   [Moon, Sung Hee] Daegu Catholic Univ, Med Ctr, Div Radiol, Taegu 705718, South Korea.
   [Jung, Jin Wook] Pohang St Mary Hosp, Pohang, South Korea.
   [Kim, So Yeon] Dongguk Univ, Med Ctr, Div Cardiol, Gyeongju, South Korea.
RP Lee, YS (corresponding author), Daegu Catholic Univ, Med Ctr, Div Cardiol, 3056-6 Daemyeong 4 Dong, Taegu 705718, South Korea.
EM mdleeys@cu.ac.kr
CR Aydinlar A, 2005, INT HEART J, V46, P97, DOI 10.1536/ihj.46.97
   Gavrielatos G, 2007, CARDIOLOGY, V107, P209, DOI 10.1159/000095419
   Korosoglou G, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-4
   Lee Young Soo, 2006, Korean Circulation Journal, V36, P823
   POST JC, 1995, CIRCULATION, V92, P3163, DOI 10.1161/01.CIR.92.11.3163
   WILKINS CE, 1988, TEX HEART I J, V15, P166
   YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110
NR 7
TC 4
Z9 4
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2011
VL 41
IS 10
BP 612
EP 614
DI 10.4070/kcj.2011.41.10.612
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IC
UT WOS:000209079100008
PM 22125561
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KH
   Youn, HJ
   Lee, WH
   Kim, JS
   Kim, JG
   Park, HW
   Min, J
   Kim, GH
   Jung, HO
AF Kim, Kyung-Hee
   Youn, Ho-Joong
   Lee, Wook-Hyun
   Kim, Jin-Suk
   Kim, Jae-Gyung
   Park, Ha-Wook
   Min, Jinsoo
   Kim, Gee-Hee
   Jung, Hae-Ok
TI A Case of Anorexia Nervosa Complicated With Strongly Suspected
   Stress-Induced Cardiomyopathy and Mural Thrombus
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Stress cardiomyopathy; Anorexia nervosa; Thrombosis
AB Stress-induced cardiomyopathy is a unique reversible cardiovascular disease precipitated by acute emotional or physical stress. It is associated with a high prevalence of chronic anxiety disorder that precedes the onset of cardiomyopathy, as well as comorbid cardiovascular risk factors that are similar to the ST segment elevation of myocardial infarction. A thirty-five-year-old woman suffering from anorexia nervosa visited our hospital complaining of severe general weakness. She was diagnosed with stress-induced cardiomyopathy and mural thrombus using a transthoracic echocardiogram. Therefore, she was given anticoagulation therapy and nutrition with immediate psychiatric interventions. After two weeks of treatment, the follow-up echocardiogram indicated a significant improvement of the left ventricular dysfunction and mural thrombus.
C1 [Kim, Kyung-Hee; Youn, Ho-Joong; Lee, Wook-Hyun; Kim, Jin-Suk; Kim, Jae-Gyung; Park, Ha-Wook; Min, Jinsoo; Kim, Gee-Hee; Jung, Hae-Ok] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, Seoul 137701, South Korea.
RP Youn, HJ (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, 505 Banpo Dong, Seoul 137701, South Korea.
EM younhj@catholic.ac.kr
RI Min, Jinsoo/D-5181-2018; Kim, Hyung-Kwan/R-8375-2019
OI Min, Jinsoo/0000-0001-6091-518X; 
CR COOKE RA, 1995, BRIT J HOSP MED, V54, P313
   Elesber AA, 2007, J AM COLL CARDIOL, V50, P448, DOI 10.1016/j.jacc.2007.03.050
   Haghi D, 2008, QJM-INT J MED, V101, P381, DOI 10.1093/qjmed/hcn017
   Hong Kyung-Soon, 2010, Korean Circ J, V40, P258, DOI 10.4070/kcj.2010.40.6.258
   ISNER JM, 1985, ANN INTERN MED, V102, P49, DOI 10.7326/0003-4819-102-1-49
   Mont L, 2003, J AM ACAD CHILD PSY, V42, P808, DOI 10.1097/01.CHI.0000046867.56865.EB
   Morris J, 2007, BMJ-BRIT MED J, V334, P894, DOI 10.1136/bmj.39171.616840.BE
   Ohwada R, 2005, INTERNAL MED, V44, P228, DOI 10.2169/internalmedicine.44.228
   Rotondi F, 2010, INTERNAL MED, V49, P1133, DOI 10.2169/internalmedicine.49.3276
   Saito S, 1999, INT J EAT DISORDER, V25, P113, DOI 10.1002/(SICI)1098-108X(199901)25:1<113::AID-EAT15>3.0.CO;2-D
   Sato H, 1990, CLIN ASPECT MYOCARDI, P56
   Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X
   이호현, 2002, Korean Circulation Journal, V32, P1054
NR 13
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2011
VL 41
IS 10
BP 615
EP 617
DI 10.4070/kcj.2011.41.10.615
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IC
UT WOS:000209079100009
PM 22125562
OA Green Published
DA 2021-04-22
ER

PT J
AU Chang, JH
   Kim, JY
   Yoon, JW
   Seol, MD
   Won, DJ
   Cho, WH
   Lee, JJ
   Jo, HJ
AF Chang, Jae-Hee
   Kim, Jeong-Yeon
   Yoon, Jin-Won
   Seol, Myung-Do
   Won, Dong-Jun
   Cho, Wook-Hyun
   Lee, Jae-Jin
   Jo, Hye-Jae
TI A Case of Infected Left Atrial Myxoma With Concomitant Mitral Valve
   Endocarditis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myxoma; Endocarditis
AB Myxoma is the most common primary tumor in the heart. Cardiac myxomas can present in various manners including embolization and fever, sometimes simulating endocarditis. However, they are rarely infected. We report here a case of an infected left atrial myxoma that seeded a normal mitral valve and atypically presented with multiple embolic events in the lower extremities along with multiple splenic and a cerebellar infarction.
C1 [Chang, Jae-Hee; Yoon, Jin-Won; Seol, Myung-Do; Won, Dong-Jun; Cho, Wook-Hyun] Samyook Med Ctr, Dept Internal Med, Div Cardiol, Seoul 130092, South Korea.
   [Kim, Jeong-Yeon] Samyook Med Ctr, Dept Internal Med, Div Infect, Seoul 130092, South Korea.
   [Lee, Jae-Jin] Samyook Med Ctr, Dept Cardiac Surg, Seoul 130092, South Korea.
   [Jo, Hye-Jae] Samyook Med Ctr, Dept Pathol, Seoul 130092, South Korea.
RP Cho, WH (corresponding author), Samyook Med Ctr, Dept Internal Med, Div Cardiol, 29-1 Hwigyeong 2 Dong, Seoul 130092, South Korea.
EM mulgang@gmail.com
CR Dekkers P, 2001, J AM SOC ECHOCARDIOG, V14, P644, DOI 10.1067/mje.2001.111476
   Duval X, 2001, CLIN MICROBIOL INFEC, V7, P3, DOI 10.1046/j.1469-0691.2001.00190.x
   EISHI K, 1995, J THORAC CARDIOV SUR, V110, P1745, DOI 10.1016/S0022-5223(95)70038-2
   Kim CJ, 1985, KOREAN CIRC J, V15, P671
   Kim H, 2009, KOREAN J THORAC CARD, V42, P513
   KLEIN RS, 1977, NEW ENGL J MED, V297, P800, DOI 10.1056/NEJM197710132971503
   Law Angeline, 2004, Eur J Echocardiogr, V5, P416, DOI 10.1016/j.euje.2004.03.005
   Llinares P, 1993, Enferm Infecc Microbiol Clin, V11, P378
   Rhim HY, 1999, KOREAN CIRC J, V29, P1317
   TUNICK PA, 1990, AM HEART J, V119, P679, DOI 10.1016/S0002-8703(05)80297-2
   Uchino K, 2002, INTERNAL MED, V41, P957, DOI 10.2169/internalmedicine.41.957
   WHITMAN MS, 1994, CLIN INFECT DIS, V18, P657, DOI 10.1093/clinids/18.4.657
NR 12
TC 4
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2011
VL 41
IS 10
BP 618
EP 621
DI 10.4070/kcj.2011.41.10.618
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IC
UT WOS:000209079100010
PM 22125563
OA Green Published
DA 2021-04-22
ER

PT J
AU Song, WJ
   Koo, JK
   Park, KH
   Kim, MK
   Choi, YJ
AF Song, Won-Jun
   Koo, Ja-Kyung
   Park, Kyoung-Ha
   Kim, Min-Kyu
   Choi, Young-Jin
TI Simultaneous Total Occlusion of Multiple Distal Coronary Arteries in
   Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Coronary artery disease; Multiple
AB Simultaneous multiple coronary artery thrombosis is a rare finding in ST segment elevation myocardial infarction (STEMI). We report a case of myocardial infarction with multiple ST segment elevation on the electrocardiography and total occlusions of the distal left anterior descending artery (dLAD), as well as of the second and third obtuse marginal artery on emergency coronary angiography. Thrombus aspiration was performed at dLAD and systemic glycoprotein IIb/IIIa inhibitor was used successfully. In patients with STEMI, multiple coronary thromboses are unusual and associated with patient fatality. However, assertive thrombus aspiration and antiplatelet therapy could be effective in STEMI patients with multiple distal coronary artery occlusions.
C1 [Song, Won-Jun; Koo, Ja-Kyung; Park, Kyoung-Ha; Kim, Min-Kyu; Choi, Young-Jin] Hallym Univ, Med Ctr, Dept Internal Med, Div Cardiovasc, Seoul 150719, South Korea.
RP Park, KH (corresponding author), Hallym Univ, Med Ctr, Dept Internal Med, Div Cardiovasc, 94-200 Yeongdeungpo Dong, Seoul 150719, South Korea.
EM pkhmd@naver.com
CR Asakura M, 2001, J AM COLL CARDIOL, V37, P1284, DOI 10.1016/S0735-1097(01)01135-4
   Burke A, 2000, Ital Heart J, V1, P832
   Derian W, 2007, INT J CARDIOL, V119, pE65, DOI 10.1016/j.ijcard.2007.02.056
   Goldstein JA, 2000, NEW ENGL J MED, V343, P915, DOI 10.1056/NEJM200009283431303
   Kanei Yumiko, 2009, J Invasive Cardiol, V21, P66
   Kang WC, 2005, KOREAN CIRC J, V35, P172
   Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416
NR 7
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2011
VL 41
IS 10
BP 622
EP 624
DI 10.4070/kcj.2011.41.10.622
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IC
UT WOS:000209079100011
PM 22125564
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, NY
   Kwon, TJ
   Park, JR
   Choi, HC
   Cheon, YH
   Kang, MK
   Hwang, SJ
   Park, Y
   Jeong, YH
   Kwak, CH
   Hwang, JY
AF Kim, Na Young
   Kwon, Tae Jung
   Park, Jeong Rang
   Choi, Ho Cheol
   Cheon, Yun Hong
   Kang, Min Kyu
   Hwang, Seok-Jae
   Park, Yongwhi
   Jeong, Young-Hoon
   Kwak, Choong Hwan
   Hwang, Jin-Yong
TI Delayed Ventricular Septal Rupture Following Blunt Chest Trauma
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ventricular septal rupture; Thoracic injuries
AB Cardiac injury is a common but occasionally serious complication of blunt chest trauma. A ventricular septal rupture (VSR) is a rare complication and is variable in its presentation, temporal course and severity. Here, we report a rare case of 75-year-old man who developed delayed VSR following blunt chest trauma.
C1 [Kim, Na Young; Kwon, Tae Jung; Park, Jeong Rang; Cheon, Yun Hong; Kang, Min Kyu; Hwang, Seok-Jae; Park, Yongwhi; Jeong, Young-Hoon; Kwak, Choong Hwan; Hwang, Jin-Yong] Gyeongsang Natl Univ Hosp, Dept Internal Med, Jinju 660702, South Korea.
   [Choi, Ho Cheol] Gyeongsang Natl Univ Hosp, Dept Radiol, Jinju 660702, South Korea.
RP Park, JR (corresponding author), Gyeongsang Natl Univ Hosp, Dept Internal Med, 90 Chiram Dong, Jinju 660702, South Korea.
EM parkjrang@gmail.com
RI Jeong, Young-Hoon/F-3476-2015; Jeong, Young-Hoon/AAO-4401-2020
OI Jeong, Young-Hoon/0000-0003-0403-3726; Kwak, Choong
   Hwan/0000-0001-6035-4415
CR Blasco PB, 2009, CARDIOL YOUNG, V19, P109, DOI 10.1017/S1047951108003223
   CLELAND WP, 1961, BRIT J DIS CHEST, V55, P17, DOI 10.1016/S0007-0971(61)80019-3
   Dehghani P, 2009, J INVASIVE CARDIOL, V21, P483
   FANG BR, 1994, EUR HEART J, V15, P705, DOI 10.1093/oxfordjournals.eurheartj.a060571
   Genoni M, 1997, HEART, V78, P316, DOI 10.1136/hrt.78.3.316
   Hamdan-Challe M, 2010, INTERACT CARDIOV TH, V11, P667, DOI 10.1510/icvts.2010.242602
   HELLING TS, 1989, J TRAUMA, V29, P961, DOI 10.1097/00005373-198907000-00009
   Jun SL, 2007, CIRCULATION, V115, pE13, DOI 10.1161/CIRCULTIONAHA.106.631275
   Lee WS, 1987, KOREAN CIRC J, V17, P381
   Pesenti-Rossi D, 2003, CHEST, V123, P2144, DOI 10.1378/chest.123.6.2144
   Sakka SG, 2000, INTENS CARE MED, V26, P792, DOI 10.1007/s001340051248
   Yun HJ, 2001, J KOREAN SOC ECHOCAR, V9, P157
NR 12
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2011
VL 41
IS 10
BP 625
EP 628
DI 10.4070/kcj.2011.41.10.625
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IC
UT WOS:000209079100012
PM 22125565
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, JH
   Lee, HS
   Lee, TY
   Jang, E
   Kang, MH
   Cho, DK
AF Choi, Joon Hyouk
   Lee, Hyung Seok
   Lee, Tae-Yu
   Jang, EunHa
   Kang, Min Ho
   Cho, Dae Kyoung
TI A Case of Postprandial Hypotension in the Intensive Care Unit Treated
   With Acarbose
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiopulmonary resuscitation; Postprandial period; Hypotension, shock
ID PATHOPHYSIOLOGY; RESUSCITATION; EPIDEMIOLOGY
AB Postprandial hypotension (PPH) has not been described as a cause of hypotension after the return of spontaneous circulation (ROSC) in the intensive care unit (ICU). A 74 year old man underwent cardiopulmonary resuscitation (CPR) due to monomorphic ventricular tachycardia. After the ROSC, inotropic agents were not reduced but increased. PPH had occurred, according to the flow sheet, so a provocation test was performed. We noted hypotension but no serum hypoglycemia or tachycardia. The hypotension was diagnosed as PPH. We chose acarbose for treatment; thus, the inotropic agents were discontinued. This is the first case in which hypotension occurred in a patient recovering after CPR in the ICU and that the PPH was treated with acarbose. PPH should be considered and treated to manage hypotension in elderly patients in the ICU.
C1 [Choi, Joon Hyouk; Lee, Hyung Seok; Lee, Tae-Yu; Jang, EunHa; Cho, Dae Kyoung] Hanmaeum Hosp, Dept Med, Cheju 690741, South Korea.
   [Kang, Min Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Cardiovasc Ctr, Seoul, South Korea.
RP Cho, DK (corresponding author), Hanmaeum Hosp, Dept Med, 52 Yeonsin Ro, Cheju 690741, South Korea.
EM yumtong001@hanmail.net
CR Choi YR, 1998, KOREAN CIRC J, V28, P1084
   Fisher AA, 2005, J AM GERIATR SOC, V53, P1313, DOI 10.1111/j.1532-5415.2005.53415.x
   JANSEN RWMM, 1995, ANN INTERN MED, V122, P286, DOI 10.7326/0003-4819-122-4-199502150-00009
   Jian ZJ, 2008, CHINESE MED J-PEKING, V121, P2054, DOI 10.1097/00029330-200810020-00021
   Luciano GL, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.06.026
   Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652
   O'Mara G, 2002, CLIN GERIATR MED, V18, P307
   Reynolds HR, 2008, CIRCULATION, V117, P686, DOI 10.1161/CIRCULATIONAHA.106.613596
   Shibao C, 2007, HYPERTENSION, V50, P54, DOI 10.1161/HYPERTENSIONAHA.107.091355
   Son JT, 2009, J KOREAN ACAD NURS, V39, P198, DOI 10.4040/jkan.2009.39.2.198
   Tack J, 2009, NAT REV GASTRO HEPAT, V6, P583, DOI 10.1038/nrgastro.2009.148
   Trzeciak S, 2009, CRIT CARE MED, V37, P2895, DOI 10.1097/CCM.0b013e3181b01d8c
   Yu SJ, 2002, J KOREAN ACAD FUNDAM, V9, P434
NR 13
TC 1
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD OCT
PY 2011
VL 41
IS 10
BP 629
EP 631
DI 10.4070/kcj.2011.41.10.629
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IC
UT WOS:000209079100013
PM 22125566
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, BH
   Kim, MH
   Chang, K
AF Hwang, Byung-Hee
   Kim, Myung-Hee
   Chang, Kiyuk
TI Molecular Imaging of High-Risk Atherosclerotic Plaques: Is It Clinically
   Translatable?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Molecular imaging; Atherosclerosis; Primary prevention
AB The explosive epidemics of diabetes and obesity as well as an aging population have led to cardiovascular diseases as the leading cause of world-wide morbidity and mortality beyond cancer. The recent introduction of drug-eluting stents and medications such as statins, dual anti-platelet therapy, and angiotensin converting enzyme inhibitors has dramatically improved clinical outcomes in patients with cardiovascular diseases. However, mortality is still increasing despite state-of-the-art therapeutics, as current diagnostic and therapeutic strategies against cardiovascular disease center on "locking the barn door after the horse has been stolen". Novel diagnostic solutions that identify individuals at risk before the disease is overt are needs. Imaging approaches that visualize molecular targets rather than anatomical structures aim to illuminate vital molecular and cellular aspects of atherosclerosis biology in vivo. Recent technological advances in small animal imaging systems and dedicated targeted/activatable molecular imaging probes have positioned molecular imaging to greatly impact atherosclerosis imaging in the next decade. However, several issues must be addressed before its clinical translation.
C1 [Chang, Kiyuk] Seoul St Marys Hosp, Ctr Cardiovasc, Seoul 137701, South Korea.
   Seoul St Marys Hosp, Div Cardiol, Seoul 137701, South Korea.
RP Chang, K (corresponding author), Seoul St Marys Hosp, Ctr Cardiovasc, 505 Banpo Dong, Seoul 137701, South Korea.
EM kiyuk@catholic.ac.kr
CR Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829
   Chang K, 2008, J NUCL CARDIOL, V15, P417, DOI 10.1016/j.nuclcard.2008.03.001
   Dollery CM, 2006, CARDIOVASC RES, V69, P625, DOI 10.1016/j.cardiores.2005.11.003
   Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068
   Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739
   Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X
   Jaffer FA, 2008, CIRCULATION, V118, P1802, DOI 10.1161/CIRCULATIONAHA.108.785881
   Jaffer FA, 2006, MOL IMAGING, V5, P85, DOI 10.2310/7290.2006.00009
   Jaffer FA, 2011, J AM COLL CARDIOL, V57, P2516, DOI 10.1016/j.jacc.2011.02.036
   Jeziorska M, 1999, HUM PATHOL, V30, P919, DOI 10.1016/S0046-8177(99)90245-9
   Kietselaer BLJH, 2004, NEW ENGL J MED, V350, P1472, DOI 10.1056/NEJM200404013501425
   Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI 10.1016/j.jacc.2009.10.015
   Lee K, 2009, CURR APPL PHYS, V9, pS15, DOI 10.1016/j.cap.2008.08.040
   Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009
   Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908
   Michel JB, 2011, EUR HEART J, V32, P1977, DOI 10.1093/eurheartj/ehr054
   Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005
   Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97
   Nahrendorf M, 2009, CIRC-CARDIOVASC IMAG, V2, P56, DOI 10.1161/CIRCIMAGING.108.839092
   Rudd JHF, 2002, CIRCULATION, V105, P2708, DOI 10.1161/01.CIR.0000020548.60110.76
   Sanz J, 2008, NATURE, V451, P953, DOI 10.1038/nature06803
   Sinusas AJ, 2008, CIRC-CARDIOVASC IMAG, V1, P244, DOI 10.1161/CIRCIMAGING.108.824359
   Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766
   Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675
   Tahara N, 2006, J AM COLL CARDIOL, V48, P1825, DOI 10.1016/j.jacc.2006.03.069
   Trivedi RA, 2006, ARTERIOSCL THROM VAS, V26, P1601, DOI 10.1161/01.ATV.0000222920.59760.df
   Wang JC, 2004, CIRCULATION, V110, P278, DOI 10.1161/01.CIR.0000135468.67850.F4
NR 27
TC 4
Z9 4
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2011
VL 41
IS 9
BP 497
EP 502
DI 10.4070/kcj.2011.41.9.497
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IB
UT WOS:000209079000001
PM 22022323
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, TH
AF Park, Tae-Ho
TI Limited Value of Resting Echocardiography to Predict Cardiac Risk in
   Patients Undergoing Noncardiac Surgery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Dong A Univ, Coll Med, Dept Cardiol, Pusan 602715, South Korea.
RP Park, TH (corresponding author), Dong A Univ, Coll Med, Dept Cardiol, 1-Dongdaesin Dong 3 Ga, Pusan 602715, South Korea.
EM thpark65@dau.ac.kr
CR American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, 2009, J Am Coll Cardiol, V54, pe13, DOI 10.1016/j.jacc.2009.07.010
   Beattie WS, 2006, ANESTH ANALG, V102, P8, DOI 10.1213/01.ane.0000189614.98906.43
   Dokainish H, 2004, AM J CARDIOL, V93, P1130, DOI 10.1016/j.amjcard.2004.01.042
   Halm EA, 1996, ANN INTERN MED, V125, P433, DOI 10.7326/0003-4819-125-6-199609150-00001
   Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043
   Park SJ, 2011, KOREAN CIRC J, V41, P505, DOI 10.4070/kcj.2011.41.9.505
NR 6
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2011
VL 41
IS 9
BP 503
EP 504
DI 10.4070/kcj.2011.41.9.503
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IB
UT WOS:000209079000002
PM 22022324
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, SJ
   Choi, JH
   Cho, SJ
   Chang, SA
   Choi, JO
   Lee, SC
   Park, SW
   Oh, JK
   Kim, DK
   Jeon, ES
AF Park, Sung-Ji
   Choi, Jin-Ho
   Cho, Soo-Jin
   Chang, Sung-A
   Choi, Jin-Oh
   Lee, Sang-Cheol
   Park, Seung Woo
   Oh, Jae K.
   Kim, Duk-Kyung
   Jeon, Eun-Seok
TI Comparison of Transthoracic Echocardiography With N-Terminal Pro-Brain
   Natriuretic Peptide as a Tool for Risk Stratification of Patients
   Undergoing Major Noncardiac Surgery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiovascular disease; Postoperative complications; Echocardiography;
   Natriuretic peptides
ID RESTING 2-DIMENSIONAL ECHOCARDIOGRAPHY; PERIOPERATIVE CARDIAC EVENTS;
   ASSOCIATION
AB Background and Objectives: The role of preoperative transthoracic echocardiography (TTE) for the risk stratification has not been well investigated yet. We compared the predictive power of TTE with N-terminal pro-brain natriuretic peptide (NT-proBNP), a representative biomarker that predicts perioperative cardiovascular risk, and investigated whether these tests have incremental value to the clinically determined risk. Subjects and Methods: We evaluated the Revised Cardiac Risk Index (RCRI), TTE, and NT-proBNP in 1,923 noncardiac surgery cases. The primary endpoint was a perioperative major cardiovascular event (PMCE), which was defined by any single or combined event of secondary endpoints including myocardial infarction, development of pulmonary edema, or primary cardiovascular death within 30 days after surgery. Results: All echocardiographic parameters including left ventricular ejection fraction, regional wall motion score index, and transmitral early diastolic velocity/tissue Doppler mitral annular early diastolic velocity (E/E') were predictive of PMCE (c-statistics=0.579 +/- 0.019 to 0.589 +/- 0.015), but none of these parameters were better than the clinically determined RCRI (c-statistics=0.594 +/- 0.019) and were inferior to NT-proBNP (c-statistics=0.748 +/- 0.019, p<0.001). The predictive power of RCRI {adjusted relative risk (RR)=1.4} could be improved by addition of echocardiographic parameters (adjusted RR=1.8, p<0.001), but not to that extent as by addition of NT-proBNP to RCRI (adjusted RR=3.7, p<0.001). Conclusion: TTE was modestly predictive of perioperative cardiovascular events but was not superior to NT-proBNP. Moreover, it did not have incremental value to the clinically determined risk. The results of our study did not support the use of routine echocardiography before noncardiac surgery.
C1 [Park, Sung-Ji; Choi, Jin-Ho; Cho, Soo-Jin; Chang, Sung-A; Choi, Jin-Oh; Lee, Sang-Cheol; Park, Seung Woo; Oh, Jae K.; Kim, Duk-Kyung; Jeon, Eun-Seok] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Cardiac & Vasc Ctr,Cardiovasc Imaging Ctr,Dept Me, Seoul 135710, South Korea.
   [Choi, Jin-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Cardiac & Vasc Ctr,Cardiovasc Imaging Ctr,Dept Em, Seoul 135710, South Korea.
   [Oh, Jae K.] Mayo Clin, Coll Med, Div Cardiovasc Dis, Rochester, MN USA.
RP Choi, JO (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Cardiac & Vasc Ctr,Cardiovasc Imaging Ctr,Dept Me, 50 Irwon Dong, Seoul 135710, South Korea.
EM choijinh@gmail.com
OI Chang, Sung-A/0000-0001-5124-605X
FU Samsung Medical Center Clinical Research Development Program; In-Sung
   Foundation for Medical Research; Korean Society of Cardiology
   (Industrial-Educational Cooperation)
FX This study was supported by grants from the Samsung Medical Center
   Clinical Research Development Program, the In-Sung Foundation for
   Medical Research and a grant from the Korean Society of Cardiology
   (Industrial-Educational Cooperation, 2005).
CR American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, 2009, J Am Coll Cardiol, V54, pe13, DOI 10.1016/j.jacc.2009.07.010
   Choi JH, 2010, HEART, V96, P56, DOI 10.1136/hrt.2009.181388
   Devereaux PJ, 2005, CAN MED ASSOC J, V173, P627, DOI 10.1503/cmaj.050011
   Dokainish H, 2004, AM J CARDIOL, V93, P1130, DOI 10.1016/j.amjcard.2004.01.042
   Feringa HHH, 2006, AM J CARDIOL, V98, P111, DOI 10.1016/j.amjcard.2006.01.058
   Halm EA, 1996, ANN INTERN MED, V125, P433, DOI 10.7326/0003-4819-125-6-199609150-00001
   Karthikeyan G, 2009, J AM COLL CARDIOL, V54, P1599, DOI 10.1016/j.jacc.2009.06.028
   Kertai MD, 2003, J CARDIOVASC SURG, V44, P431
   Kontos MC, 1996, AM HEART J, V132, P559, DOI 10.1016/S0002-8703(96)90238-0
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043
   Poldermans D, 2008, J AM COLL CARDIOL, V51, P1913, DOI 10.1016/j.jacc.2008.03.005
   Rohde LE, 2001, AM J CARDIOL, V87, P505, DOI 10.1016/S0002-9149(00)01421-1
   Schouten O, 2008, EUR HEART J, V29, P283, DOI 10.1093/eurheartj/ehm521
   Stephan C, 2003, CLIN CHEM, V49, P433, DOI 10.1373/49.3.433
   Struthers A, 2007, EUR HEART J, V28, P1678, DOI 10.1093/eurheartj/ehm234
   TAKASE B, 1993, AM HEART J, V126, P1099, DOI 10.1016/0002-8703(93)90660-2
   Yun KH, 2008, CIRC J, V72, P195, DOI 10.1253/circj.72.195
   Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690
NR 19
TC 20
Z9 21
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2011
VL 41
IS 9
BP 505
EP 511
DI 10.4070/kcj.2011.41.9.505
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IB
UT WOS:000209079000003
PM 22022325
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, WS
   Pyun, WB
   Kang, BC
AF Kim, Woo Shin
   Pyun, Wook Bum
   Kang, Byung Chul
TI The Primary Patency of Percutaneous Transluminal Angioplasty in
   Hemodialysis Patients With Vascular Access Failure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Arteriovenous fistulas; Percutaneous transluminal angioplasty; Dialysis
AB Background and Objectives: Dysfunction of arteriovenous fistulas (AVFs) and arteriovenous grafts (AVGs) contributes significantly to morbidity and hospitalization in the dialysis population. We evaluated the primary patency of AVFs following percutaneous transluminal angioplasty (PTA) in haemodialysis patients. Subjects and Methods: We performed 231 interventions in 118 patients with a mean age of 62.1 +/- 12.9 years. We performed 122 interventions in 53 AVG patients (44.9%), and 109 interventions in 65 AVF patients (55.1%). If there was thrombosis of the vascular access, urokinase was administered and/or thrombus aspiration was performed. The stent was inserted when balloon dilatation did not expand sufficiently or elastic recoil occurred. Results: For the 118 patients, the median patency time was 10.45 +/- 10.29 months at 92 months of follow-up. The primary patencies for stenotic AVFs at 6, 12, 24, 36, 48, and 60 months were 63.4%, 41.4%, 17.0%, 9.7%, 7.3%, and 2.4%, respectively. The primary patencies for AVGs at 6, 12, 24, and 36 months were 36.9%, 19.5%, 10.8%, 2.1%, respectively, and were obtained by means of the Kaplan-Meier analysis (log rank=6.42, p<0.05). The median patency time was 11.0 months and 4.45 months in the non-thrombus and thrombus groups, respectively. The complication rate was 1.73% (4/231); two cases of pseudoaneurysms and two cases of extravasation were detected. All therapy failures (5/231) occurred in thrombotic lesions of AVGs and were treated surgically. Conclusion: PTA is an efficacious method for the correction of stenosis of AVFs for hemodialysis, thus prolonging the patency of the fistulas.
C1 [Kim, Woo Shin; Pyun, Wook Bum] Ewha Womans Univ, Sch Med, Mokdong Hosp, Dept Internal Med,Div Cardiol, Seoul 158710, South Korea.
   [Kang, Byung Chul] Ewha Womans Univ, Sch Med, Mokdong Hosp, Dept Radiol, Seoul 158710, South Korea.
RP Kang, BC (corresponding author), Ewha Womans Univ, Sch Med, Mokdong Hosp, Dept Radiol, 911-1 Mok Dong, Seoul 158710, South Korea.
EM kangbc@ewha.ac.kr
CR BEATHARD GA, 1992, KIDNEY INT, V42, P1390, DOI 10.1038/ki.1992.431
   Campos Rodrigo P, 2006, Hemodial Int, V10, P152
   Coskun M, 1998, TRANSPLANT P, V30, P816, DOI 10.1016/S0041-1345(98)00061-X
   Dougherty MJ, 1999, J VASC SURG, V30, P1016, DOI 10.1016/S0741-5214(99)70039-X
   Guerra A, 2002, NEPHROL DIAL TRANSPL, V17, P843, DOI 10.1093/ndt/17.5.843
   Haage P, 2006, EUR J VASC ENDOVASC, V32, P84, DOI 10.1016/j.ejvs.2005.10.004
   Haage P, 1999, RADIOLOGY, V212, P175, DOI 10.1148/radiology.212.1.r99jl21175
   Haage P, 2000, KIDNEY INT, V57, P1169, DOI 10.1046/j.1523-1755.2000.00944.x
   Hodges TC, 1997, J VASC SURG, V26, P1009, DOI 10.1016/S0741-5214(97)70014-4
   Lahoche A, 1997, PEDIATR NEPHROL, V11, P468, DOI 10.1007/s004670050318
   LANDWEHR P, 1990, ROFO FORTSCHR RONTG, V153, P239, DOI 10.1055/s-2008-1033372
   Manninen HI, 2001, RADIOLOGY, V218, P711, DOI 10.1148/radiology.218.3.r01mr38711
   Miquelin Daniel Gustavo, 2008, Int Arch Med, V1, P16, DOI 10.1186/1755-7682-1-16
   Oakes DD, 1998, KIDNEY INT, V53, P480, DOI 10.1046/j.1523-1755.1998.00769.x
   Oderich GSC, 2000, J VASC SURG, V32, P760, DOI 10.1067/mva.2000.107988
   Overbosch EH, 1996, RADIOLOGY, V201, P485, DOI 10.1148/radiology.201.2.8888246
   PROBST P, 1982, CARDIOVASC INTER RAD, V5, P257, DOI 10.1007/BF02565407
   Pruitt A, 2002, J VASC SURG, V36, P625, DOI 10.1067/mva.2002.127340
   Roy-Chaudhury P, 2001, KIDNEY INT, V59, P2325, DOI 10.1046/j.1523-1755.2001.0590062325.x
   Sands J J, 1994, ASAIO J, V40, pM886, DOI 10.1097/00002480-199407000-00123
   SCHWAB SJ, 1989, KIDNEY INT, V36, P707, DOI 10.1038/ki.1989.250
   Surlan M, 2003, EUR J RADIOL, V46, P96, DOI 10.1016/S0720-048X(03)00074-3
   Tang S., 1998, Hong Kong Medical Journal, V4, P36
   Turmel-Rodrigues L, 2000, KIDNEY INT, V57, P1124, DOI 10.1046/j.1523-1755.2000.00940.x
   TurmelRodrigues L, 1997, J VASC INTERV RADIOL, V8, P813, DOI 10.1016/S1051-0443(97)70666-3
   Verstandig AG, 2003, CARDIOVASC INTER RAD, V26, P58, DOI 10.1007/s00270-002-1953-6
   Vorwerk D, 1996, NEPHROL DIAL TRANSPL, V11, P1058
   김재형, 2003, [Journal of the Korean Society of Radiology (JKSR), 대한영상의학회지], V48, P29
NR 28
TC 14
Z9 21
U1 0
U2 6
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2011
VL 41
IS 9
BP 512
EP 517
DI 10.4070/kcj.2011.41.9.512
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IB
UT WOS:000209079000004
PM 22022326
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, YH
   Kim, KC
   Cho, MS
   Hong, YM
AF Lee, Yun Hee
   Kim, Kwan Chang
   Cho, Min-Sun
   Hong, Young Mi
TI Changes of Pulmonary Pathology and Gene Expressions After Simvastatin
   Treatment in the Monocrotaline-Induced Pulmonary Hypertension Rat Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension, pulmonary; Gene expression; Monocrotaline; Simvastatin
AB Background and Objectives: Simvastatin's properties are suggestive of a potential pathophysiologic role in pulmonary hypertension. The objectives of this study were to investigate changes of pulmonary pathology and gene expressions, including endothelin (ET)-1, endothelin receptor A (ERA), inducible nitric oxide synthase (NOS2), endothelial nitric oxide synthase (NOS3), matrix metalloproteinase (MMP) 2, tissue inhibitor of matrix metalloproteinases (TIMP) and caspase 3, and to evaluate the effect of simvastatin on monocrotaline (M)-induced pulmonary hypertension. Materials and Methods: Six week old male Sprague-Dawley rats were treated, as follows: control group, subcutaneous (sc) injection of saline; M group, sc injection of M (60 mg/kg); and simvastatin group, sc injection of M (60 mg/kg) plus 10 mg/kg/day simvastatin orally. Results: On day 28, right ventricular hypertrophy (RVH) significantly decreased in the simvastatin group compared to the M group. Similarly, right ventricular pressure significantly decreased in the simvastatin group on day 28. From day 7, the ratio of medial thickening of the pulmonary artery was significantly increased in the M group, but there was no significant change in the simvastatin group. The number of muscular pulmonary arterioles was significantly reduced in the simvastatin group. On day 5, gene expressions of ET-1, ERA, NOS2, NOS3, MMP and TIMP significantly decreased in the simvastatin group. Conclusion: Administration of simvastatin exerted weak inhibitory effects on RVH and on the number of muscular pulmonary arterioles, during the development of M-induced pulmonary hypertension in rats. Simvastatin decreased gene expressions on day 5.
C1 [Lee, Yun Hee; Hong, Young Mi] Ewha Womans Univ, Sch Med, Dept Pediat, Seoul 158710, South Korea.
   [Kim, Kwan Chang] Ewha Womans Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Seoul 158710, South Korea.
   [Cho, Min-Sun] Ewha Womans Univ, Sch Med, Dept Pathol, Seoul 158710, South Korea.
RP Hong, YM (corresponding author), Ewha Womans Univ, Sch Med, Dept Pediat, 911-1 Mok Dong, Seoul 158710, South Korea.
EM ymhong@ewha.ac.kr
FU Korean Society of Cardiology; National Research Foundation of Korea
   (NRF) - Korean government (MEST)Ministry of Education, Science and
   Technology, Republic of KoreaNational Research Foundation of KoreaKorean
   Government [KRF-2009-0064784]
FX This work was supported by the Korean Society of Cardiology (2009) and
   National Research Foundation of Korea (NRF) grant founded by the Korean
   government (MEST) (KRF-2009-0064784).
CR Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
   Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50
   Girgis RE, 2003, AM J PHYSIOL-HEART C, V285, pH938, DOI 10.1152/ajpheart.01097.2002
   Girgis RE, 2007, AM J PHYSIOL-LUNG C, V292, pL1105, DOI 10.1152/ajplung.00411.2006
   Hampl V, 2000, PHYSIOL REV, V80, P1337
   임경아, 2009, Clinical and Experimental Pediatrics, V52, P689
   Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029
   Itoh T, 2004, AM J RESP CRIT CARE, V169, P34, DOI 10.1164/rccm.200303-346OC
   Kaneta S, 2003, ATHEROSCLEROSIS, V170, P237, DOI 10.1016/S0021-9150(03)00301-0
   KECK EW, 1989, Z KARDIOL, V78, P65
   Kim YC, 2006, BIOCHEM BIOPH RES CO, V339, P1007, DOI 10.1016/j.bbrc.2005.11.099
   Koo HS, 2011, KOREAN CIRC J, V41, P83, DOI 10.4070/kcj.2011.41.2.83
   Kubota T, 2004, BIOCHEM PHARMACOL, V67, P2175, DOI 10.1016/j.bcp.2004.02.037
   Li MX, 2008, EUR J PHARMACOL, V591, P219, DOI 10.1016/j.ejphar.2008.06.082
   Lim Kyoung Ah, 2010, Korean Circ J, V40, P459, DOI 10.4070/kcj.2010.40.9.459
   Liu B, 2009, EXP LUNG RES, V35, P411, DOI 10.1080/01902140902736819
   Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207
   McMurtry MS, 2007, AM J PHYSIOL-LUNG C, V293, pL933, DOI 10.1152/ajplung.00310.2006
   MEININGER GA, 1992, AM J PHYSIOL, V263, pH647
   Miller AA, 2005, AM J PHYSIOL-LUNG C, V289, pL299, DOI 10.1152/ajplung.00022.2005
   MIYAUCHI T, 1993, CIRC RES, V73, P887, DOI 10.1161/01.RES.73.5.887
   Nishimura T, 2002, AM J RESP CRIT CARE, V166, P1403, DOI 10.1164/rccm.200203-268OC
   Nishimura T, 2003, CIRCULATION, V108, P1640, DOI 10.1161/01.CIR.0000087592.47401.37
   PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0
   Taraseviciene-Stewart L, 2006, AM J PHYSIOL-LUNG C, V291, pL668, DOI 10.1152/ajplung.00491.2005
   TODD L, 1985, PEDIATR RES, V19, P731, DOI 10.1203/00006450-198507000-00019
   Wilkins MR, 2010, AM J RESP CRIT CARE, V181, P1106, DOI [10.1164/rccm.200911-1699OC, 10.1164/rccm.2009111-699OC]
   Yamaki S, 1997, TOHOKU J EXP MED, V182, P83, DOI 10.1620/tjem.182.83
   김미영, 2008, Korean Circulation Journal, V38, P313
NR 29
TC 5
Z9 7
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2011
VL 41
IS 9
BP 518
EP 527
DI 10.4070/kcj.2011.41.9.518
PG 10
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IB
UT WOS:000209079000005
PM 22022327
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, JY
   Sohn, IS
   Kim, JN
   Park, JH
   Park, CB
   Jin, ES
   Cho, JM
   Kim, CJ
   Bae, JH
AF Jang, Jeong Yoon
   Sohn, Il Suk
   Kim, Jong Nim
   Park, Jeong Hwan
   Park, Chang Bum
   Jin, Eun Sun
   Cho, Jin Man
   Kim, Chong Jin
   Bae, Jong Hoa
TI Treadmill Exercise Stress Echocardiography in Patients With No History
   of Coronary Artery Disease: A Single-Center Experience in Korean
   Population
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Echocardiography, stress; Electrocardiography; Exercise test; Coronary
   artery disease
AB Background and Objectives: Treadmill exercise stress echocardiography (TSE) has superior diagnostic accuracy than exercise electrocardiography (ECG). The objectives of the study are 1) to define the diagnostic accuracy and safety of TSE in patients without a history of coronary artery disease (CAD), 2) to identify the clinical characteristics that predict positive TSE results and 3) to assess the differential predictive value between TSE and concomitant exercise ECG in a Korean population. Subjects and Methods: A total of 1,287 patients among 1,500 consecutive patients with no prior history of CAD and who were referred for TSE during a 4-year 3-month period were enrolled. Results: Of the 1,287 patients, 95 (7.4%) showed positive TSE results (newly developed regional wall motion abnormality). Among the 154 patients with coronary angiography, 94 patients (61%) showed significant CAD (30 of 77 patients with negative TSE results and 64 of 77 patients with positive TSE results). The TSE positive population had more cardiovascular risk factors and showed a higher Duke treadmill score and wall motion score index than the TSE negative group. TSE showed relatively good sensitivity (68%), specificity (78%) and positive and negative predictive values (83% and 61%, respectively), and TSE also had higher diagnostic accuracy than concomitant exercise ECG (72% vs. 64%, respectively). Conclusion: TSE is safe and offers greater diagnostic power for CAD than exercise ECG in Korean population without a history of CAD. Its prognostic value in this population needs to be confirmed in a larger prospective study.
C1 [Jang, Jeong Yoon; Sohn, Il Suk; Kim, Jong Nim; Park, Jeong Hwan; Park, Chang Bum; Jin, Eun Sun; Cho, Jin Man; Kim, Chong Jin; Bae, Jong Hoa] Kyung Hee Univ Hosp Gangdong, Dept Cardiol, Seoul 134727, South Korea.
RP Sohn, IS (corresponding author), Kyung Hee Univ Hosp Gangdong, Dept Cardiol, 149 Sangil Dong, Seoul 134727, South Korea.
EM issohn@khu.ac.kr
RI SOHN, ILSUK/AAI-1097-2020; Jin, Eun-Sun/ABF-3500-2020
OI SOHN, ILSUK/0000-0001-8004-5185; 
CR Armstrong WF, 1998, J AM SOC ECHOCARDIOG, V11, P97, DOI 10.1016/S0894-7317(98)70132-4
   Bae JH, 1992, KOREAN CIRC J, V22, P517
   Cheitlin MD, 2003, J AM SOC ECHOCARDIOG, V16, P1091, DOI 10.1016/S0894-7317(03)00685-0
   DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402
   GOBEL FL, 1978, CIRCULATION, V57, P549, DOI 10.1161/01.CIR.57.3.549
   Ha JW, 2002, J AM COLL CARDIOL, V39, P323, DOI 10.1016/S0735-1097(01)01743-0
   Hendel RC, 2009, J AM COLL CARDIOL, V53, P91, DOI 10.1016/j.jacc.2008.09.006
   Kang HS, 1992, KOREAN CIRC J, V22, P968
   Kim KS, 1992, KOREAN CIRC J, V22, P583
   Kim KS, 1992, KOREAN CIRC J, V22, P591
   MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204
   Marwick TH, 2003, HEART, V89, P113, DOI 10.1136/heart.89.1.113
   MARWICK TH, 1992, J AM COLL CARDIOL, V19, P74, DOI 10.1016/0735-1097(92)90054-Q
   PATTERSON RE, 1989, J AM COLL CARDIOL, V13, P1653, DOI 10.1016/0735-1097(89)90361-6
   ROSS J, 1989, PROG CARDIOVASC DIS, V31, P455, DOI 10.1016/0033-0620(89)90020-0
   Shin JH, 2003, AM HEART J, V146, P914, DOI 10.1016/S0002-8703(03)00410-1
   Sicari R, 2008, EUR J ECHOCARDIOGR, V9, P415, DOI 10.1093/ejechocard/jen175
   Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837
NR 18
TC 4
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2011
VL 41
IS 9
BP 528
EP 534
DI 10.4070/kcj.2011.41.9.528
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IB
UT WOS:000209079000006
PM 22022328
OA Green Published
DA 2021-04-22
ER

PT J
AU Hong, YJ
   Jeong, MH
   Song, SJ
   Sim, DS
   Kim, JH
   Lim, KS
   Hachinohe, D
   Ahmed, K
   Hwang, SH
   Lee, MG
   Ko, JS
   Park, KH
   Yoon, HJ
   Yoon, NS
   Kim, KH
   Park, HW
   Kim, JH
   Ahn, Y
   Cho, JG
   Cho, DL
   Park, JC
   Kang, JC
AF Hong, Young Joon
   Jeong, Myung Ho
   Song, Sun-Jung
   Sim, Doo Sun
   Kim, Jung Ha
   Lim, Kyung Seob
   Hachinohe, Daisuke
   Ahmed, Khurshid
   Hwang, Seung Hwan
   Lee, Min Goo
   Ko, Jum Suk
   Park, Keun-Ho
   Yoon, Hyun Ju
   Yoon, Nam Sik
   Kim, Kye Hun
   Park, Hyung Wook
   Kim, Ju Han
   Ahn, Youngkeun
   Cho, Jeong Gwan
   Cho, Dong Lyun
   Park, Jong Chun
   Kang, Jung Chaee
TI Effects of Ramiprilat-Coated Stents on Neointimal Hyperplasia,
   Inflammation, and Arterial Healing in a Porcine Coronary Restenosis
   Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angiotensin-converting enzyme inhibitors; Stents; Inflammation; Coronary
   restenosis
AB Background and Objectives: The renin-angiotensin-aldosterone system has been implicated in the pathogenesis of neointimal hyperplasia, and a role for angiotensin II in the migration and proliferation of vascular smooth muscle cells in restenotic lesions has been proposed. The aim of this study was to determine the anti-proliferative and anti-inflammatory effects of ramiprilat-coated stents in a porcine coronary overstretch restenosis model. Subjects and Methods: Pigs were randomized into two groups in which the coronary arteries {16 pigs (16 coronaries in each group)} had a 3.0x17 mm ramiprilat-coated MAC stent or a 3.0x17 mm control MAC stent (AMG, Munich, Germany) implanted with oversizing (stent-to-artery ratio, 1.3:1) in porcine coronary arteries, and histopathologic analysis was assessed 28 days after stenting. Results: There were no significant differences in the injury and inflammation scores between the two groups (1.20 +/- 0.43 vs. 1.23 +/- 0.57, p=0.8; and 1.21 +/- 0.39 vs. 1.25 +/- 0.49, p=0.6, respectively). Within the neointima, most inflammatory cells were lymphohistiocytes. Significant positive correlations existed between inflammatory cell counts and the neointima areas (r=0.567, p<0.001), and between inflammatory cell counts and the percent area stenosis (r=0.478, p<0.001). There was no significant difference in the inflammatory cell counts normalized to the injury (110 +/- 89 vs. 123 +/- 83, p=0.4) and fibrin scores (0.15 +/- 0.06 vs. 0.17 +/- 0.07, p=0.8) between the 2 groups. There were trends toward a smaller neointima area (1.06 +/- 0.51 mm(2) vs. 1.28 +/- 0.35 mm(2), p=0.083) and a smaller percent area stenosis (18.9 +/- 8.7% vs. 21.8 +/- 7.2%, p=0.088) in the ramiprilat-coated stent group. Conclusion: Although the ramiprilat-coated stent did not show significant inhibitory effects on neointimal hyperplasia, the ramiprilat-coated stent showed good effects on the inflammatory reaction and arterial healing similar to the control stent in a porcine coronary restenosis model.
C1 [Hong, Young Joon; Jeong, Myung Ho; Sim, Doo Sun; Kim, Jung Ha; Lim, Kyung Seob; Hachinohe, Daisuke; Ahmed, Khurshid; Hwang, Seung Hwan; Lee, Min Goo; Ko, Jum Suk; Park, Keun-Ho; Yoon, Hyun Ju; Yoon, Nam Sik; Kim, Kye Hun; Park, Hyung Wook; Kim, Ju Han; Ahn, Youngkeun; Cho, Jeong Gwan; Park, Jong Chun; Kang, Jung Chaee] Chonnam Natl Univ, Res Inst Med Sci, Chonnam Natl Univ Hosp, Ctr Heart, Kwangju 501757, South Korea.
   [Song, Sun-Jung; Cho, Dong Lyun] Chonnam Natl Univ, Ctr Funct Nano Fine Chem, Kwangju, South Korea.
   [Song, Sun-Jung; Cho, Dong Lyun] Chonnam Natl Univ, Sch Appl Chem Engn, Kwangju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ, Res Inst Med Sci, Chonnam Natl Univ Hosp, Ctr Heart, 671 Jaebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
FU Korean Society of Circulation (Industrial-Educational Cooperation)
FX This study was supported by a grant from the Korean Society of
   Circulation (Industrial-Educational Cooperation 2008).
CR Ahn YK, 1999, CATHETER CARDIO INTE, V48, P324, DOI 10.1002/(SICI)1522-726X(199911)48:3<324::AID-CCD20>3.0.CO;2-K
   AUSTIN GE, 1985, J AM COLL CARDIOL, V6, P369, DOI 10.1016/S0735-1097(85)80174-1
   Bae Y, 1998, KOREAN CIRC J, V28, P89
   BELL L, 1990, AM J PATHOL, V137, P7
   CAMPBELLBOSWELL M, 1981, EXP MOL PATHOL, V35, P265, DOI 10.1016/0014-4800(81)90066-6
   Carter AJ, 2004, CARDIOVASC RES, V63, P617, DOI 10.1016/j.cardiores.2004.04.029
   DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450
   Farb A, 1999, CIRCULATION, V99, P44, DOI 10.1161/01.CIR.99.1.44
   Farb A, 2001, CIRCULATION, V104, P473, DOI 10.1161/hc3001.092037
   Finn AV, 2005, CIRCULATION, V112, P270, DOI 10.1161/CIRCULATIONAHA.104.508937
   FORRESTER JS, 1991, J AM COLL CARDIOL, V17, P758, DOI 10.1016/S0735-1097(10)80196-2
   GIRALDO AA, 1985, ARCH PATHOL LAB MED, V109, P173
   Grewe PH, 2000, J AM COLL CARDIOL, V35, P157, DOI 10.1016/S0735-1097(99)00486-6
   HIROOKA Y, 1992, HYPERTENSION, V20, P175, DOI 10.1161/01.HYP.20.2.175
   Hong YJ, 2005, CIRC J, V69, P1477, DOI 10.1253/circj.69.1477
   HUBER KC, 1993, AM HEART J, V125, P695, DOI 10.1016/0002-8703(93)90160-B
   Kolodgie FD, 2002, CIRCULATION, V106, P1195, DOI 10.1161/01.CIR.0000032141.31476.15
   Kornowski R, 1998, J AM COLL CARDIOL, V31, P224, DOI 10.1016/S0735-1097(97)00450-6
   Mancini GBJ, 1996, CIRCULATION, V94, P258, DOI 10.1161/01.CIR.94.3.258
   NAKAMURA M, 1994, J AM COLL CARDIOL, V24, P1321, DOI 10.1016/0735-1097(94)90115-5
   Ohishi M, 1997, CIRCULATION, V96, P3328
   POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370
   Pratt RE, 1996, CIRCULATION, V93, P848, DOI 10.1161/01.CIR.93.5.848
   Ribichini F, 2000, ATHEROSCLEROSIS, V152, P261, DOI 10.1016/S0021-9150(00)00509-8
   Ribichini F, 1998, CIRCULATION, V97, P147, DOI 10.1161/01.CIR.97.2.147
   SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267, DOI 10.1016/0735-1097(92)90476-4
   SCOTTBURDEN T, 1990, J CARDIOVASC PHARM, V16, pS36, DOI 10.1097/00005344-199016004-00009
NR 27
TC 5
Z9 6
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2011
VL 41
IS 9
BP 535
EP 541
DI 10.4070/kcj.2011.41.9.535
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IB
UT WOS:000209079000007
PM 22022329
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, JB
   Kim, JS
   Jeong, DS
   Chung, WY
   Kim, SH
   Kim, MA
   Zo, JH
AF Seo, Jae-Bin
   Kim, Jun Sung
   Jeong, Dong Seop
   Chung, Woo-Young
   Kim, Sang-Hyun
   Kim, Myoung-A
   Zo, Joo-Hee
TI A Case of Left Atrial Metastasis From Hepatocellular Carcinoma:
   Life-Saving Palliative Resection Using Cardiopulmonary Bypass
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Carcinoma, hepatocellular; Neoplasm, metastasis; Heart; Surgery
AB Hepatocellular carcinoma (HCC) with metastasis to the heart is uncommon. We report a rare case of left atrial metastasis of HCC which was resected palliatively as a live-saving procedure with the use of cardiopulmonary bypass. Despite chemoembolization, which was undertaken 11 times, cardiac metastasis occurred. Moreover, the right and left atria and left ventricle were involved simultaneously. The severe dyspnea improved dramatically after surgery. Following this, the patient underwent systemic chemotherapy and lived a life without recurrence of symptoms associated with mitral valve obstruction.
C1 [Seo, Jae-Bin; Chung, Woo-Young; Kim, Sang-Hyun; Kim, Myoung-A; Zo, Joo-Hee] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Div Cardiol,Coll Med, Seoul 156707, South Korea.
   [Kim, Jun Sung; Jeong, Dong Seop] Seoul Natl Univ, Boramae Med Ctr, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul 156707, South Korea.
RP Zo, JH (corresponding author), Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Div Cardiol, 20 Boramae Ro 5 Gil, Seoul 156707, South Korea.
EM jooheezo@hanmail.net
OI Kim, Sang-Hyun/0000-0001-8026-1582
CR Abraham K P, 1990, Am J Cardiovasc Pathol, V3, P195
   Ayoola E A, 1994, Afr J Med Med Sci, V23, P61
   Baca-Lopez FM, 2004, J AM SOC ECHOCARDIOG, V17, P192, DOI 10.1067/j.echo.2003.10.007
   Barasch E, 1994, J Am Soc Echocardiogr, V7, P547
   DAZAI Y, 1989, CHEST, V96, P434, DOI 10.1378/chest.96.2.434
   Ekmektzoglou KA, 2008, J CARDIOVASC MED, V9, P769, DOI 10.2459/JCM.0b013e3282f88e49
   GODWIN JD, 1981, CIRCULATION, V63, P448, DOI 10.1161/01.CIR.63.2.448
   Kew M, 2006, SLEISENGER FORDTRANS, P2007
   KOJIRO M, 1984, ARCH PATHOL LAB MED, V108, P989
   Kotani E, 2000, CHEST, V117, P287, DOI 10.1378/chest.117.1.287
   Lee KS, 2000, KOREAN CIRC J, V30, P1170
   Lei M H, 1992, J Formos Med Assoc, V91, P457
   Lin YS, 2007, WORLD J GASTROENTERO, V13, P3513, DOI 10.3748/wjg.v13.i25.3513
   Mansour Z, 2007, J CARDIAC SURG, V22, P231, DOI 10.1111/j.1540-8191.2007.00397.x
   Masci G, 2004, TUMORI J, V90, P345
   Matsumura M, 1990, J Cardiol, V20, P701
   McManus B, 2007, BRAUNDWALDS HEART DI, P1815
   Ryu KH, 1993, KOREAN CIRC J, V23, P123
   SALCEDO EE, 1992, CURR PROB CARDIOLOGY, V17, P75
   Uemura M, 2004, HEPATO-GASTROENTEROL, V51, P1259
NR 20
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2011
VL 41
IS 9
BP 542
EP 545
DI 10.4070/kcj.2011.41.9.542
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IB
UT WOS:000209079000008
PM 22022330
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, WG
   Oh, SW
   Kim, YJ
   Lim, JG
   Jo, YS
AF Choi, Woong Gil
   Oh, Se Won
   Kim, Young Joong
   Lim, Jong Gu
   Jo, Yoon Sik
TI Acute Cerebral Infarction Following Intravenous Glycoprotein IIb/IIIa
   Inhibitor for Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Acute stroke; Platelet glycoprotein GP IIb-IIIa
   complex
ID ISCHEMIC-STROKE; SHORT-TERM; DISEASE
AB Stroke is a rare but serious complication of acute myocardial infarction (AMI). Currently, glycoprotein (GP) IIb/IIIa inhibitor is used in clinical practice for acute coronary syndromes and percutaneous coronary interventions (PCIs). The incidence of stroke in patients receiving GP IIb/IIIa inhibitor during PCIs is very low. We report the case of a 47-year-old man who presented with AMI and suffered an acute cerebral infarction after infusion of a GP IIb/IIIa inhibitor following primary PCI.
C1 [Choi, Woong Gil; Oh, Se Won; Kim, Young Joong; Lim, Jong Gu] Konkuk Univ, Sch Med, Chungju Hosp, Dept Cardiol, Chungju 380704, South Korea.
   [Jo, Yoon Sik] Konkuk Univ, Sch Med, Chungju Hosp, Dept Neurol, Chungju 380704, South Korea.
RP Choi, WG (corresponding author), Konkuk Univ, Sch Med, Chungju Hosp, Dept Cardiol, 82 Gugwondaero, Chungju 380704, South Korea.
EM gilll@paran.com
CR Akkerhuis KM, 2001, JAMA-J AM MED ASSOC, V286, P78, DOI 10.1001/jama.286.1.78
   BEHAR S, 1991, AM J MED, V91, P45, DOI 10.1016/0002-9343(91)90072-6
   오유정, 2009, Korean Circulation Journal, V39, P75
   Chang GYN, 2001, EUR J NEUROL, V8, P267, DOI 10.1046/j.1468-1331.2001.00216.x
   FRISHMAN WH, 1995, AM HEART J, V130, P877, DOI 10.1016/0002-8703(95)90091-8
   HESS DC, 1993, NEUROL CLIN, V11, P399
   KOMRAD MS, 1984, NEUROLOGY, V34, P1403, DOI 10.1212/WNL.34.11.1403
   Mooe T, 1999, STROKE, V30, P997, DOI 10.1161/01.STR.30.5.997
   Torgano G, 2010, CEREBROVASC DIS, V29, P275, DOI 10.1159/000275503
NR 9
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2011
VL 41
IS 9
BP 546
EP 548
DI 10.4070/kcj.2011.41.9.546
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IB
UT WOS:000209079000009
PM 22022331
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, MJ
   Song, J
   Kim, SJ
   Choi, EY
   Lee, SY
   Shim, WS
AF Cho, Mi Jin
   Song, Jinyoung
   Kim, Soo Jin
   Choi, Eun Young
   Lee, Sang Yoon
   Shim, Woo Seup
TI Transcatheter Closure of Multiple Atrial Septal Defects With the
   Amplatzer Device
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart septal defects; Heart catheterization
ID OCCLUDER; EXPERIENCE; ADULTS
AB Percutaneous device occlusion of secundum atrial septal defect (ASD) has become an accepted alternative to surgical repair. A variety of devices have been used successfully. However, all of them have limitations. We report our experience with two devices used to close multiple ASDs.
C1 [Cho, Mi Jin] Kyung Hee Univ, Sch Med, Dept Pediat, Seoul, South Korea.
   [Song, Jinyoung; Kim, Soo Jin; Choi, Eun Young; Lee, Sang Yoon; Shim, Woo Seup] Sejong Gen Hosp, Dept Pediat, Puchon 422711, South Korea.
RP Song, J (corresponding author), Sejong Gen Hosp, Dept Pediat, 91-121 Sosabon 2 Dong, Puchon 422711, South Korea.
EM amyjys@naver.com
RI Kim, Soo-Jin/P-2677-2014
OI Kim, Soo-Jin/0000-0001-9671-6019
CR Awad SM, 2007, CATHETER CARDIO INTE, V70, P265, DOI 10.1002/ccd.21145
   Bramlet MT, 2008, CATHETER CARDIO INTE, V72, P531, DOI 10.1002/ccd.21668
   Cowley CG, 2001, AM J CARDIOL, V88, P589, DOI 10.1016/S0002-9149(01)01750-7
   Diab KA, 2007, J THORAC CARDIOV SUR, V134, P960, DOI 10.1016/j.jtcvs.2007.06.018
   Du ZD, 2002, J AM COLL CARDIOL, V39, P1836, DOI 10.1016/S0735-1097(02)01862-4
   Fischer G, 2003, HEART, V89, P199, DOI 10.1136/heart.89.2.199
   Ko SF, 2009, AM J ROENTGENOL, V193, P1522, DOI 10.2214/AJR.09.2854
   Mahadevan VS, 2009, INT J CARDIOL, V133, P359, DOI 10.1016/j.ijcard.2008.01.027
   Podnar T, 2001, CATHETER CARDIO INTE, V53, P386, DOI 10.1002/ccd.1187
   조수산, 2002, Korean Circulation Journal, V32, P17
NR 10
TC 5
Z9 5
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2011
VL 41
IS 9
BP 549
EP 551
DI 10.4070/kcj.2011.41.9.549
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IB
UT WOS:000209079000010
PM 22022332
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, ES
   Kang, WC
   Jang, YR
   Kim, S
   Yang, JW
   Lee, K
   Ahn, T
AF Jung, Eul Sik
   Kang, Woong Chol
   Jang, Young Rock
   Kim, Sejoong
   Yang, Ji Won
   Lee, Kyounghoon
   Ahn, Taehoon
TI Acute Severe Symptomatic Hyponatremia Following Coronary Angiography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hyponatremia; Coronary angiography
AB Hyponatremia is a relatively common electrolyte disorder. Although severe acute hyponatremia following coronary angiography is rare, potentially lethal neurologic manifestations may result. We describe a patient with severe, symptomatic hyponatremia, an unusual complication of coronary angiography. Lack of familiarity with contrast media-related hyponatremia caused a delay in diagnosis and therapy in our case. The diagnosis of acute hyponatremia should be considered in any patient who develops behavioral or neurologic manifestations following coronary angiography. Prompt diagnosis and treatment is essential to avoid permanent neurologic damage or death.
C1 [Jung, Eul Sik; Kang, Woong Chol; Jang, Young Rock; Lee, Kyounghoon; Ahn, Taehoon] Gachon Univ Med & Sci, Gil Hosp, Dept Cardiol, Inchon, South Korea.
   [Kim, Sejoong] Gachon Univ Med & Sci, Gil Hosp, Dept Nephrol, Inchon, South Korea.
   [Yang, Ji Won] Gachon Univ Med & Sci, Gil Hosp, Dept Neurol, Inchon, South Korea.
RP Kang, WC (corresponding author), Gachon Univ, Gil Hosp, Dept Cardiol, 1198 Guwol Dong, Inchon 405760, South Korea.
EM kangwch@gilhospital.com
RI Kim, Sejoong/J-5356-2015
OI Kim, Sejoong/0000-0002-7238-9962; Jung, Eul Sik/0000-0003-3898-4693
CR Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107
   ARIEFF AI, 1986, NEW ENGL J MED, V314, P1529, DOI 10.1056/NEJM198606123142401
   Boulos M, 2001, CATHETER CARDIO INTE, V53, P542, DOI 10.1002/ccd.1219
   Lim Goh-Woon, 2010, Korean Circ J, V40, P507, DOI 10.4070/kcj.2010.40.10.507
   Malin JW, 1997, ORTHOPEDICS, V20, P681
   Reddy P, 2009, INT J CLIN PRACT, V63, P1494, DOI 10.1111/j.1742-1241.2009.02103.x
   Reynolds RM, 2006, BMJ-BRIT MED J, V332, P702, DOI 10.1136/bmj.332.7543.702
   Verbalis JG, 2007, AM J MED, V120, pS1, DOI 10.1016/j.amjmed.2007.09.001
NR 8
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2011
VL 41
IS 9
BP 552
EP 554
DI 10.4070/kcj.2011.41.9.552
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IB
UT WOS:000209079000011
PM 22022333
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SP
   Choi, EK
   Kim, TM
   Park, EA
   Kim, HK
   Cho, HJ
   Oh, S
AF Lee, Seung-Pyo
   Choi, Eue-Keun
   Kim, Tae-Min
   Park, Eun-Ah
   Kim, Hyung-Kwan
   Cho, Hyun-Jai
   Oh, Seil
TI Multimodality Imaging Can Help to Doubt, Diagnose and Follow-Up Cardiac
   Mass
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Lymphoma; Heart, neoplasm; Echocardiography; Magnetic resonance imaging;
   Positron emission tomography
AB Primary cardiac lymphoma is a very rare form of lymphoma primarily or mainly involving the heart, as in the two cases presented in this report. Various imaging modalities, including coronary computed tomography angiography, cardiac magnetic resonance imaging and positron emission tomography were useful for the characterization and diagnosis of cardiac mass. Pathologic confirmation was successful with endomyocardial biopsy under echocardiographic guidance, intra- and extracardiacally. In primary cardiac lymphoma, diagnosis using multiple modalities may be useful for mass characterization, and for response monitoring after chemotherapy.
C1 [Lee, Seung-Pyo; Choi, Eue-Keun; Kim, Tae-Min; Kim, Hyung-Kwan; Cho, Hyun-Jai; Oh, Seil] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.
   [Lee, Seung-Pyo; Choi, Eue-Keun; Kim, Hyung-Kwan; Cho, Hyun-Jai; Oh, Seil] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea.
   [Park, Eun-Ah] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea.
RP Choi, EK (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM choiek17@snu.ac.kr
RI Kim, Hyung-Kwan/R-8375-2019; Oh, Seil/J-5539-2012; Choi,
   Eue-Keun/K-3752-2019; Choi, Eue-Keun/J-5968-2014
OI Oh, Seil/0000-0002-2504-9615; Choi, Eue-Keun/0000-0002-0411-6372
CR Abramowitz Yigal, 2007, Int J Cardiol, V118, pe39, DOI 10.1016/j.ijcard.2006.12.039
   CAIRNS P, 1987, ARCH PATHOL LAB MED, V111, P80
   Chang HJ, 1999, KOREAN CIRC J, V29, P828
   Cho Sung Woo, 2010, Korean Circ J, V40, P94, DOI 10.4070/kcj.2010.40.2.94
   Fujita Y, 2009, CIRC J, V73, P967, DOI 10.1253/circj.CJ-08-0064
   Higo T, 2009, CIRC J, V73, P381, DOI 10.1253/circj.CJ-08-0043
   Hoey ETD, 2009, CLIN RADIOL, V64, P1214, DOI 10.1016/j.crad.2009.09.002
   Mariani JA, 2010, J AM COLL CARDIOL, V55, pE23, DOI 10.1016/j.jacc.2009.09.070
   Patel J, 2009, EUR HEART J, V30, P2713, DOI 10.1093/eurheartj/ehp379
   Soslow RA, 1999, CANCER, V85, P2648, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2648::AID-CNCR22>3.3.CO;2-I
   Werner D, 2001, HEART, V86, P618, DOI 10.1136/heart.86.6.618
NR 11
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2011
VL 41
IS 9
BP 555
EP 558
DI 10.4070/kcj.2011.41.9.555
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IB
UT WOS:000209079000012
PM 22022334
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, Y
   Choe, H
   Kang, BR
   Park, MY
   Doh, JH
   Kwak, JJ
   Yoon, BY
   Namgung, J
   Lee, SY
   Hur, G
AF Cho, Yujung
   Choe, Hyunmin
   Kang, Bo Ram
   Park, Min Yong
   Doh, Joon Hyung
   Kwak, Jae-Jin
   Yoon, Bo Young
   Namgung, June
   Lee, Sung Yun
   Hur, Gam
TI Development of a Coronary Aneurysm at a Sirolimus-Eluting
   Stent-Implanted Lesion in a Patient With Churg-Strauss Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary aneurysm; Churg-Strauss syndrome
AB A coronary aneurysm (CA) can occur in sirolimus-eluting stent (SES)-implanted coronary lesions. Although several possible mechanisms have been suggested, the precise pathogenesis of a CA in SES-implanted lesions is still unknown. We report a patient with Churg-Strauss syndrome who underwent successful percutaneous coronary intervention with SES and then experienced a CA in an SES-implanted coronary lesion. We describe the CA characteristics through the use of coronary angiography, coronary 64-multidetector computed tomography, and intravascular ultrasound and discuss the etiological factors for the CA in this patient.
C1 [Cho, Yujung; Choe, Hyunmin; Kang, Bo Ram; Park, Min Yong; Doh, Joon Hyung; Kwak, Jae-Jin; Namgung, June; Lee, Sung Yun] Ilsan Paik Hosp, Vis Cardiac & Vasc Ctr 21, Dept Internal Med, Goyang 411706, South Korea.
   [Yoon, Bo Young] Ilsan Paik Hosp, Dept Rheumatol, Goyang 411706, South Korea.
   [Hur, Gam] Ilsan Paik Hosp, Dept Radiol, Goyang 411706, South Korea.
RP Choe, H (corresponding author), Ilsan Paik Hosp, Vis Cardiac & Vasc Ctr 21, Dept Internal Med, 2240 Daehwa Dong, Goyang 411706, South Korea.
EM hmchoi49@naver.com
CR Alfonso F, 2009, J AM COLL CARDIOL, V53, P2053, DOI 10.1016/j.jacc.2009.01.069
   Bavry AA, 2007, ANN INTERN MED, V146, P230, DOI 10.7326/0003-4819-146-3-200702060-00146
   Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6
   MASI AT, 1990, ARTHRITIS RHEUM, V33, P1094, DOI 10.1002/art.1780330806
   Mavrogeni S, 2009, ARTHRIT RHEUM-ARTHR, V61, P1121, DOI 10.1002/art.24695
   Murthy PA, 2005, AM J ROENTGENOL, V184, pS19, DOI 10.2214/ajr.184.3_supplement.01840s19
   Nienaber CA, 2009, AM J CARDIOL, V104, P1362, DOI 10.1016/j.amjcard.2009.06.058
   Noth I, 2003, LANCET, V361, P587, DOI 10.1016/S0140-6736(03)12518-4
   Wagner AD, 2007, VASC HEALTH RISK MAN, V3, P775
   Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175
NR 10
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2011
VL 41
IS 9
BP 559
EP 562
DI 10.4070/kcj.2011.41.9.559
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IB
UT WOS:000209079000013
PM 22022335
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, J
   Kim, JS
   Park, YH
   Kim, JH
   Chun, KJ
AF Kim, Jun
   Kim, Jeong Su
   Park, Yong Hyun
   Kim, June Hong
   Chun, Kook Jin
TI Engorged Serpentine Veins Across Pacemaker Scar
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Jun; Kim, Jeong Su; Park, Yong Hyun; Kim, June Hong; Chun, Kook Jin] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Sch Med, Yangsan 626770, South Korea.
RP Kim, J (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan 626770, South Korea.
EM mdjunkim@yahoo.co.kr
OI Kim, Jun/0000-0002-3573-638X
CR Haghjoo M, 2007, EUROPACE, V9, P328, DOI 10.1093/europace/eum019
   Korkeila P, 2007, PACE, V30, P199, DOI 10.1111/j.1540-8159.2007.00650.x
NR 2
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD SEP
PY 2011
VL 41
IS 9
BP 563
EP 563
DI 10.4070/kcj.2011.41.9.563
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IB
UT WOS:000209079000014
PM 22022336
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, BK
AF Lee, Byoung-Kwon
TI Computational Fluid Dynamics in Cardiovascular Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Hydrodynamics; Viscosity; Cardiovascular diseases
ID DESCENDING CORONARY-ARTERY; CAROTID BIFURCATION; NUMERICAL-SIMULATION;
   FLOW; HEMODYNAMICS; PULSATILE; MODEL; ANEURYSM; ANGLE
AB Computational fluid dynamics (CFD) is a mechanical engineering field for analyzing fluid flow, heat transfer, and associated phenomena, using computer-based simulation. CFD is a widely adopted methodology for solving complex problems in many modern engineering fields. The merit of CFD is developing new and improved devices and system designs, and optimization is conducted on existing equipment through computational simulations, resulting in enhanced efficiency and lower operating costs. However, in the biomedical field, CFD is still emerging. The main reason why CFD in the biomedical field has lagged behind is the tremendous complexity of human body fluid behavior. Recently, CFD biomedical research is more accessible, because high performance hardware and software are easily available with advances in computer science. All CFD processes contain three main components to provide useful information, such as pre-processing, solving mathematical equations, and post-processing. Initial accurate geometric modeling and boundary conditions are essential to achieve adequate results. Medical imaging, such as ultrasound imaging, computed tomography, and magnetic resonance imaging can be used for modeling, and Doppler ultrasound, pressure wire, and non-invasive pressure measurements are used for flow velocity and pressure as a boundary condition. Many simulations and clinical results have been used to study congenital heart disease, heart failure, ventricle function, aortic disease, and carotid and intra-cranial cerebrovascular diseases. With decreasing hardware costs and rapid computing times, researchers and medical scientists may increasingly use this reliable CFD tool to deliver accurate results. A realistic, multidisciplinary approach is essential to accomplish these tasks. Indefinite collaborations between mechanical engineers and clinical and medical scientists are essential. CFD may be an important methodology to understand the pathophysiology of the development and progression of disease and for establishing and creating treatment modalities in the cardiovascular field.
C1 Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med,Div Cardiol, Seoul 135720, South Korea.
RP Lee, BK (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med,Div Cardiol, 211 Eonju Ro, Seoul 135720, South Korea.
EM cardiobk@yuhs.ac
OI Lee, Byoung Kwon/0000-0001-9259-2776
CR Bove EL, 2003, J THORAC CARDIOV SUR, V126, P1040, DOI 10.1016/S0022-5223(03)00698-6
   Cebral JR, 2011, AM J NEURORADIOL, V32, P145, DOI 10.3174/ajnr.A2419
   Cebral JR, 2011, AM J NEURORADIOL, V32, P264, DOI 10.3174/ajnr.A2274
   Cheung YF, 2000, HEART, V83, P420, DOI 10.1136/heart.83.4.420
   Cho YI, 2011, KOREAN CIRC J, V41, P287, DOI 10.4070/kcj.2011.41.6.287
   de Zelicourt DA, 2006, J THORAC CARDIOV SUR, V131, P785, DOI 10.1016/j.jtcvs.2005.11.031
   Feldt RH, 1996, J THORAC CARDIOV SUR, V112, P672, DOI 10.1016/S0022-5223(96)70051-X
   Filipovic N, 2011, IEEE T INF TECHNOL B, V15, P189, DOI 10.1109/TITB.2010.2096541
   FONTAN F, 1971, THORAX, V26, P240, DOI 10.1136/thx.26.3.240
   Frauenfelder T, 2006, CARDIOVASC INTER RAD, V29, P613, DOI 10.1007/s00270-005-0227-5
   Freshwater IJ, 2006, P I MECH ENG H, V220, P743, DOI 10.1243/09544119JEIM126
   FRIEDMAN MH, 1983, ATHEROSCLEROSIS, V46, P225, DOI 10.1016/0021-9150(83)90113-2
   Fung Y C, 1981, BIOMECHANICS
   FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406
   Gerdes A, 1999, ANN THORAC SURG, V67, P1760, DOI 10.1016/S0003-4975(99)00323-9
   Gewillig M, 2005, HEART, V91, P839, DOI 10.1136/hrt.2004.051789
   Giannoglou GD, 2005, MED ENG PHYS, V27, P455, DOI 10.1016/j.medengphy.2004.12.015
   Groen HC, 2010, J BIOMECH, V43, P2332, DOI 10.1016/j.jbiomech.2010.04.039
   Hager A, 2008, ANN THORAC SURG, V85, P186, DOI 10.1016/j.athoracsur.2007.07.029
   Hammer S, 2009, ULTRASOUND MED BIOL, V35, P2069, DOI 10.1016/j.ultrasmedbio.2009.06.1099
   Hayase H, 2011, NEUROSURGERY, V68, P1096, DOI 10.1227/NEU.0b013e318208f1a0
   Karmonik C, 2011, VASC ENDOVASC SURG, V45, P157, DOI 10.1177/1538574410389342
   LaDisa JF, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-40
   LaDisa JF, 2010, MED PHYS, V37, P784, DOI 10.1118/1.3292631
   Lee BK, 2002, YONSEI MED J, V43, P590, DOI 10.3349/ymj.2002.43.5.590
   Lee BK, 1998, YONSEI MED J, V39, P166, DOI 10.3349/ymj.1998.39.2.166
   Lee BK, 2001, YONSEI MED J, V42, P375, DOI 10.3349/ymj.2001.42.4.375
   Lee SW, 2008, STROKE, V39, P2341, DOI 10.1161/STROKEAHA.107.510644
   Lee SE, 2008, J BIOMECH, V41, P2551, DOI 10.1016/j.jbiomech.2008.03.038
   Marshall I, 2010, J MAGN RESON IMAGING, V31, P928, DOI 10.1002/jmri.22096
   Martin D, 2009, BRIT J RADIOL, V82, pS33, DOI 10.1259/bjr/59367266
   Matthews IL, 2006, CARDIOL YOUNG, V16, P261, DOI 10.1017/S1047951106000345
   Milner JS, 1998, J VASC SURG, V28, P143, DOI 10.1016/S0741-5214(98)70210-1
   Myers CD, 2006, ANN THORAC SURG, V81, P257, DOI 10.1016/j.athoracsur.2005.07.003
   Nichols WW, 2005, MCDONALDS BLOOD FLOW
   O'Rourke MJ, 2008, P I MECH ENG H, V222, P737, DOI 10.1243/09544119JEIM357
   Papafaklis MI, 2007, INT J CARDIOL, V115, P276, DOI 10.1016/j.ijcard.2006.04.030
   Qiu YC, 2000, J BIOMECH ENG-T ASME, V122, P77, DOI 10.1115/1.429629
   Radaellia AG, 2008, J BIOMECH, V41, P2069, DOI 10.1016/j.jbiomech.2008.04.035
   Ramaswamy SD, 2006, J BIOMECH ENG-T ASME, V128, P40, DOI 10.1115/1.2132371
   Ramaswamy SD, 2004, ANN BIOMED ENG, V32, P1628, DOI 10.1007/s10439-004-7816-3
   Sankaranarayanan M, 2005, BIOMED ENG ONLINE, V4, DOI 10.1186/1475-925X-4-14
   Sforza DM, 2010, INT J NUMER METH BIO, V26, P1219, DOI 10.1002/cnm.1385
   Starnes SL, 2001, J THORAC CARDIOV SUR, V122, P518, DOI 10.1067/mtc.2001.115423
   Suh GY, 2011, ANN BIOMED ENG, V39, P864, DOI 10.1007/s10439-010-0202-4
   Suh SH, 2011, P 7 INT C COMP HEAT
   Tremmel M, 2010, WORLD NEUROSURG, V74, P306, DOI 10.1016/j.wneu.2010.05.008
   Tu J, 2008, COMPUTATIONAL FLUID DYNAMICS: A PRACTICAL APPROACH, P1
   Versteeg H., 1995, INTRO COMPUTATIONAL
   Westerhof N, 2009, MED BIOL ENG COMPUT, V47, P131, DOI 10.1007/s11517-008-0359-2
   Xue YJ, 2008, ACTA RADIOL, V49, P558, DOI 10.1080/02841850801918548
   Yilmaz F, 2008, KOREA-AUST RHEOL J, V20, P197
NR 52
TC 30
Z9 31
U1 3
U2 13
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 423
EP 430
DI 10.4070/kcj.2011.41.8.423
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900001
PM 21949524
OA Green Published
DA 2021-04-22
ER

PT J
AU Pak, HN
AF Pak, Hui-Nam
TI Large Circular Ring Catheter Ablation Versus Anatomically Guided
   Ablation of Atrial Fibrillation: Back to the Future for Successful
   Catheter Ablation of Atrial Fibrillation?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
ID RADIOFREQUENCY ABLATION; ANTIARRHYTHMIC-DRUGS; PULMONARY; PERSISTENT
C1 Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
RP Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM hnpak@yuhs.ac
RI Pak, Hui-Nam/C-4266-2015
OI Pak, Hui-Nam/0000-0002-3256-3620
CR Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]
   Everett TH, 2007, HEART RHYTHM, V4, P1048, DOI 10.1016/j.hrthm.2007.03.032
   Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003
   Haissaguerre MHR, 2005, J CARDIOVASC ELECTR, V16, P1138, DOI 10.1111/j.1540-8167.2005.00308.x
   Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582
   Jang SW, 2011, KOREAN CIRC J, V41, P447, DOI 10.4070/kcj.2011.41.8.447
   Nair GM, 2009, J CARDIOVASC ELECTR, V20, P138, DOI 10.1111/j.1540-8167.2008.01285.x
   Oral H, 2003, CIRCULATION, V108, P2355, DOI 10.1161/01.CIR.0000095796.45180.88
   Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955
   Pak HN, 2008, J CARDIOVASC ELECTR, V19, P473, DOI 10.1111/j.1540-8167.2007.01074.x
   Pak HN, 2006, J CARDIOVASC ELECTR, V17, P818, DOI 10.1111/j.1540-8167.2006.00503.x
   Pappone C, 2000, CIRCULATION, V102, P2619
   Perez-Lugones A, 2003, J CARDIOVASC ELECTR, V14, P803, DOI 10.1046/j.1540-8167.2003.03075.x
   Scharf C, 2009, J AM COLL CARDIOL, V54, P1450, DOI 10.1016/j.jacc.2009.07.009
   Tada H, 2002, J CARDIOVASC ELECTR, V13, P118, DOI 10.1046/j.1540-8167.2002.00118.x
   Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634
   WEST TC, 1962, AM J PHYSIOL, V202, P232
NR 17
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 431
EP 433
DI 10.4070/kcj.2011.41.8.431
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900002
PM 21949525
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SM
   Oh, HL
   Kim, JS
   Park, J
   Yim, HR
   Shin, DH
   On, YK
   Lee, SH
AF Lee, Seon Mee
   Oh, Hye Lim
   Kim, June Soo
   Park, Jungwae
   Yim, Hye Ran
   Shin, Dae Hee
   On, Young Keun
   Lee, Sang Hoon
TI Comparison of Recurrence Rate Based on the Frequency of Preceding
   Symptoms in Patients With Neurocardiogenic Syncope or Presyncope
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Neurocardiogenic syncope; Syncope, vasovagal; Recurrence
AB Background and Objectives: In patients with neurocardiogenic syncope or presyncope, symptoms developed unpredictably and intermittently. The purpose of this study was to determine whether there was any significant difference in the recurrence rate of symptoms during the follow-up period between patients with many episodes of symptoms and those with fewer episodes of symptoms before diagnosis, as well as to assess the clinical significance of previous episodes of symptoms during treatment. Subjects and Methods: A total of 100 patients with neurocardiogenic syncope or presyncope were divided in two groups (high episode group, n=54; low episode group, n=46) according to the frequency of symptoms before the head-up tilt test. We retrospectively analyzed the recurrence of symptoms using telephone interviews and medical record reviews. Results: The clinical characteristics were not significantly different between the two groups. However, the recurrence rate was significantly lower in the high episode group than in the low episode group (5.6% vs. 19.6%, p=0.001). In the high episode group, patients treated with medication showed higher recurrence of symptoms than those without medication. In the lower episode group, a similar result was observed. Conclusion: The frequency of previous symptoms at the diagnosis of neurocardiogenic syncope or presyncope did not predict the occurrence of symptoms during the follow-up period. Therefore, to continue drug treatment based on the frequency of symptoms in patients with neurocardiogenic syncope or presyncope may not be the best option.
C1 [Lee, Seon Mee; Oh, Hye Lim] Sam Anyang Gen Hosp, Dept Med, Div Cardiol, Anyang, South Korea.
   [Kim, June Soo; Park, Jungwae; Yim, Hye Ran; On, Young Keun; Lee, Sang Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Cardiac & Vasc Ctr,Dept Med,Div Cardiol, Seoul 135710, South Korea.
   [Shin, Dae Hee] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Div Cardiol, Kangnung, South Korea.
RP Kim, JS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Cardiac & Vasc Ctr,Dept Med,Div Cardiol, 50 Irwon Dong, Seoul 135710, South Korea.
EM juneskim@skku.edu
CR ABBOUD FM, 1993, NEW ENGL J MED, V328, P1117, DOI 10.1056/NEJM199304153281510
   Ahn SJ, 1998, KOREAN CIRC J, V28, P1502
   Baron-Esquivias G, 2004, AM HEART J, V147, P883, DOI 10.1016/j.ahj.2003.11.022
   Benditt DG, 1996, J AM COLL CARDIOL, V28, P263, DOI 10.1016/0735-1097(96)00236-7
   BRIGNOLE M, 1992, AM J CARDIOL, V70, P339, DOI 10.1016/0002-9149(92)90615-6
   BRIGNOLE M, 1991, AM HEART J, V122, P1644, DOI 10.1016/0002-8703(91)90282-M
   COX MM, 1995, J AM COLL CARDIOL, V26, P1293, DOI 10.1016/0735-1097(95)00320-7
   Kaufmann H, 2002, ANN NEUROL, V52, P342, DOI 10.1002/ana.10293
   KOSINSKI D, 1995, PACE, V18, P716, DOI 10.1111/j.1540-8159.1995.tb04666.x
   Kouakam C, 2001, EUR HEART J, V22, P1618, DOI 10.1053/euhj.2000.2577
   Madrid AH, 2001, J AM COLL CARDIOL, V37, P554, DOI 10.1016/S0735-1097(00)01155-4
   Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298
   NATALE A, 1995, PACE, V18, P655, DOI 10.1111/j.1540-8159.1995.tb04660.x
   Oh JH, 2003, PACE, V26, P593, DOI 10.1046/j.1460-9592.2003.00099.x
   Raviele A, 1999, CIRCULATION, V99, P1452, DOI 10.1161/01.CIR.99.11.1452
   RUIZ GA, 1995, AM HEART J, V130, P345, DOI 10.1016/0002-8703(95)90452-2
   Salim MA, 2005, J AM COLL CARDIOL, V45, P484, DOI 10.1016/j.jacc.2004.11.033
   Sheldon R, 2006, CIRCULATION, V113, P1164, DOI 10.1161/CIRCULATIONAHA.105.535161
   Sheldon R, 1996, CIRCULATION, V93, P973, DOI 10.1161/01.CIR.93.5.973
   Takata TS, 2002, CIRCULATION, V106, P1500, DOI 10.1161/01.CIR.0000029748.94931.96
   Youn HJ, 1994, KOREAN J MED, V47, P186
NR 21
TC 7
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 434
EP 439
DI 10.4070/kcj.2011.41.8.434
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900003
PM 21949526
OA Green Published
DA 2021-04-22
ER

PT J
AU Hong, YJ
   Jeong, MH
   Choi, YH
   Cho, SH
   Hwang, SH
   Ko, JS
   Lee, MG
   Park, KH
   Sim, DS
   Yoon, NS
   Yoon, HJ
   Kim, KH
   Park, HW
   Kim, JH
   Ahn, Y
   Cho, JG
   Park, JC
   Kang, JC
AF Hong, Young Joon
   Jeong, Myung Ho
   Choi, Yun Ha
   Cho, Suk Hee
   Hwang, Seung Hwan
   Ko, Jum Suk
   Lee, Min Goo
   Park, Keun Ho
   Sim, Doo Sun
   Yoon, Nam Sik
   Yoon, Hyun Ju
   Kim, Kye Hun
   Park, Hyung Wook
   Kim, Ju Han
   Ahn, Youngkeun
   Cho, Jeong Gwan
   Park, Jong Chun
   Kang, Jung Chaee
TI Relation Between High-Sensitivity C-Reactive Protein and Coronary Plaque
   Components in Patients With Acute Coronary Syndrome: Virtual
   Histology-Intravascular Ultrasound Analysis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Acute coronary syndrome; Plaque, atherosclerotic; Inflammation;
   Ultrasonography, interventional
AB Background and Objectives: We used virtual histology-intravascular ultrasound (VH-IVUS) to evaluate the relationship between high-sensitivity C-reactive protein (hs-CRP) levels and plaque components in 279 acute coronary syndrome (ACS) patients. Subjects and Methods: We divided patients into three groups according to their hs-CRP levels {lowest tertile <0.07 mg/dL (n=93), middle tertile >= 0.07, <0.4 mg/dL (n=93), and highest tertile >= 0.4 mg/dL (n=93)}. Thin-cap fibroatheroma (TCFA) was defined as focal, necrotic core (NC)-rich (>= 10% of the cross-sectional area) plaques in contact with the lumen in a plaque burden >= 40%. Results: The highest tertile group was mostly diabetics (20%, 27%, 40%, p=0.009), and had the greatest plaque plus media volume (163 +/- 139/mm(3) vs. 201 +/- 155/mm(3) vs. 232 +/- 176/mm(3), p=0.013). The highest tertile group had the greatest absolute and % NC volumes (13.6 +/- 15.1 mm(3) vs. 14.8 +/- 14.2 mm(3) vs. 23.7 +/- 24.3 mm(3), p<0.001, and 14.9 +/- 8.7% vs. 16.0 +/- 8.7% vs. 19.5 +/- 10.2%, p=0.024, respectively). The culprit lesion TCFA was observed most frequently in the highest tertile group (28% vs. 35% vs. 55%, p=0.006). By multivariable analysis, absolute NC volume was an independent predictor of hsCRP elevation {odds ratio (OR); 1.03, 95% confidence interval (CI)=1.06-1.21, p=0.004}, and hs-CRP was an independent predictor of TCFA (OR; 1.86, 95% CI=1.11-2.90, p=0.010). Conclusion: VH-IVUS analysis has demonstrated that ACS patients with elevated hs-CRP have more vulnerable plaque component (NC-rich plaques and higher frequency of culprit lesion TCFA), compared with ACS patients with normal hs-CRP.
C1 [Hong, Young Joon; Jeong, Myung Ho; Choi, Yun Ha; Cho, Suk Hee; Hwang, Seung Hwan; Ko, Jum Suk; Lee, Min Goo; Park, Keun Ho; Sim, Doo Sun; Yoon, Nam Sik; Yoon, Hyun Ju; Kim, Kye Hun; Park, Hyung Wook; Kim, Ju Han; Ahn, Youngkeun; Cho, Jeong Gwan; Park, Jong Chun; Kang, Jung Chaee] Chonnam Natl Univ, Res Inst Med Sci, Chonnam Natl Univ Hosp, Ctr Heart, Kwangju 501757, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ, Res Inst Med Sci, Chonnam Natl Univ Hosp, Heart Res Ctr, 671 Jaebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
FU Fundamental R&D Program for Core Technology of Materials - Ministry of
   Knowledge Economy, Republic of KoreaMinistry of Knowledge Economy,
   Republic of Korea [K00060-282]
FX This study was supported by a grant (K00060-282) from the Fundamental
   R&D Program for Core Technology of Materials funded by the Ministry of
   Knowledge Economy, Republic of Korea.
CR Bae JH, 2006, KOREAN CIRC J, V36, P553
   Bae JH, 2007, KOREAN CIRC J, V37, P437
   Blake GJ, 2003, J AM COLL CARDIOL, V41, p37S, DOI 10.1016/S0735-1097(02)02953-4
   BUJA LM, 1994, CIRCULATION, V89, P503, DOI 10.1161/01.CIR.89.1.503
   Burke AP, 2002, CIRCULATION, V105, P2019, DOI 10.1161/01.CIR.0000015507.29953.38
   Choi H, 2004, CIRC J, V68, P297, DOI 10.1253/circj.68.297
   DAVIES MJ, 1993, BRIT HEART J, V69, P377
   DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801
   FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657
   Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354
   Hong MK, 2004, CIRCULATION, V110, P928, DOI 10.1161/01.CIR.0000139858.69915.2E
   Hur SH, 2004, KOREAN CIRC J, V34, P548
   Jabs WJ, 2003, CIRCULATION, V108, P1428, DOI 10.1161/01.CIR.0000092184.43176.91
   James SK, 2003, J AM COLL CARDIOL, V41, P916, DOI 10.1016/S0735-1097(02)02969-8
   Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353
   Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5
   Morrow DA, 2003, CIRCULATION, V108, P250, DOI 10.1161/01.CIR.0000078080.37974.D2
   Nakanishi N, 2005, CIRC J, V69, P386, DOI 10.1253/circj.69.386
   Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45
   Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007
   Roberts WL, 2001, CLIN CHEM, V47, P418
   Rodriguez-Granillo GA, 2005, J AM COLL CARDIOL, V46, P2038, DOI 10.1016/j.jacc.2005.07.064
   Sano T, 2003, CIRCULATION, V108, P282, DOI 10.1161/01.CIR.0000079173.84669.4F
   Tanaka A, 2005, J AM COLL CARDIOL, V45, P1594, DOI 10.1016/j.jacc.2005.01.053
   van der Meer IM, 2002, ARTERIOSCL THROM VAS, V22, P838, DOI 10.1161/01.ATV.0000016249.96529.B8
   Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065
   Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262
   Virmani Renu, 2003, J Interv Cardiol, V16, P267, DOI 10.1034/j.1600-0854.2003.8042.x
NR 29
TC 13
Z9 13
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 440
EP 446
DI 10.4070/kcj.2011.41.8.440
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900004
PM 21949527
OA Green Published
DA 2021-04-22
ER

PT J
AU Jang, SW
   Shin, WS
   Kim, JH
   Choi, MS
   Choi, YS
   Oh, YS
   Lee, MY
   Rho, TH
AF Jang, Sung-Won
   Shin, Woo-Seung
   Kim, Ji-Hoon
   Choi, Min-Seok
   Choi, Yun Seok
   Oh, Yong-Seog
   Lee, Man-Young
   Rho, Tai-Ho
TI The Feasibility and Efficacy of a Large-Sized Lasso Catheter Combined
   With 3 Dimensional Mapping System for Catheter Ablation of Atrial
   Fibrillation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Catheter ablation; Pulmonary vein; Tachycardia
AB Background and Objectives: We aimed to investigate whether a large-sized Lasso catheter could increase the success rate of immediate complete pulmonary vein (PV) antral isolation and improve the outcome of catheter ablation in atrial fibrillation (AF) patients. Subjects and Methods: This study included 107 consecutive patients (67 males, mean age: 57.8 +/- 9.7 years) who underwent PV mapping and ablation due to symptomatic drug-refractory AF. The first 43 patients underwent isolation of both ipsilateral PVs using the Carto-Merge 3 dimensional mapping system (group 1). The other 64 patients underwent isolation of both ipsilateral PVs using the same technique with a large-sized (a diameter of 30 to 35 mm) Lasso catheter (group 2). When ipsilateral PVs did not show any potential after the initial circumferential ablation, we defined this as 'immediate complete antral isolation (ICAI)'. We compared the AF recurrence rate of both groups. Results: There was no significant difference of the clinical characteristics between group 1 and group 2. All the patients were followed-up for 1 year. The ICAI rate of group 1 and group 2 was significantly different (21% vs. 78%, p<0.001), and the AF recurrence rates of group 1 and group 2 were also different (34.9% vs. 18.8%, p=0.042). Using multiple logistic regression analysis, the use of a large-sized Lasso catheter was a significant predictive factor for preventing recurrence (odds ratio: 0.489, 95% confidence interval: 0.136-0.927). Conclusion: It is likely that a large-sized Lasso catheter plays an important role in achieving ICAI and in lowering the rate of AF recurrence.
C1 [Jang, Sung-Won; Shin, Woo-Seung; Kim, Ji-Hoon; Choi, Min-Seok; Choi, Yun Seok; Oh, Yong-Seog; Lee, Man-Young; Rho, Tai-Ho] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, Seoul 137040, South Korea.
RP Oh, YS (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, 505 Banpo Dong, Seoul 137040, South Korea.
EM oys@catholic.ac.kr
CR Arentz T, 2007, CIRCULATION, V115, P3057, DOI 10.1161/CIRCULATIONAHA.107.690578
   Cheema A, 2006, J CARDIOVASC ELECTR, V17, P1080, DOI 10.1111/j.1540-8167.2006.00569.x
   Chen SA, 2000, J CARDIOVASC ELECTR, V11, P218
   Dong J, 2006, J CARDIOVASC ELECTR, V17, P459, DOI 10.1111/j.1540-8167.2006.00425.x
   Haissaguerre M, 2000, CIRCULATION, V101, P1409, DOI 10.1161/01.CIR.101.12.1409
   Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003
   Hocini M, 2005, CIRCULATION, V112, P3688, DOI 10.1161/CIRCULATIONAHA.105.541052
   Jais P, 1997, CIRCULATION, V95, P572, DOI 10.1161/01.CIR.95.3.572
   Jais P, 2004, CIRCULATION, V110, P2996, DOI 10.1161/01.CIR.0000146917.75041.58
   Nam KB, 2005, KOREAN CIRC J, V35, P643
   Oral H, 2003, CIRCULATION, V108, P2355, DOI 10.1161/01.CIR.0000095796.45180.88
   Oral H, 2002, CIRCULATION, V106, P1256, DOI 10.1161/01.CIR.0000027821.55835.00
   Ouyang F, 2005, CIRCULATION, V112, P3038, DOI 10.1161/CIRCULATIONAHA.105.561183
   Ouyang FF, 2005, CIRCULATION, V111, P127, DOI 10.1161/01.CIR.0000151289.73085.36
   Ouyang FF, 2004, CIRCULATION, V110, P2090, DOI 10.1161/01.CIR.0000144459.37455.EE
   Yamane T, 2007, CIRC J, V71, P753, DOI 10.1253/circj.71.753
NR 16
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 447
EP 452
DI 10.4070/kcj.2011.41.8.447
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900005
PM 21949528
OA Green Published
DA 2021-04-22
ER

PT J
AU Abu-Kishk, I
   Baram, S
   Kozer, E
   Klin, B
   Eshel, G
AF Abu-Kishk, Ibrahim
   Baram, Shaul
   Kozer, Eran
   Klin, Baruch
   Eshel, Gideon
TI Thrombophilia, Left Ventricular Dysfunction and Intracardiac Thrombi in
   Children
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Dilated cardiomyopathy; Thrombophilia
AB Background and Objectives: Reports on the incidence of intracardiac thrombi (ICT) have increased over the last few decades, but ICT are still relatively rare among children. Left ventricular systolic dysfunction and dilatation may contribute to the formation of ICT, especially when a hypercoagulable state exists. The aim of this study was to describe the incidence of ICT in children suffering from cardiac failure with left ventricular dysfunction and to identify risk factors on admission for developing ICT. Subjects and Methods: We conducted a retrospective chart review of children up to 18 years of age admitted to the Pediatric Intensive Care Unit due to cardiac failure with left ventricular dysfunction between January 1, 2003 and December 31, 2008. Results: Twenty-one patients were admitted with clinical signs of cardiac failure and echocardiographic findings compatible with dilated cardiomyopathy or acute myocarditis. Dilated cardiomyopathy was diagnosed in 11 patients (52%). Adenoviruses and enteroviruses were suspected to be the cause of acute myocarditis in 5 cases. The personal or family history of hypercoagulable states were obtained from 19 out of 21 patients (90%). Among patients with a hypercoagulable state, 3 out of 7 developed ICT compared with none out of 12 among patients without hypercoagulability (p=0.043). Two of these 3 patients experienced an embolic event. Conclusion: Cardiac failure with left ventricular dysfunction may predispose the patient to ICT and increase the risk of thromboembolism, especially when an underlying hypercoagulable state exists. The hypercoagulable state must be carefully evaluated on admission in these patients.
C1 [Abu-Kishk, Ibrahim; Kozer, Eran; Eshel, Gideon] Assaf Harofeh Med Ctr, Div Pediat, IL-70300 Zerifin, Israel.
   [Baram, Shaul] Assaf Harofeh Med Ctr, Pediat Cardiol Unit, IL-70300 Zerifin, Israel.
   [Klin, Baruch] Assaf Harofeh Med Ctr, Dept Pediat Surg, IL-70300 Zerifin, Israel.
   Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel.
RP Abu-Kishk, I (corresponding author), Assaf Harofeh Med Ctr, Div Pediat, IL-70300 Zerifin, Israel.
EM fredricag@asaf.health.gov.il
CR Alioglu B, 2008, BLOOD COAGUL FIBRIN, V19, P294, DOI 10.1097/MBC.0b013e3282fe73b1
   Atalay S, 2002, ACTA PAEDIATR, V91, P168, DOI 10.1080/080352502317285162
   ATALAY S, 1995, ANGIOLOGY, V46, P87, DOI 10.1177/000331979504600112
   Blom JW, 2005, JAMA-J AM MED ASSOC, V293, P715, DOI 10.1001/jama.293.6.715
   BLONDHEIM DS, 1991, AM HEART J, V122, P763, DOI 10.1016/0002-8703(91)90523-K
   FAVARA BE, 1974, AM J DIS CHILD, V127, P197, DOI 10.1001/archpedi.1974.02110210047006
   Gunthard J, 1997, EUR J PEDIATR, V156, P3
   Gurgey A, 2003, PEDIATR CARDIOL, V24, P244, DOI 10.1007/s00246-002-0170-z
   Hochster Howard, 1995, Current Opinion in Oncology, V7, P304, DOI 10.1097/00001622-199507000-00002
   KADAR K, 1991, PEDIATR CARDIOL, V12, P24, DOI 10.1007/BF02238494
   Khairy P, 2008, CIRCULATION, V117, P85, DOI 10.1161/CIRCULATIONAHA.107.738559
   Kohlhase B, 1996, J PEDIATR-US, V129, P677, DOI 10.1016/S0022-3476(96)70149-X
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Lip GYH, 1999, J AM COLL CARDIOL, V33, P1424
   Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287
   MARTIN M, 1989, AM J CLIN ONCOL-CANC, V12, P229, DOI 10.1097/00000421-198906000-00010
   MELTZER RS, 1986, ANN INTERN MED, V104, P689, DOI 10.7326/0003-4819-104-5-689
   MISSET B, 1990, INTENS CARE MED, V16, P210, DOI 10.1007/BF01724805
   Monagle P, 2008, CHEST, V133, p887S, DOI 10.1378/chest.08-0762
   OZKUTLU S, 1993, INT J CARDIOL, V40, P251, DOI 10.1016/0167-5273(93)90008-5
   Ripley TL, 2009, AM J HEALTH-SYST PH, V66, P134, DOI 10.2146/ajhp080047
   ROSS P, 1989, J PEDIATR SURG, V24, P253, DOI 10.1016/S0022-3468(89)80006-5
   SASSON Z, 1994, CAN J CARDIOL, V10, P861
   Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358
   Schreijer AJM, 2006, LANCET, V367, P832, DOI 10.1016/S0140-6736(06)68339-6
   SUSKAN E, 1994, EUR J PEDIATR, V153, P862, DOI 10.1007/BF01972901
   TEGELER CH, 1991, SEMIN NEUROL, V11, P339, DOI 10.1055/s-2008-1041239
   TREASURE CB, 1990, CIRCULATION, V81, P772, DOI 10.1161/01.CIR.81.3.772
NR 28
TC 2
Z9 2
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 453
EP 457
DI 10.4070/kcj.2011.41.8.453
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900006
PM 21949529
OA Green Published
DA 2021-04-22
ER

PT J
AU Yun, KH
   Shin, IS
   Shin, SN
   Choi, JH
   Kim, SH
   Rhee, SJ
   Lee, EM
   Yoo, NJ
   Kim, NH
   Oh, SK
   Jeong, JW
AF Yun, Kyeong Ho
   Shin, Ik-Sang
   Shin, Seoung-Nam
   Choi, Jun-Ho
   Kim, Seung Hwan
   Rhee, Sang Jae
   Lee, Eun Mi
   Yoo, Nam Jin
   Kim, Nam-Ho
   Oh, Seok Kyu
   Jeong, Jin-Won
TI Effect of Previous Statin Therapy in Patients With Acute Coronary
   Syndrome and Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angioplasty; Myocardial infarction; Stents;
   Hydroxymethylglutaryl-coenzyme A reductase inhibitors; Treatment outcome
ID MYOCARDIAL-INFARCTION; ATORVASTATIN; EVENTS; PRETREATMENT; PRAVASTATIN;
   OUTCOMES
AB Background and Objectives: Statin therapy after percutaneous coronary intervention (PCI) has been associated with reduced major adverse cardiovascular events (MACE). However, it has been less clear as to whether statin therapy before acute coronary syndrome (ACS) is beneficial. We studied the effect of previous statin therapy, initiated >= 1 month before PCI, on the outcome of patients with ACS who had undergone early invasive strategies. Subjects and Methods: We stratified 479 consecutive patients with ACS who had undergone PCI, according to preprocedural statin administration as follows: previous statin-treated patients (statin group, n=237) and statin-naive patients (control group, n=242). The incidence of periprocedural myocardial infarction (MI) and in-hospital MACE was assessed. Results: The incidence of Braunwald class III angina and MI presentation were significantly lower in the statin group than in the control group. Angiographic and procedural characteristics were similar between the two groups; however, slow/no reflow phenomenon occurred more frequently in the control group. After PCI, the incidence of periprocedural MI was higher in the control group than in the statin group (6.6% vs. 2.1%, p=0.016). Multivariate analysis revealed that no prior use of statin {odds ratio (OR)=2.8; 95% confidence interval (CI)=1.1-7.2; p=0.038), procedural complication (OR=4.0; 95% CI=1.5-10.5; p=0.004), stent overlap (OR=4.7; 95% CI=1.3-16.4; p=0.015), and old age (OR=3.2; 95% CI=1.2-8.0; p=0.016) were independent predictors for in-hospital MACE. Conclusion: Previous statin therapy before ACS was associated with milder clinical presentation and lower incidence of in-hospital MACE after early invasive strategies. The beneficial outcome is attributable to a significant reduction in periprocedural MI after PCI.
C1 [Yun, Kyeong Ho; Shin, Ik-Sang; Shin, Seoung-Nam; Choi, Jun-Ho; Kim, Seung Hwan; Rhee, Sang Jae; Lee, Eun Mi; Yoo, Nam Jin; Kim, Nam-Ho; Oh, Seok Kyu; Jeong, Jin-Won] Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, Iksan 570711, South Korea.
RP Yun, KH (corresponding author), Wonkwang Univ Hosp, Reg Cardiocerebrovasc Ctr, Dept Cardiovasc Med, 344-2 Sinyong Dong, Iksan 570711, South Korea.
EM ards7210@yahoo.co.kr
CR Bauer T, 2009, J CARDIOVASC PHARM, V53, P132, DOI 10.1097/FJC.0b013e3181976a3c
   Briguori C, 2004, EUR HEART J, V25, P1822, DOI 10.1016/j.ehj.2004.07.017
   Chan AW, 2003, CIRCULATION, V107, P1750, DOI 10.1161/01.CIR.0000060541.18923.E9
   Chang SM, 2004, CATHETER CARDIO INTE, V62, P193, DOI 10.1002/ccd.20078
   Di Sciascio G, 2009, J AM COLL CARDIOL, V54, P558, DOI 10.1016/j.jacc.2009.05.028
   Ebrahimi R, 2008, J INVASIVE CARDIOL, V20, P292
   Ishii H, 2006, CLIN THER, V28, P1812, DOI 10.1016/j.clinthera.2006.11.003
   JAE LEE SANG, 2008, Korean Circulation Journal, V38, P135
   홍영준, 2003, Korean Circulation Journal, V33, P891
   Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025
   PEDERSEN TR, 1994, LANCET, V344, P1383
   Ray KK, 2005, J AM COLL CARDIOL, V46, P1405, DOI 10.1016/j.jacc.2005.03.077
   Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5
   Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401
   Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711
   SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001
   Spencer FA, 2004, ANN INTERN MED, V140, P857, DOI 10.7326/0003-4819-140-11-200406010-00006
   Sposito AC, 2002, ARTERIOSCL THROM VAS, V22, P1524, DOI 10.1161/01.ATV.0000032033.39301.6A
   최소연, 2005, Korean Circulation Journal, V35, P140
   Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486
   Tonkin A, 1998, NEW ENGL J MED, V339, P1349
   Yun KH, 2009, INT J CARDIOL, V137, P246, DOI 10.1016/j.ijcard.2008.06.055
   Yun KH, 2009, HEART VESSELS, V24, P175, DOI 10.1007/s00380-008-1110-5
NR 23
TC 10
Z9 13
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 458
EP 463
DI 10.4070/kcj.2011.41.8.458
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900007
PM 21949530
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, KH
   Shin, DG
   Son, CW
   Son, JW
   Jo, HS
   Yoon, JC
   Lee, WJ
   Lee, SH
   Hong, GR
   Park, JS
   Kim, YJ
   Choi, JH
   Lee, DH
AF Park, Kyu-Hwan
   Shin, Dong-Gu
   Son, Chang-Woo
   Son, Jang-Won
   Jo, Hyun-Su
   Yoon, Joon-Cheol
   Lee, Won-Jae
   Lee, Sang-Hee
   Hong, Geu-Ru
   Park, Jong-Seon
   Kim, Young-Jo
   Choi, Jung-Hyun
   Lee, Dong-Hyup
TI Aneurysm of Sinus of Valsalva Dissecting Into the Interventricular
   Septum After Aortic Valve Replacement: Diagnosis by Echocardiography and
   Magnetic Resonance Imaging and Treatment With Surgical Sealant
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ventricular septum; Heart aneurysm; Heart valve prosthesis implantation
AB Aneurysm of the sinus of Valsalva that causes dissection of the interventricular septum is an extremely rare entity. In this report we describe a case of aneurysm of the sinus of Valsalva dissecting into the interventricular septum, from the base to mid septum, after aortic valve replacement. After the diagnosis was made by transthoracic echocardiography and magnetic resonance imaging, the patient was successfully treated with surgical sealant-mediated occlusion of the aneurysmal sac and cardiac resynchronization therapy used for the first time.
C1 [Park, Kyu-Hwan; Shin, Dong-Gu; Son, Chang-Woo; Son, Jang-Won; Jo, Hyun-Su; Yoon, Joon-Cheol; Lee, Won-Jae; Lee, Sang-Hee; Hong, Geu-Ru; Park, Jong-Seon; Kim, Young-Jo] Yeungnam Univ, Coll Med, Dept Internal Med, Div Cardiol, Taegu 705717, South Korea.
   [Choi, Jung-Hyun] Dankook Univ, Coll Med, Dept Internal Med, Div Cardiol, Cheonan, South Korea.
   [Lee, Dong-Hyup] Yeungnam Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Taegu 705717, South Korea.
RP Shin, DG (corresponding author), Yeungnam Univ, Coll Med, Dept Internal Med, Div Cardiol, 317-1 Daemyeong Dong, Taegu 705717, South Korea.
EM dgshin@med.yu.ac.kr
CR Bapat VN, 1997, EUR J CARDIO-THORAC, V12, P759, DOI 10.1016/S1010-7940(97)00256-X
   Basaran Y, 1995, J Am Soc Echocardiogr, V8, P749, DOI 10.1016/S0894-7317(05)80393-1
   Choi RK, 2000, KOREAN CIRC J, V30, P599
   Choudhary SK, 1998, ANN THORAC SURG, V65, P735, DOI 10.1016/S0003-4975(97)01432-X
   Choudhary SK, 2003, EUR J CARDIO-THORAC, V23, P650, DOI 10.1016/S1010-7940(02)00840-0
   GALLET B, 1988, AM HEART J, V115, P1308, DOI 10.1016/0002-8703(88)90028-2
   Guler N, 2004, ECHOCARDIOGR-J CARD, V21, P645, DOI 10.1111/j.0742-2822.2004.03128.x
   HENZE A, 1983, SCAND J THORAC CARD, V17, P249, DOI 10.3109/14017438309099360
   Jung IS, 1997, KOREAN J THORAC CARD, V30, P719
   Kutay V, 2005, ANN THORAC SURG, V79, P341, DOI 10.1016/j.athoracsur.2003.08.015
   LEE EB, 1956, ANN INTERN MED, V45, P525, DOI 10.7326/0003-4819-45-3-525
   MAYER ED, 1986, ANN THORAC SURG, V42, P81, DOI 10.1016/S0003-4975(10)61842-5
   Nunes MDP, 2008, ECHOCARDIOGR-J CARD, V25, P102, DOI 10.1111/j.1540-8175.2007.00547.x
   Pan-Chih, 1981, ANN TORAC SURG, V32, P162
   RAFFA H, 1991, ANN THORAC SURG, V51, P996, DOI 10.1016/0003-4975(91)91029-U
   Sajeev CG, 2005, INT J CARDIOL, V105, P342, DOI 10.1016/j.ijcard.2004.12.043
   Seo IA, 1999, KOREAN CIRC J, V29, P625
   Silance P G, 1996, J Am Soc Echocardiogr, V9, P190, DOI 10.1016/S0894-7317(96)90028-0
   Wu QY, 2002, EUR J CARDIO-THORAC, V22, P517, DOI 10.1016/S1010-7940(02)00375-5
NR 19
TC 4
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 464
EP 468
DI 10.4070/kcj.2011.41.8.464
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900008
PM 21949531
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, BK
   Lee, HC
   Lee, HW
   Park, JS
   Oh, J
   Kim, SP
   Cha, KS
AF Choi, Bo Kyung
   Lee, Han Cheol
   Lee, Hye-Won
   Park, Jin-Sup
   Oh, Junhyok
   Kim, Sang-Pil
   Cha, Kwang Soo
TI Successful Treatment of a Ruptured Aortic Arch Aneurysm Using a Hybrid
   Procedure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aorta, thoracic; Aortic rupture; Stents
AB Aortic rupture has a high mortality rate and can be considered a medical emergency. The standard treatment for aortic rupture is surgical repair. An aortic stent graft for a ruptured descending aorta is considered an effective alternative treatment. However, an aortic stent graft is difficult when the aortic aneurysm is in the aortic arch due to supra-aortic vessels. We report on a patient with a ruptured aortic arch aneurysm treated with a hybrid procedure, which involved a carotid to carotid bypass operation and an aortic stent graft. A 71-year-old male patient visited our cardiovascular center suffering from hemoptysis. The chest CT and aortography showed a 9 cm sized aortic arch aneurysm 0.5 cm distal to the left subclavian artery and a hemothorax in the left lung. The patient refused to undergo a full open operation. We performed a carotid to carotid bypass in advance, and two pieces of aortic stent grafts were placed across the left carotid artery and left subclavian artery. The follow up CT showed the aortic stent grafts, no endoleaks and no thrombus in the aortic arch aneurysm. The patient was discharged from the hospital without complication.
C1 [Choi, Bo Kyung; Lee, Han Cheol; Lee, Hye-Won; Park, Jin-Sup; Oh, Junhyok; Cha, Kwang Soo] Pusan Natl Univ Hosp, Med Res Inst, Dept Internal Med, Div Cardiol, Pusan 602739, South Korea.
   [Kim, Sang-Pil] Pusan Natl Univ Hosp, Med Res Inst, Dept Thorac & Cardiovasc Surg, Pusan 602739, South Korea.
RP Lee, HC (corresponding author), Pusan Natl Univ Hosp, Med Res Inst, Dept Internal Med, Div Cardiol, 179 Gudeok Ro, Pusan 602739, South Korea.
EM glaraone@hanmail.net
CR Clouse WD, 1998, JAMA-J AM MED ASSOC, V280, P1926, DOI 10.1001/jama.280.22.1926
   Cohn PF, 1997, HEART DIS, P1550
   Criado FJ, 2002, J ENDOVASC THER, V9, P32, DOI 10.1583/1545-1550-9.sp3.32
   Czerny M, 2003, J THORAC CARDIOV SUR, V126, P916, DOI 10.1016/S0022-5223(03)00222-8
   Dake MD, 2001, EUR J RADIOL, V39, P42, DOI 10.1016/S0720-048X(01)00341-2
   DAKE MD, 1994, NEW ENGL J MED, V331, P1729, DOI 10.1056/NEJM199412293312601
   FAVRE JP, 1994, SURGERY, V115, P264
   Halperin JL, 2004, HURSTS HEART, P2304
   Hausegger KA, 2001, J ENDOVASC THER, V8, P472, DOI 10.1583/1545-1550(2001)008<0472:ILSAOB>2.0.CO;2
   JOHANSSON G, 1995, J VASC SURG, V21, P985, DOI 10.1016/S0741-5214(95)70227-X
   Killen DA, 2000, SOUTH MED J, V93, P195
   Kim Sang-Eok, 2009, Korean Circ J, V39, P209, DOI 10.4070/kcj.2009.39.5.209
   Kochi K, 2002, J THORAC CARDIOV SUR, V123, P363, DOI 10.1067/mtc.2002.119061
   Kouchoukos NT, 1997, NEW ENGL J MED, V336, P1876, DOI 10.1056/NEJM199706263362606
   Nishizawa J, 2004, ANN THORAC SURG, V77, P1821, DOI 10.1016/S0003-4975(03)00998-6
   Sunder-Plassmann L, 2003, J CARDIAC SURG, V18, P367, DOI 10.1046/j.1540-8191.2003.02077.x
   Zipfel B, 2009, ANN THORAC SURG, V88, P498, DOI 10.1016/j.athoracsur.2009.04.042
NR 17
TC 5
Z9 6
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 469
EP 473
DI 10.4070/kcj.2011.41.8.469
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900009
PM 21949532
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JH
   Kim, MK
   Kim, YJ
   Park, SM
   Park, KH
   Choi, YJ
AF Kim, Jae Hyun
   Kim, Min-Kyu
   Kim, Young Jin
   Park, Sun Man
   Park, Kyoung-Ha
   Choi, Young-Jin
TI Is a Metallic Microcoil Really a Permanent Embolic Agent for the
   Management of Distal Guidewire-Induced Coronary Artery Perforation?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Embolization, therapeutic; Cardiac tamponade; Angioplasty, balloon,
   coronary
AB Coronary artery perforation (CAP) after percutaneous coronary intervention is a rare, but serious complication. It can cause cardiac tamponade, acute myocardial infarction or death. The treatments of CAP involve prolonged balloon inflation, emergent surgery, coil embolization, and implantation of covered stent. We have successfully performed the emergent microcoil embolization in a patient with uncontrolled Ellis grade 3 guidewire-induced CAP resulting in delayed cardiac tamponade. Contrasting our usual expectation, the 1-year follow-up angiography showed a patent flow at the embolized site.
C1 [Kim, Jae Hyun; Kim, Min-Kyu; Kim, Young Jin; Park, Sun Man; Park, Kyoung-Ha; Choi, Young-Jin] Hallym Univ, Sch Med, Hangang Sacred Heart Hosp, Dept Internal Med,Div Cardiol, Seoul 150719, South Korea.
RP Kim, MK (corresponding author), Hallym Univ, Sch Med, Hangang Sacred Heart Hosp, Dept Internal Med,Div Cardiol, 94-200 Yeongdeungpo Dong, Seoul 150719, South Korea.
EM cagkim@hanmail.net
CR Aslam MS, 2000, CATHETER CARDIO INTE, V51, P320, DOI 10.1002/1522-726X(200011)51:3<320::AID-CCD18>3.0.CO;2-U
   Assali AR, 2000, CATHETER CARDIO INTE, V51, P487, DOI 10.1002/1522-726X(200012)51:4<487::AID-CCD25>3.0.CO;2-8
   Banerjee S, 2001, HEART, V86, P187, DOI 10.1136/heart.86.2.187
   Dippel EJ, 2001, CATHETER CARDIO INTE, V52, P279, DOI 10.1002/ccd.1065
   Fasseas P, 2004, AM HEART J, V147, P140, DOI 10.1016/S0002-8703(03)00505-2
   Fukutomi T, 2002, CIRC J, V66, P349, DOI 10.1253/circj.66.349
   Gaxiola E, 1998, CATHETER CARDIO DIAG, V43, P474, DOI 10.1002/(SICI)1097-0304(199804)43:4<474::AID-CCD29>3.0.CO;2-I
   Georgiadou Panagiota, 2009, Acute Card Care, V11, P216, DOI 10.1080/17482940903254207
   Gruberg L, 2000, AM J CARDIOL, V86, P680, DOI 10.1016/S0002-9149(00)01053-5
   Gunning MG, 2002, HEART, V88, P495, DOI 10.1136/heart.88.5.495
   Javaid A, 2006, AM J CARDIOL, V98, P911, DOI 10.1016/j.amjcard.2006.04.032
   Katsanos K, 2009, CARDIOVASC INTER RAD, V32, P1071, DOI 10.1007/s00270-009-9657-9
   Kiernan TJ, 2009, J INTERV CARDIOL, V22, P350, DOI 10.1111/j.1540-8183.2009.00469.x
   Kini AS, 2009, CATHETER CARDIO INTE, V74, P700, DOI 10.1002/ccd.22112
   Mahmud E, 2001, CATHETER CARDIO INTE, V53, P549, DOI 10.1002/ccd.1221
   Ramana Ravi K, 2005, J Invasive Cardiol, V17, P603
   Stankovic G, 2004, AM J CARDIOL, V93, P213, DOI 10.1016/j.amjcard.2003.09.042
   von Sohsten R, 2000, AM HEART J, V140, P279, DOI 10.1067/mhj.2000.107996
   Witzke Christian F, 2004, J Invasive Cardiol, V16, P257
   Wong CM, 1998, CATHETER CARDIO DIAG, V44, P93, DOI 10.1002/(SICI)1097-0304(199805)44:1<93::AID-CCD22>3.0.CO;2-P
NR 20
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 474
EP 478
DI 10.4070/kcj.2011.41.8.474
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900010
PM 21949533
OA Green Published
DA 2021-04-22
ER

PT J
AU Dahdouh, Z
   Wain-Hobson, J
   Roule, V
   Dahdouh, H
   Labombarda, F
   Abdel-Massih, T
   Sarkis, A
   Grollier, G
AF Dahdouh, Ziad
   Wain-Hobson, Julien
   Roule, Vincent
   Dahdouh, Houaida
   Labombarda, Fabien
   Abdel-Massih, Tony
   Sarkis, Antoine
   Grollier, Gilles
TI Tako-Tsubo Cardiomyopathy Triggered by Misdirection
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Tako-tsubo cardiomyopathy; Misdirection; Malnurition
AB Tako-Tsubo cardiomyopathy (TTC), also known as transient left ventricular apical ballooning syndrome or stress-induced cardiomyopathy, is a novel reversible cardiomyopathy mimicking acute myocardial infarction without epicardial coronary artery disease. The exact physiopathology of TTC remains unclear. It is usually precipitated by acute physical or emotional stress and it most commonly affects postmenopausal women. The growing number of clinical cases of TTC have demonstrated a wide field of possible etiologies beyond the emotional stress. We report a case of a 67-year-old postmenopausal woman who was being supplemented by enteral feeding via a nasogastric tube and who developed TTC due to misdirection, probably favored by the mechanical blockade by the nasogastric tube, while swallowing the drug pills.
C1 [Dahdouh, Ziad; Wain-Hobson, Julien; Roule, Vincent; Labombarda, Fabien; Grollier, Gilles] Univ Hosp Caen, Dept Cardiol, F-14033 Caen, France.
   [Dahdouh, Houaida] France Hosp, Hotel Dieu, Dept Pediat, Beirut, Lebanon.
   [Abdel-Massih, Tony; Sarkis, Antoine] France Hosp, Hotel Dieu, Dept Cardiol, Beirut, Lebanon.
RP Dahdouh, Z (corresponding author), Univ Hosp Caen, Dept Cardiol, Ave Cote de Nacre, F-14033 Caen, France.
EM ziad_dahdouh@hotmail.com
RI Labombarda, Fabien/AAE-7747-2020
CR Butman SM, 2010, CATHETER CARDIO INTE, V76, P388, DOI 10.1002/ccd.22478
   Kurisu S, 2002, AM HEART J, V143, P448, DOI 10.1067/mhj.2002.120403
   MADHAVAN M, 2010, HERZ
   Nef HM, 2008, INT J CARDIOL, V130, P266, DOI 10.1016/j.ijcard.2007.05.119
   Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046
NR 5
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 479
EP 481
DI 10.4070/kcj.2011.41.8.479
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900011
PM 21949534
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, WS
   Kang, SH
   Lee, SA
   Ryu, MS
   Park, SH
AF Kim, Woo Shin
   Kang, Seok Hyung
   Lee, Shin A.
   Ryu, Min Sun
   Park, Seong-Hoon
TI A Case of Staphylococcal Tricuspid Valve Endocarditis With Para-Aortic
   Abscess in a Patient With Bicuspid Aortic Valve
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Endocarditis; Abscess
ID INFECTIVE ENDOCARDITIS; PERIVALVULAR ABSCESSES; SURGICAL-MANAGEMENT;
   MEDICAL THERAPY; RING ABSCESS; SURVIVAL; FEATURES
AB Paravalvular abscess is a serious complication of infective endocarditis. The aortic valve and its adjacent ring are more susceptible to abscess formation and paravalvular extension than the mitral valve. A 15-years old patient with bicuspid aortic valve presented with staphylococcal tricuspid valve endocarditis complicated by para-aortic abscess that ruptured into the aortic sinus. We report the clinical, laboratory and echocardiographic features and treatment of this patient and conduct a literature review on this subject.
C1 [Kim, Woo Shin; Kang, Seok Hyung; Lee, Shin A.; Ryu, Min Sun; Park, Seong-Hoon] Ewha Womans Univ, Sch Med, Mokdong Hosp, Dept Internal Med, Seoul 158710, South Korea.
RP Park, SH (corresponding author), Ewha Womans Univ, Sch Med, Mokdong Hosp, Dept Internal Med,Div Cardiol, 911-1 Mok Dong, Seoul 158710, South Korea.
EM pseongh@ewha.ac.kr
CR ARNETT EN, 1976, CIRCULATION, V54, P140, DOI 10.1161/01.CIR.54.1.140
   BYRD BF, 1990, AM J CARDIOL, V66, P102, DOI 10.1016/0002-9149(90)90745-M
   Cha R, 2003, ANTIMICROB AGENTS CH, V47, P3960, DOI 10.1128/AAC.47.12.3960-3963.2003
   Chan KL, 2002, CAN MED ASSOC J, V167, P19
   Choussat R, 1999, EUR HEART J, V20, P232, DOI 10.1053/euhj.1998.1240
   CROFT CH, 1983, AM J CARDIOL, V51, P1650, DOI 10.1016/0002-9149(83)90203-5
   ELLIS SG, 1985, J AM COLL CARDIOL, V5, P647, DOI 10.1016/S0735-1097(85)80390-9
   JAULT F, 1993, J THORAC CARDIOV SUR, V105, P1106, DOI 10.1016/S0022-5223(19)33785-7
   JEANG MK, 1986, CHEST, V89, P613, DOI 10.1378/chest.89.4.613
   KUNIS RL, 1986, J AM COLL CARDIOL, V7, P953, DOI 10.1016/S0735-1097(86)80364-3
   박덕우, 2004, Korean Circulation Journal, V34, P883
   MULLANY CJ, 1995, MAYO CLIN PROC, V70, P517, DOI 10.4065/70.6.517
   Muller LC, 2003, ANN THORAC SURG, V75, P453, DOI 10.1016/S0003-4975(02)04062-6
   Pansini S, 1997, J HEART VALVE DIS, V6, P84
   SANDE MA, 1975, J INFECT DIS, V131, P367, DOI 10.1093/infdis/131.4.367
   SANDE MA, 1976, J LAB CLIN MED, V88, P118
   SCANLAN JG, 1982, AM J CARDIOL, V49, P1794, DOI 10.1016/0002-9149(82)90261-2
   TUCKER KJ, 1993, AM HEART J, V125, P1195, DOI 10.1016/0002-8703(93)90146-Z
   Yankah AC, 2002, EUR J CARDIO-THORAC, V21, P260, DOI 10.1016/S1010-7940(01)01084-3
NR 19
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 482
EP 485
DI 10.4070/kcj.2011.41.8.482
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900012
PM 21949535
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JH
   Kang, TS
AF Kim, Ji-Hwan
   Kang, Tae Soo
TI A Case of Distal Embolization of Left Ventricular Thrombus due to Blunt
   Chest Trauma-Induced Coronary Artery Occlusion
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary occlusion; Trauma; Embolism; Myocardial infarction; Heart
   aneurysm
AB Chest trauma can lead to various cardiac complications ranging from simple arrhythmias to myocardial rupture. A variety of injuries to the coronary arteries, including laceration, thrombosis, intimal dissection, arteriovenous fistula and pseudoaneurysm formation following blunt trauma have been rarely reported. We report a very unusual case of distal embolization of left ventricular thrombus due to blunt chest trauma-induced coronary artery occlusion.
C1 [Kim, Ji-Hwan; Kang, Tae Soo] Dankook Univ, Coll Med, Dept Internal Med, Cheonan 330715, South Korea.
RP Kang, TS (corresponding author), Dankook Univ, Coll Med, Dept Internal Med, 16-5 Anseo Dong, Cheonan 330715, South Korea.
EM neosoo70@dankook.ac.kr
CR ANTO MJ, 1984, ANGIOLOGY, V35, P802, DOI 10.1177/000331978403501209
   BARTON EN, 1988, W INDIAN MED J, V37, P236
   Chun Jung Hak, 1998, Journal of Korean Medical Science, V13, P325
   GASPARD P, 1983, CARDIOVASC INTER RAD, V6, P20, DOI 10.1007/BF02552788
   GOULAH RD, 1988, CHEST, V93, P887, DOI 10.1378/chest.93.4.887
   KAHN JK, 1987, AM HEART J, V113, P207, DOI 10.1016/0002-8703(87)90035-4
   Marcum JL, 1996, AM HEART J, V132, P1275, DOI 10.1016/S0002-8703(96)90475-5
   MARIK PE, 1990, S AFR MED J, V77, P586
   NEIMAN J, 1992, AM HEART J, V123, P1694, DOI 10.1016/0002-8703(92)90827-I
   Salmi A, 1996, J TRAUMA, V40, P832, DOI 10.1097/00005373-199605000-00028
   Tengler ML, 1985, J TRAUMA, V25, P620
   VLAY SC, 1980, AM HEART J, V100, P907, DOI 10.1016/0002-8703(80)90073-3
NR 12
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 486
EP 489
DI 10.4070/kcj.2011.41.8.486
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900013
PM 21949536
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JS
   Yang, WI
   Shim, CY
   Ha, JW
   Chung, N
   Chang, HJ
AF Kim, Jin-Sun
   Yang, Woo-In
   Shim, Chi Young
   Ha, Jong-Won
   Chung, Namsik
   Chang, Hyuk-Jae
TI Hemorrhagic Transformation of Ischemic Stroke: Severe Complications of
   Prosthetic Valve Endocarditis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart valve prosthesis; Endocarditis; Stroke; Cerebral hemorrhage;
   Anticoagulants
ID INFECTIVE ENDOCARDITIS; CARDIOEMBOLIC STROKE; CLINICAL CARDIOLOGY;
   DISEASE; ANTICOAGULATION; GUIDELINES; MANAGEMENT; THERAPY; COUNCIL
AB Ischemic stroke is a common complication of infective endocarditis (IE), occurring in 20-40% of left side IE cases. In these subsets, anticoagulation therapy may provoke hemorrhagic transformation (HT) of ischemic stroke, and complications of this magnitude deteriorate the clinical course for IE patients. However, in cases of IE complicated with a mechanical prosthetic valve, the physician can be concerned over the maintenance of anticoagulation due to the risk of thrombotic complication. According to our retrospective review, HT of ischemic stroke in prosthetic valve endocarditis occurred 13.8% (4/29) of the time in a variety of situations. Some of these even arose in patients with a subtherapeutic range of prothrombin time.
C1 [Kim, Jin-Sun; Yang, Woo-In; Shim, Chi Young; Ha, Jong-Won; Chung, Namsik; Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.
RP Chang, HJ (corresponding author), Yonsei Cardiovasc Ctr, Div Cardiol, 50 Yonsei Ro, Seoul 120752, South Korea.
EM hjchang@yuhs.ac
RI Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136; Ha, Jong-Won/0000-0002-8260-2958;
   Chang, Hyuk-Jae/0000-0002-6139-7545
CR Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486
   Aviv RI, 2009, RADIOLOGY, V250, P867, DOI 10.1148/radiol.2503080257
   Baddour LM, 2005, CIRCULATION, V111, pE394, DOI 10.1161/CIRCULATIONAHA.105.165564
   DAVENPORT J, 1990, STROKE, V21, P993, DOI 10.1161/01.STR.21.7.993
   Derex L, 2010, J NEUROL, V257, P315, DOI 10.1007/s00415-009-5364-3
   Fiorelli M, 1999, STROKE, V30, P2280, DOI 10.1161/01.STR.30.11.2280
   Hallevi H, 2008, ARCH NEUROL-CHICAGO, V65, P1169, DOI 10.1001/archneur.65.9.noc70105
   Kim JS, 2000, KOREAN CIRC J, V30, P166
   Nishimura RA, 2008, CIRCULATION, V118, P887, DOI 10.1161/CIRCULATIONAHA.108.190377
   OKADA Y, 1989, STROKE, V20, P598, DOI 10.1161/01.STR.20.5.598
   Paciaroni M, 2007, STROKE, V38, P423, DOI 10.1161/01.STR.0000254600.92975.1f
   Piechowski-Jozwiak B, 2003, NEUROLOGY, V61, P1324, DOI 10.1212/WNL.61.10.1324
   Ruttmann E, 2006, STROKE, V37, P2094, DOI 10.1161/01.STR.0000229894.28591.3f
   Ryu WS, 1984, KOREAN CIRC J, V14, P29
   Salem DN, 2001, CHEST, V119, p207S, DOI 10.1378/chest.119.1_suppl.207S
   Tornos P, 1999, ARCH INTERN MED, V159, P473, DOI 10.1001/archinte.159.5.473
NR 16
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 490
EP 493
DI 10.4070/kcj.2011.41.8.490
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900014
PM 21949537
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, DM
   Won, HS
   Ko, JK
   Jhang, WK
AF Seo, Dong-Man
   Won, Hye-Sung
   Ko, Jae Kon
   Jhang, Won Kyoung
TI Modified Damus-Kaye-Stansel/Dor Procedure for a Newborn With Severe Left
   Ventricular Aneurysm
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart aneurysm; Surgical procedures, operative
AB Congenital left ventricular aneurysm (CVA) is a rare cardiac malformation. The prognosis is variable, depending on such factors as the size in comparison to the ventricular cavity, signs of heart failure, arrhythmia and so on. Most infants and young children with large aneurysm showed poor clinical outcomes. Here, we report the case of patient who was prenatally diagnosed with a large CVA, who had severe left ventricular dysfunction at 21 weeks' gestation for which she successfully underwent a modified Damus-Kaye-Stansel/Dor procedure.
C1 [Seo, Dong-Man] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac & Cardiovasc Surg,Div Pediat Cardiac, Seoul 138736, South Korea.
   [Won, Hye-Sung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Obstet & Gynecol, Seoul 138736, South Korea.
   [Ko, Jae Kon; Jhang, Won Kyoung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pediat, Seoul 138736, South Korea.
RP Jhang, WK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pediat, 86 Asanbyeongwon Gil, Seoul 138736, South Korea.
EM wkjhang@amc.seoul.kr
OI Seo, Dong Man/0000-0002-5831-7954
CR Awad SM, 2009, PEDIATR CARDIOL, V30, P1022, DOI 10.1007/s00246-009-9482-6
   Baek SH, 1989, KOREAN CIRC J, V19, P756
   CavalleGarrido T, 1997, AM J PERINAT, V14, P393, DOI 10.1055/s-2007-994167
   Chowdhury UK, 2009, TEX HEART I J, V36, P331
   Conway J, 2008, PEDIATR CARDIOL, V29, P188, DOI 10.1007/s00246-007-9061-7
   del Nido PJ, 1999, J THORAC CARDIOV SUR, V117, P918, DOI 10.1016/S0022-5223(99)70372-7
   El Kady D, 2005, J ULTRAS MED, V24, P1011
   Krasemann T, 2001, PEDIATR CARDIOL, V22, P409, DOI 10.1007/s002460010264
   Mainwaring RD, 2000, J THORAC CARDIOV SUR, V120, P612, DOI 10.1067/mtc.2000.106657
   Marijon E, 2006, J THORAC CARDIOV SUR, V131, P433, DOI 10.1016/j.jtcvs.2005.09.046
   Matias A, 1999, CARDIOL YOUNG, V9, P175, DOI 10.1017/S1047951100008404
   McElhinney DB, 1999, CARDIOL YOUNG, V9, P123, DOI 10.1017/S1047951100008313
   Ohlow MA, 2006, CARDIOLOGY, V106, P63, DOI 10.1159/000092634
   Ohlow MA, 2009, EUROPACE, V11, P1689, DOI 10.1093/europace/eup323
   Papagiannis J, 2001, AM HEART J, V141, P491, DOI 10.1067/mhj.2001.113076
   Pipitone S, 2002, PRENATAL DIAG, V22, P131, DOI 10.1002/pd.259
   Sharma JR, 2002, PEDIATR CARDIOL, V23, P458, DOI 10.1007/s00246-002-1528-y
   Yamashiro Satoshi, 2003, Interact Cardiovasc Thorac Surg, V2, P77, DOI 10.1016/S1569-9293(02)00103-2
NR 18
TC 3
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD AUG
PY 2011
VL 41
IS 8
BP 494
EP 496
DI 10.4070/kcj.2011.41.8.494
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34IA
UT WOS:000209078900015
PM 21949538
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, CG
   Lee, JY
AF Park, Chang Gyu
   Lee, Ju Young
TI The Significance of the J-Curve in Hypertension and Coronary Artery
   Diseases
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Hypertension; J-curve; Coronary artery disease; Diastolic pressure;
   Systolic pressure; Stroke
AB The J-curve effect describes an inverse relation between low blood pressure (BP) and cardiovascular complications. This effect is more pronounced in patients with preexisting coronary artery disease (CAD), hypertension or left ventricular hypertrophy (LVH). The recent large clinical outcomes trials have observed a J-curve effect between a diastolic BP of 70-80 mmHg as well as a systolic BP <130 mmHg. The J-curve phenomenon does not appear in stroke or renal disease. This is because the coronary arteries are perfused during diastole, but the cerebral and renal perfusion mainly occurs in systole. Therefore, caution should be taken to maintain the diastolic blood pressure (DBP) at minimum of 70 mmHg and possibly to maintain the DBP between 80-85 mmHg in patients with severe LVH, CAD or vascular diseases. BP control in high-risk elderly patients should be carefully done as undergoing aggressive therapy to lower the systolic blood pressure below 140 mmHg can cause cardiovascular complications due to the severely reduced DBP and increased pulse pressure.
C1 [Park, Chang Gyu; Lee, Ju Young] Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul 152703, South Korea.
RP Park, CG (corresponding author), Korea Univ, Guro Hosp, Ctr Cardiovasc, 80 Guro Dong, Seoul 152703, South Korea.
EM packcg@kumc.or.kr
CR Bangalore S, 2010, EUR HEART J, V31, P2897, DOI 10.1093/eurheartj/ehq328
   BELLAMY RF, 1978, CIRC RES, V43, P92, DOI 10.1161/01.RES.43.1.92
   CRUICKSHANK JM, 1987, LANCET, V1, P581
   Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286
   Fagard RH, 2007, ARCH INTERN MED, V167, P1884, DOI 10.1001/archinte.167.17.1884
   FARNETT L, 1991, JAMA-J AM MED ASSOC, V265, P489, DOI 10.1001/jama.265.4.489
   FLACK JM, 1995, CIRCULATION, V92, P2437, DOI 10.1161/01.CIR.92.9.2437
   Frank E., 1911, MEDIZIN, V103, P397
   Glynn RJ, 2002, HYPERTENSION, V39, P105, DOI 10.1161/hy1201.097199
   Grossman E, 1996, JAMA-J AM MED ASSOC, V276, P1328, DOI 10.1001/jama.276.16.1328
   Hakala SM, 1998, EUR HEART J, V19, P1872, DOI 10.1053/euhj.1998.1232
   Haller H, 2011, NEW ENGL J MED, V364, P907, DOI 10.1056/NEJMoa1007994
   Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6
   HARRISON DG, 1988, CIRCULATION, V77, P1108, DOI 10.1161/01.CIR.77.5.1108
   LANGER RD, 1993, HYPERTENSION, V22, P551, DOI 10.1161/01.HYP.22.4.551
   Lewington S, 2002, LANCET, V360, P1903
   Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d
   Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005
   Pijls NHJ, 1997, CORONARY PRESSURE, P105
   POLESE A, 1991, CIRCULATION, V83, P845, DOI 10.1161/01.CIR.83.3.845
   Psaty BM, 2001, ARCH INTERN MED, V161, P1183, DOI 10.1001/archinte.161.9.1183
   Satish S, 2001, J CLIN EPIDEMIOL, V54, P961, DOI 10.1016/S0895-4356(01)00360-2
   Sleight P, 2009, J HYPERTENS, V27, P1360, DOI 10.1097/HJH.0b013e32832d7370
   Somes GW, 1999, ARCH INTERN MED, V159, P2004, DOI 10.1001/archinte.159.17.2004
   STEWART IMG, 1979, LANCET, V1, P861
   TERVAHAUTA M, 1994, J HYPERTENS, V12, P1183
   WHITE PD, 1931, HEART DIS
NR 27
TC 6
Z9 6
U1 0
U2 4
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 349
EP 353
DI 10.4070/kcj.2011.41.7.349
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800001
PM 21860634
OA Green Published
DA 2021-04-22
ER

PT J
AU Chung, IM
AF Chung, Ick-Mo
TI Prognostic Impact of Early ST-Segment Resolution and Biochemical Markers
   in Patients With ST-Elevation Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Ewha Womans Univ, Sch Med, Div Cardiol, Seoul 158710, South Korea.
RP Chung, IM (corresponding author), Ewha Womans Univ, Sch Med, Div Cardiol, 911-1 Mok 6 Dong, Seoul 158710, South Korea.
EM ickmo@ewha.ac.kr
CR Anzai T, 1997, CIRCULATION, V96, P778
   de Lemos JA, 2001, J AM COLL CARDIOL, V38, P1283, DOI 10.1016/S0735-1097(01)01550-9
   MAROKO PR, 1971, CIRCULATION, V43, P67, DOI 10.1161/01.CIR.43.1.67
   Morrow David A, 2007, Circulation, V115, pe356
   Sabatine MS, 2008, CIRCULATION, V117, P1936, DOI 10.1161/CIRCULATIONAHA.107.728022
   Schroder R, 2004, CIRCULATION, V110, pE506, DOI 10.1161/01.CIR.0000147778.05979.E6
   Scirica BM, 2010, J AM COLL CARDIOL, V55, P1403, DOI 10.1016/j.jacc.2009.09.071
   vantHof AWJ, 1997, LANCET, V350, P615, DOI 10.1016/S0140-6736(96)07120-6
   Woo JS, 2011, KOREAN CIRC J, V41, P372, DOI 10.4070/kcj.2011.41.7.372
NR 9
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 354
EP 355
DI 10.4070/kcj.2011.41.7.354
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800002
PM 21860635
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, JH
   Kim, JS
   Lee, DH
   Shim, EJ
   Lee, SY
   Min, KS
   Cho, DJ
   Lee, HR
AF Yoon, Ju Hee
   Kim, Joon Sik
   Lee, Dae Hyung
   Shim, Eun Jung
   Lee, So Yeon
   Min, Ki Sik
   Cho, Do Jun
   Lee, Hye Ran
TI Intermediate and Long-Term Results of Transcatheter Closure of Patent
   Foramen Ovale Using the Amplatzer Patent Foramen Ovale Occluder: One
   Case of Pulmonary Embolism Irrespective of Patent Foramen Ovale Closure
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Patent foramen ovale; Stroke; Transient ischemic attack; Migraine;
   Pulmonary embolism
AB Background and Objectives: Patent foramen ovale (PFO) has been implicated in the pathogenesis of cryptogenic stroke or transient ischemic attack (TIA) due to paradoxical embolism, and in the pathogenesis of migraine. This paper reports the intermediate and long-term results of transcatheter closure of PFO associated with cerebrovascular accidents (CVAs), TIAs and migraine, using the Amplatzer PFO occluder. This paper also reports a case of pulmonary embolism which developed in one patient after PFO closure. Subjects and Methods: From January 2003 to May 2010, 16 patients with PFO (seven males and nine females) with a history of at least one episode of cryptogenic stroke/TIA, CVA, or migraine and who underwent percutaneous transcatheter closure of PFO using the Amplatzer occluder. All the procedures were performed under general anesthesia and were assisted by transesophageal echocardiography. Results: The device was implanted without any significant complications in all the patients, and the PFOs were effectively closed. At an average follow-up period of 54 months, the 15 patients with TIA/CVA had no recurrence of any thromboembolic event. The symptoms in one patient with migraine subsided after occlusion of the PFO. In this study, pulmonary embolism occurred five months after PFO closure in one patient, but the cause of pulmonary embolism was not identified. However, it is believed that the pulmonary embolism occurred without stroke recurrence because occlusion of the PFO was performed when the patient had a stroke event. Conclusion: It can be concluded that according to the intermediate and long-term follow-up results, transcatheter PFO closure is an effective and safe therapeutic modality in the prevention of thromboembolic events, especially in the patients with cryptogenic stroke/TIA, and PFO closure is helpful in the treatment of migraine. However, this study involved a small number of patients and also the follow-up period was not long enough. Hence, randomized, controlled trials are necessary to determine if this approach is preferable to medical therapy for the prevention of recurrent stroke or as primary treatment for patients with migraine headache.
C1 [Yoon, Ju Hee; Kim, Joon Sik; Lee, Dae Hyung; Shim, Eun Jung; Lee, So Yeon; Min, Ki Sik; Cho, Do Jun; Lee, Hye Ran] Hallym Univ, Coll Med, Dept Pediat, Anyang 431070, South Korea.
RP Cho, DJ (corresponding author), Hallym Univ, Coll Med, Dept Pediat, 896 Pyeongchon Dong, Anyang 431070, South Korea.
EM cdj915@hanmail.net
CR Agmon Y, 1999, CIRCULATION, V99, P1942, DOI 10.1161/01.CIR.99.15.1942
   Bogousslavsky J, 1996, NEUROLOGY, V46, P1301, DOI 10.1212/WNL.46.5.1301
   Bruch L, 2002, CIRCULATION, V105, P2845, DOI 10.1161/01.CIR.0000019069.32964.0E
   Chun KJ, 2008, KOREAN CIRC J, V38, P631
   De Castro S, 2000, STROKE, V31, P2407, DOI 10.1161/01.STR.31.10.2407
   Diener HC, 2005, CURR OPIN NEUROL, V18, P299, DOI 10.1097/01.wco.0000169749.52406.74
   DITULLIO M, 1992, ANN INTERN MED, V117, P461, DOI 10.7326/0003-4819-117-6-461
   Du ZD, 2002, CATHETER CARDIO INTE, V55, P189, DOI 10.1002/ccd.10067
   Gaspardone A, 2008, G ITAL CARDIOL, V9, P593, DOI 10.1714/632.7379
   GELMERS HJ, 1989, HEADACHE, V29, P639
   GELMERS HJ, 1989, HEADACHE, V29, P633
   Homma S, 2002, CIRCULATION, V105, P2625, DOI 10.1161/01.CIR.0000017498.88393.44
   Kerut EK, 2001, J AM COLL CARDIOL, V38, P613, DOI 10.1016/S0735-1097(01)01427-9
   Lamy C, 2002, STROKE, V33, P706, DOI 10.1161/hs0302.104543
   MAS JL, 1995, AM HEART J, V130, P1083, DOI 10.1016/0002-8703(95)90212-0
   Mattioli AV, 2003, CEREBROVASC DIS, V15, P4, DOI 10.1159/000067114
   Meier B, 2005, HEART, V91, P444, DOI 10.1136/hrt.2004.052258
   Meissner I, 1999, MAYO CLIN PROC, V74, P862, DOI 10.4065/74.9.862
   Morandi Eva, 2003, J Interv Cardiol, V16, P39
   Oh BH, 1993, KOREAN CIRC J, V23, P217
   Onorato Eustaquio, 2003, J Interv Cardiol, V16, P43
   Overell JR, 2000, NEUROLOGY, V55, P1172, DOI 10.1212/WNL.55.8.1172
   STEWART WF, 1994, NEUROLOGY, V44, P17
   Wilmshurst PT, 2000, LANCET, V356, P1648, DOI 10.1016/S0140-6736(00)03160-3
   Windecker S, 2000, CIRCULATION, V101, P893, DOI 10.1161/01.CIR.101.8.893
NR 25
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 356
EP 362
DI 10.4070/kcj.2011.41.7.356
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800003
PM 21860636
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, DJ
   Han, S
   Jeon, ES
   Cho, MC
   Kim, JJ
   Yoo, BS
   Shin, MS
   Seong, IW
   Ahn, Y
   Kang, SM
   Kim, YJ
   Kim, HS
   Chae, SC
   Oh, BH
   Lee, MM
   Ryu, KH
AF Choi, Dong-Ju
   Han, Seongwoo
   Jeon, Eun-Seok
   Cho, Myeong-Chan
   Kim, Jae-Joong
   Yoo, Byung-Su
   Shin, Mi-Seung
   Seong, In-Whan
   Ahn, Youngkeun
   Kang, Seok-Min
   Kim, Yung-Jo
   Kim, Hyung Seop
   Chae, Shung Chull
   Oh, Byung-Hee
   Lee, Myung-Mook
   Ryu, Kyu-Hyung
CA KorHF Registry
TI Characteristics, Outcomes and Predictors of Long-Term Mortality for
   Patients Hospitalized for Acute Heart Failure: A Report From the Korean
   Heart Failure Registry
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart failure; Registries; Outcome
AB Background and Objectives: Acute heart failure (AHF) is associated with a poor prognosis and it requires repeated hospitalizations. However, there are few studies on the characteristics, treatment and prognostic factors of AHF. The aims of this study were to describe the clinical characteristics, management and outcomes of the patients hospitalized for AHF in Korea. Subjects and Methods: We analyzed the clinical data of 3,200 hospitalization episodes that were recorded between June 2004 and April 2009 from the Korean Heart Failure (KorHF) Registry database. The mean age was 67.6 +/- 14.3 years and 50% of the patients were female. Results: Twenty-nine point six percent (29.6%) of the patients had a history of previous HF and 52.3% of the patients had ischemic heart disease. Left ventricular ejection fraction (LVEF) was reported for 89% of the patients. The mean LVEF was 38.5 +/- 15.7% and 26.1% of the patients had preserved systolic function (LVEF >= 50%), which was more prevalent in the females (34.0% vs. 18.4%, respectively, p<0.001). At discharge, 58.6% of the patients received beta-blockers (BB), 53.7% received either angiotensin converting enzyme-inhibitors or angiotensin receptor blockers (ACEi/ARB), and 58.4% received both BB and ACEi/ARB. The 1-, 2-, 3- and 4-year mortality rates were 15%, 21%, 26% and 30%, respectively. Multivariate analysis revealed that advanced age {hazard ratio: 1.023 (95% confidence interval: 1.004-1.042); p=0.020}, a previous history of heart failure {1.735 (1.150-2.618); p=0.009}, anemia {1.973 (1.271-3.063); p=0.002}, hyponatremia {1.861 (1.184-2.926); p=0.007}, a high level of serum N-terminal pro-B-type natriuretic peptide (NT-proBNP) {3.152 (1.450-6.849); p=0.004} and the use of BB at discharge {0.599 (0.360-0.997); p=0.490} were significantly associated with total death. Conclusion: We present here the characteristics and prognosis of an unselected population of AHF patients in Korea. The long-term mortality rate was comparable to that reported in other countries. The independent clinical risk factors included age, a previous history of heart failure, anemia, hyponatremia, a high NT-proBNP level and taking BB at discharge.
C1 [Choi, Dong-Ju] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Internal Med, Songnam, South Korea.
   [Han, Seongwoo] Korea Univ, Coll Med, Dept Internal Med, Seoul 136705, South Korea.
   [Jeon, Eun-Seok] Sungkyunkwan Univ, Samsung Med Ctr, Coll Med, Dept Internal Med, Seoul, South Korea.
   [Cho, Myeong-Chan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, South Korea.
   [Kim, Jae-Joong] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea.
   [Yoo, Byung-Su] Yonsei Univ, Wonju Christian Hosp, Dept Internal Med, Wonju, South Korea.
   [Shin, Mi-Seung] Gachon Univ, Gil Hosp, Dept Internal Med, Inchon, South Korea.
   [Seong, In-Whan] Chungnam Natl Univ, Coll Med, Dept Internal Med, Taejon, South Korea.
   [Ahn, Youngkeun] Chonnam Natl Univ, Coll Med, Dept Internal Med, Kwangju, South Korea.
   [Kang, Seok-Min] Yonsei Univ, Severance Hosp, Dept Internal Med, Seoul 120749, South Korea.
   [Kim, Yung-Jo] Yeungnam Univ, Coll Med, Dept Internal Med, Taegu, South Korea.
   [Kim, Hyung Seop] Keimyung Univ, Coll Med, Dept Internal Med, Taegu, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ, Coll Med, Dept Internal Med, Taegu, South Korea.
   [Choi, Dong-Ju; Oh, Byung-Hee] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.
   [Lee, Myung-Mook] Dongguk Univ, Coll Med, Dept Internal Med, Goyang, South Korea.
   [Ryu, Kyu-Hyung] Konkuk Univ, Med Ctr, Dept Internal Med, Seoul 143729, South Korea.
RP Ryu, KH (corresponding author), Konkuk Univ, Med Ctr, Dept Internal Med, 27-2 Hwayang Dong, Seoul 143729, South Korea.
EM khryumd@hanmail.net
RI Oh, Byung-Hee/G-9875-2011
OI Oh, Byung-Hee/0000-0002-9945-4306; Jeong, Jin-Ok/0000-0003-0763-4754;
   Kang, Seok-Min/0000-0001-9856-9227; Seong, In-Whan/0000-0003-4628-0258
CR Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005
   Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0
   Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309
   Echols MR, 2006, J CARD FAIL, V12, P684, DOI 10.1016/j.cardfail.2006.08.003
   Fonarow GC, 2004, HEART FAIL REV, V9, P179, DOI 10.1007/s10741-005-6127-6
   Fonarow GC, 2008, ARCH INTERN MED, V168, P847, DOI 10.1001/archinte.168.8.847
   Fonarow GC, 2007, AM HEART J, V154, DOI [10.1016/j.ahj.2007.03.012, 10.1016/j.ahj.2007.07.043]
   Franciosa JA, 2000, J CARD FAIL, V6, P264, DOI 10.1054/jcaf.2000.9675
   HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107
   Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498
   Kawashiro N, 2008, CIRC J, V72, P2015, DOI 10.1253/circj.CJ-08-0323
   Kearney MT, 2002, J AM COLL CARDIOL, V40, P1801, DOI 10.1016/S0735-1097(02)02490-7
   Komajda M, 2003, EUR HEART J, V24, P464, DOI 10.1016/S0195-668X(02)00700-5
   Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265
   Logeart D, 2004, J AM COLL CARDIOL, V43, P635, DOI 10.1016/j.jacc.2003.09.044
   Massie BM, 1997, AM HEART J, V133, P703, DOI 10.1016/S0002-8703(97)70173-X
   McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9
   McClellan WM, 2002, J AM SOC NEPHROL, V13, P1928, DOI 10.1097/01.ASN.0000018409.45834.FA
   Mosterd A, 2001, EUR HEART J, V22, P1318, DOI 10.1053/euhj.2000.2533
   Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555
   Rudiger A, 2005, EUR J HEART FAIL, V7, P662, DOI 10.1016/j.ejheart.2005.01.014
   Tavazzi L, 2006, EUR HEART J, V27, P1207, DOI 10.1093/eurheartj/ehi845
   Tsuchihashi-Makaya M, 2009, CIRC J, V73, P1893, DOI 10.1253/circj.CJ-09-0254
   1990, AM J CARDIOL, V66, P315
NR 24
TC 75
Z9 76
U1 0
U2 8
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 363
EP 371
DI 10.4070/kcj.2011.41.7.363
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800004
PM 21860637
OA Green Published
DA 2021-04-22
ER

PT J
AU Woo, JS
   Cho, JM
   Kim, SJ
   Kim, MK
   Kim, CJ
AF Woo, Jong Shin
   Cho, Jin Man
   Kim, Soo Joong
   Kim, Myeong Kon
   Kim, Chong Jin
TI Combined Assessments of Biochemical Markers and ST-Segment Resolution
   Provide Additional Prognostic Information for Patients With ST-Segment
   Elevation Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Prognosis; C-reactive protein; N-terminal
   pro-B-type natriuretic peptide; Electrocardiogram
AB Background and Objectives: The prognostic value of biochemical markers and the resolution of ST-segment elevation on electrocardiogram are well established. However, how a combination of these two tools affects the evaluation of risk stratification has not yet been evaluated. Subjects and Methods: Between January 2006 and June 2008, 178 consecutive patients treated with primary percutaneous coronary interventions after ST-segment elevation myocardial infarctions (STEMI) were analyzed at two coronary care units. Patients were divided into the following three groups according to ST-segment resolution: complete (>= 70% depression of the elevated ST-segment, n=63), partial (30% to 70%, n=90), and incomplete (<30%, n=25). Demographic data, including history, electrocardiography, biochemical markers, initial ejection fraction, and angiographic findings were also evaluated. Results: There were 7 deaths, 3 repeated myocardial infarctions, and 17 readmissions for worsening heart failure during six months of follow-up. In a multivariate analysis to predict clinical outcomes, ejection fraction {hazard ratio (HR): 0.83 (0.76-0.91), p<0.01}, high-sensitivity C-reactive protein {HR: 1.15 (1.05-1.26), p<0.05}, and the degree of ST-segment resolution {HR: 0.96 (0.93-0.09), p<0.05} were independently associated with clinical outcomes. According to the Cox-proportional hazards model, the addition of ST-segment resolution markedly improved the prognostic utility of the model containing biochemical markers and ejection fraction. Conclusion: Assessment of biomarkers upon admission and ST-segment resolution are strong predictors of clinical outcomes. The combination of these data provides additive information about prognosis at an early point in the disease progression and further improves risk stratification for STEMI.
C1 [Woo, Jong Shin; Kim, Soo Joong; Kim, Myeong Kon] Kyung Hee Univ, Sch Med, Dept Internal Med, Div Cardiol, Seoul 134727, South Korea.
   [Cho, Jin Man; Kim, Chong Jin] Kyung Hee Univ, Gang Dong Kyung Hee Med Ctr, Ctr Cardiovasc, Seoul 134727, South Korea.
RP Cho, JM (corresponding author), Kyung Hee Univ, Sch Med, Dept Internal Med, Div Cardiol, 149 Sangil Dong, Seoul 134727, South Korea.
EM aceri@medimail.co.kr
CR Bae Eun Hui, 2005, Korean Journal of Internal Medicine, V20, P8
   Bjorklund E, 2004, EUR HEART J, V25, P113, DOI 10.1016/j.ehj.2003.10.025
   Cameron SJ, 2007, CLIN CHIM ACTA, V376, P168, DOI 10.1016/j.cca.2006.08.019
   CHOE HM, 2006, KOREAN CIRC J, V36, P526
   De Luca G, 2005, AM HEART J, V150, P1248, DOI 10.1016/j.ahj.2005.01.056
   Foussas SG, 2005, AM J CARDIOL, V96, P533, DOI 10.1016/j.amjcard.2005.04.015
   Hong Young Joon, 2003, Korean Journal of Internal Medicine, V18, P29
   Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602
   Lindahl B, 1997, J AM COLL CARDIOL, V29, P43, DOI 10.1016/S0735-1097(96)00447-0
   McLaughlin MG, 2004, J AM COLL CARDIOL, V44, P1215, DOI 10.1016/j.jacc.2004.06.053
   Mega JL, 2004, J AM COLL CARDIOL, V44, P335, DOI 10.1016/j.jacc.2004.04.033
   Morrow DA, 2003, CIRCULATION, V108, P250, DOI 10.1161/01.CIR.0000078080.37974.D2
   Nikfardjam M, 2000, J INTERN MED, V247, P341, DOI 10.1046/j.1365-2796.2000.00670.x
   Omland T, 2002, CIRCULATION, V106, P2913, DOI 10.1161/01.CIR.0000041661.63285.AE
   SCHRODER R, 1994, J AM COLL CARDIOL, V24, P384, DOI 10.1016/0735-1097(94)90292-5
   Staub D, 2006, AM HEART J, V151, P1223, DOI 10.1016/j.ahj.2005.06.045
   Tomoda H, 2000, AM HEART J, V140, P324, DOI 10.1067/mhj.2000.108244
   Zairis MN, 2002, AM HEART J, V144, P782, DOI 10.1067/mhj.2002.125622
NR 18
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 372
EP 378
DI 10.4070/kcj.2011.41.7.372
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800005
PM 21860638
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, HK
   Oh, J
   Hong, YM
   Sohn, S
AF Kim, Hyun Kwon
   Oh, Jungeun
   Hong, Young Mi
   Sohn, Sejung
TI Parameters to Guide Retreatment After Initial Intravenous Immunoglobulin
   Therapy in Kawasaki Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Kawasaki disease; Intravenous immunoglobulins; Retreatment
AB Background and Objectives: We sought to determine parameters to guide the decision of retreatment in patients with Kawasaki disease (KD) who remained febrile after initial intravenous immunoglobulin (IVIG). Subjects and Methods: A total of 129 children with KD were studied prospectively. Patients were treated with IVIG 2 to 9 days after the onset of disease. Laboratory measures, such as white blood cell (WBC), percentage of neutrophils, C-reactive protein (CRP), and N-terminal pro-brain natriuretic peptide (NT-proBNP), were determined before and 48 to 72 hours after IVIG treatment. Patients were classified into IVIG-responsive and IVIG-resistant groups, based on the response to IVIG. Results: Of a total of 129 patients, 107 patients (83%) completely responded to a single IVIG therapy and only 22 patients (17%) required retreatment: 14 had persistent fever and 8 had recrudescent fever. There was no significant difference between the groups in age, gender distribution, and duration of fever to IVIG initiation, but coronary artery lesions developed significantly more often in the resistant group than in the responsive group (31.8% vs. 2.8%, p=0.000). Compared with pre-IVIG data, post-IVIG levels of WBC, percentage of neutrophils, CRP, and NT-proBNP decreased to within the normal range in the responsive group, whereas they remained high in the resistant group. Multivariate logistic regression indicated that neutrophil counts, CRP, and NT-proBNP were independent parameters of retreatment. Conclusion: Additional therapy at an early stage of the disease should be administered for febrile patients who have high values of CRP, NT-proBNP, and/or neutrophil counts after IVIG therapy.
C1 [Kim, Hyun Kwon; Oh, Jungeun; Hong, Young Mi; Sohn, Sejung] Ewha Womans Univ, Sch Med, Dept Pediat, Seoul 158710, South Korea.
RP Sohn, S (corresponding author), Ewha Womans Univ, Sch Med, Mokdong Hosp, Dept Pediat, 911-1 Mok Dong, Seoul 158710, South Korea.
EM sohn@ewha.ac.kr
CR Burns JC, 2005, J PEDIATR-US, V146, P662, DOI 10.1016/j.jpeds.2004.12.022
   Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009
   Dahdah N, 2009, PEDIATR CARDIOL, V30, P810, DOI 10.1007/s00246-009-9441-2
   DAJANI AS, 1993, CIRCULATION, V87, P1776, DOI 10.1161/01.CIR.87.5.1776
   Fukunishi M, 2000, J PEDIATR-US, V137, P172, DOI 10.1067/mpd.2000.104815
   Hamamichi Y, 2001, PEDIATR RES, V49, P74, DOI 10.1203/00006450-200101000-00017
   JOHNSON D, 1985, PEDIATR INFECT DIS J, V4, P100, DOI 10.1097/00006454-198501000-00024
   Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865
   Lee Hyunju, 2006, Clinical and Experimental Pediatrics, V49, P539
   Mori M, 2000, J PEDIATR-US, V137, P177, DOI 10.1067/mpd.2000.107890
   Muta H, 2004, J PEDIATR-US, V144, P496, DOI 10.1016/j.jpeds.2003.12.033
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601
   RELLER M, 1984, PEDIATR CARDIOL, V5, P205, DOI 10.1007/BF02427046
   Research Committee on Kawasaki Disease, 1984, REP SUBC STAND DIAGN
   Samada K, 2002, EUR J PEDIATR, V161, P538, DOI 10.1007/s00431-002-1018-5
   Song Min Seob, 2010, Korean Circ J, V40, P334, DOI 10.4070/kcj.2010.40.7.334
   SUNDEL RP, 1993, J PEDIATR-US, V123, P657, DOI 10.1016/S0022-3476(05)80972-2
   Suzuki H, 2001, PEDIATR INT, V43, P115, DOI 10.1046/j.1442-200x.2001.01362.x
   Takahashi K, 2005, PEDIATR INT, V47, P305, DOI 10.1111/j.1442-200x.2005.02049.x
   Tse SML, 2002, J PEDIATR-US, V140, P450, DOI 10.1067/mpd.2002.122469
   Wallace CA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e78
NR 22
TC 17
Z9 23
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 379
EP 384
DI 10.4070/kcj.2011.41.7.379
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800006
PM 21860639
OA Green Published
DA 2021-04-22
ER

PT J
AU Seo, SM
   Koh, YS
   Jung, HO
   Choi, JS
   Kim, PJ
   Baek, SH
   Youn, HJ
   Lee, KH
   Seung, KB
AF Seo, Suk Min
   Koh, Yoon Seok
   Jung, Hae Ok
   Choi, Jin Soo
   Kim, Pum Joon
   Baek, Sang Hong
   Youn, Ho-Joong
   Lee, Kweon-Haeng
   Seung, Ki-Bae
TI Deoxyribonucleic Acid Copy Number Aberrations in Vasospastic Angina
   Patients Using an Array Comparative Genomic Hybridization
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Array comparative genomic hybridization; Vasospastic angina
ID HIGH-RESOLUTION ANALYSIS; CORONARY-ARTERY; DNA; CELL; IDENTIFICATION;
   MICROARRAYS; SEROTONIN; SPASM; GENE
AB Background and Objectives: Vasospastic angina (VA) is a specific type of coronary artery disease and develops as a result of coronary artery spasm. Recently, a few studies have revealed that VA caused by coronary artery spasm is related to genetic traits. The objective of this study was to use the recently developed technique of array comparative genomic hybridization (CGH) to screen the genetic aberrations of VA. Subjects and Methods: To identify candidate genes that might be causally involved in the pathogenesis of VA, genomic deoxyribonucleic acids were extracted from whole blood of 28 patients with VA who presented at Department of Cardiology at Seoul St. Mary's Hospital, Seoul, Korea. The copy number profiles of these patients was then analyzed using array CGH and reverse transcriptase (RT) quantitative polymerase chain reaction (PCR). Results: Array CGH revealed gains in 31 different regions, with losses in the 4q35.2, 7q22.1, 10q26.3, 15q11.2, 16p13.11, 17p11.2 and 19q13.3 regions (more than 32% aberration in these regions). Several loci were found to be frequently including gains of 5p and 11q (50% of samples). The most common losses were found in 7q (54% of samples). Copy number aberrations in chromosomal regions were detected and corresponding genes were confirmed by RT quantitative PCR. The fold change levels were highest in the CTDP1 (18q23), HDAC10 (22q13.33), KCNQ1 (11p15.5-p15.4), NINJ2 (12p13.33), NOTCH2 (1p12-p11.2), PCSK6 (15q26.3), SDHA (5p15.33), and MUC17 (7q22.1) genes. Conclusion: Many candidate chromosomal regions that might be related to the pathogenesis of VA were detected by array CGH and should be systematically investigated to establish the causative and specific genes for VA.
C1 [Seo, Suk Min; Koh, Yoon Seok; Jung, Hae Ok; Kim, Pum Joon; Baek, Sang Hong; Youn, Ho-Joong; Seung, Ki-Bae] Catholic Univ Korea, Coll Med, Ctr Cardiovasc, Seoul 137040, South Korea.
   [Seo, Suk Min; Koh, Yoon Seok; Jung, Hae Ok; Kim, Pum Joon; Baek, Sang Hong; Youn, Ho-Joong; Seung, Ki-Bae] Catholic Univ Korea, Coll Med, Div Cardiol, Seoul 137040, South Korea.
   [Choi, Jin Soo] Catholic Univ Korea, Coll Med, Catholic Neurosci Ctr, Seoul 137040, South Korea.
   [Lee, Kweon-Haeng] Catholic Univ Korea, Coll Med, Dept Pharmacol, Seoul 137040, South Korea.
RP Jung, HO (corresponding author), Catholic Univ Korea, Coll Med, Ctr Cardiovasc, 505 Banpo Dong, Seoul 137040, South Korea.
EM hojheart@catholic.ac.kr
RI Koh, Yoon-Seok/AAE-1749-2019; Seo, Suk Min/AAB-8238-2021
FU Korean Health 21 R&D Project, the Ministry of Health and Welfare,
   Republic of Korea [00-PJ3-PG6-GN02-0002]
FX This work was supported by a grant (00-PJ3-PG6-GN02-0002) from the
   Korean Health 21 R&D Project, the Ministry of Health and Welfare,
   Republic of Korea.
CR BERTRAND ME, 1982, CIRCULATION, V65, P1299, DOI 10.1161/01.CIR.65.7.1299
   Bonaglia MC, 2005, EUR J HUM GENET, V13, P586, DOI 10.1038/sj.ejhg.5201369
   Calvo R, 2000, P NATL ACAD SCI USA, V97, P12776, DOI 10.1073/pnas.97.23.12776
   Chang KY, 2003, CORONARY ARTERY DIS, V14, P293, DOI 10.1097/01.mca.0000073080.69657.71
   Choi JS, 2006, LUNG, V184, P355, DOI 10.1007/s00408-006-0009-0
   Choi YW, 2007, LUNG CANCER, V55, P43, DOI 10.1016/j.lungcan.2006.09.018
   Chujo M, 2002, LUNG CANCER-J IASLC, V38, P23, DOI 10.1016/S0169-5002(02)00151-4
   Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672
   Guillaud-Bataille M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh108
   Hibino H, 2006, CIRC RES, V98, P579, DOI 10.1161/01.RES.0000215571.12500.ab
   Hurst CD, 2004, ONCOGENE, V23, P2250, DOI 10.1038/sj.onc.1207260
   Ishida T, 1998, CHEST, V113, P243, DOI 10.1378/chest.113.1.243
   Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307
   Jeon JP, 2009, EXP MOL MED, V41, P618, DOI 10.3858/emm.2009.41.9.068
   Kang SM, 2008, TISSUE ENG REGEN MED, V5, P521
   Kim HS, 2007, BRAIN DEV-JPN, V29, P639, DOI 10.1016/j.braindev.2007.04.006
   조영석, 2003, Korean Circulation Journal, V33, P104
   Li YH, 2007, J CELL PHYSIOL, V211, P36, DOI 10.1002/jcp.20897
   Mantripragada KK, 2004, TRENDS GENET, V20, P87, DOI 10.1016/j.tig.2003.12.008
   Mao X, 2003, GENE CHROMOSOME CANC, V37, P176, DOI 10.1002/gcc.10184
   Moon HJ, 2006, BIOCHEM BIOPH RES CO, V344, P531, DOI 10.1016/j.bbrc.2006.03.156
   NAKAMURA M, 1987, CIRCULATION, V75, P1110, DOI 10.1161/01.CIR.75.6.1110
   Park JS, 2006, AM HEART J, V151, P864, DOI 10.1016/j.ahj.2005.06.009
   Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524
   Pinkel D, 2005, ANNU REV GENOM HUM G, V6, P331, DOI 10.1146/annurev.genom.6.080604.162140
   Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569
   Pristipino C, 2000, CIRCULATION, V101, P1102, DOI 10.1161/01.CIR.101.10.1102
   Shimizu M, 2007, INT J CARDIOL, V114, P188, DOI 10.1016/j.ijcard.2006.01.026
   Shimokawa H, 1999, CARDIOVASC RES, V43, P1029, DOI 10.1016/S0008-6363(99)00144-3
   Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754
   Wang G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh070
NR 31
TC 1
Z9 1
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 385
EP 393
DI 10.4070/kcj.2011.41.7.385
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800007
PM 21860640
OA Green Published
DA 2021-04-22
ER

PT J
AU Yun, SH
   Yang, NR
   Park, SA
AF Yun, Sang Hyun
   Yang, Nu Ri
   Park, Sin Ae
TI Associated Symptoms of Kawasaki Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mucocutaneous lymph node syndrome; Signs and symptoms
AB Background and Objectives: In addition to diagnostic criteria, a broad range of nonspecific clinical features can be found in patients with Kawasaki disease. This lack of specificity may cause confusion with other febrile illnesses and delay the diagnosis of Kawasaki disease. The purpose of this study is to describe common associated symptoms and their clinical significances in children affected with Kawasaki disease. Subjects and Methods: As a retrospective study, we reviewed the medical records of 121 children who were treated for Kawasaki disease at Presbyterian medical center from January 2005 to June 2010. All clinical symptoms, laboratory data and echocardiographic findings in patients with KD were collected and analyzed. Results: We found that there are 9 associated symptoms, namely cough, rhinorrhea, sputum, abdominal pain, vomiting, diarrhea, arthralgia, headache and seizure, which occur in patients with Kawasaki disease. Among the study group, there were only 32 children with no associated symptoms (26.4%). Patients with abdominal pain and headache had an older mean age than those without such symptoms. The incidence of seizure was significantly higher in incomplete Kawasaki disease patients compared with those with complete Kawasaki disease. Vomiting was highly associated with IVIG non-responder group. Conclusion: To decrease the incidence of serious coronary complications due to delayed diagnosis, physicians need to be aware of the manifestations of Kawasaki disease and the possibility of associated symptoms, which, being unspecific, may otherwise not raise any red flags.
C1 [Yun, Sang Hyun; Yang, Nu Ri; Park, Sin Ae] Presbyterian Med Ctr, Dept Pediat, Jeonju 560750, South Korea.
RP Park, SA (corresponding author), Presbyterian Med Ctr, Dept Pediat, 68 Seowon Ro, Jeonju 560750, South Korea.
EM psinai@hanmail.net
CR Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x
   Baker AL, 2009, J PEDIATR-US, V154, P592, DOI 10.1016/j.jpeds.2008.10.006
   Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1
   DAJANI AS, 1993, CIRCULATION, V87, P1776, DOI 10.1161/01.CIR.87.5.1776
   Do Hyun-Jeong, 2009, Korean Circ J, V39, P502, DOI 10.4070/kcj.2009.39.11.502
   조은영, 2009, Clinical and Experimental Pediatrics, V52, P1241
   HICKS RV, 1986, PEDIATR CLIN N AM, V33, P1151
   Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379
   Kawasaki T, 1967, Arerugi, V16, P178
   Lee SY, 2001, KOREAN CIRC J, V31, P119
   MELISH ME, 1990, J RHEUMATOL, V17, P2
   NAKANO H, 1985, AM J CARDIOL, V56, P846, DOI 10.1016/0002-9149(85)90767-2
   Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78
   NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305
   NEWBURGER JW, 1986, NEW ENGL J MED, V315, P341, DOI 10.1056/NEJM198608073150601
   Park EY, 2007, KOREAN J PEDIAT, V50, P292
   Research Committee on Kawasaki Disease, 1984, REP SUBC STAND DIAGN
   Terai M, 1997, J PEDIATR-US, V131, P888, DOI 10.1016/S0022-3476(97)70038-6
NR 18
TC 13
Z9 14
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 394
EP 398
DI 10.4070/kcj.2011.41.7.394
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800008
PM 21860641
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, HS
   Choi, WS
   Kim, KH
   Kang, JK
   Kim, NY
   Park, SH
   Park, Y
   Nam, EJ
   Yang, DH
   Park, HS
   Cho, Y
   Lee, JM
   Chae, SC
AF Lee, Hyun Sang
   Choi, Won Suk
   Kim, Kyun Hee
   Kang, Jung Kyu
   Kim, Na Young
   Park, Sun Hee
   Park, Youngwhi
   Nam, Eon Jeong
   Yang, Dong Heon
   Park, Hun Sik
   Cho, Yongkeun
   Lee, Jong-Myung
   Chae, Shung-Chull
TI Aseptic Endocarditis in Behcet's Disease Presenting as Tricuspid Valve
   Stenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Behcet syndrome; Endocarditis; Tricuspid valve stenosis
AB Aseptic endocarditis is an uncommon complication of Behcet's disease (BD). We describe a rare case of a 39-year-old female who had BD with aseptic endocarditis of the tricuspid valve (TV) presenting as tricuspid stenosis. She was diagnosed with BD four years ago. The mucocutaneous lesions were well-controlled with colchicine and short courses of corticosteroids. She remained free of signs and symptoms of BD for one year without any medication. Three months before admission, she gradually developed dyspnea on exertion and peripheral edema. Echocardiography revealed dilated right atrium and markedly thickened TV with severe stenosis. TV replacement was performed. Pathologic examination of the valve showed fibrinoid necrotic material and inflammatory cell infiltration. Blood cultures and cultures of the excised valve were negative for microorganisms.
C1 [Lee, Hyun Sang] CHA Univ, Coll Med, Gumi CHA Hosp, Dept Internal Med, Gumi, South Korea.
   [Choi, Won Suk; Kim, Kyun Hee; Kang, Jung Kyu; Kim, Na Young; Park, Sun Hee; Park, Youngwhi; Nam, Eon Jeong; Yang, Dong Heon; Park, Hun Sik; Cho, Yongkeun; Lee, Jong-Myung; Chae, Shung-Chull] Kyungpook Natl Univ, Coll Med, Dept Internal Med, Taegu 700721, South Korea.
RP Park, HS (corresponding author), Kyungpook Natl Univ, Coll Med, Dept Internal Med, 50 Samdeok Dong 2 Ga, Taegu 700721, South Korea.
EM hspark@knu.ac.kr
CR Aouba A, 2004, PRESSE MED, V33, P1367, DOI 10.1016/S0755-4982(04)98935-X
   Atzeni F, 2005, LUPUS, V14, P723, DOI 10.1191/0961203305lu2208oa
   CANDAN I, 1986, EUR HEART J, V7, P999, DOI 10.1093/oxfordjournals.eurheartj.a062006
   Dincer I, 2001, ECHOCARDIOGR-J CARD, V18, P15, DOI 10.1046/j.1540-8175.2001.00015.x
   Huong DLT, 1997, ANN RHEUM DIS, V56, P205, DOI 10.1136/ard.56.3.205
   HUYCKE EC, 1985, ANN INTERN MED, V102, P791, DOI 10.7326/0003-4819-102-6-791
   MADANAT WY, 1993, J RHEUMATOL, V20, P1982
   McDonald BS, 1980, J CLIN PATHOL, V33, P660
   Mogulkoc N, 2000, CHEST, V118, P479, DOI 10.1378/chest.118.2.479
   Park KM, 2005, KOREAN CIRC J, V35, P847
   SILBER H, 1993, CIRCULATION, V87, P30, DOI 10.1161/01.CIR.87.1.30
NR 11
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 399
EP 401
DI 10.4070/kcj.2011.41.7.399
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800009
PM 21860642
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, MH
   Hahn, JY
   Gwon, HC
   Song, YB
   Choi, JO
   Choi, JH
   Choi, SH
   Lee, SH
   Jeon, ES
AF Kang, Min-Ho
   Hahn, Joo-Yong
   Gwon, Hyeon-Cheol
   Song, Young Bin
   Choi, Jin Oh
   Choi, Jin-Ho
   Choi, Seung-Hyuk
   Lee, Sang Hoon
   Jeon, Eun Suk
TI Percutaneous Transseptal Left Atrial Drainage for Decompression of the
   Left Heart in an Adult Patient During Percutaneous Cardiopulmonary
   Support
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart arrest; Assisted circulation; Heart catheterization
ID EXTRACORPOREAL MEMBRANE-OXYGENATION; ORGAN DYSFUNCTION; CATHETERIZATION
AB A 28-year-old male with hemophagocytic lymphohistiocytosis presented with left ventricular dysfunction and cardiac arrest. Percutaneous cardiopulmonary support (PCPS) was initiated, but left heart distension developed with associated aggravation of pulmonary edema. Percutaneous transseptal left atrial sheath (28-Fr) drainage was incorporated into the PCPS venous circuit under fluoroscopic guidance to enable left heart decompression 1 days after PCPS initiation. The patient's pulmonary edema improved markedly, and distention of his left heart diminished. He was successfully weaned from PCPS 5 days later. Percutaneous transseptal left atrial drainage with large venous cannulae is feasible and effective in decompressing the left heart in adult patients during PCPS.
C1 [Kang, Min-Ho; Hahn, Joo-Yong; Gwon, Hyeon-Cheol; Song, Young Bin; Choi, Jin Oh; Choi, Jin-Ho; Choi, Seung-Hyuk; Lee, Sang Hoon; Jeon, Eun Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, Seoul 135710, South Korea.
RP Hahn, JY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Med, 50 Irwon Dong, Seoul 135710, South Korea.
EM jyhahn@skku.edu
RI Hahn, Joo-Yong/AAU-7250-2020
OI Hahn, Joo-Yong/0000-0002-4412-377X; Choi, Seung-Hyuk/0000-0002-0304-6317
CR Aiyagari RM, 2006, CRIT CARE MED, V34, P2603, DOI 10.1097/01.CCM.0000239113.02836.F1
   Babaliaros VC, 2008, J AM COLL CARDIOL, V51, P2116, DOI 10.1016/j.jacc.2008.01.061
   Cheung Michael M H, 2003, Pediatr Crit Care Med, V4, P447, DOI 10.1097/01.PCC.0000075325.53339.CA
   이일, 2006, Korean Circulation Journal, V36, P11
   Creput C, 2008, INTENS CARE MED, V34, P1177, DOI 10.1007/s00134-008-1111-y
   Guirgis M, 2010, INTERACT CARDIOV TH, V10, P672, DOI 10.1510/icvts.2009.228346
   Hammerstingl C, 2008, J CARDIOVASC ELECTR, V19, pE36, DOI 10.1111/j.1540-8167.2008.01115.x
   Karapinar B, 2009, PEDIATR CRIT CARE ME, V10, P285, DOI 10.1097/PCC.0b013e318198868b
   Liu TJ, 2006, AM HEART J, V151, P235, DOI 10.1016/j.ahj.2005.02.034
   Rajagopal SK, 2010, CRIT CARE MED, V38, P382, DOI 10.1097/CCM.0b013e3181bc8293
   Seib PM, 1999, CATHETER CARDIO INTE, V46, P179, DOI 10.1002/(SICI)1522-726X(199902)46:2<179::AID-CCD13>3.3.CO;2-N
   WARD KE, 1995, ANN THORAC SURG, V59, P749, DOI 10.1016/0003-4975(94)00579-6
NR 12
TC 8
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 402
EP 404
DI 10.4070/kcj.2011.41.7.402
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800010
PM 21860643
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CH
   Park, JS
   Hwang, KW
   Lee, SW
   Park, SW
   Park, SJ
AF Lee, Chang Hoon
   Park, Jong Seon
   Hwang, Ki Won
   Lee, Seung-Whan
   Park, Seong-Wook
   Park, Seung-Jung
TI Procedure-Induced Acute Common Carotid Artery Perforation Presenting
   With Airway Obstruction and Successful Treatment by Endovascular Stent
   Graft
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Carotid artery common; Stents; Endovascular procedure
AB A 63-year-old female was admitted to our hospital for catheter ablation during atrial fibrillation. After catheter ablation, the patient was transferred to the cardiac care unit and mechanically ventilated due to dyspnea and hypotension. Imaging showed active bleeding from the right common carotid artery (CCA) with extensive hematoma into the mediastinum. She was successfully treated with a stent graft at the CCA. Further bleeding or neurologic sequel did not occur after treatment.
C1 [Lee, Chang Hoon; Park, Jong Seon; Hwang, Ki Won; Lee, Seung-Whan; Park, Seong-Wook; Park, Seung-Jung] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, Seoul 138736, South Korea.
RP Park, SJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Cardiol, 86 Asanbyeongwon Gil, Seoul 138736, South Korea.
EM sjpark@amc.seoul.kr
CR Alhaddad IA, 2004, CATHETER CARDIO INTE, V63, P377, DOI 10.1002/ccd.20189
   ASENSIO JA, 1991, SURG CLIN N AM, V71, P267
   Chaloupka JC, 1999, AM J NEURORADIOL, V20, P1069
   Ciric I, 1997, NEUROSURGERY, V40, P225, DOI 10.1097/00006123-199702000-00001
   CIRIC I, 1997, NEUROSURGERY, V40, P236
   Demetriades D, 1996, SURG CLIN N AM, V76, P661, DOI 10.1016/S0039-6109(05)70475-8
   Dieter RS, 2006, CATHETER CARDIO INTE, V67, P972, DOI 10.1002/ccd.20744
   DuBose J, 2008, J TRAUMA, V65, P1561, DOI 10.1097/TA.0b013e31817fd954
   Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007
   Fabian TC, 1996, ANN SURG, V223, P522
   FAKHRY S M, 1988, Journal of Vascular Surgery, V8, P501, DOI 10.1067/mva.1988.avs0080501
   Kadkhodayan Y, 2005, AM J NEURORADIOL, V26, P2328
   Kaskarelis I, 2008, VASC MED, V13, P177, DOI 10.1177/1358863x07087549
   Kocer N, 2002, AM J NEURORADIOL, V23, P442
   MARAN AGD, 1989, J LARYNGOL OTOL, V103, P760, DOI 10.1017/S002221510011000X
   Maras D, 2006, CARDIOVASC INTER RAD, V29, P958, DOI 10.1007/s00270-005-0367-7
   MARTIN RF, 1991, J VASC SURG, V14, P789, DOI 10.1067/mva.1991.32076
   Martin RF, 1991, J VASC SURG, V4, P793
   POZZATI E, 1989, STROKE, V20, P412, DOI 10.1161/01.STR.20.3.412
   PRETRE R, 1995, J TRAUMA, V39, P1012, DOI 10.1097/00005373-199511000-00036
   Raymond J, 1997, AM J NEURORADIOL, V18, P655
   Sorial E, 2007, J VASC SURG, V46, P792, DOI 10.1016/j.jvs.2007.05.052
   WEAVER FA, 1988, ARCH SURG-CHICAGO, V123, P1106
NR 23
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 405
EP 408
DI 10.4070/kcj.2011.41.7.405
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800011
PM 21860644
OA Green Published
DA 2021-04-22
ER

PT J
AU Yang, YJ
   Kim, M
   Kim, C
   Park, J
   Oh, J
   Won, H
   Kim, BK
   Hong, MK
AF Yang, Young-June
   Kim, Mihyun
   Kim, Choongki
   Park, Junbeom
   Oh, Jaewon
   Won, Hoyoun
   Kim, Byeong-Keuk
   Hong, Myeong-Ki
TI Late Stent Thrombosis After Drug-Eluting Stent Implantation: A Rare Case
   of Accelerated Neo-Atherosclerosis and Early Manifestation of Neointimal
   Rupture
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Stents; Thrombosis; Neointima
AB An 80-year old woman suffered from sudden onset of chest pain and dyspnea, and visited the emergency room. She received stent implantation with a biolimus A9-eluting stent (Nobori (R) 3.0x24 mm) at a the mid-portion of the left anterior descending artery 5 months prior to admission. The emergency 5-month follow-up angiogram was performed under the impression of late stent thrombosis. The follow-up angiogram showed subtotal occlusion at the mid-portion of the left anterior descending artery, which was the same segment of previous stent implantation 5 months ago. Immediately after thrombus aspiration with the thrombus aspiration catheter, the optical coherence tomography showed layered appearance of neointimal hyperplasia and neointimal rupture within the previously stented segment. Thus, neointimal rupture within accelerated growth of neointimal tissue was observed within a relatively shorter period (i.e., about 5 months) after stent implantation.
C1 [Yang, Young-June; Kim, Mihyun; Kim, Choongki; Park, Junbeom; Oh, Jaewon; Won, Hoyoun; Kim, Byeong-Keuk; Hong, Myeong-Ki] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
   [Hong, Myeong-Ki] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 120752, South Korea.
RP Hong, MK (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 250 Seongsan Ro, Seoul 120752, South Korea.
EM mkhong61@yuhs.ac
OI Won, Hoyoun/0000-0001-7880-3477; Hong, Myeong-Ki/0000-0002-2090-2031;
   Kim, Byeong-Keuk/0000-0003-2493-066X; Oh, Jaewon/0000-0002-4585-1488
CR Chevalier B, 2009, CIRC-CARDIOVASC INTE, V2, P188, DOI 10.1161/CIRCINTERVENTIONS.108.823443
   Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398
   Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6
   Farb A, 2003, CIRCULATION, V108, P1701, DOI 10.1161/01.CIR.0000091115.05480.B0
   Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739
   Garg S, 2010, EUROINTERVENTION, V6, P233, DOI 10.4244/
   Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126
   Lee CW, 2010, J AM COLL CARDIOL, V55, P1936, DOI 10.1016/j.jacc.2009.10.077
   Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
   Nakazawa G, 2009, JACC-CARDIOVASC IMAG, V2, P625, DOI 10.1016/j.jcmg.2009.01.011
   Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441
NR 11
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 409
EP 412
DI 10.4070/kcj.2011.41.7.409
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800012
PM 21860645
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, KB
   Kim, WH
   Choi, JH
   Kim, JH
   Choi, YJ
   Jeong, KT
   Park, SC
   Lee, S
AF Kim, Ki Bang
   Kim, Won Ho
   Choi, Jin Ho
   Kim, Jeong Hee
   Choi, Yu Jeong
   Jeong, Kyung Tae
   Park, Sun Chang
   Lee, Sahng
TI Hybrid Approach for the Treatment of Thoracic Aortic Arch Aneurysm in a
   Patient With Chronic Obstructive Lung Disease and Retrosternal Adhesion
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Aortic aneurysm; thoracic; Vascular grafting; Endovascular procedure
AB A 73-year-old woman with a history of chronic hypertension and severe chronic obstructive pulmonary disease, presented to a district general hospital with thoracic pain in a profound state of shock. She was diagnosed with cardiac tamponade, severe mitral regurgitation, and Stanford type A (Debakey type I) intramural hematoma. Her ascending aorta was of a significant size and therefore emergent repair was done to replace the ascending aorta and mitral valve. After 6 months, an increased aneurysmal size of 6.0 cm was observed in a follow up contrast-enhanced computed tomography angiography. The patient was successfully treated by a staged hybrid procedure involving initial supra-aortic reconstruction.
C1 [Kim, Ki Bang; Kim, Won Ho; Kim, Jeong Hee; Choi, Yu Jeong; Jeong, Kyung Tae; Park, Sun Chang; Lee, Sahng] Eulji Univ Hosp, Div Cardiol, Taejon 302799, South Korea.
   [Choi, Jin Ho] Eulji Univ Hosp, Div Thorac & Cardiovasc Surg, Taejon 302799, South Korea.
RP Lee, S (corresponding author), Eulji Univ Hosp, Div Cardiol, 1306 Dunsan Dong, Taejon 302799, South Korea.
EM sahnglee@eulji.ac.kr
CR Alsac JM, 2009, ANN VASC SURG, V23, DOI 10.1016/j.avsg.2009.03.009
   BORST HG, 1994, J THORAC CARDIOV SUR, V107, P126
   DEBAKEY ME, 1978, J CARDIOVASC SURG, V19, P571
   Kang Woong Chol, 2010, Korean Circ J, V40, P399, DOI 10.4070/kcj.2010.40.8.399
   Koullias GJ, 2010, ANN THORAC SURG, V90, P689, DOI 10.1016/j.athoracsur.2009.12.016
   LIVESAY JJ, 1985, ANN THORAC SURG, V39, P37, DOI 10.1016/S0003-4975(10)62520-9
   PERKO MJ, 1995, ANN THORAC SURG, V59, P1204, DOI 10.1016/0003-4975(95)00132-5
   PRESSLER V, 1985, J THORAC CARDIOV SUR, V89, P50
   PRESSLER V, 1980, J THORAC CARDIOV SUR, V79, P489
   Sayed S, 2005, VASCULAR, V13, P148, DOI 10.1258/rsmvasc.13.3.148
   Shim Won Heum, 2010, Korean Circ J, V40, P368, DOI 10.4070/kcj.2010.40.8.368
   VONSEGESSER LK, 1993, ANN THORAC SURG, V56, P1373, DOI 10.1016/0003-4975(93)90684-A
NR 12
TC 0
Z9 0
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 413
EP 416
DI 10.4070/kcj.2011.41.7.413
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800013
PM 21860646
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, HS
   Jeong, MH
   Seo, IK
   Lee, MG
   Ko, JS
   Park, KH
   Sim, DS
   Yoon, NS
   Kim, KH
   Park, HW
   Hong, YJ
   Kim, JH
   Ahn, Y
   Cho, JG
   Park, JC
   Kang, JC
AF Choi, Hong Sang
   Jeong, Myung Ho
   Seo, Il Kook
   Lee, Min Goo
   Ko, Jum Suk
   Park, Keun Ho
   Sim, Doo Sun
   Yoon, Nam Sik
   Kim, Kye Hun
   Park, Hyung Wook
   Hong, Young Joon
   Kim, Ju Han
   Ahn, Youngkeun
   Cho, Jeong Gwan
   Park, Jong Chun
   Kang, Jung Chaee
TI Very Late Stent Thrombosis in a Drug-Eluting Stent due to Interruption
   of Anti-Platelet Agents in Patients With Acute Myocardial Infarction and
   Thrombocytosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Drug-eluting stents; Thrombosis; Essential thrombocythemia
AB Stent thrombosis is a fatal complication in patients who have undergone percutaneous coronary intervention, and discontinuation of anti-platelet agent is a major risk factor of stent thrombosis. We report a rare case of very late stent thrombosis (VLST) following discontinuation of anti-platelet agents in a patient who experienced acute myocardial infarction and essential thrombocytosis. She had undergone implantation of a drug eluting stent (DES) and a bare metal stent (BMS) two and half years prior to her presentation. VLST developed in DES, not in BMS, following interruption of anti-platelet therapy.
C1 [Choi, Hong Sang; Jeong, Myung Ho; Seo, Il Kook; Lee, Min Goo; Ko, Jum Suk; Park, Keun Ho; Sim, Doo Sun; Yoon, Nam Sik; Kim, Kye Hun; Park, Hyung Wook; Hong, Young Joon; Kim, Ju Han; Ahn, Youngkeun; Cho, Jeong Gwan; Park, Jong Chun; Kang, Jung Chaee] Chonnam Natl Univ, Cardiovasc Res Inst, Chonnam Natl Univ Hosp, Ctr Heart, Kwangju 501757, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ, Heart Res Ctr, 167 Jaebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
CR Awata M, 2007, CIRCULATION, V116, P910, DOI 10.1161/CIRCULATIONAHA.105.609057
   Colombo A, 2003, CIRCULATION, V108, P788, DOI 10.1161/01.CIR.0000086926.62288.A6
   Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6
   Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126
   Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484
   Kim Sung Soo, 2009, Korean Circ J, V39, P205, DOI 10.4070/kcj.2009.39.5.205
   Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155
   Kumagai N, 2009, J CARDIOL, V54, P485, DOI 10.1016/j.jjcc.2009.03.001
   Park DW, 2006, AM J CARDIOL, V98, P352, DOI 10.1016/j.amjcard.2006.02.039
   Serruys PW, 2002, CIRCULATION, V106, P798, DOI 10.1161/01.CIR.0000025585.63486.59
   Slottow TLP, 2008, AM J CARDIOL, V102, P298, DOI 10.1016/j.amjcard.2008.03.055
   Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633
   Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193
   Takano M, 2007, HEART, V93, P1353, DOI 10.1136/hrt.2007.132555
   Tefferi A, 2001, MAYO CLIN PROC, V76, P22, DOI 10.4065/76.1.22
   Turgut T, 1998, CATHETER CARDIO DIAG, V45, P428
   Veitch AM, 2008, GUT, V57, P1322, DOI 10.1136/gut.2007.142497
   Watanabe T, 2005, ANGIOLOGY, V56, P771, DOI 10.1177/000331970505600616
   Zhang F, 2007, INT HEART J, V48, P303, DOI 10.1536/ihj.48.303
   Zuckerman MJ, 2005, GASTROINTEST ENDOSC, V61, P189, DOI 10.1016/S0016-5107(04)02392-2
NR 20
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 417
EP 420
DI 10.4070/kcj.2011.41.7.417
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800014
PM 21860647
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JH
   Sohn, IS
   Jin, ES
   Cho, JM
   Kim, CJ
   Lee, YK
AF Park, Jeong-Hwan
   Sohn, Il-Suk
   Jin, Eun-Sun
   Cho, Jin-Man
   Kim, Chong-Jin
   Lee, Young Kyung
TI Heavy Coronary Calcium Mimicking In-Stent Restenosis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Park, Jeong-Hwan; Sohn, Il-Suk; Jin, Eun-Sun; Cho, Jin-Man; Kim, Chong-Jin] Kyung Hee Univ, East West Neo Med Ctr, Coll Med, Dept Cardiol, Seoul 134727, South Korea.
   [Lee, Young Kyung] Kyung Hee Univ, East West Neo Med Ctr, Coll Med, Dept Radiol, Seoul 134727, South Korea.
RP Sohn, IS (corresponding author), Kyung Hee Univ, East West Neo Med Ctr, Coll Med, Dept Cardiol, 149 Sangil Dong, Seoul 134727, South Korea.
EM issohn@khu.ac.kr
RI SOHN, ILSUK/AAI-1097-2020; Jin, Eun-Sun/ABF-3500-2020
OI SOHN, ILSUK/0000-0001-8004-5185; 
CR Cademartiri Filippo, 2006, Eur Radiol, V16 Suppl 7, pM44, DOI 10.1007/s10406-006-0195-0
   Choi YS, 2007, KOREAN CIRC J, V37, P167
   Gaspar T, 2005, J AM COLL CARDIOL, V46, P1573, DOI 10.1016/j.jacc.2005.07.049
NR 3
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUL
PY 2011
VL 41
IS 7
BP 421
EP 421
DI 10.4070/kcj.2011.41.7.421
PG 1
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HZ
UT WOS:000209078800015
PM 21860648
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, YI
   Cho, DJ
AF Cho, Young-Il
   Cho, Daniel J.
TI Hemorheology and Microvascular Disorders
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Blood viscosity; Hemorheology; Angina; microvascular
AB The present review presents basic concepts of blood rheology related to vascular diseases. Blood flow in large arteries is dominated by inertial forces exhibited at high flow velocities, while viscous forces (i.e., blood rheology) play an almost negligible role. When high flow velocity is compromised by sudden deceleration as at a bifurcation, endothelial cell dysfunction can occur along the outer wall of the bifurcation, initiating inflammatory gene expression and, through mechanotransduction, the cascade of events associated with atherosclerosis. In sharp contrast, the flow of blood in microvessels is dominated by viscous shear forces since the inertial forces are negligible due to low flow velocities. Shear stress is a critical parameter in microvascular flow, and a force-balance approach is proposed for determining microvascular shear stress, accounting for the low Reynolds numbers and the dominance of viscous forces over inertial forces. Accordingly, when the attractive forces between erythrocytes (represented by the yield stress of blood) are greater than the shear force produced by microvascular flow, tissue perfusion itself cannot be sustained, leading to capillary loss. The yield stress parameter is presented as a diagnostic candidate for future clinical research, specifically, as a fluid dynamic biomarker for microvascular disorders. The relation between the yield stress and diastolic blood viscosity (DBV) is described using the Casson model for viscosity, from which one may be able determine thresholds of DBV where the risk of microvascular disorders is high.
C1 [Cho, Young-Il] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
   [Cho, Daniel J.] Rheovector LLC, Pennsauken, NJ USA.
RP Cho, YI (corresponding author), Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
EM choyi@drexel.edu
CR Alexy T, 2006, TRANSFUSION, V46, P912, DOI 10.1111/j.1537-2995.2006.00823.x
   Amann K, 1998, J AM SOC NEPHROL, V9, P1018
   Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583
   AREND O, 1991, BRIT J OPHTHALMOL, V75, P514, DOI 10.1136/bjo.75.9.514
   BACHORIK PS, 2001, CLIN DIAGNOSIS MANAG, P1
   BANERJEE AK, 1992, THROMB HAEMOSTASIS, V68, P261
   Baskurt OK, 2003, SEMIN THROMB HEMOST, V29, P435
   Benedict KF, 2011, MICROCIRCULATION, V18, P63, DOI 10.1111/j.1549-8719.2010.00069.x
   Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903
   Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103
   CHATURANI P, 1988, BIORHEOLOGY, V25, P199
   CHIEN S, 1986, BIORHEOLOGY, V23, P633
   CHIEN S, 1966, J APPL PHYSIOL, V21, P81
   CHO YI, 1991, BIORHEOLOGY, V28, P241
   Cocklet GR, 2007, HDB HEMORHEOLOGY HEM, P45
   COPLEY AL, 1970, EXPERIENTIA, V26, P904, DOI 10.1007/BF02114252
   COULL BM, 1991, STROKE, V22, P162, DOI 10.1161/01.STR.22.2.162
   DESIMONE G, 1990, CIRCULATION, V81, P107, DOI 10.1161/01.CIR.81.1.107
   Dinnar U, 1981, CARDIOVASCULAR FLUID
   DITZEL J, 1971, ACTA PHYSIOL SCAND, V81, P264
   DORMANDY JA, 1974, P ROY SOC MED, V67, P446, DOI 10.1177/00359157740676P112
   Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276
   Eng E, 2003, MICROVASC RES, V65, P137, DOI 10.1016/S0026-2862(03)00004-9
   FANTL P, 1965, BIOCHEM J, V96, P886, DOI 10.1042/bj0960886
   Fung Y C, 1981, BIOMECHANICS
   GLAGOV S, 1988, ARCH PATHOL LAB MED, V112, P1018
   Hall JE, 2011, GUYTON HALL TXB MED, V12th
   Jung F, 2010, ACP-APPL CARDIOPUL P, V14, P229
   Kameneva MV, 2000, ACP-APPL CARDIOPUL P, V9, P382
   Kenyeres P, 2008, CLIN HEMORHEOL MICRO, V38, P51
   Lee BK, 2008, MICROCIRCULATION, V15, P451, DOI 10.1080/10739680701797090
   LETCHER RL, 1981, AM J MED, V70, P1195, DOI 10.1016/0002-9343(81)90827-5
   Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030
   Lipowsky HH, 2007, BIOMED HEALTH RES, V69, P307
   Lipowsky HH, 2005, MICROCIRCULATION, V12, P5, DOI 10.1080/10739680590894966
   LITWIN MS, 1970, SURGERY, V67, P342
   LUBBER DW, 1994, ADV EXP MED BIOL, V361, P51
   Lubbers DW, 1997, KIDNEY INT, V51, P372, DOI 10.1038/ki.1997.49
   Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035
   Malek AM, 1999, NEUROSURGERY, V45, P334, DOI 10.1097/00006123-199908000-00028
   Malek AM, 1999, BIOCHEM BIOPH RES CO, V254, P231, DOI 10.1006/bbrc.1998.9921
   MAYER GA, 1964, CAN MED ASSOC J, V91, P951
   McManus BM, 2008, RUBINS PATHOLOGY CLI, P229
   MERRILL EW, 1969, J APPL PHYSIOL, V26, P1
   MERRILL EW, 1963, BIOPHYS J, V3, P199, DOI 10.1016/S0006-3495(63)86816-2
   MERRILL EW, 1969, PHYSIOL REV, V49, P863
   MERRILL EW, 1963, CIRC RES, V13, P48, DOI 10.1161/01.RES.13.1.48
   Moriarty PM, 2005, CURR OPIN CARDIOL, V20, P318, DOI 10.1097/01.hco.0000167722.22453.47
   MORRIS CL, 1987, BIOPHYS J, V52, P229, DOI 10.1016/S0006-3495(87)83210-1
   Munson BR., 2009, FUNDAMENTALS FLUID M, V6th edn.
   NICHOLS WW, 1988, MCDONALDS BLOOD FLOW
   PAYMAN R, 1993, ANN OTO RHINOL LARYN, V102, P893, DOI 10.1177/000348949310201114
   Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845
   Picart C, 1999, AM J PHYSIOL-HEART C, V276, pH771
   Picart C, 1998, J RHEOL, V42, P1, DOI 10.1122/1.550883
   Picart C, 1998, J MAL VASCUL, V23, P113
   PRIES AR, 1995, AM J PHYSIOL-HEART C, V269, pH1713
   Pulanic D, 2005, COLLEGIUM ANTROPOL, V29, P341
   RAND PW, 1964, J APPL PHYSIOL, V19, P117
   Rosenson RS, 1996, CLIN CHEM, V42, P1189
   SHEA SM, 1984, MICROVASC RES, V28, P37, DOI 10.1016/0026-2862(84)90027-X
   Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485
   Skalak R, 1987, HDB BIOENGINEERING, P18
   Sloop GD, 1997, CLIN SCI, V92, P473, DOI 10.1042/cs0920473
   Sloop GD, 1998, CLIN HEMORHEOL MICRO, V19, P197
   Stoltz JF., 1999, HEMORHEOLOGY PRACTIC
   Tsuda Y, 1997, J NEUROL SCI, V147, P49, DOI 10.1016/S0022-510X(96)05309-9
   USAMI S, 1969, AM J PHYSIOL, V217, P884
   White CR, 2007, PHILOS T R SOC B, V362, P1459, DOI 10.1098/rstb.2007.2128
   Yang W.J., 1989, BIOTHERMAL FLUID SCI
   Yeow YL, 2002, BIOTECHNOL PROGR, V18, P1068, DOI 10.1021/bp025558k
   Yu PK, 2010, INVEST OPHTH VIS SCI, V51, P6735, DOI 10.1167/iovs.10-5415
   ZYDNEY AL, 1991, J RHEOL, V35, P1639, DOI 10.1122/1.550249
NR 73
TC 53
Z9 55
U1 2
U2 8
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2011
VL 41
IS 6
BP 287
EP 295
DI 10.4070/kcj.2011.41.6.287
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HY
UT WOS:000209078700001
PM 21779279
OA Green Published
DA 2021-04-22
ER

PT J
AU Sohn, IS
AF Sohn, Il-Suk
TI Cardiac Sarcoidosis: Oldies but Not Goodies
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Kyung Hee Univ, Hosp Gangdong, Ctr Cardiovasc, Seoul 134727, South Korea.
RP Sohn, IS (corresponding author), Kyung Hee Univ, Hosp Gangdong, Ctr Cardiovasc, 149 Sangil Dong, Seoul 134727, South Korea.
EM issohn@khu.ac.kr
RI SOHN, ILSUK/AAI-1097-2020
OI SOHN, ILSUK/0000-0001-8004-5185
CR [Anonymous], 2007, JPN J SARCOIDOSIS GR, V27, P89, DOI DOI 10.17996/ANC.17-00029
   BURSTOW DJ, 1989, AM J CARDIOL, V63, P478, DOI 10.1016/0002-9149(89)90323-8
   Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714
   Kim JS, 2009, AM HEART J, V157, P9, DOI 10.1016/j.ahj.2008.09.009
   ROBERTS WC, 1977, AM J MED, V63, P86, DOI 10.1016/0002-9343(77)90121-8
   SILVERMAN KJ, 1978, CIRCULATION, V58, P1204, DOI 10.1161/01.CIR.58.6.1204
   Sun BJ, 2011, KOREAN CIRC J, V41, P313, DOI 10.4070/kcj.2011.41.6.313
   Tahara N, 2010, JACC-CARDIOVASC IMAG, V3, P1219, DOI 10.1016/j.jcmg.2010.09.015
   Yazaki Y, 1998, AM J CARDIOL, V82, P537, DOI 10.1016/S0002-9149(98)00377-4
NR 9
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2011
VL 41
IS 6
BP 296
EP 298
DI 10.4070/kcj.2011.41.6.296
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HY
UT WOS:000209078700002
PM 21779280
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, SS
   Oh, CM
   Jang, JY
   Yu, HT
   Bang, WD
   Kim, JS
   Ko, YG
   Choi, D
   Hong, MK
   Shim, WH
   Cho, SY
   Jang, Y
AF Cho, Sung Soo
   Oh, Chang-Myung
   Jang, Ji-Yong
   Yu, Hee Tae
   Bang, Woo-Dae
   Kim, Jung-Sun
   Ko, Young-Guk
   Choi, Donghoon
   Hong, Myeong-Ki
   Shim, Won-Heum
   Cho, Seung-Yun
   Jang, Yangsoo
TI Percutaneous Cardiopulmonary Support-Supported Percutaneous Coronary
   Intervention: A Single Center Experience
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Shock; cardiogenic
ID HIGH-RISK PATIENTS; BYPASS SUPPORT; CARDIOGENIC-SHOCK; ANGIOPLASTY;
   OXYGENATION
AB Background and Objectives: Percutaneous cardiopulmonary support (PCPS) has proven to be a valuable technique in high-risk coronary patients undergoing percutaneous coronary intervention (PCI). However, there have been few studies on PCI associated with PCPS in Korea. We summarized our experience with PCPS-supported PCI. Subjects and Methods: We retrospectively reviewed 19 patients with PCPS-supported PCI between August 2005 and June 2009. PCPS was used as an elective procedure for 10 patients with at least two of the following conditions: left-ventricular ejection fraction <35%, target vessel(s) supplying more than 50% of the viable myocardium, high risk surgical patients, and patients who refused coronary bypass surgery. In the remaining 9 patients PCPS was used as an emergency procedure, to stabilize and even resuscitate patients with acute myocardial infarction and cardiogenic shock, in order to attempt urgent PCI. Results: Among the 19 patients who were treated with PCPS-supported PCI, 11 (57.9%) survived and 8 (42.1%) patients did not. ST elevation myocardial infarction with cardiogenic shock was more prevalent in the non-survivors than in the survivors (75% vs. 27.3%, p=0.04). The elective PCPS-supported PCI was practiced more frequently in the survivors than in the non-survivors (72.7% vs. 25%, p=0.04). In the analysis of the event-free survival curve between elective and emergency procedures, there was a significant difference in the survival rate (p=0.025). Among the survivors there were more patients with multi-vessel disease, but a lower Thrombolysis in Myocardial Infarction grade in the culprit lesions was detected in the non-survivors, before PCI. Although we studied high-risk patients, there was no procedure-related mortality. Conclusion: Our experience suggests that PCPS may be helpful in high risk patients treated with PCI, especially in elective cases. More aggressive and larger scale studies of PCPS should follow.
C1 [Cho, Sung Soo; Oh, Chang-Myung; Jang, Ji-Yong; Yu, Hee Tae; Bang, Woo-Dae; Kim, Jung-Sun; Ko, Young-Guk; Choi, Donghoon; Hong, Myeong-Ki; Shim, Won-Heum; Cho, Seung-Yun; Jang, Yangsoo] Yonsei Univ, Coll Med, Yonsei Cardiovasc Ctr, Div Cardiol, Seoul 120752, South Korea.
RP Jang, Y (corresponding author), Yonsei Univ, Coll Med, Yonsei Cardiovasc Ctr, Div Cardiol, 250 Seongsan Ro, Seoul 120752, South Korea.
EM jangys1212@yuhs.ac
OI Hong, Myeong-Ki/0000-0002-2090-2031
CR AGUIRRE FV, 1994, CARDIOLOGY, V84, P175, DOI 10.1159/000176396
   이일, 2006, Korean Circulation Journal, V36, P11
   de Lezo JS, 2002, CATHETER CARDIO INTE, V57, P467, DOI 10.1002/ccd.10340
   Ha JW, 1995, KOREAN CIRC J, V25, P85
   HILL JD, 1972, NEW ENGL J MED, V286, P629, DOI 10.1056/NEJM197203232861204
   Marasco SF, 2008, HEART LUNG CIRC, V17, pS41, DOI 10.1016/j.hlc.2008.08.009
   Matsuwaka R, 1996, HEART VESSELS, V11, P27, DOI 10.1007/BF01744596
   Obo H, 1998, SURG TODAY, V28, P797, DOI 10.1007/s005950050229
   PHILLIPS SJ, 1989, ANN THORAC SURG, V47, P121, DOI 10.1016/0003-4975(89)90252-X
   Sawa Yoshiki, 2005, J Artif Organs, V8, P217, DOI 10.1007/s10047-005-0311-2
   Schreiber TL, 1998, CATHETER CARDIO DIAG, V45, P115, DOI 10.1002/(SICI)1097-0304(199810)45:2<115::AID-CCD3>3.0.CO;2-F
   SHAWL FA, 1989, AM J CARDIOL, V64, P967, DOI 10.1016/0002-9149(89)90791-1
   Shawl FA, 1996, AM J CARDIOL, V77, P14, DOI 10.1016/S0002-9149(97)89127-8
   SHAWL FA, 1989, AM J CARDIOL, V64, P1258, DOI 10.1016/0002-9149(89)90564-X
   SIVANANTHAN MU, 1994, EUR HEART J, V15, P1057, DOI 10.1093/oxfordjournals.eurheartj.a060628
   TEIRSTEIN PS, 1993, J AM COLL CARDIOL, V21, P590, DOI 10.1016/0735-1097(93)90089-J
   Vainer J, 2007, AM J CARDIOL, V99, P771, DOI 10.1016/j.amjcard.2006.10.034
   VOGEL RA, 1988, AM J CARDIOL, V62, P811, DOI 10.1016/0002-9149(88)91229-5
   VOGEL RA, 1995, J INTERV CARDIOL, V8, P193, DOI 10.1111/j.1540-8183.1995.tb00531.x
NR 19
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2011
VL 41
IS 6
BP 299
EP 303
DI 10.4070/kcj.2011.41.6.299
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HY
UT WOS:000209078700003
PM 21779281
OA Green Published
DA 2021-04-22
ER

PT J
AU Nam, CW
   Hur, SH
   Koo, BK
   Doh, JH
   Cho, YK
   Park, HS
   Yoon, HJ
   Kim, H
   Chung, IS
   Kim, YN
   Fearon, WF
   Tahk, SJ
   Kim, KB
AF Nam, Chang-Wook
   Hur, Seung-Ho
   Koo, Bon-Kwon
   Doh, Joon Hyung
   Cho, Yun-Kyeong
   Park, Hyoung-Seob
   Yoon, Hyuck-Jun
   Kim, Hyungseop
   Chung, In-Sung
   Kim, Yoon-Nyun
   Fearon, William F.
   Tahk, Seung-Jae
   Kim, Kwon-Bae
TI Fractional Flow Reserve Versus Angiography in Left Circumflex Ostial
   Intervention After Left Main Crossover Stenting
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary disease; Physiology; Stents; Angiography
ID BIFURCATION
AB Background and Objectives: Discrepancy between angiographic percent (%) diameter stenosis and fractional flow reserve (FFR) exists in non-left main bifurcation lesions. The aim of this study was to compare angiographic stenosis severity and FFR in jailed ostial left circumflex artery (LCX) lesions after left main (LM)-to-left anterior descending artery (LAD) crossover stenting. Subjects and Methods: Twenty-nine (n=29) patients with distal LM or ostial LAD lesions treated by LM-to-LAD crossover stenting were consecutively enrolled. After successful stenting, FFR was measured at the jailed LCX. Additional intervention was performed in lesions with FFR <0.8. Results: The mean reference diameter of LCX was 3.1 +/- 0.4 mm, and percent diameter stenosis after crossover stenting was 56 +/- 21%. Angiographically significant stenosis (>50%) at the ostial LCX occurred in 59% (17/29) of cases. Among them, only five (29%) lesions had functional significance, and underwent additional procedure. During follow-up, three patients in the deferral group and two patients in the additional intervention group had target lesion revascularization. Conclusion: There was a discrepancy between angiographic percent diameter stenosis and FFR in jailed LCX lesions after LM crossover stenting.
C1 [Nam, Chang-Wook; Hur, Seung-Ho; Cho, Yun-Kyeong; Park, Hyoung-Seob; Yoon, Hyuck-Jun; Kim, Hyungseop; Chung, In-Sung; Kim, Yoon-Nyun; Kim, Kwon-Bae] Keimyung Univ, Coll Med, Dongsan Med Ctr, Dept Internal Med, Taegu 700712, South Korea.
   [Koo, Bon-Kwon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.
   [Doh, Joon Hyung] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Goyang, South Korea.
   [Fearon, William F.] Stanford Univ, Med Ctr, Stanford, CA 94305 USA.
   [Tahk, Seung-Jae] Ajou Univ, Sch Med, Dept Internal Med, Suwon 441749, South Korea.
RP Hur, SH (corresponding author), Keimyung Univ, Coll Med, Dongsan Med Ctr, Div Cardiol,Dept Internal Med, 216 Dalseong Ro, Taegu 700712, South Korea.
EM shur@dsmc.or.kr
OI Hur, Seung-Ho/0000-0002-3895-1915
FU Korean Society of Circulation, Republic of Korea; Regional Technology
   Innovation Program of the Ministry of Knowledge Economy (MKE), the
   Republic of Korea [RTI04-01-01]
FX This study was supported by a grant from the Korean Society of
   Circulation (2007), Republic of Korea. Dr. Yoon-Nyun Kim declares
   receipt of research grant No. RTI04-01-01 from the Regional Technology
   Innovation Program of the Ministry of Knowledge Economy (MKE), the
   Republic of Korea.
CR Bellenger NG, 2007, HEART, V93, P249, DOI 10.1136/hrt.2006.088690
   서정원, 2006, Korean Circulation Journal, V36, P300
   Colombo A, 2004, CIRCULATION, V109, P1244, DOI 10.1161/01.CIR.0000118474.71662.E3
   Kim YH, 2006, AM J CARDIOL, V97, P1597, DOI 10.1016/j.amjcard.2005.12.051
   김웅, 2007, Korean Circulation Journal, V37, P419
   King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208
   Koo BK, 2005, J AM COLL CARDIOL, V46, P633, DOI 10.1016/j.jacc.2005.04.054
   Koo BK, 2008, EUR HEART J, V29, P726, DOI 10.1093/eurheartj/ehn045
   Lim MJ, 2005, CATHETER CARDIO INTE, V65, P461, DOI 10.1002/ccd.20435
   MARCUS ML, 1988, J AM COLL CARDIOL, V11, P882, DOI 10.1016/0735-1097(88)90226-4
   Toyofuku M, 2009, CIRCULATION, V120, P1866, DOI 10.1161/CIRCULATIONAHA.109.873349
   WHITE CW, 1984, NEW ENGL J MED, V310, P819, DOI 10.1056/NEJM198403293101304
   Ziaee A, 2004, AM J CARDIOL, V93, P1404, DOI 10.1016/j.amjcard.2004.02.041
NR 13
TC 23
Z9 23
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2011
VL 41
IS 6
BP 304
EP 307
DI 10.4070/kcj.2011.41.6.304
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HY
UT WOS:000209078700004
PM 21779282
OA Green Published
DA 2021-04-22
ER

PT J
AU Son, J
   Hur, SH
   Kim, IC
   Cho, YK
   Park, HS
   Yoon, HJ
   Kim, H
   Nam, CW
   Kim, YN
   Kim, KB
AF Son, Jihyun
   Hur, Seung-Ho
   Kim, In Cheol
   Cho, Yun-Kyeong
   Park, Hyoung-Seob
   Yoon, Hyuck-Jun
   Kim, Hyungseop
   Nam, Chang-Wook
   Kim, Yoon-Nyun
   Kim, Kwon-Bae
TI The Impact of Moderate to Severe Renal Insufficiency on Patients With
   Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Renal insufficiency; Myocardial infarction; Percutaneous transluminal
   coronary angioplasty
ID PERCUTANEOUS CORONARY INTERVENTIONS; CHRONIC KIDNEY-DISEASE; SERUM
   CREATININE; RISK-FACTORS; OUTCOMES; DYSFUNCTION; MORTALITY; SURVIVAL;
   HEART
AB Background and Objectives: Renal insufficiency (RI) has been reported to be associated with unfavorable clinical outcomes in patients undergoing percutaneous coronary interventions (PCI). However, little data is available regarding the impact of moderate to severe RI on clinical outcomes in patients with acute myocardial infarction (AMI) undergoing PCI. Subjects and Methods: Between March 2003 and July 2007, 878 patients with AMI who underwent PCI were enrolled. Based on estimated glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease (MDRD) equation, patients were divided into two groups: eGFR <60 mL/min.m(2) (moderate to severe RI, group A) and eGFR >= 60 mL/min.m(2) (normal to mild RI, group B). The primary endpoint was all-cause mortality at 1-year after successful PCI. The secondary endpoints were non-fatal myocardial infarction (MI), target lesion revascularization (TLR), target vessel revascularization (TVR), stent thrombosis (ST) and major adverse cardiac events (MACE) at 1-year. Results: In group A, patients were more often male and older, with diabetes and hypertension. Compared to patients in group B, group A showed significantly higher incidences of all-cause mortality, cardiac mortality, non-fatal MI and MACE. The needs of TLR and TVR, and the incidence of ST were not significantly different between the two groups. Independent predictors of 1-year mortality were eGFR <60 mL/min.m(2), male gender, older age and a lower left ventricular ejection fraction. Conclusion: In patients with AMI, moderate to severe RI was associated with mortality and MACE
C1 [Son, Jihyun; Hur, Seung-Ho; Kim, In Cheol; Cho, Yun-Kyeong; Park, Hyoung-Seob; Yoon, Hyuck-Jun; Kim, Hyungseop; Nam, Chang-Wook; Kim, Yoon-Nyun; Kim, Kwon-Bae] Keimyung Univ, Coll Med, Dept Internal Med, Taegu 700712, South Korea.
RP Hur, SH (corresponding author), Keimyung Univ, Coll Med, Dongsan Med Ctr, Div Cardiol,Dept Internal Med, 216 Dalseong Ro, Taegu 700712, South Korea.
EM shur@dsmc.or.kr
OI Hur, Seung-Ho/0000-0002-3895-1915
CR Beattie JN, 2001, AM J KIDNEY DIS, V37, P1191, DOI 10.1053/ajkd.2001.24522
   Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X
   Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008
   Busch M, 2004, KIDNEY INT, V66, P338, DOI 10.1111/j.1523-1755.2004.00736.x
   Chertow GM, 2000, AM J KIDNEY DIS, V35, P1044, DOI 10.1016/S0272-6386(00)70038-2
   Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x
   Choi JH, 2004, ARTERIOSCL THROM VAS, V24, P1246, DOI 10.1161/01.ATV.0000133488.56221.4a
   Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313
   Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939
   Feldman DN, 2006, AM J CARDIOL, V98, P1334, DOI 10.1016/j.amjcard.2006.06.026
   Gruberg L, 2002, CATHETER CARDIO INTE, V55, P66, DOI 10.1002/ccd.10103
   Herzog CA, 1998, NEW ENGL J MED, V339, P799, DOI 10.1056/NEJM199809173391203
   Hsu CY, 2009, ARCH INTERN MED, V169, P342, DOI 10.1001/archinternmed.2008.605
   Kanani PM, 1999, CIRCULATION, V100, P1161, DOI 10.1161/01.CIR.100.11.1161
   Klein LW, 2002, J AM COLL CARDIOL, V40, P394, DOI 10.1016/S0735-1097(02)01992-7
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Massy Z A, 1996, Curr Opin Nephrol Hypertens, V5, P141, DOI 10.1097/00041552-199603000-00007
   Plantinga LC, 2008, ARCH INTERN MED, V168, P2268, DOI 10.1001/archinte.168.20.2268
   Romanic AM, 1998, CIRC RES, V83, P264, DOI 10.1161/01.RES.83.3.264
   Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006
   Singh M, 2003, J AM COLL CARDIOL, V42, P1722, DOI 10.1016/j.jacc.2003.05.007
   Wright RS, 2002, ANN INTERN MED, V137, P563, DOI 10.7326/0003-4819-137-7-200210010-00007
   Yamaguchi J, 2004, AM J CARDIOL, V93, P1526, DOI 10.1016/j.amjcard.2004.02.065
   Zhang RY, 2009, INT J CARDIOL, V136, P72, DOI 10.1016/j.ijcard.2008.04.028
NR 24
TC 1
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2011
VL 41
IS 6
BP 308
EP 312
DI 10.4070/kcj.2011.41.6.308
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HY
UT WOS:000209078700005
PM 21779283
OA Green Published
DA 2021-04-22
ER

PT J
AU Sun, BJ
   Lee, PH
   Choi, HO
   Ahn, JM
   Seo, JS
   Kim, DH
   Song, JM
   Choi, KJ
   Kang, DH
   Song, JK
AF Sun, Byung Joo
   Lee, Pil Hyung
   Choi, Hyung Oh
   Ahn, Jung-Min
   Seo, Jeong-Sook
   Kim, Dae-Hee
   Song, Jong-Min
   Choi, Kee Joon
   Kang, Duk-Hyun
   Song, Jae-Kwan
TI Prevalence of Echocardiographic Features Suggesting Cardiac Sarcoidosis
   in Patients With Pacemaker or Implantable Cardiac Defibrillator
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Sarcoidosis; Echocardiography; Pacemaker; Implantable
   cardioverter-defibrillators
AB Background and Objectives: Basal septal thinning or localized aneurysmal dilatation without coronary artery disease has been described as a characteristic finding suggestive of cardiac sarcoidosis. We sought to assess the prevalence of this characteristic echocardiographic finding in patients with pacemaker (PM) or implantable cardiac defibrillator (ICD). Subjects and Methods: Echocardiography of patients who received PM or ICD were retrospectively analyzed. Patients with marked thinning and akinesia confined to the basal septum (type 1), or posterolateral wall resulting in localized aneurysmal outward bulging (type 2) without history of myocardial infarction or significant coronary stenosis were included for analysis. Results: Among 1,357 consecutive patients, 21 exhibited suggestive echocardiographic findings (type 1/2=15/6) with a mean ejection fraction of 37 +/- 11%. The prevalence was 1.2% in the PM group and 4.0% in the ICD group. Only 3 patients showed histologically confirmable sarcoidosis in lymph nodes, lung and heart, respectively. Endomyocardial biopsy was attempted in 6 patients, but failed to demonstrate sarcoidosis. The 1-, 2-, 4- and 6-year clinical events (death, cardiac transplantation and hospital admission)-free survival rates were 100%, 85.7 +/- 7.6%, 75.0 +/- 9.7% and 48.6 +/- 12.4%, respectively. During follow-up, two patients with PM underwent ICD implantation, and another underwent heart transplantation. Conclusion: Prevalence of echocardiographic features suggesting prevalence of cardiac sarcoidosis is low in patients who underwent device implantation. However, considering the very low yield of endomyocardial biopsy and the rare extracardiac manifestations in cardiac sarcoidosis, characteristic echocardiographic findings could be an adjunctive diagnostic criterion in these patients.
C1 [Sun, Byung Joo; Lee, Pil Hyung; Choi, Hyung Oh; Ahn, Jung-Min; Seo, Jeong-Sook; Kim, Dae-Hee; Song, Jong-Min; Choi, Kee Joon; Kang, Duk-Hyun; Song, Jae-Kwan] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, Seoul 138736, South Korea.
RP Song, JK (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, 86 Asanbyeongwon Gil, Seoul 138736, South Korea.
EM jksong@amc.seoul.kr
OI Sun, Byung Joo/0000-0001-6019-4343; Kim, Dae-Hee/0000-0002-8275-4871
CR Bargout R, 2004, INT J CARDIOL, V97, P173, DOI 10.1016/j.ijcard.2003.07.024
   Chiu CZ, 2005, AM J CARDIOL, V95, P143, DOI 10.1016/j.amjcard.2004.08.083
   Dubrey SW, 2007, POSTGRAD MED J, V83, P618, DOI 10.1136/pgmj.2007.060608
   Hiraga H, 1993, GUIDELINE DIAGNOSIS, P23
   Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714
   Judson MA, 1999, SARCOIDOSIS VASC DIF, V16, P75
   Kim DS, 2001, SARCOIDOSIS VASC DIF, V18, P176
   최재훈, 2008, Korean Circulation Journal, V38, P500
   LEWIN RF, 1985, AM HEART J, V110, P116, DOI 10.1016/0002-8703(85)90524-1
   MATSUI Y, 1976, ANN NY ACAD SCI, V278, P455, DOI 10.1111/j.1749-6632.1976.tb47058.x
   Nelson JE, 1996, SARCOIDOSIS VASC DIF, V13, P178
   ROBERTS WC, 1977, AM J MED, V63, P86, DOI 10.1016/0002-9343(77)90121-8
   Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096
   Sekiguchi M, 1996, CARDIOVASC DRUG THER, V10, P495, DOI 10.1007/BF00050989
   SILTZBACH LE, 1974, AM J MED, V57, P847, DOI 10.1016/0002-9343(74)90160-0
   SILVERMAN KJ, 1978, CIRCULATION, V58, P1204, DOI 10.1161/01.CIR.58.6.1204
   TAWARAHARA K, 1992, AM HEART J, V124, P1383, DOI 10.1016/0002-8703(92)90431-T
   TELLIER P, 1988, AM J MED, V85, P189
   Uemura A, 1999, AM HEART J, V138, P299, DOI 10.1016/S0002-8703(99)70115-8
   VALANTINE H, 1987, BRIT HEART J, V57, P256
   Yamano T, 2007, J ECHOCARDIOGR, V5, P1, DOI DOI 10.2303/JECHO.5.1
   조용근, 2008, Korean Circulation Journal, V38, P514
NR 22
TC 8
Z9 8
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2011
VL 41
IS 6
BP 313
EP 320
DI 10.4070/kcj.2011.41.6.313
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HY
UT WOS:000209078700006
PM 21779284
OA Green Published
DA 2021-04-22
ER

PT J
AU Ahn, HM
   Park, IS
   Hong, SJ
   Hong, YM
AF Ahn, Hye Mi
   Park, In Sook
   Hong, Soo-Jong
   Hong, Young Mi
TI Interleukin-6 (-636 C/G) Gene Polymorphism in Korean Children With
   Kawasaki Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mucocutaneous lymph node syndrome; Interleukins; Polymorphism; genetic
AB Background and Objectives: Kawasaki disease (KD) is a multi-systemic vasculitis with coronary artery involvement. Serum interleukin (IL)-6 levels during acute phase showed a significant correlation with the duration of fever in patients with KD who were not treated with intravenous immunoglobulin (IVIG), suggesting that the regulation of IL-6 expression in KD patients may differ from that in normal children. However, there are controversies surrounding the association between IL-6 (-636 C/G) gene polymorphism and development of KD. Subjects and Methods: One hundred and nine children with KD and 191 children with congenital heart disease were included in this study. Echocardiography was performed to examine cardiac involvement in patients with KD. Genotyping of the IL-6 (-636 C/G) gene polymorphism was performed using the single-base extension method, and serum IL-6 concentrations were estimated using the sandwich enzyme immunoassay method. Results: Neutrophil, platelet count, liver function test, total protein and albumin concentrations were significantly different in the KD group and the serum IL-6 concentration was significantly higher in the KD group than the control group. There was no difference between the patients with coronary arterial dilatation (CAD) and those without CAD in the IL-6 (-636 C/G) polymorphism. The serum albumin concentration was significantly lower in patients with KD who had the -636 C/G or GG genotype compared with the control group. The serum IL-6 concentration was significantly higher in patients with KD who had the -636 C/G or GG genotype. Conclusion: There was no association between the IL-6 (-636 C/G) gene polymorphism and development of coronary arterial lesions in KD. Further multicenter studies are required to establish the relationship between the IL-6 (-636 C/G) gene polymorphism and development of KD.
C1 [Ahn, Hye Mi; Hong, Young Mi] Ewha Womans Univ, Sch Med, Dept Pediat, Seoul 158710, South Korea.
   [Park, In Sook; Hong, Soo-Jong] Univ Ulsan, Coll Med, Dept Pediat, Seoul, South Korea.
RP Hong, YM (corresponding author), Ewha Womans Univ, Sch Med, Dept Pediat, 911-1 Mok Dong, Seoul 158710, South Korea.
EM ymhong@ewha.ac.kr
RI Hong, Soo-Jong/AAR-1788-2020
OI Hong, Soo-Jong/0000-0003-1409-2113
FU Korean Ministry of Health and WelfareMinistry of Health & Welfare,
   Republic of Korea [01-PJ10-PG6-01GN15-0001]
FX This study was sponsored by a grant from the Korean Ministry of Health
   and Welfare (01-PJ10-PG6-01GN15-0001).
CR Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x
   Burns JC, 2005, GENES IMMUN, V6, P438, DOI 10.1038/sj.gene.6364225
   Chapman CML, 2003, EUR HEART J, V24, P1494, DOI 10.1016/S0195-668X(03)00313-0
   양순희, 2006, Korean Circulation Journal, V36, P723
   Cheung YF, 2008, PEDIATRICS, V122, pE608, DOI 10.1542/peds.2008-0646
   Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629
   Fulton D R, 2000, Curr Rheumatol Rep, V2, P324, DOI 10.1007/s11926-000-0070-2
   Hata A, 2009, J HUM GENET, V54, P67, DOI 10.1038/jhg.2008.9
   HIRANO T, 1990, IMMUNOL TODAY, V11, P443, DOI 10.1016/0167-5699(90)90173-7
   Hirao J, 1997, INT ARCH ALLERGY IMM, V112, P152, DOI 10.1159/000237447
   Hong YM, 2008, HEART VESSELS, V23, P341, DOI 10.1007/s00380-008-1041-1
   Jibiki T, 2001, ARTHRITIS RHEUM, V44, P2211, DOI 10.1002/1529-0131(200109)44:9<2211::AID-ART375>3.0.CO;2-A
   Jin HS, 2007, PEDIATR RES, V61, P584, DOI 10.1203/pdr.0b013e3180459fb5
   Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379
   Kim MK, 1992, J KOREAN PEDIAT SOC, V35, P515
   Lee Soo Jin, 2009, Korean Circ J, V39, P264, DOI 10.4070/kcj.2009.39.7.264
   LEUNG DYM, 1986, J EXP MED, V164, P1958, DOI 10.1084/jem.164.6.1958
   LinkerIsraeli M, 1996, AUTOIMMUNITY, V23, P199, DOI 10.3109/08916939608995343
   Lloyd AJ, 2001, BRIT J BIOMED SCI, V58, P122
   MAURY CPJ, 1988, NEW ENGL J MED, V319, P1670
   Morgan L, 2006, J NEUROL NEUROSUR PS, V77, P915, DOI 10.1136/jnnp.2005.081976
   Papassotiropoulos A, 1999, ANN NEUROL, V45, P666, DOI 10.1002/1531-8249(199905)45:5<666::AID-ANA18>3.0.CO;2-3
   Research Committee on Kawasaki Disease, 1984, REP SUBC STAND DIAGN
   Sohn MH, 2001, GENES IMMUN, V2, P357, DOI 10.1038/sj.gene.6363785
   Tanaka C, 2005, HYPERTENS RES, V28, P35, DOI 10.1291/hypres.28.35
   UENO Y, 1989, CLIN EXP IMMUNOL, V76, P337
   Wang CL, 2005, PEDIATR INFECT DIS J, V24, P998, DOI 10.1097/01.inf.0000183786.70519.fa
   Yeo Joong-Seok, 2010, Korean Circ J, V40, P81, DOI 10.4070/kcj.2010.40.2.81
   Zee RYL, 2004, HUM MOL GENET, V13, P389, DOI 10.1093/hmg/ddh039
NR 29
TC 6
Z9 6
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2011
VL 41
IS 6
BP 321
EP 326
DI 10.4070/kcj.2011.41.6.321
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HY
UT WOS:000209078700007
PM 21779285
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JY
   Lee, NH
   Cho, YH
   Suh, J
   Seo, HS
   Kim, DH
   Jeon, YW
AF Kim, Jae Yun
   Lee, Nae-Hee
   Cho, Yoon Haeng
   Suh, Jon
   Seo, Hye-Sun
   Kim, Do Hoi
   Jeon, Young Woo
TI Recanalization of an Accidentally Crushed Coronary Stent by
   Intravascular Ultrasonography Catheter Entrapment
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Intravascular ultrasonography; Percutaneous transluminal coronary
   angioplasty; Stents
AB Intravascular ultrasonography (IVUS) imaging is a user-friendly technique widely used during coronary interventions. An 80-year-old man was admitted with chest pain, and successful percutaneous coronary intervention was performed with stent implantation. One week later, the patient complained of further chest pain. Urgent coronary angiography showed total occlusion of the middle left anterior descending artery and the aspiration of thrombi was high. IVUS imaging showed inadequate stent strut apposition and distal dissection. We attempted another stent implantation but the IVUS catheter was stuck on the 0.014 inch wire. Therefore, we tried to pass the wire across the lateral side. After the wire was successfully passaged, the sprinter balloon was passed through the crushed stent to expand it. After 4 days later, the patient was discharged with no symptoms or electrocardiographic change.
C1 [Kim, Jae Yun; Lee, Nae-Hee; Cho, Yoon Haeng; Suh, Jon; Seo, Hye-Sun; Kim, Do Hoi; Jeon, Young Woo] Soonchunhyang Univ, Coll Med, Dept Internal Med, Div Cardiol, Puchon 420767, South Korea.
RP Cho, YH (corresponding author), Soonchunhyang Univ, Coll Med, Dept Internal Med, Div Cardiol, 1174 Jung Dong, Puchon 420767, South Korea.
EM yhcho@sch.bc.ac.kr
CR Alfonso F, 2000, CATHETER CARDIO INTE, V50, P221, DOI 10.1002/(SICI)1522-726X(200006)50:2<221::AID-CCD18>3.0.CO;2-I
   Bae JH, 2006, KOREAN CIRC J, V36, P553
   Batkoff BW, 1996, CATHETER CARDIO DIAG, V38, P238, DOI 10.1002/(SICI)1097-0304(199607)38:3<238::AID-CCD3>3.0.CO;2-9
   COLOMBO A, 1995, CIRCULATION, V91, P1676, DOI 10.1161/01.CIR.91.6.1676
   HAUSMANN D, 1995, CIRCULATION, V91, P623, DOI 10.1161/01.CIR.91.3.623
   Nicosia A, 1997, CATHETER CARDIO DIAG, V40, P265
   Sasseen BM, 2002, CATHETER CARDIO INTE, V57, P229, DOI 10.1002/ccd.10244
NR 7
TC 4
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2011
VL 41
IS 6
BP 327
EP 330
DI 10.4070/kcj.2011.41.6.327
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HY
UT WOS:000209078700008
PM 21779286
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, Y
   Cho, J
   Kim, G
   Lee, S
   Hyun, M
   Kim, Y
AF Lee, Youngok
   Cho, Joonyong
   Kim, Gunjik
   Lee, Sangbum
   Hyun, Myungchul
   Kim, Yeohyang
TI Surgical Repair of Giant Right Atrial Aneurysm in a Neonate
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Right atrium; Heart aneurysm
AB Right atrial aneurysm is an extremity rare congenital heart defect. We report a case which was diagnosed during the early fetal stage and operated on in a 2 week old neonate. Following median sternotomy, aneurysmectomy was performed under a cardiopulmonary bypass. Histopathological examination of the resected atiral tissue showed a lipotomatous degeneration and reduction of the muscular elements. There were no postoperative complications.
C1 [Lee, Youngok; Cho, Joonyong; Kim, Gunjik] Kyungpook Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Taegu 700721, South Korea.
   [Lee, Sangbum; Hyun, Myungchul] Kyungpook Natl Univ, Coll Med, Dept Pediat Cardiol, Taegu 700721, South Korea.
   [Kim, Yeohyang] Keimyung Univ, Coll Med, Dongsan Hosp, Dept Pediat Cardiol, Taegu, South Korea.
RP Cho, J (corresponding author), Kyungpook Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, 200 Dongdeok Ro, Taegu 700721, South Korea.
EM jycho@knu.ac.kr
OI Kim, Gun Jik/0000-0002-8051-2131
CR Binder TM, 2000, CHEST, V117, P1740, DOI 10.1378/chest.117.6.1740
   Klisiewicz A, 2004, J AM SOC ECHOCARDIOG, V17, P286, DOI 10.1016/j.echo.2003.11.004
   Mascio CE, 2005, ANN THORAC SURG, V80, P2382, DOI 10.1016/j.athoracsur.2003.12.065
   Moraes F, 2001, EUR J CARDIO-THORAC, V19, P943, DOI 10.1016/S1010-7940(01)00738-2
   MORROW AG, 1968, CIRCULATION, V38, P124, DOI 10.1161/01.CIR.38.1.124
   Papagiannis J, 2008, INT J CARDIOL, V129, pE5, DOI 10.1016/j.ijcard.2007.06.081
   Zeebregts CJAM, 1997, EUR J CARDIO-THORAC, V11, P591, DOI 10.1016/S1010-7940(96)01067-6
NR 7
TC 8
Z9 9
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2011
VL 41
IS 6
BP 331
EP 333
DI 10.4070/kcj.2011.41.6.331
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HY
UT WOS:000209078700009
PM 21779287
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, KT
   Hong, KS
   Han, SJ
   Yoon, DH
   Choi, H
   Lee, MY
   Ryu, MS
   Lee, CW
AF Park, Kyu Tae
   Hong, Kyung Soon
   Han, Sang Jin
   Yoon, Duck Hyoung
   Choi, Hyunhee
   Lee, Min Young
   Ryu, Myeong Shin
   Lee, Chan Woo
TI Myopericarditis in a Korean Young Male With Systemic Lupus Erythematosus
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Male; Pericarditis; Myocarditis; Systemic lupus erythematosus
AB Myocardial involvement with clinical symptoms is a rare manifestation of systemic lupus erythematosus (SLE), despite the relatively high prevalence of myocarditis at autopsies of SLE patients. In this review, we report the case of a 19-year-old male SLE patient who initially presented with myopericarditis and was successfully treated with high dose of glucocorticoids.
C1 [Park, Kyu Tae; Hong, Kyung Soon; Han, Sang Jin; Yoon, Duck Hyoung; Choi, Hyunhee; Lee, Min Young; Ryu, Myeong Shin; Lee, Chan Woo] Hallym Univ, Coll Med, Dept Internal Med, Chunchon 200704, South Korea.
RP Hong, KS (corresponding author), Hallym Univ, Coll Med, Dept Internal Med, 153 Gyo Dong, Chunchon 200704, South Korea.
EM kshong@hallym.ac.kr
CR BIDANI AK, 1980, AM J MED, V69, P849, DOI 10.1016/S0002-9343(80)80010-6
   Chakravarty EF, 2007, ARTHRITIS RHEUM, V56, P2092, DOI 10.1002/art.22641
   Doria A, 2005, LUPUS, V14, P683, DOI 10.1191/0961203305lu2200oa
   Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908
   Lahita R G, 1999, Curr Opin Rheumatol, V11, P352, DOI 10.1097/00002281-199909000-00005
   MANDELL BF, 1987, SEMIN ARTHRITIS RHEU, V17, P126, DOI 10.1016/0049-0172(87)90035-7
   Moder KG, 1999, MAYO CLIN PROC, V74, P275, DOI 10.4065/74.3.275
   Murphy JG, 2003, MYOCARDITIS: FROM BENCH TO BEDSIDE, P371
   Noutsias Michel, 2003, Heart Fail Monit, V3, P127
   PARK JI, 2005, KOREAN CIRC J, V35, P563
   TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101
   Wijetunga M, 2002, AM J MED, V113, P419, DOI 10.1016/S0002-9343(02)01223-8
NR 12
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2011
VL 41
IS 6
BP 334
EP 337
DI 10.4070/kcj.2011.41.6.334
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HY
UT WOS:000209078700010
PM 21779288
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, MJ
   Kim, DH
   Kwan, J
   Park, KS
   Shin, SH
   Woo, SI
   Park, SD
   Lee, WS
AF Lee, Man Jong
   Kim, Dae Hyeok
   Kwan, Jun
   Park, Keum Soo
   Shin, Sung Hee
   Woo, Seoung Il
   Park, Sang Don
   Lee, Won Seop
TI A Case of Malignant Pericardial Mesothelioma With Constrictive
   Pericarditis Physiology Misdiagnosed as Pericardial Metastatic Cancer
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pericardium; Mesothelioma; Constrictive pericarditis
AB Malignant pericardial mesothelioma is a rare and progressive cardiac tumor. There is no established standard treatment and the prognosis is poor. Most patients were retrospectively diagnosed from surgery or autopsy due to absence of specific clinical manifestation. Most patients with pericardial mesothelioma have demonstrated constrictive physiology on echocardiography or cardiac catheterization. Therefore, pericardial mesothelioma was often misdiagnosed as other causes of constrictive pericarditis. We report a case of primary pericardial mesothelioma misdiagnosed as pericardial metastasis of unknown origin.
C1 [Lee, Man Jong; Kim, Dae Hyeok; Kwan, Jun; Park, Keum Soo; Shin, Sung Hee; Woo, Seoung Il; Park, Sang Don; Lee, Won Seop] Inha Univ, Coll Med, Dept Internal Med, Div Cardiol, Inchon 400711, South Korea.
RP Kim, DH (corresponding author), Inha Univ, Coll Med, Dept Internal Med, Div Cardiol, Sinheung Dong 3 Ga, Inchon 400711, South Korea.
EM kdhmd@inha.ac.kr
OI Lee, Man-Jong/0000-0002-4533-2629
CR Ceresoli GL, 2006, J CLIN ONCOL, V24, P1443, DOI 10.1200/JCO.2005.04.3190
   Cherian G, 2003, AM J MED, V114, P319, DOI 10.1016/S0002-9343(02)01521-8
   Flores RM, 2003, J THORAC CARDIOV SUR, V126, P11, DOI 10.1016/s0022-5223(03)00207-1
   GOSSINGER HD, 1988, AM HEART J, V115, P1321, DOI 10.1016/0002-8703(88)90033-6
   Ha CB, 1989, KOREAN CIRC J, V19, P47
   JW Ha, 2006, HEART, V92, P494
   Kaminaga T, 2003, EUR RADIOL, V13, pL1, DOI 10.1007/s00330-002-1789-0
   KAUL TK, 1994, J CARDIOVASC SURG, V35, P261
   Kindler HL, 2005, LUNG CANCER-J IASLC, V48, P423, DOI 10.1016/j.lungcan.2004.12.002
   KRALSTEIN J, 1987, AM HEART J, V113, P785, DOI 10.1016/0002-8703(87)90720-4
   Lagrotteria DD, 2005, CAN J CARDIOL, V21, P185
   Ost P, 2008, J THORAC IMAG, V23, P35, DOI 10.1097/RTI.0b013e318156eb39
   Suman S, 2004, HEART, V90, DOI 10.1136/heart.90.1.e4
NR 13
TC 7
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2011
VL 41
IS 6
BP 338
EP 341
DI 10.4070/kcj.2011.41.6.338
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HY
UT WOS:000209078700011
PM 21779289
OA Green Published
DA 2021-04-22
ER

PT J
AU Song, MK
   Bae, EJ
   Baek, JS
   Kwon, BS
   Kim, GB
   Noh, CI
   Choi, JY
   Park, SS
AF Song, Mi Kyoung
   Bae, Eun Jung
   Baek, Jae Suk
   Kwon, Bo Sang
   Kim, Gi Beom
   Noh, Chung Il
   Choi, Jung Yun
   Park, Sung Sup
TI QT Prolongation and Life Threatening Ventricular Tachycardia in a
   Patient Injected With Intravenous Meperidine (Demerol (R))
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Long QT syndrome; Meperidine; Torsade de pointes
ID COMMON POLYMORPHISM; INTERVAL; KCNH2; ASSOCIATION; VARIANTS; GENES;
   KCNE1; SCN5A; KCNQ1
AB QT prolongation is a serious adverse drug effect, which is associated with an increased risk of Torsade de pointes and sudden death. Many drugs, including both cardiac and non-cardiac drugs, have been reported to cause prolongation of QT interval. Although meperidine has not been considered proarrhythmic, we present a unique case of a 16-year-old boy without an underlying cardiac disease, who developed polymorphic ventricular tachycardia, ventricular fibrillation and QT prolongation after an intravenous meperidine injection. He had no mutation in long QT syndrome genes (KCNQ1, KCNH2, and SCN5A), but single nucleotide polymorphisms were reported, including H558R in SCNA5A and K897T in KCNH2.
C1 [Song, Mi Kyoung; Bae, Eun Jung; Baek, Jae Suk; Kwon, Bo Sang; Kim, Gi Beom; Noh, Chung Il; Choi, Jung Yun] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul 110744, South Korea.
   [Park, Sung Sup] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul 110744, South Korea.
RP Bae, EJ (corresponding author), Seoul Natl Univ, Childrens Hosp, Dept Pediat, 101 Daehak Ro, Seoul 110744, South Korea.
EM eunjbaek@snu.ac.kr
RI Kim, Gi Beom/AAK-3377-2021; Park, Sung Sup/J-2756-2012
OI Kim, Gi Beom/0000-0002-7880-280X; Park, Sung Sup/0000-0003-3754-4848
CR Albert CM, 2010, CIRC-ARRHYTHMIA ELEC, V3, P222, DOI 10.1161/CIRCEP.110.944934
   Bezzina CR, 2003, CARDIOVASC RES, V59, P27, DOI 10.1016/S0008-6363(03)00342-0
   Crotti L, 2005, CIRCULATION, V112, P1251, DOI 10.1161/CIRCULATIONAHA.105.549071
   De Ponti F, 2000, LANCET, V356, P75, DOI 10.1016/S0140-6736(05)73412-7
   Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778
   Gouas L, 2007, EUR J HUM GENET, V15, P974, DOI 10.1038/sj.ejhg.5201866
   Gouas L, 2005, EUR J HUM GENET, V13, P1213, DOI 10.1038/sj.ejhg.5201489
   Hoffmann Peter, 2006, Journal of Pharmacological and Toxicological Methods, V53, P87, DOI 10.1016/j.vascn.2005.07.003
   Katchman AN, 2002, J PHARMACOL EXP THER, V303, P688, DOI 10.1124/jpet.102.038240
   김성만, 2007, Korean Circulation Journal, V37, P559
   현대우, 2004, Korean Circulation Journal, V34, P813
   Napolitano C, 2000, J CARDIOVASC ELECTR, V11, P691, DOI 10.1111/j.1540-8167.2000.tb00033.x
   Paulussen ADC, 2004, J MOL MED, V82, P182, DOI 10.1007/s00109-003-0522-z
   Pietila E, 2002, J AM COLL CARDIOL, V40, P511, DOI 10.1016/S0735-1097(02)01979-4
   Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426
   Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197
   Shimizu W, 2004, HEART RHYTHM, V1, P276, DOI 10.1016/j.hrthm.2004.04.021
   VELEBIT V, 1982, CIRCULATION, V65, P886, DOI 10.1161/01.CIR.65.5.886
   Wedam EF, 2007, ARCH INTERN MED, V167, P2469, DOI 10.1001/archinte.167.22.2469
   Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C
NR 20
TC 11
Z9 11
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2011
VL 41
IS 6
BP 342
EP 345
DI 10.4070/kcj.2011.41.6.342
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HY
UT WOS:000209078700012
PM 21779290
OA Green Published
DA 2021-04-22
ER

PT J
AU Koh, JS
   Jeong, YH
   Yoon, SE
   Park, JR
   Park, Y
   Hwang, SJ
   Kwak, CH
   Hwang, JY
AF Koh, Jin-Sin
   Jeong, Young-Hoon
   Yoon, Seong-Eun
   Park, Jeong Rang
   Park, Yongwhi
   Hwang, Seok-Jae
   Kwak, Choong Hwan
   Hwang, Jin-Yong
TI A Case of Spontaneous Coronary Artery Dissection Healed by Medical
   Treatment: Serial Findings of Coronary Angiography, Intravascular
   Ultrasound and Multi-Detector Computed Tomography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary artery disease; Dissection; Myocardial infarction; Angiography;
   Ultrasonography; interventional; Tomography; spiral computed
AB Spontaneous coronary artery dissection (SCAD) is an uncommon cause of acute coronary syndrome which may be related to lethal condition. Although several modalities including medical therapy have been suggested, agreement on optimal treatment has not yet been determined. We describe a case of SCAD which was presented as ST-segment elevation myocardial infarction, and treated successfully with medical treatment. Coronary angiography, intravascular ultrasound and multi-detector computed tomography showed the serial changes of this disease entity.
C1 [Koh, Jin-Sin; Jeong, Young-Hoon; Yoon, Seong-Eun; Park, Jeong Rang; Park, Yongwhi; Hwang, Seok-Jae; Kwak, Choong Hwan; Hwang, Jin-Yong] Gyeongsang Natl Univ Hosp, Dept Internal Med, Div Cardiol, Jinju 660702, South Korea.
RP Jeong, YH (corresponding author), Gyeongsang Natl Univ Hosp, Dept Internal Med, Div Cardiol, 90 Chiram Dong, Jinju 660702, South Korea.
EM goodoctor@naver.com
RI Jeong, Young-Hoon/F-3476-2015; Jeong, Young-Hoon/AAO-4401-2020
OI Jeong, Young-Hoon/0000-0003-0403-3726; Kwak, Choong
   Hwan/0000-0001-6035-4415
CR Borczuk AC, 1997, CARDIOVASC RES, V33, P527, DOI 10.1016/S0008-6363(96)00257-X
   DEMAIO SJ, 1989, AM J CARDIOL, V64, P471, DOI 10.1016/0002-9149(89)90423-2
   Hering D, 1998, Z KARDIOL, V87, P961, DOI 10.1007/s003920050253
   Maehara A, 2002, AM J CARDIOL, V89, P466, DOI 10.1016/S0002-9149(01)02272-X
   Mortensen KH, 2009, CATHETER CARDIO INTE, V74, P710, DOI 10.1002/ccd.22115
   Park Sun Hee, 2009, Korean Circ J, V39, P428, DOI 10.4070/kcj.2009.39.10.428
   Vrints CJM, 2010, HEART, V96, P801, DOI 10.1136/hrt.2008.162073
NR 7
TC 3
Z9 3
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JUN
PY 2011
VL 41
IS 6
BP 346
EP 348
DI 10.4070/kcj.2011.41.6.346
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HY
UT WOS:000209078700013
PM 21779291
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SJ
AF Kim, Soo-Jin
TI Heterotaxy Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Heterotaxy; Isomerism
ID PULMONARY ARTERIOVENOUS-MALFORMATIONS; MODIFIED FONTAN OPERATION;
   BIVENTRICULAR REPAIR; ATRIAL ISOMERISM; ASPLENIA; SEPTICEMIA; ANOMALIES
AB Heterotaxy is defined as an abnormality where the internal thoraco-abdominal organs demonstrate abnormal arrangement across the left-right axis of the body. This broad term includes patients with a wide variety of very complex cardiac lesions. Patients with heterotaxy can be stratified into the subsets of asplenia syndrome and polysplenia syndrome, or the subsets of heterotaxy with isomerism of the right atrial appendages and heterotaxy with isomerism of the left atrial appendages. Treatment of patients with isomerism is determined by the nature and severity of the associated cardiac and extracardiac lesions. Most cardiac operations for patients with isomerism are palliative in nature, since normal anatomy is rarely achieved and mortality rates remain high for patients with heterotaxy syndrome. Patients with left isomerism in general have less severe cardiac malformations than those with right isomerism and, hence, more chance of biventricular repair. For almost all patients with right isomerism, and for many with left isomerism, biventricular repair will not be feasible, and all palliative protocols are then staging procedures prior to a Fontan-type repair. Recent advances in medical management, and improvements in surgical techniques have resulted in improved survival for these patients, and the surgical outcomes are comparable to those with Fontan circulation irrespective of the presence or absence of heterotaxy.
C1 [Kim, Soo-Jin] Konkuk Univ Hosp, Dept Pediat, Div Pediat Cardiol, Seoul 143729, South Korea.
RP Kim, SJ (corresponding author), Konkuk Univ Hosp, Ctr Cardiovasc, Dept Pediat, 4-12 Hwayang Dong, Seoul 143729, South Korea.
EM ksoojn@yahoo.co.kr
RI Kim, Soo-Jin/P-2677-2014
OI Kim, Soo-Jin/0000-0001-9671-6019
CR Allen HD., 2008, MOSS ADAMS HEART DIS
   Andeson RH, 2010, PAEDIAT CARDIOLOGY
   Bartz PJ, 2006, J AM COLL CARDIOL, V48, P2301, DOI 10.1016/j.jacc.2006.07.053
   BLIEDEN LC, 1973, AM HEART J, V85, P439, DOI 10.1016/0002-8703(73)90487-0
   CULBERTSON CB, 1992, J AM COLL CARDIOL, V20, P678, DOI 10.1016/0735-1097(92)90024-H
   DETOMMASI SM, 1981, BRIT HEART J, V45, P236
   DICKINSON DF, 1979, CIRCULATION, V59, P879, DOI 10.1161/01.CIR.59.5.879
   DYKE MP, 1991, ARCH DIS CHILD, V66, P636, DOI 10.1136/adc.66.5.636
   FREEDOM RM, 1972, J PEDIATR-US, V81, P1130, DOI 10.1016/S0022-3476(72)80244-0
   Frogoudaki A, 2003, EUROPACE, V5, P189, DOI 10.1053/eupc.2002.0291
   HO SY, 1995, BRIT HEART J, V74, P437
   HUMES RA, 1988, J THORAC CARDIOV SUR, V96, P212
   JACOBS JP, 2007, CARDIOL YOUNG S2, V17, P1
   KAWASHIMA Y, 1984, J THORAC CARDIOV SUR, V87, P74
   KAWASHIMA Y, 1993, J THORAC CARDIOV SUR, V106, P248
   Kim SJ, 2000, ANN THORAC SURG, V70, P1918, DOI 10.1016/S0003-4975(00)02164-0
   Kim SJ, 2008, J THORAC CARDIOV SUR, V136, P108, DOI 10.1016/j.jtcvs.2007.12.032
   Kim SJ, 2006, ANN THORAC SURG, V82, P1245, DOI 10.1016/j.athoracsur.2006.04.082
   Kim SJ, 2009, ANN THORAC SURG, V87, P548, DOI 10.1016/j.athoracsur.2008.10.024
   Koh M, 2006, ANN THORAC SURG, V81, P1808, DOI 10.1016/j.athoracsur.2005.12.008
   Lim HG, 2009, J THORAC CARDIOV SUR, V137, P371, DOI 10.1016/j.jtcvs.2008.10.027
   McElhinney DB, 2005, ANN THORAC SURG, V80, P1597, DOI 10.1016/j.athoracsur.2005.05.101
   MOMMA K, 1990, AM J CARDIOL, V65, P231, DOI 10.1016/0002-9149(90)90090-N
   MURDOCH IA, 1991, BRIT HEART J, V65, P102
   SRIVASTAVA D, 1995, CIRCULATION, V92, P1217, DOI 10.1161/01.CIR.92.5.1217
   STUMPER O, 1995, BRIT HEART J, V74, P282
   Ticho BS, 2000, AM J CARDIOL, V85, P729, DOI 10.1016/S0002-9149(99)00849-8
   Uemura H, 2001, CARDIOL YOUNG, V11, P12, DOI 10.1017/S1047951100012361
   WALDMAN JD, 1977, J PEDIATR-US, V90, P555, DOI 10.1016/S0022-3476(77)80365-X
   WREN C, 1987, AM J CARDIOL, V59, P1156, DOI 10.1016/0002-9149(87)90866-6
   Yun TJ, 2006, J THORAC CARDIOV SUR, V131, P1108, DOI 10.1016/j.jtcvs.2005.11.036
NR 31
TC 47
Z9 56
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2011
VL 41
IS 5
BP 227
EP 232
DI 10.4070/kcj.2011.41.5.227
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HX
UT WOS:000209078600001
PM 21731561
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, Y
AF Choi, Yunseok
TI Evolving Coronary Stents Coated With New Bioactive Agents
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, Seoul 150713, South Korea.
RP Choi, Y (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, 62 Yeouido Dong, Seoul 150713, South Korea.
EM cys71@catholic.ac.kr
CR Chou TC, 2011, J AGR FOOD CHEM, V59, P3050, DOI 10.1021/jf103940u
   Indolfi L, 2011, J BIOMED MATER RES A, V97A, P201, DOI 10.1002/jbm.a.33039
   Kim HJ, 2010, ARTERIOSCL THROM VAS, V30, P2164, DOI 10.1161/ATVBAHA.110.212308
   Koga H, 2011, J SURG RES, DOI [10.1016/j.jss2011.01.011, DOI 10.1016/J.JSS2011.01.011]
   Lim KS, 2011, KOREAN CIRC J, V41, P241, DOI 10.4070/kcj.2011.41.5.241
   Lim SY, 2009, J CARDIOL, V54, P375, DOI 10.1016/j.jjcc.2009.06.005
   Mickelson JK, 1999, J AM COLL CARDIOL, V33, P97, DOI 10.1016/S0735-1097(98)00532-4
   Simon DI, 1997, ARTERIOSCL THROM VAS, V17, P528, DOI 10.1161/01.ATV.17.3.528
NR 8
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2011
VL 41
IS 5
BP 233
EP 234
DI 10.4070/kcj.2011.41.5.233
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HX
UT WOS:000209078600002
PM 21731562
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, HT
   Lim, YH
   Kim, BK
   Lee, KW
   Lee, JU
   Kim, KS
   Kim, SG
   Kim, JH
   Lim, HK
   Shin, J
   Kim, YM
AF Lee, Hyung Tak
   Lim, Young-Hyo
   Kim, Bae Keun
   Lee, Kang Won
   Lee, Jae Ung
   Kim, Kyung Soo
   Kim, Soon Gil
   Kim, Jeong Hyun
   Lim, Heon Kil
   Shin, Jinho
   Kim, Yu-Mi
TI The Relationship Between Ambulatory Arterial Stiffness Index and Blood
   Pressure Variability in Hypertensive Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Blood pressure; Blood pressure monitoring, ambulatory; Autonomic nervous
   system diseases
AB Background and Objectives: Ambulatory arterial stiffness index (AASI) is well known as a predictor of cardiovascular mortality in hypertensive patients. Mathematically, AASI reflect the standard deviation (SD) of blood pressure (BP) variation. AASI is measured higher levels in non-dipper than dipper. Thus, AASI has a possibility of not only reflecting arterial stiffness but also BP variability and/or autonomic nervous dysfunction. Subjects and Methods: Consecutive data from 418 untreated hypertensive patients were analyzed retrospectively. We examined the association between the 24-hour ambulatory BP monitoring (ABPM) parameters and AASI. Results: AASI had a simple correlation with age (R=0.189, p<0.001), relative wall thickness (RWT) (R=0.115, p=0.019), left ventricular mass index (LVMI) (R=0.192, p<0.001), average systolic BP (SBP) (R=0.232, p<0.001), average pulse pressure (PP) (R=0.363, p<0.001), SD of diastolic BP (DBP) (R=-0.352,p<0.001), SD of PP (R=0.330, p<0.001), SD of heart rate (HR) (R=-0.268, p<0.001), and nocturnal dipping (R=-0.137, p=0.005). In multiple linear regression analysis model including clinical parameters and 24 hour-ABPM parameters, independent predictors of AASI were SD of PP (beta=1.246, p<0.001), SD of DBP (beta=-1.067, p<0.001), SD of SBP (beta=-0.197, p<0.001), and non-dipper (beta=0.054, p=0.033). Conclusion: AASI is closely correlated with BP variability. The result of this study shows that AASI is not only a parameter for arterial stiffness, but also a parameter for BP variability.
C1 [Lee, Hyung Tak; Lim, Young-Hyo; Kim, Bae Keun; Lee, Kang Won; Lee, Jae Ung; Kim, Kyung Soo; Kim, Soon Gil; Kim, Jeong Hyun; Lim, Heon Kil; Shin, Jinho] Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 133792, South Korea.
   [Kim, Yu-Mi] Dong A Univ, Coll Med, Dept Prevent Med, Pusan, South Korea.
RP Shin, J (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, 17 Haengdang Dong, Seoul 133792, South Korea.
EM jhs2003@hanyang.ac.kr
OI Shin, Jinho/0000-0001-6706-6504
CR Abate G, 1997, AGING-CLIN EXP RES, V9, P408, DOI 10.1007/BF03339622
   Akselrod S, 2000, PHYSIOL MEAS, V21, P319, DOI 10.1088/0967-3334/21/2/311
   Baumann M, 2008, J HYPERTENS, V26, P210, DOI 10.1097/HJH.0b013e3282f25b6e
   DANIELS SR, 1995, AM J CARDIOL, V76, P699, DOI 10.1016/S0002-9149(99)80200-8
   DARNE B, 1989, HYPERTENSION, V13, P392, DOI 10.1161/01.HYP.13.4.392
   Dart AM, 2001, J AM COLL CARDIOL, V37, P975, DOI 10.1016/S0735-1097(01)01108-1
   DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z
   DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X
   Dolan E, 2006, BLOOD PRESS MONIT, V11, P103, DOI 10.1097/01.mbp.0000200478.19046.dd
   Dolan E, 2006, HYPERTENSION, V47, P365, DOI 10.1161/01.HYP.0000200699.74641.c5
   FRATTOLA A, 1993, J HYPERTENS, V11, P1133, DOI 10.1097/00004872-199310000-00019
   GIRERD X, 1991, AM HEART J, V122, P1210, DOI 10.1016/0002-8703(91)90941-A
   Gkaliagkousi E, 2009, HIPPOKRATIA, V13, P70
   GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079
   Hansen TW, 2006, J HYPERTENS, V24, P2247, DOI 10.1097/01.hjh.0000249703.57478.78
   이병현, 2005, Korean Circulation Journal, V35, P525
   Khattar RS, 1997, J HYPERTENS, V15, P737, DOI 10.1097/00004872-199715070-00005
   Kikuya M, 2000, HYPERTENSION, V36, P901, DOI 10.1161/01.HYP.36.5.901
   Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620
   KOHARA K, 1995, HYPERTENSION, V26, P808, DOI 10.1161/01.HYP.26.5.808
   Li Y, 2006, HYPERTENSION, V47, P359, DOI 10.1161/01.HYP.0000200695.34024.4c
   신진호, 2005, Korean Circulation Journal, V35, P683
   Mancia G, 2001, J HYPERTENS, V19, P1981, DOI 10.1097/00004872-200111000-00008
   Muscholl MW, 1998, BMJ-BRIT MED J, V317, P565, DOI 10.1136/bmj.317.7158.565
   PANNIER B, 1989, J HYPERTENS, V7, P127
   Park JS, 2004, KOREAN CIRC J, V34, P142
   Roman MJ, 2000, HYPERTENSION, V36, P489, DOI 10.1161/01.HYP.36.4.489
   Schillaci G, 2007, HYPERTENSION, V49, P986, DOI 10.1161/HYPERTENSIONAHA.106.082248
NR 28
TC 21
Z9 25
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2011
VL 41
IS 5
BP 235
EP 240
DI 10.4070/kcj.2011.41.5.235
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HX
UT WOS:000209078600003
PM 21731563
OA Green Published
DA 2021-04-22
ER

PT J
AU Lim, KS
   Hong, YJ
   Hachinohe, D
   Ahmed, K
   Jeong, MH
   Kim, JH
   Sim, DS
   Lee, MG
   Park, KH
   Kim, JH
   Ahn, Y
   Cho, JG
   Park, JC
   Song, SJ
   Jung, KW
   Cho, DL
   Kang, JC
AF Lim, Kyung Seob
   Hong, Young Joon
   Hachinohe, Daisuke
   Ahmed, Khurshid
   Jeong, Myung Ho
   Kim, Jung Ha
   Sim, Doo Sun
   Lee, Min Goo
   Park, Keun-Ho
   Kim, Ju Han
   Ahn, Youngkeun
   Cho, Jeong Gwan
   Park, Jong Chun
   Song, Sun-Jung
   Jung, Kyoung Woon
   Cho, Dong Lyun
   Kang, Jung Chaee
TI Effect of a Dual Drug-Coated Stent With Abciximab and Alpha-Lipoic Acid
   in a Porcine Coronary Restenosis Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Drug-coated stents; Coronary restenosis; Platelet aggregation
   inhibitors; Antioxidants
ID INTIMAL HYPERPLASIA; ANGIOPLASTY; ANTIOXIDANT; BLOCKADE; HEPARIN; TRIAL
AB Background and Objectives: The aim of this study was to examine the anti-proliferative and anti-inflammatory effects of a stent coated with abciximab and alpha-lipoic acid (ALA) in a porcine coronary overstretch restenosis model. Materials and Methods: A total of 10 pigs were randomized into two groups (10 pigs, 10 coronaries in each group) in which the coronary arteries were stented with a dual-coated stent and a bare metal stent (control) by randomization. Stents were deployed with oversizing (stent/artery ratio 1.3 : 1) in the porcine coronary arteries, and histopathology was assessed 28 days after stenting. Results: There was no significant difference in the injury score between the two groups. In the neointima, the lymphohistiocyte count was significantly lower in dual-coat stent group compared with the control stent group (120 +/- 85 cells vs. 159 +/- 80 cells, p=0.048). There was no significant difference in the fibrin score between the two groups (0.16 +/- 0.34 in the dual-coated stent group vs. 0.25 +/- 0.48 in the control stent group, p=0.446). The neointima area was not significantly different between both groups (1.55 +/- 0.8 mm(2) in dual-coated stent group vs. 1.40 +/- 0.86 mm(2) in the control stent group, p=0.447). Conclusion: Although the dual-coated stent with abciximab and ALA showed no significant difference in inhibition of neointimal hyperplasia when compared with the bare metal stent, it was associated with a reduced inflammatory reaction when compared with the control stent in a porcine coronary restenosis model.
C1 [Lim, Kyung Seob; Hong, Young Joon; Hachinohe, Daisuke; Ahmed, Khurshid; Jeong, Myung Ho; Kim, Jung Ha; Sim, Doo Sun; Lee, Min Goo; Park, Keun-Ho; Kim, Ju Han; Ahn, Youngkeun; Cho, Jeong Gwan; Park, Jong Chun; Kang, Jung Chaee] Chonnam Natl Univ Hosp, Korea Minist Hlth & Welf, Heart Res Ctr, Kwangju 501757, South Korea.
   [Song, Sun-Jung; Jung, Kyoung Woon; Cho, Dong Lyun] Chonnam Natl Univ, Ctr Funct Nano Fine Chem, Kwangju, South Korea.
   [Song, Sun-Jung; Jung, Kyoung Woon; Cho, Dong Lyun] Chonnam Natl Univ, Sch Appl Chem Engn, Kwangju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Korea Minist Hlth & Welf, Heart Res Ctr, 671 Jaebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
FU Korea Ministry of Knowledge and EconomyMinistry of Knowledge Economy,
   Republic of Korea [10030039]
FX This work was supported by a Grant-in-Aid for Strategy Technology
   Development Programs (No. 10030039) from the Korea Ministry of Knowledge
   and Economy.
CR Ahn YK, 1999, CATHETER CARDIO INTE, V48, P324, DOI 10.1002/(SICI)1522-726X(199911)48:3<324::AID-CCD20>3.0.CO;2-K
   AUSTIN GE, 1985, J AM COLL CARDIOL, V6, P369, DOI 10.1016/S0735-1097(85)80174-1
   Bae Y, 1998, KOREAN CIRC J, V28, P89
   Eeckhout E, 1999, EUR HEART J, V20, P1014, DOI 10.1053/euhj.1998.1395
   FAXON DP, 1994, CIRCULATION, V90, P908, DOI 10.1161/01.CIR.90.2.908
   FORRESTER JS, 1991, J AM COLL CARDIOL, V17, P758, DOI 10.1016/S0735-1097(10)80196-2
   GIRALDO AA, 1985, ARCH PATHOL LAB MED, V109, P173
   HAMM CW, 1994, NEW ENGL J MED, V331, P1037, DOI 10.1056/NEJM199410203311601
   Hong YJ, 2005, CIRC J, V69, P1477, DOI 10.1253/circj.69.1477
   Hong YJ, 2004, AM J CARDIOL, V94, P1050, DOI 10.1016/j.amjcard.2004.06.066
   Hong YJ, 2005, KOREAN CIRC J, V35, P290
   박옥영, 2003, Korean Circulation Journal, V33, P439
   Kang KT, 2001, KOREAN J MED, V60, P314
   KENT KM, 1984, AM J CARDIOL, V53, pC27, DOI 10.1016/0002-9149(84)90741-0
   박옥영, 2003, Korean Circulation Journal, V33, P121
   Kim W, 2006, J AM COLL CARDIOL, V47, P933, DOI 10.1016/j.jacc.2005.10.054
   Kolodgie FD, 2002, CIRCULATION, V106, P1195, DOI 10.1161/01.CIR.0000032141.31476.15
   Lefkovits J, 1996, AM J CARDIOL, V77, P1045, DOI 10.1016/S0002-9149(96)00128-2
   Lim SY, 2009, J CARDIOL, V54, P375, DOI 10.1016/j.jjcc.2009.06.005
   Lincoff AM, 2000, AM HEART J, V139, pS46, DOI 10.1067/mhj.2000.103743
   Packer L, 1997, Adv Pharmacol, V38, P79
   PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R
   Schwartz RS, 2008, CIRC-CARDIOVASC INTE, V1, P143, DOI 10.1161/CIRCINTERVENTIONS.108.789974
   SCHWARTZ RS, 1992, J AM COLL CARDIOL, V19, P267, DOI 10.1016/0735-1097(92)90476-4
   Simoons ML, 1997, LANCET, V349, P1429
   Song SJ, 2009, J MATER CHEM, V19, P8135, DOI 10.1039/b910351a
   Sung MJ, 2005, CIRC RES, V97, P880, DOI 10.1161/01.RES.0000186522.89544.4D
   Topol EJ, 1997, JAMA-J AM MED ASSOC, V278, P479, DOI 10.1001/jama.278.6.479
   Topol EJ, 1997, NEW ENGL J MED, V336, P1689
   Ziegler D, 1999, DIABETES CARE, V22, P1296, DOI 10.2337/diacare.22.8.1296
NR 30
TC 9
Z9 10
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2011
VL 41
IS 5
BP 241
EP 247
DI 10.4070/kcj.2011.41.5.241
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HX
UT WOS:000209078600004
PM 21731564
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, MS
   Oh, YS
   Jang, SW
   Kim, JH
   Shin, WS
   Youn, HJ
   Jung, WS
   Lee, MY
   Seong, KB
AF Choi, Min Seok
   Oh, Yong-Seog
   Jang, Sung Won
   Kim, Ji Hoon
   Shin, Woo Seung
   Youn, Ho-Joong
   Jung, Wook Sung
   Lee, Man Young
   Seong, Ki Bae
TI Comparison of Magnetic Navigation System and Conventional Method in
   Catheter Ablation of Atrial Fibrillation: Is Magnetic Navigation System
   Is More Effective and Safer Than Conventional Method?
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation
AB Background and Objectives: Although there have been so many reports of catheter ablation of atrial fibrillation (AF) with magnetic navigation system (MNS), it is not necessarily obvious that MNS is more effective than conventional ablation. We performed AF ablation with MNS and compared the clinical outcomes and radiofrequency ablation parameters with those of conventional ablation. Subjects and Methods: One hundred eleven consecutive patients (conventional group, n=70 vs. MNS group, n=41) undergoing catheter ablation of AF were enrolled. We compared and analyzed the procedural parameters, namely fluoroscopic time, procedural time, acute procedural success and 3 months success rate of both groups. Results: The MNS group was associated with slightly larger left atrial size (43.7 +/- 6.3 mm vs. 41.2 +/- 6.3 mm, p=0.04), significantly longer total procedure time (352 +/- 50 minutes vs. 283 +/- 75 minutes, p<0.0001), and shorter total fluoroscopic time (99 +/- 28 minutes vs. 238 +/- 45 minutes, p<0.0001) than the conventional group. The MNS and conventional group did not differ with respect to acute procedural success, AF recurrence, atrial flutter/atrial tachycardia recurrence, or total arrhythmia recurrence. While no complications were observed in the MNS group, eight cases of significant pericardial effusion occurred in the conventional group. Conclusion: The MNS system seems to be effective and safe in the catheter ablation of AF, particularly in the population of patients with persistent AF and slightly dilated left atria.
C1 [Choi, Min Seok; Oh, Yong-Seog; Jang, Sung Won; Kim, Ji Hoon; Shin, Woo Seung; Youn, Ho-Joong; Jung, Wook Sung; Lee, Man Young; Seong, Ki Bae] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, Seoul 137040, South Korea.
RP Oh, YS (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Cardiol, 505 Banpo Dong, Seoul 137040, South Korea.
EM oys@catholic.ac.kr
RI Jang, Sung-Won/I-1292-2017
CR Arya A, 2008, PACE, V31, P597, DOI 10.1111/j.1540-8159.2008.01047.x
   Chun JKR, 2007, EUR HEART J, V28, P190, DOI 10.1093/eurheartj/ehl447
   Dagres N, 2009, J CARDIOVASC ELECTR, V20, P1014, DOI 10.1111/j.1540-8167.2009.01493.x
   Di Blase L, 2007, J AM COLL CARDIOL, V50, P868, DOI 10.1016/j.jacc.2007.05.023
   Ernst S, 2004, CIRCULATION, V109, P1472, DOI 10.1161/01.CIR.0000125126.83579.1B
   Kim AM, 2008, PACE, V31, P1399, DOI 10.1111/j.1540-8159.2008.01202.x
   Pappone C, 2006, J AM COLL CARDIOL, V47, P1390, DOI 10.1016/j.jacc.2005.11.058
   Thornton AS, 2006, HEART RHYTHM, V3, P691, DOI 10.1016/j.hrthm.2006.01.028
NR 8
TC 19
Z9 20
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2011
VL 41
IS 5
BP 248
EP 252
DI 10.4070/kcj.2011.41.5.248
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HX
UT WOS:000209078600005
PM 21731565
OA Green Published
DA 2021-04-22
ER

PT J
AU Oh, MS
   Min, YJ
   Kwon, JE
   Cho, EJ
   Kim, JE
   Lee, WS
   Lee, KJ
   Kim, SW
   Kim, TH
   Kim, CJ
   Ryu, WS
AF Oh, Min Seok
   Min, Yun Joo
   Kwon, Jee Eun
   Cho, Eun Jeong
   Kim, Jung Eun
   Lee, Wang-Soo
   Lee, Kwang Je
   Kim, Sang-Wook
   Kim, Tae Ho
   Kim, Chee Jeong
   Ryu, Wang Seong
TI Effects of Ezetimibe Added to Ongoing Statin Therapy on C-Reactive
   Protein Levels in Hypercholesterolemic Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE C-reactive protein; Azetidines; HMG CoA reductase inhibitor; Lipid;
   Lipoproteins
ID DENSITY-LIPOPROTEIN CHOLESTEROL; ENDOTHELIAL FUNCTION; ABSORPTION
   INHIBITOR; DOUBLE-BLIND; ADD-ON; ATORVASTATIN; SIMVASTATIN; EFFICACY;
   SAFETY; DISEASE
AB Background and Objectives: Ezetimibe alone does not decrease C-reactive protein (CRP) levels in hypercholesterolemic patients. However, several reports have suggested that ezetimibe might potentiate the effect of statin not only on cholesterol but also on CRP when administered together. We investigated the effect of ezetimibe on CRP levels in patients taking statins. Subjects and Methods: Patients who had not achieved recommended low density lipoprotein-cholesterol (LDL-C) goals with statin therapy were divided into two groups, the ezetimibe group (n=60) and the control group (n=60). A third group of hypercholesterolemic patients without statin therapy was treated with statin (n=59). Patients with CRP level 10 mg/L were excluded. Lipid and CRP levels were measured before therapy commenced, and after 2 months of therapy. Results: Ezetimibe decreased cholesterol and LDL-C levels by 20.2% (p=0.000) and 28.1% (p=0.000) respectively. However, ezetimibe did not reduce CRP levels (from 0.83 +/- 0.68 to 1.14 +/- 1.21 mg/dL, p=0.11). CRP levels remained unchanged in the control group (p=0.42). In contrast, statin lowered CRP levels (from 0.82 +/- 0.73 to 0.65 +/- 0.57 mg/dL, p=0.008). In patients taking statins, changes in CRP levels were not associated with changes in LDL-C (r=-0.02, p=0.87), but with baseline CRP levels (r=-0.38, p=0.000). Conclusion: Ezetimibe failed to reduce CRP levels in hypercholesterolemic patients taking statins despite significant reduction of LDL-C. This finding suggests that the anti-inflammatory effect of statin may not be secondary to cholesterol reduction, but via other mechanisms.
C1 [Oh, Min Seok; Min, Yun Joo; Kwon, Jee Eun; Cho, Eun Jeong; Kim, Jung Eun; Lee, Wang-Soo; Lee, Kwang Je; Kim, Sang-Wook; Kim, Tae Ho; Kim, Chee Jeong; Ryu, Wang Seong] Chung Ang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 156070, South Korea.
RP Kim, CJ (corresponding author), Chung Ang Univ, Coll Med, Dept Internal Med, Div Cardiol, 224-1 Heukseok Dong, Seoul 156070, South Korea.
EM cjkim@cau.ac.kr
FU Chung-Ang University
FX This Research was supported by the Chung-Ang University Research Grants
   in 2009.
CR Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1
   Ballantyne CM, 2005, AM HEART J, V149, P464, DOI 10.1016/j.ahj.2004.11.023
   Ballantyne CM, 2003, CIRCULATION, V107, P2409, DOI 10.1161/01.CIR.0000068312.21969.C8
   Bays HE, 2004, CLIN THER, V26, P1758, DOI 10.1016/j.clinthera.2004.11.016
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Conard SE, 2008, AM J CARDIOL, V102, P1489, DOI 10.1016/j.amjcard.2008.09.075
   Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a
   Dujovne CA, 2002, AM J CARDIOL, V90, P1092, DOI 10.1016/S0002-9149(02)02798-4
   Fichtlscherer S, 2006, EUR HEART J, V27, P1182, DOI 10.1093/eurheartj/ehi881
   Forrester JS, 2007, AM J CARDIOL, V99, P732, DOI 10.1016/j.amjcard.2006.09.125
   Gagne C, 2002, AM J CARDIOL, V90, P1084, DOI 10.1016/S0002-9149(02)02774-1
   Kim CJ, 2006, J CARDIOVASC PHARM, V47, P758
   정갑성, 2004, Korean Circulation Journal, V34, P381
   Knopp RH, 2003, EUR HEART J, V24, P729, DOI 10.1016/S0195-668X(02)00807-2
   Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963
   Landmesser U, 2005, CIRCULATION, V111, P2356, DOI 10.1161/01.CIR.0000164260.82417.3F
   Libby P, 2001, CIRCULATION, V104, P365
   Liu PY, 2009, CIRCULATION, V119, P131, DOI 10.1161/CIRCULATIONAHA.108.813311
   McFarlane SI, 2002, J CLIN ENDOCR METAB, V87, P1451, DOI 10.1210/jc.87.4.1451
   Pearson TA, 2005, MAYO CLIN PROC, V80, P587, DOI 10.4065/80.5.587
   Pearson T, 2007, AM J CARDIOL, V99, P1706, DOI 10.1016/j.amjcard.2007.01.062
   Pearson TA, 2006, MAYO CLIN PROC, V81, P1177, DOI 10.4065/81.9.1177
   Pearson TA, 2009, AM J CARDIOL, V103, P369, DOI 10.1016/j.amjcard.2008.09.090
   Piorkowski M, 2007, J AM COLL CARDIOL, V49, P1035, DOI 10.1016/j.jacc.2006.10.064
   Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646
   Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C
   Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Sager PT, 2003, AM J CARDIOL, V92, P1414, DOI 10.1016/j.amjcard.2003.08.048
   김치정, 2006, Korean Circulation Journal, V36, P77
NR 30
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2011
VL 41
IS 5
BP 253
EP 258
DI 10.4070/kcj.2011.41.5.253
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HX
UT WOS:000209078600006
PM 21731566
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, EM
   Hwang, SY
   Kim, AL
AF Kim, Eun Mi
   Hwang, Seon Young
   Kim, Ae Lee
TI Knowledge of Stroke and Heart Attack Symptoms and Risk Factors Among
   Rural Elderly People: A Questionnaire Survey
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Cardiovascular diseases; Aged; Signs and symptoms; Risk factors;
   Knowledge
ID MYOCARDIAL-INFARCTION; KOREAN IMMIGRANTS; RECOGNITION; REGISTRY; SIGNS
AB Background and Objectives: To determine the level of knowledge of stroke and heart attack (HA) symptoms and risk factors of cardiovascular disease (CVD) in rural elderly people who are at risk for CVD. Subjects and Methods: A total of 444 adults over the age of 60 living in a rural province of Korea with at least one CVD risk factor participated in this survey. Results: A total of 72.5% of the participants had hypertension and 28.4% had diabetes, whereas approximately 40% exhibited over two CVD risk factors. The mean knowledge scores for HA symptoms (4.3/9) were lower than scores for stroke symptoms (5.8/9), and the mean knowledge score for risk factors was 7.3/11. Stepwise multiple regression analyses showed that old age, low level of education, and low income level were the determining factors for low knowledge levels of stroke and HA symptoms as well as CVD risk factors. A low perceived risk of stroke or HAs also predicted a low knowledge of CVD risk factors. Conclusion: Community-wide public campaigns are needed, which are designed to help elderly people in rural areas with low education levels and socioeconomic status at risk for CVD to improve the awareness of stroke and HA.
C1 [Kim, Eun Mi] Chunnam Techno Coll, Dept Nursing, Gokseong, South Korea.
   [Hwang, Seon Young] Chosun Univ, Dept Nursing, Kwangju 501759, South Korea.
   [Kim, Ae Lee] Sungshin Womens Univ, Coll Nursing, Seoul, South Korea.
RP Hwang, SY (corresponding author), Chosun Univ, Dept Nursing, 375 Seoseok Dong, Kwangju 501759, South Korea.
EM seon9772@chosun.ac.kr
CR Assali AR, 2003, CATHETER CARDIO INTE, V59, P195, DOI 10.1002/ccd.10532
   Bell M, 2009, PREV CHRONIC DIS, V6
   Blades Lynda L, 2005, Prev Chronic Dis, V2, pA14
   Brieger D, 2004, CHEST, V126, P461, DOI 10.1378/chest.126.2.461
   Canto JG, 2000, JAMA-J AM MED ASSOC, V283, P3223, DOI 10.1001/jama.283.24.3223
   Greenlund KJ, 2004, AM HEART J, V147, P1010, DOI 10.1016/j.ahj.2003.12.036
   Harwell TS, 2005, PREV MED, V41, P791, DOI 10.1016/j.ypmed.2005.07.003
   HO RHA JOUNG, 2008, [Korean Journal of Stroke, 대한뇌졸중학회지], V10, P1
   유경호, 2006, [Journal of the Korean Neurological Association, 대한신경과학회지], V24, P535
   Hwang SY, 2006, RES NURS HEALTH, V29, P337, DOI 10.1002/nur.20144
   Hwang SY, 2008, J IMMIGR MINOR HEALT, V10, P67, DOI 10.1007/s10903-007-9053-y
   Kim CJ, 1999, J KOREAN ACAD ADULT, V11, P288
   Kim JS, 1997, STROKE, V28, P1165, DOI 10.1161/01.STR.28.6.1165
   Korea National Health Insurance Corporation, 2008, NAT HLTH INS STAT YB
   Korea Statistical Information Service, 2005, CAUS DEATH STAT 2005
   Ku IH, 2006, INCOME DISPARITY POV
   Lutfiyya MN, 2008, J NATL MED ASSOC, V100, P1116
   Moser DK, 2006, CIRCULATION, V114, P168, DOI 10.1161/CIRCULATIONAHA.106.176040
   Nicol MB, 2005, VASC HEALTH RISK MAN, V1, P137, DOI 10.2147/vhrm.1.2.137.64085
   Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998
   Schuler J, 2006, CLIN RES CARDIOL, V95, P360, DOI 10.1007/s00392-006-0393-8
   Seok JH, 1997, KOREAN CIRC J, V27, P386
   Sim Doo Sun, 2009, Korean Circ J, V39, P297, DOI 10.4070/kcj.2009.39.8.297
   한남이, 2009, [Korean Journal of Adult Nursing, 성인간호학회지], V21, P314
NR 24
TC 14
Z9 16
U1 1
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2011
VL 41
IS 5
BP 259
EP 264
DI 10.4070/kcj.2011.41.5.259
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HX
UT WOS:000209078600007
PM 21731567
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, HJ
   Hur, SH
AF Yoon, Hyuck-Jun
   Hur, Seung-Ho
TI Determination of Safe Contrast Media Dosage to Estimated Glomerular
   Filtration Rate Ratios to Avoid Contrast-Induced Nephropathy After
   Elective Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Contrast media; Angiography; Acute kidney injury; Effect of drugs
ID CREATININE CLEARANCE RATIO; ACUTE-RENAL-FAILURE; PREDICTION;
   NEPHROTOXICITY; METAANALYSIS; VOLUME; GFR
AB Background and Objectives: To avoid the risk of developing contrast-induced nephropathy (CIN), it has been suggested that patients be subjected to a minimal necessary dose of contrast medium (CM-dose). However, often it is not easy to determine such a dose. This study assessed the usefulness of the ratio of CM-dose to estimated glomerular filtration rate (eGFR) in predicting the risks of CIN and sought to determine the safe level of CM-dose/eGFR in patients undergoing non-emergent percutaneous coronary intervention (PCI). Subjects and Methods: We enrolled a total of 226 patients and calculated the ratio of CM-dose using grams of iodine (g-I) to eGFR, thus expressing it as g-I/eGFR. Among the CIN patients, those with nephropathy requiring dialysis (NRD) were also evaluated. Results: Overall, there were 16 cases (7.1%) of CIN. On univariate and multivariate regression analysis, g-I/eGFR alone was found to be an independent predictor for CIN (hazard ratio=10.73, p<0.001). In an receiver operating characteristic analysis, fair discrimination for CIN was found at a g-I/eGFR level of 1.42 (C statics=0.867), and at this value, the sensitivity and specificity were 81.3% and 80%, respectively. Of patients (n=51) with g-I/eGFR >= 1.42, 23.6% (13/51) and 7.8% (4/51) developed, while those with g-I/eGFR <1.42 (n=171) had a lower incidences of CIN (1.8%, 2/171, p<0.001) and NRD (0%, 0/171, p<0.001). Conclusion: It can be concluded that a g-I/eGFR <1.42 is a simple, useful indicator for determining the safe CM-dose based on the pre-PCI eGFR values. Furthermore, g-I/eGFR might have a close relationship with the development of NRD as well as CIN.
C1 [Yoon, Hyuck-Jun; Hur, Seung-Ho] Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Devis Cardiol, Taegu 700712, South Korea.
RP Hur, SH (corresponding author), Keimyung Univ, Dongsan Med Ctr, Dept Internal Med, Devis Cardiol, 194 Dongsan Dong, Taegu 700712, South Korea.
EM shur@dsmc.or.kr
RI Demchuk, Andrew M/E-1103-2012
OI Demchuk, Andrew M/0000-0002-4930-7789; Hur, Seung-Ho/0000-0002-3895-1915
CR Altmann DB, 1997, J INTERV CARDIOL, V10, P113, DOI 10.1111/j.1540-8183.1997.tb00018.x
   Aspelin P, 2003, NEW ENGL J MED, V348, P491, DOI 10.1056/NEJMoa021833
   BARRETT BJ, 1993, RADIOLOGY, V188, P171, DOI 10.1148/radiology.188.1.8511292
   Bartholomew BA, 2004, AM J CARDIOL, V93, P1515, DOI 10.1016/j.amjcard.2004.03.008
   Carraro M, 1998, EUR RADIOL, V8, P144, DOI 10.1007/s003300050356
   CIGARROA RG, 1989, AM J MED, V86, P649, DOI 10.1016/0002-9343(89)90437-3
   COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580
   Dangas G, 2005, AM J CARDIOL, V95, P13, DOI 10.1016/j.amjcard.2004.08.056
   Davidson CJ, 2000, CIRCULATION, V101, P2172, DOI 10.1161/01.CIR.101.18.2172
   Frennby B, 2002, EUR RADIOL, V12, P475, DOI 10.1007/s003300100864
   Kelly AM, 2008, ANN INTERN MED, V148, P284, DOI 10.7326/0003-4819-148-4-200802190-00007
   Kim U, 2008, KOREAN CIRC J, V38, P301
   Laskey WK, 2007, J AM COLL CARDIOL, V50, P584, DOI 10.1016/j.jacc.2007.03.058
   Lee Kang Hyu, 2010, Korean Circ J, V40, P68, DOI 10.4070/kcj.2010.40.2.68
   LEVEY AS, 1993, J AM SOC NEPHROL, V4, P1159
   Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002
   Liss P, 2006, KIDNEY INT, V70, P1811, DOI 10.1038/sj.ki.5001887
   McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2
   McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035
   McCullough PA, 2006, AM J CARDIOL, V98, p5K, DOI 10.1016/j.amjcard.2006.01.019
   Morcos SK, 1998, BRIT J RADIOL, V71, P357, DOI 10.1259/bjr.71.844.9659127
   Murphy SW, 2000, J AM SOC NEPHROL, V11, P177
   Nyman U, 2008, ACTA RADIOL, V49, P658, DOI 10.1080/02841850802050762
   Nyman U, 2005, ACTA RADIOL, V46, P830, DOI 10.1080/02841850500335051
   PORTER GA, 1994, MINER ELECTROL METAB, V20, P232
   Rihal CS, 2002, CIRCULATION, V105, P2259, DOI 10.1161/01.CIR.0000016043.87291.33
   남궁준, 2005, Korean Circulation Journal, V35, P696
NR 27
TC 12
Z9 13
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2011
VL 41
IS 5
BP 265
EP 271
DI 10.4070/kcj.2011.41.5.265
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HX
UT WOS:000209078600008
PM 21731568
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JG
   Ryu, HJ
   Jung, YS
   Kim, KJ
   Lee, BR
   Jung, BC
   Kang, H
AF Park, Jung-Gil
   Ryu, Han-Jun
   Jung, Yeun-Su
   Kim, Ki-Ju
   Lee, Bong-Ryeol
   Jung, Byung-Chun
   Kang, Hyunjae
TI Isolated Double-Chambered Right Ventricle in a Young Adult
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart defeets, congenital; Cardiac catheterization; Echocardiography;
   Magnetic resonance imaging
AB Double-chambered right ventricle (DCRV) is a rare congenital heart disorder in which the right ventricle is divided by an anomalous muscle bundle into a high pressure inlet portion and a low pressure outlet portion. We report a case of isolated DCRV without symptoms in adulthood, diagnosed through echocardiography, cardiac catheterization and cardiac magnetic resonance imaging.
C1 [Park, Jung-Gil; Ryu, Han-Jun; Jung, Yeun-Su; Kim, Ki-Ju; Lee, Bong-Ryeol; Jung, Byung-Chun; Kang, Hyunjae] Daegu Fatima Hosp, Dept Internal Med, Taegu 701600, South Korea.
RP Kang, H (corresponding author), Daegu Fatima Hosp, Dept Cardiol, 183 Ayang Ro, Taegu 701600, South Korea.
EM tangul8845@hanmail.net
RI Park, Jung Gil/AAK-5167-2020
OI Park, Jung Gil/0000-0001-5472-4731
CR Atai M. R., 2009, KOREAN CIRC J, V4, P115
   Chang R Y, 1996, J Am Soc Echocardiogr, V9, P347, DOI 10.1016/S0894-7317(96)90151-0
   Choi Yu Jeong, 2010, Korean Journal of Internal Medicine, V25, P147, DOI 10.3904/kjim.2010.25.2.147
   CIL E, 1995, INT J CARDIOL, V50, P19
   Fahim M., 2009, KOREAN CIRC J, V1, P27, DOI DOI 10.4070/KCJ.2008.38.1.60
   Galal O, 2000, CAN J CARDIOL, V16, P167
   Galiuto L, 1996, J Am Soc Echocardiogr, V9, P300, DOI 10.1016/S0894-7317(96)90144-3
   Hachiro Y, 2001, ANN THORAC SURG, V72, P1520, DOI 10.1016/S0003-4975(01)02982-4
   Hoffman P, 2004, HEART, V90, P789, DOI 10.1136/hrt.2003.017137
   McElhinney DB, 2000, ANN THORAC SURG, V70, P124, DOI 10.1016/S0003-4975(00)01320-5
   NISHIMURA RA, 1985, MAYO CLIN PROC, V60, P321, DOI 10.1016/S0025-6196(12)60540-0
   Sato Y, 2007, INT J CARDIOL, V119, pE14, DOI 10.1016/j.ijcard.2007.01.079
   Vieillard-Baron A, 2009, CURR OPIN CRIT CARE, V15, P254, DOI 10.1097/MCC.0b013e32832b70c9
   Yang SM, 2005, J KOREAN SOC ECHOCAR, V13, P37
NR 14
TC 6
Z9 7
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2011
VL 41
IS 5
BP 272
EP 275
DI 10.4070/kcj.2011.41.5.272
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HX
UT WOS:000209078600009
PM 21731569
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, CK
   Shin, DH
   Jang, JK
   Jang, KH
   Kim, EK
   Cheong, SS
   Yoo, SY
AF Lee, Chang Kun
   Shin, Dae-Hee
   Jang, Jin Kun
   Jang, Kyeong-Hee
   Kim, Eun-Kyoung
   Cheong, Sang-Sig
   Yoo, Sang-Yong
TI Progressive Familial Heart Block Type I in a Korean Patient
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hereditary bundle branch system defect; Atrial flutter
AB A 29-year-old man was referred to the emergency department with a complaint of abdominal pain and dizziness. He had experienced two previous syncopal episodes. His family history revealed that his mother and his two uncles had received permanent pacemaker implantation. His initial heart rate was 49 beats per minute. The electrocardiography (ECG) showed atrial flutter and right bundle branch block (RBBB) with left anterior fascicular block (LAFB). On admission, 24-hour Holter showed ventricular pause up to 16 seconds during syncope. Radio frequency catheter ablation (RFCA) of atrial flutter was performed. The ECG revealed bifascicular block (RBBB and LAFB) and first-degree atrioventricular block. He received a permanent pacemaker implantation. His brother's and his sister's ECGs also showed trifascicular block and the pedigree showed autosomal dominant inheritance. This patient was diagnosed with a progressive familial heart block (PFHB) type I. This would be the first report of a PFHB type I case documented in Korea.
C1 [Lee, Chang Kun; Shin, Dae-Hee; Jang, Jin Kun; Jang, Kyeong-Hee; Cheong, Sang-Sig; Yoo, Sang-Yong] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Div Cardiol, Kangnung, South Korea.
   [Kim, Eun-Kyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Cardiac & Vasc Ctr, Seoul, South Korea.
RP Shin, DH (corresponding author), Univ Ulsan, Coll Med, Gangneung Asan Hosp, Div Cardiol,Dept Med, 415 Bangdong Ri, Sacheon Myeon 210711, Gangneung, South Korea.
EM drshin@mail.ulsan.ac.kr
CR Bardien-Kruger S, 2002, EUR J HUM GENET, V10, P36, DOI 10.1038/sj.ejhg.5200739
   BRINK AJ, 1977, S AFR MED J, V52, P53
   Brink PA, 2009, CARDIOVASC J AFR, V20, P57
   BRINK PA, 1994, S AFR J SCI, V90, P236
   BRINK PA, 1995, CIRCULATION, V91, P1633, DOI 10.1161/01.CIR.91.6.1633
   Kim WJ, 2003, KOREAN CIRC J, V33, P1155
   VANDERMERWE PL, 1988, S AFR MED J, V73, P275
   VANDERMERWE PL, 1986, S AFR MED J, V70, P356
NR 8
TC 1
Z9 1
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2011
VL 41
IS 5
BP 276
EP 279
DI 10.4070/kcj.2011.41.5.276
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HX
UT WOS:000209078600010
PM 21731570
OA Green Published
DA 2021-04-22
ER

PT J
AU Choi, WH
   Hwang, YM
   Park, MY
   Lee, SJ
   Lee, HY
   Kim, SW
   Jun, BY
   Min, JS
   Shin, WS
   Lee, JM
   Koh, YS
   Jeon, HK
   Chung, WS
   Seung, KB
AF Choi, Woo Hyung
   Hwang, You Mi
   Park, Mi Youn
   Lee, Seung Jae
   Lee, Hye Yeon
   Kim, Sei Won
   Jun, Byoung Yeon
   Min, Jin Soo
   Shin, Woo Seung
   Lee, Jong Min
   Koh, Yoon Seok
   Jeon, Hui-Kyung
   Chung, Wook Sung
   Seung, Ki-Bae
TI Pneumopericardium as a Complication of Pericardiocentesis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pneumopericardium; Pericardiocentesis
ID DRAINAGE
AB Pneumopericardium is a rare complication of pericardiocentesis, occurring either as a result of direct pleuro-pericardial communication or a leaky drainage system. Air-fluid level surrounding the heart shadow within the pericardium on a chest X-ray is an early observation at diagnosis. This clinical measurement and process is variable, depending on the hemodynamic status of the patient. The development of a cardiac tamponade is a serious complication, necessitating prompt recognition and treatment. We recently observed a case of pneumopericardium after a therapeutic pericardiocentesis in a 20-year-old man with tuberculous pericardial effusion.
C1 [Choi, Woo Hyung; Hwang, You Mi; Park, Mi Youn; Lee, Seung Jae; Lee, Hye Yeon; Kim, Sei Won; Jun, Byoung Yeon; Min, Jin Soo; Shin, Woo Seung; Lee, Jong Min; Koh, Yoon Seok; Jeon, Hui-Kyung; Chung, Wook Sung; Seung, Ki-Bae] Catholic Univ Korea, Coll Med, Div Cardiol, Dept Internal Med, Seoul, South Korea.
RP Shin, WS (corresponding author), Catholic Univ Korea, Uijeongbu St Marys Hosp, Div Cardiol, Dept Internal Med,Coll Med, 65-1 Gumo Dong, Uijongbu 480821, South Korea.
EM medsws@catholic.ac.kr
RI Koh, Yoon-Seok/AAE-1749-2019; Min, Jinsoo/D-5181-2018
OI Min, Jinsoo/0000-0001-6091-518X
CR Arroyo M, 2008, AM J MED SCI, V335, P227, DOI 10.1097/MAJ.0b013e3180cab71a
   Brander L, 2002, Heart, V88, pe5, DOI 10.1136/heart.88.4.e5
   Buchanan CL, 2003, ANN THORAC SURG, V76, P817, DOI 10.1016/S0003-4975(03)00666-0
   Lee Young-Jung, 2001, Korean Journal of Internal Medicine, V16, P205
   Mayosi BM, 2005, CIRCULATION, V112, P3608, DOI 10.1161/CIRCULATIONAHA.105.543066
   NAUNHEIM KS, 1991, EUR J CARDIO-THORAC, V5, P99, DOI 10.1016/1010-7940(91)90007-7
   Park WH, 1982, KOREAN CIRC J, V12, P135
NR 7
TC 10
Z9 10
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2011
VL 41
IS 5
BP 280
EP 282
DI 10.4070/kcj.2011.41.5.280
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HX
UT WOS:000209078600011
PM 21731571
OA Green Published
DA 2021-04-22
ER

PT J
AU Yu, HT
   Ha, JW
   Lee, S
   Shim, CY
   Moon, J
   Cho, IJ
   Kang, MK
   Yang, WI
   Choi, D
   Chung, N
AF Yu, Hee Tae
   Ha, Jong-Won
   Lee, Sak
   Shim, Chi Young
   Moon, Jeonggeun
   Cho, In-Jeong
   Kang, Min-Kyung
   Yang, Woo-In
   Choi, Donghoon
   Chung, Namsik
TI Transient Right Ventricular Dysfunction After Pericardiectomy in
   Patients With Constrictive Pericarditis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Right ventricular dysfunction; Constrictive pericarditis;
   Pericardiectomy
AB Pericardiectomy is the standard treatment in patients with chronic constrictive pericarditis who have persistent symptoms. However, myocardial atrophy with prolonged pericardial constriction and abrupt increase in venous return can lead to heart failure with volume overload after pericardial decompression, especially in the right ventricle (RV). We experienced a 44 year old male patient who developed transient RV failure after pericardiectomy for constrictive pericarditis. Echocardiography revealed a markedly dilated RV with decreased peak systolic velocity of the tricuspid annulus, suggesting severe RV dysfunction. After treatment with inotropics and diuretics, a follow-up echocardiography revealed an improved systolic function with decreased RV chamber size. This case demonstrates the importance of volume overload and RV dysfunction in patients with constrictive pericarditis undergoing pericardiectomy.
C1 [Yu, Hee Tae; Ha, Jong-Won; Shim, Chi Young; Moon, Jeonggeun; Cho, In-Jeong; Kang, Min-Kyung; Yang, Woo-In; Choi, Donghoon; Chung, Namsik] Yonsei Univ, Coll Med, Div Cardiol, Severenace Cardiovasc Hosp, Seoul 120752, South Korea.
   [Lee, Sak] Yonsei Univ, Coll Med, Div Cardiovasc Surg, Severenace Cardiovasc Hosp, Seoul 120752, South Korea.
RP Shim, CY (corresponding author), Yonsei Univ, Coll Med, Div Cardiol, Severenace Cardiovasc Hosp, 250 Seongsan Ro, Seoul 120752, South Korea.
EM cysprs@yuhs.ac
RI Shim, Chi Young/AAK-1057-2021
OI Shim, Chi Young/0000-0002-6136-0136; Ha, Jong-Won/0000-0002-8260-2958;
   Choi, Donghoon/0000-0002-2009-9760; Lee, Sak/0000-0001-6130-2342
CR Anguera I, 1997, INT J CARDIOL, V59, P212, DOI 10.1016/S0167-5273(97)02918-5
   BASHI VV, 1988, THORAX, V43, P637, DOI 10.1136/thx.43.8.637
   DINES DE, 1958, P STAFF M MAYO CLIN, V33, P93
   Geffroy A, 2004, CAN J ANAESTH, V51, P482, DOI 10.1007/BF03018312
   Ha CB, 1989, KOREAN CIRC J, V19, P47
   Ha JW, 2001, CIRCULATION, V104, P976, DOI 10.1161/hc3401.095705
   Nishimura RA, 2001, HEART, V86, P619, DOI 10.1136/heart.86.6.619
   PAYVANDI MN, 1976, CIRCULATION, V53, P86, DOI 10.1161/01.CIR.53.1.86
   Talreja DR, 2003, CIRCULATION, V108, P1852, DOI 10.1161/01.CIR.0000087606.18453.FD
   VIOLA AR, 1973, CIRCULATION, V48, P1038, DOI 10.1161/01.CIR.48.5.1038
NR 10
TC 8
Z9 8
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAY
PY 2011
VL 41
IS 5
BP 283
EP 286
DI 10.4070/kcj.2011.41.5.283
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HX
UT WOS:000209078600012
PM 21731572
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, HM
   Truong, ST
   Wong, ND
AF Lee, Hwa Mu
   Truong, Steven T.
   Wong, Nathan D.
TI Evidence of Lung Function for Stratification of Cardiovascular Disease
   Risk
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Respiratory function test
ID C-REACTIVE PROTEIN; OBSTRUCTIVE PULMONARY-DISEASE; SYSTEMIC
   INFLAMMATION; FUNCTION DECLINE; GENERAL-POPULATION; VITAL CAPACITY;
   MORTALITY; ASSOCIATION; PREDICTOR; STATINS
AB Among adults in the United States, the prevalence of reduced lung function including obstructive and restrictive lung disease is about 20%, representing an over 40 million adults. Persons with reduced lung function often demonstrate chronic systemic inflammation, such as from elevated levels of C-reactive protein. Substantial data suggests that inflammation may have a significant role in the association between reduced lung function and cardiovascular disease (CVD); however, how reduced lung function predicts CVD as risk modification remains largely unknown. Poor lung function has been shown to be a better predictor of all-cause and cardiac-specific mortality than established risk factors such as serum cholesterol, and CVD is the leading cause of mortality among those with impaired lung function. The exact mechanism of atherosclerosis is not clear, but persistent low grade inflammation is considered as one of the culprits in clot formation. The initial presentation of coronary heart disease is either myocardial infarction or sudden death in approximately half of the individuals. Unfortunately, conventional risk factor assessment predicts only 65-80% of future cardiovascular events, leaving many middle-aged and older individuals to manifest a major cardiovascular event despite being classified low risk by the Framingham risk estimates.
C1 [Lee, Hwa Mu; Truong, Steven T.; Wong, Nathan D.] Univ Calif Irvine, Dept Med, Div Cardiol, Heart Dis Prevent Program, Irvine, CA 92717 USA.
   [Lee, Hwa Mu] Univ Calif Irvine, Dept Med, Div Pulm Med, Irvine, CA 92717 USA.
RP Lee, HM (corresponding author), Univ Calif Irvine, Dept Med, Div Cardiol, Heart Dis Prevent Program, Irvine, CA 92717 USA.
EM leehwamumd@gmail.com
CR BEATY TH, 1985, J CHRON DIS, V38, P703, DOI 10.1016/0021-9681(85)90024-4
   BERK BC, 1990, AM J CARDIOL, V65, P168, DOI 10.1016/0002-9149(90)90079-G
   Curb J. David, 1990, Annals of Epidemiology, V1, P25
   D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579
   Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D
   Fogarty AW, 2007, THORAX, V62, P515, DOI 10.1136/thx.2006.066969
   Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997
   Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588
   Gluckman TJ, 2004, ARCH INTERN MED, V164, P1490, DOI 10.1001/archinte.164.14.1490
   Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001
   Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001
   Hancox RJ, 2007, THORAX, V62, P1064, DOI 10.1136/thx.2006.076877
   HIGGINS MW, 1970, ARCH ENVIRON HEALTH, V21, P418, DOI 10.1080/00039896.1970.10667260
   Hole DJ, 1996, BRIT MED J, V313, P711
   Janda S, 2009, CHEST, V136, P734, DOI 10.1378/chest.09-0194
   Jiang R, 2008, AM J EPIDEMIOL, V168, P602, DOI 10.1093/aje/kwn174
   KANNEL WB, 1983, AM HEART J, V105, P311, DOI 10.1016/0002-8703(83)90532-X
   Keddissi JI, 2007, CHEST, V132, P1764, DOI 10.1378/chest.07-0298
   LANGE P, 1990, J CLIN EPIDEMIOL, V43, P867, DOI 10.1016/0895-4356(90)90070-6
   Lee HM, 2010, EUR RESPIR J, V36, P1002, DOI 10.1183/09031936.00042410
   Lee HM, 2008, DIABETES CARE, V31, P2000, DOI 10.2337/dc08-0801
   Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323
   Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039
   Mannino DM, 2006, THORAX, V61, P472, DOI 10.1136/thx.2005.052449
   Mannino DM, 2006, AM J RESP CRIT CARE, V173, P985, DOI 10.1164/rccm.200508-1344OC
   Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2
   MARCUS EB, 1989, AM J EPIDEMIOL, V129, P97, DOI 10.1093/oxfordjournals.aje.a115128
   Nilsson J, 2005, ARTERIOSCL THROM VAS, V25, P1527, DOI 10.1161/01.ATV.0000174796.81443.3f
   Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C
   Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276
   Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656
   Scirica BM, 2006, CIRCULATION, V113, P2128, DOI 10.1161/CIRCULATIONAHA.105.611350
   Shaaban R, 2006, RESP MED, V100, P2112, DOI 10.1016/j.rmed.2006.03.027
   Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3
   Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952
   Soyseth V, 2007, EUR RESPIR J, V29, P279, DOI 10.1183/09031936.00106406
   Thompson Jason B, 2006, Curr Cardiol Rep, V8, P261, DOI 10.1007/s11886-006-0056-4
   Thyagarajan B, 2006, INT J EPIDEMIOL, V35, P1001, DOI 10.1093/ije/dyl049
   TOCKMAN MS, 1989, AM REV RESPIR DIS, V140, pS56, DOI 10.1164/ajrccm/140.3_Pt_2.S56
   Wilson PWF, 2008, CIRC-CARDIOVASC QUAL, V1, P92, DOI 10.1161/CIRCOUTCOMES.108.831198
   Wilson PW, 2003, J AM COLL CARDIOL, V41, p267A
NR 41
TC 8
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2011
VL 41
IS 4
BP 171
EP 174
DI 10.4070/kcj.2011.41.4.171
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HW
UT WOS:000209078500001
PM 21607165
OA Green Published
DA 2021-04-22
ER

PT J
AU Ihm, SH
AF Ihm, Sang-Hyun
TI Non-Dipper and Inappropriate Left Ventricular Mass in Hypertensive
   Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Ihm, Sang-Hyun] Catholic Univ Korea, Dept Internal Med, Coll Med, Div Cardiol, Puchon 420717, South Korea.
RP Ihm, SH (corresponding author), Catholic Univ Korea, Bucheon St Mary Hosp, Coll Med, Div Cardiol,Dept Internal Med, 2 Sosa Dong, Puchon 420717, South Korea.
EM limsh@catholic.ac.kr
OI Ihm, Sang Hyun/0000-0001-5017-5421
CR Chinali M, 2007, J HYPERTENS, V25, P1073, DOI 10.1097/HJH.0b013e32803fb60c
   de la Sierra A, 2009, HYPERTENSION, V53, P466, DOI 10.1161/HYPERTENSIONAHA.108.124008
   Diez J, 2008, HYPERTENSION, V52, P462, DOI 10.1161/HYPERTENSIONAHA.108.117044
   Kim BK, 2011, KOREAN CIRC J, V41, P191, DOI 10.4070/kcj.2011.41.4.191
   Kimura G, 2008, HYPERTENSION, V51, P827, DOI 10.1161/HYPERTENSIONAHA.108.110213
   Muiesan ML, 2008, HYPERTENSION, V52, P529, DOI 10.1161/HYPERTENSIONAHA.108.114140
   Muiesan ML, 2007, HYPERTENSION, V49, P1077, DOI 10.1161/HYPERTENSIONAHA.107.087320
   Parati G, 2000, J HYPERTENS, V18, P1725, DOI 10.1097/00004872-200018120-00004
NR 8
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2011
VL 41
IS 4
BP 175
EP 176
DI 10.4070/kcj.2011.41.4.175
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HW
UT WOS:000209078500002
PM 21607166
OA Green Published
DA 2021-04-22
ER

PT J
AU Hwang, HJ
   Lee, MY
   Youn, HJ
   Oh, YS
   Rho, TH
   Chung, WS
   Park, CS
   Choi, YS
   Chung, WB
   Lee, JB
   Park, HK
   Lim, K
   Lee, JH
AF Hwang, Hui-Jeong
   Lee, Man-Young
   Youn, Ho-Joong
   Oh, Yong-Seog
   Rho, Tae-Ho
   Chung, Wook-Sung
   Park, Chul-Soo
   Choi, Yun-Seok
   Chung, Woo-Baek
   Lee, Jae-Beom
   Park, Hyun-Keun
   Lim, KeunJoon
   Lee, Jae Hak
TI Association Between Plaque Thickness of the Thoracic Aorta and
   Recurrence of Atrial Fibrillation After Ablation
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Atrial fibrillation; Catheter ablation; Atherosclerosis; Aorta; thoracic
ID PULMONARY VEIN ISOLATION; RISK-FACTORS; PREDICTORS; ATHEROSCLEROSIS;
   PREVALENCE; EFFICACY; OUTCOMES
AB Background and Objectives: Several predictors of recurrence of atrial fibrillation (AF) after ablation have been identified, including age, type of AF, hypertension, left atrial diameter and impaired left ventricular ejection fraction. The aim of this study was to investigate whether the atherosclerotic plaque thickness of the thoracic aorta is associated with a recurrence of AF after circumferential pulmonary vein ablation (CPVA). Subjects and Methods: Among patients with drug-refractory paroxysmal or persistent AF, 105 consecutive (mean age 58 +/- 11 years, male : female=76 : 29) patients who underwent trans-esophageal echocardiography and CPVA were studied. The relationships between the recurrence of AF and variables, including clinical characteristics, plaque thickness of the thoracic aorta, laboratory findings and echocardiographic parameters were evaluated. Results: A univariate analysis showed that the presence of diabetes {hazard ratio (HR)=3.425; 95% confidence interval (CI), 1.422-8.249, p=0.006}, ischemic heart disease (HR=4.549; 95% CI, 1.679-12.322, p=0.003), duration of AF (HR=1.010; 95% CI, 1.001-1.018, p=0.025), type of AF (HR=2.412, 95% CI=1.042-5.584, p=0.040) and aortic plaque thickness with >= 4 mm (HR=9.514; 95% CI, 3.419-26.105, p<0.001) were significantly associated with the recurrence of AF after ablation. In Cox multivariate regression analysis, only the aortic plaque thickness (with >= 4 mm) was an independent predictor of recurrence of AF after ablation (HR=7.250, 95% CI=1.906-27.580, p=0.004). Conclusion: Significantly increased aortic plaque thickness can be a predictable marker of recurrence of AF after CPVA.
C1 [Hwang, Hui-Jeong; Lee, Man-Young; Youn, Ho-Joong; Oh, Yong-Seog; Rho, Tae-Ho; Chung, Wook-Sung; Park, Chul-Soo; Choi, Yun-Seok; Chung, Woo-Baek; Lee, Jae-Beom; Park, Hyun-Keun; Lim, KeunJoon; Lee, Jae Hak] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul 150713, South Korea.
RP Lee, MY (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, 62 Yeouido Dong, Seoul 150713, South Korea.
EM myleecardio@catholic.ac.kr
RI Chung, Woo-Baek/AAE-4587-2020
CR Agmon Y, 2001, MAYO CLIN PROC, V76, P252, DOI 10.4065/76.3.252
   AMARENCO P, 1994, NEW ENGL J MED, V331, P1474, DOI 10.1056/NEJM199412013312202
   Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946
   BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.1994.03510350050036
   Berruezo A, 2007, EUR HEART J, V28, P836, DOI 10.1093/eurheartj/ehm027
   Blackshear JL, 1999, STROKE, V30, P834, DOI 10.1161/01.STR.30.4.834
   Boisvert WA, 2006, ARTERIOSCL THROM VAS, V26, P563, DOI 10.1161/01.ATV.0000203503.82693.c1
   Calvo N, 2010, EUROPACE, V12, P30, DOI 10.1093/europace/eup320
   Cappato R, 2005, CIRCULATION, V111, P1100, DOI 10.1161/01.CIR.0000157153.30978.67
   Casaclang-Verzosa G, 2008, J AM COLL CARDIOL, V51, P1, DOI 10.1016/j.jacc.2007.09.026
   Cheema A, 2006, J INTERV CARD ELECTR, V15, P145, DOI 10.1007/s10840-006-9005-9
   Chen MS, 2004, J AM COLL CARDIOL, V43, P1004, DOI 10.1016/j.jacc.2003.09.056
   De Potter T, 2010, EUROPACE, V12, P24, DOI 10.1093/europace/eup309
   FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469
   Frost L, 2005, AM J MED, V118, P489, DOI 10.1016/j.amjmed.2005.01.031
   Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292
   Goto S, 2008, AM HEART J, V156, P855, DOI 10.1016/j.ahj.2008.06.029
   Gyo-Seung Hwang, 2004, Korean Circulation Journal, V34, P693
   Heeringa J, 2007, ARCH INTERN MED, V167, P382, DOI 10.1001/archinte.167.4.382
   Hof I, 2009, J CARDIOVASC ELECTR, V20, P159, DOI 10.1111/j.1540-8167.2008.01310.x
   Machey RH, 2007, ADV CARDIOL, V44, P234
   Natale A, 2007, J CARDIOVASC ELECTR, V18, P560, DOI 10.1111/j.1540-8167.2007.00816.x
   Oakes RS, 2009, CIRCULATION, V119, P1758, DOI 10.1161/CIRCULATIONAHA.108.811877
   Otto CM, 2009, TXB CLIN ECHOCARDIOG, P125
   Park Jeong-Hwan, 2009, Korean Circ J, V39, P185, DOI 10.4070/kcj.2009.39.5.185
   Sauer WH, 2006, HEART RHYTHM, V3, P1024, DOI 10.1016/j.hrthm.2006.05.007
   Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography, 1996, J AM SOC ECHOCARDIOG, V9, P556
   Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E
   WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983
   이광수, 2008, Korean Circulation Journal, V38, P601
NR 30
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2011
VL 41
IS 4
BP 177
EP 183
DI 10.4070/kcj.2011.41.4.177
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HW
UT WOS:000209078500003
PM 21607167
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JY
   Jeong, MH
   Ahn, YK
   Moon, JH
   Chae, SC
   Hur, SH
   Hong, TJ
   Kim, YJ
   Seong, IW
   Chae, IH
   Cho, MC
   Kim, CJ
   Jang, YS
   Yoon, J
   Seung, KB
   Park, SJ
AF Kim, Joon Young
   Jeong, Myung Ho
   Ahn, Yong Keun
   Moon, Jae Hyun
   Chae, Shung Chull
   Hur, Seung Ho
   Hong, Taek Jong
   Kim, Young Jo
   Seong, In Whan
   Chae, In Ho
   Cho, Myeong Chan
   Kim, Chong Jin
   Jang, Yang Soo
   Yoon, Junghan
   Seung, Ki Bae
   Park, Seung Jung
CA Korea Acute Myocardial Infarction
TI Decreased Glomerular Filtration Rate is an Independent Predictor of
   In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial
   Infarction Undergoing Primary Percutaneous Coronary Intervention
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Glomerular filtration rate; Acute myocardial infarction; Mortality;
   Percutaneous coronary intervention
ID INTRAVENOUS THROMBOLYTIC THERAPY; CHRONIC KIDNEY-DISEASE;
   RENAL-INSUFFICIENCY; PRIMARY ANGIOPLASTY; CARDIOVASCULAR EVENTS;
   CREATININE CLEARANCE; CLINICAL-OUTCOMES; DYSFUNCTION; IMPACT;
   ASSOCIATION
AB Background and Objectives: Patients with renal dysfunction (RD) experience worse prognosis after myocardial infarction (MI). The aim of the present study was to investigate the impact of admission estimated glomerular filtration rate (eGFR) on clinical outcomes of patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation MI (STEMI). Subjects and Methods: We retrospectively evaluated 4,542 eligible patients from the Korea Acute Myocardial Infarction Registry (KAMIR). Patients were divided into three groups according to eGFR (mL/min/1.73 m(2)): normal renal function (RF) group (eGFR >= 60, n=3,515), moderate RD group (eGFR between 30 to 59, n=894) and severe RD group (eGFR <30, n=133). Baseline characteristics, angiographic and procedural results, and in-hospital outcomes between the three groups were compared. Results: Age, gender, Killip class >= 3, hypertension, diabetes, congestive heart failure, peak creatine kinase-MB, high sensitivity C-reactive protein, B-type natriuretic peptide, left ventricle ejection fraction, multivessel disease, infarct-related artery and rate of successful PCI were significantly different between the 3 groups (p<0.05). With decline in RF, in-hospital complications developed with an increasing frequency (14.1% vs. 31.8% vs. 45.5%, p<0.0001). In-hospital mortality rate was significantly higher in the moderate and severe RD groups as compared to the normal RF group (2.3% vs. 13.9% vs. 25.6%, p<0.0001). Using multivariate logistic regression analysis, adjusted odds ratio for in-hospital mortality was 2.67 {95% confidence interval (CI) 1.44-4.93, p=0.002} in the moderate RD group, and 4.09 (95% CI 1.48-11.28, p=0.006) in the severe RD group as compared to the normal RF group. Conclusion: Decreased admission eGFR was associated with worse clinical courses and it was an independent predictor of in-hospital mortality in STEMI patients undergoing primary PCI.
C1 [Kim, Joon Young; Moon, Jae Hyun] St Carollo Hosp, Sunchon, South Korea.
   [Jeong, Myung Ho; Ahn, Yong Keun] Chonnam Natl Univ, Kwangju, South Korea.
   [Chae, Shung Chull] Kyungpook Natl Univ, Taegu, South Korea.
   [Hur, Seung Ho] Keimyung Univ, Dongsan Med Ctr, Taegu, South Korea.
   [Hong, Taek Jong] Pusan Natl Univ Hosp, Pusan, South Korea.
   [Kim, Young Jo] Yeungnam Univ Hosp, Taegu, South Korea.
   [Seong, In Whan] Chungnam Natl Univ Hosp, Taejon, South Korea.
   [Chae, In Ho] Seoul Natl Univ, Bundang Hosp, Seongam, South Korea.
   [Cho, Myeong Chan] Chungbuk Natl Univ, Cheongju, South Korea.
   [Kim, Chong Jin] Kyunghee Univ Hosp, Seoul, South Korea.
   [Jang, Yang Soo] Yonsei Univ Hosp, Seoul, South Korea.
   [Yoon, Junghan] Wonju Univ Hosp, Wonju, South Korea.
   [Seung, Ki Bae] Catholic Univ Hosp, Seoul, South Korea.
   [Park, Seung Jung] Asan Med Ctr, Seoul, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Korea Minist Hlth & Welfares, Heart Res Ctr, Korea Acute Myocardial Infarct Registry, 671 Jaebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
OI Hur, Seung-Ho/0000-0002-3895-1915; Jeong, Jin-Ok/0000-0003-0763-4754;
   Seong, In-Whan/0000-0003-4628-0258
CR Al Suwaidi J, 2002, CIRCULATION, V106, P974, DOI 10.1161/01.CIR.0000027560.41358.B3
   Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
   Beattie JN, 2001, AM J KIDNEY DIS, V37, P1191, DOI 10.1053/ajkd.2001.24522
   Berger AK, 2003, J AM COLL CARDIOL, V42, P201, DOI 10.1016/S0735-1097(03)00572-2
   Best PJM, 2002, J AM COLL CARDIOL, V39, P1113, DOI 10.1016/S0735-1097(02)01745-X
   Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939
   Ferrer-Hita JJ, 2007, INT J CARDIOL, V118, P243, DOI 10.1016/j.ijcard.2006.06.044
   Gibson CM, 2003, J AM COLL CARDIOL, V42, P1535, DOI 10.1016/j.jacc.2003.06.001
   Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031
   Hirakawa Y, 2006, INT HEART J, V47, P745, DOI 10.1536/ihj.47.745
   Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7
   Lee Kang Hyu, 2010, Korean Circ J, V40, P68, DOI 10.4070/kcj.2010.40.2.68
   Manoukian SV, 2007, J AM COLL CARDIOL, V49, P1362, DOI 10.1016/j.jacc.2007.02.027
   Marenzi G, 2007, AM HEART J, V153, P755, DOI 10.1016/j.ahj.2007.02.018
   McCullough PA, 2002, AM HEART J, V144, P226, DOI 10.1067/mhj.2002.125513
   Medi C, 2009, JACC-CARDIOVASC INTE, V2, P26, DOI 10.1016/j.jcin.2008.09.010
   Mielniczuk LM, 2008, AM HEART J, V155, P725, DOI 10.1016/j.ahj.2007.11.031
   Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987
   Pinkau T, 2004, AM J KIDNEY DIS, V44, P627, DOI 10.1053/j.ajkd.2004.05.045
   Sadeghi HM, 2003, CIRCULATION, V108, P2769, DOI 10.1161/01.CIR.0000103623.63687.21
   Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342
   Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006
   Sorensen CR, 2002, EUR HEART J, V23, P948, DOI 10.1053/euhj.2001.2989
   Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415
   Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093
   Wright RS, 2002, ANN INTERN MED, V137, P563, DOI 10.7326/0003-4819-137-7-200210010-00007
   Yamaguchi J, 2004, AM J CARDIOL, V93, P1526, DOI 10.1016/j.amjcard.2004.02.065
   Zijlstra F, 1999, NEW ENGL J MED, V341, P1413, DOI 10.1056/NEJM199911043411901
   이기홍, 2007, Korean Circulation Journal, V37, P64
   남궁준, 2005, Korean Circulation Journal, V35, P696
NR 30
TC 14
Z9 16
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2011
VL 41
IS 4
BP 184
EP 190
DI 10.4070/kcj.2011.41.4.184
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HW
UT WOS:000209078500004
PM 21607168
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, BK
   Lim, YH
   Lee, HT
   Lee, JU
   Kim, KS
   Kim, SG
   Kim, JH
   Lim, HK
   Shin, J
AF Kim, Bae Keun
   Lim, Young-Hyo
   Lee, Hyung Tak
   Lee, Jae Ung
   Kim, Kyung Soo
   Kim, Soon Gil
   Kim, Jeong Hyun
   Lim, Heon Kil
   Shin, Jinho
TI Non-Dipper Pattern is a Determinant of the Inappropriateness of Left
   Ventricular Mass in Essential Hypertensive Patients
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Hypertrophy; left ventricular; Blood pressure monitoring;
   ambulatory
AB Background and Objectives: Inappropriately high left ventricular mass (iLVM) is known to be related to cardiovascular prognosis. A non-dipper pattern has a greater mean left ventricular (LV) mass than the dipper pattern in hypertensive patients. However, the appropriateness of LV mass in dipper or non-dipper patterns has not been adequately investigated. The aim of this study was to define the relationship between nocturnal dipping and the appropriateness of LV mass. Subjects and Methods: Using the ambulatory blood pressure monitoring (ABPM) database, the data of 361 patients who underwent ABPM and echocardiography was analyzed retrospectively. Appropriateness of LV mass was calculated as observed/predicted ratio of LV mass (OPR) using a Korean-specified equation. Nocturnal dipping was expressed as percent fall in systolic blood pressure (BP) during the night compared to the day. Results: Daytime, nighttime and 24 hours BP in hypertensive patients was 140.4 +/- 14.8 mmHg, 143.7 +/- 15.2 mmHg and 129.4 +/- 20.0 mmHg, respectively. OPR was 106.3 +/- 19.9% and nocturnal dipping was 10.2 +/- 10.9 mmHg. In a multiple linear regression model, 24 hours systolic BP (beta=0.097, p=0.043) and nocturnal dipping (beta=-0.098, p=0.046) were independent determinants of OPR as well as age (beta=0.130, p=0.025) and body mass index (BMI) (beta=0.363, p<0.001). Odds ratio of the non-dipper pattern was 2.134 for iLVM (p=0.021) and 3.694 for obesity (p<0.001; BMI >25 kg/m(2)). Conclusion: The non-dipper pattern is independently associated with iLVM in hypertensive patients as well as obesity.
C1 [Kim, Bae Keun; Lim, Young-Hyo; Lee, Hyung Tak; Lee, Jae Ung; Kim, Kyung Soo; Kim, Soon Gil; Kim, Jeong Hyun; Lim, Heon Kil; Shin, Jinho] Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 133792, South Korea.
RP Shin, J (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, 17 Haengdang Dong, Seoul 133792, South Korea.
EM jhs2003@hanyang.ac.kr
OI Shin, Jinho/0000-0001-6706-6504
CR Celentano A, 2001, AM J CARDIOL, V87, P361, DOI 10.1016/S0002-9149(00)01379-5
   Chen H H, 2000, Curr Cardiol Rep, V2, P198, DOI 10.1007/s11886-000-0069-3
   de la Sierra A, 2009, HYPERTENSION, V53, P466, DOI 10.1161/HYPERTENSIONAHA.108.124008
   de Simone G, 2002, HYPERTENSION, V40, P470, DOI 10.1161/01.HYP.0000034740.99323.8A
   de Simone G, 1998, HYPERTENSION, V31, P1077, DOI 10.1161/01.HYP.31.5.1077
   DESIMONE G, 1994, HYPERTENSION, V23, P600, DOI 10.1161/01.HYP.23.5.600
   Devereux RB, 1997, CIRCULATION, V96, P1416, DOI 10.1161/01.CIR.96.5.1416
   DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X
   GLOWER DD, 1985, CIRCULATION, V71, P994, DOI 10.1161/01.CIR.71.5.994
   Hermida RC, 2010, AM J HYPERTENS, V23, P432, DOI 10.1038/ajh.2009.260
   Ikeda M, 1997, ARTERIOSCL THROM VAS, V17, P731, DOI 10.1161/01.ATV.17.4.731
   Ikeda T, 1997, AM HEART J, V133, P307, DOI 10.1016/S0002-8703(97)70225-4
   Inoue M, 1998, EXP CLIN ENDOCR DIAB, V106, P484, DOI 10.1055/s-0029-1212021
   신진호, 2005, Korean Circulation Journal, V35, P335
   KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345
   Krauser DG, 2006, HERZ, V31, P305, DOI 10.1007/s00059-006-2819-5
   Lim Young Hyo, 2009, Korean Circ J, V39, P138, DOI 10.4070/kcj.2009.39.4.138
   Mancia G, 1997, CIRCULATION, V95, P1464
   O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4
   Palmieri V, 1999, HYPERTENSION, V34, P1032, DOI 10.1161/01.HYP.34.5.1032
   Parati G, 2007, J HYPERTENS, V25, P2377, DOI 10.1097/HJH.0b013e32801143b3
   Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016
   임세중, 2008, Korean Circulation Journal, V38, P131
NR 23
TC 14
Z9 18
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2011
VL 41
IS 4
BP 191
EP 197
DI 10.4070/kcj.2011.41.4.191
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HW
UT WOS:000209078500005
PM 21607169
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, CS
   Ihm, SH
   Park, HJ
   Shin, WS
   Kim, PJ
   Chang, K
   Kim, HY
   Youn, HJ
   Chung, WS
   Seung, KB
   Kim, JH
AF Park, Chan Seok
   Ihm, Sang-Hyun
   Park, Hun-Jun
   Shin, Woo-Seung
   Kim, Pum-Jun
   Chang, Kiyuk
   Kim, Hee-Yeol
   Youn, Ho-Joong
   Chung, Wook-Sung
   Seung, Ki Bae
   Kim, Jae-Hyung
TI Relationship Between Plasma Adiponectin, Retinol-Binding Protein 4 and
   Uric Acid in Hypertensive Patients With Metabolic Syndrome
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Adiponectin; Retinol-binding protein 4; Uric acid; Hypertension;
   Metabolic syndrome
ID CARDIOVASCULAR-DISEASE; RISK; ASSOCIATION; RESISTANCE; OBESE
AB Background and Objectives: Adipokines have been suggested for their potential use in tracking the clinical progress in the subjects with metabolic syndrome (MS). To investigate the relationship between the serum levels of adipokines {adiponectin and retinol-binding protein 4 (RBP4)} and the serum level of uric acid in hypertensive (HTN) patients with MS. Subjects and Methods: In this study, 38 totally untreated HTN patients were enrolled. Anthropometric measurements, blood pressure (BP) were taken in the 12 HTN patients without MS and the 26 HTN patients with MS. Fasting blood samples were collected for measurement of adiponectin, RBP4, nitric oxide (NO), glucose, creatinine, uric acid, lipid profile and insulin. Results: The HTN with MS group had significant higher values of body mass index, waist length, serum uric acid and triglyceride levels than the HTN without MS group. Compared to the HTN without MS group, the HTN with MS group showed significantly lower adiponectin (p=0.030), NO (p=0.003) and high density lipoprotein levels (p<0.001). Serum adiponectin levels negatively correlated with insulin level (R=-0.453, p=0.026) and uric acid level (R=-0.413, p=0.036), and serum RBP4 levels positively correlated with uric acid level (R=0.527, p=0.006) in the HTN with MS group. Multiple linear regression analysis using RBP4 and adiponectin levels as the dependent variables showed that uric acid level correlated with serum RBP4 level (p=0.046) and adiponectin level (p=0.044). Conclusion: The HTN with MS group showed a correlation with two types of adipokines (adiponectin, RBP4) and uric acid. Adiponectin, RBP4 and uric acid may be important components associated with MS, especially when associated with hypertension.
C1 [Park, Chan Seok; Ihm, Sang-Hyun; Park, Hun-Jun; Shin, Woo-Seung; Kim, Pum-Jun; Chang, Kiyuk; Kim, Hee-Yeol; Youn, Ho-Joong; Chung, Wook-Sung; Seung, Ki Bae; Kim, Jae-Hyung] Catholic Univ Korea, Bucheon St Mary Hosp, Coll Med, Dept Cardiol, Puchon 420717, South Korea.
RP Ihm, SH (corresponding author), Catholic Univ Korea, Bucheon St Mary Hosp, Coll Med, Dept Cardiol, 2 Sosa Dong, Puchon 420717, South Korea.
EM heartihmsh@yahoo.co.kr
OI Ihm, Sang Hyun/0000-0001-5017-5421
CR Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8
   Balletshofer BM, 2000, CIRCULATION, V101, P1780, DOI 10.1161/01.CIR.101.15.1780
   Chen CC, 2009, METABOLISM, V58, P1812, DOI 10.1016/j.metabol.2009.06.013
   Coutinho TD, 2007, AM J HYPERTENS, V20, P83, DOI 10.1016/j.amjhyper.2006.06.015
   Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003
   Cuspidi C, 2007, AM J HYPERTENS, V20, P296, DOI 10.1016/j.amjhyper.2006.09.010
   FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008
   Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Ingelsson E, 2009, ATHEROSCLEROSIS, V206, P239, DOI 10.1016/j.atherosclerosis.2009.02.029
   Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26
   Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402
   Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709
   홍승표, 2008, Korean Circulation Journal, V38, P152
   Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057
   Patel DA, 2006, METABOLISM, V55, P1551, DOI 10.1016/j.metabol.2006.06.028
   유태우, 2004, Korean Circulation Journal, V34, P874
   Yang WS, 2002, OBES RES, V10, P1104, DOI 10.1038/oby.2002.150
NR 18
TC 6
Z9 6
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2011
VL 41
IS 4
BP 198
EP 202
DI 10.4070/kcj.2011.41.4.198
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HW
UT WOS:000209078500006
PM 21607170
OA Green Published
DA 2021-04-22
ER

PT J
AU Han, UJ
   Cho, HJ
   Cho, YK
   Choi, YY
   Ma, JS
AF Han, Ui Joung
   Cho, Hwa Jin
   Cho, Young Kuk
   Choi, Young Youn
   Ma, Jae Sook
TI Change in Blood Pressure and Pulse Pressure in Preterm Infants After
   Treatment of Patent Ductus Arteriosus With Indomethacin
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pulse pressure; Blood pressure; Preterm infant; Ductus arteriosus;
   preterm
AB Background and Objectives: Patent ductus arteriosus (PDA) is associated with increased morbidity and mortality in premature infants. Therefore, an early diagnosis and treatment of a hemodynamically significant PDA are very important. A widened pulse pressure is considered to be a well known clinical sign of a PDA in older infants and children; however, whether this is also applicable in the case of preterm infants remains to be confirmed. The aims of this study were to investigate the change in blood pressure (BP) before and after medical treatment of a PDA with indomethacin and to evaluate if the change in the pulse pressure in preterm infants with a medically treated PDA could be used as a reliable clinical predictor of a hemodynamically significant PDA. Subjects and Methods: Between January 2005 and June 2009, a retrospective analysis was performed in preterm infants with a hemodynamically significant PDA (PDA group, n=72) and preterm infants without a PDA (control group, n=72) at the Chonnam National University Hospital Neonatal Intensive Care Unit. The PDA was closed by treatment with indomethacin. The BP was compared between the two groups over the seven days after the first dose of indomethacin. Results: In preterm infants with a hemodynamically significant PDA, the mean systolic (55.1 +/- 6.0 mmHg) and diastolic BPs (31.4 +/- 6.2 mmHg) were lower than those in the controls (mean systolic BP 58.0 +/- 6.4 mmHg, mean diastolic BP 34.7 +/- 6.0 mmHg) before indomethacin treatment. When the ductus arteriosus was successfully closed by indomethacin treatment, there was a gradual increase in both the systolic and diastolic BPs without any change in the pulse pressure. Conclusion: The results of this study show that a widened pulse pressure is not a useful clinical sign of a hemodynamically significant PDA in preterm infants. However, low systolic and diastolic BPs may be useful clinical signs of a hemodynamically significant PDA in preterm infants. If the systolic and diastolic BP is low, a PDA should be considered and echocardiography should be performed for early diagnosis and treatment.
C1 [Han, Ui Joung; Cho, Hwa Jin; Cho, Young Kuk; Choi, Young Youn; Ma, Jae Sook] Chonnam Natl Univ, Sch Med, Dept Pediat, Kwangju 501757, South Korea.
RP Ma, JS (corresponding author), Chonnam Natl Univ, Sch Med, Dept Pediat, 8 Hak Dong, Kwangju 501757, South Korea.
EM cardiol@jnu.ac.kr
OI Cho, Youngkuk/0000-0001-6811-2883; cho, hwa jin/0000-0002-2458-8529
CR Bernstein D, 2007, NELSON TXB PEDIAT, P1891
   Choi SK, 1997, KOREAN CIRC J, V27, P485
   DAVIS P, 1995, ARCH PEDIAT ADOL MED, V149, P1136, DOI 10.1001/archpedi.1995.02170230090013
   EVANS N, 1992, ARCH DIS CHILD-FETAL, V67, P1169, DOI 10.1136/adc.67.10_Spec_No.1169
   EVANS N, 1993, ARCH DIS CHILD-FETAL, V68, P584, DOI 10.1136/adc.68.5_Spec_No.584
   Hegyi T, 1996, PEDIATRICS, V97, P336
   HIRSIMAKI H, 1990, CRIT CARE MED, V18, P490, DOI 10.1097/00003246-199005000-00005
   Hoffman TM, 2008, MOSS ADAMS HEART DIS, P440
   Kim HS, 1985, KOREAN CIRC J, V15, P483
   Kluckow M, 2000, J PEDIATR-US, V137, P68, DOI 10.1067/mpd.2000.106569
   Knight D B, 2001, Semin Neonatol, V6, P63, DOI 10.1053/siny.2000.0036
   Lee J, 1999, ARCH DIS CHILD-FETAL, V81, pF168, DOI 10.1136/fn.81.3.F168
   Lubetzky R, 2004, AM J PERINAT, V21, P257, DOI 10.1055/s-2004-829872
   PERLMAN JM, 1981, J PEDIATR-US, V99, P767, DOI 10.1016/S0022-3476(81)80408-8
   Rakza T, 2007, J PEDIATR-US, V151, P624, DOI 10.1016/j.jpeds.2007.04.058
   RATNER I, 1985, CRIT CARE MED, V13, P497, DOI 10.1097/00003246-198506000-00012
   RUDOLPH AM, 1964, AM HEART J, V68, P447, DOI 10.1016/0002-8703(64)90145-0
   SHIMADA S, 1994, J PEDIATR-US, V125, P270, DOI 10.1016/S0022-3476(94)70210-1
   Skinner J, 2001, Semin Neonatol, V6, P49, DOI 10.1053/siny.2000.0037
   VALDESCRUZ LM, 1981, J PEDIATR-US, V98, P298, DOI 10.1016/S0022-3476(81)80665-8
   Wyllie Jonathan, 2003, Semin Neonatol, V8, P425, DOI 10.1016/S1084-2756(03)00121-0
NR 21
TC 6
Z9 6
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2011
VL 41
IS 4
BP 203
EP 208
DI 10.4070/kcj.2011.41.4.203
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HW
UT WOS:000209078500007
PM 21607171
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, GH
   Ryu, DR
   Song, PS
   Song, YB
   Hahn, JY
   Choi, SH
   Gwon, HC
AF Kang, Gu Hyun
   Ryu, Dong Ryeol
   Song, Pil Sang
   Song, Young Bin
   Hahn, Joo-Yong
   Choi, Seung-Hyuck
   Gwon, Hyeon-Cheol
TI A Case of a Senile Systemic Amyloidosis Patient Presenting With Angina
   Pectoris and Dilated Cardiomyopathy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Amyloidosis; Heart transplantation; Microvascular angina
ID CARDIAC TROPONIN-I; ECHOCARDIOGRAPHIC FEATURES; MYASTHENIC SYMPTOMS; AL
   AMYLOIDOSIS; HEART-DISEASE; TRANSPLANTATION
AB A 77-year-old man visited our hospital complaining of aggravated exertional chest pain. He was diagnosed with syndrome X 7 years ago and underwent medical treatment in a regional hospital. Coronary angiography and echocardiography did not show any significant abnormalities. On the seventh in-hospital day, cardiogenic shock developed and echocardiography showed a dilated left ventricular (LV) cavity and severe LV systolic dysfunction. We thus inserted an intra-aortic balloon pump for hemodynamic support and were forced to maintain it because of weaning failure several times. Finally, heart transplantation was the decided necessary procedure. After successful heart transplantation, the biopsy specimen revealed a wild-type transthyretin deposition indicating senile systemic amyloidosis in the intramuscular coronary vessels and interstitium. Cardiac biopsy at the 4-year follow-up showed no recurrence of amyloid deposition.
C1 [Kang, Gu Hyun; Ryu, Dong Ryeol; Song, Pil Sang; Song, Young Bin; Hahn, Joo-Yong; Choi, Seung-Hyuck; Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Cardiac & Vasc Ctr, Seoul 135710, South Korea.
RP Gwon, HC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Cardiac & Vasc Ctr, 50 Irwon Dong, Seoul 135710, South Korea.
EM hcgwon@skku.edu
RI Hahn, Joo-Yong/AAU-7250-2020
OI Hahn, Joo-Yong/0000-0002-4412-377X; Ryu, Dong Ryeol/0000-0002-0766-8738
CR Al Suwaidi J, 1999, ANN INTERN MED, V131, P838, DOI 10.7326/0003-4819-131-11-199912070-00007
   Cantwell RV, 2002, CLIN CARDIOL, V25, P33, DOI 10.1002/clc.4950250109
   Chae JK, 2000, KOREAN CIRC J, V30, P1179
   CORNWELL GG, 1980, J CLIN PATHOL, V33, P1146, DOI 10.1136/jcp.33.12.1146
   Dubrey SW, 2004, J HEART LUNG TRANSPL, V23, P1142, DOI 10.1016/j.healun.2003.08.027
   Falk RH, 2005, CIRCULATION, V112, P2047, DOI 10.1161/CIRCULATIONAHA.104.489187
   Fuchs U, 2005, AM J TRANSPLANT, V5, P1159, DOI 10.1111/j.1600-6143.2005.00805.x
   Ikeda S, 2006, INTERNAL MED, V45, P123, DOI 10.2169/internalmedicine.45.0139
   KASKI JC, 1995, AM J CARDIOL, V76, pD35
   McCarthy RE, 1998, CLIN CARDIOL, V21, P547
   Mesquita Teresa, 2005, Rev Port Cardiol, V24, P1521
   Mueller PS, 2000, AM J MED, V109, P181, DOI 10.1016/S0002-9343(00)00471-X
   Ogawa H, 2001, ANGIOLOGY, V52, P273, DOI 10.1177/000331970105200407
   SIQUEIRAFILHO AG, 1981, CIRCULATION, V63, P188, DOI 10.1161/01.CIR.63.1.188
   Tsuda T, 1992, Kaku Igaku, V29, P1035
   Whitaker DC, 2004, HEART, V90, DOI 10.1136/hrt.2004.038984
   Yamano S, 2002, HEART VESSELS, V16, P157, DOI 10.1007/s003800200013
   Yoshita M, 2006, INTERNAL MED, V45, P159, DOI 10.2169/internalmedicine.45.1151
   Zabernigg A, 2003, ANN ONCOL, V14, P1791, DOI 10.1093/annonc/mdg487
   오수성, 2008, Korean Circulation Journal, V38, P374
NR 20
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2011
VL 41
IS 4
BP 209
EP 212
DI 10.4070/kcj.2011.41.4.209
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HW
UT WOS:000209078500008
PM 21607172
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, MJ
   Kwon, HY
   Hwang, CS
   Kang, JH
   Kim, HJ
   Kim, SM
   Lee, HG
   Kim, TI
   Cho, KI
AF Kim, Myoung-Joon
   Kwon, Hyuk-Yong
   Hwang, Chi-Sung
   Kang, Ji-Hyun
   Kim, Hyeon-Jin
   Kim, Seong-Man
   Lee, Hyeon-Gook
   Kim, Tae-Ik
   Cho, Kyoung-Im
TI Dual Fistulas of Ascending Aorta and Coronary Artery to Pulmonary Artery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary arteries; Echocardiography; Fistula
AB Coronary artery fistula to pulmonary artery is common. However, to the best of our knowledge, a case of coronary artery fistula to pulmonary artery associated with aortopulmonary fistula remains unreported. We herein report a 64-year-old female with a left anterior descending coronary artery and ascending aorta to pulmonary artery fistulas, and conduct a brief review of the literature.
C1 [Kim, Myoung-Joon; Kwon, Hyuk-Yong; Hwang, Chi-Sung; Kang, Ji-Hyun; Kim, Hyeon-Jin; Kim, Seong-Man; Lee, Hyeon-Gook; Kim, Tae-Ik; Cho, Kyoung-Im] Maryknoll Med Ctr, Dept Internal Med, Div Cardiol, Pusan 600730, South Korea.
RP Cho, KI (corresponding author), Maryknoll Med Ctr, Dept Internal Med, Div Cardiol, Daecheong Dong 4 Ga, Pusan 600730, South Korea.
EM kyoungim74@dreamwiz.com
CR Barbosa MM, 1999, J AM SOC ECHOCARDIOG, V12, P149, DOI 10.1016/S0894-7317(99)70127-6
   Brooks HS., 1885, J ANAT PHYSL, V20, P26
   Cheung DLC, 2001, ANN THORAC SURG, V71, P190, DOI 10.1016/S0003-4975(00)01862-2
   Gandy KL, 2004, ANN THORAC SURG, V77, P1081, DOI 10.1016/j.athoracsur.2003.05.006
   Kim MS, 1997, KOREAN CIRC J, V27, P900
   SAPIN P, 1990, MEDICINE, V69, P101, DOI 10.1097/00005792-199069020-00004
   Sherwood MC, 1999, AM J CARDIOL, V83, P407, DOI 10.1016/S0002-9149(98)00878-9
   Tkebuchava T, 1996, J CARDIOVASC SURG, V37, P29
   VAVURANAKIS M, 1995, CATHETER CARDIO DIAG, V35, P116, DOI 10.1002/ccd.1810350207
   VELVIS H, 1989, J AM COLL CARDIOL, V14, P968, DOI 10.1016/0735-1097(89)90474-9
NR 10
TC 3
Z9 4
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2011
VL 41
IS 4
BP 213
EP 216
DI 10.4070/kcj.2011.41.4.213
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HW
UT WOS:000209078500009
PM 21607173
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, SJ
   Choi, EY
   Jung, JH
   Rim, SJ
AF Yoon, Se-Jung
   Choi, Eui-Young
   Jung, Jae-Hun
   Rim, Se-Joong
TI An Atypical Mitral Valve Prolapse in a Patient With Behcet's Disease
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Behcet's syndrome; Heart valve prolapse; Mitral valve; Inflammation
AB We report the case of a 42-year-old male who was admitted to the hospital with progressive dyspnea. Cardiomegaly and diffuse pulmonary edema were visible on chest X-ray and multiple oral and genital ulcers on physical examination. On admission, echocardiography revealed mitral valve prolapse (MVP) predominantly involving a basal portion of the posterior leaflet, with severe mitral regurgitation. A successful mitral valve replacement with St. Jude #29 was performed, after pre-treatment with prednisolone for 2 weeks. Fifteen months following the operation, the patient expired from severe pulmonary edema and secondary pneumonia. This case demonstrates, for the first time in the literature, an unusual feature of mitral prolapse in the basal portion with severe mitral regurgitation in a patient with Behcet's disease. As suggested by this case, we should consider an atypical type of MVP as a possible inflammatory involvement of the heart in patients with Behcet's disease.
C1 [Yoon, Se-Jung] NHIC Ilsan Hosp, Div Cardiol, Goyang, South Korea.
   [Choi, Eui-Young; Rim, Se-Joong] Yonsei Univ, Coll Med, Div Cardiol, Dept Internal Med, Seoul 135720, South Korea.
   [Jung, Jae-Hun] Hallym Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul, South Korea.
RP Rim, SJ (corresponding author), Yonsei Univ, Coll Med, Div Cardiol, Gangnam Severance Hosp,Dept Internal Med, 712 Eonju Ro, Seoul 135720, South Korea.
EM sejoong@yuhs.ac
OI Rim, Se Joong/0000-0002-7631-5581; Choi, Eui-Young/0000-0003-3732-0190
CR CHENG TO, 1989, WESTERN J MED, V150, P91
   Gurgun C, 2002, JPN HEART J, V43, P389, DOI 10.1536/jhj.43.389
   JAMES DG, 1988, WESTERN J MED, V148, P433
   Park KM, 2005, KOREAN CIRC J, V35, P847
   SHEN LL, 1985, BRIT HEART J, V54, P100
   Verma S, 2009, NEW ENGL J MED, V361, P2261, DOI 10.1056/NEJMct0806111
NR 6
TC 2
Z9 2
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2011
VL 41
IS 4
BP 217
EP 219
DI 10.4070/kcj.2011.41.4.217
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HW
UT WOS:000209078500010
PM 21607174
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, WS
   Kim, DH
   Park, KS
   Woo, SI
   Shin, SH
   Jun, K
   Cheon, W
   Jeong, ES
   Park, SD
AF Lee, Won Seop
   Kim, Dae Hyeok
   Park, Keum Soo
   Woo, Sung Ill
   Shin, Sung Hee
   Jun, Kwan
   Cheon, Woong
   Jeong, Eun Seon
   Park, Sang Don
TI A Case of Variant Angina Developing Transient Collateral Circulation
   During Vasospasm
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Angina pectoris; variant; Ergonovine; Collateral circulation
AB Variant angina is characterized by spontaneous episodes of angina, usually occurring in the morning and having ST segment elevation on the electrocardiogram. However, in the case presented here, vasospasm and angina was shown by ergonovine without ST elevation. The patient was a 60-year-old man who presented with a 2-year history of frequent chest pain. There were no abnormalities in coronary angiography. When ergonovine (100 mu g) was injected, total occlusion of the proximal right coronary artery was seen, without ST elevation at the electrocardiogram. The cause was collateral from left anterior descending artery to distal right coronary artery at the left coronary angiography. Therefore, in a patient with variant angina without ST elevation, a transient collateral circulation during vasospasm should be considered.
C1 [Lee, Won Seop; Kim, Dae Hyeok; Park, Keum Soo; Woo, Sung Ill; Shin, Sung Hee; Jun, Kwan; Cheon, Woong; Jeong, Eun Seon; Park, Sang Don] Inha Univ, Coll Med, Cardiac & Vasc Ctr, Div Cardiol, Inchon 400711, South Korea.
RP Kim, DH (corresponding author), Inha Univ, Coll Med, Cardiac & Vasc Ctr, Div Cardiol, 7-206 Sin Heung Dong, Inchon 400711, South Korea.
EM kdhmd@inha.ac.kr
CR BERTRAND ME, 1982, CIRCULATION, V65, P1299, DOI 10.1161/01.CIR.65.7.1299
   Braunwald E, 2001, HEART DIS, P1324
   CREA F, 1985, AM HEART J, V110, P1064, DOI 10.1016/0002-8703(85)90212-1
   CURRY RC, 1977, CIRCULATION, V56, P803, DOI 10.1161/01.CIR.56.5.803
   FELDMAN RL, 1983, AM HEART J, V106, P1288, DOI 10.1016/0002-8703(83)90036-4
   HEUPLER FA, 1980, AM J CARDIOL, V46, P335, DOI 10.1016/0002-9149(80)90081-8
   HEUPLER FA, 1978, AM J CARDIOL, V41, P631, DOI 10.1016/0002-9149(78)90810-X
   KASKI JC, 1986, CIRCULATION, V74, P1255, DOI 10.1161/01.CIR.74.6.1255
   MASERI A, 1978, AM J CARDIOL, V42, P1019, DOI 10.1016/0002-9149(78)90691-4
   Park YB, 1988, KOERAN CIRC J, V18, P161
   Park YK, 2000, KOREAN CIRC J, V30, P1366
NR 11
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2011
VL 41
IS 4
BP 220
EP 223
DI 10.4070/kcj.2011.41.4.220
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HW
UT WOS:000209078500011
PM 21607175
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, YR
   Jeong, YH
   Koh, JS
   Choi, HC
   Kim, JW
   Park, SR
   Park, JR
   Park, Y
   Hwang, SJ
   Kwak, CH
   Hwang, JY
AF Kang, Young-Ran
   Jeong, Young-Hoon
   Koh, Jin-Sin
   Choi, Ho-Cheol
   Kim, Jong-Woo
   Park, So-Ra
   Park, Jeong Rang
   Park, Yongwhi
   Hwang, Seok-Jae
   Kwak, Choong Hwan
   Hwang, Jin-Yong
TI Asymptomatic Left Ventricular Pseudoaneurysm Evaluated With
   Multimodality Cardiac Imaging
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kang, Young-Ran; Jeong, Young-Hoon; Koh, Jin-Sin; Park, So-Ra; Park, Jeong Rang; Park, Yongwhi; Hwang, Seok-Jae; Kwak, Choong Hwan; Hwang, Jin-Yong] Gyeongsang Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, Jinju 660702, South Korea.
   [Choi, Ho-Cheol] Gyeongsang Natl Univ, Coll Med, Dept Radiol, Jinju 660702, South Korea.
   [Kim, Jong-Woo] Gyeongsang Natl Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Jinju 660702, South Korea.
RP Jeong, YH (corresponding author), Gyeongsang Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, 90 Chiram Dong, Jinju 660702, South Korea.
EM goodoctor@naver.com
RI Jeong, Young-Hoon/AAO-4401-2020; Jeong, Young-Hoon/F-3476-2015
OI Jeong, Young-Hoon/0000-0003-0403-3726; Kwak, Choong
   Hwan/0000-0001-6035-4415
CR Frances C, 1998, J AM COLL CARDIOL, V32, P557, DOI 10.1016/S0735-1097(98)00290-3
   Ghersin E, 2007, Br J Radiol, V80, pe209, DOI 10.1259/bjr/31646310
   Kim KH, 1999, KOREAN CIRC J, V29, P1357
   Konen E, 2005, RADIOLOGY, V236, P65, DOI 10.1148/radiol.2361031699
   Subban V, 2009, HEART, V95, P1139, DOI 10.1136/hrt.2008.163493
NR 5
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD APR
PY 2011
VL 41
IS 4
BP 224
EP 226
DI 10.4070/kcj.2011.41.4.224
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HW
UT WOS:000209078500012
PM 21607176
OA Green Published
DA 2021-04-22
ER

PT J
AU Nam, GB
AF Nam, Gi-Byoung
TI Exercise, Heart and Health
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Exercise; Sudden cardiac death; Health; Coronary arteries
ID SUDDEN CARDIAC DEATH; LEFT-VENTRICULAR HYPERTROPHY; ALL-CAUSE MORTALITY;
   HIGH-RISK PATIENTS; SHORT QT SYNDROME; PHYSICAL-ACTIVITY;
   AMERICAN-COLLEGE; CARDIOVASCULAR EVENTS; SCIENTIFIC STATEMENT;
   ASSOCIATION COUNCIL
AB Regular physical activity provides a variety of health benefits, including improvement in cardiopulmonary or metabolic status, reduction of the risk of coronary artery disease or stroke, prevention of cancer, and decrease in total mortality. Exercise-related cardiac events are occasionally reported during highly competitive sports activity or vigorous exercises. However, the risk of sudden death is extremely low during vigorous exercise, and habitual vigorous exercise actually decreases the risk of sudden death during exercise. The cause of sudden death is ischemic in older subjects (>= 35 years old), while cardiomyopathies or genetic ion channel diseases are important underlying pathology in younger (<35 years old) victims. The subgroup of patients who are particularly at higher risk of exercise-related sudden death may be identified in different ways, such as pre-participation history taking, physical examination and/or supplementary cardiac evaluation. Limitations exist because current diagnostic tools are not sufficient to predict a coronary artery plaque with potential risk of disruption and/or an acute thrombotic occlusion. Proper and cost-effective methods for identification of younger subjects with cardiac structural problems or genetic ion channel diseases are still controversial.
C1 Univ Ulsan, Dept Internal Med, Asan Med Ctr, Coll Med, Seoul 138736, South Korea.
RP Nam, GB (corresponding author), Univ Ulsan, Dept Internal Med, Asan Med Ctr, Coll Med, 86 Asan Byeongwon Gil, Seoul 138736, South Korea.
EM gbnam@amc.seoul.kr
FU Ministry of Health & Welfare, Republic of KoreaMinistry of Health &
   Welfare, Republic of Korea [A100607]
FX This study was supported by a grant of the Korea Healthcare technology
   R&D Project, Ministry of Health & Welfare, Republic of Korea (A100607).
CR Aiba T, 2010, CURR OPIN CARDIOL, V25, P29, DOI 10.1097/HCO.0b013e328333d3d6
   Akar FG, 2002, CIRCULATION, V105, P1247, DOI 10.1161/hc1002.105231
   Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902
   Alegria JR, 2005, EUR HEART J, V26, P1159, DOI 10.1093/eurheartj/ehi203
   Alliot E, 2000, FIGHTING SUDDEN CARD
   [Anonymous], 1978, MED SCI SPORTS EXERC, V10, pvii
   Barcin C, 2010, INT J CARDIOL, V138, P215, DOI 10.1016/j.ijcard.2008.06.056
   Basso C, 2000, J AM COLL CARDIOL, V35, P1493, DOI 10.1016/S0735-1097(00)00566-0
   Blair SN, 2009, ANN EPIDEMIOL, V19, P253, DOI 10.1016/j.annepidem.2009.01.019
   Cha YM, 2007, J CARDIOVASC ELECTR, V18, P483, DOI 10.1111/j.1540-8167.2007.00780.x
   Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081
   Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002
   Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602
   Corrado D, 2001, CARDIOVASC RES, V50, P399, DOI 10.1016/S0008-6363(01)00254-1
   Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593
   Corrado D, 2010, EUR HEART J, V31, P243, DOI 10.1093/eurheartj/ehp473
   Ector J, 2007, EUR HEART J, V28, P345, DOI 10.1093/eurheartj/ehl468
   Gaita F, 2003, CIRCULATION, V108, P965, DOI 10.1161/01.CIR.0000085071.28695.C4
   Giustetto C, 2006, EUR HEART J, V27, P2440, DOI 10.1093/eurheartj/ehl185
   Haskell WL, 2007, CIRCULATION, V116, P1081, DOI 10.1161/CIRCULATIONAHA.107.185649
   Hayek E, 2005, LANCET, V365, P507
   Lee CD, 2003, STROKE, V34, P2475, DOI 10.1161/01.STR.0000091843.02517.9D
   Lee IM, 2007, JAMA-J AM MED ASSOC, V297, P2137, DOI 10.1001/jama.297.19.2137
   LEE IM, 1995, JAMA-J AM MED ASSOC, V273, P1179, DOI 10.1001/jama.273.15.1179
   Lee IM, 2004, AM J EPIDEMIOL, V160, P636, DOI 10.1093/aje/kwh274
   Lee IM, 1998, STROKE, V29, P2049, DOI 10.1161/01.STR.29.10.2049
   Lee IM, 2003, MED SCI SPORT EXER, V35, P1823, DOI 10.1249/01.MSS.0000093620.27893.23
   Lee IM, 2003, JAMA-J AM MED ASSOC, V290, P1377, DOI 10.1001/jama.290.10.1377
   Lee IM, 1999, STROKE, V30, P1, DOI 10.1161/01.STR.30.1.1
   Lee IM, 2001, BRIT J CANCER, V85, P962, DOI [10.1038/sj.bjc.6692003, 10.1054/bjoc.2001.2003]
   Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016
   Lee IM, 2000, CIRCULATION, V102, P981, DOI 10.1161/01.CIR.102.9.981
   Liu N, 2006, CIRC RES, V99, P292, DOI 10.1161/01.RES.0000235869.50747.e1
   Luqman N, 2007, INT J CARDIOL, V119, P283, DOI 10.1016/j.ijcard.2006.09.016
   Ly HQ, 2005, CAN J CARDIOL, V21, P441
   Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067
   Maron BJ, 2007, JAMA-J AM MED ASSOC, V298, P405, DOI 10.1001/jama.298.4.405
   Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423
   Maron BJ, 2006, CIRCULATION, V114, P1633, DOI 10.1161/CIRCULATIONAHA.106.613562
   Maron BJ, 2010, NEW ENGL J MED, V362, P917, DOI 10.1056/NEJMra0910111
   Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617
   Maron BJ, 1996, J AM COLL CARDIOL, V28, P428, DOI 10.1016/0735-1097(96)00137-4
   Maron BJ, 2004, CIRCULATION, V109, P2807, DOI 10.1161/01.CIR.0000128363.85581.E1
   Maron BJ, 1997, LANCET, V350, P127, DOI 10.1016/S0140-6736(97)01282-8
   Maury P, 2008, ARCH CARDIOVASC DIS, V101, P779, DOI 10.1016/j.acvd.2008.08.009
   McKenna William J, 2002, Card Electrophysiol Rev, V6, P26, DOI 10.1023/A:1017966518021
   MUNGER TM, 1993, CIRCULATION, V87, P866, DOI 10.1161/01.CIR.87.3.866
   NICOD P, 1988, NEW ENGL J MED, V318, P1255, DOI 10.1056/NEJM198805123181907
   NISHIMURA T, 1980, CIRCULATION, V61, P832, DOI 10.1161/01.CIR.61.4.832
   Oguma Y, 2002, BRIT J SPORT MED, V36, P162, DOI 10.1136/bjsm.36.3.162
   Pappone C, 2004, NEW ENGL J MED, V351, P1197, DOI 10.1056/NEJMoa040625
   PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402
   Pelliccia A, 2002, CIRCULATION, V105, P944, DOI 10.1161/hc0802.104534
   Pelliccia A, 2006, EUR HEART J, V27, P2196, DOI 10.1093/eurheartj/ehl137
   Pelliccia A, 2010, J AM COLL CARDIOL, V55, P1619, DOI 10.1016/j.jacc.2009.10.068
   Plicht B, 2006, HERZ, V31, P14, DOI 10.1007/s00059-006-2775-0
   Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193
   Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8
   Sesso HD, 2000, CIRCULATION, V102, P975, DOI 10.1161/01.CIR.102.9.975
   Shimizu W, 2000, J AM COLL CARDIOL, V35, P778, DOI 10.1016/S0735-1097(99)00582-3
   SISCOVICK DS, 1984, NEW ENGL J MED, V311, P874, DOI 10.1056/NEJM198410043111402
   SISCOVICK DS, 1991, ARCH INTERN MED, V151, P325, DOI 10.1001/archinte.151.2.325
   Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac
   Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485
   THOMPSON PD, 1982, JAMA-J AM MED ASSOC, V247, P2535, DOI 10.1001/jama.247.18.2535
   Vogel T, 2009, INT J CLIN PRACT, V63, P303, DOI 10.1111/j.1742-1241.2008.01957.x
   Wendel-Vos GCW, 2004, INT J EPIDEMIOL, V33, P787, DOI 10.1093/ije/dyh168
   Wever EFD, 2004, J AM COLL CARDIOL, V43, P1137, DOI 10.1016/j.jacc.2003.10.053
   Wilde AAM, 2000, CIRCULATION, V102, P2796
   Yano M, 2000, CIRCULATION, V102, P2131, DOI 10.1161/01.CIR.102.17.2131
   Yano M, 2008, CIRC J, V72, P509
   Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233
NR 72
TC 5
Z9 5
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2011
VL 41
IS 3
BP 113
EP 121
DI 10.4070/kcj.2011.41.3.113
PG 9
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HV
UT WOS:000209078400001
PM 21519508
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, GY
AF Cho, Goo-Yeong
TI Interpretation of Annular Tissue Doppler Imaging
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Cho, Goo-Yeong] Seoul Natl Univ, Bundang Hosp, Coll Med, Div Cardiol,Dept Internal Med,Cardiovasc Ctr, Songnam 463707, South Korea.
RP Cho, GY (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Div Cardiol,Dept Internal Med, 166 Gumi Ro, Songnam 463707, South Korea.
EM cardioch@medimail.co.kr
CR [Anonymous], 1997, J AM COLL CARDIOL, V30, P474
   Baek HK, 2011, KOREAN CIRC J, V41, P137, DOI 10.4070/kcj.2011.41.3.137
   Daneshvar D, 2010, AM HEART J, V160, P394, DOI 10.1016/j.ahj.2010.06.040
   Holland DJ, 2009, EUR J ECHOCARDIOGR, V10, P941, DOI 10.1093/ejechocard/jep103
   Manouras A, 2009, EUR J ECHOCARDIOGR, V10, P406, DOI 10.1093/ejechocard/jen298
NR 5
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2011
VL 41
IS 3
BP 122
EP 123
DI 10.4070/kcj.2011.41.3.122
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HV
UT WOS:000209078400002
PM 21519509
OA Green Published
DA 2021-04-22
ER

PT J
AU Yoon, HJ
   Jeong, MH
   Bae, JH
   Kim, KH
   Ahn, Y
   Cho, JG
   Park, JC
   Kang, JC
AF Yoon, Hyun Ju
   Jeong, Myung Ho
   Bae, Jang Ho
   Kim, Kye Hun
   Ahn, Youngkeun
   Cho, Jeong Gwan
   Park, Jong Chun
   Kang, Jung Chaee
TI Dyslipidemia, Low Left Ventricular Ejection Fraction and High Wall
   Motion Score Index Are Predictors of Progressive Left Ventricular
   Dilatation After Acute Myocardial Infarction
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Heart failure; Prognosis
ID TIME-COURSE; COMMITTEE; DILATION; HEART; MANAGEMENT; EXPANSION; SEGMENT
AB Background and Objectives: Left ventricular (LV) remodeling is a heterogeneous process, involving both infarcted and non-infarcted zones, which affects wall thickness and chamber size, shape and function. Subjects and Methods: A total of 758 consecutive patients (62.8 +/- 12.0 years, 539 males) with acute myocardial infarction (AMI), who were examined by echo-cardiography at admission and after 6 months. An increase in LV end-diastolic volume index >10% was defined as a progressive LV dilation. They were divided into two groups according to the extent of progressive LV dilatation during 6 months. Group I with progressive LV dilatation (n=154, 61.4 +/- 11.0 years, 110 males) vs. group II without LV dilatation (n=604, 64.1 +/- 12.0 years, 429 males). Results: The age and gender were no significant differences between two groups. The levels of glucose, creatinine, maximal creatine kinase (CK), CK-MB, troponin T and I were significantly increased in group I than in group II (p<0.05). Low ejection fraction (EF) and high wall motion score index (WMSI) were more common in group I than in group II (p<0.05). The presence of dyslipidemia {odds ratio (OR); 1.559, confidence interval (CI); 1.035-2.347, p=0.03}, low EF less than 45% (OR; 3.328, CI 2.099-5.276, p<0.01) and high WMSI above 1.5 (OR; 3.328, CI 2.099-5.276, p<0.01) were significant independent predictors of progressive LV dilatation by multivariate analysis. Conclusion: Dyslipidemia, decreased systolic function and high WMSI were independent predictors of LV remodeling process in patients with AMI.
C1 [Yoon, Hyun Ju; Jeong, Myung Ho; Kim, Kye Hun; Ahn, Youngkeun; Cho, Jeong Gwan; Park, Jong Chun; Kang, Jung Chaee] Chonnam Natl Univ Hosp, Ctr Heart, Kwangju 501757, South Korea.
   [Bae, Jang Ho] Konyang Univ Hosp, Ctr Heart, Taejon, South Korea.
   [Jeong, Myung Ho; Ahn, Youngkeun; Kang, Jung Chaee] Korea Cardiovasc Stent Res Inst, Kwangju, South Korea.
RP Jeong, MH (corresponding author), Chonnam Natl Univ Hosp, Ctr Heart, 167 Jaebong Ro, Kwangju 501757, South Korea.
EM myungho@chollian.net
FU Ministry for Health, Welfare & Family Affairs, Republic of KoreaMinistry
   of Health & Welfare, Republic of Korea [A084869]; Korea Ministry of
   Knowledge EconomyMinistry of Knowledge Economy, Republic of Korea
   [10030039]
FX This study was supported by a grant from the Korea Healthcare technology
   R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of
   Korea (A084869).; This work was suppopted by a Grant-in-Aid for Strategy
   Technology Development programs (No. 10030039) from the Korea Ministry
   of Knowledge Economy.
CR Antman Elliott M, 2004, Circulation, V110, pe82
   Bolk J, 2001, INT J CARDIOL, V79, P207, DOI 10.1016/S0167-5273(01)00422-3
   Bolognese L, 2002, CIRCULATION, V106, P2351, DOI 10.1161/01.CIR.0000036014.90197.FA
   Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53
   Cerisano G, 2001, J AM COLL CARDIOL, V37, P793, DOI 10.1016/S0735-1097(00)01203-1
   Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   최소연, 2004, Korean Circulation Journal, V34, P247
   Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0
   Eefting F D, 2006, Neth Heart J, V14, P95
   ERLEBACHER JA, 1984, J AM COLL CARDIOL, V4, P201, DOI 10.1016/S0735-1097(84)80203-X
   GAUDRON P, 1993, CIRCULATION, V87, P755, DOI 10.1161/01.CIR.87.3.755
   Gaudron P, 2001, J AM COLL CARDIOL, V38, P33, DOI 10.1016/S0735-1097(01)01319-5
   Gavin JR, 1997, DIABETES CARE, V20, P1183
   Giannuzzi P, 2001, AM HEART J, V141, P131, DOI 10.1067/mhj.2001.111260
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   Hatzitolios AI, 2009, INT J CARDIOL, V134, P322, DOI 10.1016/j.ijcard.2009.02.001
   HOCHMAN JS, 1987, CIRCULATION, V75, P299, DOI 10.1161/01.CIR.75.1.299
   Hong YJ, 2005, AM J CARDIOL, V95, P619, DOI 10.1016/j.amjcard.2004.10.039
   임상춘, 2007, Korean Circulation Journal, V37, P113
   Ko Jum Suk, 2009, Korean Circ J, V39, P236, DOI 10.4070/kcj.2009.39.6.236
   PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161
   Rouleau JL, 1993, J AM COLL CARDIOL, V22, P390, DOI 10.1016/0735-1097(93)90042-Y
   Sim Doo Sun, 2009, Korean Circ J, V39, P297, DOI 10.4070/kcj.2009.39.8.297
   Simonson J S, 1989, J Am Soc Echocardiogr, V2, P25
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   WARREN SE, 1988, J AM COLL CARDIOL, V11, P12, DOI 10.1016/0735-1097(88)90159-3
   WHITE HD, 1987, CIRCULATION, V76, P44, DOI 10.1161/01.CIR.76.1.44
   Yellon DM, 2000, HEART, V83, P381, DOI 10.1136/heart.83.4.381
   ZEIHER AM, 1991, CIRCULATION, V84, P1984, DOI 10.1161/01.CIR.84.5.1984
NR 30
TC 8
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2011
VL 41
IS 3
BP 124
EP 129
DI 10.4070/kcj.2011.41.3.124
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HV
UT WOS:000209078400003
PM 21519510
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JS
   Lee, HM
   Oh, BC
   Lim, HG
   Lee, JR
AF Kim, Jun Seok
   Lee, Hak-Mo
   Oh, Byoung Chol
   Lim, Hong-Gook
   Lee, Jeong Ryul
TI Effect of Hyperkalemia and Hemolysis Caused by Hyperacute Rejection on
   Cardiac Function in Pig to Human Ex Vivo Xenogeneic Cardiac Perfusion
   Model
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Transplantation; heterologous; Hyperkalemia; Hemolysis; Extracorporeal
   circulation
ID DOUBLE FILTRATION PLASMAPHERESIS; XENOGRAFT SURVIVAL; ANTIBODIES;
   REMOVAL; BABOON; PROLONGATION; RAT
AB Background and Objectives: Hyperacute rejection (HAR) is a major obstacle to successful xenotransplantation of vascularized organs. This study was conducted to observe the effect of hemolysis of perfused human whole blood on pig heart function, and determine the major risk factors for preservation of xenoperfused cardiac function using ex-vivo pig to human xenogeneic cardiac perfusion model. Materials and Methods: Harvested pig hearts were perfused with normal human whole blood (group 1), two different types of pre-treated human whole blood (group 2: immunoglobulins were depleted by plasmapheresis, group 3: pre-treated with plasmapheresis, GAS914, cobra venom factor (CVF) and steroid), and normal porcine whole blood as control (group 4) for 3 hours. Results: Duration of heart beat was significantly prolonged in group 2 and group 3. Histological examination showed widespread HAR features but was gradually delayed in groups 2 and 3 compared to group 1. The absolute levels of serum creatine kinase-MB and Troponin I increased gradually, and was lower in group 3. Serum hemoglobin levels were rapidly increased in groups 3 and 4, compared to group 1. Extracellular potassium level increased sharply from the beginning of blood perfusion in groups 1, 2 and 3, compared to group 4. Conclusion: Pretreatment of human whole blood, including immunoglobulin depletion, CVF and steroid reduced and delayed the destruction of pig myocardium by HAR. However, the increased extracellular potassium levels in groups 1, 2 and 3 reflected that these treatments could not prohibit myocardial injury by HAR.
C1 [Kim, Jun Seok] Konkuk Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.
   [Kim, Jun Seok; Lee, Hak-Mo; Oh, Byoung Chol; Lim, Hong-Gook; Lee, Jeong Ryul] Seoul Natl Univ Hosp, Xenotransplantat Res Ctr, Seoul 110744, South Korea.
   [Lim, Hong-Gook; Lee, Jeong Ryul] Seoul Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Seoul 110744, South Korea.
RP Lee, JR (corresponding author), Seoul Natl Univ Hosp, Clin Res Inst, 101 Daehak Ro, Seoul 110744, South Korea.
EM jrl@plaza.snu.ac.kr
RI Lee, Hakmo/V-8317-2019
OI Lee, Hakmo/0000-0002-8861-4351
FU Seoul National University Hospital Research Fund [04-2006-094-0,
   04-2007-091-0]; Korean Society of Cardiology [06-2004-149-0]
FX This study was supported by grants No.04-2006-094-0 and 04-2007-091-0
   from the Seoul National University Hospital Research Fund, and by the
   Korean Society of Cardiology (Project No.: 06-2004-149-0).
CR Brandl U, 2005, XENOTRANSPLANTATION, V12, P134, DOI 10.1111/j.1399-3089.2005.00208.x
   FISCHEL RJ, 1990, TRANSPLANT P, V22, P1077
   Grimm H, 2000, J THORAC CARDIOV SUR, V119, P477, DOI 10.1016/S0022-5223(00)70126-7
   안정민, 2006, Korean Circulation Journal, V36, P794
   Katopodis AG, 2002, J CLIN INVEST, V110, P1869, DOI 10.1172/JCI200216526
   Kim CH, 1997, KOREAN CIRC J, V27, P767
   KIMIKAWA M, 1992, TRANSPLANT P, V24, P447
   Kobayashi T, 1997, TRANSPLANTATION, V64, P1255, DOI 10.1097/00007890-199711150-00005
   Kroshus TJ, 1996, TRANSPLANTATION, V62, P5, DOI 10.1097/00007890-199607150-00002
   Lee JR, 2004, KOREAN J THORAC CARD, V37, P391
   LEVENTHAL JR, 1995, TRANSPLANTATION, V59, P294, DOI 10.1097/00007890-199501270-00024
   Macchiarini P, 1997, J THORAC CARDIOV SUR, V114, P315, DOI 10.1016/S0022-5223(97)70175-2
   Nishitai R, 2001, LIVER TRANSPLANT, V7, P615, DOI 10.1053/jlts.2001.25362
   Oberholzer J, 1999, IMMUNOLOGY, V97, P173
   Rydberg Lennart, 1995, Xenotransplantation, V2, P253, DOI 10.1111/j.1399-3089.1995.tb00106.x
   SACHS DH, 1994, PATHOL BIOL, V42, P217
   Sato Y, 1992, ASAIO J, V38, pM673, DOI 10.1097/00002480-199207000-00122
   Satoh S, 1997, TRANSPLANTATION, V64, P1117, DOI 10.1097/00007890-199710270-00006
   Shimizu A, 2008, AM J PATHOL, V172, P1471, DOI 10.2353/ajpath.2008.070672
   Suga H, 1991, ASAIO Trans, V37, pM433
   SYKES M, 1994, IMMUNOL REV, V141, P245, DOI 10.1111/j.1600-065X.1994.tb00880.x
   TAMBOURGI DV, 1994, BRIT J PHARMACOL, V112, P723, DOI 10.1111/j.1476-5381.1994.tb13137.x
   Tanemura M, 2000, J CLIN INVEST, V105, P301, DOI 10.1172/JCI7358
   Tonomura N, 2008, XENOTRANSPLANTATION, V15, P129, DOI 10.1111/j.1399-3089.2008.00450.x
   Vogel CW, 2004, MOL IMMUNOL, V41, P191, DOI 10.1016/j.molimm.2004.03.011
   Walpen AJ, 2002, TRANSPL IMMUNOL, V9, P271, DOI 10.1016/S0966-3274(02)00081-3
   Yeh JH, 2004, TRANSFUSION, V44, P1621, DOI 10.1111/j.1537-2995.2004.04154.x
   백상홍, 2005, Korean Circulation Journal, V35, P415
NR 28
TC 1
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2011
VL 41
IS 3
BP 130
EP 136
DI 10.4070/kcj.2011.41.3.130
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HV
UT WOS:000209078400004
PM 21519511
OA Green Published
DA 2021-04-22
ER

PT J
AU Baek, HK
   Park, TH
   Park, SY
   Kim, JH
   Seo, JM
   Kim, WJ
   Nam, YH
   Kim, MH
   Kim, YD
AF Baek, Hee-Kyung
   Park, Tae-Ho
   Park, Sun-Yi
   Kim, Jung-Hwan
   Seo, Jeong-Min
   Kim, Woo-Jae
   Nam, Young-Hee
   Kim, Moo-Hyun
   Kim, Young-Dae
TI Determination of Diastolic Dysfunction Cut-Off Value by Tissue Doppler
   Imaging in Adults 70 Years of Age or Older: A Comparative Analysis of
   Pulsed-Wave and Color-Coded Tissue Doppler Imaging
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Heart failure; diastolic; Echocardiography; Aging
AB Background and Objectives: The cut-off value of diastolic dysfunction by tissue Doppler imaging (TDI) is affected by aging and modalities used (pulsed-wave vs. color-coded). The purpose of this study was to investigate the diastolic function of healthy elderly people and to determine the appropriate cut-off value of diastolic dysfunction in elderly individuals. Subjects and Methods: Healthy volunteers (n=76) and patients with hypertension (n=51) aged >= 70 years underwent 2-dimensional and Doppler echocardiography. Mitral annulus velocities of TDI were measured at septal and lateral sites using the pulsed-wave and color-coded modalities. The appropriate cut-off value of diastolic dysfunction for healthy elderly individuals was defined as the lower limit of the 95% confidence interval for early diastolic mitral annulus velocity (Ea). Results: The mean septal and lateral Ea were 6.5 +/- 1.5 and 8.3 +/- 1.7 cm/s, respectively, by pulsed-wave TDI, and 6.1 +/- 1.4 and 7.9 +/- 1.7 cm/s, respectively, by color-coded TDI. The cut-off values for diastolic dysfunction were as follows: septal and lateral Ea were 6.1 and 7.9 cm/s by pulsed-wave TDI, and 5.7 and 7.5 cm/s by color-coded TDI, respectively. When the group was stratified by gender, Ea was significantly lower in women than men. Conclusion: When interpreting diastolic function as measured by TDI in elderly subjects, different cut-off values should be considered based on the TDI modality, annulus site, and gender.
C1 [Baek, Hee-Kyung; Park, Tae-Ho; Park, Sun-Yi; Kim, Jung-Hwan; Seo, Jeong-Min; Kim, Woo-Jae; Nam, Young-Hee; Kim, Moo-Hyun; Kim, Young-Dae] Dong A Univ, Dept Cardiol, Coll Med, Pusan 602715, South Korea.
RP Park, TH (corresponding author), Dong A Univ, Dept Cardiol, Coll Med, 1 Dongdaesin Dong 3 Ga, Pusan 602715, South Korea.
EM thpark65@dau.ac.kr
OI Nam, Young-Hee/0000-0001-8759-2982
FU Dong-A University
FX This study was supported by research funds from Dong-A University.
CR Anderson B., 2007, ECHOCARDIOGRAPHY NOR, P323
   Chetboul V, 2004, EUR HEART J, V25, P1934, DOI 10.1016/j.ehj.2004.09.007
   Galvao M, 2006, J CARD FAIL, V12, P100, DOI 10.1016/j.cardfail.2005.09.005
   Garcia MJ, 1998, J AM COLL CARDIOL, V32, P865, DOI 10.1016/S0735-1097(98)00345-3
   Garcia MJ, 1996, J AM COLL CARDIOL, V27, P108, DOI 10.1016/0735-1097(95)00434-3
   Ha JW, 2005, KOREAN CIRC J, V35, P865
   HIROTA Y, 1980, CIRCULATION, V62, P756, DOI 10.1161/01.CIR.62.4.756
   Hunt Sharon Ann, 2005, J Am Coll Cardiol, V46, pe1, DOI 10.1016/j.jacc.2005.08.022
   Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014
   Masoudi FA, 2003, J AM COLL CARDIOL, V41, P217, DOI 10.1016/S0735-1097(02)02696-7
   Moon CI, 2001, KOREAN CIRC J, V31, P662
   Munagala VK, 2003, J AM SOC ECHOCARDIOG, V16, P1049, DOI 10.1016/S0894-7317(03)00516-9
   Nagueh SE, 2003, CLIN SCI, V105, P395, DOI 10.1042/CS20030214
   Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6
   Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7
   Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194
   Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078
   Ren XS, 2007, AM J CARDIOL, V99, P1643, DOI 10.1016/j.amjcard.2007.01.041
   Rodriguez L, 1996, AM HEART J, V131, P982, DOI 10.1016/S0002-8703(96)90183-0
   Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358
   Sohn DW, 1997, J AM COLL CARDIOL, V30, P474, DOI 10.1016/S0735-1097(97)88335-0
   Strand A, 2008, EUR J ECHOCARDIOGR, V9, P34, DOI 10.1016/j.euje.2007.02.007
   Wong CY, 2004, CIRCULATION, V110, P3081, DOI 10.1161/01.CIR.0000147184.13872.0F
   Yamada H, 1999, J AM SOC ECHOCARDIOG, V12, P574, DOI 10.1016/S0894-7317(99)70005-2
   Yancy CW, 2006, J AM COLL CARDIOL, V47, P76, DOI 10.1016/j.jacc.2005.09.022
   ZARICH SW, 1991, AM J CARDIOL, V68, P377, DOI 10.1016/0002-9149(91)90835-9
NR 26
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2011
VL 41
IS 3
BP 137
EP 142
DI 10.4070/kcj.2011.41.3.137
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HV
UT WOS:000209078400005
PM 21519512
OA Green Published
DA 2021-04-22
ER

PT J
AU Youn, YJ
   Yoon, J
   Han, SW
   Lee, JW
   Sung, JK
   Ahn, SG
   Kim, JY
   Yoo, BS
   Lee, SH
   Choe, KH
AF Youn, Young Jin
   Yoon, Junghan
   Han, Sang Woo
   Lee, Jun-Won
   Sung, Joong Kyung
   Ahn, Sung-Gyun
   Kim, Jang-Young
   Yoo, Byung-Su
   Lee, Seung-Hwan
   Choe, Kyung-Hoon
TI Feasibility of Transradial Coronary Intervention Using a Sheathless
   Guiding Catheter in Patients With Small Radial Artery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary intervention; Radial artery; Vascular access
AB Background and Objectives: Transradial coronary angiography and intervention are increasing in frequency due to lower major vascular access site complications and the potential for early mobilization. However, the small size of the radial artery (RA) is a major limitation of this technique. A sheathless guiding catheter (GC) has recently been introduced that has a 1-2 French smaller diameter compared with the corresponding introducer sheath. This catheter also has a hydrophilic coating along its entire length. We evaluated the feasibility of using a sheathless GC in patients who have small radial arteries. Subjects and Methods: The procedural results were evaluated in patients with small radial arteries (diameter <2.3 mm) who underwent transradial coronary intervention using a sheathless GC. Results: A total of 25 (male: 9) patients with 29 lesions were enrolled. The mean RA diameter was 1.81 +/- 0.26 mm. 44% of the patients had stable angina and 50.0% had acute coronary syndrome. The procedural success rate was 93.1%. Two patients (6.9%) had chronic total occlusive lesions that could not be crossed with a guide-wire despite good guiding support. An intravascular ultrasound could be used for all of the treated lesions. Multi-vessel intervention was performed in 29.2% of the patients. Two bifurcated lesions were treated with a kissing balloon technique, and one with a modified T-stenting technique. No catheter related complications were reported. Conclusion: The use of a sheathless GC is feasible in patients with small radial arteries without catheter related complications.
C1 [Youn, Young Jin; Yoon, Junghan; Han, Sang Woo; Lee, Jun-Won; Sung, Joong Kyung; Ahn, Sung-Gyun; Kim, Jang-Young; Yoo, Byung-Su; Lee, Seung-Hwan; Choe, Kyung-Hoon] Yonsei Univ, Div Cardiol, Wonju Coll Med, Wonju 220701, South Korea.
RP Yoon, J (corresponding author), Yonsei Univ, Div Cardiol, Wonju Coll Med, 162 Ilsan Dong, Wonju 220701, South Korea.
EM jyoon@yonsei.ac.kr
RI Ahn, Sung Gyun/AAG-5976-2020
OI Ahn, Sung Gyun/0000-0002-1528-2739; Lee, Jun-Won/0000-0001-6206-1704
CR Agostoni P, 2004, J AM COLL CARDIOL, V44, P349, DOI 10.1016/j.jacc.2004.04.034
   Cubero JM, 2009, CATHETER CARDIO INTE, V73, P467, DOI 10.1002/ccd.21900
   Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023
   Kiemeneij F, 2003, CATHETER CARDIO INTE, V59, P161, DOI 10.1002/ccd.10444
   Liang M, 2010, CATHETER CARDIO INTE, V75, P222, DOI 10.1002/ccd.22236
   Mamas MA, 2008, CATHETER CARDIO INTE, V72, P357, DOI 10.1002/ccd.21637
   Mamas M, 2010, CATHETER CARDIO INTE, V75, P596, DOI 10.1002/ccd.22246
   Saito S, 1999, CATHETER CARDIO INTE, V46, P173, DOI 10.1002/(SICI)1522-726X(199902)46:2<173::AID-CCD12>3.0.CO;2-4
   Yoo BS, 2000, KOREAN CIRC J, V30, P82
NR 9
TC 18
Z9 18
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2011
VL 41
IS 3
BP 143
EP 148
DI 10.4070/kcj.2011.41.3.143
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HV
UT WOS:000209078400006
PM 21519513
OA Green Published
DA 2021-04-22
ER

PT J
AU Cho, YK
   Hur, SH
   Han, CD
   Park, HS
   Yoon, HJ
   Kim, H
   Nam, CW
   Kim, YN
   Kim, KB
   Park, NH
   Park, HJ
AF Cho, Yun-Kyeong
   Hur, Seung-Ho
   Han, Chun-Duk
   Park, Hyoung-Seob
   Yoon, Hyuck-Jun
   Kim, Hyungseop
   Nam, Chang-Wook
   Kim, Yoon-Nyun
   Kim, Kwon-Bae
   Park, Nam-Hee
   Park, Hee-Jun
TI Comparison of Ezetimibe/Simvastatin 10/20 mg Versus Atorvastatin 20 mg
   in Achieving a Target Low Density Lipoprotein-Cholesterol Goal for
   Patients With Very High Risk
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Ezetimibe; Simvastatin; Atorvastatin
ID ABSORPTION INHIBITOR; SIMVASTATIN; EZETIMIBE; EFFICACY; SAFETY;
   HYPERCHOLESTEROLEMIA; SCH58235; VYTORIN; STATINS; TRIALS
AB Background and Objectives: Although recent lipid-lowering therapies are effective in reducing low density lipoprotein-cholesterol (LDL-C) levels, many patients treated with lipid-lowering agents do not achieve target LDL-C levels, especially in very high risk patients. The aim of this study is to compare the effect of ezetimibe/simvastatin 10/20 mg and atorvastatin 20 mg on achieving a target LDL-C goal in very high risk patients. Subjects and Methods: A total of 74 patients with very high risk were enrolled in the study. Very high risk patients were defined as patients that displayed established cardiovascular disease with multiple major risk factors, poorly controlled risk factors, multiple risk factors of the metabolic syndrome and acute coronary syndromes. Patients were randomized into two groups: ezetimibe/simvastatin 10/20 mg (n=36) and atorvastatin 20 mg (n=38). Follow-up lipid profile was obtained 6 weeks later. A target goal of LDL-C was defined as less than 70 mg/dL at follow-up. Results: Baseline clinical and laboratory data were similar between the two groups. Achieving a target LDL-C goal was observed in 41.7% of Group 1 and 44.7% of Group 2 at 6 weeks (p=0.82). Changes in other lipid profiles were not significantly different but the tolerability of the two groups was similar. Conclusion: Ezetimibe/simvastatin 10/20 mg and atorvastatin 20 mg showed similar effects in achieving target LDL-C levels in patients with very high risk.
C1 [Cho, Yun-Kyeong; Hur, Seung-Ho; Han, Chun-Duk; Park, Hyoung-Seob; Yoon, Hyuck-Jun; Kim, Hyungseop; Nam, Chang-Wook; Kim, Yoon-Nyun; Kim, Kwon-Bae] Keimyung Univ, Dongsan Hosp, Dept Internal Med, Taegu 700712, South Korea.
   [Park, Nam-Hee] Keimyung Univ, Dongsan Hosp, Dept Thorac & Cardiovasc Surg, Taegu 700712, South Korea.
   [Park, Hee-Jun] Keimyung Univ, Dongsan Hosp, Dept Med Informat, Taegu 700712, South Korea.
RP Hur, SH (corresponding author), Keimyung Univ, Dongsan Hosp, Dept Internal Med, 194 Jung Gu, Taegu 700712, South Korea.
EM shur@dsmc.or.kr
OI Hur, Seung-Ho/0000-0002-3895-1915
CR American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4
   Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1
   Ballantyne CM, 2005, AM HEART J, V149, P464, DOI 10.1016/j.ahj.2004.11.023
   Ballantyne CM, 2004, AM J CARDIOL, V93, P1487, DOI 10.1016/j.amjcard.2004.02.060
   Cannon CP, 2008, AM HEART J, V156, P826, DOI 10.1016/j.ahj.2008.07.023
   Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Collins R, 2002, LANCET, V360, P23
   Collins R, 2003, LANCET, V361, P2005
   Davidson MH, 2004, INT J CLIN PRACT, V58, P746, DOI 10.1111/j.1368-5031.2004.00289.x
   Davidson MH, 2002, J AM COLL CARDIOL, V40, P2125, DOI 10.1016/S0735-1097(02)02610-4
   Goldberg AC, 2004, MAYO CLIN PROC, V79, P620, DOI 10.4065/79.5.620
   Goldberg RB, 2006, MAYO CLIN PROC, V81, P1579, DOI 10.4065/81.12.1579
   Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E
   윤경호, 2007, Korean Circulation Journal, V37, P154
   KANNEL WB, 1979, ANN INTERN MED, V90, P85, DOI 10.7326/0003-4819-90-1-85
   Murphy SA, 2007, AM J CARDIOL, V100, P1047, DOI 10.1016/j.amjcard.2007.04.053
   van Heek M, 2000, BRIT J PHARMACOL, V129, P1748, DOI 10.1038/sj.bjp.0703235
   VanHeek M, 1997, J PHARMACOL EXP THER, V283, P157
NR 19
TC 10
Z9 10
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2011
VL 41
IS 3
BP 149
EP 153
DI 10.4070/kcj.2011.41.3.149
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HV
UT WOS:000209078400007
PM 21519514
OA Green Published
DA 2021-04-22
ER

PT J
AU Song, JY
   Kim, YK
   Kim, SJ
   Choi, EY
   Shim, WS
AF Song, Jinyoung
   Kim, Yu Kyung
   Kim, Soo Jin
   Choi, Eun-Young
   Shim, Woo Seup
TI An Adult Case of Internal Mammary Arterio-Venous Fistula
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Arteriovenous fistula; Embolization; therapeutic; Cardiac murmurs
ID ARTERY
AB A left internal mammary artery to vein fistula was found incidentally in a 32-year-old woman with a continuous murmur. There was no significant history of trauma and no cardiac symptoms. A percutaneous embolization with vascular plug and coil was performed.
C1 [Song, Jinyoung; Kim, Soo Jin; Choi, Eun-Young; Shim, Woo Seup] Sejong Gen Hosp, Dept Pediat, Sejong Cardiovasc Ctr, Puchon 422711, South Korea.
   [Kim, Yu Kyung] Pohang Sunlin Hosp, Dept Pediat, Pohang, South Korea.
RP Song, JY (corresponding author), Sejong Gen Hosp, Dept Pediat, Sejong Cardiovasc Ctr, 91-121 Sosabon 2 Dong, Puchon 422711, South Korea.
EM amyjys@naver.com
RI Kim, Soo-Jin/P-2677-2014
OI Kim, Soo-Jin/0000-0001-9671-6019
CR Anguera I, 1999, J CARDIOVASC SURG, V40, P523
   이숙진, 2002, Korean Circulation Journal, V32, P163
   Kirke R, 2007, EUR J CARDIO-THORAC, V32, P165, DOI 10.1016/j.ejcts.2007.03.042
   Moura R, 1993, Cardiovasc Surg, V1, P86
   ZULLO MA, 1991, CHEST, V100, P572, DOI 10.1378/chest.100.2.572
NR 5
TC 5
Z9 5
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2011
VL 41
IS 3
BP 154
EP 155
DI 10.4070/kcj.2011.41.3.154
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HV
UT WOS:000209078400008
PM 21519515
OA Green Published
DA 2021-04-22
ER

PT J
AU Jo, YJ
   Lee, EJ
   Oh, JW
   Moon, CM
   Cho, DK
   Cho, YH
   Byun, KH
   Eun, LY
AF Jo, Yun Ju
   Lee, Eun Jeong
   Oh, Jin Won
   Moon, Chang Min
   Cho, Deok Kyu
   Cho, Yun Hyeong
   Byun, Ki Hyun
   Eun, Lucy Youngmin
TI Aortic Dissection and Rupture in a Child
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Children; Chest pain; Aorta; Aneurysm; disseching; Aortic rupture
AB After developing sudden severe chest pain, an 11-year-old boy presented to the emergency room with chest pain and palpitations and was unable to stand up. The sudden onset of chest pain was first reported while swimming at school about 30 minutes prior to presentation. Arterial blood pressure (BP) was 150/90 mmHg, heart rate was 120/minute, and the chest pain was combined with shortness of breath and diaphoresis. During the evaluation in the emergency room, the chest pain worsened and abdominal pain developed. An aortic dissection was suspected and a chest and abdomen CT was obtained. The diagnosis of aortic dissection type B was established by CT imaging. The patient went to surgery immediately with BP control. He died prior to surgery due to aortic rupture. Here we present this rare case of aortic dissection type B with rupture, reported in an 11-year-old Korean child.
C1 [Jo, Yun Ju; Lee, Eun Jeong; Oh, Jin Won; Moon, Chang Min; Eun, Lucy Youngmin] Kwandong Univ, Dept Pediat Cardiol, Myongji Hosp Cardiovasc Ctr, Goyang 412270, South Korea.
   [Cho, Deok Kyu; Cho, Yun Hyeong; Byun, Ki Hyun] Kwandong Univ, Dept Adult Cardiol, Myongji Hosp Cardiovasc Ctr, Goyang 412270, South Korea.
RP Eun, LY (corresponding author), Kwandong Univ, Dept Pediat Cardiol, Myongji Hosp Cardiovasc Ctr, Goyang 412270, South Korea.
EM lucyeun@gmail.com
OI Eun, Lucy/0000-0002-4577-3168
CR Cho Seong Ho, 2009, Korean Circ J, V39, P270, DOI 10.4070/kcj.2009.39.7.270
   COOPER DR, 1986, AM FAM PHYSICIAN, V34, P137
   DESANCTIS RW, 1987, NEW ENGL J MED, V317, P1060, DOI 10.1056/NEJM198710223171705
   Edwin Frank, 2009, Interact Cardiovasc Thorac Surg, V9, P368, DOI 10.1510/icvts.2009.202234B
   Fikar Charles R, 2009, Clin Cardiol, V32, pE23, DOI 10.1002/clc.20383
   FIKAR CR, 1981, CLIN PEDIATR, V20, P578, DOI 10.1177/000992288102000904
   Fikar GR, 2000, CLIN PEDIATR, V39, P71, DOI 10.1177/000992280003900201
   Fishbein MC, 2009, CARDIOVASC PATHOL
   Gray J, 2005, EUR J EMERG MED, V12, P253, DOI 10.1097/00063110-200510000-00012
   HASHIMOTO A, 1991, JPN CIRC J, V55, P821, DOI 10.1253/jcj.55.821
   Hatzaras IS, 2007, AM J CARDIOL, V100, P1470, DOI 10.1016/j.amjcard.2007.06.039
   HORWITZ AE, 1986, MONATSSCHR KINDERH, V134, P28
   강웅철, 2003, Korean Circulation Journal, V33, P457
   이석, 2006, Korean Circulation Journal, V36, P387
   Mitsnefes MM, 2006, PEDIATR CLIN N AM, V53, P493, DOI 10.1016/j.pcl.2006.02.008
   Park Sun Hee, 2009, Korean Circ J, V39, P428, DOI 10.4070/kcj.2009.39.10.428
   Qureshi Shakeel Ahmed, 2009, Korean Circ J, V39, P261, DOI 10.4070/kcj.2009.39.7.261
   Rizzoli G, 1997, EUR J CARDIO-THORAC, V12, P202, DOI 10.1016/S1010-7940(97)00157-7
   Schor JS, 1996, ANN THORAC SURG, V61, P1339, DOI 10.1016/0003-4975(96)00105-1
   TEIEN D, 1991, ACTA PAEDIATR SCAND, V80, P1246, DOI 10.1111/j.1651-2227.1991.tb11818.x
NR 20
TC 4
Z9 4
U1 0
U2 7
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2011
VL 41
IS 3
BP 156
EP 159
DI 10.4070/kcj.2011.41.3.156
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HV
UT WOS:000209078400009
PM 21519516
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, MY
   Lee, MG
   Hong, KS
   Lee, CY
   Park, KT
   Lee, CW
   Ryu, MS
   Kim, YM
   Hwang, DH
AF Lee, Min Young
   Lee, Myung-Goo
   Hong, Kyung-Soon
   Lee, Chang Yul
   Park, Kyu Tae
   Lee, Chan Woo
   Ryu, Myeong Shin
   Kim, Young Muk
   Hwang, Dae Hyun
TI A Case of Paraplegia Following Endovascular Stent Repair of Descending
   Thoracic Aortic Aneurysm
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Stents; Spinal cord ischemia; Aortic aneurysm; abdominal
ID SPINAL-CORD ISCHEMIA; COMPLICATIONS
AB Paraplegia secondary to spinal cord infarction is a recognized complication of open thoracic and thoracoabdominal aortic aneurysm (TAA) repair. TAA is serious and unpredictable condition. Therefore, aortic repair requires thorough information on managing the potential complications will facilitate improve control the problem. We report the symptoms and management of paraplegia in a patient who underwent stent insertion as TAA.
C1 [Lee, Min Young; Lee, Myung-Goo; Hong, Kyung-Soon; Lee, Chang Yul; Park, Kyu Tae; Lee, Chan Woo; Ryu, Myeong Shin; Kim, Young Muk] Hallym Univ, Coll Med, Dept Internal Med, Chuncheon Sacred Heart Hosp, Chunchon 200704, South Korea.
   [Hwang, Dae Hyun] Hallym Univ, Coll Med, Hangang Sacred Heart Hosp, Dept Radiol, Chunchon 200704, South Korea.
RP Lee, MG (corresponding author), Hallym Univ, Coll Med, Dept Internal Med, Div Pulm Allergy & Crit Care Med, 153 Gyodong, Chunchon 200704, South Korea.
EM mglee@hallym.or.kr
CR Ahn，Chul-Min, 2007, Korean Circulation Journal, V37, P459
   Berg P, 2001, EUR J VASC ENDOVASC, V22, P342, DOI 10.1053/ejvs.2001.1470
   Bracken MB, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001046
   Cheung AT, 2005, ANN THORAC SURG, V80, P1280, DOI 10.1016/j.athoracsur.2005.04.027
   최진호, 2008, The Korean Journal of Thoracic and Cardiovascular Surgery, V41, P239
   Fattori R, 2003, RADIOLOGY, V229, P176, DOI 10.1148/radiol.2291020905
   Garcia ND, 2002, ANN VASC SURG, V16, P509, DOI 10.1007/s10016-001-0033-8
   Gowda RM, 2003, CHEST, V124, P714, DOI 10.1378/chest.124.2.714
   Grabenwoger M, 2000, ANN THORAC SURG, V69, P441, DOI 10.1016/S0003-4975(99)01291-6
   Lim KJ, 2005, KOREAN J ANESTHESIOL, V49, P106
   Piffaretti G, 2006, J CARDIOTHORAC SURG, V1, DOI 10.1186/1749-8090-1-26
   Sullivan TM, 2006, J VASC SURG, V43, p85A, DOI 10.1016/j.jvs.2005.10.048
   Weigang E, 2005, EUR J VASC ENDOVASC, V30, P624, DOI 10.1016/j.ejvs.2005.05.029
   ZUBER WF, 1970, ANN SURG, V172, P909, DOI 10.1097/00000658-197011000-00018
NR 14
TC 3
Z9 3
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2011
VL 41
IS 3
BP 160
EP 163
DI 10.4070/kcj.2011.41.3.160
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HV
UT WOS:000209078400010
PM 21519517
OA Green Published
DA 2021-04-22
ER

PT J
AU Park, JS
   Pak, HN
   Lee, MH
   Kim, SS
   Joung, B
AF Park, Jong Sung
   Pak, Hui-Nam
   Lee, Moon-Hyoung
   Kim, Sung Soon
   Joung, Boyoung
TI Implantable Cardioverter-Defibrillator Lead Extraction by Conventional
   Traction and Counter-Traction Technique
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Implantable cardioverter defibrillators; Medical device failure; Device
   removal
AB A 46-year-old man presented to our institution with inappropriate implantable cardioverter-defibrillator (ICD) shock delivery. The ICD (single chamber, dual shock coils) was implanted for sustained monomorphic ventricular tachycardia with unstable hemodynamics and underlying systolic left ventricular dysfunction. ICD interrogation revealed recurrent episodes of ICD shock due to noise sensing and increased impedance of right ventricular-lead. With the impression of lead fracture, ICD lead extraction was performed. The fractured ICD lead was completely removed by traction of locking stylet and counter-traction of polypropylene dilator sheath. A new lead was inserted and the patient was discharged without complications after 2 days. To our knowledge, this is the first report on ICD lead extraction by conventional traction and counter-traction technique in Korea.
C1 [Park, Jong Sung; Pak, Hui-Nam; Lee, Moon-Hyoung; Kim, Sung Soon; Joung, Boyoung] Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, Seoul 120752, South Korea.
RP Joung, B (corresponding author), Yonsei Univ Hlth Syst, Severance Cardiovasc Hosp, Div Cardiol, 250 Seongsan No, Seoul 120752, South Korea.
EM cby6908@yuhs.ac
RI Pak, Hui-Nam/C-4266-2015
OI Pak, Hui-Nam/0000-0002-3256-3620
CR Alt E, 1996, PACE, V19, P18, DOI 10.1111/j.1540-8159.1996.tb04786.x
   BECKER AE, 1972, CIRCULATION, V46, P409, DOI 10.1161/01.CIR.46.2.409
   Bohm A, 1998, PACE, V21, P629, DOI 10.1111/j.1540-8159.1998.tb00111.x
   Byrd CL, 2002, PACE, V25, P804, DOI 10.1046/j.1460-9592.2002.t01-1-00804.x
   Byrd CL, 1999, PACE, V22, P1348, DOI 10.1111/j.1540-8159.1999.tb00628.x
   Eckart RE, 2006, PACE, V29, P784, DOI 10.1111/j.1540-8159.2006.00435.x
   Hauser RG, 2010, EUROPACE, V12, P395, DOI 10.1093/europace/eup375
   Kim DH, 2005, KOREAN CIRC J, V35, P69
   Kim YH, 2004, KOREAN CIRC J, V34, P395
   Klug D, 2002, PACE, V25, P1023, DOI 10.1046/j.1460-9592.2002.01023.x
   Molina JE, 1997, ANN THORAC SURG, V63, P504
   Neuzil P, 2007, EUROPACE, V9, P98, DOI 10.1093/europace/eul171
   Rosenheck S, 2002, PACE, V25, P1029, DOI 10.1046/j.1460-9592.2002.01029.x
   SMITH HJ, 1994, PACE, V17, P2016, DOI 10.1111/j.1540-8159.1994.tb03792.x
NR 14
TC 1
Z9 1
U1 0
U2 5
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2011
VL 41
IS 3
BP 164
EP 166
DI 10.4070/kcj.2011.41.3.164
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HV
UT WOS:000209078400011
PM 21519518
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JH
   Kim, SK
   Kim, DC
   Park, HC
   Choi, SI
   Shin, JH
   Lee, JU
   Kim, JH
   Lim, HK
AF Kim, Jae Hoon
   Kim, Soon Kil
   Kim, Dong Chan
   Park, Hwan Cheol
   Choi, Sung Il
   Shin, Jin Ho
   Lee, Jae Ung
   Kim, Jeong Hyun
   Lim, Heon Kil
TI Recurrent Infective Endocarditis Associated With Pyogenic
   Spondylodiskitis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Infective endocarditis; Spondylodiskitis
ID SEPTIC DISCITIS
AB Infective endocarditis is a life-threatening condition caused by microbial infection of the heart's endocardial surface. This condition can also be associated with bacterial infections of other organs. We experienced an unusual case of recurrent infective endocarditis associated with pyogenic spondylodiskitis. A 70-year-old man presented with persistent fever and lower back pain visited our hospital. The patient had a past history of recurrent infective endocarditis. He was diagnosed with infective endocarditis again based on clinical symptoms and echocardiographic findings. Magnetic resonance imaging was used to evaluate lower back pain, which showed acute spondylodiskitis on L3 and L4 vertebrae. The patient completely recovered following four weeks of antibiotic therapy.
C1 [Kim, Jae Hoon; Kim, Soon Kil; Kim, Dong Chan; Park, Hwan Cheol; Choi, Sung Il; Shin, Jin Ho; Lee, Jae Ung; Kim, Jeong Hyun; Lim, Heon Kil] Hanyang Univ, Guri Hosp, Dept Internal Med, Coll Med, 249-1 Gyomundong, Guri 471701, South Korea.
RP Kim, SK (corresponding author), Hanyang Univ, Guri Hosp, Dept Internal Med, Coll Med, 249-1 Gyomundong, Guri 471701, South Korea.
EM kimsg@hanyang.ac.kr
OI Shin, Jinho/0000-0001-6706-6504; Choi, Seongil/0000-0001-5927-8574
CR Cottle L, 2008, J INFECTION, V56, P401, DOI 10.1016/j.jinf.2008.02.005
   Duval X, 2008, LANCET INFECT DIS, V8, P225, DOI 10.1016/S1473-3099(08)70064-1
   Hopkinson N, 2001, QJM-MON J ASSOC PHYS, V94, P465, DOI 10.1093/qjmed/94.9.465
   Joon Lee Myung, 2006, Korean Circulation Journal, V36, P236
   박창범, 2005, Korean Circulation Journal, V35, P633
   Kim MK, 2000, KOREAN J MED, V58, P28
   Kiyooka T, 2007, CIRCULATION, V116, P173, DOI 10.1161/CIRCULATIONAHA.106.183095
   Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X
   Pigrau C, 2005, AM J MED, V118, DOI 10.1016/j.amjmed.2005.02.027
   PONTE CD, 1992, J FAM PRACTICE, V34, P767
   Talsania N, 2005, INTERNET J RHEUMATOL, V2, P3
   Udayaraj UP, 2003, J RHEUMATOL, V30, P632
NR 12
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD MAR
PY 2011
VL 41
IS 3
BP 167
EP 170
DI 10.4070/kcj.2011.41.3.167
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HV
UT WOS:000209078400012
PM 21519519
OA Green Published
DA 2021-04-22
ER

PT J
AU Akagi, T
AF Akagi, Teiji
TI Catheter Interventions for Kawasaki Disease: Current Concepts and Future
   Directions
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Kawasaki disease; Angioplasty balloon; Coronary arteries
AB During the past 15 years, clinical experience with catheter interventional treatment in patients with Kawasaki disease, including balloon angioplasty, stent implantation, rotational ablation, and transluminal coronary revascularization, has been gradually increasing. Because the coronary artery lesions in Kawasaki disease involve severe calcifications, the indications or catheter intervention techniques have not been established for adult patients with Kawasaki disease. Satisfactory acute results for coronary balloon angioplasty have been obtained in patients with a relatively short interval from the onset of disease, especially within 6 years; however, the incidence of restenosis after angioplasty is still high. Rotational ablation may be the most appropriate catheter intervention technique for patients with Kawasaki disease. The advantage of rotational ablation is the high success rate, even in patients with calcified coronary artery stenosis. Stent implantation requires larger arterial access and is not possible in younger children. Care should be paid to the detection of newly-formed aneurysms, as the formation of new aneurysms is associated with the use of additional balloon angioplasty using high pressure balloon inflation. Anticoagulation or anti-platelet regimens are essential for long-term management. Coronary intervention in Kawasaki disease requires special techniques and knowledge of cardiovascular involvement. The procedure should be managed under the close collaboration between pediatric cardiologists and coronary interventional cardiologists.
C1 Okayama Univ, Cardiac Intens Care Unit, Okayama 7008558, Japan.
RP Akagi, T (corresponding author), Okayama Univ, Cardiac Intens Care Unit, 2-5-1 Shikata Cho, Okayama 7008558, Japan.
EM t-akagi@cc.okayama-u.ac.jp
CR Akagi T, 2000, J PEDIATR-US, V137, P181, DOI 10.1067/mpd.2000.107164
   Akagi T, 2005, PEDIATR CARDIOL, V26, P206, DOI 10.1007/s00246-004-0964-2
   Hashmi A, 1999, CATHETER CARDIO INTE, V46, P333, DOI 10.1002/(SICI)1522-726X(199903)46:3<333::AID-CCD14>3.3.CO;2-W
   Hijazi ZM, 1997, J INVASIVE CARDIOL, V9, P534
   Iemura M, 2000, HEART, V83, P307, DOI 10.1136/heart.83.3.307
   Ino T, 1996, CIRCULATION, V93, P1709, DOI 10.1161/01.CIR.93.9.1709
   Ishii M, 2002, CIRCULATION, V105, P3004, DOI 10.1161/01.CIR.0000019733.56553.D8
   Ishii M, 2001, PEDIATR INT, V43, P558, DOI 10.1046/j.1442-200X.2001.01464.x
   KATO H, 1991, Acta Paediatrica Japonica, V33, P27
   Kato H, 1998, J INTERV CARDIOL, V11, P355, DOI 10.1111/j.1540-8183.1998.tb00138.x
   Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379
   KATO H, 1992, LANCET, V340, P1127, DOI 10.1016/0140-6736(92)93152-D
   KITAMURA S, 1994, J THORAC CARDIOV SUR, V107, P663
   Kitamura S, 2009, CIRCULATION, V120, P60, DOI 10.1161/CIRCULATIONAHA.108.840603
   Muta H, 2010, J PEDIATR-US, V157, P120, DOI 10.1016/j.jpeds.2010.01.032
   Ogawa S, 1997, CIRCULATION, V96, P3384
   Ogawa S, 2004, J AM COLL CARDIOL, V43, P653, DOI 10.1016/j.jacc.2003.10.032
   Sugimura T, 1997, CIRCULATION, V96, P3928
   SUGIMURA T, 1994, CIRCULATION, V89, P258, DOI 10.1161/01.CIR.89.1.258
   Suzuki A, 2000, CIRCULATION, V101, P2935, DOI 10.1161/01.CIR.101.25.2935
   Tsuda E, 2011, CARDIOL YOUNG, V21, P74, DOI 10.1017/S1047951110001502
   Yamakawa R, 1998, J AM COLL CARDIOL, V31, P1074, DOI 10.1016/S0735-1097(98)00033-3
   Yoshikawa Y, 2000, EUR J CARDIO-THORAC, V17, P515, DOI 10.1016/S1010-7940(00)00355-9
NR 23
TC 14
Z9 18
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2011
VL 41
IS 2
BP 53
EP 57
DI 10.4070/kcj.2011.41.2.53
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HU
UT WOS:000209078300001
PM 21430988
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, YD
AF Kim, Young Dae
TI Emerging Pathogenetic Mechanisms of Pulmonary Arterial Hypertension:
   Nitric Oxide and More
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 Dong A Univ, Dept Internal Med, Coll Med, Pusan 602715, South Korea.
RP Kim, YD (corresponding author), Dong A Univ, Dept Internal Med, Coll Med, 1 Dongdaesin Dong 3 Ga, Pusan 602715, South Korea.
EM kimdy@mail.donga.ac.kr
CR Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007
   Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707
   Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104
   Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020
   Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008
   Cool CD, 2005, CHEST, V128, p565S, DOI 10.1378/chest.128.6_suppl.565S
   Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297
   GIAID A, 1995, NEW ENGL J MED, V333, P214, DOI 10.1056/NEJM199507273330403
   Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103
   Jeffery TK, 2002, PROG CARDIOVASC DIS, V45, P173, DOI 10.1053/pcad.2002.130041
   Koo HS, 2011, KOREAN CIRC J, V41, P83, DOI 10.4070/kcj.2011.41.2.83
   Landsberg JW, 2004, NEWS PHYSIOL SCI, V19, P44, DOI 10.1152/nips.01457.2003
   Mathew R, 2004, CIRCULATION, V110, P1499, DOI 10.1161/01.CIR.0000141576.39579.23
   McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540
   Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018
   Mukhopadhyay S, 2007, AM J PHYSIOL-HEART C, V292, pH1373, DOI 10.1152/ajpheart.00990.2006
   Nishihara A, 2002, MOL BIOL CELL, V13, P3055, DOI 10.1091/mbc.E02-02-0063
   Pietra GG, 2004, J AM COLL CARDIOL, V43, p25S, DOI 10.1016/j.jacc.2004.02.033
   Pullamsetti S, 2005, FASEB J, V19, P1175, DOI 10.1096/fj.04-3223fje
   REINDEL JF, 1991, AM J PATHOL, V138, P707
   Resta TC, 1997, AM J PHYSIOL-HEART C, V272, pH806
   Sehgal PB, 2007, AM J RESP CELL MOL, V37, P31, DOI 10.1165/rcmb.2007-0066TR
   SMITH P, 1990, J PATHOL, V160, P111, DOI 10.1002/path.1711600204
   Teichert-Kuliszewska K, 2006, CIRC RES, V98, P209, DOI 10.1161/01.RES.0000200180.01710.e6
   Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741
   Xu WL, 2004, FASEB J, V18, P1746, DOI 10.1096/fj.04-2317fje
   Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68
NR 27
TC 3
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2011
VL 41
IS 2
BP 58
EP 60
DI 10.4070/kcj.2011.41.2.58
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HU
UT WOS:000209078300002
PM 21430989
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, YS
   Kim, KS
   Lee, JB
   Ryu, JK
   Choi, JY
   Kim, BK
   Chang, SG
   Hur, SH
   Lee, BR
   Jung, BC
   Hong, GR
   Kim, BS
   Park, TH
   Kim, YD
   Kim, TI
   Kim, DS
AF Lee, Young Soo
   Kim, Kee Sik
   Lee, Jin Bae
   Ryu, Jae Kean
   Choi, Ji Yong
   Kim, Byong-Kyu
   Chang, Sung Gug
   Hur, Seung Ho
   Lee, Bong Ryeol
   Jung, Byung Chun
   Hong, Geu Ru
   Kim, Byung Soo
   Park, Tae Ho
   Kim, Young Dae
   Kim, Tae Ik
   Kim, Dong Soo
TI Effect of Valsartan on N-Terminal Pro-Brain Natriuretic Peptide in
   Patient With Stable Chronic Heart Failure: Comparison With Enalapril
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Brain natriuretic peptide; Angiotensin-converting enzyme inhibitors;
   Angiotensin receptor blocker; Congestive heart failure
ID SYMPATHETIC-NERVE ACTIVITY; PLASMA ANGIOTENSIN-II; BIOCHEMICAL MARKER;
   MORBIDITY; MORTALITY; SYSTEM; TRIAL; COUGH
AB Background and Objectives: The plasma concentration of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) is a strong prognostic indicator for patients with heart failure (HF) across all stages of the condition. Several clinical trials have demonstrated convincingly that neurohormonal modulation on the renin angiotensin system (RAS) decreases plasma NT-proBNP level and results in favorable outcomes. But there are still limited comparative data on the neuro-hormonal modulatory effects of two RAS inhibitors: angiotensin converting enzyme inhibitor and angiotensin receptor blocker. Subjects and Methods: This study was a prospective, multi-center, randomized, open-label, controlled, and non-inferiority study involving 445 patients with left ventricular ejection fraction (LVEF) less than 45%. Patients were assigned to receive either valsartan (target dose of 160 mg bid) or enalapril (target dose of 10 mg bid) for 12 months. We compared plasma NT-pro-BNP, high sensitive C-reactive protein (hs-CRP) level and echocardiographic parameters before and after treatment with valsartan or enalapril. Results: The NT-pro-BNP and hs-CRP levels were significantly decreased after 12 months of treatment with valsartan and enalapril. The percentage change was similar between both groups. LVEF improved and left ventricular internal dimensions were decreased in both groups, and there were no significant differences between two groups. Conclusion: Valsartan is as effective on improving plasma NT-pro-BNP level as enalapril in patients with stable chronic HF.
C1 [Lee, Young Soo; Kim, Kee Sik; Lee, Jin Bae; Ryu, Jae Kean; Choi, Ji Yong; Kim, Byong-Kyu; Chang, Sung Gug] Catholic Univ Daegu, Dept Cardiol, Taegu 705718, South Korea.
   [Lee, Young Soo; Kim, Kee Sik; Lee, Jin Bae; Ryu, Jae Kean; Choi, Ji Yong; Kim, Byong-Kyu; Chang, Sung Gug] Catholic Univ Daegu, Inst Atherosclerosis, Taegu 705718, South Korea.
   [Lee, Young Soo; Kim, Kee Sik; Lee, Jin Bae; Ryu, Jae Kean; Choi, Ji Yong; Kim, Byong-Kyu; Chang, Sung Gug] Catholic Univ Daegu, CVD, Taegu 705718, South Korea.
   [Hur, Seung Ho] Keimyung Univ, Coll Med, Dept Cardiol, Taegu, South Korea.
   [Lee, Bong Ryeol; Jung, Byung Chun] Fatima Gen Hosp, Dept Cardiol, Taegu, South Korea.
   [Hong, Geu Ru] Yeungnam Univ, Coll Med, Dept Cardiol, Taegu, South Korea.
   [Kim, Byung Soo] DaeDong Hosp, Dept Cardiol, Pusan, South Korea.
   [Park, Tae Ho; Kim, Young Dae] Dong A Univ, Coll Med, Dept Cardiol, Pusan, South Korea.
   [Kim, Tae Ik] Maryknoll Med Ctr, Dept Cardiol, Pusan, South Korea.
   [Kim, Dong Soo] Busan Paik Hosp, Dept Cardiol, Pusan, South Korea.
RP Kim, KS (corresponding author), Catholic Univ Daegu, Dept Cardiol, 3056-6 Daemyeong 4 Dong, Taegu 705718, South Korea.
EM kks7379@cu.ac.kr
OI Hur, Seung-Ho/0000-0002-3895-1915
FU Norvatis Korea
FX This study was sponsored by Norvatis Korea.
CR Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713
   CURTISS C, 1978, CIRCULATION, V58, P763, DOI 10.1161/01.CIR.58.5.763
   Harrap SB, 1996, CIRCULATION, V93, P1148, DOI 10.1161/01.CIR.93.6.1148
   김성해, 2004, Korean Circulation Journal, V34, P894
   Kasama S, 2006, HEART, V92, P625, DOI 10.1136/hrt.2005.062463
   Kasama S, 2002, J NUCL MED, V43, P1279
   Koglin J, 2001, J AM COLL CARDIOL, V38, P1934, DOI 10.1016/S0735-1097(01)01672-2
   KOHNO M, 1992, AM J MED, V92, P29, DOI 10.1016/0002-9343(92)90011-Y
   Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005
   Latini R, 2002, CIRCULATION, V106, P2454, DOI 10.1161/01.CIR.0000036747.68104.AC
   Levin ER, 1998, NEW ENGL J MED, V339, P321
   Maeda K, 2000, J AM COLL CARDIOL, V36, P1587, DOI 10.1016/S0735-1097(00)00912-8
   McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1
   Nagaya N, 1998, AM HEART J, V135, P21, DOI 10.1016/S0002-8703(98)70338-2
   Nishizawa A, 2000, P UCLA HLTH, V4, P35
   SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429
   Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2
   Tseng DS, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.06.032
   Tsutamoto T, 1997, CIRCULATION, V96, P509
   Tsutamoto T, 1999, EUR HEART J, V20, P1799, DOI 10.1053/euhj.1999.1746
   WOO KS, 1995, AM J CARDIOL, V75, P967
   YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195
   YEO WW, 1990, J HUM HYPERTENS, V4, P517
   YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501
   정일형, 2006, Korean Circulation Journal, V36, P200
NR 25
TC 3
Z9 3
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2011
VL 41
IS 2
BP 61
EP 67
DI 10.4070/kcj.2011.41.2.61
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HU
UT WOS:000209078300003
PM 21430990
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, HY
   Kim, JH
   Kim, BO
   Kang, YJ
   Ahn, HS
   Hwang, MW
   Park, KM
   Byun, YS
   Goh, CW
   Rhee, KJ
AF Lee, Hye Young
   Kim, Jeong Hoon
   Kim, Byung Ok
   Kang, Yoon Jung
   Ahn, Hyo Seung
   Hwang, Mee Won
   Park, Kyoung Min
   Byun, Young Sup
   Goh, Choong Won
   Rhee, Kun Joo
TI Effect of Aspiration Thrombectomy on Microvascular Dysfunction in
   ST-Segment Elevation Myocardial Infarction With an Elevated Neutrophil
   Count
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Myocardial infarction; Neutrophils
AB Background and Objectives: Aspiration thrombectomy (AT) during primary percutaneous coronary intervention (PCI) is an effective adjunctive therapy for ST-segment elevation myocardial infarction (STEMI). An elevated neutrophil count in STEMI is associated with microvascular dysfunction and adverse outcomes. We evaluated whether AT can improve microvascular dysfunction in patients with STEMI and an elevated neutrophil count. Subjects and Methods: Seventy patients with STEMI undergoing primary PCI from August 2007 to February 2009 in our institution were classified by tertiles of neutrophil count on admission (<5,300/mm(3), 5,300-7,600/mm(3), and >7,600/mm(3)). The angiographic outcome was post-procedural thrombolysis in myocardial infarction (TIMI) flow grade. Microvascular dysfunction was assessed by TIMI myocardial perfusion (TMP) grade and ST-segment resolution on electrocardiography 90 minutes after PCI. The clinical outcome was major adverse cardiac event (MACE), defined as cardiac death, re-infarction, and target lesion revascularization at 9 months. Results: There were no significant differences in the clinical characteristics and pre- and post-procedural TIMI flow grades between the neutrophil tertiles. As the neutrophil count increased, a lower tendency toward TMP grade 3 (83% vs. 52% vs. 54%, p=0.06) and more persistent residual ST-segment elevation (> 4 mm: 13% vs. 26% vs. 58%, p=0.005) was observed. The 9-month MACE rate was similar between the groups. On subgroup analysis of AT patients (n=52) classified by neutrophil tertiles, the same tendency toward less frequent TMP grade 3 (77% vs. 56% vs. 47%, p=0.06) and persistent residual ST-segment elevation (> 4 mm: 12% vs. 28% vs. 53%, p=0.05) was observed as neutrophil count increased. Conclusion: A higher neutrophil count at presentation in STEMI is associated with more severe microvascular dysfunction after primary PCI, which is not improved with AT.
C1 [Lee, Hye Young; Kim, Jeong Hoon; Kim, Byung Ok; Kang, Yoon Jung; Ahn, Hyo Seung; Hwang, Mee Won; Park, Kyoung Min; Byun, Young Sup; Goh, Choong Won; Rhee, Kun Joo] Inje Univ, Coll Med, Sanggye Paik Hosp, Div Cardiol,Dept Internal Med, Seoul 139707, South Korea.
RP Kim, BO (corresponding author), Inje Univ, Coll Med, Sanggye Paik Hosp, Div Cardiol,Dept Internal Med, Seoul 139707, South Korea.
EM byungokim@paik.ac.kr
CR Arakawa K, 2009, CIRC J, V73, P139, DOI 10.1253/circj.CJ-08-0609
   Chia S, 2009, AM J CARDIOL, V103, P333, DOI 10.1016/j.amjcard.2008.09.085
   Han J, 2004, KOREAN CIRC J, V34, P735
   Huang G, 2009, EUR J CLIN INVEST, V39, P348, DOI 10.1111/j.1365-2362.2009.02107.x
   Javaid A, 2008, AM J CARDIOL, V101, P452, DOI 10.1016/j.amjcard.2007.09.091
   Kang WC, 2005, KOREAN CIRC J, V35, P172
   Kim KY, 2005, KOREAN CIRC J, V35, P240
   Kirtane AJ, 2004, AM J CARDIOL, V93, P532, DOI 10.1016/j.amjcard.2003.11.013
   KLONER RA, 1991, CIRCULATION, V84, P1758, DOI 10.1161/01.CIR.84.4.1758
   Koh YY, 1998, KOREAN CIRC J, V28, P1905
   Lee JH, 2003, KOREAN CIRC J, V33, P878
   Mariani M, 2006, EUR HEART J, V27, P2511, DOI 10.1093/eurheartj/ehl191
   MEHTA JL, 1988, J AM COLL CARDIOL, V11, P1309, DOI 10.1016/0735-1097(88)90297-5
   Merlini PA, 2004, AM J CARDIOL, V93, P822, DOI 10.1016/j.amjcard.2003.12.017
   Miyao Y, 1999, JPN CIRC J, V63, P362, DOI 10.1253/jcj.63.362
   Mongeon FP, 2010, CIRC-CARDIOVASC INTE, V3, P6, DOI 10.1161/CIRCINTERVENTIONS.109.904037
   NICHOLS WW, 1988, J MOL CELL CARDIOL, V20, P943, DOI 10.1016/S0022-2828(88)80148-2
   Sabatine MS, 2002, J AM COLL CARDIOL, V40, P1761, DOI 10.1016/S0735-1097(02)02484-1
   Sezer M, 2007, HEART, V93, P313, DOI 10.1136/hrt.2006.094763
   Shin SH, 2005, KOREAN CIRC J, V35, P155
   Svilaas T, 2008, NEW ENGL J MED, V358, P557, DOI 10.1056/NEJMoa0706416
   Takahashi T, 2007, AM J CARDIOL, V100, P35, DOI 10.1016/j.amjcard.2007.02.049
   Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006
   Turner SJ, 2008, AM HEART J, V155, P806, DOI 10.1016/j.ahj.2007.11.037
   van't Hof AWJ, 1998, CIRCULATION, V97, P2302, DOI 10.1161/01.CIR.97.23.2302
NR 25
TC 7
Z9 7
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2011
VL 41
IS 2
BP 68
EP 75
DI 10.4070/kcj.2011.41.2.68
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HU
UT WOS:000209078300004
PM 21430991
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, HT
   Shin, J
   Lim, YH
   Kim, BK
   Kim, YT
   Lee, JU
   Hong, S
   Song, SY
   Cho, SH
AF Lee, Hyung Tak
   Shin, Jinho
   Lim, Young-Hyo
   Kim, Bae Keun
   Kim, Young Taek
   Lee, Jae Ung
   Hong, Sangmo
   Song, Soon Young
   Cho, Sam Hyun
TI The Relationship Between Coronary Artery Calcification and Bone Mineral
   Density in Patients According to Their Metabolic Syndrome Status
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Bone density; Metabolic syndrome X; Coronary artery disease
ID INSULIN-RESISTANCE; VASCULAR CALCIFICATION; INFLAMMATION;
   ATHEROSCLEROSIS; OSTEOPOROSIS; WOMEN; DIAGNOSIS; HEALTH; MEN
AB Background and Objectives: The extent of coronary artery calcification (CAC) is closely related to total atherosclerotic plaque burden. However, the pathogenesis of CAC is still unclear. Conditions such as diabetes mellitus, renal failure, smoking, and chronic inflammation have been suggested to link vascular calcification and bone loss. In the present study, we hypothesized that bone loss can contribute to the pathogenesis of CAC in patients with the chronic inflammatory condition that accompanies metabolic syndrome (MetS). The objective of this study was to investigate the relationship between CAC and bone mineral density (BMD) in patients with MetS and in patients without MetS, by using coronary multidetector-row computed tomography (MDCT). Subjects and Methods: Data from 395 consecutive patients was analyzed retrospectively. From the MDCT database, only those patients who underwent both coronary MDCT and dual-energy X-ray absorptiometry within an interval of one month, were selected. The presence of MetS was determined by the updated criteria as defined by the Third Adult Treatment Panel Report of the National Cholesterol Education Program. Results: In patients with MetS, a significant correlation was found between CAC and age {odds ratio (OR)=1.139, 95% confidence interval (CI) 1.080 to 1.201, p<0.001}, CAC and male sex (OR=3.762, 95% CI 1.339 to 10.569, p=0.012), and CAC and T-score of L-spine (OR=0.740, 95% CI 0.550 to 0.996, p=0.047) using a forward multiple logistic regression analysis model including clinical variables of gender, age, lipid profile, body mass index, diabetes mellitus, hypertension, smoking, and BMD. But in patients without MetS, BMD by itself was not found to contribute to CAC. Conclusion: BMD was inversely correlated with CAC only in patients with MetS. This finding suggests that low BMD accompanied by MetS, may have significant clinical implications.
C1 [Lee, Hyung Tak; Shin, Jinho; Lim, Young-Hyo; Kim, Bae Keun; Kim, Young Taek; Lee, Jae Ung] Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, Seoul 133792, South Korea.
   [Hong, Sangmo] Hanyang Univ, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul 133792, South Korea.
   [Song, Soon Young] Hanyang Univ, Coll Med, Dept Radiol, Seoul 133792, South Korea.
   [Cho, Sam Hyun] Hanyang Univ, Coll Med, Dept Obstet & Gynecol, Seoul 133792, South Korea.
RP Shin, J (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Div Cardiol, 17 Haengdang Dong, Seoul 133792, South Korea.
EM jhs2003@hanyang.ac.kr
RI Hong, Sangmo/C-9515-2018
OI Shin, Jinho/0000-0001-6706-6504
CR Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42
   AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T
   Barengolts EI, 1998, CALCIFIED TISSUE INT, V62, P209, DOI 10.1007/s002239900419
   Cha BongSoo, 2003, Korean Circulation Journal, V33, P645
   김동희, 2008, Korean Circulation Journal, V38, P29
   Choi SH, 2009, CLIN ENDOCRINOL, V71, P644, DOI 10.1111/j.1365-2265.2009.03535.x
   Christian RC, 2002, J CLIN ENDOCR METAB, V87, P1062, DOI 10.1210/jc.87.3.1062
   Farhat GN, 2006, CALCIFIED TISSUE INT, V79, P102, DOI 10.1007/s00223-006-0052-0
   Farhat GN, 2006, J BONE MINER RES, V21, P1839, DOI 10.1359/JBMR.060903
   Fernandez-Real JM, 1999, DIABETOLOGIA, V42, P1367, DOI 10.1007/s001250051451
   Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42
   Grundy SM, 2006, CURR OPIN CARDIOL, V21, P1, DOI 10.1097/01.hco.0000200416.65370.a0
   Hofbauer LC, 2007, OSTEOPOROSIS INT, V18, P251, DOI 10.1007/s00198-006-0282-z
   Lee WY, 2004, DIABETES RES CLIN PR, V65, P143, DOI 10.1016/j.diabres.2003.12.007
   Mazzini MJ, 2006, EUR J RADIOL, V57, P384, DOI 10.1016/j.ejrad.2005.12.025
   Moe SM, 2005, BLOOD PURIFICAT, V23, P64, DOI 10.1159/000082013
   Reilly MP, 2004, CIRCULATION, V110, P803, DOI 10.1161/01.CIR.0000138740.84883.9C
   RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157
   Sakkinen PA, 2000, AM J EPIDEMIOL, V152, P897, DOI 10.1093/aje/152.10.897
   Sinnott B, 2006, CALCIFIED TISSUE INT, V78, P195, DOI 10.1007/s00223-005-0244-z
   Wong ND, 2003, J AM COLL CARDIOL, V41, P1547, DOI 10.1016/S0735-1097(03)00193-1
   노혜진, 2006, Korean Circulation Journal, V36, P802
NR 22
TC 10
Z9 10
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2011
VL 41
IS 2
BP 76
EP 82
DI 10.4070/kcj.2011.41.2.76
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HU
UT WOS:000209078300005
PM 21430992
OA Green Published
DA 2021-04-22
ER

PT J
AU Koo, HS
   Kim, KC
   Hong, YM
AF Koo, Hee Sun
   Kim, Kwan Chang
   Hong, Young Mi
TI Gene Expressions of Nitric Oxide Synthase and Matrix Metalloproteinase-2
   in Monocrotaline-Induced Pulmonary Hypertension in Rats After Bosentan
   Treatment
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Pulmonary hypertension; Monocrotaline; Gene expression; Nitric oxide
   synthase; Matrix metalloproteinases
ID RECEPTOR ANTAGONIST BOSENTAN; UP-REGULATION; PROTEIN EXPRESSION; NO
   SYNTHASE; BLOOD-FLOW; ENOS; HYPOXIA; ENDOTHELIN-1; COMBINATION;
   SILDENAFIL
AB Background and Objectives: Nitric oxide (NO) is a major endothelium dependent vasomediator and growth inhibitor. NO synthesis is catalyzed by endothelial nitric oxide synthase (eNOS), and NO can also produce peroxynitrite, which activates matrix metalloproteinases (MMPs). The purpose of this study was to determine the gene expression of eNOS and MMP-2 in the lungs of a rat model of pulmonary hypertension after bosentan treatment. Materials and Methods: Six-week-old male Sprague-Dawley rats were treated as follows: control group, subcutaneous (sc) injection of saline; monocrotaline (MCT) group, sc injection of MCT (60 mg/kg); and bosentan group, sc injection of MCT (60 mg/kg) plus 20 mg/day bosentan orally. The rats were sacrificed after 1, 5, 7, 14 and 28 days. Results: The right ventricle/(left ventricle+septum) ratio significantly increased in the MCT group compared to the control group on day 14 and 28. The expression of eNOS messenger ribonucleic acid was significantly increased in the MCT group compared to the control group on day 28. MMP-2 gene expression was significantly increased in the MCT-treated rats compared to the control group on day 5 and 28. Following bosentan treatment to reduce pulmonary hypertension, the expression levels of MMP-2 gene were significantly decreased on day 7 and 28. eNOS and tissue inhibitor of MMPs genes were also significantly decreased on day 28 after bosentan treatment. Conclusion: These results suggest that elevated eNOS expression may be responsible for MMP-2 activation. The causal relationship between eNOS and MMP-2 and their role in pulmonary hypertension require further investigations.
C1 [Koo, Hee Sun; Hong, Young Mi] Ewha Womans Univ, Dept Pediat, Sch Med, Seoul 158710, South Korea.
   [Kim, Kwan Chang] Ewha Womans Univ, Sch Med, Dept Thorac & Cardiovasc Surg, Seoul 158710, South Korea.
RP Hong, YM (corresponding author), Ewha Womans Univ, Dept Pediat, Sch Med, 911-1 Mok Dong, Seoul 158710, South Korea.
EM ymhong@ewha.ac.kr
FU National Research Foundation of Korea - Ministry of Education Science
   and TechnologyMinistry of Education, Science and Technology, Republic of
   KoreaNational Research Foundation of Korea [KRF-2009-0064784]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea funded by the Ministry of
   Education Science and Technology (KRF-2009-0064784).
CR Black SM, 1998, AM J PHYSIOL-HEART C, V275, pH1643, DOI 10.1152/ajpheart.1998.275.5.H1643
   Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X
   Chou TF, 2002, EUR J CARDIO-THORAC, V21, P331, DOI 10.1016/S1010-7940(01)01129-0
   Clozel M, 2006, EXP BIOL MED, V231, P967
   Dai ZK, 2002, CLIN SCI, V103, p289S, DOI 10.1042/CS103S289S
   Everett AD, 1998, AM J PHYSIOL-LUNG C, V274, pL1058
   Fagan K A, 2001, Respir Res, V2, P306, DOI 10.1186/rr74
   Frisdal E, 2001, EUR RESPIR J, V18, P838, DOI 10.1183/09031936.01.00084601
   GIAID A, 1995, NEW ENGL J MED, V333, P214, DOI 10.1056/NEJM199507273330403
   Hampl V, 2000, PHYSIOL REV, V80, P1337
   임경아, 2009, Clinical and Experimental Pediatrics, V52, P689
   Hessel MHM, 2006, AM J PHYSIOL-HEART C, V291, pH2424, DOI 10.1152/ajpheart.00369.2006
   Itoh T, 2004, AM J RESP CRIT CARE, V169, P34, DOI 10.1164/rccm.200303-346OC
   Komai H, 2001, CARDIOVASC PATHOL, V10, P29, DOI 10.1016/S1054-8807(00)00063-6
   Le Cras TD, 2001, AM J PHYSIOL-LUNG C, V280, pL575
   LeCras TD, 1996, AM J PHYSIOL-LUNG C, V270, pL164
   Lepetit H, 2005, EUR RESPIR J, V25, P834, DOI 10.1183/09031936.05.00072504
   Lim Kyoung Ah, 2010, Korean Circ J, V40, P459, DOI 10.4070/kcj.2010.40.9.459
   Mathew Rajamma, 2002, Heart Dis, V4, P152, DOI 10.1097/00132580-200205000-00004
   MIYAUCHI T, 1993, CIRC RES, V73, P887, DOI 10.1161/01.RES.73.5.887
   Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018
   Mukhopadhyay S, 2007, AM J PHYSIOL-HEART C, V292, pH1373, DOI 10.1152/ajpheart.00990.2006
   Murata T, 2002, J BIOL CHEM, V277, P44085, DOI 10.1074/jbc.M205934200
   Resta TC, 1997, AM J PHYSIOL-HEART C, V272, pH806
   Resta TC, 1999, AM J PHYSIOL-HEART C, V276, pH699
   Tyler RC, 1999, AM J PHYSIOL-LUNG C, V276, pL297
   Umar S, 2007, PATHOL RES PRACT, V203, P863, DOI 10.1016/j.prp.2007.08.006
   WANG QD, 1995, J CARDIOVASC PHARM, V26, pS445
   Winkler MK, 2003, AM J PHYSIOL-LUNG C, V284, pL557, DOI 10.1152/ajplung.00195.2002
   Xue C, 1996, HYPERTENSION, V28, P743, DOI 10.1161/01.HYP.28.5.743
   김미영, 2008, Korean Circulation Journal, V38, P313
NR 31
TC 23
Z9 23
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2011
VL 41
IS 2
BP 83
EP 90
DI 10.4070/kcj.2011.41.2.83
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HU
UT WOS:000209078300006
PM 21430993
OA Green Published
DA 2021-04-22
ER

PT J
AU Na, SH
   Koo, BK
   Kim, JC
   Yang, HM
   Park, KW
   Kang, HJ
   Kim, HS
   Oh, BH
   Park, YB
AF Na, Sang-Hoon
   Koo, Bon-Kwon
   Kim, Jeong Chul
   Yang, Han-Mo
   Park, Kyung-Woo
   Kang, Hyun-Jae
   Kim, Hyo-Soo
   Oh, Byung-Hee
   Park, Young-Bae
TI Evaluation of Local Flow Conditions in Jailed Side Branch Lesions Using
   Computational Fluid Dynamics
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Fluid dynamics; Pressure; Blood flow velocity; Shear strength;
   Fractional flow reserve, myocardial
ID ENDOTHELIAL SHEAR-STRESS; BIFURCATION LESIONS; STENT IMPLANTATION;
   NEOINTIMAL HYPERPLASIA; CORONARY; OUTCOMES; DISEASE
AB Background and Objectives: Lesions of vascular bifurcation and their treatment outcomes have been evaluated by anatomical and physiological methods, such as intravascular ultrasound and fractional flow reserve (FFR). However, local changes in flow dynamics in lesions of bifurcation have not been well evaluated. This study aimed at evaluating changes in the local flow patterns of bifurcation lesions. Materials and Methods: Eight (n=8) representative simulation-models were constructed: 1 normal bifurcation, 5 main-branch (MB) stenting models with various side-branch (SB) stenoses (ostial or non-ostial 75% diameter stenosis with 1- or 2-cm lesion lengths, ostial 75% diameter stenosis caused by carina shift), and 2 post-kissing models (no or 50% SB residual stenosis). Pressure, velocity, and wall shear stress (WSS) profiles around the bifurcation sites were investigated using computational fluid dynamics. Results: Post-stenting models revealed significant pressure drop in the SB (FFR <0.75), excluding the carina shift model (FFR=0.89). In the post-kissing models, there was no significant pressure drop. All post-stenting models revealed eccentric low velocity flow patterns and areas of low WSS, primarily in the lateral wall on distal MB. Post-kissing angioplasty improved pressure drop in the SB but resulted in alteration of flow distribution in the MB. In the carina shift model, kissing ballooning resulted in deteriorated local flow conditions due to increased area of low velocity and WSS. Conclusion: This study suggests that the most commonly used bifurcation intervention strategy may cause local flow disturbances, which may partially explain high restenosis and event rates in patients with bifurcation lesions.
C1 [Na, Sang-Hoon; Koo, Bon-Kwon; Yang, Han-Mo; Park, Kyung-Woo; Kang, Hyun-Jae; Kim, Hyo-Soo; Oh, Byung-Hee; Park, Young-Bae] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea.
   [Na, Sang-Hoon] Seoul Natl Univ, Coll Med, Dept Emergency Med, Seoul 110744, South Korea.
   [Na, Sang-Hoon; Koo, Bon-Kwon; Yang, Han-Mo; Park, Kyung-Woo; Kang, Hyun-Jae; Kim, Hyo-Soo; Oh, Byung-Hee; Park, Young-Bae] Seoul Natl Univ Hosp, Ctr Cardiovasc, Seoul 110744, South Korea.
   [Kim, Jeong Chul] Seoul Natl Univ, Med Res Ctr, Inst Med & Biol Engn, Seoul 110744, South Korea.
RP Koo, BK (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM bkkoo@snu.ac.kr
RI Kang, Hyun-Jae/D-6121-2012; Oh, Byung-Hee/G-9875-2011; Park, Kyung
   Woo/AAX-3046-2020
OI Kang, Hyun-Jae/0000-0002-3500-1746; Oh, Byung-Hee/0000-0002-9945-4306; 
FU Cardiology [2009-2]; Clinical Research Center for Ischemic Heart
   Disease, Seoul, the Republic of Korea [0412-CR02-0704-0001]; Innovative
   Research Institute for Cell Therapy, Seoul National University Hospital
   - Ministry of Health, Welfare & Family, Republic of the Republic of
   Korea [A062260]
FX This study was supported by grants from the Cardiology (2009-2), the
   Clinical Research Center for Ischemic Heart Disease, Seoul, the Republic
   of Korea (0412-CR02-0704-0001) and the Innovative Research Institute for
   Cell Therapy, Seoul National University Hospital (A062260), sponsored by
   the Ministry of Health, Welfare & Family, Republic of the Republic of
   Korea.
CR 박근호, 2008, Korean Circulation Journal, V38, P468
   BonKwon Koo，, 2008, Korean Circulation Journal, V38, P393
   Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059
   서정원, 2006, Korean Circulation Journal, V36, P300
   Colombo A, 2004, CIRCULATION, V109, P1244, DOI 10.1161/01.CIR.0000118474.71662.E3
   Colombo A, 2009, CIRCULATION, V119, P71, DOI 10.1161/CIRCULATIONAHA.108.808402
   Ferenc M, 2008, EUR HEART J, V29, P2859, DOI 10.1093/eurheartj/ehn455
   Finet Gerard, 2008, EuroIntervention, V3, P490, DOI 10.4244/EIJV3I4A87
   Gwon HC, 2010, CIRC J, V74, P2322, DOI 10.1253/circj.CJ-10-0352
   Ikeno F, 2006, CATHETER CARDIO INTE, V67, P198, DOI 10.1002/ccd.20556
   Koo BK, 2010, CIRC-CARDIOVASC INTE, V3, P113, DOI 10.1161/CIRCINTERVENTIONS.109.887406
   LaDisa JF, 2005, AM J PHYSIOL-HEART C, V288, pH2465, DOI 10.1152/ajpheart.01107.2004
   Lefevre T, 2005, J AM COLL CARDIOL, V46, P592, DOI 10.1016/j.jacc.2005.05.033
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Louvard Y, 2004, HEART, V90, P713, DOI 10.1136/hrt.2002.007682
   Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035
   Melikian Narbeh, 2003, J Interv Cardiol, V16, P507, DOI 10.1046/j.1540-8183.2003.01056.x
   Murata T, 2002, CIRC J, V66, P489, DOI 10.1253/circj.66.489
   Niemela M, 2011, CIRCULATION, V123, P79, DOI 10.1161/CIRCULATIONAHA.110.966879
   Ormiston J, 2007, CATHETER CARDIO INTE, V70, P335, DOI 10.1002/ccd.21206
   Park JY, 2007, COMPUT BIOL MED, V37, P1063, DOI 10.1016/j.compbiomed.2006.09.012
   Pflederer T, 2006, INVEST RADIOL, V41, P793, DOI 10.1097/01.rli.0000239318.88270.9f
   Pijls NHJ, 2004, HEART, V90, P1085, DOI 10.1136/hrt.2003.032151
   Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604
   Sharma S K, 2009, Minerva Cardioangiol, V57, P667
   Sharma SK, 2006, CARDIOL CLIN, V24, P233, DOI 10.1016/j.ccl.2006.02.003
   Steigen TK, 2006, CIRCULATION, V114, P1955, DOI 10.1161/CIRCULATIONAHA.106.664920
   Stone PH, 2003, CIRCULATION, V108, P438, DOI 10.1161/01.CIR.0000080882.35274.AD
   Wang JC, 2004, CIRCULATION, V110, P278, DOI 10.1161/01.CIR.0000135468.67850.F4
   Williams AR, 2010, J APPL PHYSIOL, V109, P532, DOI 10.1152/japplphysiol.00086.2010
NR 30
TC 8
Z9 8
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2011
VL 41
IS 2
BP 91
EP 96
DI 10.4070/kcj.2011.41.2.91
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HU
UT WOS:000209078300007
PM 21430994
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, EK
   Lee, SC
   Park, SB
   Park, S
   Bahng, S
   Choe, YH
   Sung, K
AF Kim, Eun Kyoung
   Lee, Sang Chol
   Park, Sung Bum
   Park, Silvia
   Bahng, Sunha
   Choe, Yeon Hyeon
   Sung, Kiick
TI A Huge Mediastinal Organizing Hematoma Causing Reversal of Atrial Septal
   Defect Shunt Flow
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Mediastinal cyst; Atrial septal defect; Hematoma
AB We report a case of a 46-year-old woman who presented with subacute exertional dyspnea and severe hypoxia. A large cystic mass compressing the right side of the heart along with right-to-left atrial shunt flow through an alleged atrial septal defect (ASD) were detected on echocardiography. CT scan of the chest and MRI of the heart revealed a loculated cystic mediastinal mass with hemorrhage measuring 5.5x8 cm compressing the right atrium and ventricle. The patient underwent cyst resection and primary closure of the ASD. This report illustrates a case of an unusual symptomatic pericardial mass compressing the right atrium and ventricle in a patient with an secundum ASD.
C1 [Kim, Eun Kyoung; Lee, Sang Chol; Park, Sung Bum; Park, Silvia; Bahng, Sunha] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Cardiol,Dept Internal Med, Seoul 135710, South Korea.
   [Choe, Yeon Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul 135710, South Korea.
   [Choe, Yeon Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci,Cardiovasc Imaging Ctr, Seoul 135710, South Korea.
   [Sung, Kiick] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul 135710, South Korea.
RP Lee, SC (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, 50 Irwon Dong, Seoul 135710, South Korea.
EM sclee@skku.edu
RI Choe, Yeon Hyeon/F-1422-2010
OI Choe, Yeon Hyeon/0000-0002-9983-048X
CR Bandeira F C, 1996, J Am Soc Echocardiogr, V9, P108, DOI 10.1016/S0894-7317(96)90113-3
   Borges AC, 1997, ANN THORAC SURG, V63, P845, DOI 10.1016/S0003-4975(96)01373-2
   BORGNAPIGNATTI C, 1994, MED PEDIATR ONCOL, V22, P70, DOI 10.1002/mpo.2950220115
   Brickner ME, 2000, NEW ENGL J MED, V342, P334, DOI 10.1056/NEJM200002033420507
   CHOPRA PS, 1991, ANN THORAC SURG, V51, P840, DOI 10.1016/0003-4975(91)90149-K
   Elamin Wael Faroug, 2008, Cases J, V1, P26, DOI 10.1186/1757-1626-1-26
   Jin KH, 1987, KOREAN CIRC J, V17, P795
   Komodromos T, 2004, HEART VESSELS, V19, P49, DOI 10.1007/s00380-003-0716-x
   Koshy T, 2008, ANN CARD ANAESTH, V11, P129, DOI 10.4103/0971-9784.41584
   Lee JA, 1991, KOREAN CIRC J, V21, P791
   Lesniak-Sobelga AM, 2008, ANN THORAC SURG, V85, P1811, DOI 10.1016/j.athoracsur.2007.12.043
   Modi S, 2009, J CARDIOVASC MED, V10, P646, DOI 10.2459/JCM.0b013e328329ea03
   Ogah O S, 2009, Afr J Med Med Sci, V38, P83
   Tanoue Y, 2007, ANN THORAC SURG, V84, P282, DOI 10.1016/j.athoracsur.2007.01.058
NR 14
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2011
VL 41
IS 2
BP 97
EP 100
DI 10.4070/kcj.2011.41.2.97
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HU
UT WOS:000209078300008
PM 21430995
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SY
   Yoon, JH
   Lee, SH
AF Kim, Soo-Young
   Yoon, Ji Hyun
   Lee, Sang-Hak
TI Takotsubo-Like Severe Left Ventricular Dysfunction After Cesarean
   Delivery in a 28-Year Old Woman
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Postpartum period; Takotsubo cardiomyopathy; Cesarean section; Heart
   failure
AB Takotsubo cardiomyopathy typically affects post-menopausal women who experience severe psychological or physical stress. It can also develop after medical procedures or surgery. Although the underlying mechanism has not been clearly elucidated, catecholamine overload is one of the most plausible etiologies. Herein we report a case of takotsubo-like left ventricular (LV) dysfunction in a 28-year old woman who underwent Cesarean delivery. She presented with acute heart failure and pulmonary edema immediately after the delivery. Her echocardiography showed severe LV dysfunction and apical ballooning. This case is clinically and pathophysiologically similar to peripartum cardiomyopathy.
C1 [Kim, Soo-Young; Yoon, Ji Hyun; Lee, Sang-Hak] Yonsei Univ, Coll Med, Div Cardiol, Dept Internal Med, Seoul 120752, South Korea.
RP Lee, SH (corresponding author), Yonsei Univ, Coll Med, Div Cardiol, Dept Internal Med, 250 Seongsan Ro, Seoul 120752, South Korea.
EM shl1106@yuhs.ac
CR Crimi E, 2008, CIRCULATION, V117, P3052, DOI 10.1161/CIRCULATIONAHA.107.744102
   DEMAKIS JG, 1971, CIRCULATION, V44, P964, DOI 10.1161/01.CIR.44.5.964
   Jabaudon M, 2007, ANAESTHESIA, V62, P519, DOI 10.1111/j.1365-2044.2007.05061.x
   Kawai S, 2007, CIRC J, V71, P990, DOI 10.1253/circj.71.990
   Littlejohn F Craig, 2008, Cases J, V1, P227, DOI 10.1186/1757-1626-1-227
   Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008
   Sharkey SW, 2005, CIRCULATION, V111, P472, DOI 10.1161/01.CIR.0000153801.51470.EB
   Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X
   Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046
   이호현, 2002, Korean Circulation Journal, V32, P1054
NR 10
TC 10
Z9 10
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2011
VL 41
IS 2
BP 101
EP 104
DI 10.4070/kcj.2011.41.2.101
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HU
UT WOS:000209078300009
PM 21430996
OA Green Published
DA 2021-04-22
ER

PT J
AU Jung, IS
   Jeong, JO
   Kim, SS
   Shin, BS
   Shin, SK
   Park, YK
   Jin, SA
   Ahn, KT
   Seong, IW
AF Jung, Il Soon
   Jeong, Jin-Ok
   Kim, Song Soo
   Shin, Byung Seok
   Shin, Sung Kyun
   Park, Yong Kyu
   Jin, Seon-Ah
   Ahn, Kye Taek
   Seong, In-Whan
TI Iatrogenic Left Internal Mammary Artery to Great Cardiac Vein
   Anastomosis Treated With Coil Embolization
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary Artery Bypass Surgery; Internal Mammary-Coronary Artery
   Anastomosis; Arteriovenous fistula; Embolization, therapeutic
AB Inadvertent left internal mammary artery (LIMA)-great cardiac vein (GCV) anastomosis is a rare complication of coronary artery bypass graft surgery. Patients with iatrogenic aortocoronary fistula (ACF) were usually treated surgical repair, percutaneous embolic occlusion with coil or balloon. We report a case of iatrogenic LIMA to GCV anastomosis successfully treated with coil embolization and protected left main coronary intervention through the percutaneous transfemoral approach. Percutaneous transcatheter coil embolization in acquired ACF appears to be a feasible, safe and time-sparing technique.
C1 [Jung, Il Soon; Jeong, Jin-Ok; Shin, Sung Kyun; Park, Yong Kyu; Jin, Seon-Ah; Ahn, Kye Taek; Seong, In-Whan] Chungnam Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, Taejon 301721, South Korea.
   [Kim, Song Soo; Shin, Byung Seok] Chungnam Natl Univ, Sch Med, Dept Radiol, Taejon 301721, South Korea.
RP Jeong, JO (corresponding author), Chungnam Natl Univ, Sch Med, Dept Internal Med, Div Cardiol, 33 Munhwa Ro, Taejon 301721, South Korea.
EM jojeong@cnu.ac.kr
OI SHIN, BYUNGSEOK/0000-0003-4416-1415; jin, seon-ah/0000-0001-6895-9101;
   Seong, In-Whan/0000-0003-4628-0258; Kim, Song Soo/0000-0002-3078-2184;
   Jeong, Jin-Ok/0000-0003-0763-4754
CR An Hye-Sung, 2009, Korean Circ J, V39, P548, DOI 10.4070/kcj.2009.39.12.548
   Balanescu S, 2001, Ital Heart J, V2, P669
   Braun P, 1999, Z KARDIOL, V88, P812, DOI 10.1007/s003920050356
   Calkins JB, 1996, CATHETER CARDIO DIAG, V37, P55, DOI 10.1002/(SICI)1097-0304(199601)37:1<55::AID-CCD14>3.0.CO;2-V
   Garcia-Rinaldi R, 2010, TEX HEART I J, V37, P254
   GRAEB DA, 1990, CATHETER CARDIO DIAG, V20, P58, DOI 10.1002/ccd.1810200115
   HUBERT JW, 1982, SOUTHERN MED J, V75, P1144, DOI 10.1097/00007611-198209000-00035
   LAWRIE GM, 1976, ANN THORAC SURG, V22, P87, DOI 10.1016/S0003-4975(10)63958-6
   LONGMIRE WP, 1958, NEW ENGL J MED, V259, P993, DOI 10.1056/NEJM195811202592101
   Lopez JJ, 1996, CATHETER CARDIO DIAG, V37, P339, DOI 10.1002/(SICI)1097-0304(199603)37:3<339::AID-CCD28>3.0.CO;2-B
   Maier LS, 2002, CATHETER CARDIO INTE, V55, P109, DOI 10.1002/ccd.10044
   Okubo M, 2001, CATHETER CARDIO INTE, V52, P510, DOI 10.1002/ccd.1114.abs
   Pemberton J, 2007, AM J CARDIOL, V100, P337, DOI 10.1016/j.amjcard.2007.02.105
   PEREGRIN JH, 1992, CATHETER CARDIO DIAG, V27, P137, DOI 10.1002/ccd.1810270213
   Martinez UR, 2006, CIRCULATION, V114, pE359, DOI 10.1161/CIRCULATIONAHA.106.616151
   SCHOLZ KH, 1993, EUR J CARDIO-THORAC, V7, P441, DOI 10.1016/1010-7940(93)90010-9
   VINEBERG A, 1951, CAN MED ASSOC J, V64, P204
   White RW, 2010, INTERACT CARDIOV TH, V10, P256, DOI 10.1510/icvts.2009.219360
NR 18
TC 5
Z9 5
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2011
VL 41
IS 2
BP 105
EP 108
DI 10.4070/kcj.2011.41.2.105
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HU
UT WOS:000209078300010
PM 21430997
OA Green Published
DA 2021-04-22
ER

PT J
AU Jo, YM
   Park, TH
   Jeong, IH
   Kim, HJ
   Ahn, JH
   Kim, WJ
   Cho, YR
   Baek, HK
   Kim, MH
   Kim, YD
AF Jo, Yong-Min
   Park, Tae-Ho
   Jeong, Il-Hwan
   Kim, Hyun-Jeong
   Ahn, Ji-Hye
   Kim, Woo-Jae
   Cho, Young-Rak
   Baek, Hee-Kyung
   Kim, Moo-Hyun
   Kim, Young-Dae
TI Warfarin-Induced Eosinophilic Pleural Effusion
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Warfarin; Pleural effusion
AB A 29-year-old man suffering from dyspnea and eosinophilic pleural effusion after being on warfarin for pulmonary thromboembolism for a period of one month, was readmitted to our hospital. Etiology of pleural effusion other than warfarin was excluded. To the best of our knowledge, this is the first case of warfarin-induced pleural effusion reported in Korea.
C1 [Jo, Yong-Min; Park, Tae-Ho; Jeong, Il-Hwan; Kim, Hyun-Jeong; Ahn, Ji-Hye; Kim, Woo-Jae; Cho, Young-Rak; Baek, Hee-Kyung; Kim, Moo-Hyun; Kim, Young-Dae] Dong A Univ, Div Cardiol, Dept Internal Med, Coll Med, Pusan 602715, South Korea.
RP Park, TH (corresponding author), Dong A Univ, Div Cardiol, Dept Internal Med, Coll Med, 1 Dongdae Sin Dong 3 Ga, Pusan 602715, South Korea.
EM thpark65@dau.ac.kr
CR ANSHELEVICH YV, 1986, TERAPEVT ARKH, V58, P142
   COOPER JAD, 1986, AM REV RESPIR DIS, V133, P488
   Huggins JT, 2004, CLIN CHEST MED, V25, P141, DOI 10.1016/S0272-5231(03)00125-4
   Kalomenidis L, 2003, CURR OPIN PULM MED, V9, P254, DOI 10.1097/00063198-200307000-00002
   Krenke R, 2009, EUR RESPIR J, V34, P1111, DOI 10.1183/09031936.00197708
   KUWAHARA T, 1995, INTERNAL MED, V34, P794, DOI 10.2169/internalmedicine.34.794
   Martinez-Garcia MA, 2000, EUR RESPIR J, V15, P166, DOI 10.1034/j.1399-3003.2000.15a30.x
   Mo EK, 1995, KOREAN J MED, V48, P625
   Moufarrege G, 2003, PAIN MED, V4, P85, DOI 10.1046/j.1526-4637.2003.03003.x
   SIMON HB, 1969, J AMER MED ASSOC, V208, P1830, DOI 10.1001/jama.208.10.1830
   Stein PD, 1997, CHEST, V112, P974, DOI 10.1378/chest.112.4.974
   You Sung-Hye, 2009, Korean Circ J, V39, P545, DOI 10.4070/kcj.2009.39.12.545
NR 12
TC 9
Z9 9
U1 1
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD FEB
PY 2011
VL 41
IS 2
BP 109
EP 112
DI 10.4070/kcj.2011.41.2.109
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HU
UT WOS:000209078300011
PM 21430998
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, JY
   Yoon, J
AF Kim, Jang-Young
   Yoon, Junghan
TI Transradial Approach as a Default Route in Coronary Artery Interventions
SO KOREAN CIRCULATION JOURNAL
LA English
DT Review
DE Angioplasty; Coronary arteries; Radial artery
AB Advances in percutaneous coronary intervention (PCI) and peri-procedural potent antithrombotic treatments during the past decade have dramatically improved the outcomes of ischemic heart disease. The femoral artery is the vascular route used in PCI in most catheterization labs. However, when the femoral artery is used as the approaching vessel, local hemorrhagic complication is not rare in the era of potent antithrombotics. Recent studies have suggested that peri-procedural bleeding complications after PCI are associated with increased short-and long-term morbidity and mortality. On the other hand, there has been growing interest in transradial PCI due to rare complications at the puncture site, patient conveniences, early discharge and shortened hospitalization periods. Furthermore, the indications of transradial PCI are expanding to the complex lesion subsets due to the miniaturization of devices used, improvement of devices and techniques, and accumulated experience with the use of transradial PCI. In this review, we discuss the data of transradial PCI as a potential default route in coronary artery interventions, as well as other issues that may raise concerns with transradial PCI.
C1 [Kim, Jang-Young; Yoon, Junghan] Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, Wonju 220701, South Korea.
RP Yoon, J (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Cardiol, 162 Ilsan Dong, Wonju 220701, South Korea.
EM jyoon@yonsei.ac.kr
CR Agostoni P, 2004, J AM COLL CARDIOL, V44, P349, DOI 10.1016/j.jacc.2004.04.034
   Amoroso G, 2007, J CARDIOVASC MED, V8, P230, DOI 10.2459/01.JCM.0000263494.10865.0f
   Bertrand OF, 2010, JACC-CARDIOVASC INTE, V3, P1022, DOI 10.1016/j.jcin.2010.07.013
   Cha KS, 2003, AM J CARDIOL, V92, P1220, DOI 10.1016/j.amjcard.2003.07.038
   Chase AJ, 2008, HEART, V94, P1019, DOI 10.1136/hrt.2007.136390
   Cooper CJ, 1999, AM HEART J, V138, P430, DOI 10.1016/S0002-8703(99)70143-2
   Dahm JB, 2002, CATHETER CARDIO INTE, V57, P172, DOI 10.1002/ccd.10321
   Doyle BJ, 2008, JACC-CARDIOVASC INTE, V1, P202, DOI 10.1016/j.jcin.2007.12.006
   Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812
   Fleckenstein K, 1996, KOREAN CIRC J, V58, P914
   GAJRAJ NM, 1994, ANESTH ANALG, V78, P574
   Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023
   Kessel DO, 2003, CARDIOVASC INTER RAD, V26, P146, DOI 10.1007/s00270-001-0114-7
   Kim JY, 2006, YONSEI MED J, V47, P680, DOI 10.3349/ymj.2006.47.5.680
   Kim Jang-Young, 2007, J Invasive Cardiol, V19, P6
   Kim JY, 2005, YONSEI MED J, V46, P503, DOI 10.3349/ymj.2005.46.4.503
   Kim JY, 2006, KOREAN CIRC J, V36, P780
   Liang M, 2010, CATHETER CARDIO INTE, V75, P222, DOI 10.1002/ccd.22236
   Lin YJ, 2004, INT J CARDIOL, V97, P311, DOI 10.1016/j.ijcard.2003.05.052
   Mamas MA, 2008, CATHETER CARDIO INTE, V72, P357, DOI 10.1002/ccd.21637
   Nikolsky E, 2007, EUR HEART J, V28, P1936, DOI 10.1093/eurheartj/ehm194
   Pancholy SB, 2009, AM J CARDIOL, V104, P1083, DOI 10.1016/j.amjcard.2009.05.057
   Rao SV, 2008, JACC-CARDIOVASC INTE, V1, P379, DOI 10.1016/j.jcin.2008.05.007
   Rathore S, 2009, CATHETER CARDIO INTE, V73, P883, DOI 10.1002/ccd.21922
   Saito S, 2003, CATHETER CARDIO INTE, V59, P305, DOI 10.1002/ccd.10505
   Saito S, 2003, CATHETER CARDIO INTE, V59, P26, DOI 10.1002/ccd.10493
   Sanghvi K, 2008, J INTERV CARDIOL, V21, P385, DOI 10.1111/j.1540-8183.2008.00384.x
   Sciahbasi A, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.10.003
   Spaulding C, 1996, CATHETER CARDIO DIAG, V39, P365, DOI 10.1002/(SICI)1097-0304(199612)39:4<365::AID-CCD8>3.0.CO;2-B
   Stella PR, 1997, CATHETER CARDIO DIAG, V40, P156, DOI 10.1002/(SICI)1097-0304(199702)40:2<156::AID-CCD7>3.3.CO;2-E
   Vorobcsuk A, 2009, AM HEART J, V158, P814, DOI 10.1016/j.ahj.2009.08.022
   Yang YJ, 2007, CHINESE MED J-PEKING, V120, P539, DOI 10.1097/00029330-200704010-00003
   Yatskar L, 2007, CATHETER CARDIO INTE, V69, P961, DOI 10.1002/ccd.21087
   Yoo BS, 2005, INT J CARDIOL, V101, P421, DOI 10.1016/j.ijcard.2004.03.061
   Yoon J, 1998, KOREAN CIRC J, V28, P1670
   Youn YJ, 2011, KOREAN CIRC IN PRESS
NR 36
TC 14
Z9 14
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2011
VL 41
IS 1
BP 1
EP 8
DI 10.4070/kcj.2011.41.1.1
PG 8
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HT
UT WOS:000209078200001
PM 21359061
OA Green Published
DA 2021-04-22
ER

PT J
AU Jeon, DS
AF Jeon, Doo Soo
TI Role of Brain Natriuretic Peptide as a Prognostic Marker in Non-Cardiac
   Surgery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Jeon, Doo Soo] Catholic Univ Korea, Dept Internal Med, Coll Med, Div Cardiol, Inchon 430720, South Korea.
RP Jeon, DS (corresponding author), Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Div Cardiol,Dept Internal Med, 665 Bupyeong 6 Dong, Inchon 430720, South Korea.
EM jeondoosoo@hanmail.net
CR Hoeks SE, 2010, POL ARCH MED WEWN, V120, P294, DOI 10.20452/pamw.951
   Karthikeyan G, 2009, J AM COLL CARDIOL, V54, P1599, DOI 10.1016/j.jacc.2009.06.028
   Kim SE, 2011, KOREAN CIRC J, V41, P11, DOI 10.4070/kcj.2011.41.1.11
   Ryding ADS, 2009, ANESTHESIOLOGY, V111, P311, DOI 10.1097/ALN.0b013e3181aaeb11
NR 4
TC 1
Z9 1
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2011
VL 41
IS 1
BP 9
EP 10
DI 10.4070/kcj.2011.41.1.9
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HT
UT WOS:000209078200002
PM 21359062
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, SE
   Park, DG
   Lee, JH
   Han, KR
   Oh, DJ
AF Kim, Sung Eun
   Park, Dae-Gyun
   Lee, Jun Hee
   Han, Kyoo Rok
   Oh, Dong Jin
TI Utility of B-Type Natriuretic Peptide for Predicting Perioperative
   Cardiovascular Events in Patients Without History of Cardiovascular
   Disease Undergoing Major Non-Cardiac Surgery
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE B-type natriuretic peptide; Perioperative care; Cardiovascular disease
ID POSTOPERATIVE CARDIAC EVENTS; LEFT ATRIAL ENLARGEMENT; RISK; DEATH;
   SIZE; ASSOCIATION; MORTALITY; INDEX
AB Background and Objectives: Patients without previous history of cardiac disease can be regarded as low-risk when undergoing major non-cardiac surgery. The aim of this study was to examine whether preoperative B-type natriuretic peptide (BNP) level predicted postoperative cardiac events in these patients. Subjects and Methods: Preoperative BNP level was measured in 163 patients whose risk was considered low according to the Revised Cardiac Risk Index. Postoperative cardiac events, including death during hospitalization, myocardial injury, arrhythmia, cerebrovascular accidents and congestive heart failure were assessed. Results: Postoperative cardiac events occurred in 8 patients (4.9%). Preoperative BNP levels were significantly higher among patients who experienced postoperative cardiac events, compared to those who did not (130.6+/-148.8 vs. 57.9+/-70.8 pg/mL, p=0.009). Conclusion: Preoperative BNP level may provide prognostic information in low-risk patients undergoing major non-cardiac surgery.
C1 [Kim, Sung Eun; Park, Dae-Gyun; Lee, Jun Hee; Han, Kyoo Rok; Oh, Dong Jin] Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Div Cardiol,Dept Internal Med, Seoul 134701, South Korea.
RP Park, DG (corresponding author), Hallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Div Cardiol,Dept Internal Med, 445 Gil 1 Dong, Seoul 134701, South Korea.
EM dgpark@hallym.or.kr
OI Lee, Junhee/0000-0001-6897-2824
CR Bayes-Genis A, 2007, EUR J HEART FAIL, V9, P802, DOI 10.1016/j.ejheart.2007.05.001
   BENJAMIN EJ, 1995, CIRCULATION, V92, P835, DOI 10.1161/01.CIR.92.4.835
   Cuthbertson BH, 2007, BRIT J ANAESTH, V99, P170, DOI 10.1093/bja/aem158
   Cuthbertson BH, 2007, ANAESTHESIA, V62, P875, DOI 10.1111/j.1365-2044.2007.05146.x
   Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021
   de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053
   Dernellis J, 2006, HEART, V92, P1645, DOI 10.1136/hrt.2005.085530
   DETSKY AS, 1986, ARCH INTERN MED, V146, P2131, DOI 10.1001/archinte.146.11.2131
   Eagle KA, 2002, CIRCULATION, V105, P1257, DOI 10.1161/hc1002.104956
   Feringa HHH, 2006, AM J CARDIOL, V98, P111, DOI 10.1016/j.amjcard.2006.01.058
   Gibson SC, 2007, BRIT J SURG, V94, P903, DOI 10.1002/bjs.5690
   Gilbert K, 2000, ANN INTERN MED, V133, P356, DOI 10.7326/0003-4819-133-5-200009050-00011
   Goldman L, 1987, J Cardiothorac Anesth, V1, P237, DOI 10.1016/S0888-6296(87)80011-X
   GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601
   Halm EA, 1996, ANN INTERN MED, V125, P433, DOI 10.7326/0003-4819-125-6-199609150-00001
   Laukkanen JA, 2005, ARCH INTERN MED, V165, P1788, DOI 10.1001/archinte.165.15.1788
   Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043
   MILLER JT, 1988, AM HEART J, V116, P1048, DOI 10.1016/0002-8703(88)90158-5
   Tsioufis C, 2006, J HYPERTENS, V24, P965, DOI 10.1097/01.hjh.0000222768.15100.00
   VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724
   Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994
   최현민, 2006, Korean Circulation Journal, V36, P526
   정일형, 2006, Korean Circulation Journal, V36, P200
NR 23
TC 11
Z9 11
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2011
VL 41
IS 1
BP 11
EP 15
DI 10.4070/kcj.2011.41.1.11
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HT
UT WOS:000209078200003
PM 21359063
OA Green Published
DA 2021-04-22
ER

PT J
AU Bae, BS
   Kim, KJ
   Park, JG
   Jung, YS
   Ryu, HJ
   Kang, HJ
   Lee, BR
   Jung, BC
AF Bae, Byung Seok
   Kim, Ki Ju
   Park, Jung Gil
   Jung, Yeoun Su
   Ryu, Han Jun
   Kang, Hyun Jae
   Lee, Bong Ryeol
   Jung, Byung Chun
TI Improvement in Left Ventricular Systolic Dyssynchrony in Hypertensive
   Patients After Treatment of Hypertension
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Hypertension; Left ventricular dyssynchrony
AB Background and Objectives: Left ventricular (LV) dyssynchrony has been commonly detected among hypertensive patients with normal LV systolic function and no evidence of congestive heart failure. The purpose of our study was to assess the changes in LV systolic dyssynchrony (SDSLV) among hypertensive patients after antihypertensive treatment, and to determine the relationship between SDSLV and other conventional echocardiographic parameters. Subjects and Methods: Forty one hypertensive patients with normal LV ejection fraction were enrolled. By performing a conventional echocardiographic study, the SDSLV was measured as the time difference between the shortest and longest time of the peak myocardial systolic velocities among 12 segments of the basal and mid-levels of the 3 apical views, and radial dyssynchrony of the basal (RDSbase) and mid-levels (RDSmid) measured as the time difference between the earliest and latest peak values on the radial strain curves of each level of the parasternal short-axis views. Results: Compared to baseline after six months of antihypertensive treatment, the SDSLV improved significantly (48.7+/-37.9 ms vs. 29.5+/-34.1 ms, p=0.020). Also the RDSbase and RDSmid improved significantly in respect to the baseline values (129.9+/-136.3 ms vs. 38.8+/-45.4 ms, p=0.002 and 75.2+/-63.8 ms vs. 28.2+/-37.7 ms, respectively, p<0.001). Conclusion: The severity of SDSLV improved with antihypertensive treatment, and was associated with the regression of LV mass. Furthermore, it might precede improvement in the mitral inflow pattern, as assessed by conventional echocardiography, so that early detection of the benefit of antihypertensive treatment may be possible.
C1 [Bae, Byung Seok; Kim, Ki Ju; Park, Jung Gil; Jung, Yeoun Su; Ryu, Han Jun; Kang, Hyun Jae; Lee, Bong Ryeol; Jung, Byung Chun] Fatima Gen Hosp, Dept Cardiol, Taegu 701724, South Korea.
RP Jung, BC (corresponding author), Fatima Gen Hosp, Dept Cardiol, 302-1 Sinam Dong, Taegu 701724, South Korea.
EM Augustjbc@yahoo.co.kr
RI Park, Jung Gil/AAK-5167-2020
OI Park, Jung Gil/0000-0001-5472-4731
CR AURIGEMMA GP, 1995, J AM COLL CARDIOL, V26, P195, DOI 10.1016/0735-1097(95)00153-Q
   Bleeker GB, 2006, J AM COLL CARDIOL, V48, P2243, DOI 10.1016/j.jacc.2006.07.067
   Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560
   Gorcsan J, 2007, J AM COLL CARDIOL, V50, P1476, DOI 10.1016/j.jacc.2007.06.043
   Hawkins NM, 2006, EUR HEART J, V27, P1270, DOI 10.1093/eurheartj/ehi826
   Kass DA, 2008, J AM COLL CARDIOL, V51, P12, DOI 10.1016/j.jacc.2007.09.027
   Leclercq C, 2002, CIRCULATION, V106, P1760, DOI 10.1161/01.CIR.0000035037.11968.5C
   MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601
   Nagueh SF, 2008, J AM COLL CARDIOL, V51, P18, DOI 10.1016/j.jacc.2007.08.052
   Ommen SR, 2000, CIRCULATION, V102, P1788
   Penicka M, 2004, CIRCULATION, V109, P978, DOI 10.1161/01.CIR.0000116765.43251.D7
   Poulsen SH, 2003, J AM SOC ECHOCARDIOG, V16, P724, DOI 10.1016/S0894-7317(03)00403-6
   SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1
   Suffoletto MS, 2006, CIRCULATION, V113, P960, DOI 10.1161/CIRCULATIONAHA.105.571455
   Wang JW, 2007, J AM COLL CARDIOL, V49, P88, DOI 10.1016/j.jacc.2006.10.023
   Wang YC, 2007, AM HEART J, V154, P278, DOI 10.1016/j.ahj.2007.04.008
   Yang B, 2008, CLIN CARDIOL, V31, P597, DOI 10.1002/clc.20350
   Yu CM, 2007, J AM COLL CARDIOL, V49, P97, DOI 10.1016/j.jacc.2006.10.022
   Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289
NR 19
TC 2
Z9 2
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2011
VL 41
IS 1
BP 16
EP 22
DI 10.4070/kcj.2011.41.1.16
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HT
UT WOS:000209078200004
PM 21359064
OA Green Published
DA 2021-04-22
ER

PT J
AU Won, HS
   Kim, DY
   Yang, MS
   Lee, SJ
   Shin, HH
   Park, JB
AF Won, Hyun Sun
   Kim, Do Yi
   Yang, Moon Seok
   Lee, Sung Ja
   Shin, Hyun-Ho
   Park, Jeong Bae
TI Pregnancy-Induced Hypertension, But Not Gestational Diabetes Mellitus,
   Is a Risk Factor for Venous Thromboembolism in Pregnancy
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Venous thromboembolism; Pregnancy-induced hypertension; Gestational
   diabetes
ID WOMEN; HEPARIN; HISTORY; SAFETY
AB Background and Objectives: The aim of this study was to identify the association of pregnancy-induced hypertension (PIH) or gestational diabetes mellitus (GDM) with the development of venous thromboembolism (VTE). Subjects and Methods: This was a retrospective study of 57,009 pregnancies during 2002-2008 at Cheil General Hospital, Kwandong University. The diagnosis of VTE {deep vein thrombosis or pulmonary embolism (PE)} was based on clot visualization via ultrasound or computed tomography. Results: In total, 27 cases (PE, 20 cases) were detected. The incidence of VTE was 0.47 per 1,000 pregnancies. To determine risk factors associated with pregnancy-induced VTE, univariate analysis using a chi-square test was performed. Cesarean (C)-section, multiple pregnancy, PIH, placenta previa, and assisted reproduction technique (ART) were statistically significant compared to the controls (all, p=0.000). However, age, premature rupture of membrane, and GDM were not statistically related to VTE. Logistic regression analysis was used to calculate the odds ratios for the risk factors. Placenta previa showed a 12.6-fold higher risk, while PIH had a 9.8-fold higher risk for the occurrence of VTE. C-section and ART procedures increased the risk of VTE by 4.2 times compared to that of the controls. Conclusion: Placenta previa and PIH were significant risk factors for VTE, whereas the known traditional risk factors of increased age and GDM were not found to be associated with VTE.
C1 [Won, Hyun Sun; Kim, Do Yi; Yang, Moon Seok; Lee, Sung Ja; Shin, Hyun-Ho; Park, Jeong Bae] Kwandong Univ, Coll Med, Cheil Gen Hosp, Div Med Cardiol, Seoul 100380, South Korea.
RP Park, JB (corresponding author), Kwandong Univ, Coll Med, Cheil Gen Hosp, Div Med Cardiol, 1-19 Mukjeong Dong, Seoul 100380, South Korea.
EM mdparkjb@gmail.com
CR Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204
   Brill-Edwards P, 2000, NEW ENGL J MED, V343, P1439, DOI 10.1056/NEJM200011163432002
   CARPENTER MW, 1982, AM J OBSTET GYNECOL, V144, P768, DOI 10.1016/0002-9378(82)90349-0
   Cheung NW, 2003, DIABETES CARE, V26, P2005, DOI 10.2337/diacare.26.7.2005
   Gherman RB, 1999, OBSTET GYNECOL, V94, P730, DOI 10.1016/S0029-7844(99)00426-3
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Greer IA, 1999, LANCET, V353, P1258, DOI 10.1016/S0140-6736(98)10265-9
   Heit JA, 2009, ARTERIOSCL THROM VAS, V29, P1399, DOI 10.1161/ATVBAHA.109.189290
   Jacobsen AF, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.041
   James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008
   James AH, 2008, CURR OPIN OBSTET GYN, V20, P550, DOI 10.1097/GCO.0b013e328317a427
   Kestenbaum B, 2003, AM J KIDNEY DIS, V42, P982, DOI 10.1016/j.ajkd.2003.07.001
   Kim KY, 2002, KOREAN CIRC J, V32, P521
   Koonin L M, 1997, MMWR CDC Surveill Summ, V46, P17
   Lee SW, 2004, KOREAN CIRC J, V34, P214
   Lindqvist P, 1999, OBSTET GYNECOL, V94, P595, DOI 10.1016/S0029-7844(99)00308-7
   Marik PE, 2008, NEW ENGL J MED, V359, P2025, DOI 10.1056/NEJMra0707993
   Morris NH, 1996, BRIT J OBSTET GYNAEC, V103, P4, DOI 10.1111/j.1471-0528.1996.tb09508.x
   Pabinger I, 2005, J THROMB HAEMOST, V3, P949, DOI 10.1111/j.1538-7836.2005.01307.x
   Petrauskiene V, 2005, DIABETOLOGIA, V48, P1017, DOI 10.1007/s00125-005-1715-5
   문홍주, 2005, Korean Circulation Journal, V35, P474
   Roberts RN, 1998, BRIT J OBSTET GYNAEC, V105, P1095, DOI 10.1111/j.1471-0528.1998.tb09942.x
   Ros HS, 2002, AM J OBSTET GYNECOL, V186, P198, DOI 10.1067/mob.2002.119177
   Royal College of Obstetricians and Gynaecologists (RCOG), 1995, REP ROYAL COLL OBST
   Royal College of Obstetricians and Gynaecologists (RCOG), 2004, THROMB PREGN LAB VAG
   Santoro R, 2009, BLOOD COAGUL FIBRIN, V20, P240, DOI 10.1097/MBC.0b013e3283299c02
   Spyropoulos AC, 2006, J THROMB HAEMOST, V4, P1246, DOI 10.1111/j.1538-7836.2006.01908.x
   Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182
NR 28
TC 20
Z9 22
U1 0
U2 3
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2011
VL 41
IS 1
BP 23
EP 27
DI 10.4070/kcj.2011.41.1.23
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HT
UT WOS:000209078200005
PM 21359065
OA Green Published
DA 2021-04-22
ER

PT J
AU Kim, GB
   Kim, JK
   Park, S
   Jeong, JJ
   Yoon, HS
   Ko, SH
   Ko, JE
   Park, SJ
   Nam, SW
   Lee, JH
   Hyon, MS
AF Kim, Goeng Bae
   Kim, Jeong Kyung
   Park, Sul
   Jeong, Jae Jin
   Yoon, Hyung Sik
   Ko, Sang Hun
   Ko, Jae Ee
   Park, Soo Jin
   Nam, Seon Woo
   Lee, Jae Hwan
   Hyon, Min Soo
TI Effect of Atorvastatin and Clopidogrel Co-Administration After Coronary
   Stenting in Korean Patients With Stable Angina
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Clopidogrel; Cardiovascular diseases; Cytochrome P450 3A4 protein,
   human; Atorvastatin; Stents
AB Background and Objectives: It was reported that atorvastatin co-administered with clopidogrel for 8 months did not affect the anti-platelet potency of clopidogrel in Korean patients with acute coronary syndrome, but not in patients with stable angina. We investigated whether co-administration of statins with clopidogrel affected the anti-platelet efficacy of clopidogrel in Korean patients with stable angina. Subjects and Methods: This was a randomized, open-label and two-period crossover design study conducted at two centers. Two hundreds thirty three patients with stable angina scheduled for coronary stenting were randomized into two groups. In Group A, 119 patients first received atorvastatin (10 mg) followed by fluvastatin (80 mg) for 12 weeks per treatment. In Group B, 114 patients received the same treatments in reverse order. Results: Baseline adenosine diphosphate (ADP, 10 mu mol/L)-induced platelet aggregation was 54.4+/-9.1% in Group A and 53.8+/-9.0% in Group B (p=0.44), and significant differences were noted after each treatment period (p<0.001). Inhibition of platelet aggregation was similar between Group A and Group B at 24 hours following clopidogrel loading (29.2+/-11.0% vs. 30.4+/-12.7%; p=0.42). The two treatment least square means of 12-week ADP (10 mu mol/L)-induced platelet aggregation [29.50+/-0.79 {standard error (SE)}% on the atorvastatin treatment group vs. 28.16+/-0.70 (SE)% in the fluvastatin treatment group] in a 2x2 cross-over study were not significantly different (p=0.204). Conclusion: Statin and clopidogrel co-administration for 12 weeks is not associated with attenuated anti-platelet activity of clopidogrel in Korean patients with stable angina after coronary stenting, in support of the findings of similar studies conducted in Caucasian populations.
C1 [Kim, Goeng Bae; Kim, Jeong Kyung; Park, Sul; Jeong, Jae Jin; Yoon, Hyung Sik; Ko, Sang Hun; Ko, Jae Ee; Park, Soo Jin] Sun Gen Hosp, Ctr Cardiovasc, Taejon 301725, South Korea.
   [Nam, Seon Woo] Sun Gen Hosp, Dept Neurol, Taejon 301725, South Korea.
   [Lee, Jae Hwan] Chungnam Natl Univ Hosp, Ctr Cardiovasc, Taejon, South Korea.
   [Hyon, Min Soo] Soonchunhyang Univ, Coll Med, Dept Cardiol, Seoul, South Korea.
RP Kim, JK (corresponding author), Sun Gen Hosp, Ctr Cardiovasc, 10-7 Mok Dong, Taejon 301725, South Korea.
EM mdzoa@paran.com
OI Lee, Jae-Hwan/0000-0002-6561-7760
CR Baek JH, 2001, KOREAN CIRC J, V31, P434
   Bertrand ME, 2000, CIRCULATION, V102, P624, DOI 10.1161/01.CIR.102.6.624
   Bhatt DL, 2002, J AM COLL CARDIOL, V39, P9, DOI 10.1016/S0735-1097(01)01713-2
   Chae，Sung-Chul, 2004, Korean Circulation Journal, V34, P23
   Chow S-C, 1999, DESIGN ANAL BIOAVAIL
   Chow SC, 2003, SAMPLE SIZE CALCULAT
   Clarke TA, 2003, DRUG METAB DISPOS, V31, P53, DOI 10.1124/dmd.31.1.53
   Cutlip DE, 2001, CIRCULATION, V103, P1967
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
   Geisleri T, 2008, EUR HEART J, V29, P1635, DOI 10.1093/eurheartj/ehn212
   Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3
   Hong SJ, 2009, CIRC J, V73, P1111, DOI 10.1253/circj.CJ-08-1120
   윤경호, 2007, Korean Circulation Journal, V37, P154
   Lau WC, 2003, CIRCULATION, V107, P32, DOI 10.1161/01.CIR.0000047060.60595.CC
   Lee Kyounghoon, 2009, Korean Circ J, V39, P512, DOI 10.4070/kcj.2009.39.12.512
   Mach F, 2005, EUR J CLIN INVEST, V35, P476, DOI 10.1111/j.1365-2362.2005.01522.x
   Malek LA, 2008, CIRC J, V72, P1165, DOI 10.1253/circj.72.1165
   Maron DJ, 2000, CIRCULATION, V101, P207, DOI 10.1161/01.CIR.101.2.207
   Mitsios JV, 2004, CIRCULATION, V109, P1335, DOI 10.1161/01.CIR.0000124581.18191.15
   Mukherjee D, 2005, HEART, V91, P23, DOI 10.1136/hrt.2004.035014
   Neubauer H, 2003, EUR HEART J, V24, P1744, DOI 10.1016/S0195-668X(03)00442-1
   Savi P, 2000, THROMB HAEMOSTASIS, V84, P891
   SAVI P, 1992, BIOCHEM PHARMACOL, V44, P527, DOI 10.1016/0006-2952(92)90445-O
   SAVI P, 1994, THROMB HAEMOSTASIS, V72, P313
   Saw J, 2003, CIRCULATION, V108, P921, DOI 10.1161/01.CIR.0000088780.57432.43
   Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702
   Schomig A, 2002, J AM COLL CARDIOL, V40, P854, DOI 10.1016/S0735-1097(02)02053-3
   Serebruany VL, 2004, ARCH INTERN MED, V164, P2051, DOI 10.1001/archinte.164.18.2051
   Wienbergen H, 2003, AM J CARDIOL, V92, P285, DOI 10.1016/S0002-9149(03)00626-X
   World Medical Association, WMA DECL HELS ETH PR
   Yusuf S, 2001, NEW ENGL J MED, V345, P494
NR 32
TC 5
Z9 8
U1 0
U2 1
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2011
VL 41
IS 1
BP 28
EP 33
DI 10.4070/kcj.2011.41.1.28
PG 6
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HT
UT WOS:000209078200006
PM 21359066
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, HK
   Namgung, J
   Choi, WH
   Choe, H
   Kwon, SU
   Doh, JH
   Lee, SY
   Lee, WR
AF Lee, Hyo Keun
   Namgung, June
   Choi, Won-Ho
   Choe, Hyunmin
   Kwon, Sung Uk
   Doh, Joon Hyung
   Lee, Sung Yun
   Lee, Won Ro
TI Stenting of the Left Main Coronary Artery in a Patient With Takayasu's
   Arteritis
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Takayasu arteritis; Coronary artery disease; Percutaneous transluminal
   coronary angioplasty
ID ELUTING STENT; ANGIOGRAPHIC FINDINGS; STENOSIS; RESTENOSIS
AB Management of Takayasu's arteritis of the left main coronary artery (LMCA) is difficult because of the possibility of restenosis. Clinically significant stenotic lesions must be considered anatomical correlation. Many studies have reported that the management of stenotic lesions of the LMCA with endoluminal stenting and balloon angioplasty and de-novo stenting is safe and effective for patients with Takayasu's arteritis. We report the case of a patient with Takayasu's arteritis of the LMCA. The patient had undergone two consecutive percutaneous coronary interventions because of recurrent restenosis of in-stent lesions, and eventually underwent coronary artery bypass graft (CABG) surgery for myocardial infarction in the same lesion. We suggested treatment with CABG because the pathophysiology of Takayasu's arteritis is different from that of atherosclerotic stenosis.
C1 [Lee, Hyo Keun; Namgung, June; Choi, Won-Ho; Choe, Hyunmin; Kwon, Sung Uk; Doh, Joon Hyung; Lee, Sung Yun; Lee, Won Ro] Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Vis Cardiac & Vasc Ctr 21, Goyang 411706, South Korea.
RP Namgung, J (corresponding author), Inje Univ, Ilsan Paik Hosp, Dept Internal Med, Vis Cardiac & Vasc Ctr 21, 2240 Daehwa Dong, Goyang 411706, South Korea.
EM medngj@gmail.com
CR Amir O, 2006, TEX HEART I J, V33, P253
   Antelmi I, 1993, Arq Bras Cardiol, V60, P37
   Bulut S, 2007, NETH HEART J, V15, P260, DOI 10.1007/BF03085995
   Endo M, 2003, J THORAC CARDIOV SUR, V125, P570, DOI 10.1067/mtc.2003.39
   Furukawa Y, 2005, CIRC J, V69, P752, DOI 10.1253/circj.69.752
   HALL S, 1985, MEDICINE, V64, P89, DOI 10.1097/00005792-198503000-00002
   Kang KT, 2001, KOREAN CIRC J, V31, P246
   Kang WC, 2006, CIRCULATION, V113, P735, DOI 10.1161/CIRCULATIONAHA.105.540336
   Kang WC, 2006, INT J CARDIOL, V108, P120, DOI 10.1016/j.ijcard.2005.02.024
   Kim KC, 2001, KOREAN CIRC J, V31, P1106
   LUPIHERRERA E, 1977, AM HEART J, V93, P94, DOI 10.1016/S0002-8703(77)80178-6
   Matsubara O, 1992, Heart Vessels Suppl, V7, P26, DOI 10.1007/BF01744540
   PARK JH, 1989, AM J ROENTGENOL, V153, P1069, DOI 10.2214/ajr.153.5.1069
   Park Jin-Sup, 2009, Korean Circ J, V39, P551, DOI 10.4070/kcj.2009.39.12.551
   Punamiya K, 1997, CATHETER CARDIO DIAG, V40, P272, DOI 10.1002/(SICI)1097-0304(199703)40:3<272::AID-CCD11>3.0.CO;2-R
   Sakai H, 2006, INT HEART J, V47, P795, DOI 10.1536/ihj.47.795
   Son JW, 1998, INT J CARDIOL, V65, P295, DOI 10.1016/S0167-5273(98)00126-0
   TRAZZERA S, 1995, AM HEART J, V130, P1122, DOI 10.1016/0002-8703(95)90218-X
NR 18
TC 3
Z9 3
U1 0
U2 2
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2011
VL 41
IS 1
BP 34
EP 37
DI 10.4070/kcj.2011.41.1.34
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HT
UT WOS:000209078200007
PM 21359067
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, JH
   Kim, GH
   Kim, SM
   Lee, SY
   Lee, WY
   Bae, JW
   Shin, KS
   Hwang, KK
   Kim, DW
   Cho, MC
AF Lee, Ju-Hee
   Kim, Gi-Hyun
   Kim, Sang Min
   Lee, Sang Yeub
   Lee, Won-Yik
   Bae, Jang-Whan
   Shin, Kyung-Sub
   Hwang, Kyung-Kuk
   Kim, Dong-Won
   Cho, Myeong-Chan
TI A Case of Sparganosis That Presented as a Recurrent Pericardial Effusion
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Sparganosis; Pericardial effusion; Praziquantel
AB Sparganosis is caused by a larval tapeworm of the genus Spirometra, which commonly invades subcutaneous tissue, but less frequently invades muscle, intestines, spinal cord, and the peritoneopleural cavity. The authors managed a female patient who presented with a recurrent pericardiopleural effusion and peripheral eosinophilia. The anti-sparganum-specific IgG serum level was significantly higher than normal control levels. In this patient, sparganosis was caused by the ingestion of raw frogs in an effort to control her thyroid disease. The recurrent pericardiopleural effusion and peripheral eosinophilia were controlled by 3 consecutive doses of praziquantel (75 mg/kg/day). The patient is doing well 4 years after presentation. Sparganosis should be considered a rare, but possible cause of recurrent pericardial effusion and peripheral eosinophilia. Immunoserologic testing using enzyme linked immunosorbent assays can be helpful in diagnosing human sparganosis, especially in cases without a subcutaneous lump or mass. Praziquantel is an alternative treatment for sparganosis in surgically-unresectable cases.
C1 [Lee, Ju-Hee; Kim, Gi-Hyun; Kim, Sang Min; Lee, Sang Yeub; Lee, Won-Yik; Bae, Jang-Whan; Hwang, Kyung-Kuk; Kim, Dong-Won; Cho, Myeong-Chan] Chungbuk Natl Univ, Sch Med, Dept Internal Med, Cheongju 361711, South Korea.
   [Shin, Kyung-Sub] Chungbuk Natl Univ, Sch Med, Dept Lab Med, Cheongju 361711, South Korea.
RP Bae, JW (corresponding author), Chungbuk Natl Univ, Sch Med, Dept Internal Med, 62 Gaesin Dong, Cheongju 361711, South Korea.
EM drcorazon@hanmail.net
CR Cho K J, 1987, J Korean Med Sci, V2, P137
   CHO S-Y, 1975, Korean Journal of Parasitology, V13, P60, DOI 10.3347/kjp.1975.13.1.60
   Conrad S. M., 1999, KOREAN J THORAC CARD, V8, P147
   Eo WK, 1990, KOREAN CIRC J, V20, P211
   Ishii H, 2001, INTERNAL MED, V40, P783, DOI 10.2169/internalmedicine.40.783
   Kamiya Hiroyuki, 2004, Nihon Kokyuki Gakkai Zasshi, V42, P1019
   KIM H, 1984, Korean Journal of Parasitology, V22, P222, DOI 10.3347/kjp.1984.22.2.222
   Kim HJ, 2005, J CLIN OTOLARYNGOL H, V16, P330
   하재경, 2003, Korean Circulation Journal, V33, P227
   Min D Y, 1990, Kisaengchunghak Chapchi, V28 Suppl, P123, DOI 10.3347/kjp.1990.28.Suppl.123
   MUELLER JF, 1974, J PARASITOL, V60, P3
   Shimada M, 1989, JPN J PARASITOL, V38, P145
   Sim Seobo, 2002, Korean Journal of Parasitology, V40, P187, DOI 10.3347/kjp.2002.40.4.187
   Sohn Woon-Mok, 1993, Korean Journal of Parasitology, V31, P135, DOI 10.3347/kjp.1993.31.2.135
   Sun T., 1999, PARASITIC DISORDERS, P285
   Tanaka Shuya, 1997, Parasitology International, V46, P73, DOI 10.1016/S1383-5769(97)00001-9
   Voller A, 1994, ENZYME LINKED IMMUNO, P19
   Yamasaki H, 1994, JUNTENDO MED J, V40, P262
   Yeo In-Sok, 1994, Yonsei Medical Journal, V35, P43
   김대현, 2006, The Korean Journal of Thoracic and Cardiovascular Surgery, V39, P502
NR 20
TC 15
Z9 17
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA 101-1704, LOTTE CASTLE PRESIDENT, 109, MAPO-DAERO, MAPO-GU, SEOUL,
   04146, SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2011
VL 41
IS 1
BP 38
EP 42
DI 10.4070/kcj.2011.41.1.38
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HT
UT WOS:000209078200008
PM 21359068
OA Green Published
DA 2021-04-22
ER

PT J
AU Kang, MK
   Jeong, YH
   Yoon, SE
   Koh, JS
   Jung, KT
   Park, Y
   Hwang, SJ
   Kwak, CH
   Jeon, KN
   Hwang, JY
AF Kang, Min-Kyung
   Jeong, Young-Hoon
   Yoon, Seong-Eun
   Koh, Jin-Sin
   Jung, Kwon Tae
   Park, Yongwhi
   Hwang, Seok-Jae
   Kwak, Choong-Hwan
   Jeon, Kyung-Nyeo
   Hwang, Jin-Yong
TI Isolated Left Main Coronary Artery Spasm Detected by Multidetector
   Computed Tomography
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Coronary vessels; Coronary vasospasm; Computed tomography, spiral;
   Interventional ultrasonography
AB Although atherosclerotic obstruction is the main cause of left main coronary artery (LMCA) disease, it can also be associated with vasospasm. We report a case of a 61-year-old male who presented with ostial stenosis of the LMCA, detected by 64-slice multi-detector computed tomographic coronary angiography (MDCT-CA). Careful review of MDCT and intravascular ultrasound findings showed suspicion of an isolated spasm of the LMCA without a significant atherosclerotic lesion. The patient was successfully treated with nitrates and a calcium channel blocker.
C1 [Kang, Min-Kyung; Jeong, Young-Hoon; Yoon, Seong-Eun; Koh, Jin-Sin; Jung, Kwon Tae; Park, Yongwhi; Hwang, Seok-Jae; Kwak, Choong-Hwan; Hwang, Jin-Yong] Gyeongsang Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, Jinju 660702, South Korea.
   [Jeon, Kyung-Nyeo] Gyeongsang Natl Univ, Coll Med, Dept Radiol, Jinju 660702, South Korea.
RP Jeong, YH (corresponding author), Gyeongsang Natl Univ, Coll Med, Dept Internal Med, Div Cardiol, 90 Chiram Dong, Jinju 660702, South Korea.
EM goodoctor@naver.com
RI Jeong, Young-Hoon/AAO-4401-2020; Jeong, Young-Hoon/F-3476-2015
OI Jeong, Young-Hoon/0000-0003-0403-3726; Kwak, Choong
   Hwan/0000-0001-6035-4415
CR Chuang YT, 2009, CIRC J, V73, P1961, DOI 10.1253/circj.CJ-08-0589
   Lee Ju Hwan, 2009, Korean Circ J, V39, P423, DOI 10.4070/kcj.2009.39.10.423
   Parakh N, 2009, J CARDIOVASC MED, V10, P288, DOI 10.2459/JCM.0b013e3283249ada
   Park SJ, 2009, CIRC-CARDIOVASC INTE, V2, P167, DOI 10.1161/CIRCINTERVENTIONS.108.799494
   Pflederer Tobias, 2008, J Cardiovasc Comput Tomogr, V2, P406, DOI 10.1016/j.jcct.2008.10.001
   Yasue H, 2008, J CARDIOL, V51, P2, DOI 10.1016/j.jjcc.2008.01.001
   Yoo Sang-Yong, 2009, Korean Circ J, V39, P505, DOI 10.4070/kcj.2009.39.12.505
NR 7
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2011
VL 41
IS 1
BP 43
EP 45
DI 10.4070/kcj.2011.41.1.43
PG 3
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HT
UT WOS:000209078200009
PM 21359069
OA Green Published
DA 2021-04-22
ER

PT J
AU Hahn, S
   Kim, J
   Choi, JH
   Lim, SH
   Kang, TS
   Park, BE
   Lee, MY
AF Hahn, Sunghwahn
   Kim, Jihwan
   Choi, Jung Hyun
   Lim, Seong-Hoon
   Kang, Tae Soo
   Park, Byoung Eun
   Lee, Myung-Yong
TI Management of a Remnant Electrode in a Patient With
   Cardioverter-Defibrillator Infection After Refusal of Intravascular
   Electrode Removal
SO KOREAN CIRCULATION JOURNAL
LA English
DT Article
DE Defibrillators, implantable; Infection; Electrodes, implanted
AB Treatments of choice for cardiac implantable electronic device (CIED) infections are the removal of the entire CIED system, control of infection, and new device implantation. Occasionally, a complete CIED removal can not be performed for several reasons, such as very old age, severe comobidity, limited life expectancy, or refusal by a patient. We encountered a male patient who developed traumatic CIED infection five years after cardioverter-defibrillator implantation. An intravenous electrode could not be removed by a simple transvenous extraction procedure, and he refused surgical removal of the remnant electrode. After control of local infection, the tips of the electrode were separated and buried between muscles, and the wound was closed with a local flap. CIED infection did not recur for 12 months even without relying on long-term antimicrobial treatment.
C1 [Hahn, Sunghwahn; Kim, Jihwan; Choi, Jung Hyun; Lim, Seong-Hoon; Kang, Tae Soo; Park, Byoung Eun; Lee, Myung-Yong] Dankook Univ, Sch Med, Dept Internal Med, Div Cardiol, Cheonan 330715, South Korea.
RP Lee, MY (corresponding author), Dankook Univ, Sch Med, Dept Internal Med, Div Cardiol, San 16-5 Anseo Dong, Cheonan 330715, South Korea.
EM mel_lee@dankook.ac.kr
OI Lee, Myung Yong/0000-0003-2147-7134
CR Al-Khatib SM, 2005, J AM COLL CARDIOL, V46, P1536, DOI 10.1016/j.jacc.2005.04.063
   Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665
   Baddour LM, 2003, CIRCULATION, V108, P2015, DOI 10.1161/01.CIR.0000093201.57771.47
   Baddour LM, 2001, AM J MED SCI, V322, P209, DOI 10.1097/00000441-200110000-00011
   Baman TS, 2009, CIRC-ARRHYTHMIA ELEC, V2, P129, DOI 10.1161/CIRCEP.108.816868
   Bloom H, 2006, PACE, V29, P142, DOI 10.1111/j.1540-8159.2006.00307.x
   Chamis AL, 2001, CIRCULATION, V104, P1029, DOI 10.1161/hc3401.095097
   Choi HS, 1998, KOREAN CIRC J, V28, P768
   Choi KJ, 1996, KOREAN CIRC J, V26, P1198
   Chua JD, 2000, ANN INTERN MED, V133, P604, DOI 10.7326/0003-4819-133-8-200010170-00011
   Da Costa A, 1998, CIRCULATION, V97, P1796, DOI 10.1161/01.CIR.97.18.1796
   de Oliveira JC, 2009, CIRC-ARRHYTHMIA ELEC, V2, P29, DOI 10.1161/CIRCEP.108.795906
   Field ME, 2007, HEART RHYTHM, V4, P978, DOI 10.1016/j.hrthm.2007.05.022
   Gaynor SL, 2006, PACE, V29, P1352, DOI 10.1111/j.1540-8159.2006.00547.x
   Gould PA, 2006, JAMA-J AM MED ASSOC, V295, P1907, DOI 10.1001/jama.295.16.1907
   Kapa S, 2007, PACE, V30, P730, DOI 10.1111/j.1540-8159.2007.00742.x
   Kim DH, 2005, KOREAN CIRC J, V35, P69
   Klug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664
   Lai KK, 1998, CLIN INFECT DIS, V27, P265, DOI 10.1086/514673
   Lekkerkerker JC, 2009, HEART, V95, P715, DOI 10.1136/hrt.2008.151985
   Love CJ, 2000, PACE, V23, P544
   ONunain S, 1997, J THORAC CARDIOV SUR, V113, P121, DOI 10.1016/S0022-5223(97)70407-0
   Sohail MR, 2008, MAYO CLIN PROC, V83, P46, DOI 10.4065/83.1.46
   Sohail MR, 2007, CLIN INFECT DIS, V45, P166, DOI 10.1086/518889
   Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072
   Sopena B, 2010, CLIN MICROBIOL INFEC, V16, P274, DOI 10.1111/j.1469-0691.2009.02787.x
   TRAPPE HJ, 1995, BRIT HEART J, V73, P20
NR 27
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2011
VL 41
IS 1
BP 46
EP 50
DI 10.4070/kcj.2011.41.1.46
PG 5
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HT
UT WOS:000209078200010
PM 21359070
OA Green Published
DA 2021-04-22
ER

PT J
AU Lee, SP
   Kim, HK
   Kim, SY
   Oh, IY
   Cho, HJ
   Kim, YJ
   Sohn, DW
AF Lee, Seung-Pyo
   Kim, Hyung-Kwan
   Kim, Song-Yi
   Oh, Il-Young
   Cho, Hyun-Jai
   Kim, Yong-Jin
   Sohn, Dae-Won
TI A Thief Caught in the Act
SO KOREAN CIRCULATION JOURNAL
LA English
DT Editorial Material
C1 [Kim, Hyung-Kwan] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea.
   Seoul Natl Univ, Coll Med, Ctr Cardiovasc, Seoul 110744, South Korea.
RP Kim, HK (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 101 Daehak Ro, Seoul 110744, South Korea.
EM cardiman@medimail.co.kr
RI Kim, Hyung-Kwan/R-8375-2019
CR John SH, 2004, KOREAN CIRC J, V34, P328
   KINNEY EL, 1989, AM HEART J, V118, P569, DOI 10.1016/0002-8703(89)90274-3
   Rose PS, 2002, CHEST, V121, P806, DOI 10.1378/chest.121.3.806
   Torbicki A, 2003, J AM COLL CARDIOL, V41, P2245, DOI 10.1016/S0735-1097(03)00479-0
NR 4
TC 0
Z9 0
U1 0
U2 0
PU KOREAN SOC CARDIOLOGY
PI SEOUL
PA RM 801, MASTERS TOWER BLDG, 331 DONGMAK-RO MAPO-GU, SEOUL, 121-040,
   SOUTH KOREA
SN 1738-5520
EI 1738-5555
J9 KOREAN CIRC J
JI Korean Circ. J.
PD JAN
PY 2011
VL 41
IS 1
BP 51
EP 52
DI 10.4070/kcj.2011.41.1.51
PG 2
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA V34HT
UT WOS:000209078200011
PM 21359071
OA Green Published
DA 2021-04-22
ER

EF